<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006375.pub4" GROUP_ID="INCONT" ID="054106111409250218" MERGED_FROM="" MODIFIED="2017-07-30 16:31:35 +0100" MODIFIED_BY="Sheila Wallace" REVIEW_NO="1" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2017-07-30 16:31:19 +0100" MODIFIED_BY="Sheila Wallace">
<TITLE MODIFIED="2015-03-16 10:48:13 +0000" MODIFIED_BY="[Empty name]">Mid-urethral sling operations for stress urinary incontinence in women</TITLE>
<CONTACT MODIFIED="2017-07-30 16:31:19 +0100" MODIFIED_BY="Sheila Wallace"><PERSON ID="A3AA6C2E82E26AA2003C855E6CCB81FF" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Joseph</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Ogah</LAST_NAME><POSITION>Consultant Urogynaecologist</POSITION><EMAIL_1>joe.ogah@mbht.nhs.uk</EMAIL_1><EMAIL_2>joeogah007@hotmail.com</EMAIL_2><ADDRESS><DEPARTMENT>Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>University Hospitals of Morecambe Bay NHS Foundation Trust</ORGANISATION><ADDRESS_1>Dalton Road</ADDRESS_1><CITY>Barrow in Furness</CITY><ZIP>LA14 4LF</ZIP><REGION>Cumbria</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1229491067</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2017-07-30 16:31:19 +0100" MODIFIED_BY="Sheila Wallace"><PERSON ID="z1311191450523467250928853730255" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Abigail</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Ford</LAST_NAME><SUFFIX>MBBS</SUFFIX><POSITION>Clinical Research Registrar</POSITION><EMAIL_1>abigail.ford@doctors.org.uk</EMAIL_1><ADDRESS><DEPARTMENT>Department of Urogynaecology</DEPARTMENT><ORGANISATION>Imperial Healthcare Trust, St Mary's Hospital</ORGANISATION><ADDRESS_1>Praed Street</ADDRESS_1><ADDRESS_2>Paddington</ADDRESS_2><CITY>London</CITY><ZIP>W2 1NY</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="B6E3B99382E26AA2005347C3CC710695" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Lynne</FIRST_NAME><LAST_NAME>Rogerson</LAST_NAME><POSITION>Lead Urogynaecologist</POSITION><EMAIL_1>lynne.rogerson@nhs.net</EMAIL_1><ADDRESS><DEPARTMENT>Department of Urogynaecology</DEPARTMENT><ORGANISATION>The Leeds Teaching Hospitals NHS Trust</ORGANISATION><ADDRESS_1>Beckett Street</ADDRESS_1><CITY>Leeds</CITY><ZIP>LS9 7TF</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 113 2065871</PHONE_1><FAX_1>+44 113 3923185</FAX_1></ADDRESS></PERSON><PERSON ID="7298" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>June</FIRST_NAME><MIDDLE_INITIALS>D</MIDDLE_INITIALS><LAST_NAME>Cody</LAST_NAME><POSITION>Review Author</POSITION><EMAIL_1>djunecody@gmail.com</EMAIL_1><URL>http://incontinence.cochrane.org/</URL><ADDRESS><DEPARTMENT>c/o Cochrane Incontinence Group</DEPARTMENT><ORGANISATION>Newcastle University</ORGANISATION><ADDRESS_1>Institute of Health &amp; Society</ADDRESS_1><ADDRESS_2>Baddiley-Clarke Building, Richardson Road</ADDRESS_2><CITY>Newcastle upon Tyne</CITY><ZIP>NE2 4AX</ZIP><REGION>Tyne and Wear</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z1609221211042414731193967472946" ROLE="AUTHOR"><PREFIX>Miss</PREFIX><FIRST_NAME>Patricia</FIRST_NAME><LAST_NAME>Aluko</LAST_NAME><POSITION>Researcher</POSITION><EMAIL_1>patricia.aluko@ncl.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Health and Society</DEPARTMENT><ORGANISATION>Newcastle University</ORGANISATION><ADDRESS_1>Richardson Road</ADDRESS_1><CITY>Newcastle Upon Tyne</CITY><ZIP>NE2 4AX</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="A3AA6C2E82E26AA2003C855E6CCB81FF" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Joseph</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Ogah</LAST_NAME><POSITION>Consultant Urogynaecologist</POSITION><EMAIL_1>joe.ogah@mbht.nhs.uk</EMAIL_1><EMAIL_2>joeogah007@hotmail.com</EMAIL_2><ADDRESS><DEPARTMENT>Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>University Hospitals of Morecambe Bay NHS Foundation Trust</ORGANISATION><ADDRESS_1>Dalton Road</ADDRESS_1><CITY>Barrow in Furness</CITY><ZIP>LA14 4LF</ZIP><REGION>Cumbria</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 1229491067</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2017-07-10 21:21:03 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="26" MONTH="6" YEAR="2014"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="26" MONTH="6" YEAR="2014"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="12" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2009"/>
<LAST_CITATION_ISSUE ISSUE="7" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-07-24 16:41:12 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2017-07-24 16:41:12 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="7" YEAR="2017"/>
<DESCRIPTION>
<P>Brief economic commentary (BEC) added. Economics related sections revised: the Abstract, Plain language summary, Background, Methods (outcomes, search<BR/>methods), and Discussion were amended. Appendix added with details of search strategies for BECs.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-07-24 16:40:34 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="7" YEAR="2017"/>
<DESCRIPTION>
<P>Brief economic commentary (BEC) added. Economics-related sections revised.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2017-07-10 21:40:23 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2017-07-10 21:40:19 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="5" YEAR="2015"/>
<DESCRIPTION>
<P>Following new trials were added in this update: <LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Chen-2012" TYPE="STUDY">Chen 2012</LINK>; <LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-Choe-2013" TYPE="STUDY">Choe 2013</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-Diab-2012" TYPE="STUDY">Diab 2012</LINK>; <LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Hammoud-2011" TYPE="STUDY">Hammoud 2011</LINK>; <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>; <LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK>; <LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Kilic-2007" TYPE="STUDY">Kilic 2007</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Leanza-2009" TYPE="STUDY">Leanza 2009</LINK>; <LINK REF="STD-Mehdiyev-2010" TYPE="STUDY">Mehdiyev 2010</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Palomba-2008" TYPE="STUDY">Palomba 2008</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Peattie-2006" TYPE="STUDY">Peattie 2006</LINK>; <LINK REF="STD-Rechberger-2009" TYPE="STUDY">Rechberger 2009</LINK>; <LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; Ross 2009; <LINK REF="STD-Salem-2014" TYPE="STUDY">Salem 2014</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-07-10 21:40:23 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="21" MONTH="5" YEAR="2015"/>
<DESCRIPTION>
<P>Following new trials were added in this update: <LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Chen-2012" TYPE="STUDY">Chen 2012</LINK>; <LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-Choe-2013" TYPE="STUDY">Choe 2013</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-Diab-2012" TYPE="STUDY">Diab 2012</LINK>; <LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Hammoud-2011" TYPE="STUDY">Hammoud 2011</LINK>; <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>; <LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK>; <LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Kilic-2007" TYPE="STUDY">Kilic 2007</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Leanza-2009" TYPE="STUDY">Leanza 2009</LINK>; <LINK REF="STD-Mehdiyev-2010" TYPE="STUDY">Mehdiyev 2010</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Palomba-2008" TYPE="STUDY">Palomba 2008</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Peattie-2006" TYPE="STUDY">Peattie 2006</LINK>; <LINK REF="STD-Rechberger-2009" TYPE="STUDY">Rechberger 2009</LINK>; <LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; Ross 2009; <LINK REF="STD-Salem-2014" TYPE="STUDY">Salem 2014</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>
</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2015-04-23 13:03:49 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="9" YEAR="2009"/>
<DESCRIPTION>
<P>changed conclusion in abstract, typographical error</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-07-24 15:31:32 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="3" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2017-07-24 17:28:19 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2017-07-24 17:28:19 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2017-07-24 17:27:51 +0100" MODIFIED_BY="[Empty name]">
<NAME>The National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Incontinence Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. The NIHR is the largest single funder of the Cochrane Incontinence Group.</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2017-07-24 17:28:19 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>This project, to add Brief Economic Commentaries to our surgery for UI in women reviews, was supported by the National Institute for Health Research (NIHR), via the Cochrane Review Incentive Scheme 2016, to the Cochrane Incontinence Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. </P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-07-29 11:34:33 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-07-29 11:34:33 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2015-06-03 11:54:00 +0100" MODIFIED_BY="[Empty name]">Mid-urethral sling operations for stress urinary incontinence in women</TITLE>
<SUMMARY_BODY MODIFIED="2017-07-29 11:34:33 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Background information</B>
</P>
<P>Stress urinary incontinence (involuntary leakage of urine on effort or exertion; or on sneezing, coughing or laughing) is the commonest form of incontinence in women and leads to a reduction in their quality of life. Women with stress urinary incontinence can also have problems with sexual intercourse, as leakage of urine can occur. A significant amount of the woman's and her family's income can be spent on managing the symptoms. One in three women over the age of 18 years will be affected by stress urinary incontinence at some point in her lifetime.</P>
<P>Over the years, surgery to stop this problem has become less invasive. Mid-urethral sling operations are one of the various types of surgeries available. These operations are suitable for women who are having their first operation and those who had previous unsuccessful surgery. In a mid-urethral sling operation a tape is placed underneath the urethra, which is the tube that carries urine out of the bladder. When the woman coughs, the tape compresses the tube, thus providing the support necessary to prevent urine leakage.</P>
<P>There are two main ways of carrying out these operations, either by inserting a tape behind the pubic bone through the abdomen ('retropubic'), or through the groin ('transobturator').</P>
<P>
<B>What this review tried to find out</B>
</P>
<P>We looked at the effects and costs of mid-urethral sling operations using the two different methods. We also compared different ways of inserting the tape, and using tapes made from different materials. The purpose of this review was to find out how effective these operations are in the treatment of stress urinary incontinence and help determine potential complications rate.</P>
<P>
<B>Main findings of this review</B>
</P>
<P>We performed a thorough literature search up to June 2014. We identified 81 trials that had a total of 12,113 women. These trials showed that over 80% of women with stress urinary incontinence are cured, or have significant improvement in their symptoms, with either operation, for up to five years after surgery, irrespective of the tapes used and the route of tape insertion. The studies used different questionnaires to assess quality of life, which meant that we could not combine their results . However, the information available for quality of life shows that it improves as a result of these operations, though there is no clear difference between the two procedures. In terms of costs, a non-systematic review of economic studies suggested that transobturator had lower costs than retropubic methods. Only a few trials provided information about the effectiveness of these tapes more than five years after surgery. The evidence that we have been able to assess indicates that the positive effects persist.</P>
<P>
<B>Adverse effects</B>
</P>
<P>Tapes passing behind the pubic bone (retropubic) seem to carry a greater risk of injuring the bladder during the operation and of women experiencing problems emptying their bladder completely after surgery. However, this operation leads to less groin pain in the short term. There is some limited evidence that this way of inserting the tape has a lower risk of requiring a repeat operation in the long term compared to tapes passing through the groin (transobturator). There is moderate quality evidence that overall reported rates of tape-related complications are low, such as erosion of the tape into the vagina at about 2% for both routes of tape insertion. The reported occurrence of problems with sexual intercourse including pain was low, and leakage of urine during intercourse are improved following insertion of these tapes.</P>
<P>
<B>Limitations of the review</B>
</P>
<P>Most of our results are based on moderate quality evidence. Most trials did not describe their methods clearly, thus leading to some degree of uncertainty in the findings. At present there are only a limited number of randomised controlled trials (these produce the most reliable results) that have published data beyond five years after surgery. This means that evidence about how effective and safe these procedures are in the longer term lags behind the evidence for them in the short and medium term (up to five years). Longer-term data are required to help increase the reliability of longer-term results.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-07-28 17:48:13 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2017-07-28 17:48:13 +0100" MODIFIED_BY="[Empty name]">
<P>Urinary incontinence is a very common and debilitating problem affecting about 50% of women at some point in their lives. Stress urinary incontinence (SUI) is a predominant cause in 30% to 80% of these women imposing significant health and economic burden on society and the women affected. Mid-urethral sling (MUS) operations are a recognised minimally invasive surgical treatment for SUI. MUS involves the passage of a small strip of tape through either the retropubic or obturator space, with entry or exit points at the lower abdomen or groin, respectively. This review does not include single-incision slings.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2017-07-25 16:52:26 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the clinical effects of mid-urethral sling (MUS) operations for the treatment of SUI, urodynamic stress incontinence (USI) or mixed urinary incontinence (MUI) in women.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-07-25 16:51:51 +0100" MODIFIED_BY="[Empty name]">
<P>We searched: Cochrane Incontinence Specialised Register (including: CENTRAL, MEDLINE, MEDLINE In-Process, ClinicalTrials.gov) (searched 26 June 2014); Embase Classic (January 1947 to Week 25 2014); WHO ICTRP (searched 30 June 2014); reference lists.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2015-06-22 09:50:15 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;As its already been mentioned in he background that SIS will be excluded there isnt really a need to repeat that here (selection criteria) is there?&lt;/p&gt;" NOTES_MODIFIED="2015-06-22 09:50:15 +0100" NOTES_MODIFIED_BY="[Empty name]">
<P>Randomised or quasi-randomised controlled trials amongst women with SUI, USI or MUI, in which both trial arms involve a MUS operation.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2017-07-25 16:53:32 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed the methodological quality of potentially eligible studies and extracted data from included trials.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2015-06-22 09:52:41 +0100" MODIFIED_BY="[Empty name]">
<P>We included 81 trials that evaluated 12,113 women. We assessed the quality of evidence for outcomes using the GRADE assessment tool; the quality of most outcomes was moderate, mainly due to risk of bias or imprecision.</P>
<P>Fifty-five trials with data contributed by 8652 women compared the use of the transobturator route (TOR) and retropubic route (RPR). There is moderate quality evidence that in the short term (up to one year) the rate of subjective cure of TOR and RPR are similar (RR 0.98, 95% CI 0.96 to 1.00; 36 trials, 5514 women; moderate quality evidence) ranging from 62% to 98% in the TOR group, and from 71% to 97% in the RPR group. Short-term objective cure was similar in the TOR and RPR groups (RR 0.98, 95% CI 0.96 to 1.00; 40 trials, 6145 women). Fewer trials reported medium-term (one to five years) and longer-term (over five years) data, but subjective cure was similar between the groups (RR 0.97, 95% CI 0.87 to 1.09; 5 trials, 683 women; low quality evidence; and RR 0.95, 95% CI 0.80 to 1.12; 4 trials, 714 women; moderate quality evidence, respectively). In the long term, subjective cure rates ranged from 43% to 92% in the TOR group, and from 51% to 88% in the RPR group.</P>
<P>MUS procedures performed using the RPR had higher morbidity when compared to TOR, though the overall rate of adverse events remained low. The rate of bladder perforation was lower after TOR (0.6% versus 4.5%<I>; </I>RR 0.13, 95% CI 0.08 to 0.20; 40 trials, 6372 women; moderate quality evidence). Major vascular/visceral injury, mean operating time, operative blood loss and length of hospital stay were lower with TOR.</P>
<P>Postoperative voiding dysfunction was less frequent following TOR (RR 0.53, 95% CI 0.43 to 0.65; 37 trials, 6200 women; moderate quality evidence). Overall rates of groin pain were higher in the TOR group (6.4% versus 1.3%; RR 4.12, 95% CI 2.71 to 6.27; 18 trials, 3221 women; moderate quality evidence) whereas suprapubic pain was lower in the TOR group (0.8% versus 2.9%<I>;</I> RR 0.29, 95% CI 0.11 to 0.78); both being of short duration. The overall rate of vaginal tape erosion/exposure/extrusion was low in both groups: 24/1000 instances with TOR compared with 21/1000 for RPR (RR 1.13, 95% CI 0.78 to 1.65; 31 trials, 4743 women; moderate quality evidence). There were only limited data to inform the need for repeat incontinence surgery in the long term, but it was more likely in the TOR group than in the RPR group (RR 8.79, 95% CI 3.36 to 23.00; 4 trials, 695 women; low quality evidence).</P>
<P>A retropubic bottom-to-top route was more effective than top-to-bottom route for subjective cure (RR 1.10, 95% CI 1.01 to 1.19; 3 trials, 477 women; moderate quality evidence). It incurred significantly less voiding dysfunction, and led to fewer bladder perforations and vaginal tape erosions.</P>
<P>Short-and medium-term subjective cure rates between transobturator tapes passed using a medial-to-lateral as opposed to a lateral-to-medial approach were similar (RR 1.00, 95% CI 0.96 to 1.06; 6 trials, 759 women; moderate quality evidence, and RR 1.06, 95% CI 0.91 to 1.23; 2 trials, 235 women; moderate quality evidence). There was moderate quality evidence that voiding dysfunction was more frequent in the medial-to-lateral group (RR 1.74, 95% CI 1.06 to 2.88; 8 trials, 1121 women; moderate quality evidence), but vaginal perforation was less frequent in the medial-to-lateral route (RR 0.25, 95% CI 0.12 to 0.53; 3 trials, 541 women). Due to the very low quality of the evidence, it is unclear whether <I>t</I>he lower rates of vaginal epithelial perforation affected vaginal tape erosion (RR 0.42, 95% CI 0.16 to 1.09; 7 trials, 1087 women; very low quality evidence).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-07-25 16:25:15 +0100" MODIFIED_BY="[Empty name]">
<P>Mid-urethral sling operations have been the most extensively researched surgical treatment for stress urinary incontinence (SUI) in women and have a good safety profile. Irrespective of the routes traversed, they are highly effective in the short and medium term, and accruing evidence demonstrates their effectiveness in the long term. This review illustrates their positive impact on improving the quality of life of women with SUI. However, a brief economic commentary (BEC) identified three studies suggesting that transobturator may be more cost-effective compared with retropubic. Fewer adverse events occur with employment of a transobturator approach with the exception of groin pain. When comparing transobturator techniques of a medial-to-lateral versus a lateral-to-medial insertion, there is no evidence to support the use of one approach over the other. However, a bottom-to-top route was more effective than top-to-bottom route for retropubic tapes.</P>
<P>A salient point illustrated throughout this review is the need for reporting of longer-term outcome data from the numerous existing trials. This would substantially increase the evidence base and provide clarification regarding uncertainties about long-term effectiveness and adverse event profile. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-07-25 16:29:00 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-07-24 17:30:44 +0100" MODIFIED_BY="[Empty name]">
<P>Urinary incontinence is a very common condition in women. It is associated with significant physical morbidity, sexual dysfunction, loss of independence and a reduction in psychological well being, with consequent decreased participation in social and domestic activities (<LINK REF="REF-Wetle-1995" TYPE="REFERENCE">Wetle 1995</LINK>; <LINK REF="REF-Thom-1998" TYPE="REFERENCE">Thom 1998</LINK>; <LINK REF="REF-Van-Oyen-2002" TYPE="REFERENCE">Van Oyen 2002</LINK>; <LINK REF="REF-Salonia-2004" TYPE="REFERENCE">Salonia 2004</LINK>; <LINK REF="REF-Botlero-2010" TYPE="REFERENCE">Botlero 2010</LINK>). Overall the prevalence of urinary incontinence in adult women has been estimated to be between 10% and 40%, and is considered severe in about 3% to 17%, with annual incidence ranging from 2% to 11% (<LINK REF="REF-Hunskaar-2002" TYPE="REFERENCE">Hunskaar 2002</LINK>; <LINK REF="REF-Milsom-2009" TYPE="REFERENCE">Milsom 2009</LINK>). The prevalence of stress urinary incontinence (SUI) in women is between 12% to 46% (<LINK REF="REF-Botlero-2008" TYPE="REFERENCE">Botlero 2008</LINK>; <LINK REF="REF-Coyne-2009" TYPE="REFERENCE">Coyne 2009</LINK>; <LINK REF="REF-Irwin-2006" TYPE="REFERENCE">Irwin 2006</LINK>). This is a potentially debilitating social problem, with significant cost implications to the individuals and the healthcare service. The estimated annual cost to the healthcare system in the UK exceeds GBP 700 million (1999/2000 GBP) (<LINK REF="REF-Turner-2004" TYPE="REFERENCE">Turner 2004</LINK>) while in the USA, the annual total direct costs in both men and women is over USD 16 billion (1995 USD) (<LINK REF="REF-Chong-2011" TYPE="REFERENCE">Chong 2011</LINK>) with societal costs of USD 26.2 billion (1995 USD) (<LINK REF="REF-Wagner-1998" TYPE="REFERENCE">Wagner 1998</LINK>). Approximately, USD 13.12 billion (1995 USD) of the total direct costs of urinary incontinence is spent on SUI (<LINK REF="REF-Chong-2011" TYPE="REFERENCE">Chong 2011</LINK>; <LINK REF="REF-Kunkle-2015" TYPE="REFERENCE">Kunkle 2015</LINK>). In the USA,about 70% of this USD 13.12 billion is borne by the patients mainly through routine care (purchasing pads and disposable underwear (diapers), laundry and dry cleaning). Of the remaining 30%, 14% is spent on nursing home admission, 9% on treatment, 6% on addressing complications and 1% on diagnosis (<LINK REF="REF-Chong-2011" TYPE="REFERENCE">Chong 2011</LINK>). In the UK an estimated more than GBP 178 million (1999/2000 GBP) is borne by women on an individual basis annually (<LINK REF="REF-Turner-2004" TYPE="REFERENCE">Turner 2004</LINK>; <LINK REF="REF-Papanicolaou-2005" TYPE="REFERENCE">Papanicolaou 2005</LINK>).This constitutes a significant individual financial burden.</P>
<P>A study reported that about 1% of the median annual household income (USD 50,000 to USD 59,999) was spent by women on incontinence management. This study estimated that women spent an annual mean cost of USD 751 to USD 1277 (2006 USD) on incontinence. This cost increases based on the severity of the symptoms (<LINK REF="REF-Subak-2008" TYPE="REFERENCE">Subak 2008</LINK>).The indirect cost associated exerts social and psychological burdens which are unquantifiable. (<LINK REF="REF-Chong-2011" TYPE="REFERENCE">Chong 2011</LINK>; <LINK REF="REF-Kilonzo-2004" TYPE="REFERENCE">Kilonzo 2004</LINK>). Nevertheless, <LINK REF="REF-Birnbaum-2004" TYPE="REFERENCE">Birnbaum 2004</LINK> estimated that the annual average direct medical costs of SUI for one year (1998 USD) was USD 5642 and USD 4208 for indirect workplace costs.The cost of management and treatment of SUI appears to have increased over time due to increasing prevalence and an increased desire for improved quality of life (QOL). This in turn has resulted from improved recognition of the condition, as well as increased use of surgical and non-surgical managements.</P>
<P>Continence is achieved through interplay of the normal anatomical and physiological properties of the bladder, urethra, urethral sphincter and pelvic floor, with the nervous system co-ordinating these organs. The urethra and its sphincter act as a closure mechanism during bladder filling to contain urine within the bladder, thereby allowing storage of urine until a convenient time and place to void is reached. The pelvic floor provides support to the bladder and urethra, and allows normal abdominal pressure transmission to the proximal urethra, which is essential in the maintenance of continence. Crucial to the healthy functioning of the bladder, urethra, sphincter and pelvic floor is co-ordination between them, which is facilitated by an intact nervous system.</P>
<P>There are many theories hypothesizing the pathophysiology of stress urinary incontinence. Historically Goran Enhorning was first to measure simultaneous bladder and urethral pressures. He suggested that during the cough impulse, pressure is transmission from the abdomen to the urethra with a concurrent reduction in urethral closure pressure that results in SUI (<LINK REF="REF-Enhorning-1961" TYPE="REFERENCE">Enhorning 1961</LINK>). McGuire&#8217;s modified classification of SUI emphasizes the principle of intrinsic sphincter deficiency (ISD) as a cause of SUI. This is said to occur due to poor urethral closure function resulting from defective urethral mucosal coaptation. These two theories informed procedures such as the Burch Colposuspension and Marshall Marchetti Krantz operations. De Lancey&#8217;s 'hammock' theory suggested that abdominal pressure transmission to the bladder neck and urethra leads to the proximal urethra being compressed against the pubo-vesical fascia and anterior vaginal wall, thus maintaining continence (<LINK REF="REF-DeLancey-1994" TYPE="REFERENCE">DeLancey 1994</LINK>).</P>
<P>Recent findings on the pathophysiology of urinary incontinence have demonstrated that mid-urethral support, provided by the pubo-urethral ligaments, also plays an important role in maintaining continence when the intra-abdominal pressure rises. This has led to the 'integrated theory' for the maintenance of continence in female SUI (<LINK REF="REF-Petros-1990" TYPE="REFERENCE">Petros 1990</LINK>; <LINK REF="REF-Petros-1993" TYPE="REFERENCE">Petros 1993</LINK>). This theory, in turn, is the basis for the current use of minimally invasive mid-urethral tapes in the treatment of SUI.</P>
<P>When performing mid-urethral tape surgery there are different types of synthetic materials used. Synthetic meshes are divided into four groups:</P>
<UL>
<LI>type 1 are macroporous, monofilament;</LI>
<LI>type 2 are microporous;</LI>
<LI>type 3 are macroporous, multifilament;</LI>
<LI>type 4 are submicronic, coated biomaterials with pore sizes of less than 1 &#956;m.</LI>
</UL>
<P>Type 1 mesh has the highest biocompatibility with the least propensity for infection. Differences in their efficacy and complications are likely to be due to several factors including the different knits and weaves of the various tape materials, their biomechanical properties and histological biocompatibility. Pore size affects the inflammatory response and resultant connective tissue formation within and into the mesh, and the rearrangement of materials such as collagen within the mesh structure. Macroporous meshes (pore size in excess of 75 &#956;m) easily allow macrophages, leukocytes, fibroblasts, blood vessels and collagen to transverse the pores: thus macroporous meshes promote tissue host ingrowth with resultant biocompatibility and low risk of infection (<LINK REF="REF-Amid-1997" TYPE="REFERENCE">Amid 1997</LINK>). Monofilament tapes are widely available and now predominate in current clinical practice.</P>
<P>In contrast, microporous meshes (pore size greater than 10 &#956;m) allow bacteria to pass through and replicate, but exclude macrophages. Multifilament tapes have smaller pore sizes, and are thus microporous. This perhaps explains why tape erosion was more common in the multifilament tapes, though statistical significance was not reached.</P>
<CONDITION MODIFIED="2015-06-03 12:15:27 +0100" MODIFIED_BY="[Empty name]">
<P>Incontinence occurs when this normal relationship between the lower urinary tract components is disrupted, as a result of nerve damage or direct mechanical disruption to the pelvic organs. Advancing age, higher parity, vaginal delivery, obesity and post menopausal status are all associated with an increased risk of urinary incontinence (<LINK REF="REF-Wilson-1996" TYPE="REFERENCE">Wilson 1996</LINK>).</P>
<P>There are different forms of urinary incontinence of which SUI is the most common type, accounting for at least 50% of cases of urinary incontinence in women (<LINK REF="REF-Hannestad-2000" TYPE="REFERENCE">Hannestad 2000</LINK>). SUI is the involuntary loss of urine that occurs with physical exertion (e.g. sporting activities), or on sneezing or coughing (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>). Urodynamic stress incontinence (USI) is the involuntary leakage of urine observed during filling cystometry, it is associated with increased intra-abdominal pressure, in the absence of a detrusor contraction (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>). Two mechanisms for stress incontinence are recognized: hyper-mobility or significant displacement of the urethra and bladder neck during exertion, and intrinsic urethral sphincter deficiency (<LINK REF="REF-Blaivas-1988" TYPE="REFERENCE">Blaivas 1988</LINK>). These mechanisms may co-exist in women (<LINK REF="REF-O_x0027_Donnell-1994" TYPE="REFERENCE">O'Donnell 1994</LINK>). Few clinical trials have distinguished between the two conditions, probably because there is currently no standardised and validated test available for this (<LINK REF="REF-Blaivas-1988" TYPE="REFERENCE">Blaivas 1988</LINK>; <LINK REF="REF-McGuire-1993" TYPE="REFERENCE">McGuire 1993</LINK>). We considered women whose incontinence could be due to either mechanism together in this review.</P>
<P>The diagnosis of urodynamic stress incontinence implies that urodynamic investigation has been done to confirm stress incontinence; it may also identify the presence of detrusor overactivity, in mixed urinary incontinence. Standard clinical assessment includes history taking, physical examination, frequency/volume charts and urine analysis. Some authors described women with the symptom of stress urinary incontinence only (diagnosis made on clinical evaluation without urodynamics). Women with stress urinary incontinence and those with urodynamic stress incontinence have been included in this review.</P>
<P>Urgency urinary incontinence (UUI) is a sudden, compelling desire to pass urine, which is difficult to defer (urgency), accompanied by the involuntary loss of urine. Detrusor overactivity (DO) is a diagnosis that denotes involuntary detrusor contractions observed during the filling phase of a urodynamic assessment. It may be spontaneous or provoked and can be qualified according to cause - neurogenic or idiopathic (<LINK REF="REF-Haylen-2010" TYPE="REFERENCE">Haylen 2010</LINK>). We included women with UUI and the formal urodynamic diagnosis of DO in the review only if they had co-existing stress incontinence (so called mixed urinary incontinence (MUI)).</P>
<P>Women with MUI who were included in this review had symptoms of SUI plus either urgency or UUI, or urodynamic stress incontinence (USI) plus DO (urodynamic diagnosis).</P>
</CONDITION>
<INTERVENTION MODIFIED="2015-06-03 12:19:38 +0100" MODIFIED_BY="[Empty name]">
<P>Management of SUI includes conservative, mechanical, pharmacological and surgical interventions.</P>
<UL>
<LI>Conservative management centres on lifestyle modifications, physical methods including pelvic floor muscle training, electrical stimulation, biofeedback and the use of weighted cones.</LI>
<LI>Mechanical devices that prevent or reduce urinary leakage are available, and include metal plugs or patches and urethral or vaginal inserts.</LI>
<LI>Drug therapies, such as oestrogens and alpha adrenergic agents, have been used in the past. Recently, inhibitors of serotonin and norepinephrine reuptake have been proposed as new drug therapy for SUI, used alone or in combination with other conservative management (<LINK REF="REF-Ghoniem-2005" TYPE="REFERENCE">Ghoniem 2005</LINK>).</LI>
</UL>
<P>A trial of such conservative treatments should be undertaken before resorting to surgery. The following interventions are the subject of separate Cochrane reviews.</P>
<UL>
<LI>Lifestyle interventions for the treatment of urinary incontinence in adults (<LINK REF="REF-Imamura-2010" TYPE="REFERENCE">Imamura 2010</LINK>).</LI>
<LI>Bladder training for urinary incontinence in adults (<LINK REF="REF-Wallace-2004" TYPE="REFERENCE">Wallace 2004</LINK>).</LI>
<LI>Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women (<LINK REF="REF-Hay_x002d_Smith-2011" TYPE="REFERENCE">Hay-Smith 2011</LINK>).</LI>
<LI>Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women (<LINK REF="REF-Herderschee-2011" TYPE="REFERENCE">Herderschee 2011</LINK>).</LI>
<LI>Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women (<LINK REF="REF-Ayeleke-2013" TYPE="REFERENCE">Ayeleke 2013</LINK>).</LI>
<LI>Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women (<LINK REF="REF-Dumoulin-2014" TYPE="REFERENCE">Dumoulin 2014</LINK>).</LI>
<LI>Combined conservative interventions for urge, stress or mixed incontinence in adults (<LINK REF="REF-French-2010" TYPE="REFERENCE">French 2010</LINK>).</LI>
<LI>Weighted vaginal cones for urinary incontinence (<LINK REF="REF-Herbison-2013" TYPE="REFERENCE">Herbison 2013</LINK>).</LI>
<LI>Mechanical devices for urinary incontinence in women (<LINK REF="REF-Lipp-2011" TYPE="REFERENCE">Lipp 2011</LINK>).</LI>
<LI>Oestrogen therapy for urinary incontinence in post-menopausal women (<LINK REF="REF-Cody-2012" TYPE="REFERENCE">Cody 2012</LINK>).</LI>
<LI>Adrenergic drugs for urinary incontinence in adults (<LINK REF="REF-Alhasso-2005" TYPE="REFERENCE">Alhasso 2005</LINK>).</LI>
<LI>Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults (<LINK REF="REF-Mariappan-2005" TYPE="REFERENCE">Mariappan 2005</LINK>).</LI>
<LI>Acupuncture for stress urinary incontinence in adults (<LINK REF="REF-Wang-2013" TYPE="REFERENCE">Wang 2013</LINK>).</LI>
</UL>
<P>Surgical procedures to remedy SUI generally aim to lift and support the urethro-vesical junction, but in the last decade the emphasis has been on suburethral support at the mid-urethral level. Owing to disagreement on the precise mechanism by which continence is achieved, the choice of surgical procedure is influenced by co-existent problems, surgeon's preference and the physical features of the person affected.</P>
<P>Numerous surgical methods for SUI have been described and evaluated in Cochrane reviews. Traditionally, they fall into seven categories:</P>
<UL>
<LI>suburethral slings (including traditional suburethral slings and minimally invasive sling operations; <LINK REF="REF-Rehman-2011" TYPE="REFERENCE">Rehman 2011</LINK>);</LI>
<LI>open abdominal retropubic suspension (e.g. colposuspension (Burch/modified Burch), Marshall-Marchetti-Krantz (MMK); <LINK REF="REF-Lapitan-2012" TYPE="REFERENCE">Lapitan 2012</LINK>);</LI>
<LI>laparoscopic retropubic suspension (<LINK REF="REF-Dean-2006" TYPE="REFERENCE">Dean 2006</LINK>);</LI>
<LI>anterior vaginal repair (anterior colporrhaphy; <LINK REF="REF-Glazener-2001" TYPE="REFERENCE">Glazener 2001</LINK>);</LI>
<LI>needle suspensions (<LINK REF="REF-Glazener-2004" TYPE="REFERENCE">Glazener 2004</LINK>);</LI>
<LI>urethral injections (<LINK REF="REF-Kirchin-2012" TYPE="REFERENCE">Kirchin 2012</LINK>); and</LI>
<LI>artificial sphincters.</LI>
</UL>
<P>Suburethral slings have become the favourite primary continence surgery in current clinical practice. Several developments in type and technique have resulted in the separation of the original sling review, <LINK REF="REF-Bezerra-2005" TYPE="REFERENCE">Bezerra 2005</LINK>, into three different reviews focusing on:</P>
<UL>
<LI>traditional suburethral slings (<LINK REF="REF-Rehman-2011" TYPE="REFERENCE">Rehman 2011</LINK>)</LI>
<LI>minimally invasive slings such as TVT and TOT (<LINK REF="REF-Ogah-2009" TYPE="REFERENCE">Ogah 2009</LINK>), and</LI>
<LI>single incision slings, also known as mini-slings (<LINK REF="REF-Nambiar-2014" TYPE="REFERENCE">Nambiar 2014</LINK>).</LI>
</UL>
<P>The materials that have been used for slings may be biological or synthetic. The first of these reviews concentrates on traditional (biological) suburethral sling operations (<LINK REF="REF-Rehman-2011" TYPE="REFERENCE">Rehman 2011</LINK>). A traditional suburethral sling operation requires a combined abdominal and vaginal approach. Strips of material are tunnelled under the proximal urethra. They are attached either to the rectus muscle or the iliopectineal ligaments, resulting in a tightening of the sling and increased bladder support every time the woman strains to prevent leaking. They are applied under open surgery and are fixed with sutures.</P>
<P>This current review is an update of the second of these reviews, focusing on minimally invasive suburethral sling operations using artifical (synthetic) non-absorbable sling materials (<LINK REF="REF-Ogah-2009" TYPE="REFERENCE">Ogah 2009</LINK>). The techniques of these procedures are described below. This review does not include single incision slings.</P>
<P>The third of these reviews is a new, recently published review that compares a new type of sling, the single incision sling, which is also known as the mini-sling (<LINK REF="REF-Nambiar-2014" TYPE="REFERENCE">Nambiar 2014</LINK>). The technique differs from that of the original synthetic slings in that a single incision is made within the vagina using a significantly shorter tape and there are no tape exit incisions.</P>
</INTERVENTION>
<THEORY MODIFIED="2015-06-22 09:53:15 +0100" MODIFIED_BY="[Empty name]">
<P>The current review focuses on mid-urethral sling operations. These involve the insertion of a tape covered by a plastic sheath around the mid-urethra without suture fixation, performed in some centres under local anaesthesia (<LINK REF="REF-Ulmsten-1995a" TYPE="REFERENCE">Ulmsten 1995a</LINK>; <LINK REF="REF-Ulmsten-1996" TYPE="REFERENCE">Ulmsten 1996</LINK>; <LINK REF="REF-Smith-2002" TYPE="REFERENCE">Smith 2002</LINK>). The aim is to restore or enhance the patient's urethral support during a sudden movement, such as a cough or sneeze, which would prevent the involuntary loss of urine. Ultrasound studies suggest that the mechanism of action is the intermittent or dynamic obstruction of the urethra by the tape when increased abdominal pressure occurs (such as when coughing or sneezing; <LINK REF="REF-Dietz-2004" TYPE="REFERENCE">Dietz 2004</LINK>).</P>
<P>There are two main types of surgical approaches.</P>
<UL>
<LI>
<B>Retropubic: </B>This procedure involves the insertion of two needles passed through the retropubic space blindly from the vagina to abdomen or from the abdomen to the vagina. Cystoscopy is recommended to detect any perforation of the bladder or urethra (<LINK REF="REF-Ulmsten-1995a" TYPE="REFERENCE">Ulmsten 1995a</LINK>; <LINK REF="REF-Ulmsten-1995b" TYPE="REFERENCE">Ulmsten 1995b</LINK>).</LI>
<LI>
<B>Transobturator; </B>This is another type of minimally invasive synthetic suburethral sling operation in which the tape is inserted in a horizontal plane underneath the middle of the urethra between the two obturator foramina. The ends of the tape are tunnelled percutaneously with a tunneller (curved needle), again without suture fixation. As the retropubic space is not breached, it is argued that cystoscopy is not required (<LINK REF="REF-Delorme-2001" TYPE="REFERENCE">Delorme 2001</LINK>; <LINK REF="REF-Delorme-2003" TYPE="REFERENCE">Delorme 2003</LINK>; <LINK REF="REF-Delorme-2004" TYPE="REFERENCE">Delorme 2004</LINK>). Shortly after the development of this technique a similar operation was described in which a tape is passed percutaneously through the obturator foramina, using an inside-to-outside technique, i.e. medio-lateral (<LINK REF="REF-de-Leval-2003" TYPE="REFERENCE">de Leval 2003</LINK>; <LINK REF="REF-de-Leval-2005" TYPE="REFERENCE">de Leval 2005</LINK>).</LI>
</UL>
<P>We included only mid-urethral sling operations, with synthetic tape materials applied through minimally invasive surgeries, either through the retropubic space or the transobturator route in this review. However, a number of modifications of transobturator surgery using the same route have been described and we have included these too.</P>
<P>In this update, in contrast to the original review in which trials of minimally invasive slings were compared to traditional slings, open colposuspension, or laparoscopic colposuspension, these comparator techniques have not been included, as these are now covered by other Cochrane reviews (<LINK REF="REF-Dean-2006" TYPE="REFERENCE">Dean 2006</LINK>; <LINK REF="REF-Rehman-2011" TYPE="REFERENCE">Rehman 2011</LINK>; <LINK REF="REF-Lapitan-2012" TYPE="REFERENCE">Lapitan 2012</LINK>).</P>
<P>A concern of using synthetic material is the potential risk of complications caused by infection and tissue reaction to the tapes. Some aspects of the material that may vary include pore size, mono- or multifilament design, and biocompatibility. We included all types of mesh used in different minimally invasive slings in this review, and assessed possible differences between the risk of complications.</P>
</THEORY>
<IMPORTANCE MODIFIED="2015-06-22 09:53:18 +0100" MODIFIED_BY="[Empty name]">
<P>There is a plethora of minimally invasive synthetic tapes available and used worldwide for treatment of SUI. The reported effectiveness and safety of these procedures have made them very popular, but in the past there has been controversy about which of these procedures is best, as the introduction of many of these procedures and tapes was market driven and was not accompanied by rigorous prospective randomised controlled trials of effectiveness. Now more randomised controlled trials that assess their effectiveness have been published, but many trials are too small to draw definitive conclusions, hence the need for the first review.</P>
<P>Our initial review, <LINK REF="REF-Ogah-2009" TYPE="REFERENCE">Ogah 2009</LINK>, showed evidence of efficacy in the short-term, as many trials only reported a 12-month follow-up. A significant advantage of a Cochrane review is not only the rigorous database search and methodology, but most importantly the ability to update the review and meta-analysis as new evidence becomes available. This meta-analysis of the trials available is necessary to help make judgements on medium- and longer-term efficacy, since we now have 18 years-worth of data since the initial report of the retropubic mid-urethral tape, and it is over 11 years since the first randomised trials of the tension-free vaginal tape and transobturator tapes were published. It is also necessary to provide evidence on medium- and longer-term safety of the devices both suspected and expected, and the unexpected adverse events in the long-term. This review update aims to clarify the uncertainty surrounding the use mid-urethral slings in terms of surgical approach, route of insertion and the type of tape used.</P>
<P>This current update analyses only the effects of mid-urethral slings, and excludes both single incision slings and other surgical procedures e.g. traditional slings and colposuspension. The options of no treatment, conservative treatment and pharmacological treatment are also excluded, as this will be addressed in a future Cochrane review.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2015-06-22 09:53:19 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the clinical effects of mid-urethral sling (MUS) operations for the treatment of stress urinary incontinence (SUI), urodynamic stress incontinence (USI) or mixed urinary incontinence (MUI) in women.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-07-24 16:45:35 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-07-06 16:05:12 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2015-06-21 18:26:00 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised or quasi-randomised controlled trials amongst women with USI (urodynamic diagnosis), or symptoms of SUI or MUI (clinical diagnosis), in which both trial arms involve a mid-urethral sling operation.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2015-06-03 12:33:30 +0100" MODIFIED_BY="[Empty name]">
<P>Adult women with SUI due to hyper-mobility and intrinsic sphincter deficiency, or both, diagnosed clinically or with urodynamics, and women with MUI in which stress incontinence was the predominant symptom. Classification of diagnoses were accepted as defined by the trialists.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2015-06-22 09:53:20 +0100" MODIFIED_BY="[Empty name]">
<P>Both trial arms of a study must involve mid-urethral sling operations to treat SUI or MUI.</P>
<P>We made the following comparisons.</P>
<UL>
<LI>Transobturator route (TOR) versus retropubic route (RPR).</LI>
<LI>Retropubic bottom-to-top approach versus retropubic top-to-bottom approach.</LI>
<LI>Obturator medial-to-lateral approach versus obturator lateral-to-medial approach.</LI>
<LI>One method of mid-urethral tape insertion versus another method, same route.</LI>
<LI>One type of tape material versus another</LI>
</UL>
<P>Comparisons with other types of surgery (i.e. traditional slings, single incision slings and colposuspension) for urinary incontinence are covered in other recent Cochrane reviews. The options of no treatment, conservative treatment and pharmacological treatment have also been removed as these will be addressed in a future Cochrane review.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-07-06 16:05:12 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-06-03 12:35:10 +0100" MODIFIED_BY="[Empty name]">
<P>We selected the outcome measures used in this review on the basis of their relevance to the clinical cure or improvement of incontinence. We regarded the principal measures of effectiveness as being:</P>
<SUBSECTION>
<HEADING LEVEL="5">1. Women's observations</HEADING>
<UL>
<LI>the proportion of women cured (continent or dry) following surgery; </LI>
<LI>the proportion of women whose incontinence is improved;</LI>
<LI>cure and improvement measured in the short term (less than one year); medium term (one to five years); and long term (more than five years).</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-07-06 16:05:12 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">2. Women's observations</HEADING>
<UL>
<LI>Urgency symptoms or urgency incontinence.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Quantification of symptoms</HEADING>
<UL>
<LI>Pad changes (from self-reported number of pads used).</LI>
<LI>Incontinence episodes (from self-completed bladder chart).</LI>
<LI>Pad tests of quantified leakage (mean volume or weight of urine loss).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. Clinician's observations</HEADING>
<UL>
<LI>Objective cure rates in the short term (less than one year); medium term (one to five years); and long term (more than five years).</LI>
<LI>De novo detrusor overactivity (urodynamic diagnosis).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. Surgical outcome measures</HEADING>
<UL>
<LI>Duration of operation.</LI>
<LI>Length of inpatient stay.</LI>
<LI>Time to return to normal activity level.</LI>
<LI>Operative blood loss.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">6. Adverse events</HEADING>
<UL>
<LI>Major vascular or visceral injury.</LI>
<LI>Bladder, urethral or bowel perforation.</LI>
<LI>Nerve damage.</LI>
<LI>Perioperative surgical complications (e.g. infection, bacteriuria, haemorrhage with or without major vessel lesion).</LI>
<LI>Voiding dysfunction or difficulty after three months (with or without urodynamic confirmation) or need for long-term catheterisation.</LI>
<LI>Infection related to use of synthetic mesh.</LI>
<LI>Tape erosion or extrusion or exposure into the vagina.</LI>
<LI>Tape erosion or extrusion or exposure into the bladder or urethra.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">7. Need for further treatment</HEADING>
<UL>
<LI>Physiotherapy treatment.</LI>
<LI>Drug treatment for urinary incontinence or symptoms.</LI>
<LI>Pelvic organ prolapse (e.g. cystocoele, rectocoele, enterocoele).</LI>
<LI>Repeat incontinence surgery.</LI>
<LI>Later prolapse surgery.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">8. Quality of life</HEADING>
<P>Quality of life assessed by means of:</P>
<UL>
<LI>general health status measures (e.g. Short Form 36 (<LINK REF="REF-Ware-1993" TYPE="REFERENCE">Ware 1993</LINK>));</LI>
<LI>condition-specific instruments designed to assess incontinence, e.g. the Bristol Female Lower Urinary Tract Symptoms questionnaire (BFLUTS; <LINK REF="REF-Jackson-1996" TYPE="REFERENCE">Jackson 1996</LINK>);</LI>
<LI>condition-specific sexual function assessment e.g. via Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12;<LINK REF="REF-Rogers-2003" TYPE="REFERENCE">Rogers 2003</LINK>);</LI>
<LI>psychological measures.</LI>
<LI/>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">9. Other outcomes</HEADING>
<UL>
<LI>Non-prespecified outcomes judged to be important when performing the review.</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-07-24 16:45:35 +0100" MODIFIED_BY="[Empty name]">
<P>Unless otherwise stated we did not impose language or other restrictions on any of the searches which are described below.</P>
<ELECTRONIC_SEARCHES MODIFIED="2017-07-24 16:45:35 +0100" MODIFIED_BY="[Empty name]">
<P>This review drew on the search strategy developed for the Cochrane Incontinence Group. We identified relevant trials from the Cochrane Incontinence Group Specialised Trials Register. For more details of the search methods used to build the Specialised Register please see the Group's <A HREF="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/INCONT/frame.html">module</A> in <I>The Cochrane Library</I>. The Register contains trials identified from the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and MEDLINE in process, ClinicalTrials.gov and handsearching of journals and conference proceedings. Most of the trials in the Cochrane Incontinence Group Specialised Register are also contained in CENTRAL. The date of the last search was 26 June 2014.</P>
<P>The terms used to search the Incontinence Group Specialised Register are given in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>Additionally the following electronic databases were searched, details of the searches and the terms used are given in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<UL>
<LI>Embase and Embase Classic (January 1947 to Week 25 2014; searched on 26 June 2014; limited to those years not searched via the CENTRAL search of Embase, i.e. 1 January 2010 to Week 25 2014 inclusive).</LI>
<LI>WHO ICTRP (searched on 30 June 2014)</LI>
</UL>
<P>Details of the searches performed for the previous version of this review can be found in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
<P>We performed additional searches for the Brief Economic Commentaries (BECs). We conducted them in MEDLINE(1 January 1946 to March 2017), Embase (1 January 1980 to 2017 Week 12) and NHS EED (1st Quarter 2016). We ran all searches on 6 April 2017. Details of the searches run and the search terms used can be found in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-09-29 12:05:13 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of relevant articles.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-07-06 16:05:20 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2015-06-03 12:36:21 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised and quasi-randomised trials were identified using the above search strategy. We excluded studies from the review if they were not randomised or quasi-randomised controlled trials for incontinent women, or if they made comparisons other than those pre-specified. Excluded studies are listed in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table along with reasons for their exclusion. We evaluated all potentially eligible studies for appropriateness for inclusion without prior consideration of the results. We retrieved reports of potentially eligible trials in full.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2015-06-03 12:36:31 +0100" MODIFIED_BY="[Empty name]">
<P>We extracted data independently using a standard form containing pre-specified outcomes. Where data may have been collected but not reported, we sought clarification from the trialists. We processed included trial data as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We resolved differences of opinion relating to study inclusion, methodological quality or data extraction by discussion among the reviewers, and when necessary, referred them to a third party for arbitration.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2015-06-03 12:41:09 +0100" MODIFIED_BY="[Empty name]">
<P>Miss Abigail Ford and Mr Joseph Ogah (review authors) extracted data and independently assessed the included trials for methodological quality and validity using the 'Risk of bias' assessment tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We assessed the risk of bias in the results of the included trials by examining the following features: selection bias, which results from insecure random allocation of treatments; performance bias that occurs when knowledge of the procedure actually performed might have affected the participant or care provider; attrition bias caused by incomplete reporting of outcome data, or from dropouts or losses to follow-up, particularly if there is a differential dropout rate between groups; and biased ascertainment (detection bias) of outcome where knowledge of the allocation might have influenced the measurement of outcome. These were assessed under the headings below:</P>
<UL>
<LI>sequence generation;</LI>
<LI>allocation sequence concealment;</LI>
<LI>blinding of participants and personnel;</LI>
<LI>blinding of outcome assessment;</LI>
<LI>incomplete outcome data.</LI>
</UL>
<P>These were presented in the 'Risk of bias' tables, graphs and summary figures.</P>
<P>The GRADE (Grades of Recommendation, Assessment, Development and Evaluation) system was used to assess and grade the quality of evidence for each individual outcome (<LINK REF="REF-Guyatt-2011a" TYPE="REFERENCE">Guyatt 2011a</LINK>; <LINK REF="REF-Guyatt-2011b" TYPE="REFERENCE">Guyatt 2011b</LINK>; <LINK REF="REF-Guyatt-2013a" TYPE="REFERENCE">Guyatt 2013a</LINK>; <LINK REF="REF-Guyatt-2013b" TYPE="REFERENCE">Guyatt 2013b</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2015-06-03 13:08:29 +0100" MODIFIED_BY="[Empty name]">
<P>The review was conducted using the standard Cochrane software Review Manager 'Revman' version 5.2 (<LINK REF="REF-Reference-Manager-2012" TYPE="REFERENCE">Reference Manager 2012</LINK>). For categorical outcomes we related the numbers reporting an outcome to the numbers at risk in each group to derive a summary risk ratio (RR). For continuous variables we used means and standard deviations to derive a mean difference (MD) if the outcomes were measured in the same way between trials. Any continuous data that were the product of a number of different scales (for example, scales used to assess symptoms such as pain or quality of life) we summarised as the standardised mean difference (SMD) using a fixed-effect model. A fixed-effect model was used for calculation of all summary estimates and 95% confidence intervals (CIs) except when there was significant heterogeneity. When appropriate, we undertook meta-analysis.</P>
<P>We undertook a narrative review of eligible trials where statistical synthesis of data from more than one study was not possible, or considered inappropriate.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2015-06-03 13:08:41 +0100" MODIFIED_BY="[Empty name]">
<P>We did not perform analysis of trials with non-standard designs, such as cross-over trials and cluster-randomised trials, as there were no such trials. We analysed trials with multiple treatment groups by treating each pair of arms as a separate comparison, as appropriate.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2015-06-03 13:09:17 +0100" MODIFIED_BY="[Empty name]">
<P>We defined 'intention-to-treat analysis' as meaning that all participants were analysed in their randomised groups whether or not they received the allocated intervention. We included data as they were reported for each outcome and did not impute missing values, but used the data as presented by the trialists. Where intraoperative outcomes were reported, we used the number of patients undergoing the described procedure as the denominator. Follow-up outcomes were reported with the exclusion of patients lost to follow-up. We would have performed sensitivity analyses had there been differential dropout from the randomised groups, or another reason to suspect systematic bias from missing data.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2015-06-03 13:09:28 +0100" MODIFIED_BY="[Empty name]">
<P>We used a fixed-effect approach for the analysis unless there was evidence of heterogeneity across trials. Differences between trials were investigated when apparent either through visual inspection of the results, or when statistically significant heterogeneity was demonstrated by using the Chi test at the 10% probability level or assessment of the I statistic (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>).</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2015-06-03 13:09:36 +0100" MODIFIED_BY="[Empty name]">
<P>We examined publication bias by means of a funnel plot where there were 10 or more trials contributing to a meta-analysis.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2015-06-03 13:09:45 +0100" MODIFIED_BY="[Empty name]">
<P>We used fixed-effect model analysis for the meta-analyses, except when significant heterogeneity was suspected, when we used a random-effects model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2015-06-03 13:11:25 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Heterogeneity</HEADING>
<P>Where there was no obvious reason for heterogeneity to exist (after consideration of populations, interventions, outcomes and settings of the individual trials), or it persisted despite the removal of trials that were clearly different from the others, we used a random-effects model.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Subgroup analysis</HEADING>
<P>Clinical factors such as symptoms of SUI, USI, MUI, diagnosis of intrinsic urethral sphincter deficiency or urethral hypermobility, obesity, previous incontinence surgery, presence or absence of prolapse, anaesthesia used, or experience of the surgeon and other concomitant surgical intervention, might all influence the outcomes of surgery and consideration of subgroup analysis was taken into account.</P>
</SUBSECTION>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2017-07-06 16:05:20 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;span modified=&quot;2014-06-13 00:53:00 +0100&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;H&lt;/span&gt;ow do i activate the 'Summary of findings' as a heading (heading 3)&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2017-07-06 16:05:20 +0100" NOTES_MODIFIED_BY="[Empty name]">
<P>We performed sensitivity analysis to explore the robustness of the results in some outcomes. We planned to carry out sensitivity analysis for the primary outcomes by restricting our analysis to trials assessed as having a low risk of bias for the of domain attrition bias; if more than 30% of participants had been lost to follow-up, these trials would have been excluded from sensitivity analyses. This was not necessary.</P>
<SUBSECTION>
<HEADING LEVEL="3">Summary of findings</HEADING>
<P>We employed the GRADE approach to interpret findings (<LINK REF="REF-Guyatt-2011a" TYPE="REFERENCE">Guyatt 2011a</LINK>; <LINK REF="REF-Guyatt-2011b" TYPE="REFERENCE">Guyatt 2011b</LINK>; <LINK REF="REF-Guyatt-2013a" TYPE="REFERENCE">Guyatt 2013a</LINK>; <LINK REF="REF-Guyatt-2013b" TYPE="REFERENCE">Guyatt 2013b</LINK>; <LINK REF="REF-Langendam-2013" TYPE="REFERENCE">Langendam 2013</LINK>), and the GRADE profiler (GRADEpro) was used to import data from RevMan 5.2 to create 'Summary of findings&#8217; tables. These tables provide outcome-specific information concerning the overall quality of evidence from trials included in a comparison, the magnitude of effect of the interventions examined, and the sum of the available data on the outcomes we considered.</P>
<P>We included the following outcomes in the 'Summary of findings&#8217; tables.</P>
<UL>
<LI>Subjective cure: medium term (one to five years).</LI>
<LI>Subjective cure: long term (more than 5 years).</LI>
<LI>Bladder or urethral perforation.</LI>
<LI>Voiding dysfunction: short term and medium term (up to five years).</LI>
<LI>De novo urgency or urgency incontinence: short term (less than one year).</LI>
<LI>Vaginal tape erosion: short term and medium term (up to five years).</LI>
<LI>Repeat continence surgery: short term (less than one year).</LI>
<LI>Repeat continence surgery: long term (more than five years).</LI>
<LI>Groin pain: short term (less than one year).</LI>
<LI>Quality of life.</LI>
</UL>
<P>We assessed the overall quality of evidence for these outcomes and downgraded the evidence level from high quality by one level for serious, or by two levels for very serious study limitations (risk of bias), indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias.</P>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-07-24 16:46:28 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2015-06-09 11:08:55 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;&lt;span modified=&quot;2014-07-30 03:10:00 +0100&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;this needs to be updated following addition of scherlitz 5 year data&lt;/span&gt; - 13.10.14 Joe says data not added as authors did not respond with information for the denominator&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;span modified=&quot;2014-12-23 15:50:00 +0000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;Sheila There are now 81 included studies&lt;/span&gt;&lt;span modified=&quot;2014-12-23 16:07:00 +0000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;(with six trials supplying an extra co&lt;/span&gt;&lt;span modified=&quot;2014-12-23 16:08:00 +0000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;mparison each thus there were 87 comparisons)&lt;/span&gt;&lt;span modified=&quot;2014-12-23 15:50:00 +0000&quot; modified_by=&quot;[Empty name]&quot; class=&quot;inserted&quot;&gt;. The PRISMA chart needs to reflect this&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2015-06-09 11:08:55 +0100" NOTES_MODIFIED_BY="[Empty name]">
<P>We screened the 841 records identified by the literature searches and obtained a total of 290 full-text articles for further assessment. Altogether 217 reports concerning 81 randomised trials met the inclusion criteria. A further two trials were ongoing.</P>
<P>We excluded 551 records on the basis of either the title or abstract alone, and 71 reports relating to 62 studies after retrieval of the full text publication. Exclusion was either because they were not randomised trials, they did not include a mid-urethral sling operation, or because the women included in the trial were not urinary incontinent. A full description of these trials can be found in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> section of this review. The flow of literature through the assessment process is shown in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>We analysed trials with multiple treatment groups by treating each pair of arms as a separate comparison, as appropriate. There were six trials in this review that supplied data and for which this method was employed, thus leading to 87 comparisons. There were no trials with non-standard designs, such as cross-over trials and cluster-randomised trials.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<P>Further characteristics of the trials are reported in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies </LINK>table.</P>
<SUBSECTION>
<HEADING LEVEL="4">Comparisons and interventions</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">1. Transobturator (TOR) versus retropubic route (RPR)</HEADING>
<P>This comparison of mid-urethral sling operations was based on the routes that the tapes traverse, i.e. transobturator route (TOR) versus retropubic route (RPR). There were 55 trials that investigated this (<LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Chen-2012" TYPE="STUDY">Chen 2012</LINK>; <LINK REF="STD-Choe-2013" TYPE="STUDY">Choe 2013</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Diab-2012" TYPE="STUDY">Diab 2012</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Enzelsberger-2005" TYPE="STUDY">Enzelsberger 2005</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Hammoud-2011" TYPE="STUDY">Hammoud 2011</LINK>; <LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Kilic-2007" TYPE="STUDY">Kilic 2007</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Leanza-2009" TYPE="STUDY">Leanza 2009</LINK>; <LINK REF="STD-Lee-2007" TYPE="STUDY">Lee 2007</LINK>; <LINK REF="STD-Liapis-2006" TYPE="STUDY">Liapis 2006</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Mehdiyev-2010" TYPE="STUDY">Mehdiyev 2010</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Oliveira-2006" TYPE="STUDY">Oliveira 2006</LINK>; <LINK REF="STD-Palomba-2008" TYPE="STUDY">Palomba 2008</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Rechberger-2009" TYPE="STUDY">Rechberger 2009</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; Ross 2009; <LINK REF="STD-Salem-2014" TYPE="STUDY">Salem 2014</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">2. Retropubic bottom-to-top approach versus retropubic top-to-bottom approach</HEADING>
<P>Trials in this group compared the retropubic bottom-to-top approach (e.g. tension-free vaginal tape (TVT<SUP>TM</SUP>); tape inserted from the vagina through the retropubic space and exiting onto the abdominal skin in the suprapubic region) with a retropubic top-to-bottom approach (e.g. suprapubic urethral support sling (SPARC<SUP>TM</SUP>); tape inserted from the abdomen in the suprapubic region through the retropubic space and exiting in the vagina). There were five such trials (<LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">3. Obturator medial-to-lateral approach versus obturator lateral-to-medial approach</HEADING>
<P>Ten trials reported on this comparison which compared tapes traversing the obturator route: obturator lateral-to-medial approach, (e.g. TOT<SUP>TM</SUP> tape inserted in the thigh crease and through the obturator route exiting in the vagina) with obturator medial-to-lateral approach (e.g. TVT-O<SUP>TM</SUP> tape inserted in the vagina and through the obturator route exiting in the thigh crease; <LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>; <LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK>; <LINK REF="STD-Lee-2008" TYPE="STUDY">Lee 2008</LINK>; <LINK REF="STD-Liapis-2008" TYPE="STUDY">Liapis 2008</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Peattie-2006" TYPE="STUDY">Peattie 2006</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">4. One method of mid-urethral tape insertion versus another method, same route</HEADING>
<P>Ten trials compared different methods of carrying out operations using the same route (<LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>).</P>
<P>The trials compared the following operations.</P>
<SUBSECTION>
<HEADING LEVEL="6">Transobturator lateral to medial</HEADING>
<UL>
<LI>Monarc<SUP></SUP> TOT versus TOT<SUP></SUP> (<LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>).</LI>
<LI>TOT versus adjustable TOT (<LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>).</LI>
<LI>TOT versus TOT with two-point fixation sutures (<LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>).</LI>
<LI>Synthetic TOT versus biological TOT (<LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Transobturator medial to lateral</HEADING>
<UL>
<LI>TVT-O versus modified TVT-O (shorter tape and less lateral dissection; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>).</LI>
<LI>TVT-O versus TVT-O plus Ingleman-Sundberg bladder denervation procedure (<LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>).</LI>
<LI>TVT-O versus modified TVT-O (reduced dissection; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>).</LI>
<LI>TVT-O versus modified TVT-O (self-tailored mesh; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Retropubic</HEADING>
<UL>
<LI>TVT versus modified TVT, bottom-to-top (suburethral pad; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>).</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">5. One type of tape material versus another</HEADING>
<P>A final group compared different mid-urethral sling operations based on the properties of the tape material. All used synthetic non-absorbable mesh for the tape material, but differed in the structure of the material, i.e. monofilament tapes versus multifilament tapes. There were four such trials (<LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>), which made the following comparisons.</P>
<UL>
<LI>Monofilament (TVT SPARC) verus multifilament (IVS; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>).</LI>
<LI>Monofilament (TVT) versus multifilament (IVS; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>).</LI>
<LI>Synthetic monofilament (prolene light mesh) versus a combined synthetic mesh coated with a biological film (Ultrapro mesh) versus a multifilament mesh (Vypro; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>).</LI>
<LI>Monofilament (TVT) versus multifilament (IVS; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>).</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Publication type and sample characteristics</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">1. Retropubic route versus transobturator route</HEADING>
<P>The sample sizes ranged from 20 to 597; with a median of 131.</P>
<P>Twelve of the 55 trials were reported only as abstracts (<LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-Choe-2013" TYPE="STUDY">Choe 2013</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-Diab-2012" TYPE="STUDY">Diab 2012</LINK>; <LINK REF="STD-Hammoud-2011" TYPE="STUDY">Hammoud 2011</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Leanza-2009" TYPE="STUDY">Leanza 2009</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Oliveira-2006" TYPE="STUDY">Oliveira 2006</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; <LINK REF="STD-Salem-2014" TYPE="STUDY">Salem 2014</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>).</P>
<P>Inclusion and exclusion criteria were not clearly stated in eight trials (<LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Mehdiyev-2010" TYPE="STUDY">Mehdiyev 2010</LINK>; <LINK REF="STD-Oliveira-2006" TYPE="STUDY">Oliveira 2006</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>).</P>
<P>All trials had women either presenting with SUI or had USI confirmed. In addition other characteristics included:</P>
<UL>
<LI>23 trials included women with MUI (<LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Lee-2007" TYPE="STUDY">Lee 2007</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>).</LI>
<LI>ten trials included women with previous incontinence surgery (<LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Lee-2007" TYPE="STUDY">Lee 2007</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>).</LI>
<LI>28 trials included women with pelvic organ prolapse (POP; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-Chen-2012" TYPE="STUDY">Chen 2012</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Rechberger-2009" TYPE="STUDY">Rechberger 2009</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>).</LI>
<LI>in 13 trials women had concomitant pelvic or prolapse surgery (<LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>).</LI>
</UL>
<P>Follow-up for women ranged from one month to five years with a median follow-up of 12 months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Retropubic bottom-to-top approach versus retropubic top-to-bottom approach</HEADING>
<P>Five trials investigated a retropubic bottom-to-top approach versus a retropubic top-to-bottom approach (<LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>). One of the five trials was reported only as an abstract (<LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>), and this was the only study without clear inclusion and exclusion criteria.</P>
<P>The sample sizes ranged from 62 to 304; the average sample size, <I>'n'</I> (standard deviation), for retropubic in-out was 62 (49) and for retropubic out-in was 64 (53).</P>
<P>All trials had women either presenting with SUI or had USI confirmed. All trials except <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK> included women with MUI. <LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK> and <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK> included women with previous incontinence surgery.</P>
<P>All the trials included women with POP and had concomitant pelvic or POP surgery performed.</P>
<P>Follow-up for women ranged from 1.5 months to 2 years with a median of 12 months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. Obturator medial-to-lateral approach versus obturator lateral-to-medial approach</HEADING>
<P>Nine trials compared the obturator medial-to-lateral approach with the obturator lateral-to-medial approach (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>; <LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK>; <LINK REF="STD-Lee-2008" TYPE="STUDY">Lee 2008</LINK>; <LINK REF="STD-Liapis-2008" TYPE="STUDY">Liapis 2008</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>). With the exception of <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>, which was reported only as an abstract, the other eight trials were reported as full articles. <LINK REF="STD-Peattie-2006" TYPE="STUDY">Peattie 2006</LINK> appears in a trials registry but its status is unclear; we have contacted the authors and are awaiting a response.</P>
<P>The sample sizes ranged from 74 to 341 with a median size of 110.</P>
<P>Inclusion and exclusion criteria were not clearly stated in two trials (<LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>).</P>
<P>All trials had women either presenting with SUI or had USI confirmed.</P>
<P>Five trials included women with MUI (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Lee-2008" TYPE="STUDY">Lee 2008</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>), and two trials included women who had undergone previous incontinence surgery (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>). <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK> included women with POP and women with concomitant pelvic or POP surgery.</P>
<P>Follow-up ranged from three months to three years with a median follow up of 12 months.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">4. One method of mid-urethral tape insertion versus another method, same route</HEADING>
<P>Ten trials investigated one method of mid-urethral tape versus another method, using the same route (<LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>). Three of these trials were reported only as abstract publications (<LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>). The sample sizes ranged from 72 to 463 with a median of 156.</P>
<P>All the trials included women with SUI or USI. <LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK> reported women with ISD. Inclusion and exclusion criteria were not clearly defined in four of the ten trials (<LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>). <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>, <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK> and <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK> included women with MUI, whilst <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK> and <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK> included women who had undergone previous incontinence surgery. Women with prolapse were included in <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK> and <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>, but concomitant POP surgery was performed only in <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>.</P>
<P>Follow-up ranged from three months to three years.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5. One type of tape material versus another</HEADING>
<P>Four trials investigated the use of monofilament tape versus multifilament tape (<LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>). All four trials were reported as full article publications.</P>
<P>The sample sizes ranged from 70 to 182 with a median value of 144.</P>
<P>The trials had women either presenting with SUI or had USI confirmed: all had clear inclusion and exclusion criteria. Three trials included women with POP (<LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>). Two trials included women with MUI (<LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>). Three trials included women with previous incontinence surgery (<LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>), whereas only <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK> included women who had concomitant pelvic or POP surgery.</P>
<P>Follow-up for women ranged from three months to three years.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>The trials reported their outcomes in a variety of different ways. The primary outcome, subjective cure of urinary incontinence (UI), was defined as follows:</P>
<UL>
<LI>no subjective report of UI (<LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>; <LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK>; <LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>; <LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Leanza-2009" TYPE="STUDY">Leanza 2009</LINK>; <LINK REF="STD-Liapis-2006" TYPE="STUDY">Liapis 2006</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>);</LI>
<LI>no subjective report of UI and negative stress test (<LINK REF="STD-Lee-2007" TYPE="STUDY">Lee 2007</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>; <LINK REF="STD-Rechberger-2009" TYPE="STUDY">Rechberger 2009</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>);</LI>
<LI>no or improved subjective report of UI (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; Ross 2009; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</LI>
</UL>
<P>Secondary outcome objective cure was defined by the trialists as follows:</P>
<UL>
<LI>absence of USI on urodynamics (UDS) (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-Enzelsberger-2005" TYPE="STUDY">Enzelsberger 2005</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Kilic-2007" TYPE="STUDY">Kilic 2007</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>);</LI>
<LI>absence of SUI and negative stress test (<LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>);</LI>
<LI>one-hour pad test less than 2 g (<LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; Ross 2009; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>);</LI>
<LI>24-hour pad test less than 5 g (<LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>);</LI>
<LI>negative stress test (<LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>);</LI>
<LI>multiple objective measures used (<LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Liapis-2006" TYPE="STUDY">Liapis 2006</LINK>; <LINK REF="STD-Liapis-2008" TYPE="STUDY">Liapis 2008</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Oliveira-2006" TYPE="STUDY">Oliveira 2006</LINK>; <LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>).</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<P>We excluded 62 studies after retrieval of the full text publication because they were not randomised trials, did not include a mid-urethral sling operation, the participants did not have urinary incontinence, or the participants were randomised to an intervention other than a mid-urethral sling (such as no treatment, pelvic floor muscle training, drugs, or a different class of surgery). The details of the reasons for exclusion are given in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
<SUBSECTION>
<HEADING LEVEL="4">Ongoing trials</HEADING>
<P>There are two ongoing trials: <LINK REF="STD-Cavkaytar-2013" TYPE="STUDY">Cavkaytar 2013</LINK> and <LINK REF="STD-Sung-2013" TYPE="STUDY">Sung 2013</LINK>.</P>
<P>
<LINK REF="STD-Cavkaytar-2013" TYPE="STUDY">Cavkaytar 2013</LINK> is a randomised controlled trial (RCT) comparing RPR and TOR for the treatment of SUI in women with no intrinsic sphincter deficiency. This study is currently recruiting and includes women with SUI and excludes women with MUI or detrusor overactivity (DO), previous incontinence surgery, and women with a body mass index greater than 35. Fifty women have been randomly assigned into each arm for evaluation. </P>
<P>
<LINK REF="STD-Sung-2013" TYPE="STUDY">Sung 2013</LINK> is an RCT comparing mid-urethral sling operations and behavioural or pelvic floor therapy in combination versus suburethral sling operations alone for women with MUI. The ESTEEM trial includes women over 18 years of age who have had urodynamic investigation within the last 18 months, and excludes women with prolapse, previous incontinence surgery, and women currently on antimuscarinic medication. This trial is currently recruiting participants.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Studies awaiting classification</HEADING>
<P>There are no studies awaiting classification.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">New trials included in this update</HEADING>
<P>We have included 48 new trials in this update (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Chen-2012" TYPE="STUDY">Chen 2012</LINK>; <LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-Choe-2013" TYPE="STUDY">Choe 2013</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-Diab-2012" TYPE="STUDY">Diab 2012</LINK>; <LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>; <LINK REF="STD-Hammoud-2011" TYPE="STUDY">Hammoud 2011</LINK>; <LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Kilic-2007" TYPE="STUDY">Kilic 2007</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Leanza-2009" TYPE="STUDY">Leanza 2009</LINK>; <LINK REF="STD-Mehdiyev-2010" TYPE="STUDY">Mehdiyev 2010</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Palomba-2008" TYPE="STUDY">Palomba 2008</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Peattie-2006" TYPE="STUDY">Peattie 2006</LINK>; <LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; Ross 2009; <LINK REF="STD-Salem-2014" TYPE="STUDY">Salem 2014</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Previously included trials with new outcome data</HEADING>
<P>We have included new data from 11 trials previously included in this review, including the report of medium- or long-term outcomes (<LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Rechberger-2009" TYPE="STUDY">Rechberger 2009</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Previously included trials with no new outcome data</HEADING>
<P>Twenty-two trials included in the earlier version of this review have not published new outcome data (<LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Enzelsberger-2005" TYPE="STUDY">Enzelsberger 2005</LINK>; <LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Lee-2007" TYPE="STUDY">Lee 2007</LINK>; <LINK REF="STD-Lee-2008" TYPE="STUDY">Lee 2008</LINK>; <LINK REF="STD-Liapis-2006" TYPE="STUDY">Liapis 2006</LINK>; <LINK REF="STD-Liapis-2008" TYPE="STUDY">Liapis 2008</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Oliveira-2006" TYPE="STUDY">Oliveira 2006</LINK>; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>; <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK>).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<P>Details of the criteria used to assess the risk of bias and the ratings for each study are reported in the 'Risk of bias' tables that accompany the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. Further information on the risk of bias in included trials is shown in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> the 'Risk of bias' graph and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK> the &#8216;Risk of bias' summary.</P>
<P>The risk of bias in the trials included was variable, though overall only few trials were judged to be at high risk of bias. In over 50% of trials the random sequence generation was judged to be adequate, for example with the use of a computer-generated list or a table of random numbers. Approximately 30% of trials confirmed that secure concealment of the randomisation process was used, for example allocation by a remote person or the use of sealed envelopes.</P>
<P>Blinding of participants was unclear in the majority of trials. This is an obvious limitation with trials comparing surgical interventions, though one trial described the use of a 'sham' procedure (<LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>). Blinding of patients and the post-operative reviewer was not reported in most trials. Loss to follow-up in most trials was minimal, and in approximately 50% of included trials the risk of attrition bias was judged to be low.</P>
<P>We judged that 39 trials had adequate random sequence generation (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-Chen-2012" TYPE="STUDY">Chen 2012</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; Ross 2009; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</P>
<P>We judged that adequate allocation concealment occurred in 26 trials (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; Ross 2009; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</P>
<P>We judged that 24 trials had an adequate randomisation process and secure concealment of the randomisation process (<LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; Ross 2009; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</P>
<P>We judged that 22 trials adequately blinded outcome assessors (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Liapis-2006" TYPE="STUDY">Liapis 2006</LINK>; <LINK REF="STD-Liapis-2008" TYPE="STUDY">Liapis 2008</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</P>
<P>We judged 36 trials to be at a low risk of attrition bias (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Liapis-2006" TYPE="STUDY">Liapis 2006</LINK>; <LINK REF="STD-Liapis-2008" TYPE="STUDY">Liapis 2008</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Rechberger-2009" TYPE="STUDY">Rechberger 2009</LINK>; Ross 2009; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-07-24 16:46:28 +0100" MODIFIED_BY="[Empty name]">
<P>The results of all the included studies can be found in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 1. Transobturator versus retropubic route</HEADING>
<P>Fifty-five trials addressed this comparison (<LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Alkady-2009" TYPE="STUDY">Alkady 2009</LINK>; <LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Aniuliene-2009" TYPE="STUDY">Aniuliene 2009</LINK>; <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Cervigni-2006" TYPE="STUDY">Cervigni 2006</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Chen-2012" TYPE="STUDY">Chen 2012</LINK>; <LINK REF="STD-Choe-2013" TYPE="STUDY">Choe 2013</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-Diab-2012" TYPE="STUDY">Diab 2012</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Enzelsberger-2005" TYPE="STUDY">Enzelsberger 2005</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Hammoud-2011" TYPE="STUDY">Hammoud 2011</LINK>; <LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>; <LINK REF="STD-Kamel-2009" TYPE="STUDY">Kamel 2009</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Kilic-2007" TYPE="STUDY">Kilic 2007</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Leanza-2009" TYPE="STUDY">Leanza 2009</LINK>; <LINK REF="STD-Lee-2007" TYPE="STUDY">Lee 2007</LINK>; <LINK REF="STD-Liapis-2006" TYPE="STUDY">Liapis 2006</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Mehdiyev-2010" TYPE="STUDY">Mehdiyev 2010</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Oliveira-2006" TYPE="STUDY">Oliveira 2006</LINK>; <LINK REF="STD-Palomba-2008" TYPE="STUDY">Palomba 2008</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Rechberger-2009" TYPE="STUDY">Rechberger 2009</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; Ross 2009; <LINK REF="STD-Salem-2014" TYPE="STUDY">Salem 2014</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-van-Leijsen-2013" TYPE="STUDY">van Leijsen 2013</LINK>; <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2009" TYPE="STUDY">Wang 2009</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">1.1 Women's observations</HEADING>
<P>Subjective cure within 12 months was reported in 36 trials with a total of 5514 participants. Assessment of cure was self-reported by participants and by responses to symptom-based questionnaires. The combined results from the 36 trials showed no statistically significant difference in the subjective cure rates between the two routes (RR 0.98, 95% CI 0.96 to 1.00; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). The short-term subjective cure ranged from 62% to 98% for TOR and from 71% to 97% for RPR.</P>
<P>The mean subjective cure rate across both groups was 83.3% and, using this as the assumed control subjective cure rate in the RPR group, for every 1000 women there were 17 fewer cured in the TOR group (95% CI from 0 fewer to 33 fewer per 1000). This was not statistically significant and is also unlikely to be considered to be a clinically significant difference. The funnel plot inspection shows no strong evidence of publication bias <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>.</P>
<P>There was also no statistically significant difference between the two groups in terms of symptomatic improvement and cure rate (RR 0.98, 95% CI 0.96 to 1.00; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="5">Medium-term outcomes</HEADING>
<P>Only seven trials provided information after the first year (<LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Nyyssonen-2014" TYPE="STUDY">Nyyssonen 2014</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>). Five trials (683 participants) contributed medium-term data between one and five years after surgery, which showed no significant difference in subjective cure between the two groups (RR 0.97, 95% CI 0.87 to 1.09; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). Subjective cure rates ranged from 82% to 91% in the TOR group and from 77% to 98% in the RPR group.</P>
<P>The average medium-term subjective cure rate across both groups was 86.9% and, using this as the assumed control cure rate in the RPR group, for every 1000 women there were 26 fewer women cured in the TOR group (95% CI from 26 per 1000 more to 70 per 1000 fewer).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Long-term outcomes</HEADING>
<P>Four trials (714 women) reported long-term results for subjective cure after five years (<LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>); the difference between the groups was not statistically significant (RR 0.95, 95% CI 0.80 to 1.12; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). Subjective cure rates range from 43% to 92% in the TOR group and from 51% to 88% in the RPR group.</P>
<P>The average long-term subjective cure rate across both groups was 84.3% and, using this as the assumed control cure rate in the RPR group, for every 1000 women there were 42 fewer women cured in the TOR group (95% CI from 110 per 1000 less to 34 per 1000 more).</P>
<P>Two trials with 340 women reported long-term data for subjective cure and improvement and the difference between the groups was not statistically significant (RR 0.92, 95% CI 0.67 to 1.28; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>); due to significant heterogeneity we also performed a random-effects analysis that produced similar results and, as there were only two trials, the fixed-effect analysis was maintained.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.2 Quantification of symptoms</HEADING>
<P>Only two trials provided data about pad test weights (<LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK> used a non standardised modified/simplified pad test and <LINK REF="STD-Wang-2006" TYPE="STUDY">Wang 2006</LINK> used the standard one-hour pad test). The information provided was not suitable for meta-analysis, but each reported a significant reduction in pad weight postoperatively in each group without a significant difference between the groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.3 Clinician's observations</HEADING>
<P>Objective cure was assessed by 40 trials with 6145 participants in the short term using a variety of measures such as urodynamic assessment, negative cough-stress test, one-hour pad test of 2 g or less, one-hour pad test of 1 g or less, and 24-hour pad test of 5g or less. The cure rate with the obturator route was 85.7% versus 87.2% for the RPR (RR 0.98, 95% CI 0.96 to 1.00, <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). The confidence interval was narrow and this statistically non significant difference between the groups (2%) is unlikely to represent a clinically significant difference in outcome between the two methods in the short term.</P>
<P>The small difference in the objective cure and improvement rate in the short term was not statistically - nor was it likely to be clinically - significant (RR 0.98, 95% CI 0.96 to 1.01; 10 studies, 1478 women; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). The same holds true for the medium-term objective cure rates (RR 1.00, 95% CI 0.95 to 1.06; 5 studies, 596 women; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>), and long-term cure rates (RR 0.97, 95% CI 0.90 to 1.06; 3 studies, 400 women; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.4 Surgical outcome measures</HEADING>
<P>Duration of operation was significantly shorter, by an average of approximately seven minutes, with the TOR compared with the RPR (MD -7.54 minutes, 95% CI -9.31 to -5.77). There was statistically significant heterogeneity, but all the trials reported a shorter operating time with the TOR. This may be attributable to most surgeons routinely performing a cystoscopy following a RPR procedure, but not necessarily doing this after a TOR procedure.</P>
<P>To investigate this theory, we performed a sensitivity analysis to assess the difference in operative time between the RPR and TOR approach in trials where cystoscopy was performed in both comparison groups as defined by the trialists. In eight trials where cystoscopy was performed in both TOR and RPR groups we still found a shorter operating time with the TOR in comparison to the RPR (MD -6.50 95% CI -7.57 to -5.44) although high heterogeneity persisted. Using a random-effects method on the full analysis of 31 trials still showed the duration of operation to be statistically significantly shorter with TOR approach (MD -7.54 minutes, 95% CI -9.31 to -5.77; <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
<P>Intraoperative blood loss was small (mean loss ranged from 15 ml to 125 ml), but was significantly less with the TOR approach (MD -6.49 ml, 95% CI -12.33 to -0.65; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). There was significant heterogeneity that was accounted for by three small trials (<LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>). In view of the small blood volumes involved, this is unlikely to be a clinically significant finding.</P>
<P>Length of stay was also significantly shorter by an average of 0.17 days with the TOR compared with the retropubic route (MD -0.17, 95% CI -0.25 to -0.10; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>). A high level of between-study heterogeneity (I 94%) was present with the length of stay, thus a random-effects model was used, which then showed no significant difference (MD -0.25, 95% CI -0.59 to 0.09; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P>
<P>The mean time the women took to return to normal activity ranged from under two weeks to just over five weeks, with no statistically significant difference between the two surgical approaches (MD -0.05, 95% CI -0.15 to 0.06; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>). This confirms the minimally invasive nature of both operations, compared with a more normal recovery period of three months after major abdominal surgery.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.5 Adverse events</HEADING>
<P>In trials where overall perioperative complication rates were reported there were no statistically significant differences in the rate of perioperative complications between the TOR and RPR groups (RR 0.91, 95% CI 0.73 to 1.14; <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>).</P>
<P>In trials where specific complications were recorded there were significant differences in the rate of each individual complication sustained.</P>
<SUBSECTION>
<HEADING LEVEL="5">Major vascular/visceral injury</HEADING>
<P>Major vascular injury such as retropubic haematoma or major visceral injury, for example bowel perforation, was reported by 28 trials with 4676 women. This occurred significantly less often with TOR than with RPR (RR 0.33, 95% CI 0.19 to 0.55; <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Bladder/urethral perforation</HEADING>
<P>Forty trials assessed rate of bladder perforation. The rate was significantly lower in the TOR group than the RPR group (RR 0.13, 95% CI 0.08 to 0.20; <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>). The average bladder perforation rate across both groups was 2.54% and, using this as the assumed control bladder perforation rate in the RPR group, there were 22 fewer perforations per 1000 in the TOR group (95% CI from 20 to 23 per 1000 fewer). There was some degree of asymmetry in the funnel plot, which raised the possibility of some publication bias <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Postoperative voiding dysfunction (POVD)</HEADING>
<P>Rates of postoperative voiding dysfunction (POVD) was assessed in 37 trials with 6200 participants. This showed significantly lower rates in the TOR group than in the RPR group (RR 0.53 95% CI 0.43 to 0.65; <LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>). The average POVD rate across both groups was 5.53% and, using this as the assumed control rate in the RPR group, there were 26 fewer POVD per 1000 in the TOR group (95% CI from 19 to 32 per 1000 fewer). The funnel plot showed symmetry on visual inspection, which suggests a low likelihood of publication bias <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Urgency and urgency urinary incontinence (UUI)</HEADING>
<P>The 31 trials (4923 women) that reported de novo urgency and urgency urinary incontinence (UUI) showed no statistically significant difference between the two groups (RR 0.98, 95% CI 0.82 to 1.17; <LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>). In the short term the average rate of de novo urgency/UUI across both groups was 8.35% and, using this as the assumed control rate in the RPR group, there were two fewer cases per 1000 in the TOR group (95% CI from 15 per 1000 fewer to 14 per 1000 more).</P>
<P>Equally, in the medium term the rate of de novo urgency and UUI was not significantly different (RR 0.98, 95% CI 0.55 to 1.73, <LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>). <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK> reported long-term data for de novo urgency and UUI for 253 women; this showed no difference between the groups (RR 0.81, 95% CI 0.18 to 3.53; 253 women; <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>).</P>
<P>Four trials with 853 women with DO showed a rate of 8% in both groups (RR 1.00, 95% CI 0.58 to 1.73; <LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>).</P>
<P>In one trial of women with MUI (<LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>), 84% who had pre-existing moderate or severe urinary frequency and urgency symptoms were cured of these symptoms post operatively at the five-year follow-up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Vaginal tape erosion</HEADING>
<P>Vaginal tape erosion was assessed in 31 trials with 4743 participants. No significant difference was demonstrated between the groups (RR 1.13, 95% CI 0.78 to 1.65; <LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>). The average rate of vaginal tape erosion across both groups was 2.09%, and, using this as the assumed control rate in the RPR group, there were three more cases per 1000 in the TOR group (95% CI from 5 per 1000 fewer to 14 per 1000 more). The funnel plot showed symmetry on visual inspection suggesting low likelihood of publication bias <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>. In the one trial that reported long-term tape erosion (<LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>), no tape erosion was reported in either group. Bladder or urethral tape erosion was assessed in four trials with 374 participants. No significant difference was demonstrated between the groups (RR 0.34, 95% CI 0.01 to 8.13; <LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Pain</HEADING>
<P>There was a significantly higher occurrence of groin pain in women who underwent a TOR procedure than in women who underwent a RPR procedure (RR 4.12, 95% CI 2.71 to 6.27; <LINK REF="CMP-001.24" TYPE="ANALYSIS">Analysis 1.24</LINK>). The average rate of groin pain across both groups was 4.51% and, using this as the assumed control rate in the RPR group, there were 163 more cases per 1000 in the TOR group (95% CI from 94 to 266 per 1000 more). Conversely, suprapubic pain was found to be significantly lower in women who underwent a TOR procedure than a RPR procedure (RR 0.29, 95% CI 0.11 to 0.78; <LINK REF="CMP-001.25" TYPE="ANALYSIS">Analysis 1.25</LINK>). Both groin and suprapubic pain occurrence were short-lasting, with most resolving within the first six months. The duration of pain ranged from two to 52 weeks, with a median duration of eight weeks. The funnel plot for groin pain showed symmetry on visual inspection, suggesting low likelihood of publication bias <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.6 Need for further treatment</HEADING>
<P>Nine trials (1402 women) reported the number of women who required repeat incontinence surgery in the short term (up to one year). The difference between the TOR and RPR groups was not statistically significant (RR 1.64, 95% CI 0.85 to 3.16; <LINK REF="CMP-001.26" TYPE="ANALYSIS">Analysis 1.26</LINK>). The average rate of repeat incontinence surgery in the short term across both groups was 2.43% and, using this as the assumed control rate in the RPR group, there were 12 more cases per 1000 in the TOR group (95% CI from 3 per 1000 fewer to 41 per 1000 more).</P>
<P>More women required repeat incontinence surgeries in the TOR group in the medium term (RR 21.89, 95% CI 4.36 to 109.77; two studies, 355 women; <LINK REF="CMP-001.27" TYPE="ANALYSIS">Analysis 1.27</LINK>).</P>
<P>In the long term, three trials with data from 487 women, found that more women required repeat incontinence surgery in the TOR group (RR 8.79, 95% CI 3.36 to 23.00; <LINK REF="CMP-001.28" TYPE="ANALYSIS">Analysis 1.28</LINK>). The average rate of repeat incontinence surgery in the long term across both groups was 5.34% and, using this as the assumed control rate in the RPR group, there were 231 more cases per 1000 in the TOR group (95% CI from 45 to 767/1000 more).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1.7 Quality of life</HEADING>
<P>Thirty-three of the 55 trials in this comparison assessed quality of life (QoL; <LINK REF="STD-Aigmuller-2014" TYPE="STUDY">Aigmuller 2014</LINK>; <LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Chen-2012" TYPE="STUDY">Chen 2012</LINK>; <LINK REF="STD-Darabi-Mahboub-2012" TYPE="STUDY">Darabi Mahboub 2012</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-El_x002d_Hefnawy-2010" TYPE="STUDY">El-Hefnawy 2010</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Jakimiuk-2012" TYPE="STUDY">Jakimiuk 2012</LINK>; <LINK REF="STD-Karateke-2009" TYPE="STUDY">Karateke 2009</LINK>; <LINK REF="STD-Kim-2005" TYPE="STUDY">Kim 2005</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Leanza-2009" TYPE="STUDY">Leanza 2009</LINK>; <LINK REF="STD-Mansoor-2003" TYPE="STUDY">Mansoor 2003</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Nerli-2009" TYPE="STUDY">Nerli 2009</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; Ross 2009; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Tanuri-2010" TYPE="STUDY">Tanuri 2010</LINK>; <LINK REF="STD-Tarcan-2011" TYPE="STUDY">Tarcan 2011</LINK>; <LINK REF="STD-Teo-2011" TYPE="STUDY">Teo 2011</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>; <LINK REF="STD-Wang-2010" TYPE="STUDY">Wang 2010</LINK>; <LINK REF="STD-Wang-2011" TYPE="STUDY">Wang 2011</LINK>; <LINK REF="STD-Zullo-2007" TYPE="STUDY">Zullo 2007</LINK>); however only 11 of these trials reported QoL scores (<LINK REF="STD-Andonian-2007" TYPE="STUDY">Andonian 2007</LINK>; <LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-David_x002d_Montefiore-2006" TYPE="STUDY">David-Montefiore 2006</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Laurikainen-2007" TYPE="STUDY">Laurikainen 2007</LINK>; <LINK REF="STD-Meschia-2007" TYPE="STUDY">Meschia 2007</LINK>; <LINK REF="STD-Porena-2007" TYPE="STUDY">Porena 2007</LINK>; <LINK REF="STD-Riva-2006" TYPE="STUDY">Riva 2006</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>; <LINK REF="STD-Wang-2008" TYPE="STUDY">Wang 2008</LINK>).</P>
<P>A wide variety of measures were used by different trials to assess this outcome, including:</P>
<SUBSECTION>
<HEADING LEVEL="5">Condition-specific measures</HEADING>
<UL>
<LI>Incontinence Impact Questionnaire (IIQ-7).</LI>
<LI>Urogenital Distress Inventory (UDI-6).</LI>
<LI>International Consultation on Incontinence Questionnaire (ICIQ).</LI>
<LI>Urinary Incontinence Quality of Life Scale (I-QOL).</LI>
<LI>Kings Health Questionnaire (KHQ).</LI>
<LI>Bristol Female Lower Urinary Tract Symptoms questionnaire (BFLUTS).</LI>
<LI>Women Irritative Prostate Symptoms Score (W-IPSS).</LI>
<LI>Urinary Incontinence Severity Score (UISS).</LI>
<LI>Detrusor Instability Score (DIS).</LI>
<LI>A Visual Analogue Scale (VAS).</LI>
<LI>CONTILIFE.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Generic measures</HEADING>
<UL>
<LI>EuroQoL 5-Dimensional Classification Component Scores (EuroQoL-5D).</LI>
<LI>Short-Form Health-Related QoL (SF-36).</LI>
<LI>Patient Global Impression of Severity (PGI-S).</LI>
<LI>Patient Global Impression of Improvement (PGI-I).</LI>
</UL>
<P>The data on quality of life outcomes were reported in different ways, which precluded meta-analysis. In general, with the exception of <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK>, all trials found that women's QoL improved significantly post-operatively within each group, but no statistically significant differences were found between the randomised groups. Only the <LINK REF="STD-Araco-2008" TYPE="STUDY">Araco 2008</LINK> trial found the I-QOL scores to be statistically significantly higher postoperatively after the retropubic approach.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sexual function quality of life measures</HEADING>
<P>Sexual function was addressed in 10 trials (<LINK REF="STD-Barber-2008" TYPE="STUDY">Barber 2008</LINK>; <LINK REF="STD-Barry-2008" TYPE="STUDY">Barry 2008</LINK>; <LINK REF="STD-Deffieux-2010" TYPE="STUDY">Deffieux 2010</LINK>; <LINK REF="STD-de-Tayrac-2004" TYPE="STUDY">de Tayrac 2004</LINK>; <LINK REF="STD-Freeman-2011" TYPE="STUDY">Freeman 2011</LINK>; <LINK REF="STD-Krofta-2010" TYPE="STUDY">Krofta 2010</LINK>; <LINK REF="STD-Richter-2010" TYPE="STUDY">Richter 2010</LINK>; Ross 2009; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>; <LINK REF="STD-Schierlitz-2008" TYPE="STUDY">Schierlitz 2008</LINK>), which used a variety of measures including validated questionnaires and direct questioning. Questionnaires employed were:</P>
<UL>
<LI>Prolapse/Incontinence Symptoms Questionairre (PISQ-12);</LI>
<LI>Bristol Female Lower Urinary Tract Symptoms questionnaire (BFLUTS);</LI>
<LI>International Consultation on Incontinence Questionnaire Lower Urinary Tract Symptoms quality of life questionnaire (ICIQ-LUTSqol); and</LI>
<LI>Visual Analogue Scale (VAS).</LI>
</UL>
<P>In all the trials there was significant improvement in sexual function from baseline scores during the follow-up period that spanned six to 24 months. There were no significant differences between the two groups. At 24-month follow-up, rates of superficial and deep dyspareunia were low, with no difference between the groups.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 2. Retropubic bottom-to-top approach versus retropubic top-to-bottom approach</HEADING>
<P>Five small trials, with 636 women in total, addressed this comparison (<LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">2.1 Women's observations</HEADING>
<P>Three trials (477 women) investigated subjective cure defined as self-reported absence of urinary leakage on stress (<LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>). In the 12 months following surgery, women were significantly more often dry with the bottom-to-top approach (TVT<SUP>TM</SUP>) compared to the top-to-bottom approach (SPARC<SUP>TM;</SUP> 87.34% versus 79.58%; RR 1.10, 95% CI 1.01 to 1.19; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.2 Quantification of symptoms</HEADING>
<P>No data were reported for this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.3 Clinician's observation</HEADING>
<P>Five trials assessed objective cure using a variety of measures (<LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>; <LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK>; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Lord-2006" TYPE="STUDY">Lord 2006</LINK>; <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>): one-hour pad test of 2g or less, negative stress test on urodynamics (UDS), the observed absence of urinary leakage when the patient coughed while supine and with a comfortably full bladder, and one-hour pad test of 1g or less, respectively. In a total of 622 participants, the objective cure rate was similar between the two groups (94.19% versus 89.10%; RR 1.06, 95% CI 0.97 to 1.17; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.4 Surgical outcome measures</HEADING>
<P>Two small trials, <LINK REF="STD-Kim-2004" TYPE="STUDY">Kim 2004</LINK> and <LINK REF="STD-Tseng-2005" TYPE="STUDY">Tseng 2005</LINK>, reported that there were no statistically significant differences in duration of operation (<LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>) or length of hospital stay (<LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.5 Adverse events</HEADING>
<P>No statistically significant difference was seen in overall perioperative complications, but the confidence interval was wide (RR 0.98, 95% CI 0.53 to 1.84; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>).</P>
<P>Significantly fewer women experienced certain complications with the bottom-to-top approach (TVT<SUP>TM</SUP>), which included:</P>
<UL>
<LI>bladder perforation (RR 0.55, 95% CI 0.31 to 0.98; 5 trials; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>);</LI>
<LI>voiding dysfunction after the bottom-to-top approach (TVT<SUP>TM</SUP>; RR 0.40, 95% CI 0.18 to 0.90; 5 trials; <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>);</LI>
<LI>vaginal tape erosions (RR 0.27, 95% CI 0.08 to 0.95; 4 trials; <LINK REF="CMP-002.10" TYPE="ANALYSIS">Analysis 2.10</LINK>).</LI>
</UL>
<P>There were no statistically significant differences between the two groups with respect to:</P>
<UL>
<LI>postoperative de novo urgency symptoms and UUI (RR 0.84, 95% CI 0.52 to 1.34; 4 trials; <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>); or</LI>
<LI>DO (1 trial; <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>).</LI>
</UL>
<P>However, the confidence intervals were wide for each of these five outcomes, which reflects the small number of trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.6 Need for further treatment</HEADING>
<P>No data were reported on the need for further treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2.7 Quality of life</HEADING>
<P>Only one of the five trials, <LINK REF="STD-Andonian-2005" TYPE="STUDY">Andonian 2005</LINK>, assessed the QoL of women using the Incontinence Impact Questionnaire (IIQ; <LINK REF="REF-Shumaker-1994" TYPE="REFERENCE">Shumaker 1994</LINK>), where a score of less than 50 represents a good QoL, 50 to 70 represents moderate QoL, and over 70 indicates a poor QoL. In this study the mean IIQ scores were similar in the groups preoperatively and improved postoperatively, but there was no significant difference between the groups after operation. At one year follow-up, there was no statistically significant difference in the mean IIQ scores (mean difference of -4.6; 95% CI: -7.5 to 16.7).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 3. Obturator medial-to-lateral approach versus obturator lateral-to-medial approach</HEADING>
<P>Ten trials reported this comparison (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK>; <LINK REF="STD-Chen-2010" TYPE="STUDY">Chen 2010</LINK>; <LINK REF="STD-Hassan-2013" TYPE="STUDY">Hassan 2013</LINK>; <LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK>; <LINK REF="STD-Lee-2008" TYPE="STUDY">Lee 2008</LINK>; <LINK REF="STD-Liapis-2008" TYPE="STUDY">Liapis 2008</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>; <LINK REF="STD-Peattie-2006" TYPE="STUDY">Peattie 2006</LINK>; <LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">3.1 Women's observations</HEADING>
<P>Six trials investigated short-term subjective cure rate and five of these assessed subjective cure and improvement in the short term (within 12 months of surgery). There were no statistically significant differences in either subjective cure rates (RR 1.0, 95% CI 0.96 to 1.06; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>) or subjective cure and improvement rates (RR 1.02, 95% CI 0.97 to 1.08 <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>), and the confidence intervals for each were quite narrow. Two trials reported no statistically significant difference in subjective cure in the medium term (RR 1.06, 95% CI 0.91 to 1.23; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>) and a further two trials reported no significant difference in subjective cure and improvement in the medium term (RR 1.00, 95% CI 0.90 to 1.11; <LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>). There are no published trials with long-term data.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.2 Quantification of symptoms</HEADING>
<P>No data were reported for this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.3 Clinician's observation</HEADING>
<P>Six trials assessed objective cure (short term, &#8804; 1 year); there was no statistically significant difference between the two groups (RR 0.99, 95% CI 0.95 to 1.04; <LINK REF="CMP-003.05" TYPE="ANALYSIS">Analysis 3.5</LINK>), and the confidence interval was narrow. There was also no statistically significant difference in the objective cure or improvement rate between the two groups (RR 1.00, 95% CI 0.95 to 1.07; <LINK REF="CMP-003.06" TYPE="ANALYSIS">Analysis 3.6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.4 Surgical outcome measures</HEADING>
<P>There were no statistically significant differences between the two groups in terms of:</P>
<UL>
<LI>duration of operation, (in minutes, MD 0.52, 95% CI -1.09 to 2.13; 4 studies, 481 women; <LINK REF="CMP-003.07" TYPE="ANALYSIS">Analysis 3.7</LINK>);</LI>
<LI>operative blood loss (in ml, MD 1.11, 95% CI -6.01 to 8.22; 3 studies, 255 women; <LINK REF="CMP-003.08" TYPE="ANALYSIS">Analysis 3.8</LINK>);</LI>
<LI>length of hospital stay (in days, MD -0.77, 95% CI -2.54 to 0.99; 2 studies, 190 women; <LINK REF="CMP-003.09" TYPE="ANALYSIS">Analysis 3.9</LINK>);</LI>
<LI>time to return to normal activity (in weeks, MD -0.60, 95% CI -1.80 to 0.60; 1 study, 100 women; <LINK REF="CMP-003.10" TYPE="ANALYSIS">Analysis 3.10</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.5 Adverse events</HEADING>
<P>Vaginal perforation was significantly less likely to occur with the medial-to-lateral approach (RR 0.25, 95% CI 0.12 to 0.53; I of 43%; <LINK REF="CMP-003.13" TYPE="ANALYSIS">Analysis 3.13</LINK>). The average rate of vaginal wall perforation across both groups was 7.39% and, using this as the assumed control rate in the lateral-to-medial group, there were 55 fewer cases per 1000 in the medial-to-lateral group (95% CI from 35 per 1000 fewer to 65 per 1000 more).</P>
<P>Voiding dysfunction occurred significantly more in the medial-to-lateral compared to the lateral-to-medial group (RR 1.74, 95% CI 1.06 to 2.88; I of 0%; 8 studies, 1121 women; <LINK REF="CMP-003.15" TYPE="ANALYSIS">Analysis 3.15</LINK>). The average rate of POVD across both groups was 5.53% and, using this as the assumed control rate in the lateral-to-medial group, there were 41 more cases per 1000 in the medial-to-lateral group (95% CI from 3 to 104 per 1000 more).</P>
<P>There were no statistically significant differences between the two groups in terms of:</P>
<UL>
<LI>overall perioperative complication rate (RR 1.30, 95% CI 0.23 to 7.51; 2 studies, 214 women; <LINK REF="CMP-003.11" TYPE="ANALYSIS">Analysis 3.11</LINK>);</LI>
<LI>major vascular/visceral injury (RR 0.71, 95% CI 0.23 to 2.19; 4 studies, 622 women; <LINK REF="CMP-003.12" TYPE="ANALYSIS">Analysis 3.12</LINK>);</LI>
<LI>bladder perforation (RR 0.38, 95% CI 0.07 to 1.92; 6 studies, 794 women; <LINK REF="CMP-003.14" TYPE="ANALYSIS">Analysis 3.14</LINK>);</LI>
<LI>de novo urgency symptoms and UUI rates (RR 1.01, 95% CI 0.46 to 2.20; 3 studies, 357 women; <LINK REF="CMP-003.16" TYPE="ANALYSIS">Analysis 3.16</LINK>);</LI>
<LI>detrusor overactivity (RR 0.87, 95% CI 0.27 to 2.84; 1 study, 114 women; <LINK REF="CMP-003.17" TYPE="ANALYSIS">Analysis 3.17</LINK>);</LI>
<LI>vaginal tape erosions (RR 0.42, 95% CI 0.16 to 1.09; 7 studies, 1087 women; <LINK REF="CMP-003.18" TYPE="ANALYSIS">Analysis 3.18</LINK>);</LI>
<LI>groin/thigh pain (9.2% versus 8%; RR 1.15, 95% CI 0.75 to 1.76; 6 studies, 837 women; <LINK REF="CMP-003.19" TYPE="ANALYSIS">Analysis 3.19</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.6 Need for further treatment</HEADING>
<P>Two large trials showed no significant difference in the rates of repeat incontinence surgery in the medium term (4.6% versus 7.1%; RR 0.64, 95% CI 0.32 to 1.30; <LINK REF="CMP-003.20" TYPE="ANALYSIS">Analysis 3.20</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3.7 Quality of life</HEADING>
<P>Quality of life was assessed in five of the ten trials using validated QoL questionnaires. All of these trials reported QoL scores.</P>
<SUBSECTION>
<HEADING LEVEL="5">Condition-specific QoL scores</HEADING>
<UL>
<LI>
<LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK> used the short forms of the IIQ-7 and UDI-6. Within each group there was significant improvement postoperatively compared to scores obtained preoperatively, but no significant postoperative differences between the two groups (MD 16.54, 95% CI 4.84 to 28.24; 1 study, 42 women).</LI>
<LI>
<LINK REF="STD-But-2008" TYPE="STUDY">But 2008</LINK> assessed QoL with IIQ and UDI questionnaires and VAS scores, but reported no results.</LI>
<LI>
<LINK REF="STD-Lee-2008" TYPE="STUDY">Lee 2008</LINK> used a validated Korean version of the Incontinence QoL questionnaire (I-QoL) and showed improvements within the groups, but with no significant differences between the groups after surgery.</LI>
<LI>
<LINK REF="STD-Scheiner-2012" TYPE="STUDY">Scheiner 2012</LINK> used the KHQ and found no significantly difference between the groups at baseline and postoperatively, but with improvement following surgery compared to baseline scores in all domains.</LI>
<LI>
<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK> used the KHQ, Birmingham Bowel and Urinary Symptoms Questionnaire (BBUSQ-22), PISQ-12, PGI-I and the short form of the ICIQ (ICIQ-SF) to assess QoL. Overall there was statistically significant improvement in total scores, as well as in each of the nine domains of the KHQ. This remained the case when comparing baseline score in each group postoperatively; there was no significant difference in the QoL scores between the two routes.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sexual function</HEADING>
<P>Sexual function was addressed in three trials that used a variety of measures including validated questionnaires and direct questioning (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>; <LINK REF="STD-Houwert-2009" TYPE="STUDY">Houwert 2009</LINK>; <LINK REF="STD-Park-2012" TYPE="STUDY">Park 2012</LINK>). Questionnaires included: the PISQ-12, and BFLUTS (<LINK REF="STD-Abdel_x002d_Fattah-2010" TYPE="STUDY">Abdel-Fattah 2010</LINK>). There was significant improvement in PISQ-12 scores following surgery (improved sexual function compared to baseline), but no significant difference between the two groups at follow-up. Rates of dyspareunia following surgery were extremely low, with evidence of resolution by 24 months.<BR/>
</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 4. One method of mid-urethral tape insertion versus another method, same route</HEADING>
<P>Ten trials compared different methods of carrying out TOR and RPR operations using the same route (<LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>; <LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>; <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>; <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>). The following operations were compared.</P>
<SUBSECTION>
<HEADING LEVEL="4">Transobturator lateral-to-medial</HEADING>
<UL>
<LI>Monarc<SUP></SUP> TOT versus TOT<SUP></SUP> (<LINK REF="STD-Cho-2010" TYPE="STUDY">Cho 2010</LINK>).</LI>
<LI>TOT versus adjustable TOT (<LINK REF="STD-Elbadry-2014" TYPE="STUDY">Elbadry 2014</LINK>).</LI>
<LI>TOT versus TOT with two-point fixation sutures (<LINK REF="STD-Rechberger-2011" TYPE="STUDY">Rechberger 2011</LINK>).</LI>
<LI>Synthetic TOT versus biological TOT (<LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK>; <LINK REF="STD-Ugurlucan-2013" TYPE="STUDY">Ugurlucan 2013</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Transobturator medial-to-lateral</HEADING>
<UL>
<LI>TVT-O versus modified TVT-O (shorter tape and less lateral dissection; <LINK REF="STD-de-Leval-2011" TYPE="STUDY">de Leval 2011</LINK>).</LI>
<LI>TVT-O versus TVT-O plus Ingleman-Sundberg bladder denervation procedure (<LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>).</LI>
<LI>TVT-O versus modified TVT-O (reduced dissection; <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK>).</LI>
<LI>TVT-O versus modified TVT-O (self-tailored mesh; <LINK REF="STD-Zhang-2011" TYPE="STUDY">Zhang 2011</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Retropubic</HEADING>
<UL>
<LI>TVT versus modified TVT, bottom-to-top (suburethral pad; <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK>).</LI>
</UL>
<P>Each comparison group included only a small single trial, which precluded any meaningful statistical analysis of the outcomes measured, except for the synthetic versus biological TOT comparison, for which there were two small trials (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>; <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>; <LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>; <LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>; <LINK REF="CMP-004.04" TYPE="ANALYSIS">Analysis 4.4</LINK>; <LINK REF="CMP-004.06" TYPE="ANALYSIS">Analysis 4.6</LINK>; <LINK REF="CMP-004.07" TYPE="ANALYSIS">Analysis 4.7</LINK>; <LINK REF="CMP-004.08" TYPE="ANALYSIS">Analysis 4.8</LINK>; <LINK REF="CMP-004.10" TYPE="ANALYSIS">Analysis 4.10</LINK>; <LINK REF="CMP-004.11" TYPE="ANALYSIS">Analysis 4.11</LINK>; <LINK REF="CMP-004.12" TYPE="ANALYSIS">Analysis 4.12</LINK>; <LINK REF="CMP-004.13" TYPE="ANALYSIS">Analysis 4.13</LINK>; <LINK REF="CMP-004.14" TYPE="ANALYSIS">Analysis 4.14</LINK>; <LINK REF="CMP-004.15" TYPE="ANALYSIS">Analysis 4.15</LINK>; <LINK REF="CMP-004.16" TYPE="ANALYSIS">Analysis 4.16</LINK>). <LINK REF="STD-Naumann-2006" TYPE="STUDY">Naumann 2006</LINK> reported no usable data.</P>
<P>For all outcomes measured in each trial, there were no statistically significant differences reported, with the exception of <LINK REF="STD-Juang-2007" TYPE="STUDY">Juang 2007</LINK>, where significant differences were found in favour of TVT-O plus Ingleman-Sundberg bladder denervation procedure for objective cure, operative time and intraoperative blood loss. Objecture cure in the short term for synthetic versus biological TOT showed no significant difference (RR 1.03, 95% CI 0.94 to 1.14; 2 trials; <LINK REF="CMP-004.05" TYPE="ANALYSIS">Analysis 4.5</LINK>.2)</P>
<P>Sexual function was assessed by <LINK REF="STD-Paparella-2010" TYPE="STUDY">Paparella 2010</LINK> and <LINK REF="STD-Tommaselli-2012" TYPE="STUDY">Tommaselli 2012</LINK> using the PISQ-12. The PISQ-12 scores decreased after the procedure in both groups, indicating improved sexual function after surgery. No significant differences were observed between groups after the procedures.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison 5. One type of tape material versus another</HEADING>
<P>Four trials compared different mid-urethral sling operations based on their tape properties, e.g. monofilament tapes versus multifilament tapes (<LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>). The interventions compared were:</P>
<UL>
<LI>monofilament (TVT SPARC) verus multifilament (IVS; <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>);</LI>
<LI>monofilament (TVT) versus multifilament (IVS; <LINK REF="STD-Meschia-2006" TYPE="STUDY">Meschia 2006</LINK>);</LI>
<LI>synthetic monofilament (prolene light mesh) versus combined synthetic and biological (Ultrapro mesh) versus multifilament mesh (Vypro; <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK>);</LI>
<LI>monofilament (TVT) versus multifilament (IVS; <LINK REF="STD-Rechberger-2003" TYPE="STUDY">Rechberger 2003</LINK>).</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="4">5.1 Women's observations</HEADING>
<P>In the short and medium term there was no statistically significant difference between monofilament and multifilament tapes in terms of their subjective cure rates; neither was there a significant difference found where the combined synthetic and biological tapes were compared to monofilament tapes (RR 1.03, 95% CI 0.95 to 1.10; RR 0.91, 95% CI 0.79 to 1.05; RR 1.10, 95% CI 0.96 to 1.26; <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>: RR 1.03, 95% CI 0.85 to 1.23; RR 0.91, 95% CI 0.78 to 1.06; RR 1.13, 95% CI 0.96 to 1.32; <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.2 Quantification of symptoms</HEADING>
<P>No data were reported for this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.3 Clinician's observation</HEADING>
<P>The objective cure rate for monofilament tape and multifilament tapes show no significant difference between the groups (RR 1.07, 95% CI 0.96 to 1.19; <LINK REF="CMP-005.03" TYPE="ANALYSIS">Analysis 5.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.4 Surgical outcome measures</HEADING>
<P>There were no statistically significant differences in the duration of operation or length of hospital stay reported (RR 0.00, 95% CI -1.49 to 1.49; <LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>: RR 0.20, 95% CI -0.09 to 0.49; <LINK REF="CMP-005.05" TYPE="ANALYSIS">Analysis 5.5</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.5 Adverse events</HEADING>
<P>There were few perioperative complications with no statistically significant difference between the groups (RR 1.16, 95% CI 0.36 to 3.69; <LINK REF="CMP-005.06" TYPE="ANALYSIS">Analysis 5.6</LINK>). No major vascular/visceral injury was reported in any of the trials (<LINK REF="CMP-005.07" TYPE="ANALYSIS">Analysis 5.7</LINK>). Bladder perforation occurred in 4.49% of monofilament and 3.67% of multifilament tape procedures (RR 1.15, 95% CI 0.49 to 2.70; <LINK REF="CMP-005.08" TYPE="ANALYSIS">Analysis 5.8</LINK>).</P>
<P>There were no statistically significant differences between the groups for:</P>
<UL>
<LI>POVD (RR 2.10, 95% CI 0.96 to 4.59; <LINK REF="CMP-005.09" TYPE="ANALYSIS">Analysis 5.9</LINK>);</LI>
<LI>de novo urgency symptoms and UUI (RR 1.11, 95% CI 0.68 to 1.82; <LINK REF="CMP-005.10" TYPE="ANALYSIS">Analysis 5.10</LINK>);</LI>
<LI>DO (RR 0.70, 95% CI 0.12 to 4.06; <LINK REF="CMP-005.11" TYPE="ANALYSIS">Analysis 5.11</LINK>).</LI>
</UL>
<P>In three trials, vaginal tape erosions were more common in the multifilament group, but this did not reach statistical significance (RR 0.79, 95% CI 0.09 to 6.84; <LINK REF="CMP-005.12" TYPE="ANALYSIS">Analysis 5.12</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.6 Need for further treatment</HEADING>
<P>No data were reported regarding the need for further treatment in this comparison.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">5.7 Quality of life</HEADING>
<P>Only the <LINK REF="STD-Okulu-2013" TYPE="STUDY">Okulu 2013</LINK> study assessed QoL and showed improvement from baseline scores, with no significant difference between the comparison groups. At 48 months mean postoperative ICI-Q QoL scores were significantly better in the monofilament group than in the multifilament group (MD -0.06, 95% CI -0.76 to -0.44; 1 study, 96 women; <LINK REF="CMP-005.13" TYPE="ANALYSIS">Analysis 5.13</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-07-25 16:29:00 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2017-07-24 17:31:55 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">1.Transobturator (TOR) versus retropubic route (RPR)</HEADING>
<P>Comparison of the transobturator (TOR) versus retropubic route (RPR) was addressed by 55 trials that included 8652 women. Thirty-six of these trials (5514 women) contributed data to the primary outcome of subjective cure, which showed that in the short term there was no difference between TOR and RPR. Only six of these 53 trials reported medium- or long-term data, again with relatively small numbers of women showing no significant difference in symptomatic cure. These small numbers limit the judgements that can be made about cure rates in the longer term for both the efficacy of individual tapes, or for comparison of the route of tape insertion. There was potential for at least 22 of these trials to have published either medium- or longer-term outcomes, given their dates of publication. Similarly, objective cure rates showed no significant difference between the two routes.</P>
<P>Evidence from 40 trials (6372 women) showed a 30 fold percentage increase in the rate of bladder perforation with the RPR approach compared to the TOR approach. In practice, for this reason, some clinicians favour the TOR for patients at higher risk of bladder/urethral perforation, for example, those who have had previous pelvic or incontinence surgery. Similarly, 37 trials (6217 women) that assessed postoperative voiding dysfunction (POVD) showed this adverse outcome to be significantly less frequent when the TOR was employed. However, the reported sequale for both of these outcomes is usually of short duration.</P>
<P>Thirty-one trials (4743 women) that assessed vaginal tape erosion showed no significant difference when either route was used. More women experienced groin pain in the TOR group than in the RPR group. This groin pain was usually of short duration and resolved within eight weeks in most cases. The occurrence of suprapubic pain following an RPR procedure was poorly reported. This was more common in the RPR group; however, when data was provided, only a minority of women suffered this symptom and for a short period of time.</P>
<P>Overall mid-urethral slings are a highly effective treatment for stress urinary incontinence (SUI). In the short term there is equivalence in the efficacy between the two routes, and this persists into the medium and longer term, though the data for this is somewhat limited by small numbers. There is some evidence that suggests women are more likely to require repeat incontinence surgery in the longer term with the TOR, but this requires cautious interpretation, as there are extremely small numbers. There is an equal improvement in the overall quality of life of women for both routes. Sexual function improved in both groups as a result of the surgery, most probably from reduction in coital incontinence, with no significant difference in sexual function between the two groups.</P>
<P>To supplement the main systematic review of effects, we sought to identify economic evaluations which have compared TOR with RPR in the treatment of SUI in women. A supplementary search in Ovid MEDLINE, Embase and NHS EED, identified three economic evaluations (<LINK REF="REF-Lier-2011" TYPE="REFERENCE">Lier 2011</LINK>; <LINK REF="REF-Lier-2016" TYPE="REFERENCE">Lier 2016</LINK>; <LINK REF="REF-Seklehner-2014" TYPE="REFERENCE">Seklehner 2014</LINK>). The search strategies used are given in <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>. <LINK REF="REF-Lier-2016" TYPE="REFERENCE">Lier 2016</LINK> reported both a cost-utility and cost-effectiveness analysis while <LINK REF="REF-Lier-2011" TYPE="REFERENCE">Lier 2011</LINK> was a cost-effectiveness analysis. Both studies analysed costs and resources used from public payer perspective (Alberta, Canada) and used clinical data from the same RCT (<LINK REF="REF-Ross-2009" TYPE="REFERENCE">Ross 2009</LINK>) with results presented at one year (<LINK REF="REF-Lier-2011" TYPE="REFERENCE">Lier 2011</LINK>) and five years (<LINK REF="REF-Lier-2016" TYPE="REFERENCE">Lier 2016</LINK>) post-surgery. <LINK REF="REF-Seklehner-2014" TYPE="REFERENCE">Seklehner 2014</LINK> reported a decision model based cost-effectiveness analysis with clinical evidence collected from MEDLINE search of RCTs on TOR and RPR. This study adopted a US healthcare system perspective with a 10-year time horizon. <LINK REF="REF-Lier-2016" TYPE="REFERENCE">Lier 2016</LINK>, which was a further follow-up of <LINK REF="REF-Lier-2011" TYPE="REFERENCE">Lier 2011</LINK>, reported that TOR was slightly more effective than RPR with a mean QALY gain of 0.04 over five years (95% Cl -0.06 to 0.14). <LINK REF="REF-Seklehner-2014" TYPE="REFERENCE">Seklehner 2014</LINK> reported that on average TOR was slightly more effective, with a QALY gain of 0.03 over 10 years. Both <LINK REF="REF-Lier-2016" TYPE="REFERENCE">Lier 2016</LINK> and <LINK REF="REF-Lier-2011" TYPE="REFERENCE">Lier 2011</LINK> reported no statistically significant difference in the cure rate (81% for TOR versus 77% for RPR, P value not stated) but there was a significant difference in the number of patients in the TOR arm with groin pain and palpation of the surgical tape on vaginal examination (26% difference, P = 0.001) even after five years (<LINK REF="REF-Lier-2016" TYPE="REFERENCE">Lier 2016</LINK>). In all three studies TOR was less costly in when compared with RPR (<LINK REF="REF-Lier-2011" TYPE="REFERENCE">Lier 2011</LINK>; <LINK REF="REF-Lier-2016" TYPE="REFERENCE">Lier 2016</LINK>; <LINK REF="REF-Seklehner-2014" TYPE="REFERENCE">Seklehner 2014</LINK>). In <LINK REF="REF-Lier-2016" TYPE="REFERENCE">Lier 2016</LINK>, TOR was on average less costly, with an average total cost difference which rose from CAD -414 (95% Cl -1415 to 587) (<LINK REF="REF-Lier-2011" TYPE="REFERENCE">Lier 2011</LINK>) to CAD -2368 (95% Cl -7166 to 2548) at five years (2011 Canadian dollars). In <LINK REF="REF-Seklehner-2014" TYPE="REFERENCE">Seklehner 2014</LINK> the average cost difference was CAD -562 (Cl not stated).The three studies each suggested that TOR may be cost-effective.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2.Retropubic bottom-to-top approach versus retropubic top-to-bottom approach</HEADING>
<P>Five trials with 636 women compared the retropubic bottom-to-top with the retropubic top-to-bottom approach. These showed that passage of the tape through the retropubic route in a bottom-to-top path (e.g. TVT<SUP>TM</SUP>) was more effective than passage in a top-to-bottom path (e.g. SPARC<SUP>TM</SUP>), and resulted in fewer intra and postoperative adverse events.We took the same approach for TOR versus RPR to identify economic evaluations, but found no results.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3.Obturator medial-to-lateral approach versus obturator lateral-to-medial approach</HEADING>
<P>Ten trials with 1199 women compared the obturator medial-to-lateral approach with the obturator lateral-to-medial approach. Evidence from the ten trials, two of which reported medium-term data, showed no difference between the two approaches with respect to most outcomes measured. The only exceptions were voiding dysfunction, where higher rates were reported in the medial-to-lateral group, and vaginal perforation, which had higher rates in the lateral-to-medial group. Despite this, there was no resultant increase in the rate of tape erosion. It is, therefore, not unreasonable to exercise operator preference when deciding which of these two approaches to adopt. Notably, each route improved quality of life and sexual function postoperatively. We took the same approach for TOR versus RPR to identify economic evaluations, but found no results.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">4.One method of mid-urethral tape insertion versus another method, same route</HEADING>
<P>Ten trials with 1569 women compared one method of mid-urethral tape insertion with another using the same route. Despite several design or procedural modifications to tapes traversing the same route, there was no difference in the efficacy, surgical outcomes or occurrence of adverse events.The same approach done for TOR versus RPR was carried out to identify economic evaluations but yielded no result.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">5.One type of tape material versus another</HEADING>
<P>Four trials with 505 women compared monofilament tapes with multifilament tapes. There was no statistical difference in physician-observed cure rates or patient-reported cure between the groups. There was no significant difference in the rate of vaginal tape erosion. We took the same approach for TOR versus RPR to identify economic evaluations, but found no results.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-07-25 16:29:00 +0100" MODIFIED_BY="[Empty name]">
<P>Many of the trials contributing to this review did provide evidence regarding the primary outcome, which was to determine the effectiveness of mid-urethral sling operations in the treatment of urinary incontinence. They confirm that mid-urethral sling operations for SUI are an effective surgical treatment available in current practice. A major limitation was the variable quality of many of the trials.</P>
<P>We did not attempt to analyse the data by subgroups according to the clinical characteristics of the women, such as symptoms of SUI, urodynamic stress incontinence, diagnosis of intrinsic urethral sphincter deficiency or urethral hypermobility, obesity, previous incontinence surgery, presence or absence of prolapse, anaesthesia used, or experience of the surgeon. In fact the majority of trials did not describe these characteristics of the women.</P>
<P>We did not subject the three identified economic evaluations to critical appraisal and we do not attempt to draw any firm or general conclusions about the relative costs or efficiency of TOR for treatment of SUI<I>. </I>However, the economic evidence available suggests that TOR is cost-effective when compared with RPR in the treatment of SUI in women.</P>
<SUBSECTION>
<HEADING LEVEL="3">Complications</HEADING>
<P>Major complications such as nerve, bowel or major vascular injuries, pelvic haematoma, necrotizing fasciitis, ischiorectal abscess and death are uncommon and unlikely to be picked up by small randomised controlled trials (RCTs). There is potential to determine a more accurate incidence from large national registries and voluntary reporting registries or databases for reporting complications, such as the United States Food and Drug Administration's (FDA) manufacturer and user facility device experience (MAUDE). One must bear in mind, though, the limitations of this method. Several of these registries have reported their findings (<LINK REF="REF-Collinet-2008" TYPE="REFERENCE">Collinet 2008</LINK>; <LINK REF="REF-Dyrkorn-2010" TYPE="REFERENCE">Dyrkorn 2010</LINK>; <LINK REF="REF-Kuuva-2002" TYPE="REFERENCE">Kuuva 2002</LINK>; <LINK REF="REF-Koops-2005" TYPE="REFERENCE">Koops 2005</LINK>; <LINK REF="REF-Tamussino-2001" TYPE="REFERENCE">Tamussino 2001</LINK>; <LINK REF="REF-Tamussino-2007" TYPE="REFERENCE">Tamussino 2007</LINK>; <LINK REF="REF-Tincello-2011" TYPE="REFERENCE">Tincello 2011</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Retropubic tapes</HEADING>
<P>From the above list of registries, fortension-free vaginal tape the number of procedures reported ranged from809 to 4281, and there were found to be low rates of major complications.</P>
<UL>
<LI>Bladder perforation occurred in 2.7% to 3.9% of cases.</LI>
<LI>Reoperation rates relating to tape insertion or postoperative voiding dysfunction (POVD) ranged from 1.6% to 2.4%.</LI>
<LI>Urinary retention rate was 1.6%.</LI>
<LI>Pelvic haematoma occurred in 0.7% to 1.9% of women.</LI>
<LI>Infection rate was 0.7%.</LI>
<LI>Vaginal tape erosion/extrusion rate was 1.5%.</LI>
<LI>Groin pain occurred in 0.4% of women.</LI>
</UL>
<P>These rates are largely of the same order as those reported in the trials included in this review. There were also a few cases of major visceral injuries such as bowel and urethral injuries.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Transobturator tapes</HEADING>
<P>Registries of transobturator tapes reported much lower rates of complications.</P>
<UL>
<LI>Bladder perforation occurred in 0.4% of cases.</LI>
<LI>Reoperation rates relating to tape insertion ranged from 0.8% to 2.2%.</LI>
<LI>Urinary retention rate was 0.5%.</LI>
<LI>Pelvic haematoma occurred in 0.5% of women.</LI>
<LI>Infection rate was 0.6%.</LI>
<LI>Vaginal tape erosion/extrusion rate was 0.4%.</LI>
<LI>Groin pain occurred in 1.6% of women.</LI>
</UL>
<P>The FDA received 1876 reports of complications associated with the use of slings for SUI in the period between 1 January 2008 to 30 September 2011. The most common complications reported were pain, vaginal tape erosion (exposure, extrusion or protrusion), infection, urinary problems, recurrent incontinence, pain during sexual intercourse (dyspareunia), bleeding, organ perforation, neuro-muscular problems and vaginal scarring. Many of these complications required further medical intervention, and sometimes required surgical treatment or hospitalisation, or both. With the exception of tape erosion, the above complications were also found to occur following non-mesh surgical repairs for SUI. It should be borne in mind that this sort of reporting system is a passive surveillance system limited by the inclusion of the potential submission of incomplete or inaccurate data, under-reporting of events, lack of denominator data (number of tapes), and the lack of report timeliness.</P>
<P>It should be noted that the latest FDA white paper and safety communications on meshes released in 2011 - unlike the previous 2008 release (<LINK REF="REF-FDA-2008" TYPE="REFERENCE">FDA 2008</LINK>) - relates to ongoing concern with mesh used to treat pelvic organ prolapse (POP) and not the small strip of mesh/tape/sling used to treat SUI (<LINK REF="REF-FDA-2011a" TYPE="REFERENCE">FDA 2011a</LINK>; <LINK REF="REF-FDA-2011b" TYPE="REFERENCE">FDA 2011b</LINK>). In fact the FDA states that the safety and effectiveness of mid-urethral slings is well established in clinical trials with 1-year follow-up (<LINK REF="REF-FDA-2013" TYPE="REFERENCE">FDA 2013</LINK>).</P>
<P>Equally, because of the increasing numbers of adverse events and patient concerns reported, in 2012 the Medicines and Healthcare Products and Regulatory Agency (MHRA) in Europe published a commissioned report on the most frequently reported adverse events associated with different meshes/tapes/slings (<LINK REF="REF-MHRA-2012" TYPE="REFERENCE">MHRA 2012</LINK>). The report showed that for the treatment of SUI the rate of vaginal tape erosion was low, at between 1.1% to 2.5%. Even in a selected cohort of women presenting primarily with adverse events of mesh, those with mid-urethral sling were significantly less likely to present with mesh erosions than those who had mesh for POP repair. Presentation of mesh erosion following SUI treatment is less severe, and less likely to require surgical treatment under general anaesthesia than erosion following mesh insertion for POP repair. This relates to complication classification severity grade 4 (<LINK REF="REF-Abbott-2014" TYPE="REFERENCE">Abbott 2014</LINK>; <LINK REF="REF-Strasberg-2009" TYPE="REFERENCE">Strasberg 2009</LINK>).</P>
<P>In their 2014 report, the MHRA concluded that from the review of the information available, there appeared to be no evidence that vaginal mesh implants for SUI are unsafe, nor was there evidence to justify MHRA taking enforcement action to take them off the market, or remove them from use. The report concluded that the overall benefit outweighed the relatively low rate of complications (<LINK REF="REF-MHRA-2014" TYPE="REFERENCE">MHRA 2014</LINK>).</P>
<P>Although the number of adverse events was generally low and they were rarely serious, it is recognised that the ability of RCTs to identify rarer adverse effects is poor. With the increasing popularity of MUS procedures the occurrence of complications in the short term is well established, but in general these are easily treated or resolve spontaneously. However, because few trialists have carried out long-term follow-up, there is very little information about whether there is a hidden cache of serious adverse effects that might be set against the benefits of curing incontinence.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Longer-term outcomes after MUS</HEADING>
<P>Observational studies of MUS show data confirming effectiveness in the long term with some data that cover 15 to 17 years (<LINK REF="REF-Aigmueller-2011" TYPE="REFERENCE">Aigmueller 2011</LINK>; <LINK REF="REF-Athanasiou-2014" TYPE="REFERENCE">Athanasiou 2014</LINK>; <LINK REF="REF-Heinonen-2013" TYPE="REFERENCE">Heinonen 2013</LINK>; <LINK REF="REF-Nilsson-2013" TYPE="REFERENCE">Nilsson 2013</LINK>; <LINK REF="REF-Serati-2012" TYPE="REFERENCE">Serati 2012</LINK>; <LINK REF="REF-Serati-2013" TYPE="REFERENCE">Serati 2013</LINK>; <LINK REF="REF-Svenningsen-2013a" TYPE="REFERENCE">Svenningsen 2013a</LINK>; <LINK REF="REF-Svenningsen-2013b" TYPE="REFERENCE">Svenningsen 2013b</LINK>). These trials of MUS, like similar observational studies for open colposuspension, show a decline in effectiveness that is time-dependent, and also reveal high rates of de novo urgency symptoms (15%) and voiding difficulties (23%). It is difficult to elucidate the reasons for these long-term symptoms, but they could be age related, or due to new pathology, or a true consequence of the surgery. Nevertheless, they emphasise the need for longer-term data from RCTs to help counsel women appropriately.</P>
<P>With regard to long-term data from RCTs, there is a paucity of trials that reported longer-term outcomes and most long-term data reported for both open colposuspension and MUS are for five to six years. If evidence from RCTs mirrors that from observational studies, we will not only require the many RCTs that have been published for MUS to report their longer-term data, but will in fact need to follow these women up for at least 10 to 15 years. This would allow us to discover whether there is a time-dependent decline in effectiveness, and enable us to elucidate the development in the long term of new adverse effects.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparisons with other methods of continence surgery</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">'Gold standard' surgical treatment for stress urinary incontinence (SUI)</HEADING>
<P>Open abdominal retropubic colposuspension used to be considered the gold standard treatment for SUI. It is noteworthy that there are no randomised controlled trials of open colposuspension versus no treatment. Two small trials that compared open colposuspension with conservative treatment were unreliable because of very small numbers of participant and a high risk of bias (<LINK REF="REF-Lapitan-2012" TYPE="REFERENCE">Lapitan 2012</LINK>). Equaliy the evidence for MUS versus no treatment or conservative treatment is limited and we will be addressing this in a future Cochrane review.</P>
<P>Our initial review showed the effectiveness of MUS in the short term and, as time has moved on, it was hoped that with reports of long-term data it would become clear whether long-term efficacy of MUS could be compared with that of open retropubic colposuspension. A Cochrane review of open retropubic colposuspension identified 15 RCTs that compared the mid-urethral sling operations (12 RPR and three TOR) with colposuspension (<LINK REF="REF-Lapitan-2012" TYPE="REFERENCE">Lapitan 2012</LINK>). This review concluded that there was no significant difference in incontinence rates between the two procedures for all time periods assessed. Both procedures led to improvement in the quality of life of women. While some complications, such as bladder perforation, were reported more with MUS, the numbers were small. Other complications such as POVD, which were reported to be higher with MUS, were influenced by a large trial that reported no risk of voiding difficulties at all after colposuspension, but consistent data from TVT trials showed no significant difference in the risk of voiding dysfunction between MUS and colposuspension. MUS had a shorter operating time, length of hospital stay and cost. Only one RCT that compared MUS with open colposuspension has reported results for a five-year follow-up, and it failed to detect significant difference between the success rates of MUS and colposuspension. It also showed that the effect on cure of incontinence and improvement in quality of life was maintained for both procedures at five years (<LINK REF="REF-Ward-2008" TYPE="REFERENCE">Ward 2008</LINK>).</P>
<P>Observational data for open colposuspension with follow-up of 10 to 20 years show high rates of effectiveness in the long term (<LINK REF="REF-Alcalay-1995" TYPE="REFERENCE">Alcalay 1995</LINK>; <LINK REF="REF-Kjolhede-2005" TYPE="REFERENCE">Kjolhede 2005</LINK>; <LINK REF="REF-Brubaker-2012" TYPE="REFERENCE">Brubaker 2012</LINK>). This long-term cure is shown to be time-dependent with cure rates plateauing at about 69% at 10 to 12 years. In addition some reports show continence rates of only 44% at 14 years, with high rates of voiding difficulties (of 36%) at 14-year follow-up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mid-urethral sling operations versus traditional slings</HEADING>
<P>Historically, traditional suburethral sling procedures were used for women who had recurrent stress incontinence (after a previous failed continence operation). However, the review did not report the results separately for women with new or recurrent incontinence (<LINK REF="REF-Rehman-2011" TYPE="REFERENCE">Rehman 2011</LINK>). These procedures were designed to restore normal urethrovesical junction support by mechanical compression or kinking of the proximal urethra.</P>
<P>Minimally invasive synthetic suburethral slings appeared to be as effective as traditional suburethral slings in short-term incontinence rates (RR 0.97; 95% CI 0.78 to 1.20), although the confidence interval is compatible with minimally invasive slings being 20% better or 12% worse. The operating time and length of stay were also significantly shorter with minimally invasive synthetic suburethral sling operations, and women had fewer perioperative complications and less detrusor overactivity.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mid-urethral sling operations versus open retropubic colposuspension</HEADING>
<P>Although 14 RCTs were found that compared TVT operations with colposuspension (<LINK REF="REF-Lapitan-2012" TYPE="REFERENCE">Lapitan 2012</LINK>), data from five of them showed no clear differences in the short- or medium-term chance of incontinence compared with open colposuspension. While there were more complications after the sling operations, the numbers were small.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mid-urethral sling operations versus laparoscopic colposuspension</HEADING>
<P>Another Cochrane review identified eight trials that compared mid-urethral sling operations to laparoscopic colposuspension (<LINK REF="REF-Dean-2006" TYPE="REFERENCE">Dean 2006</LINK>). Overall, the review showed that the subjective cure rates were similar for both of these minimal access techniques in the short term, while operation times were shorter for the slings. Long-term data are lacking, however.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mid-urethral sling operations versus single incision slings</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Single-incision slings compared with retropubic mid-urethral slings</HEADING>
<P>Women were twice as likely to be incontinent after a single-incision sling as after a retropubic TVT (RR 2.08, 95% CI 1.04 to 4.14; <LINK REF="REF-Nambiar-2014" TYPE="REFERENCE">Nambiar 2014</LINK>), although the surgery took less time to perform. However, this finding mostly related to one type of single-incision sling (TVT-Secur), which has now been withdrawn from the market due to this lack of efficacy.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Single-incision slings compared with transobturator mid-urethral slings</HEADING>
<P>Women were twice as likely to be incontinent after a single-incision sling procedure as after a transobturator sling procedure (RR 1.91, 95% CI 1.53 to 2.39; <LINK REF="REF-Nambiar-2014" TYPE="REFERENCE">Nambiar 2014</LINK>). In addition, they were more likely to need a further operation for complications or repeat surgery for their incontinence. However, the risks of postoperative pain and long-term pain were slightly higher with transobturator slings.</P>
<P>For the economic evidence, two cost-effectiveness analyses also compared single-incision mini-slings with transobturator mid-urethral slings. These adopted the perspective of the Spanish (<LINK REF="REF-Casta_x00f1_eda-2014" TYPE="REFERENCE">Castaeda 2014</LINK>) and UK healthcare systems (<LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK>) respectively. <LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK> used clinical evidence from a prospective RCT (<LINK REF="REF-Mostafa-2012" TYPE="REFERENCE">Mostafa 2012</LINK>), while <LINK REF="REF-Casta_x00f1_eda-2014" TYPE="REFERENCE">Castaeda 2014</LINK> used evidence from a retrospective observational study, using a one-year follow-up in both cases. Both studies reported no statistically significant differences in the clinical outcomes: 6.7% difference, 95% Cl -6.6 to 20.0, P = 0.527 (<LINK REF="REF-Casta_x00f1_eda-2014" TYPE="REFERENCE">Castaeda 2014</LINK>); 5% difference, 95% Cl 0.38 to 2.26, P = 1.000 (<LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK>), and also no statistically significant differences in intraoperative complications: P = 0.023 (<LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK>); P = 0.553 (<LINK REF="REF-Casta_x00f1_eda-2014" TYPE="REFERENCE">Castaeda 2014</LINK>). <LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK> also reported the impact on health-related quality of life reported as quality adjusted life years (QALYs). There was no significant difference in QALYs (mean difference -0.003, 95% Cl -0.008 to 0.002) (<LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK>).However, in the single-incision sling arm, there were statistically significant improved postoperative pain scores up to four weeks with a pain score of zero compared with mid-urethral slings with a total pain score of two (P &lt; 0.001, 95% Cl 1.245 to 1.853). There was also a statistically significant one day earlier return to normal activities with single-incision slings (P = 0.025, 95% Cl 6.1 to 9.4 days) (<LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK>) and less repeated urinary tract infections (<LINK REF="REF-Casta_x00f1_eda-2014" TYPE="REFERENCE">Castaeda 2014</LINK>). Single-incision mini-slings were less costly in both studies. The mean total direct cost of single-incision mini-sling in <LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK> was GBP 1277 (2011 GBP) while that of transobturator sling procedure was GBP 1462 (2011 GBP), with a 94% probability (95% Cl GBP -316.99 to GBP 32.17) of being cost-saving compared to the transobturator sling procedure, irrespective of whether single-incision mini-slings were performed under local or general anaesthesia. In <LINK REF="REF-Casta_x00f1_eda-2014" TYPE="REFERENCE">Castaeda 2014</LINK>, the average cost of single-incision mini-slings (2013 euro) was EUR 2059 (95% Cl 1914 to 2285), while the cost of the transobturator sling procedure was EUR 2821 (95% Cl 2661 to 2997). There was a 100% probability of single-incision mini-slings being cost-saving. Both studies (<LINK REF="REF-Boyers-2013" TYPE="REFERENCE">Boyers 2013</LINK>; <LINK REF="REF-Casta_x00f1_eda-2014" TYPE="REFERENCE">Castaeda 2014</LINK>) suggested that the transobturator sling procedure is less cost-effective when compared with mini-sling based on comparative effectiveness of both interventions and lower costs associated with single-incision mini-slings.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Mid-urethral sling operations versus anterior repair</HEADING>
<P>To date, no trials have been identified that compared the original operation for SUI, anterior repair (with urethral buttressing sutures, or Kelly sutures) directly to mid-urethral slings (<LINK REF="REF-Glazener-2001" TYPE="REFERENCE">Glazener 2001</LINK>). However, in the current climate of concern about adverse effects from the use of synthetic mesh or tape materials, perhaps it is time to reassess the value of this operation, not least because of its additional role in the management of prolapse.</P>
</SUBSECTION>
</SUBSECTION>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2015-06-22 09:54:57 +0100" MODIFIED_BY="[Empty name]">
<P>We judged the quality of evidence using the GRADE classification as moderate for the majority of outcomes. The remaining outcomes assessed were low level evidence. The main reason for the decrease in the quality of evidence for many outcomes was a high risk of bias where allocation concealment or random sequence generation were deemed uncertain. Imprecision of effects estimates also contributed to the variable quality of evidence in some outcomes.</P>
<P>In the main comparison between TOR and RPR, the quality of evidence for most outcomes was moderate. The downgrade from high quality to moderate quality evidence was mainly because of a small proportion of trials in which there was a high risk of bias from either study design or implementation, which then reduced our confidence in the estimates of effects.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2015-06-05 13:09:40 +0100" MODIFIED_BY="[Empty name]">
<P>GRADE-specific outcomes were selected at the time of the original review. These have been modified for this update. There is potential for introduction of bias, as ideally these GRADE-specific outcomes should have been selected at the time of the protocol, and there would have been consistency between the outcomes selected in the original review and in the update.</P>
</POTENTIAL_BIASES>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-07-24 17:04:07 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2015-06-05 13:10:47 +0100" MODIFIED_BY="[Empty name]">
<P>Mid-urethral sling operations are now widely accepted as a routine surgical treatment for stress urinary incontinence (SUI). This review has identified evidence that addresses the comparative effects of different ways of inserting tapes, including different insertion routes, surgical approaches and tapes.</P>
<P>Irrespective of the routes traversed, these procedures are highly effective in the short and medium term and mounting evidence demonstrates their effectiveness in the long term.</P>
<P>There is low to moderate quality evidence that retropubic tapes and transobturator tapes have comparable effects on cure of incontinence between one and five years, and limited evidence for the same in the long term. With the exception of a two-fold increase in the incidence of groin pain, transobturator tapes have fewer adverse events. Retropubic tapes have an eight-fold increase in the incidence of bladder perforation and a two-fold increase in the incidence of post operative voiding difficulties. Although women's outcomes for quality of life and sexual function improved significantly after all surgical approaches, our analyses could not establish whether there was any difference between retropubic and transobturator tapes. Evidence for longer-term effects is required to evaluate the need for further surgery following either approach.</P>
<P>There was moderate quality evidence that when a retropubic route (RTR) is employed a bottom-to-top approach is more effective in terms of subjective cure than a top-to-bottom approach. When traversing the transobturator route (TOR), there was moderate quality evidence showing that medial-to-lateral ('inside-out') and lateral-to-medial ('outside-in') approaches have similar effects.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-07-24 17:04:07 +0100" MODIFIED_BY="[Empty name]">
<P>Many trials have evaluated the use of mid-urethral tapes in the short term. However, the long-term effects of surgery, and how the different insertion routes affect long-term outcome, have not been established. It is unfortunate that although 35 of the 81 trials included should be in a position to report their long-term data (i.e. over five years), only three have done so. More of the trials included in this review should publish the results of their longer-term follow-up to increase the robustness of evidence supporting the use of mid-urethral sling (MUS) in the long term, to provide answers about the long-term adverse events of these operations, including whether there is a significant decline in the effectiveness of these procedures over time, and to identify the point at which decline becomes significant enough to require women to need repeat procedures.</P>
<P>More research is required into trials assessing the clinical effectiveness of different routes (RPR or TOR) in women with urodynamic stress incontinence where hypermobility is differentiated from intrinsic urethral sphincter deficiency, as data for most of the outcomes are sparse. Equally, trials assessing the effectiveness of RPR or TOR in a cohort of women presenting with recurrent SUI after a failed MUS procedure are needed. More adequately powered trials are needed to address the issue of MUS in women who also have symptomatic or asymptomatic pelvic organ prolapse, as presently it is unclear whether concomitant pelvic organ prolapse surgery is necessary, and, if performed, whether it enhances or detracts from the effectiveness of the MUS. Conversely, there is only indirect evidence to suggest that MUS are more effective than anterior repair, as no RCTs have compared them directly.</P>
<P>Future randomised controlled trials should be robustly designed to be of good quality and adequately powered with standardised woman-reported (subjective) outcome measures and objective outcomes. When reporting, these trials should follow the CONSORT guidelines (<LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>; <LINK REF="REF-Schulz-2010" TYPE="REFERENCE">Schulz 2010</LINK>). There needs to be long-term follow-up and adequate reporting of adverse effects. It is essential that outcomes relevant to both women and policy makers who commission treatments are incorporated into these trials. In particular, quality of life, sexual function and economic implications should be assessed.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2015-06-22 09:55:05 +0100" MODIFIED_BY="[Empty name]">
<P>We thank Sheila Wallace for all her help and also for conducting the literature search.</P>
<P>We thank Dr Muhammad Imran Omar and Professor Cathryn Glazener for their input and help with arbitration of disagreements.</P>
<P>We also thank Dr Michaela Weingarten who assisted us in the translation of non-English manuscripts.</P>
<P>We would like to thank Dr Carlos Bezerra and Dr Mauricio S Plata for their contribution to the original protocol.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-07-24 17:04:25 +0100" MODIFIED_BY="[Empty name]">
<P>Abigail A Ford: For the 2015 review: Johnson and Johnson for part sponsorship to attend International Urogynaecology Association conference (IUGA), Washington, 2014. For the 2017 BECs review update: Astellas: money given towards travel costs to IUGA meeting 2016, no other financial benefit. This had no impact on this current work.</P>
<P>Lynne Rogerson: For the 2015 review: Astellas: Paid in full for attendance at European Urogynaecological Association meeting in Berlin. For the 2017 BECs review update: registration fee for ICS Rio 2014 paid by Boston Scientific for October 2014 - paid directly to the conference but nothing to do with Cochrane.</P>
<P>June D Cody: For the 2015 review: nothing to declare. For the 2017 BECs review update: None known.</P>
<P>Joseph Ogah: For the 2015 review: part sponsorship for conference registration fees and speaker honoraria by Astellas UK; sponsored to attend workshops by Johnson and Johnson and Speciality European Pharma. All these sponsorships are unrelated to this review. For the 2017 BECs review update: None known.</P>
<P>Patricia Aluko: For the 2017 BECs review: This project, to add Brief Economic Commentaries to our 'Surgery for UI in women' reviews, was supported by the National Institute for Health Research (NIHR), via the Cochrane Review Incentive Scheme 2016, to the Cochrane Incontinence Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-07-24 17:04:16 +0100" MODIFIED_BY="[Empty name]">
<P>Abigail Ford and Joseph Ogah wrote the text of the main review.</P>
<P>Abigail Ford performed the initial screening of studies for inclusion into the review, assessment of methodological quality, data extraction, and analysis of results.</P>
<P>Joseph Ogah performed the second and confirmatory screening of studies for inclusion, assessment of methodological quality, and data extraction.</P>
<P>Abigail Ford, Joseph Ogah, June Cody and Lynne Rogerson assisted in the analysis and interpretation of the results.</P>
<P>Abigail Ford, Joseph Ogah and Lynne Rogerson were also responsible for the clinical input for the review and made a significant input to the writing of the final review.</P>
<P>For the July 2017 addition of the BECs to this review: Patricia Aluko was responsible for the entire BECs-related work on this review, i.e. she ran the search for studies, screened the search results, extracted data from relevant studies, revised any existing economics-related text, added the BECs-related text, and responded to any peer referee comments. All authors had the opportunity to comment on the revised review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-07-24 17:04:36 +0100" MODIFIED_BY="[Empty name]">
<P>The review authors decided to focus this update on the use of minimally invasive mid-urethral slings in women with urinary incontinence, as this has become the gold standard for surgery for stress urinary incontinence (SUI). The alternative surgical treatments, including single incision slings, have been addressed in linked Cochrane reviews and are therefore not included, but are summarised and referenced in the Discussion. Conservative and pharmacological treatments will be addressed in a future Cochrane review. This review therefore now addresses the effectiveness of mid-urethral slings in the treatment of SUI in women compared to another mid-urethral sling.</P>
<P>The primary outcome remains the same, but has been measured in time scales that differ from those previously set out; short term (less than 12 months), medium term (one to five years) and long term (over five years). This was done after the first review showed evidence of tape efficacy to establish whether this procedure continued to be effective in the longer term. The primary outcome was repeated as a secondary outcome and this repetition has been amended.</P>
<P>A <LINK TAG="MISSING_DATA" TYPE="SECTION">Dealing with missing data</LINK> section has been added into the review. Very few trials reported outcome data for clinically relevant subgroups, therefore no subgroup analyses were performed.</P>
<P>July 2017 update: we have added Brief Economic Commentaries (BECs) to all of our 'Surgery for UI in women' Cochrane Reviews. We have revised the economic elements throughout the review; if incorrect, we have stripped them out. We have added new economics-related text. This involved revisions to the Background section, Methods section, e.g. search section referring to added Appendix, Discussion section, Abstract and Plain Language Summary. We have added an appendix with details of the economics searches. The Conclusions section of the review has not changed. The rest of the review has not changed. </P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2008-03-25 12:55:18 +0000" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-07-30 16:31:35 +0100" MODIFIED_BY="Sheila Wallace">
<STUDIES MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abdel_x002d_Fattah-2010" MODIFIED="2015-06-17 15:48:34 +0100" MODIFIED_BY="[Empty name]" NAME="Abdel-Fattah 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-05-22 17:26:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Familusi A, Ramsay I, Ayansina D, Mostafa A</AU>
<TI>Preoperative determinants for failure of transobturator tapes in the management of female urodynamic stress incontinence</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>2010</YR>
<VL>110</VL>
<NO>1</NO>
<PG>18-22</PG>
<IDENTIFIERS MODIFIED="2014-03-24 11:52:55 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417828"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER MODIFIED="2014-03-24 11:52:55 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40971"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:04:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Familusi A, Ramsay I, N'Dow J</AU>
<TI>A randomised prospective single-blinded study comparing "inside-out" versus "outside-in" transobturator tapes in the management of female stress urinary incontinence (E-TOT study); 3 years follow-up (Abstract number 18)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>6</NO>
<PG>825-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417829"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42168"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 17:26:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Hasafa Z, Mostafa A</AU>
<TI>Correlation of three validated questionnaires for assessment of outcomes following surgical treatment of stress urinary incontinence in women</TI>
<SO>European Journal of Obstetrics, Gynecology, and Reproductive Biology</SO>
<YR>2011</YR>
<VL>157</VL>
<NO>2</NO>
<PG>226-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417830"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41753"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:11:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22534058&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Eur Urol. 62(5):843-51, 2012 Nov&lt;br&gt;JC - enm, 7512719&lt;br&gt;CP - Switzerland&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20121005&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 11:11:14 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Mostafa A, Familusi A, Ramsay I, N'Dow J</AU>
<TI>Prospective randomised controlled trial of transobturator tapes in management of urodynamic stress incontinence in women: 3-year outcomes from the evaluation of transobturator tapes study</TI>
<SO>European Urology</SO>
<YR>2012</YR>
<VL>62</VL>
<NO>5</NO>
<PG>843-51</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417831"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont45947"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:04:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Mostafa A, Young D, Ramsay I</AU>
<TI>Evaluation of transobturator tension free vaginal tapes in management of women with stress urinary incontinence and previous failed incontinence surgery (Abstract number 156)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>6</NO>
<PG>1027-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417832"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40148"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 17:28:08 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21640964&lt;br&gt;ST - In-Process&lt;br&gt;AS - Am J Obstet Gynecol. 205(2):150.e1-6, 2011 Aug&lt;br&gt;JC - 3ni, 0370476&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;LG - English&lt;br&gt;DC - 20111117&lt;/p&gt;" NOTES_MODIFIED="2015-05-22 17:28:08 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Mostafa A, Young D, Ramsay I</AU>
<TI>Evaluation of transobturator tension-free vaginal tapes in the management of women with mixed urinary incontinence: one-year outcomes</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2011</YR>
<VL>205</VL>
<NO>2</NO>
<PG>150-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417833"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42990"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:04:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Mostafa A, Young D, Ramsay I</AU>
<TI>Impact of transobturator tension free vaginal tapes on quality of life and sexual function in women with mixed urinary incontinence (Abstract number 28)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>6</NO>
<PG>844-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417834"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40119"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:05:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Ali H, Young D, et al</AU>
<TI>Evaluation of transobturator tension-free vaginal tapes in management of women with recurrent stress urinary incontinence</TI>
<SO>Urology</SO>
<YR>2011</YR>
<VL>77</VL>
<NO>5</NO>
<PG>1070-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417835"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41485"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:04:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Ali H, Young D, et al</AU>
<TI>Randomised prospective single-blinded study comparing 'inside-out' versus 'outside-in' transobturator tapes in the management of urodynamic stress incontinence: 1-year outcomes from the E-TOT study</TI>
<SO>BJOG: an International Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2010</YR>
<VL>117</VL>
<NO>7</NO>
<PG>870-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417836"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont39920"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:39:14 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Ali H</AU>
<TI>Evaluation of transobturator tapes (E-TOT) study: randomised prospective single-blinded study comparing inside-out vs. outside-in transobturator tapes in management of urodynamic stress incontinence: short term outcomes</TI>
<SO>European Journal of Obstetrics, Gynecology, &amp; Reproductive Biology</SO>
<YR>2010</YR>
<VL>149</VL>
<NO>1</NO>
<PG>106-11</PG>
<IDENTIFIERS MODIFIED="2013-12-04 11:01:05 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417837"/><IDENTIFIER MODIFIED="2013-12-04 11:00:09 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="39661"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER MODIFIED="2013-12-04 11:01:05 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont39661"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:02:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Tierney J, Ali H</AU>
<TI>(E-TOT) Study: a randomised prospective single-blinded study of two transobturator tapes in management of urodynamic stress incontinence: objective &amp; patient reported outcomes (Abstract number 2)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>Suppl 2</NO>
<PG>S2-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417838"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31053"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:02:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Tierney J, Young D</AU>
<TI>(E-TOT) Study: a randomised prospective single blinded study of two transobturator tapes in management of urodynamic stress incontinence: quality of life; sexual function at 1-year (Abstract number 200)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>Suppl 2</NO>
<PG>S168-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417839"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31050"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 15:48:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Abdel-Fattah M, Ramsay I</AU>
<TI>Transvaginal tension free vaginal tape-obturator (TVT-O) versus transobturator tape-mentor (TOT) in the management of urodynamic stress urinary incontinence</TI>
<SO>ClinicalTrials.gov (http://ClinicalTrials.gov/show/NCT00136071) (accessed 20 September 2010)</SO>
<YR>2005</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417840"/><IDENTIFIER TYPE="OTHER" VALUE="ETOT"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40211"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-26 09:09:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hopper LR, Mostafa A, Abdel-Fattah M</AU>
<TI>The effectiveness of transobturator tapes in the surgical management of women with mixed urinary incontinence: 3 year outcomes (Abstract number 612)</TI>
<SO>Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26-30, Barcelona, Spain</SO>
<YR>2013</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417841"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont60036"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 17:32:53 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21839452&lt;br&gt;ST - In-Process&lt;br&gt;AS - Int J Gynaecol Obstet. 115(1):49-52, 2011 Oct&lt;br&gt;JC - e4t, 0210174&lt;br&gt;CP - Ireland&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;LG - English&lt;br&gt;DC - 20110921&lt;/p&gt;" NOTES_MODIFIED="2015-05-22 17:32:53 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mostafa A, Madhuvrata P, Abdel-Fattah M</AU>
<TI>Preoperative urodynamic predictors of short-term voiding dysfunction following a transobturator tension-free vaginal tape procedure</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>2011</YR>
<VL>115</VL>
<NO>1</NO>
<PG>49-52</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417842"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00136071"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42671"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 11:53:17 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417827"/><IDENTIFIER MODIFIED="2014-03-24 11:53:05 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00136071"/><IDENTIFIER MODIFIED="2014-03-24 11:53:17 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ETOT"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aigmuller-2014" MODIFIED="2015-06-08 15:28:57 +0100" MODIFIED_BY="[Empty name]" NAME="Aigmuller 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-02-26 11:16:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Aigmuller T, Tammaa A, Tamussino K, Hanzal E, Umek W, Kolle D, et al</AU>
<TI>Retropubic vs. transobturator tension-free vaginal tape for female stress urinary incontinence: 3-month results of a randomized controlled trial</TI>
<SO>International Urogynecology Journal</SO>
<YR>2014</YR>
<VL>25</VL>
<NO>8</NO>
<PG>1023-30</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:16:02 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417844"/><IDENTIFIER MODIFIED="2014-08-20 21:07:41 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00192-014-2384-z"/><IDENTIFIER MODIFIED="2015-02-26 11:16:02 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00441454"/><IDENTIFIER MODIFIED="2015-02-26 11:01:58 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont62534"/><IDENTIFIER TYPE="PUBMED" VALUE="24819327"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:28:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bjelic Radisic V, Trutnovsky G, Tammaa A , Hanzal E, Umek W, Koelle D, et al</AU>
<TI>Quality of life in patients with stress incontinence: results of a randomized trial comparing retropubic and transobturator tension-free vaginal tape (Abstract number 042)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>Suppl 1</NO>
<PG>S36-7</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:03:14 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417845"/><IDENTIFIER MODIFIED="2015-02-26 11:03:14 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont62184"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:28:51 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Conference Abstract&lt;br&gt;English; ABSTRACT LANGUAGE:English&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 15:28:51 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tammaa A, Aigmueller T, Umek W, Hanzal E, Kropshofer S, Lang P, et al</AU>
<TI>Retropubic versus transobturator TVT: five-year results of the Austrian trial (Abstract number: Oral Poster 18)</TI>
<SO>Journal of Minimally Invasive Gynecology</SO>
<YR>2014</YR>
<VL>21</VL>
<NO>2 Suppl 1</NO>
<PG>S21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417846"/><IDENTIFIER TYPE="OTHER" VALUE="sr-incont62148"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:28:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tamussino K, Tammaa A, Hanzal E, Umek W, Bjelic V, Koelle D</AU>
<TI>TVT vs. TVT-O for primary stress incontinence: a randomized clinical trial (Abstract number 112)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>Suppl 1</NO>
<PG>S20-1</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:05:36 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417847"/><IDENTIFIER MODIFIED="2015-02-26 11:05:36 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont26969"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-06-30 15:36:43 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417843"/><IDENTIFIER MODIFIED="2014-06-30 15:36:43 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00441454"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alkady-2009" MODIFIED="2015-06-08 15:29:32 +0100" MODIFIED_BY="[Empty name]" NAME="Alkady 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-06-08 15:29:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alkady HM, Eid A</AU>
<TI>Tension-free vaginal tape versus transobturator vaginal tape inside-out for the treatment of female stress urinary incontinence</TI>
<SO>Medical Journal of Cairo University</SO>
<YR>2009</YR>
<VL>77</VL>
<NO>4</NO>
<PG>317-26</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:08:34 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417849"/><IDENTIFIER MODIFIED="2015-02-26 11:08:34 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont50307"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417848"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Andonian-2005" MODIFIED="2015-06-08 16:55:20 +0100" MODIFIED_BY="[Empty name]" NAME="Andonian 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-02-26 11:10:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Andonian S, Chen T, St Denis B, Corcos J</AU>
<TI>Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension-free vaginal tape (TVT): one-year results</TI>
<SO>European Urology</SO>
<YR>2005</YR>
<VL>47</VL>
<NO>4</NO>
<PG>537-41</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:10:10 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757271"/><IDENTIFIER MODIFIED="2015-02-26 11:10:10 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont20378"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 16:55:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Andonian S, Chen TY, Corcos J</AU>
<TI>Randomized clinical trial comparing SPARC and TVT procedure for the treatment of SUI: preliminary report on peri-operative and short term complications (Abstract)</TI>
<SO>Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5-9, Florence, Italy</SO>
<YR>2003</YR>
<PG>547-8</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:10:31 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417850"/><IDENTIFIER MODIFIED="2015-02-26 11:10:31 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont17163"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757270"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Andonian-2007" MODIFIED="2014-09-19 11:47:57 +0100" MODIFIED_BY="[Empty name]" NAME="Andonian 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-07-02 17:42:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andonian S, St-Denis B, Lemieux MC, Corcos J</AU>
<TI>Prospective clinical trial comparing Obtape and DUPS to TVT: one-year safety and efficacy results</TI>
<SO>European Urology</SO>
<YR>2007</YR>
<VL>52</VL>
<NO>1</NO>
<PG>245&#8211;2</PG>
<IDENTIFIERS MODIFIED="2014-07-02 17:42:10 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417851"/><IDENTIFIER MODIFIED="2014-07-02 17:42:10 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23793"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757273"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aniuliene-2009" MODIFIED="2015-02-26 11:14:08 +0000" MODIFIED_BY="[Empty name]" NAME="Aniuliene 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-02-26 11:14:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aniuliene R</AU>
<TI>Tension-free vaginal tape versus tension-free vaginal tape obturator (inside-outside) in the surgical treatment of female stress urinary incontinence</TI>
<SO>Medicina (Kaunas, Lithuania)</SO>
<YR>2009</YR>
<VL>45</VL>
<NO>8</NO>
<PG>639-43</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:14:08 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417853"/><IDENTIFIER MODIFIED="2015-02-26 11:14:08 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont34372"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417852"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Araco-2008" MODIFIED="2015-06-09 11:10:12 +0100" MODIFIED_BY="[Empty name]" NAME="Araco 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-06-08 16:37:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Araco F, Gravante G, Sorge R, Overton J, De Vita D, Sesti F, et al</AU>
<TI>TVT-O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>7</NO>
<PG>917-26</PG>
<IDENTIFIERS MODIFIED="2014-07-02 17:43:57 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417854"/><IDENTIFIER MODIFIED="2014-03-24 11:54:39 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s00192-007-0554-y"/><IDENTIFIER MODIFIED="2014-07-02 17:43:57 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont27794"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 17:36:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Araco F, Gravante G, Sorge R, Piccione E</AU>
<TI>TVT-O vs. TVT: reply to comments by Burton et al [letter]</TI>
<SO>International Urogynecology Journal</SO>
<YR>2009</YR>
<VL>20</VL>
<PG>371-2</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:45:11 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417855"/><IDENTIFIER MODIFIED="2013-12-06 11:14:04 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="DOI 10.1007/s00192-008-0795-4"/><IDENTIFIER MODIFIED="2015-02-26 11:45:11 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont27794"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 11:10:12 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 18843435&lt;br&gt;CM - Comment on: Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul;19(7):917-26; PMID: 18217177&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 20(3):369; author reply 371-2, 2009 Mar&lt;br&gt;JC - cl5, 9514583&lt;br&gt;SB - IM&lt;br&gt;CP - England&lt;br&gt;PT - Comment&lt;br&gt;PT - Letter&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2015-06-09 11:10:12 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Burton C, Latthe P, Toozs-Hobson P</AU>
<TI>Comments on Araco et al: TVT-O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence [comment] [letter]</TI>
<SO>International Urogynecology Journal.</SO>
<YR>1920</YR>
<VL>20</VL>
<NO>3</NO>
<PG>369</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:45:47 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417856"/><IDENTIFIER MODIFIED="2015-02-26 11:45:47 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont27794"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31410"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757277"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barber-2008" MODIFIED="2015-06-21 16:40:09 +0100" MODIFIED_BY="[Empty name]" NAME="Barber 2008" YEAR="2007">
<REFERENCE MODIFIED="2015-05-22 17:36:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barber M, Kleeman S, Karram M, Paraiso MF, Walters M, Vasavada S, et al</AU>
<TI>A multi-center randomized trial comparing the transobturator tape with tension-free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 113)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>5</NO>
<PG>742-3</PG>
<IDENTIFIERS MODIFIED="2015-02-26 11:50:05 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417858"/><IDENTIFIER MODIFIED="2015-02-26 11:50:05 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23758"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 17:45:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barber MD, Kleeman S, Karram MM, Paraiso MF, Ellerkmann M, Vasavada S, et al</AU>
<TI>Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2008</YR>
<VL>199</VL>
<NO>6</NO>
<PG>666.e1-7</PG>
<IDENTIFIERS MODIFIED="2014-03-24 11:55:26 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417859"/><IDENTIFIER MODIFIED="2014-03-24 11:55:26 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00475839"/><IDENTIFIER TYPE="OTHER" VALUE="srincont29239"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 17:37:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barber MD, Kleeman S, Karram MM, Paraiso MF, Walters MD, Vasavada S, et al</AU>
<TI>Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2008</YR>
<VL>111</VL>
<NO>3</NO>
<PG>611-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417860"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00475839"/><IDENTIFIER TYPE="OTHER" VALUE="srincont26837"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:35:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barber MD, Kleeman SD, Karram MM, Paraiso MF, Walters MD, Vasavada S, et al</AU>
<TI>A multi-center randomized trial comparing the transobturator tape with tension-free vaginal tape for the surgical treatment of stress urinary incontinence (Abstract number 9 Oral)</TI>
<SO>Journal of Pelvic Medicine &amp; Surgery</SO>
<YR>2007</YR>
<VL>13</VL>
<NO>5</NO>
<PG>234-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417861"/><IDENTIFIER TYPE="OTHER" VALUE="srincont34199"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-21 16:39:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen CC, Rooney CM, Paraiso MF, Kleeman SD, Walters MD, Karram MM, et al</AU>
<TI>Leak point pressure does not correlate with incontinence severity or bother in women undergoing surgery for urodynamic stress incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>9</NO>
<PG>1193-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417862"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27712"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-21 16:40:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frick AC, Ridgeway B, Ellerkmann M, Karram MM, Paraiso MF, Walters MD, et al</AU>
<TI>Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2010</YR>
<VL>184</VL>
<NO>5</NO>
<PG>2013-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417863"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40342"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 11:55:43 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417857"/><IDENTIFIER MODIFIED="2014-03-24 11:55:43 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00475839"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barry-2008" MODIFIED="2015-05-22 17:47:27 +0100" MODIFIED_BY="[Empty name]" NAME="Barry 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-07-02 17:46:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Barry C, Lim YN, Muller R, Hitchins S, Corstiaans A, Foote A, et al</AU>
<TI>A multi-centre, randomised clinical control trial comparing the retropubic (RP) approach versus the transobturator approach (TO) for tension-free, suburethral sling treatment of urodynamic stress incontinence: the TORP study</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>2</NO>
<PG>171&#8211;8</PG>
<IDENTIFIERS MODIFIED="2014-07-02 17:46:32 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417864"/><IDENTIFIER MODIFIED="2014-07-02 17:46:32 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont26462"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 17:47:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barry CL, Lim Y, Muller R, Greenland H, Hitchens S, Corstiaans A, et al</AU>
<TI>A multi-centre, prospective, randomised trial comparing the retropubic (RP-SUS) approach versus the transobturator approach (TO-SUS) for tension free, suburethral sling treatment of urodynamic stress incontinence - the TORP study (Abstract number 53)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2006</YR>
<VL>25</VL>
<NO>6</NO>
<PG>572-3</PG>
<IDENTIFIERS MODIFIED="2015-02-26 13:05:11 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417865"/><IDENTIFIER MODIFIED="2015-02-26 13:05:11 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23754"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757288"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-But-2008" MODIFIED="2014-09-19 11:55:58 +0100" MODIFIED_BY="[Empty name]" NAME="But 2008" YEAR="2007">
<REFERENCE MODIFIED="2013-12-04 12:00:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>But I, Faganelj M</AU>
<TI>Complications and short-term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>6</NO>
<PG>857-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417867"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27423"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 11:59:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>But I, Zegura B, Pakiz M, Rakic S</AU>
<TI>Outside-in vs inside-out transobturator approach in women with stress and mixed urinary incontinence: a prospective, randomized, head-to-head comparison study (Abstract number 18)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S11-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417868"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27320"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417866"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cervigni-2006" MODIFIED="2015-05-22 17:50:16 +0100" MODIFIED_BY="[Empty name]" NAME="Cervigni 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-05-22 17:49:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cervigni M, Natale F, La Penna C, Agostini M, Antomarchi F, Lo Voi R, et al</AU>
<TI>Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans-obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 280)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S215</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417869"/><IDENTIFIER TYPE="OTHER" VALUE="srincont29660"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 17:50:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cervigni M, Natale F, La Penna C, Agostini M, Antomarchi F, Lo Voi R, et al</AU>
<TI>Surgical correction of stress urinary incontinence associated with pelvic organ prolapse: trans-obturator approach (MONARC) versus retropubic approach (TVT) (Abstract number 36)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2006</YR>
<VL>25</VL>
<NO>6</NO>
<PG>552</PG>
<IDENTIFIERS MODIFIED="2015-02-26 13:08:30 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417870"/><IDENTIFIER MODIFIED="2015-02-26 13:08:30 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23756"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757294"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2010" MODIFIED="2015-06-09 11:10:23 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-06-09 11:10:23 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 20890856&lt;br&gt;ST - In-Process&lt;br&gt;AS - Urologia. 77(1):37-41; discussion 42, 2010 Sep 23&lt;br&gt;JC - 0417372&lt;br&gt;CP - Italy&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2015-06-09 11:10:23 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen Z, Chen Y, Du GH, Yuan XY, Wu J, Zeng XY, et al</AU>
<TI>Comparison of three kinds of mid-urethral slings for surgical treatment of female stress urinary incontinence</TI>
<SO>Urologia (Treviso)</SO>
<YR>2010</YR>
<VL>77</VL>
<NO>1</NO>
<PG>37-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417872"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40354"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417871"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2012" MODIFIED="2015-06-22 10:01:06 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-06-22 10:01:06 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - CCTR&lt;br&gt;AN - CN-00895685 NEW&lt;/p&gt;" NOTES_MODIFIED="2015-06-22 10:01:06 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen H-X, Lv J-W, Leng J, Li J-Y, Bo J-J, Huang Y-R</AU>
<TI>Efficacy and complications of TVT procedure and TVT-O procedure in treatment of female stress urinary incontinence [Chinese]</TI>
<SO>Journal of Shanghai Jiaotong University (Medical Science)</SO>
<YR>2012</YR>
<VL>32</VL>
<NO>4</NO>
<PG>412-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417874"/><IDENTIFIER TYPE="OTHER" VALUE="srincont59712"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417873"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cho-2010" MODIFIED="2014-09-19 11:48:58 +0100" MODIFIED_BY="[Empty name]" NAME="Cho 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-03-23 17:29:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Cho ST, Lee ST, Kim K, Lee YG, Kim KK, Choi NG</AU>
<TI>A sequential comparison of postoperative voiding pattern and uroflowmetry between two transobturator midurethral tape procedures (Monarc (trademark) and TOT (trademark)) (Abstract number 750)</TI>
<SO>Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23-27, Toronto, Canada</SO>
<YR>2010</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417876"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40199"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417875"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Choe-2013" MODIFIED="2015-06-08 15:32:26 +0100" MODIFIED_BY="[Empty name]" NAME="Choe 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-06-08 15:32:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Choe JH, Lee HD, Park SH, Jo DG, Lee HS, Lee JS, et al</AU>
<TI>Comparison of postoperative pain after transobturator or retropubic suburethral sling for female stress urinary incontinence: a prospective randomized study (Abstract number MP17-08)</TI>
<SO>Journal of Endourology</SO>
<YR>2013</YR>
<VL>27</VL>
<NO>S1</NO>
<PG>A263</PG>
<IDENTIFIERS MODIFIED="2014-06-28 23:16:08 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417878"/><IDENTIFIER MODIFIED="2014-06-28 23:15:58 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont62161"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417877"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Darabi-Mahboub-2012" MODIFIED="2015-06-08 16:40:33 +0100" MODIFIED_BY="[Empty name]" NAME="Darabi Mahboub 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-06-08 15:33:10 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Conference Abstract&lt;br&gt;English; ABSTRACT LANGUAGE:English&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 15:33:10 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darabi MR, Keshvari M, Sheikhi Z</AU>
<TI>Evaluation study between tension-free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number S88)</TI>
<SO>European Urology Supplements</SO>
<YR>2013</YR>
<VL>12</VL>
<NO>4</NO>
<PG>e1196</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417880"/><IDENTIFIER TYPE="OTHER" VALUE="sr-incont62158"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 16:40:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Darabi Mahboub MR, Keshvari M, Sheikhi Z</AU>
<TI>Evaluation study between tension - free vaginal tape (TVT) and transobturator tape (TOT) in treatment stress incontinence in female (Abstract number 788)</TI>
<SO>Proceedings of the 42nd Annual Meeting of the International Continence (ICS), 2012 Oct 15-19, Beijing, China</SO>
<YR>2012</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417881"/><IDENTIFIER TYPE="OTHER" VALUE="srincont48402"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 18:01:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Mahbob MRD</AU>
<TI>Evaluation study between Tension-Free Vaginal Tape and Transobturator Tape in treatment stress incontinence in women</TI>
<SO>Iranian Registry of Clinical Trials (IRCT) (available at: http://www.irct.ir/searchresult.php?id=8228&amp;number=4 )</SO>
<YR>2009</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417882"/><IDENTIFIER TYPE="OTHER" VALUE="sr-incont 62304"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:38:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mahboub MRD, Keshvari M, Sheikhi Z</AU>
<TI>Evaluation study between tension free vaginal tape and transobturator tape in treatment stress incontinence in female (Abstract number BR03-09)</TI>
<SO>Journal of Endourology</SO>
<YR>2011</YR>
<VL>25</VL>
<NO>Suppl 1</NO>
<PG>A12</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417883"/><IDENTIFIER TYPE="OTHER" VALUE="srincont62292"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-02 18:19:54 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417879"/><IDENTIFIER MODIFIED="2014-07-02 18:19:54 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="IRCT201112148228N4"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-David_x002d_Montefiore-2006" MODIFIED="2015-06-08 15:38:12 +0100" MODIFIED_BY="[Empty name]" NAME="David-Montefiore 2006" YEAR="2007">
<REFERENCE MODIFIED="2013-12-06 12:45:14 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21409548&lt;br&gt;ST - MEDLINE&lt;br&gt;AS - World J Urol. 30(1):117-22, 2012 Feb&lt;br&gt;JC - bry, 8307716&lt;br&gt;CP - Germany&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Multicenter Study&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;LG - English&lt;br&gt;DC - 20120124&lt;/p&gt;" NOTES_MODIFIED="2013-12-06 12:45:14 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ballester M, Bui C, Frobert JL, Grisard-Anaf M, Lienhart J, Fernandez H, et al</AU>
<TI>Four-year functional results of the suburethral sling procedure for stress urinary incontinence: a French prospective randomized multicentre study comparing the retropubic and transobturator routes</TI>
<SO>World Journal of Urology</SO>
<YR>2012</YR>
<VL>30</VL>
<NO>1</NO>
<PG>117-22</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417885"/><IDENTIFIER TYPE="OTHER" VALUE="srincont44520"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-26 13:13:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Darai E, Frobert JL, Grisard-Anaf M, Lienhart J, Fernandez H, Dubernard G, et al</AU>
<TI>Functional results after the suburethral sling procedure for urinary stress incontinence: a prospective randomized multicentre study comparing the retropubic and transobturator routes</TI>
<SO>European Urology</SO>
<YR>2007</YR>
<VL>51</VL>
<NO>3</NO>
<PG>795-802</PG>
<IDENTIFIERS MODIFIED="2014-03-24 11:57:52 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417886"/><IDENTIFIER MODIFIED="2014-03-24 11:57:52 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont22550"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:38:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>David-Montefiore E, Frobert JL, Grisard-Anaf M, Liehart J, Fernandez H, Dubernard G, et al</AU>
<TI>Functional results after suburethral sling procedure for urinary stress incontinence at 1 year: a French prospective randomised multicentre study comparing the retropubic and transobturator routes (Abstract number 063)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S95</PG>
<IDENTIFIERS MODIFIED="2015-02-26 13:22:19 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417887"/><IDENTIFIER MODIFIED="2015-02-26 13:22:19 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont49146"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-26 13:14:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>David-Montefiore E, Frobert JL, Grisard-Anaf M, Lienhart J, Bonnet K, Poncelet C, et al</AU>
<TI>Peri-operative complications and pain after the suburethral sling procedure for urinary stress incontinence: a French prospective randomised multicentre study comparing the retropubic and transobturator routes</TI>
<SO>European Urology</SO>
<YR>2006</YR>
<VL>49</VL>
<NO>1</NO>
<PG>133-8</PG>
<IDENTIFIERS MODIFIED="2014-03-24 11:58:09 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417888"/><IDENTIFIER MODIFIED="2014-03-24 11:58:09 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont21623"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417884"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deffieux-2010" MODIFIED="2015-06-09 08:43:19 +0100" MODIFIED_BY="[Empty name]" NAME="Deffieux 2010" YEAR="2007">
<REFERENCE MODIFIED="2013-12-07 19:17:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deffieux X, Daher N, Mansoor A, Debodinance P, Deval B, Salet-Lizee D, et al</AU>
<TI>Tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of female stress urinary incontinence: a multicenter randomised controlled trial (Abstract number 33)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S19-20</PG>
<IDENTIFIERS MODIFIED="2013-12-07 19:17:09 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417890"/><IDENTIFIER MODIFIED="2013-12-07 19:17:09 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00135616"/><IDENTIFIER MODIFIED="2013-12-07 19:12:06 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont27322"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:38:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Deffieux X, Daher N, Mansoor A, Debodinance P, Muhlstein J, Fernandez H</AU>
<TI>Transobturator TVT-O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow-up</TI>
<SO>International Urogynecology Journal</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1337-45</PG>
<IDENTIFIERS MODIFIED="2014-03-24 11:58:35 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417891"/><IDENTIFIER MODIFIED="2014-03-24 11:58:35 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00135616"/><IDENTIFIER MODIFIED="2013-12-07 19:12:35 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont40895"/><IDENTIFIER TYPE="PUBMED" VALUE="20552165"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 08:43:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deffieux X, Fernandez H</AU>
<TI>Female sexual function following trans-obturator suburethral tape from inside to outside (TVT-O) and tension-free vaginal tape (TVT): a randomized controlled trial (Abstract number 70)</TI>
<SO>Journal of Minimally Invasive Gynecology</SO>
<YR>2009</YR>
<VL>16</VL>
<NO>6</NO>
<PG>S22</PG>
<IDENTIFIERS MODIFIED="2013-12-07 19:17:33 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417892"/><IDENTIFIER MODIFIED="2013-12-07 19:17:33 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00135616"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40862"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-02-02 00:39:04 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21036491&lt;br&gt;ST - In-Process&lt;br&gt;OT - Resultats fonctionnels de la chirurgie de l'incontinence urinaire a l'effort par bandelette sous-uretrale par voie retropubienne et transobturatrice&lt;br&gt;AS - J Gynecol Obstet Biol Reprod (Paris). 39(8):614-23, 2010 Dec&lt;br&gt;JC - iaz, 0322206&lt;br&gt;CP - France&lt;br&gt;PT - English Abstract&lt;br&gt;PT - Journal Article&lt;br&gt;LG - French&lt;br&gt;DC - 20101126&lt;/p&gt;" NOTES_MODIFIED="2014-02-02 00:39:04 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trichot C, Salet-Lizee D, Descamps P, Deval B, Hocke C, Fatton B, et al</AU>
<TI>[Functional results following transobturator and retropubic mid-urethral sling] [French]</TI>
<SO>Journal de Gynecologie, Obstetrique et Biologie de la Reproduction</SO>
<YR>2010</YR>
<VL>39</VL>
<NO>8</NO>
<PG>614-23</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417893"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00135616"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41067"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 11:58:48 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417889"/><IDENTIFIER MODIFIED="2014-03-24 11:58:48 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00135616"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Leval-2011" MODIFIED="2015-06-09 08:43:31 +0100" MODIFIED_BY="[Empty name]" NAME="de Leval 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-12-04 17:06:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Thomas A, Waltregny D, de Leval J</AU>
<TI>One year results of a prospective randomized trial comparing the original inside-out transobturator (TVT-O) procedure and a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 153)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>6</NO>
<PG>1023-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417895"/><IDENTIFIER TYPE="OTHER" VALUE="ISRCTN65635093"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40146"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 16:43:41 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Embase&lt;br&gt;UI - 70836138&lt;br&gt;LG - English&lt;br&gt;PT - Journal: Conference Abstract&lt;br&gt;EM - 201235&lt;br&gt;DD - 20120823&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 16:43:41 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Waltregny D, Thomas A, Blockx C, de Leval J</AU>
<TI>Three year results of a prospective randomized trial comparing the original inside-out transobturator (TVT-O<SUP>TM</SUP>) procedure with a modified version using a shortened tape and reduced dissection for the treatment of female stress urinary incontinence (Abstract number 254)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>6</NO>
<PG>1056-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417896"/><IDENTIFIER TYPE="OTHER" VALUE="ISRCTN65635093"/><IDENTIFIER TYPE="OTHER" VALUE="srincont46716"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-09-19 12:30:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Waltregny D, de Leval J</AU>
<TI>New surgical technique for treatment of stress urinary incontinence TVT-ABBREVO from development to clinical experience</TI>
<SO>Surgical Technology International</SO>
<YR>2012</YR>
<VL>22</VL>
<PG>149-57</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417897"/><IDENTIFIER TYPE="OTHER" VALUE="srincont49404"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 08:43:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Waltregny D</AU>
<TI>Clincial comparison between the original TVT-O and a modified procedure (mini TVT-O) for the surgical treatment of female stress urinary incontinence: a randomised clinical trial with 1-year follow-up</TI>
<SO>http://isrctn.org/ISRCTN65635093</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2014-07-01 09:14:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417898"/><IDENTIFIER MODIFIED="2014-07-01 09:14:52 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont62307"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 11:59:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de Leval J, Thomas A, Waltregny D</AU>
<TI>The original versus a modified inside-out transobturator procedure: 1-year results of a prospective randomized trial</TI>
<SO>International Urogynecology Journal</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>2</NO>
<PG>145-56</PG>
<IDENTIFIERS MODIFIED="2014-03-24 11:59:16 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417899"/><IDENTIFIER MODIFIED="2014-03-24 11:59:16 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ISRCTN65635093"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40993"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 11:59:30 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417894"/><IDENTIFIER MODIFIED="2014-03-24 11:59:30 +0000" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="ISRCTN65635093"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-de-Tayrac-2004" MODIFIED="2015-06-08 16:57:21 +0100" MODIFIED_BY="[Empty name]" NAME="de Tayrac 2004" YEAR="2004">
<REFERENCE MODIFIED="2015-06-08 16:44:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>de Tayrac R, Deffieux X, Droupy S, Chauveaud-Lambling A, Calvanese-Benamour L, Fernandez H</AU>
<TI>A prospective randomized trial comparing tension-free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>190</VL>
<NO>3</NO>
<PG>602-8</PG>
<IDENTIFIERS MODIFIED="2015-02-26 13:33:19 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417900"/><IDENTIFIER MODIFIED="2015-02-26 13:33:19 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont17259"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 16:57:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>de Tayrac R, Droupy S, Calvanese L, Fernandez H</AU>
<TI>A prospective randomized study comparing TVT and transobturator suburethral tape (T.O.T.) for the surgical treatment of stress incontinence (Abstract)</TI>
<SO>Proceedings of the 33rd Annual Meeting of the International Continence Society (ICS), 203 Oct 5-9, Florence, Italy</SO>
<YR>2003</YR>
<PG>266-7</PG>
<IDENTIFIERS MODIFIED="2015-02-26 13:33:28 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417901"/><IDENTIFIER MODIFIED="2015-02-26 13:33:28 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont17153"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757326"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Diab-2012" MODIFIED="2015-04-23 11:12:39 +0100" MODIFIED_BY="[Empty name]" NAME="Diab 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-04-23 11:12:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Diab DE, Zayed AM, Allam MN, Maroof AM, Ibraheem E, El-Sayed DE</AU>
<TI>A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number 177)</TI>
<SO>European Urology Supplements</SO>
<YR>2012</YR>
<VL>11</VL>
<NO>1</NO>
<PG>e177</PG>
<IDENTIFIERS MODIFIED="2014-06-29 02:00:08 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417903"/><IDENTIFIER MODIFIED="2014-06-29 02:00:08 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont62249"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417902"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Elbadry-2014" MODIFIED="2015-04-23 11:12:44 +0100" MODIFIED_BY="[Empty name]" NAME="Elbadry 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-04-23 11:12:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Elbadry M, Shaaban A, Gabre A</AU>
<TI>Adjustable versus ordinary trans-obturator tape for female stress incontinence...is there a difference? A randomized trial (Abstract number MP75-09)</TI>
<SO>Journal of Urology</SO>
<YR>2014</YR>
<VL>191</VL>
<NO>4 Suppl 1</NO>
<PG>e876</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417905"/><IDENTIFIER TYPE="OTHER" VALUE="srincont62136"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417904"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-El_x002d_Hefnawy-2010" MODIFIED="2014-09-19 11:50:08 +0100" MODIFIED_BY="[Empty name]" NAME="El-Hefnawy 2010" YEAR="2013">
<REFERENCE MODIFIED="2013-12-04 13:31:51 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 20424826&lt;br&gt;ST - In-Process&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 21(8):947-53, 2010 Aug&lt;br&gt;JC - cl5, 9514583&lt;br&gt;CP - England&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 13:31:51 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>El-Hefnawy AS, Wadie BS, El Mekresh M, Nabeeh A, Bazeed MA</AU>
<TI>TOT for treatment of stress urinary incontinence: how should we assess its equivalence with TVT?</TI>
<SO>International Urogynecology Journal</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>8</NO>
<PG>947-53</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417907"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40077"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 13:31:27 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 23011257&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - World J Urol. 31(3):645-9, 2013 Jun&lt;br&gt;JC - bry, 8307716&lt;br&gt;CP - Germany&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20130523&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 13:31:27 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wadie BS, Elhefnawy AS</AU>
<TI>TVT versus TOT, 2-year prospective randomized study</TI>
<SO>World Journal of Urology</SO>
<YR>2013</YR>
<VL>31</VL>
<NO>3</NO>
<PG>645-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417908"/><IDENTIFIER TYPE="OTHER" VALUE="srincont48133"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417906"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Enzelsberger-2005" MODIFIED="2015-06-08 15:38:34 +0100" MODIFIED_BY="[Empty name]" NAME="Enzelsberger 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-06-08 15:38:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Enzelsberger H, Schalupny J, Heider R, Mayer G</AU>
<TI>TVT versus TOT - a prospective randomized study for the treatment of female stress urinary incontinence at a follow-up of 1 year [German]</TI>
<SO>Geburtshilfe und Frauenheilkunde</SO>
<YR>2005</YR>
<VL>65</VL>
<NO>5</NO>
<PG>506-11</PG>
<IDENTIFIERS MODIFIED="2014-03-24 11:59:59 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417909"/><IDENTIFIER MODIFIED="2014-03-24 11:59:59 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont21007"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757336"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Freeman-2011" MODIFIED="2014-09-19 11:50:17 +0100" MODIFIED_BY="[Empty name]" NAME="Freeman 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-05-22 14:17:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Freeman R, Holmes D, Hillard T, Smith P, James M, Sultan A, et al</AU>
<TI>What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence-a multi-centre randomised controlled trial</TI>
<SO>International Urogynecology Journal</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>3</NO>
<PG>279-86</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417911"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41009"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 13:36:46 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Freeman R, Holmes D, Smith P, Hillard T, Yang Q, Agur W, et al</AU>
<TI>Is trans-obturator tape (TOT) as effective as tension-free vaginal tape (TVT) in the treatment of women with urodynamic stress incontinence? Results of a multicentre RCT (Abstract number 3)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>7</NO>
<PG>573-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417912"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31849"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417910"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hammoud-2011" MODIFIED="2015-06-08 15:38:50 +0100" MODIFIED_BY="[Empty name]" NAME="Hammoud 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-06-08 15:38:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hammoud K, Elsheikh M, Haitham M, Fayad A, Ghamrawy H, Aboumohamed A</AU>
<TI>Tension-free vaginal tape versus transobturator vaginal tape in management of female stress urinary incontinence. Long-term follow-up: which to choose (Abstract number UP-01.075)</TI>
<SO>Urology</SO>
<YR>2011</YR>
<VL>78</VL>
<NO>3 Suppl 1</NO>
<PG>S209-10</PG>
<IDENTIFIERS MODIFIED="2014-06-29 20:11:22 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417914"/><IDENTIFIER MODIFIED="2014-06-29 20:11:22 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont62233"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:38:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hammoud KM, El Sheikh MG, Haitham M, Fayad AS, El Ghamrawy HK, Mohamed AARA</AU>
<TI>Tension-free vaginal tape versus trans-obturator vaginal tape in the management of female stress urinary incontinence long term follow-up: which to choose (Abstract number MP07-01)</TI>
<SO>Journal of Endourology</SO>
<YR>2012</YR>
<VL>26</VL>
<NO>Suppl 1</NO>
<PG>A59</PG>
<IDENTIFIERS MODIFIED="2014-06-29 20:30:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417915"/><IDENTIFIER MODIFIED="2014-06-29 20:30:52 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont62245"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417913"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hassan-2013" MODIFIED="2015-06-08 16:49:36 +0100" MODIFIED_BY="[Empty name]" NAME="Hassan 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-06-08 16:49:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hassan S, Aly H</AU>
<TI>Randomised Comparative study between inside-out transobturator tape and outside-in transobturator tape for urodynamic stress incontinence</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2013</YR>
<VL>32</VL>
<NO>6</NO>
<PG>777</PG>
<IDENTIFIERS MODIFIED="2014-03-25 10:46:42 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417917"/><IDENTIFIER MODIFIED="2014-03-25 10:46:42 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont49205"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417916"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Houwert-2009" MODIFIED="2015-06-17 12:14:16 +0100" MODIFIED_BY="[Empty name]" NAME="Houwert 2009" YEAR="2007">
<REFERENCE MODIFIED="2015-06-08 15:40:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Houwert M, Vos MC, Vervest HAM</AU>
<TI>Transobturator tape (TOT), inside-out versus outside-in approaches: outcome after 1 year (Abstract number 56)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S33</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417919"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27326"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 12:04:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Houwert RM, Renes-Zijl C, Vos MC, Vervest HA</AU>
<TI>TVT-O versus Monarc after a 2-4-year follow-up: a prospective comparative study</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2009</YR>
<VL>20</VL>
<NO>11</NO>
<PG>1327-33</PG>
<IDENTIFIERS MODIFIED="2015-06-17 12:04:16 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417920"/><IDENTIFIER MODIFIED="2015-06-17 12:04:16 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont50308"/><IDENTIFIER TYPE="PUBMED" VALUE="19597718"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 12:14:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vervest H, de Bruin JP, Renes-Zeijl CC</AU>
<TI>Transobturator tape (TOT), inside-out or outside-in approaches: does it matter? (Abstract number 167)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2005</YR>
<VL>16</VL>
<NO>2 Suppl</NO>
<PG>S69-70</PG>
<IDENTIFIERS MODIFIED="2015-06-17 12:05:32 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417921"/><IDENTIFIER MODIFIED="2015-06-17 12:05:32 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont27406"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417918"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakimiuk-2012" MODIFIED="2015-06-22 10:34:22 +0100" MODIFIED_BY="[Empty name]" NAME="Jakimiuk 2012" YEAR="2007">
<REFERENCE MODIFIED="2015-06-22 10:34:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jakimiuk AJ, Issat T, Fritz-Rdzanek A, Maciejewski T, Rogowski A, Baranowski W</AU>
<TI>Is there any difference? A prospective, multicenter, randomized,single blinded clinical trial, comparing TVT with TVT-O (POLTOS study) in management of stress urinary incontinence. Short-term outcomes</TI>
<SO>Pelviperineology</SO>
<YR>2012</YR>
<VL>31</VL>
<PG>5-9</PG>
<IDENTIFIERS MODIFIED="2015-06-17 12:16:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417923"/><IDENTIFIER MODIFIED="2015-06-17 12:16:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont50305"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-22 18:25:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakimiuk AJJ, Maciejewski TM, Fritz AF, Baranowski WB, Wladysiuk-Blicharz MWB</AU>
<TI>Single-blind randomized clinical trial comparing efficacy and safety of TVT (tension free vaginal tape) vs TVT-O (tension free vaginal tape obturator system) in treatment of stress urinary incontinence (POLTOS) preliminary report (Abstract number 348)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S189</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417924"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27324"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 12:01:00 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417922"/><IDENTIFIER MODIFIED="2014-03-24 12:01:00 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="POLTOS"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Juang-2007" MODIFIED="2014-09-19 11:51:56 +0100" MODIFIED_BY="[Empty name]" NAME="Juang 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-12-04 13:54:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Juang CM, Yu KJ, Chou P, Yen MS, Twu NF, Horng HC, et al</AU>
<TI>Efficacy analysis of trans-obturator tension-free vaginal tape (TVT-O) plus modified Ingelman-Sundberg procedure versus TVT-O alone in the treatment of mixed urinary incontinence: a randomized study</TI>
<SO>European Urology</SO>
<YR>2007</YR>
<VL>51</VL>
<NO>6</NO>
<PG>1671-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417926"/><IDENTIFIER TYPE="OTHER" VALUE="srincont23260"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417925"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kamel-2009" MODIFIED="2015-06-08 16:52:25 +0100" MODIFIED_BY="[Empty name]" NAME="Kamel 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-06-08 16:52:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Kamel A</AU>
<TI>A comparison between TVT &amp; TVTO as regards safety. An African experience (Abstract number 830)</TI>
<SO>Proceedings of the 39th Annual Meeting of the International Continence Society (ICS), 2009 Sep 29 - Oct 3, San Francisco, CA</SO>
<YR>2009</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417928"/><IDENTIFIER TYPE="OTHER" VALUE="srincont35630"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417927"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karateke-2009" MODIFIED="2014-09-19 11:52:12 +0100" MODIFIED_BY="[Empty name]" NAME="Karateke 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-12-04 13:58:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karateke A, Haliloglu B, Cam C, Sakalli M</AU>
<TI>Comparison of TVT and TVT-O in patients with stress urinary incontinence: short-term cure rates and factors influencing the outcome. A prospective randomised study</TI>
<SO>Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2009</YR>
<VL>49</VL>
<NO>1</NO>
<PG>99-105</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417930"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31429"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417929"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kilic-2007" MODIFIED="2015-06-08 15:41:10 +0100" MODIFIED_BY="[Empty name]" NAME="Kilic 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-08 15:41:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kilic G, Olgun G, Bilen MA, Orhan A, Dunn B</AU>
<TI>[The comparison of TVT (tension free vaginal tape) and TOT (trans-obturator vaginal tape) in the treatment of the urinary incontinence and literature search]</TI>
<SO>Jinekoloji Ve Obstetrik Dergisi</SO>
<YR>2007</YR>
<VL>21</VL>
<NO>1</NO>
<PG>26-31</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417932"/><IDENTIFIER TYPE="OTHER" VALUE="srincont28036"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417931"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2004" MODIFIED="2015-06-08 16:58:12 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 2004" YEAR="2004">
<REFERENCE MODIFIED="2015-06-08 16:58:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kim J, Baek U, Kwon S, Jung H, Moon K, Park T, et al</AU>
<TI>The efficacy of Iris procedure in stress urinary incontinence: comparison with TVT and SPARC (Abstract)</TI>
<SO>Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, Joint Meeting, 23-27 Aug, 2004, Paris</SO>
<YR>2004</YR>
<PG>Abstract number 313</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:01:26 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417933"/><IDENTIFIER MODIFIED="2014-03-24 12:01:26 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont19058"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757361"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2005" MODIFIED="2015-06-21 16:45:10 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-03-24 12:01:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kim Y-W, Na Y-G, Sul C-K</AU>
<TI>[Randomized prospective study between pubovaginal sling using SPARC sling system and MONARC sling system for the treatment of female stress urinary incontinence: short term results]</TI>
<SO>Korean Journal of Urology</SO>
<YR>2005</YR>
<VL>46</VL>
<NO>10</NO>
<PG>1078-82</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:01:43 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757364"/><IDENTIFIER MODIFIED="2014-03-24 12:01:43 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont22116"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:01:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Na YG, Rob AS, Youk SM, Kim YW, Kim HS, Sul CK, et al</AU>
<TI>A prospective multicentre randomized study comparing transvaginal tapes (SPARC sling system) and transobturator suburethral tapes (Monarc sling system) for the surgical treatment of stress urinary incontinence (Abstract number 49)</TI>
<SO>European Urology Supplements</SO>
<YR>2005</YR>
<VL>4</VL>
<NO>3</NO>
<PG>15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417934"/><IDENTIFIER TYPE="OTHER" VALUE="srincont26609"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757363"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krofta-2010" MODIFIED="2015-06-17 12:24:04 +0100" MODIFIED_BY="[Empty name]" NAME="Krofta 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-06-17 12:23:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krofta L, Feyereisl J, Otcenasek M, Kasikova E, Pan M</AU>
<TI>[Tension free vaginal tape and transobturator suburethral tape for surgical treatment of stress urinary incontinence] [Czech]</TI>
<SO>Ceska Gynekologie</SO>
<YR>2008</YR>
<VL>73</VL>
<NO>4</NO>
<PG>231-9</PG>
<IDENTIFIERS MODIFIED="2015-06-17 12:23:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417936"/><IDENTIFIER MODIFIED="2015-06-17 12:23:23 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont27504"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 12:24:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Krofta L, Feyereisl J, Otcenasek M, Velebil P, Kasikova E, Krcmar M</AU>
<TI>TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial</TI>
<SO>International Urogynecology Journal</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>2</NO>
<PG>141-8</PG>
<IDENTIFIERS MODIFIED="2015-06-17 12:24:04 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417937"/><IDENTIFIER MODIFIED="2015-06-17 12:24:04 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont39511"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417935"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laurikainen-2007" MODIFIED="2015-06-17 13:08:02 +0100" MODIFIED_BY="[Empty name]" NAME="Laurikainen 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-17 13:02:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brubaker L, Brincat C, Mueller E</AU>
<TI>Are we satisfied? Perspective on five-year outcomes of midurethral slings [editorial]</TI>
<SO>European Urology</SO>
<YR>2014</YR>
<VL>65</VL>
<NO>6</NO>
<PG>1115-6</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:01:43 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417939"/><IDENTIFIER MODIFIED="2015-06-17 13:01:43 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont67651"/><IDENTIFIER TYPE="PUBMED" VALUE="24568893"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 12:04:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laurikainen E, Takala T, Aukee P, Kivela A, Rinne K, Valpas A, et al</AU>
<TI>Retropubic TVT compared with transobturator TVT (TVT-O) in treatment of stress urinary incontinence: five-year results of a randomized trial (Abstract number 2)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>6</NO>
<PG>803-5</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:04:07 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417940"/><IDENTIFIER MODIFIED="2014-03-24 12:04:07 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00379314"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42162"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:06:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laurikainen E, Valpas A, Aukee P, Kivela A, Rinne K, Takala T, et al</AU>
<TI>Five-year results of a randomized trial comparing retropubic and transobturator midurethral slings for stress incontinence</TI>
<SO>European Urology</SO>
<YR>2014</YR>
<VL>65</VL>
<NO>6</NO>
<PG>1109-14</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:06:47 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417941"/><IDENTIFIER MODIFIED="2015-06-17 13:06:47 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont60594"/><IDENTIFIER TYPE="PUBMED" VALUE="24508070"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:07:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laurikainen E, Valpas A, Kiilholma P, Takala T, Kivela A, Aukee P, et al</AU>
<TI>A prospective randomised trial comparing TVT and TVT-O procedures for the treatment of SUI: immediate outcome and complications (Abstract no 077)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S104-5</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:07:22 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417942"/><IDENTIFIER MODIFIED="2015-06-17 13:07:22 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont49149"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:08:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Laurikainen E, Valpas A, Kivela A, Kalliola T, Rinne K, Takala T, et al</AU>
<TI>Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2007</YR>
<VL>109</VL>
<NO>1</NO>
<PG>4-11</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:08:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417943"/><IDENTIFIER MODIFIED="2015-06-17 13:08:02 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont22553"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 12:15:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Nilsson CG</AU>
<TI>A randomized, prospective, multicenter trial comparing TVT with TVT-O procedures in treatment of female primary urinary stress incontinence (Trial registry number: NCT00379314)</TI>
<SO>http://clinicaltrials.gov/show/NCT00379314</SO>
<YR>2004</YR>
<IDENTIFIERS MODIFIED="2014-03-24 12:15:34 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417944"/><IDENTIFIER MODIFIED="2014-03-24 12:15:12 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00379314"/><IDENTIFIER MODIFIED="2014-03-24 12:15:34 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont49342"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:13:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Palva K, Nilsson CG</AU>
<TI>Prevalence of urinary urgency symptoms decreases by mid-urethral sling procedures for treatment of stress incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>10</NO>
<PG>1241-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417945"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00379314"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42695"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:12:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Palva K, Rinne K, Aukee P, Kivela A, Laurikainen E, Takala T, et al</AU>
<TI>A randomized trial comparing tension-free vaginal tape with tension-free vaginal tape-obturator: 36-month results</TI>
<SO>International Urogynecology Journal</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>9</NO>
<PG>1049-55</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417946"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00379314"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40052"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:32:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rinne K, Aukee P, Heikkinen AM, Kalliola T, Kiilholma P, Kivela A, et al</AU>
<TI>A randomized clinical trial comparing TVT with TVT-O for treatment of stress urinary incontinence: 12 months results (Abstract number 48)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S28-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417947"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27323"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-01-26 13:21:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rinne K, Laurikainen E, Kivela A, Aukee P, Takala T, Valpas A, et al</AU>
<TI>A randomized trial comparing TVT with TVT-O: 12-month results</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>8</NO>
<PG>1049-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417948"/><IDENTIFIER TYPE="OTHER" VALUE="NCT000379314"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31311"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 14:48:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rinne K</AU>
<TI>Comparison of two mid-urethral sling operations and their effect on urethral mobility assessed by dynamic magnetic resonance imaging [dissertation]</TI>
<SO>Dissertations in Health Sciences (Publications of the University of Eastern Finland)</SO>
<YR>2010</YR>
<VL>33</VL>
<PG>1-77</PG>
<IDENTIFIERS MODIFIED="2014-03-24 14:48:51 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417949"/><IDENTIFIER MODIFIED="2014-03-24 14:48:19 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ISBN: 978-952-61-0236-8 (pdf)"/><IDENTIFIER MODIFIED="2014-03-24 14:48:51 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ISSN:1798-5714 (pdf)"/><IDENTIFIER MODIFIED="2014-03-24 14:43:06 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00379314"/><IDENTIFIER MODIFIED="2014-03-24 14:42:50 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont 60054"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 12:04:25 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417938"/><IDENTIFIER MODIFIED="2014-03-24 12:04:25 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00379314"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leanza-2009" MODIFIED="2015-06-17 13:11:16 +0100" MODIFIED_BY="[Empty name]" NAME="Leanza 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-06-17 13:11:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leanza V, Dati S, Gasbarro N, Leanza G</AU>
<TI>Retropubic versus transobturator tension free procedures: a comparative study (Abstract number 7)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>S1</NO>
<PG>6-7</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:11:16 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417951"/><IDENTIFIER MODIFIED="2014-07-02 18:53:42 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/nau.21134"/><IDENTIFIER MODIFIED="2015-06-17 13:11:16 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont50306"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-01-21 23:13:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Leanza V, Dati S, Gasbarro N</AU>
<TI>A multicenter randomized trial of prepubic and retropubic Leanza-Gasbarro-Caschetto tension-free procedures (Abstract number 001)</TI>
<SO>International Urogynaecology Journal</SO>
<YR>2009</YR>
<VL>20</VL>
<NO>Suppl 2</NO>
<PG>S73</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417952"/><IDENTIFIER TYPE="OTHER" VALUE="srincont39881"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417950"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2007" MODIFIED="2015-06-17 13:12:01 +0100" MODIFIED_BY="[Empty name]" NAME="Lee 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-17 13:12:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lee KS, Han DH, Choi YS, Yum SH, Song SH, Doo CK, et al</AU>
<TI>A prospective trial comparing tension-free vaginal tape and transobturator vaginal tape inside-out for the surgical treatment of female stress urinary incontinence: 1-year follow up</TI>
<SO>Journal of Urology</SO>
<YR>2007</YR>
<VL>177</VL>
<NO>1</NO>
<PG>214-8</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:12:01 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417953"/><IDENTIFIER MODIFIED="2015-06-17 13:12:01 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont28039"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:57:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ryu KH, Shin JS, Du JK, Choo MS, Lee KS</AU>
<TI>Randomized trial of tension-free vaginal tape (TVT) vs. tension-free vaginal tape obturator (TVT-O) in the surgical treatment of stress urinary incontinence: comparison of operation related morbidity (Abstract number 50)</TI>
<SO>European Urology Supplements</SO>
<YR>2005</YR>
<VL>4</VL>
<NO>3</NO>
<PG>15</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417954"/><IDENTIFIER TYPE="OTHER" VALUE="srincont26610"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757384"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee-2008" MODIFIED="2015-06-17 13:13:08 +0100" MODIFIED_BY="[Empty name]" NAME="Lee 2008" YEAR="2007">
<REFERENCE MODIFIED="2015-06-17 13:13:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee K-S, Choo M-S, Lee YS, Han J-Y, Kim J-Y, Jung BJ, et al</AU>
<TI>Prospective comparison of the &#8216;inside&#8211;out&#8217; and &#8216;outside&#8211;in&#8217; transobturator tape procedures for the treatment of female stress urinary incontinence</TI>
<SO>International Urogynecology Journal Including Pelvic Floor Dysfunction</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>4</NO>
<PG>577-82</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:13:08 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757388"/><IDENTIFIER MODIFIED="2015-06-17 13:13:08 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont34482"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757387"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liapis-2006" MODIFIED="2015-05-22 18:30:56 +0100" MODIFIED_BY="[Empty name]" NAME="Liapis 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-05-22 18:30:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liapis A, Bakas P, Giner M, Creatsas G</AU>
<TI>Tension-free vaginal tape versus tension-free vaginal tape obturator in women with stress urinary incontinence</TI>
<SO>Gynecologic and Obstetric Investigation</SO>
<YR>2006</YR>
<VL>62</VL>
<NO>3</NO>
<PG>160-4</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:06:36 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417955"/><IDENTIFIER MODIFIED="2014-03-24 12:06:36 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont22245"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757389"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liapis-2008" MODIFIED="2015-06-17 13:14:31 +0100" MODIFIED_BY="[Empty name]" NAME="Liapis 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-06-17 13:14:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liapis A, Bakas P, Creatsas G</AU>
<TI>Monarc vs TVT-O for the treatment of primary stress incontinence: a randomised study</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<PG>185-90</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:14:31 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757392"/><IDENTIFIER MODIFIED="2015-06-17 13:14:31 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont26461"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757391"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lim-2005" MODIFIED="2015-06-17 15:53:21 +0100" MODIFIED_BY="[Empty name]" NAME="Lim 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-06-17 13:16:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balakrishnan S, Lim YK, Barry C, Corstiaans A, Kannan K, Rane A</AU>
<TI>Sling distress: a subanalysis of the IVS tapes from the SUSPEND trial</TI>
<SO>Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2007</YR>
<VL>47</VL>
<NO>6</NO>
<PG>496-8</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:16:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417956"/><IDENTIFIER MODIFIED="2015-06-17 13:16:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont26475"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 08:44:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lim YN, Muller R, Corstiaans A, Dietz HP, Barry C, Rane A</AU>
<TI>Suburethral slingplasty evaluation study in North Queensland, Australia: the SUSPEND trial</TI>
<SO>Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2005</YR>
<VL>45</VL>
<NO>1</NO>
<PG>52-9</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:06:55 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417957"/><IDENTIFIER MODIFIED="2014-03-24 12:06:55 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont20403"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 15:52:39 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lim YN, Rane A, Barry C, Corstiaans A, Dietz HP, Muller R</AU>
<TI>The suburethral slingplasty evaluation study in North Queensland (SUSPEND): a randomized controlled trial (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>5/6</NO>
<PG>495-6</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:07:05 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417958"/><IDENTIFIER MODIFIED="2014-03-24 12:07:05 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont19012"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-06-17 15:53:21 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757393"/><IDENTIFIER MODIFIED="2015-06-17 15:53:21 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="TrialID.SUSPEND"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lord-2006" MODIFIED="2015-05-23 05:55:19 +0100" MODIFIED_BY="[Empty name]" NAME="Lord 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-05-23 05:55:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lord HE, Taylor JD, Finn JC, Tsokos N, Jeffery JT, Atherton MJ, et al</AU>
<TI>A randomized controlled equivalence trial of short-term complications and efficacy of tension-free vaginal tape and suprapubic urethral support sling for treating stress incontinence</TI>
<SO>BJU International</SO>
<YR>2006</YR>
<VL>98</VL>
<NO>2</NO>
<PG>367-76</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:07:18 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757398"/><IDENTIFIER MODIFIED="2014-03-24 12:07:18 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont22369"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757397"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mansoor-2003" MODIFIED="2015-06-17 13:17:36 +0100" MODIFIED_BY="[Empty name]" NAME="Mansoor 2003" YEAR="2003">
<REFERENCE MODIFIED="2015-06-17 13:17:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mansoor A, Vedrine N, Darcq C</AU>
<TI>Surgery of female urinary incontinence using transobturator tape (TOT): a prospective randomised comparative study with TVT (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2003</YR>
<VL>22</VL>
<NO>5</NO>
<PG>488-9</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:17:36 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417959"/><IDENTIFIER MODIFIED="2015-06-17 13:17:36 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont17107"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757399"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mehdiyev-2010" MODIFIED="2015-06-08 15:42:47 +0100" MODIFIED_BY="[Empty name]" NAME="Mehdiyev 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-06-08 15:42:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mehdiyev M, Itil IM, Sendag F, Akdemir A, Askar N</AU>
<TI>Comparing the transvaginal tape (TVT) and transobturator tape (TOT) in stress urinary incontinance for their efficiency and their effects on quality of life</TI>
<SO>Turk Jinekoloji ve Obstetrik Dernegi Dergisi</SO>
<YR>2010</YR>
<VL>7</VL>
<NO>2</NO>
<PG>117-24</PG>
<IDENTIFIERS MODIFIED="2014-06-29 17:03:48 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417961"/><IDENTIFIER MODIFIED="2014-06-29 17:03:48 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont62297"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417960"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meschia-2006" MODIFIED="2015-06-17 13:19:40 +0100" MODIFIED_BY="[Empty name]" NAME="Meschia 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-06-17 13:18:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Meschia M, Pifarotti P, Bernasconi F, Magatti F, Vigano R, Bertozzi R, et al</AU>
<TI>Tension-free vaginal tape (TVT) and intravaginal slingplasty (IVS) for stress urinary incontinence: a multicenter randomized trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2006</YR>
<VL>195</VL>
<NO>5</NO>
<PG>1338-42</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:18:44 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417962"/><IDENTIFIER MODIFIED="2015-06-17 13:18:44 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont22268"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:19:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Meschia M, Pifarotti P, Bernasconi F, Magatti F, Vigano R</AU>
<TI>Multicenter randomized trial of TVT and IVS for the treatment of stress urinary incontinence in women (Abstract)</TI>
<SO>Proceedings of the 33rd Annual Meeting International Continence Society (ICS), 2003 Oct 5-9, Florence</SO>
<YR>2003</YR>
<PG>318-9</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:19:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417963"/><IDENTIFIER MODIFIED="2015-06-17 13:19:07 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont16339"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:19:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pifarotti P, Meschia M, Gattei U, Bernasconi F, Magatti F, Vigano R</AU>
<TI>Multicenter randomized trial of tension-free vaginal tape (TVT) and intravaginal slingplasty (IVS) for the treatment of stress urinary incontinence in women (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>5/6</NO>
<PG>494-5</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:19:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417964"/><IDENTIFIER MODIFIED="2015-06-17 13:19:40 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont19011"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757403"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meschia-2007" MODIFIED="2015-06-17 13:24:51 +0100" MODIFIED_BY="[Empty name]" NAME="Meschia 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-12-04 14:52:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Meschia M, Bertozzi R, Pifarotti P, Baccichet R, Bernasconi F, Guercio E, et al</AU>
<TI>Peri-operative morbidity and early results of a randomised trial comparing TVT and TVT-O</TI>
<SO>International Urogynecology Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>11</NO>
<PG>1257-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417965"/><IDENTIFIER TYPE="OTHER" VALUE="srincont23958"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:43:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meschia M, Pifarotti P, Baccichet R, Bernasconi F, Cortese P, Magatti F, et al</AU>
<TI>A multicenter randomized comparison of tension-free vaginal tape (TVT) and trans-obturator in-out technique (TVT-O) for the treatment of stress urinary incontinence: one year results (Abstract number 3)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417966"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27318"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:24:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meschia M, Pifarotti P, Bernasconi F, Baccichet R, Magatti F, Cortese P, et al</AU>
<TI>A multicentre randomised comparison of tension free vaginal tape (TVT) and transobturator in-out technique (TVT-O) for the treatment of stress urinary incontinence (Abstract number 059)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S92-S93</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:24:51 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417967"/><IDENTIFIER MODIFIED="2015-06-17 13:24:51 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont49147"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-23 06:00:45 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 18438600&lt;br&gt;CM - Comment on: Int Urogynecol J Pelvic Floor Dysfunct. 2007 Nov;18(11):1257-61; PMID: 17345002&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 19(12):1725, author reply 1727, 2008 Dec&lt;br&gt;JC - cl5, 9514583&lt;br&gt;SB - IM&lt;br&gt;CP - England&lt;br&gt;PT - Comment&lt;br&gt;PT - Letter&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2015-05-23 06:00:45 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Minassian VA, Parekh M, Langroudi MH</AU>
<TI>Comment on Meschia et al: peri-operative morbidity and early results of a randomised trial comparing TVT and TVT-O [comment]</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>12</NO>
<PG>1725</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417968"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31222"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757407"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Naumann-2006" MODIFIED="2015-06-17 13:28:02 +0100" MODIFIED_BY="[Empty name]" NAME="Naumann 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-06-17 13:27:27 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;                           TVT(123) , LIFT(125)&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Subjective cure 107/123 , 109/125&lt;/p&gt;&lt;p&gt;Subjective improvement 10/123 , 13/125&lt;/p&gt;&lt;p&gt;Bladder perforation 2/123 , 1/125&lt;/p&gt;&lt;p&gt;vaginal tape erosion 3/123,  7/125&lt;/p&gt;" NOTES_MODIFIED="2015-06-17 13:27:27 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Naumann G, Lobodasch K, Bettin S, Meyer P, Koelbl H</AU>
<TI>Tension free vaginal tape (TVT) vs less invasive free tape (LIFT) - a randomized multicentric study of suburethral sling surgery (Abstract number 062)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S94-5</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:27:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417969"/><IDENTIFIER MODIFIED="2015-06-17 13:27:27 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont49145"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:28:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Naumann G, Lobodasch K, Bettin S, Meyer P, Koelbl H</AU>
<TI>Tension free vaginal tape (TVT<SUP>TM</SUP>) vs less invasive free tape (LIFT<SUP>TM</SUP>) - a randomized multicentre study of suburethral sling surgery (Abstract number 481)</TI>
<SO>Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27-Dec 1, Christchurch, New Zealand</SO>
<YR>2006</YR>
<IDENTIFIERS MODIFIED="2015-06-17 13:28:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417970"/><IDENTIFIER MODIFIED="2015-06-17 13:28:02 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23752"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757412"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nerli-2009" MODIFIED="2014-09-19 11:58:31 +0100" MODIFIED_BY="[Empty name]" NAME="Nerli 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-12-04 15:03:24 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - CCTR&lt;br&gt;AN - CN-00754057 NEW&lt;br&gt;PT - Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 15:03:24 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nerli RB, Kumar AG, Koura A, Prabha V, Alur SB</AU>
<TI>Transobturator vaginal tape in comparison to tension-free vaginal tape: a prospective trial with a minimum 12 months follow-up</TI>
<SO>Indian Journal of Urology</SO>
<YR>2009</YR>
<VL>25</VL>
<NO>3</NO>
<PG>321-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417972"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40242"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417971"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nyyssonen-2014" MODIFIED="2015-06-08 15:43:27 +0100" MODIFIED_BY="[Empty name]" NAME="Nyyssonen 2014" YEAR="2014">
<REFERENCE MODIFIED="2015-06-08 15:43:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nyyssonen V, Talvensaari-Mattila A, Santala M</AU>
<TI>A prospective randomized trial comparing tension-free vaginal tape versus transobturator tape in patients with stress or mixed urinary incontinence: subjective cure rate and satisfaction in median follow-up of 46 months</TI>
<SO>Scandinavian Journal of Urology</SO>
<YR>2014</YR>
<VL>48</VL>
<NO>3</NO>
<PG>309-15</PG>
<IDENTIFIERS MODIFIED="2014-06-30 15:34:28 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417974"/><IDENTIFIER MODIFIED="2014-06-30 15:34:28 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont62072"/><IDENTIFIER TYPE="PUBMED" VALUE="24286482"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417973"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Okulu-2013" MODIFIED="2015-06-17 13:29:31 +0100" MODIFIED_BY="[Empty name]" NAME="Okulu 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-06-17 13:29:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Okulu E, Kayigil O, Aldemir M, Onen E</AU>
<TI>Use of three types of synthetic mesh material in sling surgery: a prospective randomized clinical trial evaluating effectiveness and complications</TI>
<SO>Scandinavian Journal of Urology</SO>
<YR>2013</YR>
<VL>47</VL>
<NO>3</NO>
<PG>217-24</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:29:31 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417976"/><IDENTIFIER MODIFIED="2015-06-17 13:29:31 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont48505"/><IDENTIFIER TYPE="PUBMED" VALUE="23095128"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:43:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Okulu E</AU>
<TI>Synthetic mesh materials in sling surgery</TI>
<SO>www.ClinicalTrials.gov (accessed 19 December 2011)</SO>
<YR>2011</YR>
<IDENTIFIERS MODIFIED="2014-03-24 12:07:52 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417977"/><IDENTIFIER MODIFIED="2014-03-24 12:07:52 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT01348334"/><IDENTIFIER MODIFIED="2013-12-07 18:38:45 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont42756"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 12:08:06 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417975"/><IDENTIFIER MODIFIED="2014-03-24 12:08:06 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01348334"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oliveira-2006" MODIFIED="2015-06-09 09:10:57 +0100" MODIFIED_BY="[Empty name]" NAME="Oliveira 2006" YEAR="2006">
<REFERENCE MODIFIED="2013-12-04 15:08:50 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Oliveira L, Sartori M, Castro R, Fonseca E, Rodrigues A, Girao M</AU>
<TI>A prospective randomized study to compare TVT, TVT-O and pre-pubic TVT for the treatment of women with stress urinary incontinence, with or without intrinsic sphincter deficiency (Abstract number 208)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>Suppl 2</NO>
<PG>S173-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417978"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31051"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 09:10:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Oliveira LM, Girao MJBC, Sartori MGF, Castro RA, Fonseca ESM, Prior EL</AU>
<TI>Comparison of retro pubic TVT, pre pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 354)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S253</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417979"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27309"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:08:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oliveira LM, Girao MJBC, Sartori MGF, Castro RA, Fonseca ESM</AU>
<TI>Comparison of retro-pubic TVT, pre-pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 203)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2005</YR>
<VL>16</VL>
<NO>Suppl 2</NO>
<PG>S80</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417980"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27307"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 12:48:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>de Oliveira LM, Girao MJBC, Sartori MGF, Castro RA, Fonseca ESM</AU>
<TI>Comparison of retro-pubic TVT, pre-pubic TVT and TVT transobturator in surgical treatment of women with stress urinary incontinence (Abstract number 328)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S180</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417981"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27310"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757422"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Palomba-2008" MODIFIED="2015-06-17 13:32:51 +0100" MODIFIED_BY="[Empty name]" NAME="Palomba 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-06-17 13:32:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Palomba S, Zullo F</AU>
<TI>A Comparison in Terms of Efficacy and Safety Between Transobturator and Transvaginal Tape Performed at the Same Time of Anterior Defect Correction With Mesh</TI>
<SO>http://clinicaltrials.gov/show/NCT00743535</SO>
<YR>2008</YR>
<IDENTIFIERS MODIFIED="2014-03-24 12:21:06 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417983"/><IDENTIFIER MODIFIED="2014-03-24 12:08:28 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00743535"/><IDENTIFIER MODIFIED="2014-03-24 12:21:06 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont49348"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 12:08:45 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417982"/><IDENTIFIER MODIFIED="2014-03-24 12:08:45 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00743535"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Paparella-2010" MODIFIED="2015-06-09 09:11:26 +0100" MODIFIED_BY="[Empty name]" NAME="Paparella 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-06-09 09:11:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Paparella R, Marturano M, Pelino L, Scarpa A, Scambia G, La Torre G, et al</AU>
<TI>Prospective randomized trial comparing synthetic vs biological out-in transobturator tape: a mean 3-year follow-up study</TI>
<SO>International Urogynecology Journal</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1327-36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417985"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40360"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-01-17 11:38:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Riva D, Baccichet R, Paparella L, Cianci A, Simonazzi M, Pisapia Cioffi G</AU>
<TI>Synthetic versus biological trans-obturator sling for stress urinary incontinence: a randomized study (Abstract number 1)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>Suppl 2</NO>
<PG>S1</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417986"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31054"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417984"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-2012" MODIFIED="2014-09-19 11:59:21 +0100" MODIFIED_BY="[Empty name]" NAME="Park 2012" YEAR="2010">
<REFERENCE MODIFIED="2013-12-04 14:06:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim D, Jang HC</AU>
<TI>Randomized control study of Monarc (trademark) vs. tension-free vaginal tape obturator (TVT-O) (trademark) in the treatment of female urinary incontinence in: comparison of medium term cure rate (Abstract number: 219)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>6</NO>
<PG>1123-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417988"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40160"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:18:06 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22536469&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Korean J Urol. 53(4):258-62, 2012 Apr&lt;br&gt;JC - 101499376&lt;br&gt;CP - Korea (South)&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20120426&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 15:18:06 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Park YJ, Kim DY</AU>
<TI>Randomized controlled study of MONARC [Registered trademark] vs. tension-free vaginal tape obturator (TVT-O [Registered trademark]) in the treatment of female urinary incontinence: comparison of 3-year cure rates</TI>
<SO>Korean Journal of Urology</SO>
<YR>2012</YR>
<VL>53</VL>
<NO>4</NO>
<PG>258-62</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417989"/><IDENTIFIER TYPE="OTHER" VALUE="srincont44720"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417987"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peattie-2006" MODIFIED="2015-06-17 13:36:20 +0100" MODIFIED_BY="[Empty name]" NAME="Peattie 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-06-17 13:36:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Peattie A</AU>
<TI>Randomised controlled trial of transvaginal tension-free vaginal tape-obturator (TVT-O) versus Monarc in treatment of urodynamic stress incontinence</TI>
<SO>ISRCTN (http://isrctn.org/ISRCTN71562338)</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417991"/><IDENTIFIER TYPE="OTHER" VALUE="ISRCTN71562338"/><IDENTIFIER TYPE="OTHER" VALUE="sr-incont62312"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-03 12:40:38 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6417990"/><IDENTIFIER MODIFIED="2014-07-03 12:40:38 +0100" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="ISRCTN71562338"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Porena-2007" MODIFIED="2015-06-17 13:42:37 +0100" MODIFIED_BY="[Empty name]" NAME="Porena 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-17 13:37:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Costantini E, Kocjancic E, Saccomanni M, Giannantoni A, Porena M, Frea B</AU>
<TI>Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract number 54)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2006</YR>
<VL>25</VL>
<NO>6</NO>
<PG>573-5</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:37:55 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417992"/><IDENTIFIER MODIFIED="2015-06-17 13:37:55 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23753"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:38:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Costantini E, Lazzeri M, Giannantoni A, Bini V, Kocjancic E, Porena M, et al</AU>
<TI>Retropubic versus transobturator mid-urethral slings: in a randomised controlled trial preoperative VLPP may not predict mid-term outcome (Abstract number 112)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>5</NO>
<PG>741-2</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:38:15 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417993"/><IDENTIFIER MODIFIED="2015-06-17 13:38:15 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23757"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-29 13:19:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Costantini E, Lazzeri M, Giannantoni A, Bini V, Vianello A, Kocjancic E, et al</AU>
<TI>Preoperative Valsava leak point pressure may not predict outcome of mid-urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid-urethral slings</TI>
<SO>International Braz J Urol</SO>
<YR>2008</YR>
<VL>34</VL>
<NO>1</NO>
<PG>73-81; discussion 81-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417994"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27817"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:38:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Costantini E, Lazzeri M, Kocjancic E, Di Biase M, Salvini E, Porena M</AU>
<TI>Prolonged follow-up shows continence deterioration after trans-obturator tape: results from a randomised controlled study</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2013</YR>
<VL>32</VL>
<NO>6</NO>
<PG>525-6</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:38:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417995"/><IDENTIFIER MODIFIED="2015-06-17 13:38:58 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont49187"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:44:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Costantini E, Lazzeri M, Zucchi A, Bruno R, Salvini E, Pietropaolo A, et al</AU>
<TI>Deterioration of continence after TOT when the follow-up is extended: results from a randomised controlled study (Abstract number 729)</TI>
<SO>European Urology Supplements</SO>
<YR>2013</YR>
<VL>12</VL>
<NO>1</NO>
<PG>e729</PG>
<IDENTIFIERS MODIFIED="2014-07-02 18:59:30 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417996"/><IDENTIFIER MODIFIED="2014-07-02 18:59:30 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont62144"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:39:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Costantini E, Lazzeri M, Zucchi A, Di Biase M, Porena M</AU>
<TI>Long-term efficacy of the transobturator and retropubic midurethral slings for stress urinary incontinence: single-center update from a randomized controlled trial</TI>
<SO>European Urology</SO>
<YR>2014</YR>
<VL>66</VL>
<NO>3</NO>
<PG>599-603</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:39:44 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417997"/><IDENTIFIER MODIFIED="2015-06-17 13:39:44 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont64001"/><IDENTIFIER TYPE="PUBMED" VALUE="24768493"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-26 14:04:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Kocjancic E, Constantini E, Crivellaro S, Tosco L, Grossetti B, Frea B, et al</AU>
<TI>Mixed incontinence: the best solution for a difficult task (Abstract number 485)</TI>
<SO>Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20-24, Cairo, Egypt</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417998"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31875"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:41:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kocjancic E, Costantini E, Giannantoni A, Crivellaro S, Mearini L, Frea B, et al</AU>
<TI>Tension free vaginal tape (TVT) and trans obturator suburethral tape (TOT) a prospective randomized study (Poster abstract number 1462)</TI>
<SO>Proceedings of the American Urological Association (AUA) Annual Meeting, 2007 May 19-24, Anaheim, CA</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2015-06-17 13:41:20 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6417999"/><IDENTIFIER MODIFIED="2015-06-17 13:41:20 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23765"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:24:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Porena M, Costantini E, Frea B, Giannantoni A, Ranzoni S, Mearini L, et al</AU>
<TI>Tension-free vaginal tape versus transobturator tape as surgery for stress urinary incontinence: results of a multicentre randomised trial</TI>
<SO>European Urology</SO>
<YR>2007</YR>
<VL>52</VL>
<NO>5</NO>
<PG>1481-91</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418000"/><IDENTIFIER TYPE="OTHER" VALUE="srincont23832"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:42:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Porena M, Kocjancic E, Costantini E, Cecchetti G, Bini V, Crivellaro S, et al</AU>
<TI>Tension free vaginal tape vs trans obturator tape as surgery for stress urinary incontinence: results of a multicenter randomised trial (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2005</YR>
<VL>24</VL>
<NO>5/6</NO>
<PG>416-8</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:42:37 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418001"/><IDENTIFIER MODIFIED="2015-06-17 13:42:37 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont20982"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757437"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rechberger-2003" MODIFIED="2015-06-17 13:46:04 +0100" MODIFIED_BY="[Empty name]" NAME="Rechberger 2003" YEAR="2003">
<REFERENCE MODIFIED="2015-06-17 13:46:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rechberger T, Rzezniczuk K, Skorupski P, Adamiak A, Tomaszewski J, Baranowski W, et al</AU>
<TI>A randomized comparison between monofilament and multifilament tapes for stress incontinence surgery</TI>
<SO>International Urogynecology Journal</SO>
<YR>2003</YR>
<VL>14</VL>
<NO>6</NO>
<PG>432-6</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:46:04 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757449"/><IDENTIFIER MODIFIED="2015-06-17 13:46:04 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont16673"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757448"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rechberger-2009" MODIFIED="2015-06-17 13:48:10 +0100" MODIFIED_BY="[Empty name]" NAME="Rechberger 2009" YEAR="2007">
<REFERENCE MODIFIED="2015-06-17 13:46:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rechberger T, Adamiak A, Jankiewicz K, Futyma K, Skorupski P</AU>
<TI>The comparison of clinical effectiveness of retropubic (IVS 02) and transobturator (IVS04) midurethral slings (Abstract number 076)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S104</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:46:49 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418003"/><IDENTIFIER MODIFIED="2015-06-17 13:46:49 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont49148"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:30:34 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 20179903&lt;br&gt;ST - In-Process&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 21(7):801-6, 2010 Jul&lt;br&gt;JC - cl5, 9514583&lt;br&gt;CP - England&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 15:30:34 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rechberger T, Futyma K, Jankiewicz K, Adamiak A, Bogusiewicz M, Skorupski P</AU>
<TI>Body mass index does not influence the outcome of anti-incontinence surgery among women whereas menopausal status and ageing do: a randomised trial</TI>
<SO>International Urogynecology Journal</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>7</NO>
<PG>801-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418004"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40095"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-09-07 14:19:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Rechberger T, Futyma K, Jankiewicz K, Adamiak A, Skorupski P</AU>
<TI>The clinical effectiveness of retropubic (IVS-02) and transobturator (IVS-04) midurethral slings: randomized trial</TI>
<SO>European Urology</SO>
<YR>2009</YR>
<VL>56</VL>
<NO>1</NO>
<PG>24-30</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418005"/><IDENTIFIER TYPE="OTHER" VALUE="srincont35437"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:28:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rechberger T, Jankiewicz K, Futyma K, Adamiak A, Skorupski P</AU>
<TI>Clinical effectiveness of retropubic (IVS-02) and transobturator (IVS-04) slings in the treatment of female stress urinary incontinence - a semi-randomized trial on 398 patients (Abstract number 515)</TI>
<SO>Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20-24, Cairo, Egypt</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418006"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31877"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:48:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Rechberger T, Jankiewicz K, Skorupski P, Adamiak A, Futyma K, Gogacz M, et al</AU>
<TI>Transobturator vs retropubic vaginal tape for female stress urinary incontinence: one year follow-up in 296 patients (Abstract number 288)</TI>
<SO>Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20-24, Rotterdam, The Netherlands</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2015-06-17 13:48:10 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418007"/><IDENTIFIER MODIFIED="2015-06-17 13:48:10 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont23763"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418002"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rechberger-2011" MODIFIED="2014-09-19 12:00:02 +0100" MODIFIED_BY="[Empty name]" NAME="Rechberger 2011" YEAR="2011">
<REFERENCE MODIFIED="2014-03-23 22:09:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rechberger T, Futyma K, Jankiewicz K, Adamiak A, Bogusiewicz M, Bartuzi A, et al</AU>
<TI>Tape fixation: an important surgical step to improve success rate of anti-incontinence surgery</TI>
<SO>Journal of Urology</SO>
<YR>2011</YR>
<VL>186</VL>
<NO>1</NO>
<PG>180-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418009"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41735"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418008"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Richter-2010" MODIFIED="2015-06-17 15:56:35 +0100" MODIFIED_BY="[Empty name]" NAME="Richter 2010" YEAR="2011">
<REFERENCE MODIFIED="2015-06-08 15:45:26 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21925636&lt;br&gt;ST - MEDLINE&lt;br&gt;AS - Am J Obstet Gynecol. 205(5):498.e1-6, 2011 Nov&lt;br&gt;JC - 3ni, 0370476&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;LG - English&lt;br&gt;DC - 20111031&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 15:45:26 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo KJ, Lloyd KL, et al</AU>
<TI>Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2011</YR>
<VL>205</VL>
<NO>5</NO>
<PG>498.e1-6</PG>
<IDENTIFIERS MODIFIED="2013-12-04 11:55:12 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418011"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER MODIFIED="2013-12-04 11:55:12 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont43397"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 10:46:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brubaker L, Rickey L, Stoddard A, Lemack G, Xu Y, Ghetti C, et al</AU>
<TI>Symptoms of combined prolapse and urinary incontinence in large surgical cohorts (Abstract 020)</TI>
<SO>International Urogynaecology Journal</SO>
<YR>2009</YR>
<VL>20</VL>
<NO>Suppl 2</NO>
<PG>S96-7</PG>
<IDENTIFIERS MODIFIED="2013-12-05 07:35:35 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418012"/><IDENTIFIER MODIFIED="2013-12-05 07:35:11 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00064662"/><IDENTIFIER MODIFIED="2013-12-05 07:35:35 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont39882"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 11:33:52 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20120420&lt;br&gt;IS - 1520-6777 (Electronic)&lt;br&gt;IS - 0733-2467 (Linking)&lt;br&gt;LA - eng&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;SB - IM&lt;/p&gt;" NOTES_MODIFIED="2014-03-24 11:33:52 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chai TC, Huang L, Kenton K, Richter HE, Baker J, Kraus S, et al</AU>
<TI>Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2012</YR>
<VL>31</VL>
<NO>4</NO>
<PG>496-501</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418013"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont49292"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 12:05:16 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22542356&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Urology. 79(6):1256-61, 2012 Jun&lt;br&gt;JC - wsy, 0366151&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20120604&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 12:05:16 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chai TC, Kenton K, Xu Y, Sirls L, Zyczynski H, Wilson TS, et al</AU>
<TI>Effects of concomitant surgeries during midurethral slings (MUS) on postoperative complications, voiding dysfunction, continence outcomes, and urodynamic variables</TI>
<SO>Urology</SO>
<YR>2012</YR>
<VL>79</VL>
<NO>6</NO>
<PG>1256-61</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418014"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="srincont44637"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:51:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Gormley A</AU>
<TI>TOMUS-Trial Of Mid-Urethral Slings [results posted online] (Trials registry number: NCT00325039)</TI>
<SO>ClinicalTrials.gov (http://clinicaltrials.gov/show/NCT00325039)</SO>
<YR>2006</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418015"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont49293"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-30 15:26:08 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Conference Abstract&lt;br&gt;English; ABSTRACT LANGUAGE:English&lt;/p&gt;" NOTES_MODIFIED="2014-06-30 15:26:08 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kenton K, Stoddard A, Zyczynski H, Rickey L, Wai C, Albo M, et al</AU>
<TI>5-year outcomes after retropubic and transobturator midurethral sling (Abstract number PII-03)</TI>
<SO>Journal of Urology</SO>
<YR>2014</YR>
<VL>191</VL>
<NO>4 Suppl 1</NO>
<PG>e493</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418016"/><IDENTIFIER TYPE="OTHER" VALUE="sr-incont62138"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 13:52:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kenton K, Stoddard AM, Zyczynski H, Albo M, Rickey L, Norton P, et al</AU>
<TI>5-year longitudinal followup after retropubic and transobturator mid urethral slings</TI>
<SO>The Journal of Urology</SO>
<YR>2014</YR>
<VL>193</VL>
<PG>203-10</PG>
<IDENTIFIERS MODIFIED="2015-06-17 13:52:47 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418017"/><IDENTIFIER MODIFIED="2015-06-17 13:52:47 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont64661"/><IDENTIFIER TYPE="PUBMED" VALUE="25158274"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 15:56:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kraus S, Lemack G, Chai T, Leng W, Albo M, Mueller E, et al</AU>
<TI>Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract number 13)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>6</NO>
<PG>819-20</PG>
<IDENTIFIERS MODIFIED="2015-06-17 15:56:35 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418018"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER MODIFIED="2015-06-17 15:56:35 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont42167"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:45:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kraus S, Lemack G, Chai T, Leng W, Albo M, Mueller E, et al</AU>
<TI>Urodynamic changes 12 months after retropubic and transobturator midurethral slings (Abstract: Podium number 14)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>2</NO>
<PG>210</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418019"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41349"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 14:41:31 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22669421&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 24(2):269-74, 2013 Feb&lt;br&gt;JC - cl5, 9514583, 101567041&lt;br&gt;CP - England&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20130129&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 14:41:31 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lemack GE, Litman HJ, Nager C, Brubaker L, Lowder J, Norton P, et al</AU>
<TI>Preoperative clinical, demographic, and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>2</NO>
<PG>269-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418020"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00064662"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="SISTEr"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont47045"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 12:18:34 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 24358480&lt;br&gt;ST - In-Process&lt;br&gt;AS - Urology. 82(5):1038-41, 2013 Nov&lt;br&gt;JC - wsy, 0366151&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;NO - U001 DK58225 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58229 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58231 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58234 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60379 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60393 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60395 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60397 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60401 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01DK60380 (United States NIDDK NIH HHS)&lt;br&gt;LG - English&lt;br&gt;DC - 20131219&lt;/p&gt;" NOTES_MODIFIED="2014-03-24 12:18:34 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Norton PA, Nager CW, Chai TC, Mueller E, Stoddard A, Lowder J, et al</AU>
<TI>Risk factors for incomplete bladder emptying after midurethral sling</TI>
<SO>Urology</SO>
<YR>2013</YR>
<VL>82</VL>
<NO>5</NO>
<PG>1038-41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418021"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="srincont50470"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 15:06:41 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21560012&lt;br&gt;ST - In-Process&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 22(10):1255-65, 2011 Oct&lt;br&gt;JC - cl5, 9514583, 101567041&lt;br&gt;CP - England&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;NO - U01 DK 58225 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58229 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58231 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58234 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60379 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60380 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60393 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60395 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60397 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60401 (United States NIDDK NIH HHS)&lt;br&gt;LG - English&lt;br&gt;DC - 20110908&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 15:06:41 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nygaard I, Brubaker L, Chai TC, Markland AD, Menefee SA, Sirls L, et al</AU>
<TI>Risk factors for urinary tract infection following incontinence surgery</TI>
<SO>International Urogynecology Journal</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>10</NO>
<PG>1255-65</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418022"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00064662"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="SISTEr"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42698"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 09:14:12 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20100518&lt;br&gt;IS - 1533-4406 (Electronic)&lt;br&gt;IS - 0028-4793 (Linking)&lt;br&gt;LA - ENG&lt;br&gt;PT - JOURNAL ARTICLE&lt;/p&gt;" NOTES_MODIFIED="2015-06-09 09:14:12 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, et al</AU>
<TI>Retropubic versus transobturator midurethral slings for stress incontinence</TI>
<SO>New England Journal of Medicine</SO>
<YR>2010</YR>
<VL>362</VL>
<NO>22</NO>
<PG>2066-76</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418023"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont39867"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-23 06:25:17 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21422865&lt;br&gt;ST - In-Process&lt;br&gt;AS - Obstet Gynecol. 117(4):913-21, 2011 Apr&lt;br&gt;JC - oc2, 0401101&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;SI - ClinicalTrials.gov&lt;br&gt;SA - ClinicalTrials.gov/NCT00325039&lt;br&gt;NO - 2K24-DK068389 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58229 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58231 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58234 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60379 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60380 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60393 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60395 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60397 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60401 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01DK58225 (United States NIDDK NIH HHS)&lt;br&gt;LG - English&lt;br&gt;DC - 20110322&lt;/p&gt;" NOTES_MODIFIED="2015-05-23 06:25:17 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Richter HE, Litman HJ, Lukacz ES, Sirls LT, Rickey L, Norton P, et al</AU>
<TI>Demographic and clinical predictors of treatment failure one year after midurethral sling surgery</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2011</YR>
<VL>117</VL>
<NO>4</NO>
<PG>913-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418024"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41490"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 12:23:26 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 24307896&lt;br&gt;ST - PubMed-not-MEDLINE&lt;br&gt;AS - Adv. urol.. 2013:567375, 2013&lt;br&gt;JC - 101476240&lt;br&gt;CP - Egypt&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20131205&lt;/p&gt;" NOTES_MODIFIED="2014-03-24 12:23:26 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rickey LM, Huang L, Rahn DD, Hsu Y, Litman HJ, Mueller ER</AU>
<TI>Risk factors for urgency incontinence in women undergoing stress urinary incontinence surgery</TI>
<SO>Advances in Urology</SO>
<YR>2013</YR>
<VL>2013</VL>
<PG>567375</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418025"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00064662"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="srincont50474"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 12:27:40 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20101112&lt;br&gt;IS - 1527-3792 (Electronic)&lt;br&gt;IS - 0022-5347 (Linking)&lt;br&gt;LA - eng&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;SB - AIM&lt;br&gt;SB - IM&lt;/p&gt;" NOTES_MODIFIED="2014-03-24 12:27:40 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirls LT, Tennstedt S, Albo M, Chai T, Kenton K, Huang L, et al</AU>
<TI>Factors associated with quality of life in women undergoing surgery for stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2010</YR>
<VL>184</VL>
<NO>6</NO>
<PG>2411-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418026"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="srincont49291"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 16:47:20 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22983273&lt;br&gt;ST - MEDLINE&lt;br&gt;AS - Female pelvic med. reconstr. surg.. 18(5):291-5, 2012 Sep-Oct&lt;br&gt;JC - 101528690&lt;br&gt;CP - United States&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;NO - U01 DK58225 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58229 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58231 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK58234 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60379 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60380 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60393 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60395 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60397 (United States NIDDK NIH HHS)&lt;br&gt;NO - U01 DK60401 (United States NIDDK NIH HHS)&lt;br&gt;LG - English&lt;br&gt;DC - 20120917&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 16:47:20 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sirls LT, Tennstedt S, Lukacz E, Rickey L, Kraus SR, Markland AD, et al</AU>
<TI>Condition-specific quality of life 24 months after retropubic and transobturator sling surgery for stress urinary incontinence</TI>
<SO>Female Pelvic Medicine &amp; Reconstructive Surgery</SO>
<YR>2012</YR>
<VL>18</VL>
<NO>5</NO>
<PG>291-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418027"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="srincont45799"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:45:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Urinary Incontinence Treatment Network (UITN)</AU>
<TI>The trial of mid-urethral slings (TOMUS): design and methodology</TI>
<SO>Journal of Applied Research</SO>
<YR>2008</YR>
<VL>8</VL>
<NO>1</NO>
<PG>1-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418028"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27938"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-24 12:33:36 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DA - 20130502&lt;br&gt;IS - 1873-233X (Electronic)&lt;br&gt;IS - 0029-7844 (Linking)&lt;br&gt;LA - eng&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Multicenter Study&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;PT - Research Support, N.I.H., Extramural&lt;br&gt;SB - AIM&lt;br&gt;SB - IM&lt;/p&gt;" NOTES_MODIFIED="2014-03-24 12:33:36 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wai CY, Curto TM, Zyczynski HM, Stoddard AM, Burgio KL, Brubaker L, et al</AU>
<TI>Patient satisfaction after midurethral sling surgery for stress urinary incontinence</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2013</YR>
<VL>121</VL>
<NO>5</NO>
<PG>1009-16</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418029"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="srincont49289"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-30 15:31:46 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Conference Abstract&lt;br&gt;English; ABSTRACT LANGUAGE:English&lt;/p&gt;" NOTES_MODIFIED="2014-06-30 15:31:46 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zyczynski HM, Brubaker L</AU>
<TI>Sexual activity and function in women for two years after midurethral slings (Abstract number 176)</TI>
<SO>European Urology Supplements</SO>
<YR>2012</YR>
<VL>11</VL>
<NO>1</NO>
<PG>e176</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418030"/><IDENTIFIER TYPE="OTHER" VALUE="sr-incont62250"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-05-23 06:27:27 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22840975&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Am J Obstet Gynecol. 207(5):421.e1-6, 2012 Nov&lt;br&gt;JC - 3ni, 0370476&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20121030&lt;/p&gt;" NOTES_MODIFIED="2015-05-23 06:27:27 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zyczynski HM, Rickey L, Dyer KY, Wilson T, Stoddard AM, Gormley EA, et al</AU>
<TI>Sexual activity and function in women more than 2 years after midurethral sling placement</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2012</YR>
<VL>207</VL>
<NO>5</NO>
<PG>421-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418031"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00325039"/><IDENTIFIER TYPE="OTHER" VALUE="TOMUS"/><IDENTIFIER TYPE="OTHER" VALUE="srincont45909"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 11:34:38 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418010"/><IDENTIFIER MODIFIED="2014-03-24 11:34:31 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00325039"/><IDENTIFIER MODIFIED="2014-03-24 11:34:38 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="TOMUS"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Riva-2006" MODIFIED="2015-06-17 16:06:10 +0100" MODIFIED_BY="[Empty name]" NAME="Riva 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-06-17 16:06:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Riva D, Sacca V, Tonta A, Casolati E, Luerti M, Banfi G, et al</AU>
<TI>TVT versus TOT a randomised study at 1 year follow up (Abstract number 060)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S93</PG>
<IDENTIFIERS MODIFIED="2015-06-17 16:06:10 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418032"/><IDENTIFIER MODIFIED="2015-06-17 16:06:10 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont49150"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757480"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salem-2014" MODIFIED="2014-09-19 12:00:45 +0100" MODIFIED_BY="[Empty name]" NAME="Salem 2014" YEAR="2014">
<REFERENCE MODIFIED="2014-07-02 19:10:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salem H, Mostafa M, Diab DE, Abdulla A, Nageeb M, Hashem SA</AU>
<TI>A prospective randomized study comparing the safety and efficacy of transobturator tape (TOT) versus tension free vaginal tape (TVT) in treatment of female stress urinary incontinence (Abstract number MP33-13)</TI>
<SO>Journal of Urology</SO>
<YR>2014</YR>
<VL>191</VL>
<NO>4 Suppl 1</NO>
<PG>e342-3</PG>
<IDENTIFIERS MODIFIED="2014-06-29 14:44:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418034"/><IDENTIFIER MODIFIED="2014-06-29 14:44:40 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont62143"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418033"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scheiner-2012" MODIFIED="2015-06-08 15:46:26 +0100" MODIFIED_BY="[Empty name]" NAME="Scheiner 2012" YEAR="2008">
<REFERENCE MODIFIED="2013-12-04 16:05:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Scheiner D, Betschart C, Kollbrunner S, Werder H, Fink D, Perucchini D</AU>
<TI>Retropubic or transobturator out-in or in-out sling? A prospective randomized study! (Abstract number 484)</TI>
<SO>Proceedings of the 38th Annual Meeting of the International Continence Society (ICS), 2008 Oct 20-24, Cairo, Egypt</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418036"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00642109"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31874"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:46:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scheiner D, Betschart C, Werder H, Fink D, Perucchini D</AU>
<TI>Retropubic TVT vs transobturator outside-in TOT and inside-out TVT-O one-year results from our prospective randomized study (Abstract number 4)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2009</YR>
<VL>28</VL>
<NO>7</NO>
<PG>585-6</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:10:28 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418037"/><IDENTIFIER MODIFIED="2014-03-24 12:10:28 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT00642109"/><IDENTIFIER TYPE="OTHER" VALUE="srincont34588"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 16:07:29 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21887548&lt;br&gt;ST - MEDLINE&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 23(2):197-206, 2012 Feb&lt;br&gt;JC - cl5, 9514583, 101567041&lt;br&gt;CP - England&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Randomized Controlled Trial&lt;br&gt;LG - English&lt;br&gt;DC - 20120119&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 16:07:29 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Scheiner DA, Betschart C, Wiederkehr S, Seifert B, Fink D, Perucchini D</AU>
<TI>Twelve months effect on voiding function of retropubic compared with outside-in and inside-out transobturator midurethral slings</TI>
<SO>International Urogynecology Journal</SO>
<YR>2012</YR>
<VL>23</VL>
<NO>2</NO>
<PG>197-206</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418038"/><IDENTIFIER TYPE="OTHER" VALUE="srincont44532"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 12:10:42 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418035"/><IDENTIFIER MODIFIED="2014-03-24 12:10:42 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00642109"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schierlitz-2008" MODIFIED="2015-06-08 15:46:44 +0100" MODIFIED_BY="[Empty name]" NAME="Schierlitz 2008" YEAR="2007">
<REFERENCE MODIFIED="2013-12-04 12:50:12 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21811769&lt;br&gt;ST - MEDLINE&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 23(2):153-8, 2012 Feb&lt;br&gt;JC - cl5, 9514583, 101567041&lt;br&gt;CP - England&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Multicenter Study&lt;br&gt;LG - English&lt;br&gt;DC - 20120119&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 12:50:12 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Souza A, Dwyer PL, Rosamilia A, Hiscock R, Lim YN, Murray C, et al</AU>
<TI>Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency: a multicentre prospective study</TI>
<SO>International Urogynecology Journal</SO>
<YR>2012</YR>
<VL>23</VL>
<NO>2</NO>
<PG>153-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418040"/><IDENTIFIER TYPE="OTHER" VALUE="srincont44534"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 12:50:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Souza A, Schierlitz L, Rosamilia A, Dwyer P, Murray C, Thomas E, et al</AU>
<TI>Sexual function following retropubic TVT and transobturator Monarc sling in women with intrinsic sphincter deficiency (Abstract)</TI>
<SO>Australian and New Zealand Continence Journal</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>4</NO>
<PG>104</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418041"/><IDENTIFIER TYPE="OTHER" VALUE="srincont29144"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 14:59:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Murray C, Schierlitz L, Dwyer PL, Rosamilia A, Hiscock R, De Souza A, et al</AU>
<TI>Overactive bladder (OAB) symptoms following retropubic TVT and Monarc TOT in women with intrinsic sphincter deficiency (ISD) and stress incontinence (Abstract)</TI>
<SO>Australian and New Zealand Continence Journal</SO>
<YR>2008</YR>
<VL>14</VL>
<NO>4</NO>
<PG>102</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418042"/><IDENTIFIER TYPE="OTHER" VALUE="srincont29145"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:46:32 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 19461438&lt;br&gt;CM - Comment on: Obstet Gynecol. 2008 Dec;112(6):1253-61; PMID: 19037033&lt;br&gt;AS - Obstet Gynecol. 113(6):1368, author reply 1368-9, 2009 Jun&lt;br&gt;JC - oc2, 0401101&lt;br&gt;SB - AIM, IM&lt;br&gt;CP - United States&lt;br&gt;PT - Comment&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 15:46:32 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Plotti F, Calcagno M, Sansone M, Panici PB</AU>
<TI>Effectiveness of tension-free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial [comment] [letter]</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2009</YR>
<VL>113</VL>
<NO>6</NO>
<PG>1368; author reply 1368-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418043"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31355"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 16:20:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schierlitz L, Dwyer P, Rosamilia A, Murray C, Thomas E, Fitzgerald E, et al</AU>
<TI>A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans-obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three year follow up (Abstract number 1)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>6</NO>
<PG>805-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418044"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40112"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 16:24:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schierlitz L, Dwyer PL, Rosamilia A, Hiscock R, De Souza A, Lim YN, et al</AU>
<TI>A randomised controlled study to compare tension-free vaginal tape (TVT) and Monarc (trademark) transobturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD): the three-year follow-up (Abstract)</TI>
<SO>Australian and New Zealand Continence Journal</SO>
<YR>2010</YR>
<VL>16</VL>
<NO>4</NO>
<PG>120-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418045"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40800"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:46:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schierlitz L, Dwyer PL, Rosamilia A, Murray C, Thomas E, De Souza A, et al</AU>
<TI>Effectiveness of tension-free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2008</YR>
<VL>112</VL>
<NO>6</NO>
<PG>1253-61</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:11:07 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418046"/><IDENTIFIER MODIFIED="2014-03-24 12:11:07 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ACTRN12608000093381"/><IDENTIFIER TYPE="OTHER" VALUE="srincont28699"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:46:44 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22270284&lt;br&gt;ST - In-Process&lt;br&gt;AS - Obstet Gynecol. 119(2 Pt 1):321-7, 2012 Feb&lt;br&gt;JC - oc2, 0401101&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20120124&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 15:46:44 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schierlitz L, Dwyer PL, Rosamilia A, Murray C, Thomas E, De Souza A, et al</AU>
<TI>Three-year follow-up of tension-free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2012</YR>
<VL>119</VL>
<NO>2 Pt 1</NO>
<PG>321-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418047"/><IDENTIFIER TYPE="OTHER" VALUE=" ACTRN12608000093381"/><IDENTIFIER TYPE="OTHER" VALUE="srincont43343"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 16:19:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schierlitz LHE, Dwyer PL, Rosamilia A, Murray C, Thomas E, Taylor N, et al</AU>
<TI>A randomized controlled study to compare tension free vaginal tape (TVT) and Monarc trans-obturator tape in the treatment of women with urodynamic stress incontinence (USI) and intrinsic sphincter deficiency (ISD) (Abstract number 32)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S19</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418048"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27321"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 12:11:23 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418039"/><IDENTIFIER MODIFIED="2014-03-24 12:11:23 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ACTRN12608000093381"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tanuri-2010" MODIFIED="2015-05-23 06:30:56 +0100" MODIFIED_BY="[Empty name]" NAME="Tanuri 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-05-23 06:30:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tanuri AL, Feldner PC Jr, Bella ZI, Castro RA, Sartori MG, Girao MJ</AU>
<TI>[Retropubic and transobturator sling in treatment of stress urinary incontinence.] [Portuguese]</TI>
<SO>Revista Da Associacao Medica Brasileira</SO>
<YR>2010</YR>
<VL>56</VL>
<NO>3</NO>
<PG>348-54</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418050"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40054"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418049"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tarcan-2011" MODIFIED="2015-06-21 16:50:36 +0100" MODIFIED_BY="[Empty name]" NAME="Tarcan 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-06-21 16:50:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="OTHER">
<AU>Tarcan T, Mangir N, Tanidir Y, Top T, IIker Y</AU>
<TI>A randomised study comparing transvaginal and transobturator mid-urethral sling surgeries in women with stress urinary incontinence (Abstract number 845)</TI>
<SO>Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29-Sept 2, Glasgow, Scotland</SO>
<YR>2011</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418052"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42237"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-26 09:08:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Tarcan T, Sahan A, Sulukaya M, Mangir N, Ilker Y</AU>
<TI>2-year results of a randomized study comparing retropubic and transobturator mid-urethral slings in the treatment of urodynamic female stress urinary incontinence (Abstract number 448)</TI>
<SO>Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26-30, Barcelona, Spain</SO>
<YR>2013</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418053"/><IDENTIFIER TYPE="OTHER" VALUE="srincont60034"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418051"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Teo-2011" MODIFIED="2015-06-17 16:15:30 +0100" MODIFIED_BY="[Empty name]" NAME="Teo 2011" YEAR="2007">
<REFERENCE MODIFIED="2015-06-17 16:15:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Mayne C</AU>
<TI>Randomised trial of tension-free vaginal tape and transobturator tape as treatment for urinary stress incontinence in women</TI>
<SO>ISRCTN (http://isrctn.org/ISRCTN34377436)</SO>
<YR>2004</YR>
<IDENTIFIERS MODIFIED="2014-07-01 09:12:51 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418055"/><IDENTIFIER MODIFIED="2014-07-01 09:12:51 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont62313"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 17:03:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Teo R, Moran P, Mayne C, Tincello D</AU>
<TI>Randomised trial of TVT and TVT-O for the treatment of urodynamic stress incontinence in women (Abstract number 2)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>7</NO>
<PG>572-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418056"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31848"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:46:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Teo R, Moran P, Mayne C, Tincello D</AU>
<TI>Randomised trial of tension-free vaginal tape and transobturator tape for the treatment of urodynamic stress incontinence in women (Abstract number 283)</TI>
<SO>Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20-24, Rotterdam, The Netherlands</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2014-03-24 12:11:55 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418057"/><IDENTIFIER MODIFIED="2014-03-24 12:11:55 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont23761"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2013-12-04 17:03:55 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21334654&lt;br&gt;ST - In-Process&lt;br&gt;AS - J Urol. 185(4):1350-5, 2011 Apr&lt;br&gt;JC - kc7, 0376374&lt;br&gt;CP - United States&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20110322&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 17:03:55 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Teo R, Moran P, Mayne C, Tincello D</AU>
<TI>Randomized trial of tension-free vaginal tape and tension-free vaginal tape-obturator for urodynamic stress incontinence in women</TI>
<SO>Journal of Urology</SO>
<YR>2011</YR>
<VL>185</VL>
<NO>4</NO>
<PG>1350-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418058"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41497"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-01 09:13:19 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418054"/><IDENTIFIER MODIFIED="2014-07-01 09:13:19 +0100" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="ISRCTN34377436"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tommaselli-2012" MODIFIED="2015-06-17 16:18:17 +0100" MODIFIED_BY="[Empty name]" NAME="Tommaselli 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-06-17 16:18:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tommaselli GA, D'Afiero A, Di CC, Formisano C, Fabozzi A, Nappi C</AU>
<TI>Efficacy of a modified technique for TVT-O positioning: a 12 month, randomized, single-blind, multicentre, non inferiority study</TI>
<SO>European Journal of Obstetrics, Gynecology, and Reproductive Biology</SO>
<YR>2013</YR>
<VL>167</VL>
<NO>2</NO>
<PG>225-9</PG>
<IDENTIFIERS MODIFIED="2015-06-17 16:18:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418060"/><IDENTIFIER MODIFIED="2015-06-17 16:18:17 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont47602"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-06-30 15:30:31 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Conference Abstract&lt;br&gt;English; ABSTRACT LANGUAGE:English&lt;/p&gt;" NOTES_MODIFIED="2014-06-30 15:30:31 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tommaselli GA, D'Afiero A, Di Carlo C, Formisano C, Fabozzi A, Nappi C</AU>
<TI>Effect of a modified surgical technique for the positioning of TVT-O on post-operative pain (Abstract number 110)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>Suppl 1</NO>
<PG>S110</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418061"/><IDENTIFIER TYPE="OTHER" VALUE="sr-incont62263"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-01-03 11:10:53 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22527555&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 23(9):1293-9, 2012 Sep&lt;br&gt;JC - cl5, 9514583, 101567041&lt;br&gt;CP - England&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20120816&lt;/p&gt;" NOTES_MODIFIED="2014-01-03 11:10:53 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tommaselli GA, Formisano C, Di Carlo C, Fabozzi A, Nappi C</AU>
<TI>Effects of a modified technique for TVT-O positioning on postoperative pain: single-blind randomized study</TI>
<SO>International Urogynecology Journal</SO>
<YR>2012</YR>
<VL>23</VL>
<NO>9</NO>
<PG>1293-9</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418062"/><IDENTIFIER TYPE="OTHER" VALUE="srincont45107"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418059"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tseng-2005" MODIFIED="2014-03-24 12:12:16 +0000" MODIFIED_BY="[Empty name]" NAME="Tseng 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-03-24 12:12:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tseng LH, Wang AC, Lin YH, Li SJ, Ko YJ</AU>
<TI>Randomized comparison of the suprapubic arc sling procedure vs tension-free vaginal taping for stress incontinent women</TI>
<SO>International Urogynecology Journal</SO>
<YR>2005</YR>
<VL>16</VL>
<NO>3</NO>
<PG>230-5</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:12:16 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757519"/><IDENTIFIER MODIFIED="2014-03-24 12:12:16 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont20354"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757518"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ugurlucan-2013" MODIFIED="2015-06-17 16:19:43 +0100" MODIFIED_BY="[Empty name]" NAME="Ugurlucan 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-06-17 16:19:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ugurlucan FG, Erkan HA, Onal M, Yalcin O</AU>
<TI>Randomized trial of graft materials in transobturator tape operation: biological versus synthetic</TI>
<SO>International Urogynecology Journal</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>8</NO>
<PG>1315-23</PG>
<IDENTIFIERS MODIFIED="2015-06-17 16:19:43 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418064"/><IDENTIFIER MODIFIED="2015-06-17 16:19:43 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont48489"/><IDENTIFIER TYPE="PUBMED" VALUE="23184140"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418063"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Leijsen-2013" MODIFIED="2015-06-17 16:21:35 +0100" MODIFIED_BY="[Empty name]" NAME="van Leijsen 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-06-30 15:28:10 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Journal: Conference Abstract&lt;br&gt;English; ABSTRACT LANGUAGE:English&lt;/p&gt;" NOTES_MODIFIED="2014-06-30 15:28:10 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mengerink BB</AU>
<TI>The impact of midurethral sling operation on sexual function in women with stress urinary incontinence, a multicenter prospective study (Abstract number 193)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>1 Suppl</NO>
<PG>S147</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418066"/><IDENTIFIER TYPE="OTHER" VALUE="sr-incont62175"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 16:21:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>van Leijsen SA, Kluivers KB, Mol BW, Hout Ji, Milani AL, Roovers JP, et al</AU>
<TI>Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2013</YR>
<VL>121</VL>
<NO>5</NO>
<PG>999-1008</PG>
<IDENTIFIERS MODIFIED="2015-06-17 16:21:00 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418067"/><IDENTIFIER MODIFIED="2015-06-17 16:21:00 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont47434"/><IDENTIFIER TYPE="PUBMED" VALUE="23635736"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 16:21:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Leijsen SA, Kluivers KB, Mol BWJ, Broekhuis SR, Milani FL, Vaart CHvan D, et al</AU>
<TI>Protocol for the value of urodynamics prior to stress incontinence surgery (VUSIS) study: a multicenter randomized controlled trial to assess the cost effectiveness of urodynamics in women with symptoms of stress urinary incontinence in whom surgical treatment is considered</TI>
<SO>BMC Women's Health</SO>
<YR>2009</YR>
<VL>9</VL>
<PG>22</PG>
<IDENTIFIERS MODIFIED="2015-06-17 16:21:35 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418068"/><IDENTIFIER MODIFIED="2015-06-17 16:21:35 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont32078"/><IDENTIFIER TYPE="PUBMED" VALUE="19622153"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2015-05-21 12:37:44 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418065"/><IDENTIFIER MODIFIED="2015-05-21 12:34:38 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00814749"/><IDENTIFIER MODIFIED="2015-05-21 12:37:44 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="VUSIS-2"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2006" MODIFIED="2014-03-24 12:12:29 +0000" MODIFIED_BY="[Empty name]" NAME="Wang 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-03-24 12:12:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang AC, Lin YH, Tseng LH, Chih SY, Lee CJ</AU>
<TI>Prospective randomized comparison of transobturator suburethral sling (Monarc) vs suprapubic arc (Sparc) sling procedures for female urodynamic stress incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>5</NO>
<PG>439-43</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:12:29 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757527"/><IDENTIFIER MODIFIED="2014-03-24 12:12:29 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont22217"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757526"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2008" MODIFIED="2015-06-17 16:22:45 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-06-17 16:22:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang WY, Zhu L, Lang JH, Sun ZJ, Hai N</AU>
<TI>[Clinical study on tension-free vaginal tape and tension-free vaginal tape obturator for surgical treatment of severe stress urinary incontinence] [Chinese]</TI>
<SO>Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics &amp; Gynecology]</SO>
<YR>2008</YR>
<VL>43</VL>
<NO>3</NO>
<PG>180-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418070"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27746"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418069"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2009" MODIFIED="2015-06-17 16:24:24 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-06-09 09:16:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wang W, Zhu L, Lang J</AU>
<TI>Transobturator tape procedure versus tension-free vaginal tape for treatment of stress urinary incontinence</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>2009</YR>
<VL>104</VL>
<NO>2</NO>
<PG>113-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418072"/><IDENTIFIER TYPE="OTHER" VALUE="srincont29200"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:48:00 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21600117&lt;br&gt;ST - In-Process&lt;br&gt;AS - Chung Hua I Hsueh Tsa Chih. 91(13):898-901, 2011 Apr 5&lt;br&gt;JC - cdg, 7511141&lt;br&gt;CP - China&lt;br&gt;PT - English Abstract&lt;br&gt;PT - Journal Article&lt;br&gt;LG - Chinese&lt;br&gt;DC - 20110523&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 15:48:00 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang WY, Zhu L, Lang JH, Li B</AU>
<TI>[A prospective randomized trial of comparing the clinical outcome of tension-free vaginal tape and transobturator tape for stress urinary incontinence] [Chinese]</TI>
<SO>Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]</SO>
<YR>2011</YR>
<VL>91</VL>
<NO>13</NO>
<PG>898-901</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418073"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41799"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-26 14:47:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu I, Lang J, Chen R, Hai N, Wong F</AU>
<TI>Comparing TVT and TVT-O sub urethral tape for treatment patients with mild and moderate stress urinary incontinence (Abstract number 364)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S198</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418074"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27325"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-17 16:24:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu I, Lang J,</AU>
<TI>A prospective randomised trial comparing tension free vaginal tape and transobturator suburethral tape for surgical treatment of slight and moderate stress urinary incontinence (Abstract number 461)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2006</YR>
<VL>17</VL>
<NO>Suppl 2</NO>
<PG>S307</PG>
<IDENTIFIERS MODIFIED="2015-06-17 16:24:24 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418075"/><IDENTIFIER MODIFIED="2015-06-17 16:24:24 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont49151"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 09:15:18 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhu L, Lang J, Hai N, Wong F</AU>
<TI>Comparing vaginal tape and transobturator tape for the treatment of mild and moderate stress incontinence</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>2007</YR>
<VL>99</VL>
<NO>1</NO>
<PG>14-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418076"/><IDENTIFIER TYPE="OTHER" VALUE="srincont23870"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418071"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2010" MODIFIED="2014-09-19 12:04:16 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-12-04 20:58:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Wang F, Song Y, Huang H</AU>
<TI>Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China</TI>
<SO>Archives of Gynecology and Obstetrics</SO>
<YR>2010</YR>
<VL>281</VL>
<NO>2</NO>
<PG>279-86</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418078"/><IDENTIFIER TYPE="OTHER" VALUE="srincont35408"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418077"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2011" MODIFIED="2014-09-19 12:04:40 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-12-04 21:18:32 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang YJ, Li FP, Wang Q, Yang S, Cai XG, Chen YH</AU>
<TI>Comparison of three mid-urethral tension-free tapes (TVT, TVT-O, and TVT-Secur) in the treatment of female stress urinary incontinence: 1-year follow-up</TI>
<SO>International Urogynecology Journal</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>11</NO>
<PG>1369-74</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418080"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42639"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418079"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2011" MODIFIED="2014-09-19 12:05:03 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-12-04 21:58:52 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 22030046&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Taiwan. j. obstet. gynecol.. 50(3):318-21, 2011 Sep&lt;br&gt;JC - 101213819&lt;br&gt;CP - China&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20111027&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 21:58:52 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang Y, Jiang M, Tong XW, Fan BZ, Li HF, Chen XL</AU>
<TI>The comparison of an inexpensive-modified transobturator vaginal tape versus TVT-O procedure for the surgical treatment of female stress urinary incontinence</TI>
<SO>Taiwanese Journal of Obstetrics &amp; Gynecology</SO>
<YR>2011</YR>
<VL>50</VL>
<NO>3</NO>
<PG>318-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418082"/><IDENTIFIER TYPE="OTHER" VALUE="srincont42665"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418081"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zullo-2007" MODIFIED="2015-06-09 09:17:10 +0100" MODIFIED_BY="[Empty name]" NAME="Zullo 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-12-04 11:17:13 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 20709444&lt;br&gt;ST - In-Process&lt;br&gt;CM - Comment in: Eur Urol. 2010 Nov;58(5):678-9; discussion 680; PMID: 20822848&lt;br&gt;AS - Eur Urol. 58(5):671-7, 2010 Nov&lt;br&gt;JC - enm, 7512719&lt;br&gt;CP - Switzerland&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20110318&lt;/p&gt;" NOTES_MODIFIED="2013-12-04 11:17:13 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Angioli R, Plotti F, Muzii L, Montera R, Panici PB, Zullo MA</AU>
<TI>Tension-free vaginal tape versus transobturator suburethral tape: five-year follow-up results of a prospective, randomised trial</TI>
<SO>European Urology</SO>
<YR>2010</YR>
<VL>58</VL>
<NO>5</NO>
<PG>671-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418083"/><IDENTIFIER TYPE="OTHER" VALUE="srincont41500"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 09:17:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Zullo MA, Plotti F, Calcagno M, Marullo E, Palaia I, Bellati F, et al</AU>
<TI>One-year follow-up of tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial</TI>
<SO>European Urology</SO>
<YR>2007</YR>
<VL>51</VL>
<NO>5</NO>
<PG>1376-82; discussion 1383-4</PG>
<IDENTIFIERS MODIFIED="2014-03-24 12:13:07 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418084"/><IDENTIFIER MODIFIED="2014-03-24 12:13:07 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont23246"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757542"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2015-06-21 16:52:47 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Tayyem-2007" MODIFIED="2015-06-08 15:48:09 +0100" MODIFIED_BY="[Empty name]" NAME="Al-Tayyem 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-08 15:48:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-Tayyem A, Benness C, Korda A, Farnsworth B, Burton G</AU>
<TI>TVT vs TVT-O: a study comparing early complications (Abstract number 062)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S37</PG>
<IDENTIFIERS MODIFIED="2013-12-04 11:14:06 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418085"/><IDENTIFIER MODIFIED="2013-12-04 11:14:06 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="27330"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757545"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amat-2007" MODIFIED="2015-06-08 15:48:15 +0100" MODIFIED_BY="[Empty name]" NAME="Amat 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-08 15:48:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amat LL, Martinez F, Hernandez S, Vela M</AU>
<TI>Needleless: a new technique for the correction of urinary incontinence. Randomised controlled trial compared with TVT-O. Preliminary results (Abstract number 225)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S128</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418086"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757547"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ballert-2010" MODIFIED="2015-06-08 15:48:26 +0100" MODIFIED_BY="[Empty name]" NAME="Ballert 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-06-08 15:48:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ballert KN, Rose AE, Biggs GY, Rosenblum N, Nitti VW</AU>
<TI>Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures?</TI>
<SO>The Journal of Urology</SO>
<YR>2010</YR>
<VL>183</VL>
<NO>4</NO>
<PG>1455-8</PG>
<IDENTIFIERS MODIFIED="2014-05-22 13:42:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418088"/><IDENTIFIER TYPE="PUBMED" VALUE="20171698"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418087"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bekker-2009" MODIFIED="2013-12-07 18:28:21 +0000" MODIFIED_BY="[Empty name]" NAME="Bekker 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-12-07 18:28:21 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 19627468&lt;br&gt;ST - MEDLINE&lt;br&gt;AS - J Sex Med. 6(11):3208-13, 2009 Nov&lt;br&gt;JC - 101230693&lt;br&gt;CP - United States&lt;br&gt;PT - Clinical Trial&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2013-12-07 18:28:21 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bekker M, Beck J, Putter H, Venema P, Nijeholt A, Pelger R, et al</AU>
<TI>Sexual function improvement following surgery for stress incontinence: the relevance of coital incontinence</TI>
<SO>Journal of Sexual Medicine</SO>
<YR>2009</YR>
<VL>6</VL>
<NO>11</NO>
<PG>3208-13</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418090"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418089"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Borrell-2005" MODIFIED="2015-06-08 15:48:33 +0100" MODIFIED_BY="[Empty name]" NAME="Borrell 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-06-08 15:48:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Borrell PA, Chicote FP, Beltran MJF, Queipo ZJA, Esteve Claramunt J, Pastor Sempere F</AU>
<TI>Comparison of different suburethral slings for the treatment of stress urinary incontinence</TI>
<SO>Actas Urologicas Espa&#328;olas</SO>
<YR>2005</YR>
<VL>29</VL>
<PG>757-63</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418091"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757553"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bracken-2012" MODIFIED="2015-06-08 15:48:41 +0100" MODIFIED_BY="[Empty name]" NAME="Bracken 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-05-23 06:42:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bracken JN, Huffaker RK, Yandell PM, Handcock T, Higgins EW, Kuehl TJ, et al</AU>
<TI>A randomized comparison of bupivacaine versus saline during placement of tension-free vaginal tape</TI>
<SO>Female Pelvic Medicine &amp; Reconstructive Surgery</SO>
<YR>2012</YR>
<VL>18</VL>
<NO>2</NO>
<PG>93-6</PG>
<IDENTIFIERS MODIFIED="2014-05-22 14:31:22 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418093"/><IDENTIFIER TYPE="PUBMED" VALUE="22453319"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:48:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Huffaker RK, Bracken JN, Yandell PM, Handcock T, Higgins EW, Kuehl TJ, et al</AU>
<TI>A randomised, double-blind comparison of bupivacaine containing saline with saline only hydrodissection on voiding function and pain control in the postoperative interval following placement of tension-free vaginal tape (Abstract number 854)</TI>
<SO>Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29-Sept 2, Glasgow, Scotland</SO>
<YR>2011</YR>
<IDENTIFIERS MODIFIED="2014-05-22 14:33:19 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418094"/><IDENTIFIER MODIFIED="2014-05-22 14:33:19 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="Sricont42239"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418092"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bruschini-2005" MODIFIED="2015-04-23 11:13:34 +0100" MODIFIED_BY="[Empty name]" NAME="Bruschini 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-04-23 11:13:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Bruschini H, Nunes R, Truzzi JC, Simonetti R, Cury J, Otiz V, et al</AU>
<TI>Low cost polypropylene sling procedure for correction of stress urinary incontinence: a possible solution for developing countries? (Abstract number 360)</TI>
<SO>Proceedings of the International Continence Society (ICS), 35th Annual Meeting, 2005 Aug 28-Sep 2, Montreal, Canada</SO>
<YR>2005</YR>
<IDENTIFIERS MODIFIED="2014-05-22 14:02:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418096"/><IDENTIFIER MODIFIED="2014-05-22 14:02:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="Srincont21055"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-03 09:44:14 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418095"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2008" MODIFIED="2015-06-08 15:48:50 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-06-08 15:48:50 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 17594046&lt;br&gt;IN - Department of Obstetrics and Gynecology, China Medical University Hospital, No. 2 Yu-Der Road, Taichung 404, Taiwan. d888208@ms45.hinet.net&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 19(1):117-21, 2008 Jan&lt;br&gt;JC - cl5, 9514583&lt;br&gt;SB - IM&lt;br&gt;CP - England&lt;br&gt;PT - Clinical Trial&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 15:48:50 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen HY, Ho M, Hung YC, Huang LC</AU>
<TI>Analysis of risk factors associated with vaginal erosion after synthetic sling procedures for stress urinary incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>1</NO>
<PG>117-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418098"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27217"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418097"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen-2011" MODIFIED="2015-06-08 15:48:57 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-06-08 15:48:57 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - CCTR&lt;br&gt;AN - CN-00899651 NEW&lt;/p&gt;" NOTES_MODIFIED="2015-06-08 15:48:57 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen X, Jiang M, Tong X, Li H, Qiu J, Shao L, et al</AU>
<TI>A modified inexpensive transobturator vaginal tape inside-out procedure versus tension-free vaginal tape for the treatment of SUI: a prospective comparative study</TI>
<SO>Archives of Gynecology and Obstetrics</SO>
<YR>2011</YR>
<VL>284</VL>
<NO>6</NO>
<PG>1461-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418100"/><IDENTIFIER TYPE="OTHER" VALUE="srincont59743"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418099"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chene-2009" MODIFIED="2014-01-30 17:28:21 +0000" MODIFIED_BY="[Empty name]" NAME="Chene 2009" YEAR="2009">
<REFERENCE MODIFIED="2014-01-30 17:28:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chene G, Tardieu A-S, Cotte B, Chauleur C, Savary D, Krief M, et al</AU>
<TI>[Health-related quality of life in women operated on by surgical anti-incontinence procedures: comparison of three techniques]</TI>
<SO>Gynecologie Obstetrique Fertilite</SO>
<YR>2009</YR>
<VL>36</VL>
<NO>1</NO>
<PG>3-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418102"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40235"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418101"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chong-2003" MODIFIED="2015-06-21 16:52:47 +0100" MODIFIED_BY="[Empty name]" NAME="Chong 2003" YEAR="">
<REFERENCE MODIFIED="2015-05-23 06:44:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chong C, Bane A, Corstiaans A</AU>
<TI>Intraoperative division of tensionless vaginal tape (TVT) - prospective randomized trial (Abstract)</TI>
<SO>Singapore Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2003</YR>
<VL>34</VL>
<NO>Suppl 1</NO>
<PG>55</PG>
<EN>34</EN>
<IDENTIFIERS MODIFIED="2014-07-03 09:47:42 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418104"/><IDENTIFIER MODIFIED="2014-07-03 09:47:42 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="17187"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418103"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Corcos-2001" MODIFIED="2014-07-03 09:47:55 +0100" MODIFIED_BY="[Empty name]" NAME="Corcos 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-07-03 09:47:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corcos J, Collet JP, Shapiro S, Schick E, Macramallah E, Tessier J, et al</AU>
<TI>Surgery vs collagen for the treatment of female stress urinary incontinence (SUI): results of a multicentric randomized trial (Abstract)</TI>
<SO>Journal of Urology</SO>
<YR>2001</YR>
<VL>165</VL>
<NO>5 Suppl</NO>
<PG>198</PG>
<IDENTIFIERS MODIFIED="2014-07-03 09:47:55 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757569"/><IDENTIFIER MODIFIED="2014-07-03 09:47:55 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="12912"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757568"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Corcos-2005" MODIFIED="2014-07-03 09:50:57 +0100" MODIFIED_BY="[Empty name]" NAME="Corcos 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-07-03 09:50:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corcos J, Collet JP, Shapiro S, Herschorn S, Radomski SB, Schick E, et al</AU>
<TI>Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence</TI>
<SO>Urology</SO>
<YR>2005</YR>
<VL>65</VL>
<NO>5</NO>
<PG>898-904</PG>
<IDENTIFIERS MODIFIED="2014-07-03 09:50:57 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757571"/><IDENTIFIER MODIFIED="2014-07-03 09:50:57 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="20346"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757570"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cotte-2006" MODIFIED="2015-05-23 06:46:03 +0100" MODIFIED_BY="[Empty name]" NAME="Cotte 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-05-23 06:46:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cotte B, Dumousset E, Boda C, Mansoor A</AU>
<TI>Comparison of transobturator tape (TO) and tension free vaginal tape (TVT) using perineal ultrasound</TI>
<SO>Gynecologie, Obstetrique &amp; Fertilite</SO>
<YR>2006</YR>
<VL>34</VL>
<PG>298-303</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418105"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757572"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Courtney_x002d_Watson-2002" MODIFIED="2014-07-03 09:51:13 +0100" MODIFIED_BY="[Empty name]" NAME="Courtney-Watson 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-07-03 09:51:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Courtney-Watson C</AU>
<TI>Comparison of two surgical methods for curing stress incontinence (recurrent)</TI>
<SO>Data on file</SO>
<YR>2002</YR>
<IDENTIFIERS MODIFIED="2014-07-03 09:51:13 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757575"/><IDENTIFIER MODIFIED="2014-07-03 09:51:13 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="16382"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757574"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Debodinance-2006" MODIFIED="2015-06-08 15:49:13 +0100" MODIFIED_BY="[Empty name]" NAME="Debodinance 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-06-08 15:49:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Debodinance P</AU>
<TI>Transobturator urethral sling for surgical correction of female urinary incontinence: outside-in (Monarc) versus inside-out (TVT-O). Are both ways safe?</TI>
<SO>Journal de Gynecologie Obstetrique et Biologie de la Reproduction</SO>
<YR>2006</YR>
<VL>35</VL>
<NO>6</NO>
<PG>571-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418106"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757576"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dietz-2005" MODIFIED="2015-06-09 09:18:13 +0100" MODIFIED_BY="[Empty name]" NAME="Dietz 2005" YEAR="2005">
<REFERENCE MODIFIED="2015-06-09 09:08:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Dietz HP, Barry C, Lim Y, Rane A</AU>
<TI>2D and 3D ultrasound imaging of suburethral slings: data from the 'suspend' randomized controlled trial (Abstract number 674)</TI>
<SO>Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, 2004 Aug 25-27, Paris</SO>
<YR>2004</YR>
<IDENTIFIERS MODIFIED="2014-07-03 09:52:29 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418107"/><IDENTIFIER MODIFIED="2014-07-03 09:52:29 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="19084"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 09:18:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dietz HP, Barry C, Lim YN, Rane A</AU>
<TI>Two-dimensional and three-dimensional ultrasound imaging of suburethral slings</TI>
<SO>Ultrasound in Obstetrics &amp; Gynecology</SO>
<YR>2005</YR>
<VL>26</VL>
<NO>2</NO>
<PG>175-9</PG>
<IDENTIFIERS MODIFIED="2014-07-03 09:52:57 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418108"/><IDENTIFIER MODIFIED="2014-07-03 09:52:57 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="20763"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757578"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Du-2008" MODIFIED="2015-05-23 06:49:23 +0100" MODIFIED_BY="[Empty name]" NAME="Du 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-05-23 06:49:23 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 19094644&lt;br&gt;IN - Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. ghdu@tjh.tjmu.edu.cn&lt;br&gt;AS - Chung Hua Wai Ko Tsa Chih. 46(20):1529-32, 2008 Oct 15&lt;br&gt;JC - d86, 0153611&lt;br&gt;SB - IM&lt;br&gt;CP - China&lt;br&gt;PT - English Abstract&lt;br&gt;PT - Journal Article&lt;br&gt;LG - Chinese&lt;/p&gt;" NOTES_MODIFIED="2015-05-23 06:49:23 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Du G-H, Chen Z, HU WF, Zhang C-H, Zhang J-Y, Zhu Z-Q, et al</AU>
<TI>[A multicenter study of mid urethral sling procedures in treatment of female stress urinary incontinence] [Chinese]</TI>
<SO>Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery]</SO>
<YR>2008</YR>
<VL>46</VL>
<NO>20</NO>
<PG>1529-32</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418110"/><IDENTIFIER TYPE="OTHER" VALUE="srincont29216"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418109"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Falconer-2001" MODIFIED="2014-07-03 09:53:09 +0100" MODIFIED_BY="[Empty name]" NAME="Falconer 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-07-03 09:53:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Falconer C, Rosblad P-G</AU>
<TI>A randomized comparative study between local and low spinal anesthesia for tension-free vaginal tape operation</TI>
<SO>International Urogynecology Journal</SO>
<YR>2001</YR>
<VL>12</VL>
<NO>Suppl 3</NO>
<PG>S21</PG>
<IDENTIFIERS MODIFIED="2014-07-03 09:53:09 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757584"/><IDENTIFIER MODIFIED="2014-07-03 09:53:09 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="15455"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757583"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fischer-2005" MODIFIED="2009-08-09 22:06:38 +0100" MODIFIED_BY="[Empty name]" NAME="Fischer 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-08-09 22:06:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fischer A, Fink T, Zachmann S, Eickenbusch U</AU>
<TI>Comparison of retropubic and outside-in transoburator sling systems for the cure of female genuine stress urinary incontinence</TI>
<SO>European Urology</SO>
<YR>2005</YR>
<VL>48</VL>
<NO>5</NO>
<PG>799-804</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757586"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757585"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Foote-2012" MODIFIED="2015-06-08 15:50:10 +0100" MODIFIED_BY="[Empty name]" NAME="Foote 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-06-08 15:50:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Foote A</AU>
<TI>A randomised trial comparing two vaginal prolene sling surgeries for female urinary incontinence</TI>
<SO>www.anzctr.org (accessed 19 Sep 2012)</SO>
<YR>2012</YR>
<IDENTIFIERS MODIFIED="2014-07-03 09:53:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418112"/><IDENTIFIER MODIFIED="2014-07-03 09:53:40 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ACTRN12612000314820 "/><IDENTIFIER TYPE="OTHER" VALUE="srincont45458"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-03 09:53:54 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418111"/><IDENTIFIER MODIFIED="2014-07-03 09:53:54 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ACTRN12612000314820 "/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goldberg-2001" MODIFIED="2015-06-08 15:50:16 +0100" MODIFIED_BY="[Empty name]" NAME="Goldberg 2001" YEAR="2001">
<REFERENCE MODIFIED="2015-06-08 15:50:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Goldberg RP, Koduri S, Lobel RW, Culligan PJ, Tomezsko JE, Winkler HA, et al</AU>
<TI>Long-term effects of three different anti-incontinence procedures on the posterior compartment (Abstract number 243)</TI>
<SO>Proceedings of the 31st Annual Meeting of the International Continence Society (ICS), 2001 Sept 18-21, Seoul, Korea</SO>
<YR>2001</YR>
<IDENTIFIERS MODIFIED="2014-07-03 09:54:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418113"/><IDENTIFIER MODIFIED="2014-07-03 09:54:02 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="14471"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757589"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gopinath-2013" MODIFIED="2014-03-23 19:11:17 +0000" MODIFIED_BY="[Empty name]" NAME="Gopinath 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-03-23 18:24:26 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 23114890&lt;br&gt;ST - In-Data-Review&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 24(6):969-75, 2013 Jun&lt;br&gt;JC - cl5, 9514583, 101567041&lt;br&gt;CP - England&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20130604&lt;/p&gt;" NOTES_MODIFIED="2014-03-23 18:24:26 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gopinath D, Smith AR, Holland C, Reid FM</AU>
<TI>Why don't women participate? A qualitative study on non-participation in a surgical randomised controlled trial</TI>
<SO>International Urogynecology Journal</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>6</NO>
<PG>969-75</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418115"/><IDENTIFIER TYPE="OTHER" VALUE="srincont48114"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418114"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harmanli-2011" MODIFIED="2015-06-08 15:50:24 +0100" MODIFIED_BY="[Empty name]" NAME="Harmanli 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-05-23 06:54:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Harmanli O, Boyer R, Metz S, Jones K, Tunitsky E</AU>
<TI>Double-blinded randomized trial of preoperative antibiotics in midurethral sling procedures (Abstract number 1184)</TI>
<SO>Proceedings of the Joint Meeting of the International Continence Society (ICS) and the International Urogynecological Association, 2010 Aug 23-27, Toronto, Canada</SO>
<YR>2010</YR>
<IDENTIFIERS MODIFIED="2014-05-22 14:11:39 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418117"/><IDENTIFIER MODIFIED="2014-05-22 14:11:39 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="Srincont 40210"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:50:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Harmanli O, Boyer RL, Metz S, Tunitsky E, Jones KA</AU>
<TI>Double-blinded randomized trial of preoperative antibiotics in midurethral sling procedures and review of the literature</TI>
<SO>International Urogynecology Journal</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>10</NO>
<PG>1249-53</PG>
<IDENTIFIERS MODIFIED="2014-05-22 14:07:42 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418118"/><IDENTIFIER TYPE="PUBMED" VALUE="21789661"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418116"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jackson-2013" MODIFIED="2014-07-03 09:58:34 +0100" MODIFIED_BY="[Empty name]" NAME="Jackson 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-03-23 18:50:01 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 23611930&lt;br&gt;ST - In-Process&lt;br&gt;AS - Female pelvic med. reconstr. surg.. 19(3):137-41, 2013 May-Jun&lt;br&gt;JC - 101528690&lt;br&gt;CP - United States&lt;br&gt;PT - Clinical Trial&lt;br&gt;PT - Journal Article&lt;br&gt;PT - Research Support, Non-U.S. Gov't&lt;br&gt;SI - ClinicalTrials.gov&lt;br&gt;SA - ClinicalTrials.gov/NCT00734968&lt;br&gt;LG - English&lt;br&gt;DC - 20130424&lt;/p&gt;" NOTES_MODIFIED="2014-03-23 18:50:01 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackson D, Higgins E, Bracken J, Yandell PM, Shull B, Foster RT Sr</AU>
<TI>Antibiotic prophylaxis for urinary tract infection after midurethral sling: a randomized controlled trial</TI>
<SO>Female Pelvic Medicine &amp; Reconstructive Surgery</SO>
<YR>2013</YR>
<VL>19</VL>
<NO>3</NO>
<PG>137-41</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418120"/><IDENTIFIER TYPE="OTHER" VALUE="CARPET"/><IDENTIFIER TYPE="OTHER" VALUE="NCT00734968"/><IDENTIFIER TYPE="OTHER" VALUE="srincont48136"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-03 09:58:34 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418119"/><IDENTIFIER MODIFIED="2014-07-03 09:58:34 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00734968"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jeon-2008" MODIFIED="2015-05-23 06:54:54 +0100" MODIFIED_BY="[Empty name]" NAME="Jeon 2008" YEAR="2008">
<REFERENCE MODIFIED="2015-05-23 06:54:54 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 17713345&lt;br&gt;IN - Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea&lt;br&gt;AS - Gynecol Obstet Invest. 65(1):41-6, 2008&lt;br&gt;JC - fya, 7900587&lt;br&gt;SB - IM&lt;br&gt;CP - Switzerland&lt;br&gt;PT - Clinical Trial&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2015-05-23 06:54:54 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jeon MJ, Chung da J, Park JH, Kim SK, Kim JW, Bai SW</AU>
<TI>Surgical therapeutic index of tension-free vaginal tape and transobturator tape for stress urinary incontinence</TI>
<SO>Gynecologic and Obstetric Investigation</SO>
<YR>2008</YR>
<VL>65</VL>
<NO>1</NO>
<PG>41-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418122"/><IDENTIFIER TYPE="OTHER" VALUE="srincont26783"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418121"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones-2010" MODIFIED="2015-06-08 15:50:32 +0100" MODIFIED_BY="[Empty name]" NAME="Jones 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-06-08 15:50:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jones R, Abrams P, Hilton P, Ward K, Drake M</AU>
<TI>Risk of tape-related complications after TVT is at least 4%</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>1</NO>
<PG>40-1</PG>
<IDENTIFIERS MODIFIED="2014-07-03 09:58:55 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418124"/><IDENTIFIER TYPE="OTHER" VALUE="srincont39866"/><IDENTIFIER TYPE="PUBMED" VALUE="20025030"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418123"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karagkounis-2007" MODIFIED="2015-06-08 15:50:37 +0100" MODIFIED_BY="[Empty name]" NAME="Karagkounis 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-08 15:50:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karagkounis SC, Pantelis A, Parashou GC, Paplomata E, Madenis N, Chrisanthoupoulos C, et al</AU>
<TI>Stress urinary incontinence: TVT OB system versus Duloxetine-HCL and the winner is? (Abstract number 005)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S3-4</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418125"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757602"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2005a" MODIFIED="2015-06-21 16:45:44 +0100" MODIFIED_BY="[Empty name]" NAME="Kim 2005a" YEAR="2005">
<REFERENCE MODIFIED="2014-03-23 21:44:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim YB, Jeon YT, Jee BC, Park KH, Suh CS</AU>
<TI>The efficacy and safety of tension-free vaginal tape and transobturator suburethral tape in the surgical treatment of stress urinary incontinence (Abstract number 237)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2005</YR>
<VL>16</VL>
<NO>Suppl 2</NO>
<PG>S87</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418127"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27308"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418126"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kim-2006" MODIFIED="2014-03-26 09:47:28 +0000" MODIFIED_BY="[Empty name]" NAME="Kim 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-03-26 09:43:42 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;write to aurhor &lt;a href=&quot;mailto:jtandro@skku.edu&quot; protected=&quot;true&quot;&gt;jtandro@skku.edu&lt;/a&gt; ask how women were assigned to each group ie ? randomised or not&lt;/p&gt;" NOTES_MODIFIED="2014-03-26 09:43:42 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kim WT, Kim KT, Kim JW, Choe JH, Lee JS, Seo JT</AU>
<TI>[Comparative study of the tension-free vaginal tape (TVT) procedure and the suprapubic arc sling (SPARC) procedure for treating female stress urinary incontinence: A 1-year follow-up]</TI>
<SO>Korean Journal of Urology</SO>
<YR>2006</YR>
<VL>47</VL>
<NO>4</NO>
<PG>397-401</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418129"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27044"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418128"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kulseng_x002d_Hanssen-2004" MODIFIED="2015-06-08 15:50:46 +0100" MODIFIED_BY="[Empty name]" NAME="Kulseng-Hanssen 2004" YEAR="2004">
<REFERENCE MODIFIED="2015-06-08 15:50:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Kulseng-Hanssen S</AU>
<TI>Do preoperative objective and subjective findings predict the outcome of TVT operations in females complaining of mixed urinary incontinence? (Abstract number 310)</TI>
<SO>Proceedings of the International Continence Society (34th Annual Meeting) and the International Urogynecological Association, 2004, Aug 23-27, Paris</SO>
<YR>2004</YR>
<IDENTIFIERS MODIFIED="2014-07-03 10:00:04 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418130"/><IDENTIFIER MODIFIED="2014-07-03 10:00:04 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="19057"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757608"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kulseng_x002d_Hanssen-2007" MODIFIED="2015-06-08 15:50:52 +0100" MODIFIED_BY="[Empty name]" NAME="Kulseng-Hanssen 2007" YEAR="2004">
<REFERENCE MODIFIED="2015-06-08 15:50:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kulseng-Hanssen S, Husby H, Schiotz HA</AU>
<TI>The tension free vaginal tape operation for women with mixed incontinence: do preoperative variables predict the outcome?</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<PG>115-21</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418131"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757610"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kwon-2002" MODIFIED="2014-07-03 10:00:58 +0100" MODIFIED_BY="[Empty name]" NAME="Kwon 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-07-03 10:00:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kwon C, Goldberg R, Sanjay G, Sumana K, Krotz S, Sand P</AU>
<TI>Protective effect of transvaginal slings on recurrent anterior vaginal wall prolapse after pelvic reconstructive surgery (Abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>4</NO>
<PG>321-2</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:00:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757613"/><IDENTIFIER MODIFIED="2014-07-03 10:00:58 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="14540"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757612"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liapis-2007" MODIFIED="2009-07-03 12:29:01 +0100" MODIFIED_BY="[Empty name]" NAME="Liapis 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-07-03 12:29:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liapis A, Bakas P, Creatsas G</AU>
<TI>Assessment of TVT efficacy in the management of patients with genuine stress incontinence with the use of epidural vs intravenous anesthesia</TI>
<SO>International Urogynecology Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<PG>1197&#8211;200</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757615"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757614"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liapis-2010" MODIFIED="2014-01-18 16:33:01 +0000" MODIFIED_BY="[Empty name]" NAME="Liapis 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-01-18 16:33:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liapis A, Bakas P, Georgantopoulou C, Creatsas G</AU>
<TI>The use of oestradiol therapy in postmenopausal women after TVT-O anti-incontinence surgery</TI>
<SO>Maturitas</SO>
<YR>2010</YR>
<VL>66</VL>
<NO>1</NO>
<PG>101-6</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418133"/><IDENTIFIER TYPE="OTHER" VALUE="srincont39604"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418132"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Markland-2007" MODIFIED="2015-06-09 09:19:05 +0100" MODIFIED_BY="[Empty name]" NAME="Markland 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-05-23 06:56:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kirby AC, Nager CW, Litman HJ, FitzGerald MP, Kraus S, Norton P, et al</AU>
<TI>Preoperative voiding detrusor pressures and stress incontinence surgery outcomes (Abstract number 38)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>6</NO>
<PG>860-1</PG>
<IDENTIFIERS MODIFIED="2014-05-22 14:26:53 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418135"/><IDENTIFIER MODIFIED="2014-05-22 14:26:53 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="Srincont 40122"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-05-22 14:24:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kirby AC, Nager CW, Litman HJ, FitzGerald MP, Kraus S, Norton P, et al</AU>
<TI>Preoperative voiding detrusor pressures do not predict stress incontinence surgery outcomes</TI>
<SO>International urogynecology journal</SO>
<YR>2011</YR>
<VL>22</VL>
<NO>6</NO>
<PG>657-63</PG>
<IDENTIFIERS MODIFIED="2014-05-22 14:24:48 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418136"/><IDENTIFIER TYPE="PUBMED" VALUE="21153471"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 09:19:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Markland AD, Kraus SR, Richter HE, Nager CW, Kenton K, Kerr L, et al</AU>
<TI>Prevalence and risk factors of fecal incontinence in women undergoing stress incontinence surgery</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2007</YR>
<VL>197</VL>
<NO>6</NO>
<PG>662.e1-7</PG>
<IDENTIFIERS MODIFIED="2014-05-22 13:31:56 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418137"/><IDENTIFIER TYPE="PUBMED" VALUE="18060972"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-03 10:07:21 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418134"/><IDENTIFIER MODIFIED="2014-07-03 10:07:21 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00064662"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McClure-2006" MODIFIED="2014-07-03 10:08:06 +0100" MODIFIED_BY="[Empty name]" NAME="McClure 2006" YEAR="2006">
<REFERENCE MODIFIED="2014-07-03 10:08:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McClure LA, Brown MB</AU>
<TI>A likelihood approach to analyzing clinical trial data when treatments favour different outcomes</TI>
<SO>Contemporary Clinical Trials</SO>
<YR>2006</YR>
<VL>27</VL>
<NO>4</NO>
<PG>340-52</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:08:06 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757623"/><IDENTIFIER MODIFIED="2014-07-03 10:08:06 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="22391"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757622"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meschia-2002" MODIFIED="2015-06-08 15:51:09 +0100" MODIFIED_BY="[Empty name]" NAME="Meschia 2002" YEAR="2002">
<REFERENCE MODIFIED="2015-06-08 15:51:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Meschia M, Pifarotti P, Gattei U, Ronchetti A, Stoppelli S, Lampugnani F</AU>
<TI>TVT and prolapse repair for treatment of occult stress urinary incontinence: a randomized study (Abstract)</TI>
<SO>Proceedings of the 32nd Annual Meeting of the International Continence Society (ICS), 2002 Aug 28-30, Heidelberg, Germany</SO>
<YR>2002</YR>
<PG>198-9</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:08:19 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418138"/><IDENTIFIER MODIFIED="2014-07-03 10:08:19 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="14518"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757624"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Osman-2003" MODIFIED="2014-07-03 10:08:27 +0100" MODIFIED_BY="[Empty name]" NAME="Osman 2003" YEAR="2003">
<REFERENCE MODIFIED="2014-07-03 10:08:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osman T</AU>
<TI>Stress incontinence surgery for patients presenting with mixed incontinence and a normal cystometrogram</TI>
<SO>BJU International</SO>
<YR>2003</YR>
<VL>92</VL>
<NO>9</NO>
<PG>964-8</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:08:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757627"/><IDENTIFIER MODIFIED="2014-07-03 10:08:27 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="16660"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757626"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pace-2008" MODIFIED="2013-12-31 14:48:03 +0000" MODIFIED_BY="[Empty name]" NAME="Pace 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-12-31 14:39:37 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 18237371&lt;br&gt;IN - Universty of L'Aquila-Surgery, L'Aquila, Italy. pacegianna@beactive.it&lt;br&gt;AS - J Sex Med. 5(2):387-93, 2008 Feb&lt;br&gt;JC - 101230693&lt;br&gt;SB - IM&lt;br&gt;CP - United States&lt;br&gt;PT - Clinical Trial&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;/p&gt;" NOTES_MODIFIED="2013-12-31 14:39:37 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pace G, Vicentini C</AU>
<TI>Female sexual function evaluation of the tension-free vaginal tape (TVT) and transobturator suburethral tape (TOT) incontinence surgery: results of a prospective study</TI>
<SO>Journal of Sexual Medicine</SO>
<YR>2008</YR>
<VL>5</VL>
<NO>2</NO>
<PG>387-93</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418140"/><IDENTIFIER TYPE="OTHER" VALUE="srincont27116"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418139"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Padilla_x002d_Fern_x00e1_ndez-2013" MODIFIED="2014-03-26 10:06:44 +0000" MODIFIED_BY="[Empty name]" NAME="Padilla-Fernndez 2013" YEAR="2013">
<REFERENCE MODIFIED="2014-03-26 10:06:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Padilla-Fernandez B, Garcia-Cenador MB, Collazos-Robles RE, Garcia-Sanchez MH, Garcia-Sanchez A, Lorenzo-Gomez MF</AU>
<TI>Transobturator tape with whipstitch edges for urinary incontinence allows postoperative adjustment and improves outcomes (Abstract number 606)</TI>
<SO>Proceedings of the 43rd Annual Meeting of the International Continence Society (ICS), 2013 Aug 26-30, Barcelona, Spain</SO>
<YR>2013</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418142"/><IDENTIFIER TYPE="OTHER" VALUE="srincont60035"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418141"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Park-2008" MODIFIED="2014-03-23 22:04:53 +0000" MODIFIED_BY="[Empty name]" NAME="Park 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-03-23 22:03:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Park HK, Lee HW, Kim HG, Lee KS</AU>
<TI>Does tape tension have an effect on the success rate of transobturator tape surgery? (Abstract number 122)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2008</YR>
<VL>27</VL>
<NO>7</NO>
<PG>714-5</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418144"/><IDENTIFIER TYPE="OTHER" VALUE="srincont31858"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418143"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sabadell-2008" MODIFIED="2014-03-26 12:57:27 +0000" MODIFIED_BY="[Empty name]" NAME="Sabadell 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-03-26 12:57:27 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - CCTR&lt;br&gt;AN - CN-00753956 NEW&lt;br&gt;OT - Comparacion de las vias de insercion outside-in e inside-out en el uso de bandas transobturadoras para el tratamiento de la incontinencia urinaria de esfuerzo&lt;br&gt;PT - Journal: Article&lt;/p&gt;" NOTES_MODIFIED="2014-03-26 12:57:27 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sabadell J, Luis Poza J, Sanchez-Iglesias JL, Martinez-Gomez X, Pla F, Xercavins J</AU>
<TI>[Comparison of the outside-in and inside-out routes in the use of transobturator tapes for the treatment of stress urinary incontinence]</TI>
<SO>Progresos en Obstetricia y Ginecologia</SO>
<YR>2008</YR>
<VL>51</VL>
<NO>8</NO>
<PG>464-70</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418146"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40241"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418145"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schierlitz-2007" MODIFIED="2015-06-09 08:50:33 +0100" MODIFIED_BY="[Empty name]" NAME="Schierlitz 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-09 08:50:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schierlitz L, Dwyer P, Rosamilia A, Murray C, Thomas E, Taylor N, et al</AU>
<TI>A prospective randomised controlled study comparing vaginal prolapse repair with and without tension free vaginal tape (TVT) in women with severe pelvic organ prolapse and occult stress incontinence (Abstract number 114)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>5</NO>
<PG>743-4</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:08:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418148"/><IDENTIFIER MODIFIED="2014-07-03 10:08:52 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23759"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418147"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schostak-2001" MODIFIED="2014-07-03 10:09:02 +0100" MODIFIED_BY="[Empty name]" NAME="Schostak 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-07-03 10:09:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schostak M, Gottfried HW, Heicappell R, Muller M, Sauter T, Steiner U, et al</AU>
<TI>Minimally invasive bone anchoring for female stress incontinence: a treatment with moderate results (Abstract)</TI>
<SO>European Urology</SO>
<YR>2001</YR>
<VL>39</VL>
<NO>Suppl 5</NO>
<PG>3</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:09:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757639"/><IDENTIFIER MODIFIED="2014-07-03 10:09:02 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="16374"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757638"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Seo-2007" MODIFIED="2015-06-08 15:51:17 +0100" MODIFIED_BY="[Empty name]" NAME="Seo 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-08 15:51:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Seo JH, Lee JW, Kim DY, Lee YG, Seo YJ, Kwon TG, et al</AU>
<TI>Treatment of obstructive voiding dysfunction after transobturator sling surgery: results of multicenter study (Abstract number 287)</TI>
<SO>Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20-24, Rotterdam, The Netherlands</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2014-07-03 10:09:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418149"/><IDENTIFIER MODIFIED="2014-07-03 10:09:11 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23762"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757640"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shin-2010" MODIFIED="2014-03-26 13:01:50 +0000" MODIFIED_BY="[Empty name]" NAME="Shin 2010" YEAR="2010">
<REFERENCE MODIFIED="2014-03-26 13:01:50 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - CCTR&lt;br&gt;AN - CN-00892389 NEW&lt;/p&gt;" NOTES_MODIFIED="2014-03-26 13:01:50 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shin JH, Lim JS, Song KH, Sul CK, Na YG</AU>
<TI>Prospective study comparing the suprapubic arc (Sparc) procedure and the transobturator (Monarc) procedure for treating female stress urinary incontinence</TI>
<SO>LUTS: Lower Urinary Tract Symptoms</SO>
<YR>2010</YR>
<VL>2</VL>
<NO>1</NO>
<PG>37-42</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418151"/><IDENTIFIER TYPE="OTHER" VALUE="srincont59687"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418150"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sivaslioglu-2007" MODIFIED="2015-06-02 11:53:48 +0100" MODIFIED_BY="[Empty name]" NAME="Sivaslioglu 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-08-09 22:19:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sivaslioglu AA, Unlubilgin E, Dolen I, Kaplan M</AU>
<TI>The comparison of tissue fixation system (TFS) with transobturator tape (TOT) in the treatment of stress urinary incontinence (Abstract no. 061)</TI>
<SO>International Urogynecology Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>Suppl 1</NO>
<PG>S36</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418152"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757644"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Surkont-2007" MODIFIED="2009-08-09 22:20:13 +0100" MODIFIED_BY="[Empty name]" NAME="Surkont 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-08-09 22:20:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Surkont G, Wlazlak E, Kazimierak W, Dunicz-Sokolowska A, Suzin J</AU>
<TI>The influence of SUI operative treatment with use of IVS tape on quality of life</TI>
<SO>Ginekologia Polska</SO>
<YR>2007</YR>
<VL>78</VL>
<NO>5</NO>
<PG>381-3</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757647"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757646"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Takeyama-2006" MODIFIED="2015-06-08 15:51:24 +0100" MODIFIED_BY="[Empty name]" NAME="Takeyama 2006" YEAR="2006">
<REFERENCE MODIFIED="2015-06-08 15:51:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Takeyama M, Fukumoto Y, Noma M, Yamamoto K, Yamanaka M, Uesaka Y</AU>
<TI>A prospective study about trans-obturator-tape (TOT) procedures with the tape from the Gynecare TVT device and a C-shape tunneller - comparison between outside-in and inside-out procedures (Abstract number 489)</TI>
<SO>Proceedings of the 36th Annual Meeting of the International Continence Society (ICS), 2006 Nov 27-Dec 1, Christchurch, New Zealand</SO>
<YR>2006</YR>
<IDENTIFIERS MODIFIED="2014-07-03 10:09:22 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418153"/><IDENTIFIER MODIFIED="2014-07-03 10:09:22 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23751"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757648"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tantanasis-2013" MODIFIED="2015-05-23 07:00:51 +0100" MODIFIED_BY="[Empty name]" NAME="Tantanasis 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-05-23 07:00:51 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 24052223&lt;br&gt;ST - In-Process&lt;br&gt;AS - Arch Gynecol Obstet. 288(5):995-1001, 2013 Nov&lt;br&gt;JC - 6ys, 8710213&lt;br&gt;CP - Germany&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20131016&lt;/p&gt;" NOTES_MODIFIED="2015-05-23 07:00:51 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tantanasis T, Daniilidis A, Pantelis A, Chatzis P, Vrachnis N</AU>
<TI>Minimally invasive techniques for female stress urinary incontinence, how, why, when</TI>
<SO>Archives of Gynecology and Obstetrics</SO>
<YR>2013</YR>
<VL>288</VL>
<NO>5</NO>
<PG>995-1001</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418155"/><IDENTIFIER TYPE="OTHER" VALUE="srincont49470"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418154"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tincello-2009" MODIFIED="2015-06-09 09:20:26 +0100" MODIFIED_BY="[Empty name]" NAME="Tincello 2009" YEAR="2009">
<REFERENCE MODIFIED="2015-06-08 15:51:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bakali E, Pitchforth E, Tincello DG, Kenyon S, Slack M, Toozs-Hobson P, et al</AU>
<TI>Clinicians' views on the feasibility of surgical randomized trials in urogynecology: results of a questionnaire survey</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>1</NO>
<PG>69-74</PG>
<IDENTIFIERS MODIFIED="2014-05-22 13:39:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418157"/><IDENTIFIER TYPE="PUBMED" VALUE="20658541"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-07-03 10:10:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jackson CJ, Dixon-Woods M, Eborall H, Kenyon S, Toozs-Hobson P, Tincello DG</AU>
<TI>Women's views and experiences of a patient preference trial in surgery: a qualitative study of the CARPET1 trial</TI>
<SO>Clinical Trials</SO>
<YR>2010</YR>
<VL>7</VL>
<NO>6</NO>
<PG>696-704</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:10:37 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418158"/><IDENTIFIER MODIFIED="2014-07-03 10:10:37 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="CARPET1"/><IDENTIFIER MODIFIED="2014-07-03 10:09:52 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ISRCTN34759911"/><IDENTIFIER TYPE="OTHER" VALUE="srincont40885"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 09:20:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tincello DG, Kenyon S, Slack M, Toozs-Hobson P, Mayne C, Jones D, et al</AU>
<TI>Colposuspension or TVT with anterior repair for urinary incontinence and prolapse: results of and lessons from a pilot randomised patient-preference study (CARPET 1)</TI>
<SO>BJOG : an international journal of obstetrics and gynaecology</SO>
<YR>2009</YR>
<VL>116</VL>
<NO>13</NO>
<PG>1809-14</PG>
<IDENTIFIERS MODIFIED="2014-03-23 18:45:45 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418159"/><IDENTIFIER TYPE="PUBMED" VALUE="19781044"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-03 10:10:23 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418156"/><IDENTIFIER MODIFIED="2014-07-03 10:10:15 +0100" MODIFIED_BY="[Empty name]" TYPE="ISRCTN" VALUE="ISRCTN34759911"/><IDENTIFIER MODIFIED="2014-07-03 10:10:23 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="CARPET1"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tinelli-2007" MODIFIED="2014-03-23 22:17:29 +0000" MODIFIED_BY="[Empty name]" NAME="Tinelli 2007" YEAR="2007">
<REFERENCE MODIFIED="2014-03-23 22:16:16 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tinelli A, Malvasi A, D'Anna L, Tinelli R, Perrone A, Tinelli FG</AU>
<TI>Presurgical promestriene therapy in postmenopausal women with stress urinary incontinence</TI>
<SO>Gynecological Endocrinology</SO>
<YR>2007</YR>
<VL>23</VL>
<NO>8</NO>
<PG>445-50</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418161"/><IDENTIFIER TYPE="OTHER" VALUE="srincont23949"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418160"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trezza-2001" MODIFIED="2015-06-08 15:51:36 +0100" MODIFIED_BY="[Empty name]" NAME="Trezza 2001" YEAR="2001">
<REFERENCE MODIFIED="2015-06-08 15:51:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trezza G, Rotondi M, Palmisano B, Iervolino P</AU>
<TI>Uterovaginal prolapse and occult urinary incontinence: a prospective randomized study on the necessity to associate reconstructive surgery and antiincontinence procedure. [Italian]</TI>
<SO>Urogynaecologia International Journal</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>1 Suppl</NO>
<PG>152-4</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:10:56 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418162"/><IDENTIFIER MODIFIED="2014-07-03 10:10:56 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="13713"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757658"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wang-2001" MODIFIED="2014-07-03 10:11:03 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-07-03 10:11:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wang AC, Chen MC</AU>
<TI>Randomized comparison of local versus epidural anesthesia for tension-free vaginal tape operation</TI>
<SO>Journal of Urology</SO>
<YR>2001</YR>
<VL>165</VL>
<NO>4</NO>
<PG>1177-80</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:11:03 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757661"/><IDENTIFIER MODIFIED="2014-07-03 10:11:03 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="12424"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757660"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wei-2012" MODIFIED="2015-06-09 09:21:41 +0100" MODIFIED_BY="[Empty name]" NAME="Wei 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-04-23 11:13:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wei J, Nygaard I, Richter H, Brown M, Barber M, Xiao Xu, et al</AU>
<TI>Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods</TI>
<SO>Clinical Trials</SO>
<YR>2009</YR>
<VL>6</VL>
<NO>2</NO>
<PG>162-71</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:13:28 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418164"/><IDENTIFIER MODIFIED="2014-07-03 10:13:28 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont31120"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-09 09:21:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wei J</AU>
<TI>A midurethral sling prevents incontinence among women undergoing vaginal prolapse repair - the OPUS trial</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2011</YR>
<VL>30</VL>
<NO>6</NO>
<PG>809-10</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418165"/><IDENTIFIER TYPE="OTHER" VALUE="SRINCONT 42165"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2015-06-08 15:52:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wei JT, Nygaard I, Richter HE, Nager CW, Barber MD, Kenton K, et al</AU>
<TI>A midurethral sling to reduce incontinence after vaginal prolapse repair</TI>
<SO>The New England Journal of Medicine</SO>
<YR>2012</YR>
<VL>366</VL>
<NO>25</NO>
<PG>2358-67</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418166"/><IDENTIFIER TYPE="PUBMED" VALUE="22716974"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-07-03 10:14:15 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418163"/><IDENTIFIER MODIFIED="2014-07-03 10:14:02 +0100" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT00460434"/><IDENTIFIER MODIFIED="2014-07-03 10:14:15 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="OPUS"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2003" MODIFIED="2014-07-03 10:14:29 +0100" MODIFIED_BY="[Empty name]" NAME="Williams 2003" YEAR="2003">
<REFERENCE MODIFIED="2014-07-03 10:14:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Williams JG, Cheung WY, Cohen DR, Hutchings HA, Longo MF, Russell IT</AU>
<TI>Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment</TI>
<SO>Health Technology Assessment (Winchester, England)</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>26</NO>
<PG>1-117</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:14:29 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757667"/><IDENTIFIER MODIFIED="2014-07-03 10:14:29 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="16488"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757666"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2012" MODIFIED="2013-12-10 21:52:48 +0000" MODIFIED_BY="[Empty name]" NAME="Yang 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-12-10 21:51:37 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;DB - Ovid MEDLINE(R)&lt;br&gt;UI - 21850506&lt;br&gt;ST - MEDLINE&lt;br&gt;AS - Int Urogynecol J Pelvic Floor Dysfunct. 23(1):99-104, 2012 Jan&lt;br&gt;JC - cl5, 9514583, 101567041&lt;br&gt;CP - England&lt;br&gt;PT - Comparative Study&lt;br&gt;PT - Controlled Clinical Trial&lt;br&gt;PT - Journal Article&lt;br&gt;LG - English&lt;br&gt;DC - 20120105&lt;/p&gt;" NOTES_MODIFIED="2013-12-10 21:51:37 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang X, Jiang M, Chen X, Tong X, Li H, Qiu J, et al</AU>
<TI>TVT-O vs. TVT for the treatment of SUI: a non-inferiority study</TI>
<SO>International Urogynecology Journal</SO>
<YR>2012</YR>
<VL>23</VL>
<NO>1</NO>
<PG>99-104</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418168"/><IDENTIFIER TYPE="OTHER" VALUE="srincont44553"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418167"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoo-2007" MODIFIED="2015-06-08 15:52:11 +0100" MODIFIED_BY="[Empty name]" NAME="Yoo 2007" YEAR="2007">
<REFERENCE MODIFIED="2015-06-08 15:52:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Yoo ES, Jung HC, Shin HS, Seo JH, Seo YJ</AU>
<TI>Comparison of the two different approaches for the treatment of female stress urinary incontinence (Abstract number 282)</TI>
<SO>Proceedings of the 37th Annual Meeting of the International Continence Society (ICS), 2007 Aug 20-24, Rotterdam, The Netherlands</SO>
<YR>2007</YR>
<IDENTIFIERS MODIFIED="2014-07-03 10:14:41 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418169"/><IDENTIFIER MODIFIED="2014-07-03 10:14:41 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="23760"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757670"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoon-2011" MODIFIED="2015-06-08 15:52:17 +0100" MODIFIED_BY="[Empty name]" NAME="Yoon 2011" YEAR="2011">
<REFERENCE MODIFIED="2015-06-08 15:52:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Yoon H, Lee DH, Kim YJ</AU>
<TI>Early results of comparison of Contasure-needleless (trademark) and TOT outside-in midurethral slings (Abstract number 852)</TI>
<SO>Proceedings of the 41st Annual Meeting of the International Continence Society (ICS), 2011 Aug 29-Sept 2, Glasgow, Scotland</SO>
<YR>2011</YR>
<IDENTIFIERS MODIFIED="2014-05-22 12:53:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418171"/><IDENTIFIER MODIFIED="2014-05-22 12:53:27 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="SRINcont42238" TYPE="OTHER" VALUE=""/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418170"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zaccardi-2010" MODIFIED="2015-06-09 08:50:57 +0100" MODIFIED_BY="[Empty name]" NAME="Zaccardi 2010" YEAR="2010">
<REFERENCE MODIFIED="2015-06-09 08:50:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zaccardi JE, Wilson L, Mokrzycki ML</AU>
<TI>The effect of pelvic floor re-education on comfort in women having surgery for stress urinary incontinence</TI>
<SO>Urologic Nursing</SO>
<YR>2010</YR>
<VL>30</VL>
<NO>2</NO>
<PG>137-46, 148</PG>
<IDENTIFIERS MODIFIED="2014-05-22 12:26:09 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418173"/><IDENTIFIER TYPE="PUBMED" VALUE="20469573"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418172"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zullo-2005" MODIFIED="2014-07-03 10:17:42 +0100" MODIFIED_BY="[Empty name]" NAME="Zullo 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-07-03 10:17:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zullo MA, Plotti F, Calcagno M, Palaia I, Muzii L, Manci N, et al</AU>
<TI>Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial</TI>
<SO>Menopause</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>4</NO>
<PG>421-7</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:17:42 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2757677"/><IDENTIFIER MODIFIED="2014-07-03 10:17:42 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="20805"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2757676"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2014-07-10 14:16:17 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2015-06-17 16:44:43 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Cavkaytar-2013" MODIFIED="2015-06-17 16:42:41 +0100" MODIFIED_BY="[Empty name]" NAME="Cavkaytar 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-06-17 16:42:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Cavkaytar S, Aksakal SO, Kokanali MK, Topcu HO, Doganay M</AU>
<TI>Prospective randomized study comparing TVT and TOT in female stress urinary incontinence with no intrinsic sphincter deficiency</TI>
<SO>http://clinicaltrials.gov/show/NCT01903590</SO>
<YR>2013</YR>
<IDENTIFIERS MODIFIED="2014-03-24 11:29:19 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418175"/><IDENTIFIER MODIFIED="2014-03-24 11:28:52 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT01903590"/><IDENTIFIER MODIFIED="2014-03-24 11:29:19 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="srincont49363"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 11:29:54 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418174"/><IDENTIFIER MODIFIED="2014-03-24 11:29:54 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01903590"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sung-2013" MODIFIED="2015-06-17 16:44:43 +0100" MODIFIED_BY="[Empty name]" NAME="Sung 2013" YEAR="2013">
<REFERENCE MODIFIED="2015-06-17 16:44:43 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;; Contact_Firstname: ; Contact_Tel: ; Contact_Affiliation: Brown/ Women and Infants Hospital of Rhode Island, Center for Women's Pelvic Medicine and Reconstructive Surgery;RTI International Primary_sponsor: NICHD Pelvic Floor Disorders Network&lt;/p&gt;" NOTES_MODIFIED="2015-06-17 16:44:43 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Sung VW, Wallace D</AU>
<TI>Effects of Surgical Treatment Enhanced with Exercise for Mixed Urinary Incontinence (ESTEEM)</TI>
<SO>http://clinicaltrials.gov/show/NCT01959347</SO>
<YR>2013</YR>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6418177"/><IDENTIFIER TYPE="OTHER" VALUE="ESTEEM"/><IDENTIFIER TYPE="OTHER" VALUE="NCT01959347"/><IDENTIFIER TYPE="OTHER" VALUE="srincont49234"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2014-03-24 12:30:37 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6418176"/><IDENTIFIER MODIFIED="2014-03-24 12:30:30 +0000" MODIFIED_BY="[Empty name]" TYPE="CTG" VALUE="NCT01959347"/><IDENTIFIER MODIFIED="2014-03-24 12:30:37 +0000" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ESTEEM"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-07-24 17:26:05 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-07-24 17:26:05 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Abbott-2014" MODIFIED="2017-07-03 13:16:00 +0100" MODIFIED_BY="[Empty name]" NAME="Abbott 2014" TYPE="JOURNAL_ARTICLE">
<AU>Abbott S, Unger CA, Evans JM, Jallad K, Mishra K, Karram MM, et al</AU>
<TI>Evaluation and management of complications from synthetic mesh after pelvic reconstructive surgery: a multicenter study</TI>
<SO>American Hournal of Obstetrics and Gynecology</SO>
<YR>2014</YR>
<VL>210</VL>
<NO>2</NO>
<PG>163.e1-8</PG>
<IDENTIFIERS MODIFIED="2017-07-03 13:16:00 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-03 13:16:00 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="24126300"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Aigmueller-2011" MODIFIED="2015-06-08 15:52:44 +0100" MODIFIED_BY="[Empty name]" NAME="Aigmueller 2011" TYPE="JOURNAL_ARTICLE">
<AU>Aigmueller T, Trutnovsky G, Tamussino K, Kargl J, Wittmann A, Surtov M, et al</AU>
<TI>Ten-year follow-up after the tension-free vaginal tape procedure</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2011</YR>
<VL>205</VL>
<NO>5</NO>
<PG>496.e1-5</PG>
<IDENTIFIERS MODIFIED="2014-06-28 14:48:30 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="21944223"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Alcalay-1995" MODIFIED="2015-06-08 15:52:51 +0100" MODIFIED_BY="[Empty name]" NAME="Alcalay 1995" TYPE="JOURNAL_ARTICLE">
<AU>Alcalay M, Monga A, Stanton SL</AU>
<TI>Burch colposuspension: a 10-20 year follow up</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1995</YR>
<VL>102</VL>
<NO>9</NO>
<PG>740-5</PG>
<IDENTIFIERS MODIFIED="2014-06-23 20:20:05 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="7547767"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Alhasso-2005" MODIFIED="2014-07-03 10:19:16 +0100" MODIFIED_BY="[Empty name]" NAME="Alhasso 2005" TYPE="COCHRANE_REVIEW">
<AU>Alhasso A, Glazener CMA, Pickard R, N'dow J</AU>
<TI>Adrenergic drugs for urinary incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2014-07-03 10:19:16 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 10:19:16 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001842.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Amid-1997" MODIFIED="2009-07-10 16:34:19 +0100" MODIFIED_BY="[Empty name]" NAME="Amid 1997" TYPE="JOURNAL_ARTICLE">
<AU>Amid P</AU>
<TI>Classification of biomaterials and their related complications in abdominal wall hernia surgery</TI>
<SO>Hernia</SO>
<YR>1997</YR>
<VL>1</VL>
<NO>1</NO>
<PG>15-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Athanasiou-2014" MODIFIED="2015-06-08 15:53:00 +0100" MODIFIED_BY="[Empty name]" NAME="Athanasiou 2014" TYPE="JOURNAL_ARTICLE">
<AU>Athanasiou S, Grigoriadis T, Zacharakis D, Skampardonis N, Lourantou D, Antsaklis A</AU>
<TI>Seven years of objective and subjective outcomes of transobturator (TVT-O) vaginal tape: why do tapes fail?</TI>
<SO>International Urogynecology Journal</SO>
<YR>2014</YR>
<VL>25</VL>
<NO>2</NO>
<PG>219-25</PG>
<IDENTIFIERS MODIFIED="2014-06-28 14:49:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="23892532"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ayeleke-2013" MODIFIED="2015-05-23 07:17:44 +0100" MODIFIED_BY="[Empty name]" NAME="Ayeleke 2013" TYPE="COCHRANE_REVIEW">
<AU>Ayeleke RO, Hay-Smith EJ, Omar MI</AU>
<TI>Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:03:01 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:03:01 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD010551.pub2"/><IDENTIFIER TYPE="PUBMED" VALUE="24259154"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bezerra-2005" MODIFIED="2014-07-03 10:19:40 +0100" MODIFIED_BY="[Empty name]" NAME="Bezerra 2005" TYPE="COCHRANE_REVIEW">
<AU>Bezerra CCB, Bruschini H, Cody JD</AU>
<TI>Traditional suburethral sling operations for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2014-07-03 10:19:40 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 10:19:40 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001754.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Birnbaum-2004" MODIFIED="2017-07-24 17:11:37 +0100" MODIFIED_BY="[Empty name]" NAME="Birnbaum 2004" TYPE="JOURNAL_ARTICLE">
<AU>Birnbaum HG, Leong SA, Oster EF, Kinchen K, Sun P</AU>
<TI>Cost of stress urinary incontinence: a claims data analysis.</TI>
<SO>Pharmacoeconomics</SO>
<YR>2004</YR>
<VL>22</VL>
<NO>2</NO>
<PG>95-105</PG>
<IDENTIFIERS MODIFIED="2017-06-01 12:36:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-01 12:36:11 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="14731051"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blaivas-1988" MODIFIED="2009-08-10 13:14:16 +0100" MODIFIED_BY="[Empty name]" NAME="Blaivas 1988" TYPE="JOURNAL_ARTICLE">
<AU>Blaivas JG, Olsson CA</AU>
<TI>Stress-incontinence - classification and surgical approach</TI>
<SO>Journal of Urology</SO>
<YR>1988</YR>
<VL>139</VL>
<NO>4</NO>
<PG>727-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Botlero-2008" MODIFIED="2015-06-08 15:53:06 +0100" MODIFIED_BY="[Empty name]" NAME="Botlero 2008" TYPE="JOURNAL_ARTICLE">
<AU>Botlero R, Urquhart DM, Davis SR, Bell RJ</AU>
<TI>Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues</TI>
<SO>International Journal of Urology : official journal of the Japanese Urological Association</SO>
<YR>2008</YR>
<VL>15</VL>
<NO>3</NO>
<PG>230-4</PG>
<IDENTIFIERS MODIFIED="2014-05-10 11:48:13 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="18304218"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Botlero-2010" MODIFIED="2014-05-10 11:49:06 +0100" MODIFIED_BY="[Empty name]" NAME="Botlero 2010" TYPE="JOURNAL_ARTICLE">
<AU>Botlero R, Bell RJ, Urquhart DM, Davis SR</AU>
<TI>Urinary incontinence is associated with lower psychological general well-being in community-dwelling women</TI>
<SO>Menopause (New York, N.Y.)</SO>
<YR>2010</YR>
<VL>17</VL>
<NO>2</NO>
<PG>332-7</PG>
<IDENTIFIERS MODIFIED="2014-05-10 11:49:04 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="20216275"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Boyers-2013" MODIFIED="2017-07-11 11:07:46 +0100" MODIFIED_BY="[Empty name]" NAME="Boyers 2013" TYPE="JOURNAL_ARTICLE">
<AU>Boyers D, Kilonzo M, Mostafa A, Abdel-Fattah M</AU>
<TI>Comparison of an adjustable anchored single-incision mini-sling, Ajust((R)) , with a standard mid-urethral sling, TVT-O(TM) : a health economic evaluation</TI>
<SO>BJU international</SO>
<YR>2013</YR>
<VL>112</VL>
<NO>8</NO>
<PG>1169-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brubaker-2012" MODIFIED="2015-06-08 15:53:12 +0100" MODIFIED_BY="[Empty name]" NAME="Brubaker 2012" TYPE="JOURNAL_ARTICLE">
<AU>Brubaker L, Richter HE, Norton PA, Albo M, Zyczynski HM, Chai TC, et al</AU>
<TI>5-year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence</TI>
<SO>The Journal of Urology</SO>
<YR>2012</YR>
<VL>187</VL>
<NO>4</NO>
<PG>1324-30</PG>
<IDENTIFIERS MODIFIED="2014-06-28 15:15:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="22341290"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Casta_x00f1_eda-2014" MODIFIED="2017-07-24 12:35:04 +0100" MODIFIED_BY="[Empty name]" NAME="Castaeda 2014" TYPE="JOURNAL_ARTICLE">
<AU>Castaeda E, Sanz-Granda , Hidalgo, Meza D, Carreras M, MarquetaJ.</AU>
<TI>Cost Effectiveness analysis of surgical treatment of stress urinary incontinence using single-incision mini-slings vs. tension-free vaginal obturator in Spain</TI>
<SO>Surgical Research - Open Journal</SO>
<YR>2014</YR>
<VL>1</VL>
<NO>1</NO>
<PG>17-24</PG>
<IDENTIFIERS MODIFIED="2017-07-24 12:35:04 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-24 12:34:31 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.17140/SROJ-1-103"/><IDENTIFIER MODIFIED="2017-07-24 12:35:04 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="27201564"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chong-2011" MODIFIED="2017-07-24 17:13:02 +0100" MODIFIED_BY="[Empty name]" NAME="Chong 2011" TYPE="JOURNAL_ARTICLE">
<AU>Chong E, Khan A, Anger J.</AU>
<TI>The financial burden of stress urinary incontinence among women in the United States</TI>
<SO>Current Urology Reports</SO>
<YR>2011</YR>
<VL>12</VL>
<NO>5</NO>
<PG>358-62</PG>
<IDENTIFIERS MODIFIED="2017-06-01 11:45:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-01 11:45:27 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1007/s11934-011-0209-x."/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Cody-2012" MODIFIED="2015-05-23 07:18:39 +0100" MODIFIED_BY="[Empty name]" NAME="Cody 2012" TYPE="COCHRANE_REVIEW">
<AU>Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A</AU>
<TI>Oestrogen therapy for urinary incontinence in post-menopausal women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>10</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:10:00 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:10:00 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001405.pub3"/><IDENTIFIER TYPE="PUBMED" VALUE="23076892"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Collinet-2008" MODIFIED="2009-07-10 16:34:19 +0100" MODIFIED_BY="[Empty name]" NAME="Collinet 2008" TYPE="JOURNAL_ARTICLE">
<AU>Collinet P, Ciofu C, Costa P, Cosson M, Deval B, Grise P, et al</AU>
<TI>The safety of the inside-out transobturator approach for transvaginal tape (TVT-O) treatment in stress urinary incontinence: French registry data on 984 women</TI>
<SO>International Urogynecology Journal</SO>
<YR>2008</YR>
<VL>19</VL>
<NO>5</NO>
<PG>711-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Coyne-2009" MODIFIED="2014-05-10 12:18:14 +0100" MODIFIED_BY="[Empty name]" NAME="Coyne 2009" TYPE="JOURNAL_ARTICLE">
<AU>Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, et al</AU>
<TI>The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study</TI>
<SO>BJU international</SO>
<YR>2009</YR>
<VL>104</VL>
<NO>3</NO>
<PG>352-60</PG>
<IDENTIFIERS MODIFIED="2014-05-10 12:18:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="19281467"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-de-Leval-2003" MODIFIED="2009-08-10 13:19:40 +0100" MODIFIED_BY="[Empty name]" NAME="de Leval 2003" TYPE="JOURNAL_ARTICLE">
<AU>de Leval J</AU>
<TI>Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out</TI>
<SO>European Urology</SO>
<YR>2003</YR>
<VL>44</VL>
<NO>6</NO>
<PG>724-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-de-Leval-2005" MODIFIED="2009-08-10 13:24:48 +0100" MODIFIED_BY="[Empty name]" NAME="de Leval 2005" TYPE="JOURNAL_ARTICLE">
<AU>de Leval J, Waltregny D</AU>
<TI>New surgical technique for treatment of stress urinary incontinence TVT-Obturator: new developments and results</TI>
<SO>Surgical Technology International</SO>
<YR>2005</YR>
<VL>14</VL>
<PG>212-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dean-2006" MODIFIED="2014-07-03 10:20:41 +0100" MODIFIED_BY="[Empty name]" NAME="Dean 2006" TYPE="COCHRANE_REVIEW">
<AU>Dean NM, Ellis G, Wilson PD, Herbison PH</AU>
<TI>Laparoscopic colposuspension for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2014-07-03 10:20:41 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 10:20:41 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002239.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-DeLancey-1994" MODIFIED="2015-06-09 08:51:16 +0100" MODIFIED_BY="[Empty name]" NAME="DeLancey 1994" TYPE="JOURNAL_ARTICLE">
<AU>DeLancey JO</AU>
<TI>Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1994</YR>
<VL>170</VL>
<NO>6</NO>
<PG>1713-20; discussion 1720-3</PG>
<IDENTIFIERS MODIFIED="2014-05-10 14:48:38 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="8203431"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Delorme-2001" MODIFIED="2015-05-23 07:20:37 +0100" MODIFIED_BY="[Empty name]" NAME="Delorme 2001" TYPE="JOURNAL_ARTICLE">
<AU>Delorme E</AU>
<TI>[Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women]</TI>
<SO>Progres en Urologie</SO>
<YR>2001</YR>
<VL>11</VL>
<NO>6</NO>
<PG>1306-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Delorme-2003" MODIFIED="2015-05-23 07:20:28 +0100" MODIFIED_BY="[Empty name]" NAME="Delorme 2003" TYPE="JOURNAL_ARTICLE">
<AU>Delorme E, Droupy S, de Tayrac R, Delmas V</AU>
<TI>[Transobturator tape (Uratape). A new minimally invasive method in the treatment of urinary incontinence in women]</TI>
<SO>Progres en Urologie</SO>
<YR>2003</YR>
<VL>13</VL>
<NO>4</NO>
<PG>656-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Delorme-2004" MODIFIED="2008-11-21 23:20:18 +0000" MODIFIED_BY="[Empty name]" NAME="Delorme 2004" TYPE="JOURNAL_ARTICLE">
<AU>Delorme E, Droupy S, de Tayrac R, Delmar V</AU>
<TI>Transobturator tape (Uratape): a new minimally invasive procedure to treat female urinary incontinence</TI>
<SO>European Urology</SO>
<YR>2004</YR>
<VL>45</VL>
<NO>2</NO>
<PG>203-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dietz-2004" MODIFIED="2009-07-10 16:34:19 +0100" MODIFIED_BY="[Empty name]" NAME="Dietz 2004" TYPE="JOURNAL_ARTICLE">
<AU>Dietz HP, Wilson PD</AU>
<TI>The 'iris effect': how two-dimensional and three-dimensional ultrasound can help us understand anti-incontinence procedures</TI>
<SO>Ultrasound in Obstetrics &amp; Gynecology</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>3</NO>
<PG>267-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dumoulin-2014" MODIFIED="2015-05-23 07:21:08 +0100" MODIFIED_BY="[Empty name]" NAME="Dumoulin 2014" TYPE="COCHRANE_REVIEW">
<AU>Dumoulin C, Hay-Smith EJ, Mac Habee-Seguin G</AU>
<TI>Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>5</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:13:56 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:13:56 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005654.pub3"/><IDENTIFIER TYPE="PUBMED" VALUE="24823491"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Dyrkorn-2010" MODIFIED="2015-06-08 15:53:21 +0100" MODIFIED_BY="[Empty name]" NAME="Dyrkorn 2010" TYPE="JOURNAL_ARTICLE">
<AU>Dyrkorn OA, Kulseng-Hanssen S, Sandvik L</AU>
<TI>TVT compared with TVT-O and TOT: results from the Norwegian National Incontinence Registry</TI>
<SO>International Urogynecology Journal</SO>
<YR>2010</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1321-6</PG>
<IDENTIFIERS MODIFIED="2014-07-10 14:14:38 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="20559618"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Enhorning-1961" MODIFIED="2015-06-09 08:51:30 +0100" MODIFIED_BY="[Empty name]" NAME="Enhorning 1961" TYPE="JOURNAL_ARTICLE">
<AU>Enhorning G</AU>
<TI>Simultaneous recording of intravesical and intra-urethral pressure. A study on urethral closure in normal and stress incontinent women</TI>
<SO>Acta Chirurgica Scandinavica. Supplementum</SO>
<YR>1961</YR>
<VL>Suppl 276</VL>
<PG>1-68</PG>
<IDENTIFIERS MODIFIED="2014-05-11 00:46:57 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="13696922"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-FDA-2008" MODIFIED="2015-06-08 15:53:36 +0100" MODIFIED_BY="[Empty name]" NAME="FDA 2008" TYPE="OTHER">
<AU>US Food and Drug Administration (FDA)</AU>
<TI>FDA Public Health Notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence</TI>
<SO>FDA Public Health Notification (www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm)</SO>
<YR>2008</YR>
<IDENTIFIERS><IDENTIFIER TYPE="OTHER" VALUE="srincont47910"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-FDA-2011a" MODIFIED="2015-06-08 15:53:44 +0100" MODIFIED_BY="[Empty name]" NAME="FDA 2011a" TYPE="OTHER">
<AU>US Food and Drug Administration (FDA)</AU>
<TI>FDA Safety Communication: UPDATE on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse</TI>
<SO>FDA Public Health Notification (www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm)</SO>
<YR>2011</YR>
<IDENTIFIERS><IDENTIFIER TYPE="OTHER" VALUE="srincont47910"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-FDA-2011b" MODIFIED="2015-06-08 15:53:52 +0100" MODIFIED_BY="[Empty name]" NAME="FDA 2011b" TYPE="OTHER">
<AU>FDA</AU>
<TI>Urogynecologic Surgical Mesh; Update on the Safety and Effectiveness of Vaginal Placement for Pelvic Organ Prolapse</TI>
<SO>www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/UCM262760.pdf</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FDA-2013" MODIFIED="2015-06-22 11:17:15 +0100" MODIFIED_BY="[Empty name]" NAME="FDA 2013" TYPE="OTHER">
<AU>FDA</AU>
<TI>Considerations about surgical mesh for SUI</TI>
<SO>www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/ucm345219.htm</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-French-2010" MODIFIED="2014-07-03 13:16:04 +0100" MODIFIED_BY="[Empty name]" NAME="French 2010" TYPE="COCHRANE_PROTOCOL">
<AU>French B, Thomas LH, Leathley MJ, Sutton CJ, Booth J, Brittain K, et al</AU>
<TI>Combined conservative interventions for urge, stress or mixed incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>12</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2014-05-18 11:22:48 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD008910"/><IDENTIFIER TYPE="OTHER" VALUE="CD008910"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ghoniem-2005" MODIFIED="2009-08-10 13:36:12 +0100" MODIFIED_BY="[Empty name]" NAME="Ghoniem 2005" TYPE="JOURNAL_ARTICLE">
<AU>Ghoniem GM, Van Leeuwen JS, Elser DM, Freeman RM, Zhao YD, Yalcin I, et al (Duloxetine/Pelvic Floor Muscle Training Clinical Trial Group)</AU>
<TI>A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence</TI>
<SO>Journal of Urology</SO>
<YR>2005</YR>
<VL>173</VL>
<NO>5</NO>
<PG>1453-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Glazener-2001" MODIFIED="2014-07-03 10:22:37 +0100" MODIFIED_BY="[Empty name]" NAME="Glazener 2001" TYPE="COCHRANE_REVIEW">
<AU>Glazener CMA, Cooper K</AU>
<TI>Anterior vaginal repair for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2014-07-03 10:22:37 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 10:22:37 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001755"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Glazener-2004" MODIFIED="2014-07-03 10:22:52 +0100" MODIFIED_BY="[Empty name]" NAME="Glazener 2004" TYPE="COCHRANE_REVIEW">
<AU>Glazener CMA, Cooper K</AU>
<TI>Bladder neck needle suspension for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2014-07-03 10:22:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 10:22:52 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003636.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011a" MODIFIED="2015-05-23 07:26:00 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011a" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A</AU>
<TI>GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>4</NO>
<PG>380-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2011b" MODIFIED="2015-05-23 07:25:57 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2011b" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al</AU>
<TI>GRADE guidelines: 9. Rating up the quality of evidence</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2011</YR>
<VL>64</VL>
<NO>12</NO>
<PG>1311-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2013a" MODIFIED="2015-06-08 15:54:05 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2013a" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, et al</AU>
<TI>GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2013</YR>
<VL>66</VL>
<NO>2</NO>
<PG>173-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guyatt-2013b" MODIFIED="2015-05-23 07:26:07 +0100" MODIFIED_BY="[Empty name]" NAME="Guyatt 2013b" TYPE="JOURNAL_ARTICLE">
<AU>Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al</AU>
<TI>GRADE guidelines: 12. Preparing Summary of Findings tables-binary outcomes</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2013</YR>
<VL>66</VL>
<NO>2</NO>
<PG>158-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hannestad-2000" MODIFIED="2015-06-08 15:54:11 +0100" MODIFIED_BY="[Empty name]" NAME="Hannestad 2000" TYPE="JOURNAL_ARTICLE">
<AU>Hannestad YS, Rortveit G, Sandvik H, Hunskaar S</AU>
<TI>A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2000</YR>
<VL>53</VL>
<NO>11</NO>
<PG>1150-7</PG>
<IDENTIFIERS MODIFIED="2014-05-18 12:05:51 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="11106889"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hay_x002d_Smith-2011" MODIFIED="2015-05-23 07:27:10 +0100" MODIFIED_BY="[Empty name]" NAME="Hay-Smith 2011" TYPE="COCHRANE_REVIEW">
<AU>Hay-Smith EJ, Herderschee R, Dumoulin C, Herbison GP</AU>
<TI>Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>12</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:21:30 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:21:30 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD009508"/><IDENTIFIER TYPE="PUBMED" VALUE="22161451"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Haylen-2010" MODIFIED="2015-06-08 15:54:17 +0100" MODIFIED_BY="[Empty name]" NAME="Haylen 2010" TYPE="JOURNAL_ARTICLE">
<AU>Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al</AU>
<TI>An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2010</YR>
<VL>29</VL>
<NO>1</NO>
<PG>4-20</PG>
<IDENTIFIERS MODIFIED="2014-05-10 15:02:36 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="19941278"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Heinonen-2013" MODIFIED="2015-06-08 15:54:23 +0100" MODIFIED_BY="[Empty name]" NAME="Heinonen 2013" TYPE="JOURNAL_ARTICLE">
<AU>Heinonen P, Ala-Nissila S, Raty R, Laurikainen E, Kiilholma P</AU>
<TI>Objective cure rates and patient satisfaction after the transobturator tape procedure during 6.5-year follow-up</TI>
<SO>Journal of Minimally Invasive Gynecology</SO>
<YR>2013</YR>
<VL>20</VL>
<NO>1</NO>
<PG>73-8</PG>
<IDENTIFIERS MODIFIED="2014-06-28 15:02:31 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="23312245"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Herbison-2013" MODIFIED="2015-05-23 07:27:39 +0100" MODIFIED_BY="[Empty name]" NAME="Herbison 2013" TYPE="COCHRANE_REVIEW">
<AU>Herbison GP, Dean N</AU>
<TI>Weighted vaginal cones for urinary incontinence</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:26:50 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:26:50 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002114.pub2"/><IDENTIFIER TYPE="PUBMED" VALUE="23836411"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Herderschee-2011" MODIFIED="2015-05-23 07:27:47 +0100" MODIFIED_BY="[Empty name]" NAME="Herderschee 2011" TYPE="COCHRANE_REVIEW">
<AU>Herderschee R, Hay-Smith EJ, Herbison GP, Roovers JP, Heineman MJ</AU>
<TI>Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:29:48 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:29:48 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD009252"/><IDENTIFIER TYPE="PUBMED" VALUE="21735442"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2009-07-10 16:34:19 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<NO>7414</NO>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2015-04-23 11:14:39 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hunskaar-2002" MODIFIED="2015-06-08 15:54:30 +0100" MODIFIED_BY="[Empty name]" NAME="Hunskaar 2002" TYPE="CONFERENCE_PROC">
<AU>Hunskaar S, Burgio K, Diokno AC, Herzog AR, Hjalmas K, Lapitan MC</AU>
<TI>Epidemiology and natural history of urinary incontinence (UI)</TI>
<SO>Incontinence: 2nd International Consultation on Incontinence. Recommendations of the International Scientific Committee: the evaluation and treatment of urinary incontinence. 2001 Jul 1-3, Paris</SO>
<YR>2002</YR>
<ED>Abrams P, Cardozo L, Khoury S, Wein A</ED>
<CY>Plymouth, UK</CY>
<MD>Health Publication Ltd</MD>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Imamura-2010" MODIFIED="2014-07-03 13:30:18 +0100" MODIFIED_BY="[Empty name]" NAME="Imamura 2010" TYPE="COCHRANE_PROTOCOL">
<AU>Imamura M, Williams K, Wells M, McGrother C</AU>
<TI>Lifestyle interventions for the treatment of urinary incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>9</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2014-05-18 11:36:13 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD003505.pub4"/><IDENTIFIER TYPE="OTHER" VALUE="CD003505"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Irwin-2006" MODIFIED="2015-06-08 15:54:37 +0100" MODIFIED_BY="[Empty name]" NAME="Irwin 2006" TYPE="JOURNAL_ARTICLE">
<AU>Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al</AU>
<TI>Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study</TI>
<SO>European Urology</SO>
<YR>2006</YR>
<VL>50</VL>
<NO>6</NO>
<PG>1306-14; discussion 1314-5</PG>
<IDENTIFIERS MODIFIED="2014-05-10 12:18:35 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="17049716"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jackson-1996" MODIFIED="2009-05-13 12:27:05 +0100" MODIFIED_BY="[Empty name]" NAME="Jackson 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P</AU>
<TI>The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing</TI>
<SO>British Journal of Urology</SO>
<YR>1996</YR>
<VL>77</VL>
<NO>6</NO>
<PG>805 -12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kilonzo-2004" MODIFIED="2017-07-24 17:12:04 +0100" MODIFIED_BY="[Empty name]" NAME="Kilonzo 2004" TYPE="JOURNAL_ARTICLE">
<AU>Kilonzo M, Vale L, Stearns S, Grant A, Cody J, Glazener C, et al.</AU>
<TI>Cost effectiveness of tension-free vaginal tape for the surgical management of female stress incontinence</TI>
<SO>International Journal of Technology Assessment in Health Care</SO>
<YR>2004</YR>
<VL>20</VL>
<NO>4</NO>
<PG>455-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kirchin-2012" MODIFIED="2015-05-23 07:28:56 +0100" MODIFIED_BY="[Empty name]" NAME="Kirchin 2012" TYPE="COCHRANE_REVIEW">
<AU>Kirchin V, Page T, Keegan PE, Atiemo K, Cody JD, McClinton S</AU>
<TI>Urethral injection therapy for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:32:02 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:32:02 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003881.pub3"/><IDENTIFIER TYPE="PUBMED" VALUE="22336797"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kjolhede-2005" MODIFIED="2015-06-08 15:54:48 +0100" MODIFIED_BY="[Empty name]" NAME="Kjolhede 2005" TYPE="JOURNAL_ARTICLE">
<AU>Kjolhede P</AU>
<TI>Long-term efficacy of Burch colposuspension: a 14-year follow-up study</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2005</YR>
<VL>84</VL>
<NO>8</NO>
<PG>767-72</PG>
<IDENTIFIERS MODIFIED="2014-06-23 19:22:36 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="16026403"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Koops-2005" MODIFIED="2015-06-08 15:54:58 +0100" MODIFIED_BY="[Empty name]" NAME="Koops 2005" TYPE="JOURNAL_ARTICLE">
<AU>Schraffordt Koops SE, Bisseling TM, Heintz AP, Vervest HAM</AU>
<TI>Prospective analysis of complications of tension-free vaginal tape from the Netherlands Tension-free Vaginal Tape study</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2005</YR>
<VL>193</VL>
<NO>1</NO>
<PG>45-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kunkle-2015" MODIFIED="2017-07-24 17:23:49 +0100" MODIFIED_BY="[Empty name]" NAME="Kunkle 2015" TYPE="JOURNAL_ARTICLE">
<AU>Kunkle C, Hallock J, Hu X, Blomquist J, Thung S, Werner E</AU>
<TI>Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence</TI>
<SO>Female Pelvic Medicine &amp; Reconstructive Surgery</SO>
<YR>2015</YR>
<VL>21</VL>
<NO>3</NO>
<PG>154-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kuuva-2002" MODIFIED="2009-07-03 12:51:10 +0100" MODIFIED_BY="[Empty name]" NAME="Kuuva 2002" TYPE="JOURNAL_ARTICLE">
<AU>Kuuva N,Nilsson CG</AU>
<TI>A nationwide analysis of complications associated with the tension-free vaginal tape (TVT) procedure</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2002</YR>
<VL>81</VL>
<NO>1</NO>
<PG>72-7</PG>
<IDENTIFIERS MODIFIED="2008-11-14 00:21:15 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="DOI" VALUE="10.1034/j.1600-0412.2002.810113.x"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Langendam-2013" MODIFIED="2015-06-09 08:51:58 +0100" MODIFIED_BY="[Empty name]" NAME="Langendam 2013" TYPE="JOURNAL_ARTICLE">
<AU>Langendam MW, Akl EA, Dahm P, Glasziou P, Guyatt G, Schunemann HJ</AU>
<TI>Assessing and presenting summaries of evidence in Cochrane Reviews</TI>
<SO>Systematic Reviews</SO>
<YR>2013</YR>
<VL>2</VL>
<PG>81</PG>
<IDENTIFIERS MODIFIED="2014-06-13 01:07:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="24059250"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lapitan-2012" MODIFIED="2015-05-23 07:29:43 +0100" MODIFIED_BY="[Empty name]" NAME="Lapitan 2012" TYPE="COCHRANE_REVIEW">
<AU>Lapitan MCM, Cody JD</AU>
<TI>Open retropubic colposuspension for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>6</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:37:38 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:37:38 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002912.pub5"/><IDENTIFIER TYPE="PUBMED" VALUE="22696331"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lier-2011" MODIFIED="2017-07-16 12:48:14 +0100" MODIFIED_BY="Kate Cahill" NAME="Lier 2011" TYPE="JOURNAL_ARTICLE">
<AU>Lier D, Ross S, Tang S, Robert M, Jacobs P
; Calgary Women's Pelvic Health Research Group</AU>
<TI>Trans-obturator tape compared with tension-free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis</TI>
<SO>BJOG</SO>
<YR>2011</YR>
<VL>118</VL>
<NO>5</NO>
<PG>550-6</PG>
<IDENTIFIERS MODIFIED="2014-07-03 14:29:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 14:29:52 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="sr-incont41520"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lier-2016" MODIFIED="2017-07-24 17:24:02 +0100" MODIFIED_BY="[Empty name]" NAME="Lier 2016" TYPE="OTHER">
<AU>Lier D, Robert M, Tang S, Ross S</AU>
<TI>Surgical treatment of stress urinary incontinence&#8211;trans-obturator tape compared with tension-free vaginal tape&#8211;5-year follow up: an economic evaluation</TI>
<SO>BJOG: An International Journal of Obstetrics &amp; Gynaecology</SO>
<YR>2016 Aug 10 [Epub ahead of print]</YR>
<IDENTIFIERS MODIFIED="2017-07-10 21:45:19 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-10 21:45:19 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1111/1471-0528.14227"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Lipp-2011" MODIFIED="2015-05-23 07:29:57 +0100" MODIFIED_BY="[Empty name]" NAME="Lipp 2011" TYPE="COCHRANE_REVIEW">
<AU>Lipp A, Shaw C, Glavind K</AU>
<TI>Mechanical devices for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:48:59 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:48:59 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001756.pub5"/><IDENTIFIER TYPE="PUBMED" VALUE="21735385"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mariappan-2005" MODIFIED="2014-07-03 10:25:27 +0100" MODIFIED_BY="[Empty name]" NAME="Mariappan 2005" TYPE="COCHRANE_REVIEW">
<AU>Mariappan P, Ballantyne Z, N'Dow JMO, Alhasso AA</AU>
<TI>Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2014-07-03 10:25:27 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 10:25:27 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004742.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-McGuire-1993" MODIFIED="2014-10-10 11:14:46 +0100" MODIFIED_BY="[Empty name]" NAME="McGuire 1993" TYPE="JOURNAL_ARTICLE">
<AU>McGuire EJ, Fitzpatrick CC, Wan J, Bloom D, Sanvordenker J, Ritchey M, et al</AU>
<TI>Clinical assessment of urethral sphincter function</TI>
<SO>Journal of Urology</SO>
<YR>1993</YR>
<VL>150</VL>
<NO>5 Pt 1</NO>
<PG>1452-4</PG>
<IDENTIFIERS MODIFIED="2014-10-10 11:14:46 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-10-10 11:14:46 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="8411422"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-MHRA-2012" MODIFIED="2015-06-22 11:13:28 +0100" MODIFIED_BY="[Empty name]" NAME="MHRA 2012" TYPE="BOOK">
<AU>Mahon J, Cikalo M, Varley D, Glanville J, York Health Economics Consortium</AU>
<SO>Summaries of the safety/adverse effects of vaginal tapes/slings/meshes for stress urinary incontinence and prolapse. Final report. November 2012 [report]</SO>
<YR>2012. Available at: https://www.mhra.gov.uk/home/groups/comms-ic/documents/websiteresources/con205383.pdf (accessed 21 May 2015)</YR>
<PB>MHRA, Medicines and Healthcare Products Regulatory Agency, Department of Health</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-MHRA-2014" MODIFIED="2015-06-22 11:12:39 +0100" MODIFIED_BY="[Empty name]" NAME="MHRA 2014" TYPE="BOOK">
<AU>Medicines and Healthcare Products Regulatory Agency (MHRA)</AU>
<SO>A summary of the evidence on the benefits and risks of vaginal mesh implants [report]</SO>
<YR>28 October 2014. Document available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/402162/Summary_of_the_evidence_on_the_benefits_and_risks_of_vaginal_mesh_implants.pdf. Relevant MHRA webpage: https://www.gov.uk/government/publications/vaginal-mesh-implants-summary-of-benefits-and-risks</YR>
<PB>Medicines and Healthcare Products Regulatory Agency (MHRA)</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Milsom-2009" MODIFIED="2015-06-09 10:15:39 +0100" MODIFIED_BY="[Empty name]" NAME="Milsom 2009" TYPE="CONFERENCE_PROC">
<AU>Milsom I, Altman D, Lapitan MC, Nelson R, Sillen U, Thom D</AU>
<TI>Epidemiology of urinary incontinence (UI) anal incontinence (AI) and pelvic organ prolapse (POP)</TI>
<SO>Incontinence: 4th International Consultation on Incontinence (ICI). Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence, 2008 Jul 5-8, Paris, France</SO>
<YR>2008</YR>
<ED>Abrams P, Cardozo L, Khoury S, Wein A</ED>
<PB>Health Publication Ltd</PB>
<CY>Plymouth, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" MODIFIED="2009-08-10 13:59:24 +0100" MODIFIED_BY="[Empty name]" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman DG</AU>
<TI>The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials</TI>
<SO>BMC Medical Research Methodology</SO>
<YR>2001</YR>
<VL>1</VL>
<PG>2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mostafa-2012" MODIFIED="2017-07-11 11:11:27 +0100" MODIFIED_BY="[Empty name]" NAME="Mostafa 2012" TYPE="JOURNAL_ARTICLE">
<AU>Mostafa A, Agur W, Abdel-All M, Guerrero K, Lim C, Allam M, et al</AU>
<TI>A multicentre prospective randomised study of single-incision mini-sling (Ajust) versus tension-free vaginal tape-obturator (TVT-O) in the management of female stress urinary incontinence: pain profile and short-term outcomes</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>2012</YR>
<VL>165</VL>
<NO>1</NO>
<PG>115-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nambiar-2014" MODIFIED="2014-07-03 14:09:58 +0100" MODIFIED_BY="[Empty name]" NAME="Nambiar 2014" TYPE="OTHER">
<AU>Nambiar A, Cody JD, Jeffery ST</AU>
<TI>Single-incision sling operations for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2014</YR>
<NO>6</NO>
<PB>John Wiley &amp; Sons, Ltd</PB>
<IDENTIFIERS MODIFIED="2014-07-03 14:09:58 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 14:09:49 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD008709.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nilsson-2013" MODIFIED="2015-06-08 15:56:13 +0100" MODIFIED_BY="[Empty name]" NAME="Nilsson 2013" TYPE="JOURNAL_ARTICLE">
<AU>Nilsson CG, Palva K, Aarnio R, Morcos E, Falconer C</AU>
<TI>Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence</TI>
<SO>International Urogynecology Journal</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>8</NO>
<PG>1265-9</PG>
<IDENTIFIERS MODIFIED="2014-06-23 19:58:30 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="23563892"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-O_x0027_Donnell-1994" MODIFIED="2015-06-02 11:55:11 +0100" MODIFIED_BY="[Empty name]" NAME="O'Donnell 1994" TYPE="BOOK_SECTION">
<AU>O'Donnell P</AU>
<TI>Goals of therapy and mechanisms of urethral incontinence</TI>
<SO>Female Urology</SO>
<YR>1994</YR>
<PG>175-201</PG>
<EN>1st Edition</EN>
<ED>McGuire EJ, Kursh ED</ED>
<PB>J B Lippincott Company</PB>
<CY>Philadelphia, Pensylvania, USA</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Papanicolaou-2005" MODIFIED="2015-06-08 15:56:21 +0100" MODIFIED_BY="[Empty name]" NAME="Papanicolaou 2005" TYPE="JOURNAL_ARTICLE">
<AU>Papanicolaou S, Pons ME, Hampel C, Monz B, Quail D, Schulenburg MG, et al</AU>
<TI>Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting: examples from three countries participating in the PURE study</TI>
<SO>Maturitas</SO>
<YR>2005</YR>
<VL>52</VL>
<NO>Supplement 2</NO>
<PG>35-47</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Petros-1990" MODIFIED="2015-06-08 15:56:27 +0100" MODIFIED_BY="[Empty name]" NAME="Petros 1990" TYPE="JOURNAL_ARTICLE">
<AU>Petros PE, Ulmsten UI</AU>
<TI>An integral theory of female urinary incontinence. Experimental and clinical considerations</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica. Supplement</SO>
<YR>1990</YR>
<VL>153</VL>
<PG>7-31</PG>
<IDENTIFIERS MODIFIED="2014-05-10 14:44:18 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="2093278"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Petros-1993" MODIFIED="2015-06-08 15:56:34 +0100" MODIFIED_BY="[Empty name]" NAME="Petros 1993" TYPE="JOURNAL_ARTICLE">
<AU>Petros PE, Ulmsten UI</AU>
<TI>An integral theory and its method for the diagnosis and management of female urinary incontinence</TI>
<SO>Scandinavian Journal of Urology and Nephrology. Supplementum</SO>
<YR>1993</YR>
<VL>153</VL>
<PG>1-93</PG>
<IDENTIFIERS MODIFIED="2014-05-10 14:53:08 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="8108659"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Reference-Manager-2012" MODIFIED="2015-06-09 10:19:58 +0100" MODIFIED_BY="[Empty name]" NAME="Reference Manager 2012" TYPE="COMPUTER_PROGRAM">
<TI>Reference Manager Professional Edition Version 12</TI>
<YR>2012</YR>
<PB>Thomson Reuters</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rehman-2011" MODIFIED="2015-05-23 07:34:46 +0100" MODIFIED_BY="[Empty name]" NAME="Rehman 2011" TYPE="COCHRANE_REVIEW">
<AU>Rehman H, Bezerra CC, Bruschini H, Cody JD</AU>
<TI>Traditional suburethral sling operations for urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2011</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2014-07-03 13:58:15 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 13:58:15 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001754.pub3"/><IDENTIFIER TYPE="PUBMED" VALUE="21249648"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rogers-2003" MODIFIED="2015-06-08 15:56:41 +0100" MODIFIED_BY="[Empty name]" NAME="Rogers 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C</AU>
<TI>A short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)</TI>
<SO>International Urogynecology Journal and Pelvic Floor Dysfunction</SO>
<YR>2003</YR>
<VL>14</VL>
<NO>3</NO>
<PG>164-8; discussion 168</PG>
<IDENTIFIERS MODIFIED="2014-09-07 18:39:37 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="12955337"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ross-2009" MODIFIED="2017-07-24 17:25:14 +0100" MODIFIED_BY="[Empty name]" NAME="Ross 2009" TYPE="JOURNAL_ARTICLE">
<AU>Ross S, Robert M, Swaby C, Dederer L, Lier D, Tang S, et al.</AU>
<TI>Randomized trial of trans-obturator tape versus tension-free vaginal tape for stress incontinence</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2009</YR>
<VL>114</VL>
<NO>6</NO>
<PG>1287-94</PG>
<IDENTIFIERS MODIFIED="2017-07-24 11:58:31 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-07-24 11:58:31 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1097/AOG.0b013e3181c2a151 "/><IDENTIFIER MODIFIED="2017-07-24 11:57:54 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE=" 19935032"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Salonia-2004" MODIFIED="2015-06-08 15:56:46 +0100" MODIFIED_BY="[Empty name]" NAME="Salonia 2004" TYPE="JOURNAL_ARTICLE">
<AU>Salonia A, Zanni G, Nappi RE, Briganti A, Deho F, Fabbri F, et al</AU>
<TI>Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study</TI>
<SO>European Urology</SO>
<YR>2004</YR>
<VL>45</VL>
<NO>5</NO>
<PG>642-8; discussion 648</PG>
<IDENTIFIERS MODIFIED="2014-05-10 11:49:54 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="15082208"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schulz-2010" MODIFIED="2014-06-24 02:41:20 +0100" MODIFIED_BY="[Empty name]" NAME="Schulz 2010" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Altman DG, Moher D</AU>
<TI>CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials</TI>
<SO>PLoS medicine</SO>
<YR>2010</YR>
<VL>7</VL>
<NO>3</NO>
<PG>e1000251</PG>
<IDENTIFIERS MODIFIED="2014-06-24 02:41:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="20352064"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Seklehner-2014" MODIFIED="2017-07-24 17:25:35 +0100" MODIFIED_BY="[Empty name]" NAME="Seklehner 2014" TYPE="JOURNAL_ARTICLE">
<AU>Seklehner S, Laudano MA, Te AE, Kaplan SA, Chughtai B, Lee RK</AU>
<TI>A cost-effectiveness analysis of retropubic midurethral sling versus transobturator midurethral sling for female stress urinary incontinence</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2014</YR>
<VL>33</VL>
<NO>8</NO>
<PG>1186-92</PG>
<IDENTIFIERS MODIFIED="2017-06-01 13:25:53 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-01 13:25:53 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/nau.22483"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Serati-2012" MODIFIED="2015-06-08 15:56:55 +0100" MODIFIED_BY="[Empty name]" NAME="Serati 2012" TYPE="JOURNAL_ARTICLE">
<AU>Serati M, Ghezzi F, Cattoni E, Braga A, Siesto G, Torella M, et al</AU>
<TI>Tension-free vaginal tape for the treatment of urodynamic stress incontinence: efficacy and adverse effects at 10-year follow-up</TI>
<SO>European Urology</SO>
<YR>2012</YR>
<VL>61</VL>
<NO>5</NO>
<PG>939-46</PG>
<IDENTIFIERS MODIFIED="2014-06-28 14:49:11 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="22305110"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Serati-2013" MODIFIED="2015-06-08 15:57:06 +0100" MODIFIED_BY="[Empty name]" NAME="Serati 2013" TYPE="JOURNAL_ARTICLE">
<AU>Serati M, Bauer R, Cornu JN, Cattoni E, Braga A, Siesto G, et al</AU>
<TI>TVT-O for the treatment of pure urodynamic stress incontinence: efficacy, adverse effects, and prognostic factors at 5-year follow-up</TI>
<SO>European Urology</SO>
<YR>2013</YR>
<VL>63</VL>
<NO>5</NO>
<PG>872-8</PG>
<IDENTIFIERS MODIFIED="2014-07-05 16:00:53 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="23274106"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Shumaker-1994" MODIFIED="2009-08-10 14:12:31 +0100" MODIFIED_BY="[Empty name]" NAME="Shumaker 1994" TYPE="JOURNAL_ARTICLE">
<AU>Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA</AU>
<TI>Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group</TI>
<SO>Quality of Life Research</SO>
<YR>1994</YR>
<VL>3</VL>
<NO>5</NO>
<PG>291-306</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-2002" MODIFIED="2015-06-09 10:28:30 +0100" MODIFIED_BY="[Empty name]" NAME="Smith 2002" TYPE="BOOK_SECTION">
<AU>Smith ARB, Daneshgari F, Dmochowski R, Ghoniem G, Jarvis GJ, Nitti V, et al</AU>
<TI>Surgical treatment of incontinence in women</TI>
<SO>Incontinence. 2nd International Consultation on Incontinence, 2001 Jul 1-3, Paris, France</SO>
<YR>2002</YR>
<PG>823-63</PG>
<ED>Abrams P, Cardozo L, Khoury S, Wein A</ED>
<PB>Health Publication Ltd</PB>
<CY>Plymouth, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Strasberg-2009" MODIFIED="2015-06-08 15:57:12 +0100" MODIFIED_BY="[Empty name]" NAME="Strasberg 2009" TYPE="JOURNAL_ARTICLE">
<AU>Strasberg SM, Linehan DC, Hawkins WG</AU>
<TI>The accordion severity grading system of surgical complications</TI>
<SO>Annals of Surgery</SO>
<YR>2009</YR>
<VL>250</VL>
<NO>2</NO>
<PG>177-86</PG>
<IDENTIFIERS MODIFIED="2014-06-27 11:33:29 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="19638919"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Subak-2008" MODIFIED="2017-07-24 17:25:53 +0100" MODIFIED_BY="[Empty name]" NAME="Subak 2008" TYPE="JOURNAL_ARTICLE">
<AU>Subak L, Brubaker, L, Chai T, Creasman J, Diokno A, Goode P, et al.</AU>
<TI>High costs of urinary incontinence among women electing surgery to treat stress incontinence</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2008</YR>
<VL>111</VL>
<NO>4</NO>
<PG>899-907</PG>
<IDENTIFIERS MODIFIED="2017-06-01 12:25:42 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-01 12:25:42 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1097/AOG.0b013e31816a1e12"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Svenningsen-2013a" MODIFIED="2015-06-09 10:31:33 +0100" MODIFIED_BY="[Empty name]" NAME="Svenningsen 2013a" TYPE="OTHER">
<AU>Svenningsen R, Staff AC, Schiotz HA, Western K, Sandvik L, Kulseng-Hanssen S</AU>
<TI>Risk factors for long-term failure of the retropubic tension-free vaginal tape procedure</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2014</YR>
<VL>33</VL>
<NO>7</NO>
<PG>1140-6</PG>
<IDENTIFIERS MODIFIED="2014-07-03 10:31:35 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 10:31:35 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/nau.22466"/><IDENTIFIER MODIFIED="2014-07-03 10:29:18 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23946255"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Svenningsen-2013b" MODIFIED="2015-06-08 15:57:26 +0100" MODIFIED_BY="[Empty name]" NAME="Svenningsen 2013b" TYPE="JOURNAL_ARTICLE">
<AU>Svenningsen R, Staff AC, Schiotz HA, Western K, Kulseng-Hanssen S</AU>
<TI>Long-term follow-up of the retropubic tension-free vaginal tape procedure</TI>
<SO>International Urogynecology Journal</SO>
<YR>2013</YR>
<VL>24</VL>
<NO>8</NO>
<PG>1271-8</PG>
<IDENTIFIERS MODIFIED="2014-06-23 19:30:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="23417313"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tamussino-2001" MODIFIED="2015-06-09 08:53:29 +0100" MODIFIED_BY="[Empty name]" NAME="Tamussino 2001" TYPE="JOURNAL_ARTICLE">
<AU>Tamussino KF, Engelbert H, Kolle D, Ralph G, Riss PA</AU>
<TI>Tension-free vaginal tape operation: results of the Austrian registry</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2001</YR>
<VL>98</VL>
<NO>5 (Pt 1)</NO>
<PG>732-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tamussino-2007" MODIFIED="2015-06-08 15:57:41 +0100" MODIFIED_BY="[Empty name]" NAME="Tamussino 2007" TYPE="JOURNAL_ARTICLE">
<AU>Tamussino K, Hanzal E, Koelle D, Tammaa A, Preyer O, Umek W, et al</AU>
<TI>Transobturator tapes for stress urinary incontinence: results of the Austrian registry</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2007</YR>
<VL>197</VL>
<NO>6</NO>
<PG>634-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Thom-1998" MODIFIED="2014-05-10 11:50:57 +0100" MODIFIED_BY="[Empty name]" NAME="Thom 1998" TYPE="JOURNAL_ARTICLE">
<AU>Thom DH, Brown JS</AU>
<TI>Reproductive and hormonal risk factors for urinary incontinence in later life: a review of the clinical and epidemiologic literature</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>1998</YR>
<VL>46</VL>
<NO>11</NO>
<PG>1411-7</PG>
<IDENTIFIERS MODIFIED="2014-05-10 11:50:54 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="9809764"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Tincello-2011" MODIFIED="2015-06-08 15:57:48 +0100" MODIFIED_BY="[Empty name]" NAME="Tincello 2011" TYPE="JOURNAL_ARTICLE">
<AU>Tincello DG, Botha T, Grier D, Jones P, Subramanian D, Urquhart C, et al</AU>
<TI>The TVT Worldwide Observational Registry for Long-Term Data: safety and efficacy of suburethral sling insertion approaches for stress urinary incontinence in women</TI>
<SO>The Journal of Urology</SO>
<YR>2011</YR>
<VL>186</VL>
<NO>6</NO>
<PG>2310-5</PG>
<IDENTIFIERS MODIFIED="2014-07-10 14:15:45 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="22014817"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Turner-2004" MODIFIED="2009-08-10 14:21:55 +0100" MODIFIED_BY="[Empty name]" NAME="Turner 2004" TYPE="JOURNAL_ARTICLE">
<AU>Turner DA, Shaw C, McGrother CW, Dallosso HM, Cooper NJ</AU>
<TI>The cost of clinically significant urinary storage symptoms for community dwelling adults in the UK</TI>
<SO>BJU International</SO>
<YR>2004</YR>
<VL>93</VL>
<NO>9</NO>
<PG>1246-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ulmsten-1995a" MODIFIED="2015-06-02 11:49:38 +0100" MODIFIED_BY="[Empty name]" NAME="Ulmsten 1995a" TYPE="JOURNAL_ARTICLE">
<AU>Ulmsten U</AU>
<TI>Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence</TI>
<SO>Scandinavian Journal of Urology and Nephrology</SO>
<YR>1995</YR>
<VL>29</VL>
<NO>1</NO>
<PG>75-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ulmsten-1995b" MODIFIED="2015-06-08 15:57:55 +0100" MODIFIED_BY="[Empty name]" NAME="Ulmsten 1995b" TYPE="JOURNAL_ARTICLE">
<AU>Ulmsten U, Petros P</AU>
<TI>Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence</TI>
<SO>Scandinavian Journal of Urology and Nephrology</SO>
<YR>1995</YR>
<VL>29</VL>
<NO>1</NO>
<PG>75-82</PG>
<IDENTIFIERS MODIFIED="2014-05-10 14:06:56 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="7618052"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ulmsten-1996" MODIFIED="2009-08-10 14:29:49 +0100" MODIFIED_BY="[Empty name]" NAME="Ulmsten 1996" TYPE="JOURNAL_ARTICLE">
<AU>Ulmsten U, Henriksson L, Johnson P, Varhos G</AU>
<TI>An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence</TI>
<SO>International Urogynecology Journal including Pelvic Floor Dysfunction</SO>
<YR>1996</YR>
<VL>7</VL>
<NO>2</NO>
<PG>81-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Van-Oyen-2002" MODIFIED="2015-06-08 15:58:03 +0100" MODIFIED_BY="[Empty name]" NAME="Van Oyen 2002" TYPE="JOURNAL_ARTICLE">
<AU>Van Oyen H, Van Oyen P</AU>
<TI>Urinary incontinence in Belgium; prevalence, correlates and psychosocial consequences</TI>
<SO>Acta Clinica Belgica</SO>
<YR>2002</YR>
<VL>57</VL>
<NO>4</NO>
<PG>207-18</PG>
<IDENTIFIERS MODIFIED="2014-05-10 11:54:48 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="12462797"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wagner-1998" MODIFIED="2017-07-24 17:26:05 +0100" MODIFIED_BY="[Empty name]" NAME="Wagner 1998" TYPE="JOURNAL_ARTICLE">
<AU>Wagner T, Hu T</AU>
<TI>Economic costs of urinary incontinence in 1995</TI>
<SO>Urology</SO>
<YR>1998</YR>
<VL>51</VL>
<NO>3</NO>
<PG>355-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wallace-2004" MODIFIED="2014-07-03 10:34:22 +0100" MODIFIED_BY="[Empty name]" NAME="Wallace 2004" TYPE="COCHRANE_REVIEW">
<AU>Wallace SA, Roe B, Williams K, Palmer M</AU>
<TI>Bladder training for urinary incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2014-07-03 10:34:22 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2014-07-03 10:34:22 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001308.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wang-2013" MODIFIED="2015-06-09 10:48:34 +0100" MODIFIED_BY="[Empty name]" NAME="Wang 2013" TYPE="COCHRANE_REVIEW">
<AU>Wang Y, Zhishun L, Peng W, Zhao J, Liu B</AU>
<TI>Acupuncture for stress urinary incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>7</NO>
<IDENTIFIERS MODIFIED="2015-06-09 10:48:34 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-06-09 10:48:34 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD009408.pub2"/><IDENTIFIER TYPE="PUBMED" VALUE="23818069"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ward-2008" MODIFIED="2015-01-25 23:28:23 +0000" MODIFIED_BY="[Empty name]" NAME="Ward 2008" TYPE="JOURNAL_ARTICLE">
<AU>Ward KL, Hilton P</AU>
<TI>Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up</TI>
<SO>BJOG : an international journal of obstetrics and gynaecology</SO>
<YR>2008</YR>
<VL>115</VL>
<NO>2</NO>
<PG>226-33</PG>
<IDENTIFIERS MODIFIED="2015-01-25 23:28:18 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="17970791"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ware-1993" MODIFIED="2009-05-13 12:27:05 +0100" MODIFIED_BY="[Empty name]" NAME="Ware 1993" TYPE="BOOK">
<AU>Ware JE, Snow KK, Kosinski M, Gandek B</AU>
<SO>SF-36 Health survey manual and interpretation guide</SO>
<YR>1993</YR>
<PB>The Health Institute, New England Medical Centre</PB>
<CY>Boston (MA)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wetle-1995" MODIFIED="2014-05-10 11:51:19 +0100" MODIFIED_BY="[Empty name]" NAME="Wetle 1995" TYPE="JOURNAL_ARTICLE">
<AU>Wetle T, Scherr P, Branch LG, Resnick NM, Harris T, Evans D, et al</AU>
<TI>Difficulty with holding urine among older persons in a geographically defined community: prevalence and correlates</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>1995</YR>
<VL>43</VL>
<NO>4</NO>
<PG>349-55</PG>
<IDENTIFIERS MODIFIED="2014-05-10 11:51:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER TYPE="PUBMED" VALUE="7706622"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wilson-1996" MODIFIED="2009-08-10 14:32:37 +0100" MODIFIED_BY="[Empty name]" NAME="Wilson 1996" TYPE="JOURNAL_ARTICLE">
<AU>Wilson PD, Herbison RM, Herbison GP</AU>
<TI>Obstetric practice and the prevalence of urinary incontinence three months after delivery</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1996</YR>
<VL>103</VL>
<NO>2</NO>
<PG>154-61</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2017-06-01 11:44:01 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Ogah-2009" MODIFIED="2014-07-03 10:38:17 +0100" MODIFIED_BY="[Empty name]" NAME="Ogah 2009" TYPE="COCHRANE_REVIEW">
<AU>Ogah J, Cody JD, Rogerson L</AU>
<TI>Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>4</NO>
<PG>CD006375</PG>
<IDENTIFIERS><IDENTIFIER TYPE="DOI" VALUE="10.1002/14651858.CD006375.pub2"/><IDENTIFIER TYPE="PUBMED" VALUE="19821363"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2014-07-04 10:39:00 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2015-06-21 18:17:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abdel_x002d_Fattah-2010">
<CHAR_METHODS MODIFIED="2015-06-01 12:51:41 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT-O vs TOT&#8211;ARIS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-20 14:53:06 +0100" MODIFIED_BY="[Empty name]">
<P>341 women from the west of Scotland, UK, Urogynaecology tertiary referral centre</P>
<P>Inclusion criteria: women with USI or MUI (but with SUI as the predominant troublesome symptom). Women with previous incontinence surgery were included. All women had failed or declined pelvic floor muscle training</P>
<P>Exclusion criteria: predominant OAB symptoms; or had specific co-morbidities such as known neurological conditions (e.g. multiple sclerosis); diabetes; &#8805; stage 2 POP-Q or concomitant surgery, or both</P>
<P>There were no significant differences in participant characteristics between the 2 groups</P>
<P>Mean age (years): Group A: 51.5; Group B: 52.1</P>
<P>Mean BMI kg/m: Group A: 28.1; Group B: 28.9</P>
<P>MUI: Group A: 40/170; Group B: 43/171</P>
<P>Previous incontinence surgery: Group A: 28/170; Group B: 18/171</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-01 12:51:41 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 170)</P>
<P>Group B: TOT (n = 171)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 18:17:01 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: absence of USI on UDS</P>
<P>Secondary outcome measures:</P>
<UL>
<LI>patient-reported success rates on the PGI-I</LI>
<LI>objective cure (ICS 1-hr pad test)</LI>
<LI>subjective success on PGI-I</LI>
<LI>bladder/urethral perforation</LI>
<LI>voiding dysfunction</LI>
<LI>tape erosion</LI>
<LI>groin pain</LI>
<LI>repeat continence surgery</LI>
<LI>QoL assessed via: KHQ, Birmingham Bowel Urinary Symptom (BBUSQ-22)and PISQ-12. In addition PGI-I and ICIQ-SF questionnaires.</LI>
<LI>sexual dysfunction: PISQ-12 employed</LI>
<LI>intermediate (3 year) subjective success on PGI-I</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-01 12:51:41 +0100" MODIFIED_BY="[Empty name]">
<P>Loss to follow up at 1 year: Group A: 18/170, Group B: 24/171</P>
<P>Loss to follow up at 3 years: Group A: 44/170, Group B: 59/171</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 15:15:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aigmuller-2014">
<CHAR_METHODS MODIFIED="2015-06-05 13:21:34 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of Gynecare TVT vs Gynecare TVT-O; Gynecare, Ethicon</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 13:21:34 +0100" MODIFIED_BY="[Empty name]">
<P>Trial conducted by Austrian Urogynecology Working Group in 25 gynaecology units in Austria and Germany</P>
<P>554 women</P>
<P>Inclusion criteria: women with USI (positive cough stress test at bladder filling of 300 ml); no concomitant prolapse surgery or hysterectomy</P>
<P>Exclusion criteria: DO or a predominant complaint of OAB; concomitant prolapse surgery; other major concomitant surgery (e.g. hysterectomy); previous incontinence surgery other than colporrhaphy; residual urine &#8805;100 ml; neurologic disease; allergy to local anaesthetic agents; and coagulation disorders or other contraindications for surgery</P>
<P>Age (years): Group A: 59.7  11.3; Group B: 58.6  10.7</P>
<P>BMI kg/m: Group A: 27.7  5.3; Group B: 28.5  4.9</P>
<P>Parity: Group A: 2.2  1.2; Group B: 2.2  1.3</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:21:40 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT: (n = 285; 38 of whom were lost to follow-up)</P>
<P>Group B: TVT-O: (n = 269; 36 of whom were lost to follow-up)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 15:15:20 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were evaluated at 3 months, with a further evaluation scheduled at 5 years</P>
<UL>
<LI>Objective cure of SUI: defined as a negative cough stress test and stable cystometry to 300 ml</LI>
<LI>Subjective cure defined on PGI as 'very much better' and 'better'</LI>
<LI>Objective cure</LI>
<LI>Subjective cure </LI>
<LI>Subjective cure and improvement</LI>
<LI>Operating time </LI>
<LI>Bladder perforation</LI>
<LI>Vascular injury</LI>
<LI>Voiding dysfunction</LI>
<LI>Major visceral injury</LI>
<LI>Infection</LI>
<LI>De novo OAB</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-20 15:13:27 +0100" MODIFIED_BY="[Empty name]">
<P>QoL: Short-Form Health Survey (SF-12), EuroQol-5D (EQ-5D) condition-specific QoL was assessed with the German language version of the KHQ, the Incontinence Outcome Questionnaire (IOQ), and PGI-S and PGI-I</P>
<P>Cystoscopy was performed with all retropubic placements but not routinely with transobturator insertions</P>
<P>The number of women in each group seen at 5-year follow-up was not available, so the data reported could not be used for meta-analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 15:18:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alkady-2009">
<CHAR_METHODS MODIFIED="2014-01-24 17:57:37 +0000" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-20 13:58:29 +0100" MODIFIED_BY="[Empty name]">
<P>30 women with SUI in Kuwait Maternity Hospital</P>
<P>Inclusion criteria: SUI with or without a prolapse; USI with or without urethral hypermobility; MUI without urodynamic DO; absence of a contractile urinary bladder or obstruction</P>
<P>Exclusion criteria: acute cystitis; predominant urge incontinence; urodynamic DO;</P>
<P>maximum flow (Qmax) less than 15 ml/s and/or PVR urine of more than 20% of the volume voided; genital prolapse of stage 4 or 5</P>
<P>Menopausal: Group A: 3/15; Group B: 4/15</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:23:02 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 15)</P>
<P>Group B: TVT-O (n = 15)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 15:18:17 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objectively cure: absence of SUI and a negative stress test</LI>
<LI>Objective improvement: lower volume and frequency of SUI, but positive stress test</LI>
<LI>Objectively cure</LI>
<LI>Objective cure &amp; improvement</LI>
<LI>Mean blood loss</LI>
<LI>Mean hospital stay</LI>
<LI>Bladder perforation</LI>
<LI>Major vascular injury</LI>
<LI>Voiding dysfunction</LI>
<LI>Tape erosion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 13:23:13 +0100" MODIFIED_BY="[Empty name]">
<P>No participants lost to follow-up at 6 and 12 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 15:19:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Andonian-2005">
<CHAR_METHODS MODIFIED="2015-06-05 13:25:03 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT with SPARC</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 13:24:23 +0100" MODIFIED_BY="[Empty name]">
<P>84 women presenting with SUI, or SUI with MUI if cystometrogram showed normal capacity, compliance and no uninhibited contractions. Women with previous failed anti-incontinence surgeries or bulking agents treatments were also eligible for the study. Both groups were similar in terms of age, severity of symptoms, 1-h pad test and preoperative IIQ (of Shumaker)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:24:50 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: SPARC (n = 41)</P>
<P>Group B: TVT (n = 43)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 15:19:42 +0100" MODIFIED_BY="[Empty name]">
<P>Primary endpoint: objective cure defined as 1-h pad test of 2g<BR/>Secondary endpoint: QoL assessed through Shumaker's IIQ, a score of &lt;50 represented good QoL, 50-70 moderate QoL, and &gt;70 poor QoL</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 13:24:55 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up assessment of cure at 1 year was unavailable in 1 woman (Group B) who died from a myocardial infarct</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:43:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Andonian-2007">
<CHAR_METHODS MODIFIED="2015-06-05 13:36:43 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TOT (Obtape) versus <B>d</B>istal <B>u</B>rethral <B>p</B>olypropylene <B>s</B>ling (DUPS) versus TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 13:36:44 +0100" MODIFIED_BY="[Empty name]">
<P>190 women</P>
<P>Inclusion criteria: women with SUI with or without POP or pelvic surgery; previous failed anti-incontinence surgeries or bulking agent treatments permitted; women with MUI were not excluded as long as their cystometrogram showed normal capacity; compliance and no uninhibited contractions</P>
<P>Exclusion criteria: obstruction; unstable bladder function, or neurogenic bladder; UTI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:36:49 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: Obtape (n = 78)</P>
<P>Group B: DUPS (n = 32)</P>
<P>Group C: TVT (n = 80)</P>
<P>1 participant in the Obtape group had a urethral diverticulum, which was repaired, but the Obtape procedure was cancelled, leaving 77 patients in the Obtape group for the final analysis</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-05 13:53:56 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: objective cure defined by 1-h pad test of &#8804; 2 g</P>
<P>Secondary outcome: subjective cure rates determined by the ICIQ-SF</P>
<P>Postoperatively, all women were re-evaluated by history and physical examination at 1, 6, and 12 months. At the 12-month visit, participants completed the ICIQ-SF, and underwent the 1-h pad test conducted by the dedicated UDS nurse who was blinded to the procedure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-21 15:43:48 +0100" MODIFIED_BY="[Empty name]">
<P>Mentor's Obtape is a non woven monofilament thermally bonded micropore (50 m) polypropylene mesh which was withdrawn by its manufacturers in 2006. There have been many reports of tape erosions and some cases of ischiorectal abscess and necrotizing fasciitis</P>
<P>DUPS is not a minimally invasive sling, but a woven polypropylene mesh (by Ethicon, New Jersey). Absorbable sutures are used to fix the sling into position until adhesions form and adhere it naturally to the retropubic space. As it was not a minimally invasive sling there was no need to compare DUPS in the review</P>
<P>The DUPS procedure was discontinued because of a higher postoperative retention rate combined with several complaints of suprapubic abdominal discomfort on straining</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:43:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aniuliene-2009">
<CHAR_METHODS MODIFIED="2015-05-26 15:47:27 +0100" MODIFIED_BY="[Empty name]">
<P>A prospective RCT of TVT-O vs TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 15:43:58 +0100" MODIFIED_BY="[Empty name]">
<P>264 women with SUI in Lithuania hospital setting. The degree of incontinence was 2&#8211;3 according to the Ingelman-Sundberg scale</P>
<P>Inclusion criteria: women with SUI</P>
<P>Exclusion criteria: urogenitale prolapse greater than stage 2; urinary retention; OAB and psychiatric problems</P>
<P>Post menopausal: Group A: 47/150; Group B: 48/114</P>
<P>Mean BMI kg/m (SD): Group A: 28.2 (3.8); Group B: 27.9 (4.0)</P>
<P>Previous incontinence surgery: Group A: 18/150; Group B: 16/114</P>
<P>POP-Q stage 2: Group A: 29/150; Group B: 22/114</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:38:26 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 150)</P>
<P>Group B: TVT (n = 114)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 15:52:41 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: negative stress provocation test with 300 ml of urine in the bladder</LI>
<LI>Subjective cure: self-reported absence of SUI with or without mild urgency incontinence.</LI>
<LI>Mean duration of procedure </LI>
<LI>Mean hospital stay days </LI>
<LI>Bladder perforation</LI>
<LI>Post operative urinary retention</LI>
<LI>Haematoma</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 13:38:38 +0100" MODIFIED_BY="[Empty name]">
<P>Urodynamics assessment was not performed in all participants</P>
<P>Cystoscopy and cough test were routinely performed only in the TVT group</P>
<P>No patients were lost to follow-up</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 15:59:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Araco-2008">
<CHAR_METHODS MODIFIED="2015-06-05 13:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT-O versus TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 13:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>240 women with different degrees of SUI</P>
<P>Inclusion criteria: symptomatic SUI grades 1 and 2a (McGuire classification)</P>
<P>Exclusion criteria: women with ISD; OAB; associated prolapses; neurovegetative disorders and recurrent SUI or under rehabilitative/medical therapies</P>
<P>Diagnosis based on ambulatory UDS</P>
<P>Average age of 54 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:39:14 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 120)<BR/>Group B: TVT (n = 120)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 15:59:25 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: cure rate of SUI evaluated with the postoperative ambulatory urodynamic tests 1 year after surgery<BR/>Secondary outcomes:</P>
<UL>
<LI>operating times</LI>
<LI>length of hospitalisation</LI>
<LI>number of catheterization days</LI>
<LI>postoperative pain</LI>
<LI>other complications (haematomas, bladder obstructions/perforations, vaginal perforations)</LI>
<LI>number of additional operations required</LI>
</UL>
<P>A positive pad weight result was defined as &gt; 2g of leakage</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 13:39:45 +0100" MODIFIED_BY="[Empty name]">
<P>The participants were classified according to the SUI system on the basis of urodynamics studies (McGuire classification), performed at 250 ml bladder volume. SUI was classified into 3 grades considering the severity of symptoms referred (SUI1 = loss of urine during excessive strains, SUI2 = during minor strains, SUI3 = at rest) and the urodynamic evaluation (McGuire classification: SUI1 = abdominal leak-point pressure (ALPP) &gt; 90 cm water, SUI2 = ALPP of 60-90 cm water, SUI 3 = intrinsic sphincter deficiency and ALPP &lt; 60 cm water)<BR/>Cystoscopy was performed in all cases</P>
<P>Loss to follow-up: 32 women were lost to follow-up due to work commitments, Group A:12/120 TVT, Group B: 20/120</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 15:56:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barber-2008">
<CHAR_METHODS MODIFIED="2015-06-05 13:40:01 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs Monarc TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 13:40:01 +0100" MODIFIED_BY="[Empty name]">
<P>Setting: 3 USA tertiary academic medical centres</P>
<P>Inclusion criteria: 170 women aged over 21 years with USI with or without concurrent POP</P>
<P>Exlusion criteria: DO; previous incontinence surgery; PVR &gt; 100 ml; desiring future childbearing; history of hidradenitis suppurativa, inguinal lymphadenopathy, or an inguinal or vulvar mass; history of a bleeding diathesis or ongoing anticoagulation therapy; current genitourinary fistula or urethral diverticulum</P>
<P>Mean age in years (SD): Group A: 52 (11); Group B: 53 (12)</P>
<P>Mean BMI kg/m (SD): Group A: 30 (7); Group B: 29 (6)</P>
<P>Postmenopausal: Group A: 53/88; Group B: 58/82</P>
<P>Previous continence surgery: Group A: 5/88; Group B: 10/82</P>
<P>MUI: Group A: 76/88; Group B: 66/82</P>
<P>VLPP: &lt; 60 cm/H<SUB>2</SUB>O: Group A: 14/88; Group B: 16/82</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:40:30 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 88)</P>
<P>Group B: TOT (n = 82)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 15:56:40 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: presence or absence of 'abnormal bladder function', a composite outcome defined as the presence of any the following: incontinence symptoms - any type (ISI &gt; 0), a positive cough-stress test, re-treatment for SUI or postoperative urinary retention assessed 1-year after surgery</P>
<P>Secondary outcomes: assessed by use of SF12, PISQ-12, bladder diary at 12 and 24 months:</P>
<UL>
<LI>subjective cure (self-reported)</LI>
<LI>objective cure (negative cough stress test)</LI>
<LI>mean operating time</LI>
<LI>bladder perforation</LI>
<LI>major vascular injury</LI>
<LI>tape erosion</LI>
<LI>de novo urgency/UUI</LI>
<LI>voiding dysfunction</LI>
<LI>re-operation</LI>
<LI>QoL: overall improvement in QoL and sexual function scores at follow-up assessments compared with preoperative baseline scores. No difference between the groups. Used PFDI-20, PFIQ-7, PISQ-12</LI>
<LI>sexual dysfunction assessed using PISQ-12. Scores improved post operatively and at 12 months follow up in both groups, though the relative change in scores post-operatively was small (1.9%) showing moderate responsiveness to incontinence specific outcome measures. There was no significant difference reported between the two groups.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 13:40:18 +0100" MODIFIED_BY="[Empty name]">
<P>Intraoperative cystoscopy performed in both groups</P>
<P>Concomitant surgery performed in Group A: 48/88; Group B: 45/82</P>
<P>Loss to follow-up: Group A: 3/88; Group B: 7/82</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-05 14:26:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barry-2008">
<CHAR_METHODS MODIFIED="2015-06-05 13:41:04 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TOT (Monarc) versus TVT</P>
<P>Random allocation of participants but method of sequence generation and allocation concealment not described</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 13:41:04 +0100" MODIFIED_BY="[Empty name]">
<P>140 women diagnosed with USI</P>
<P>Participants in both groups had similar background characteristics including age, BMI, parity, HRT use, menopausal status, previous incontinence surgery, prolapse etc</P>
<P>Inclusion criteria: participants had either failed conservative management for symptomatic stress incontinence or required prophylactic incontinence surgery during prolapse repair for occult stress incontinence (no preoperative subjective complaint of urinary stress leakage but found to have USI)</P>
<P>Exclusion criteria: significant voiding dysfunction (maximum urine flow rate &lt; 10th percentile according to Liverpool nomogram and PVR volume &gt; 50 ml); known allergy to polypropylene; immunosuppressant therapy and a past history of neurological disease; urogenital malignancy; fistula or pelvic radiotherapy</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:41:04 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT (n = 58)<BR/>Group B: TVT (n = 82)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-05 14:26:34 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes included Immediate- and short-term complications, cure rates and patient satisfaction</P>
<P>Primary outcome: reduction in incidence of bladder injury</P>
<P>Secondary outcomes:</P>
<UL>
<LI>other intra-operative complications</LI>
<LI>improvement of symptomatology</LI>
<LI>incontinence impact</LI>
<LI>improvement in incontinence episodes and pad usage</LI>
<LI>objective improvement on UDS: defined as no visible leakage on coughing at the external urethral meatus</LI>
<LI>postoperative complications, such as sling erosion; </LI>
<LI>blood loss: surgeon's subjective estimate of blood volume lost</LI>
<LI>sexual dysfunction via the BFLUTS questionnaire</LI>
</UL>
<P>Improvement of a particular symptom denoted at least 50% reduction in frequency of occurrence in 3-day bladder diary when compared to preoperative state</P>
<P>Measures used for assessment included:</P>
<UL>
<LI>symptomatology (using standardised, validated BFLUTS)</LI>
<LI>incontinence impact (using standardised, validated short IIQ-7)</LI>
<LI>3-day bladder diary findings and pad usage</LI>
<LI>clinical examination findings (POP-Q ICS)</LI>
<LI>UDS findings</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 13:41:48 +0100" MODIFIED_BY="[Empty name]">
<P>23 women from the TVT group and 21 from TOT group were lost to follow-up. Thus, at follow-up complete data set available for 82 women in TVT group and 58 in the TOT group. There were no differences between the group unavailable for analysis when compared to those finally analysed</P>
<P>No mention of intraoperative cystoscopy in either group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 16:22:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-But-2008">
<CHAR_METHODS MODIFIED="2013-12-06 19:06:41 +0000" MODIFIED_BY="[Empty name]">
<P>RCT of TVT-O versus TOT (Monarc)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 13:43:05 +0100" MODIFIED_BY="[Empty name]">
<P>120 women with SUI (31) and MUI (89)</P>
<P>Inclusion criteria: women with SUI, or MUI, with SUI as the predominant symptom</P>
<P>Exclusion criteria: MUI with predominant UUI</P>
<P>Performed under local anaesthesia</P>
<P>Mean age years (SD): 52.6 (6.8)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:43:05 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 60)</P>
<P>Group B: TOT (n = 60)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 16:22:15 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure rates: negative pad test</LI>
<LI>Subjective cure rates: absence of reported SUI</LI>
<LI>Post operative voiding difficulties</LI>
<LI>Tape erosion</LI>
<LI>Duration of operation</LI>
<LI>Duration and intensity of postoperative pain according to a modified VAS</LI>
<LI>QoL (UDI) significantly improved post operatively in each group with no significant intergroup difference.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 13:42:44 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up 3 months</P>
<P>All women attended for follow-up</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-05 14:05:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cervigni-2006">
<CHAR_METHODS MODIFIED="2015-06-05 14:02:00 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT versus Monarc TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:02:11 +0100" MODIFIED_BY="[Empty name]">
<P>118 women</P>
<P>Inclusion criteria: women with SUI and POP-Q &#8805; stage 2</P>
<P>Mean age 57.43 years</P>
<P>All women had cystocoele repair and levator myorraphy</P>
<P>73 women were post menopausal</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 14:02:14 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT</P>
<P>Group B: TOT</P>
<P>(exact numbers in each group not reported)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-05 14:05:07 +0100" MODIFIED_BY="[Empty name]">
<P>Cure rates: TVT (98.3%), TOT (97.1%) as exact number of women in each group was not given there were no data that could be extracted</P>
<P>Intraoperative and postoperative complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:05:08 +0100" MODIFIED_BY="[Empty name]">
<P>Numbers in each group unreported. It was, thus, impossible to abstract results</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 16:24:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2010">
<CHAR_METHODS MODIFIED="2015-06-05 14:06:02 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT, TOT and TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:06:08 +0100" MODIFIED_BY="[Empty name]">
<P>187 women</P>
<P>Inclusion criteria: women with urodynamically proven SUI in the urology department of a Chinese hospital</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 14:06:20 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 77)</P>
<P>Group B: TOT (n = 45)</P>
<P>Group C: TVT-O (n = 65)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 16:24:55 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: negative stress test </LI>
<LI>Mean operative time in minutes </LI>
<LI>Mean postoperative hospital stay days (SD)</LI>
<LI>Bladder perforation</LI>
<LI>Vascular injury</LI>
<LI>Voiding dysfunction</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:06:41 +0100" MODIFIED_BY="[Empty name]">
<P>No quality of life measures undertaken</P>
<P>Cystoscopy performed in TVT group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 16:27:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2012">
<CHAR_METHODS MODIFIED="2015-06-05 14:07:19 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TVT-O</P>
<P>Recruitment Feb 2009-Feb 2010</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:07:22 +0100" MODIFIED_BY="[Empty name]">
<P>205 women with SUI</P>
<P>Inclusion criteria: women with urodynamically proven SUI with or without prolapse</P>
<P>Exclusion criteria: DO; MUI</P>
<P>All women had similar background characteristics</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 14:07:26 +0100" MODIFIED_BY="[Empty name]">
<P>A: TVT (n = 102)</P>
<P>B: TVT-O (n = 103)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 16:27:37 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up 12-24 months</P>
<UL>
<LI>Objective cure: negative pad test and stress test</LI>
<LI>Objective cure</LI>
<LI>Cure and improvement</LI>
<LI>Operative time</LI>
<LI>Blood loss (ml)</LI>
<LI>Length of stay (days)</LI>
<LI>QoL via questionnaires</LI>
<LI>Adverse effects:</LI>
<UL>
<LI>Bladder injury</LI>
<LI>Voiding dysfunction</LI>
<LI>Groin pain</LI>
</UL>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:09:28 +0100" MODIFIED_BY="[Empty name]">
<P>Needs translation for further information</P>
<P>Article written in Chinese and translated to English for interpretation and extraction</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-01 14:51:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cho-2010">
<CHAR_METHODS MODIFIED="2015-06-01 14:51:17 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of Monarc system and TOT system</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-01 14:51:17 +0100" MODIFIED_BY="[Empty name]">
<P>93 women having urodynamic evaluation</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-01 14:51:17 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: Monarc TOT (n = 48)</P>
<P>Group B: TOT (n = 45)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-01 14:51:17 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes assessed 12 months postoperatively</P>
<UL>
<LI>Subjective cure</LI>
<LI>Voiding dysfunction</LI>
<LI>Tape erosion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-01 14:51:17 +0100" MODIFIED_BY="[Empty name]">
<P>Monarc is outside-to-in TOT with open edge polypropylene mesh that contains an absorbable tensioning suture threaded into the length of the mesh. The tension free obturator tape (TOT) system used here is the same outside-in type, but has a closed edge polypropylene mesh without absorbable tensioning suture</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:44:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Choe-2013">
<CHAR_METHODS MODIFIED="2015-05-26 15:16:39 +0100" MODIFIED_BY="[Empty name]">
<P>RCT OF TVT vs TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-01 14:52:18 +0100" MODIFIED_BY="[Empty name]">
<P>41 women</P>
<P>Inclusion criteria: women with SUI; able to complete a questionnaire</P>
<P>Exclusion criteria: prior spine surgery; back pain; scoliosis; traumatic spine injury; neurological disease; or hip or knee surgery</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-01 14:52:18 +0100" MODIFIED_BY="[Empty name]">
<P>41 women, number in each group was not given</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 15:44:52 +0100" MODIFIED_BY="[Empty name]">
<P>Postoperative pain was assessed using a 10-point visual analogue scale (VAS) at fixed time-points: 30 minutes, 3hr and 24hr after surgery</P>
<P>Length of procedure (minutes)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-01 14:52:18 +0100" MODIFIED_BY="[Empty name]">
<P>We were not able to use the data provided, as the number in each group was not specified</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:45:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Darabi-Mahboub-2012">
<CHAR_METHODS MODIFIED="2015-06-05 14:10:51 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TOT versus TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 15:45:13 +0100" MODIFIED_BY="[Empty name]">
<P>Women with SUI</P>
<P>Age in years (SD): Group A: 52.02 (0.88); Group B: 52.27 (7.34)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 14:11:04 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT (n = 40)</P>
<P>Group B: TVT (n = 40)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 16:31:41 +0100" MODIFIED_BY="[Empty name]">
<P>A validated stress and urge incontinence questionnaire</P>
<P>24-h pad test</P>
<P>6-month follow-up of ICIQ</P>
<P>Operative time</P>
<P>Mean hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:12:03 +0100" MODIFIED_BY="[Empty name]">
<P>Intraoperative cystoscopy not mentioned in either group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 16:34:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-David_x002d_Montefiore-2006">
<CHAR_METHODS MODIFIED="2015-06-05 14:13:12 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TOR and RTR of sling procedures for SUI using the I-STOP device</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:14:21 +0100" MODIFIED_BY="[Empty name]">
<P>Multicentre (3 gynaecology and 2 urology departments in France)</P>
<P>88 women</P>
<P>Inclusion criteria: women &gt; 18 years with SUI, proven by clinical and urodynamic examinations, or MUI</P>
<P>Exclusion criteria: women with previous history of radio- or chemotherapy; on anticoagulant or antipsychotic treatment; or pregnant </P>
<P>Mean age: Group A: 58.8 years; Group B: 53.4 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 14:14:25 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: RPR (n = 42)</P>
<P>Group B: TOR (n = 46)</P>
<P>The I-STOP device (CL Medical, Lyon, France) was used for both the RPR and the TOR procedures</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 16:34:49 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure (success or improved):</LI>
<UL>
<LI>participants considered cured (success) if they had no stress incontinence by clinical and urodynamic examinations, no incontinence during the stress provocation test, and no urinary retention or a residual urine volume of &lt; 150 ml</LI>
<LI>participants were considered cured (improved) if no incontinence occurred during stress provocation test. All other cases were considered failures</LI>
</UL>
<LI>QoL via validated questionnaires: UDI, IIQ at first postoperative visit (4-6 weeks after surgery), and 3, 6, 12, and 24 months postoperatively. Quality of life as measured by UDI and IIQ questionnaires showed significant improvement following both RPR and TOR tape insertion at 1 year. At 4 yr review, there was a reduction in the initial improvement in quality of life.</LI>
<LI>Reported results for within 1 year, though follow-up was at 1, 3, 6 and 12 months and 4 years</LI>
</UL>
<UL>
<LI>De novo urgency and urge incontinence</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>Loss to follow-up at 4 years: Group A: 8/42; Group B: 9/46</P>
<P>Length of follow-up ranged from 48 months to 61 months (RPR) and 48 months to 63 months (TOR)</P>
<P>The mean follow-up was 10 months, with 37 women having 6 months of follow-up and 51 women having at least 12 months of follow-up</P>
<P>Cystoscopy was performed for both procedures</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 16:37:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Leval-2011">
<CHAR_METHODS MODIFIED="2015-06-05 14:28:53 +0100" MODIFIED_BY="[Empty name]">
<P>QRCT of TVT-O vs modified TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:28:53 +0100" MODIFIED_BY="[Empty name]">
<P>175 women</P>
<P>Inclusion criteria: women aged 25-85 years with USI;</P>
<P>positive stress test with at least a maximum cystometric capacity of 300 ml</P>
<P>Exclusion criteria: DO or detrusor acontractility; neurogenic bladder; or POP stage 3 or above</P>
<P>Mean age years (SD): Group A: 60.0 (11.7); Group B: 57.2 (2.7)</P>
<P>BMI kg/m (SD): Group A: 26.4 (4.8) Group B: 26.8 (5.3)</P>
<P>Previous surgery for SUI: Group A: 4/87; B Group: 4/88</P>
<P>Previous surgery for POP: Group A: 4/87; Group B: 2/88</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 14:28:58 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 87)</P>
<P>Group B: modified TVT-O (n = 88)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 16:37:52 +0100" MODIFIED_BY="[Empty name]">
<P>At 1 -year follow-up:</P>
<UL>
<LI>objective cure: negative cough test</LI>
<LI>subjective cure: disappearance of SUI using symptom scoring system</LI>
<LI>subjective cure and improvement:</LI>
<LI>Intraoperative complications</LI>
<LI>de novo urgency</LI>
<LI>mesh erosion</LI>
<LI>groin pain</LI>
</UL>
<P>At 3-year follow-up:</P>
<UL>
<LI>objective cure: negative cough test</LI>
<LI>subjective cure</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:30:49 +0100" MODIFIED_BY="[Empty name]">
<P>The modified TVT-O was shortened to a total tape length of 12 cm and had a reduction in the depth of lateral dissection, the obturator membrane was not perforated with the scissors or the guide</P>
<P>Follow-up assessments carried out at 1, 6, 12 months, and 3 years</P>
<P>Lost to follow-up:</P>
<UL>
<LI>at 1 year: Group A: 3/87; Group B: 2/88</LI>
<LI>at 3-year follow-up: Group A: 13/87; Group B: 9/88 </LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 16:44:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-de-Tayrac-2004">
<CHAR_METHODS MODIFIED="2015-06-05 14:31:42 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT with TOT </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:31:57 +0100" MODIFIED_BY="[Empty name]">
<P>61 women</P>
<P>Inclusion criteria: USI</P>
<P>Exclusion criteria: predominant urge incontinence; urodynamic detrusor instability; or prolapse </P>
<P>Mean age (years; SD): Group A: 54.7 (11.9); Group B: 53.6 (12.5)</P>
<P>Mean BMI kg/m (SD): Group A: 24 (3.2); Group B: 25.2 (4.3)</P>
<P>Postmenopausal status: Group A: 18/30; Group B: 16/31</P>
<P>Previous continence surgery: Group A: 4/30; Group B: 1/31</P>
<P>Previous prolapse surgery: Group A: 4/30; Group B: 1/31</P>
<P>ISD: Group A: 4/30; Group B: 3/31</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-20 16:38:42 +0100" MODIFIED_BY="[Empty name]">
<P>Group: A: TOT (n = 30)</P>
<P>Group: B: TVT (n = 31)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 16:44:00 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure</LI>
<LI>Objective cure (negative cough stress test)</LI>
<LI>Objective cure and improvement</LI>
<LI>Mean operating time</LI>
<LI>Mean length of hospital stay</LI>
<LI>Bladder perforation</LI>
<LI>Vaginal tape erosion</LI>
<LI>Urethral tape erosion</LI>
<LI>De novo urgency/UUI</LI>
<LI>Voiding dysfunction</LI>
<LI>Sexual dysfunction measured using mean VAS score. No significant difference between the 2 groups in terms of improvement of sexual function</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:33:33 +0100" MODIFIED_BY="[Empty name]">
<P>The full article was retracted at the request of authors because appropriate ethics committee approval was not received prior to starting study. Nevertheless, participants did give written consent to be included in the trial and consented for the procedures. No methodological flaws were identified: the review authors therefore decided to include the data</P>
<P>TOT: Uratape mentor-porges</P>
<P>Cystoscopy performed following TVT procedure</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-05 14:33:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deffieux-2010">
<CHAR_METHODS MODIFIED="2015-06-01 15:10:36 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT and TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:33:47 +0100" MODIFIED_BY="[Empty name]">
<P>Multicentred RCT, 14 centres in France (university hospitals and 3 general hospitals)</P>
<P>149 women with SUI</P>
<P>Inclusion criteria: age &gt;18 years; isolated or mixed USI; indication for surgical treatment of USI; positive cough stress test</P>
<P>Exclusion criteria: concomitant POP surgery; concomitant hysterectomy; previous incontinence surgery; pregnancy; anticoagulant therapy; higher than stage 1 urogenital prolapse (POP-Q ICS)</P>
<P>All women had similar background characteristics</P>
<P>Mean age (years; SD): Group A: 54.6 (10.9); Group B: 52.8 (9.8)</P>
<P>Mean BMI kg/m (SD): Group A: 26.3 (4.5); Group B: 26.3 (5.7)</P>
<P>Postmenopausal: Group A: 43/75; Group B: 40/74</P>
<P>POP-Q stage 1: Group A: 245/75; Group B: 24/74</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-01 15:10:37 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 75)</P>
<P>Group B: TVT-O (n = 74)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-01 15:10:36 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes assessed at 2, 6, 12 and 24 months</P>
<UL>
<LI>Subjective cure: self-reported via questionnaires</LI>
<LI>Objective cure: negative cough stress test</LI>
<LI>Bladder injury</LI>
<LI>Major vascular injury</LI>
<LI>Tape erosion</LI>
<LI>Voiding dysfunction</LI>
<LI>Groin/suprapubic pain</LI>
<LI>Re-operation rates</LI>
<LI>QoL and sexual function: CONTILIFE questionnaire and use of VAS to determine sexual activity satisfaction and reported dyspareunia</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-01 15:10:37 +0100" MODIFIED_BY="[Empty name]">
<P>Cystoscopy performed in both groups</P>
<P>Loss to follow-up: at 12 months: Group A: 6/75; Group B: 5/74</P>
<P>Loss to follow-up at 24 months: Group A: 8/75; Group B: 9/74</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:46:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Diab-2012">
<CHAR_METHODS MODIFIED="2015-06-01 15:13:29 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TOT vs TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-26 16:09:44 +0100" MODIFIED_BY="[Empty name]">
<P>70 women with SUI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 14:37:25 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT (n = 31)</P>
<P>Group B: TVT (n = 32)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 17:01:46 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cure rates</LI>
<LI>Voiding dysfunction</LI>
<LI>De novo urgency</LI>
<LI>Reoperation rate</LI>
<LI>Postoperative groin/thigh pain </LI>
<LI>Impact of incontinence on QoL assessed by I-QoL questionnaire</LI>
<LI>Operative time</LI>
<LI>Estimated blood loss</LI>
<LI>Operative complications</LI>
<LI>Retropubic haematoma</LI>
<LI>Vaginal tape extrusion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-21 15:46:08 +0100" MODIFIED_BY="[Empty name]">
<P>Mean follow up in months (SD): A: 28 (12.3) and B: 26 (13.6) </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 17:09:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-El_x002d_Hefnawy-2010">
<CHAR_METHODS MODIFIED="2015-06-05 14:39:11 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing Gynecare TVT <SUP>R</SUP> and Aris TOT<SUP>R</SUP> outside-in</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:38:22 +0100" MODIFIED_BY="[Empty name]">
<P>40 women</P>
<P>Inclusion criteria: women with urodynamically proven SUI</P>
<P>Exclusion criteria: women who reported urgency incontinence as predominant complaint; had pelvic or vaginal surgery within the preceding 6 months; had associated urethral and/or bladder pathology or active UTI; neuropathic bladder; POP &gt; stage 2 (Baden Walker classification)</P>
<P>Mean age (years; SD): Group A:47 (5); Group B: 45 (7)</P>
<P>Concomitant POP stage 1-2: Group A: 10; Group B: 13</P>
<P>Mean BMI kg/m (SD): Group A: 34 (5); Group B: 32(5)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-20 17:02:33 +0100" MODIFIED_BY="[Empty name]">
<P>Preliminary results:</P>
<P>Group A: TVT: (n = 19)</P>
<P>Group B: TOT: (n = 21)</P>
<P>At 24 months:</P>
<P>Group A: TVT: (n = 45)</P>
<P>Group B: TOT: (n = 42)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 17:09:13 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up at 3, 6, 12 and 24 months</P>
<UL>
<LI>Objective cure: negative stress test, 1-h pad test &lt;2g, and no re-treatment for stress incontinence</LI>
<LI>12 months negative stress test</LI>
<LI>24 months negative stress test</LI>
<LI>24 months negative 1hr pad test</LI>
<LI>Subjective cure: no reported SUI</LI>
<LI>Mean operative time</LI>
<LI>Mean blood loss</LI>
<LI>Vascular injury</LI>
<LI>Bladder injury</LI>
<LI>Groin pain (no report of suprapubic pain)</LI>
<LI>Tape erosion</LI>
<LI>De novo urgency</LI>
<LI>QOL measured using UDI-6 and IIQ-7 at baseline, 12 and 24 months</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:41:54 +0100" MODIFIED_BY="[Empty name]">
<P>Intraoperative cystoscopy carried out only in the TVT group to exclude bladder or urethral injury</P>
<P>Concomittant surgery was performed in 9 participants; 5 participants underwent abdominal hysterectomy, 4 participants underwent anterior colporrhaphy</P>
<P>Lost to follow-up at 12 months: Group A: 0/19; Group B: 0/21</P>
<P>Lost to follow-up at 24 months: Group A: 9/45; Group B: 7/42</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 17:22:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Elbadry-2014">
<CHAR_METHODS MODIFIED="2015-06-05 14:46:44 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of adjustable TOT vs TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-05 14:46:51 +0100" MODIFIED_BY="[Empty name]">
<P>96 women with SUI, with a mean age of 53 + 9.9 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 14:46:52 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: adjustable TOT (n = 48)</P>
<P>Group B: TOT: (n = 48)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 17:22:09 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cure</LI>
<LI>Mean operative time</LI>
<LI>Operative blood loss</LI>
<LI>bladder injury</LI>
<LI>number of tape ajdustments</LI>
<LI>Length of hospital stay </LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-05 14:48:41 +0100" MODIFIED_BY="[Empty name]">
<P>The advantage of the adjustable tape is that it can be adjusted postoperatively to address over- or under-correction</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 17:35:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Enzelsberger-2005">
<CHAR_METHODS MODIFIED="2015-06-01 15:22:29 +0100" MODIFIED_BY="[Empty name]">
<P>QRCT comparing TVT and TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-01 15:22:29 +0100" MODIFIED_BY="[Empty name]">
<P>110 women</P>
<P>Inclusion criteria: women with SUI, all had preoperative stress test</P>
<P>Exclusion criteria: previous surgery for SUI; mixed incontinence; renal disease; metabolic disorders; or POP</P>
<P>Mean age was 51 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-01 15:22:29 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT (n = 56)</P>
<P>Group B: TVT (n = 54)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 17:35:03 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Operative time</LI>
<LI>Objective cure rate</LI>
<LI>Operative complications</LI>
<LI>Bladder perforation</LI>
<LI>Voiding dysfunction</LI>
<LI>Detrusor overactivity</LI>
<LI>Tape erosion</LI>
<LI>Groin pain</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-01 15:22:29 +0100" MODIFIED_BY="[Empty name]">
<P>No mention of intraoperative cystoscopy</P>
<P>Followed-up at 15 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:46:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Freeman-2011">
<CHAR_METHODS MODIFIED="2015-06-05 16:03:47 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TOT and TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 15:46:37 +0100" MODIFIED_BY="[Empty name]">
<P>Multicentre RCT &#8211; 21 centres across the UK</P>
<P>192 women</P>
<P>Inclusion criteria: women &gt;21 years of age; USI or MUI for which SUI was the predominant symptom; must have failed with conservative measures</P>
<P>Exclusion criteria: women with neurological disease; previous surgery for USI (those with previous prolapse surgery were not excluded); urodynamic DO or low compliance; POP extending beyond the hymen</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 16:04:19 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: Monarc TOT (n = 100)</P>
<P>Group B: Gynaecare TVT (n = 92)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 17:38:07 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up at 4 weeks, 6 months and 12 months</P>
<UL>
<LI>Subjective cure: self-reported via response to ICIQ-FLUTS questionnaire:</LI>
<LI>Mean operation time</LI>
<LI>Operative blood loss</LI>
<LI>Bladder perforation</LI>
<LI>Vaginal perforation</LI>
<LI>Tape erosion</LI>
<LI>Voiding dysfunction</LI>
<LI>De novo OAB</LI>
<LI>Groin pain</LI>
<LI>Sexual function: assessed via ICIQ-LUTSqol scores. </LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-20 17:37:57 +0100" MODIFIED_BY="[Empty name]">
<P>The trial was a non-inferiority design. Outcome measures calculated by intention-to-treat</P>
<P>Assessed via ICIQ-FLUTS long form, ICIQ</P>
<P>LUTSqol; KHQ questionnaires and 4-day urinary diary</P>
<P>Sexual function assessed by ICIQ-LUTSqol question, &#8216;does your urinary problem affect your sex life?&#8217;</P>
<P>Cystoscopy: not mentioned whether routinely performed in either group</P>
<P>Lost to follow-up: Group A: 5/100; Group B: 7/92 (and 1 excluded as she did not have the operation)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 17:38:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hammoud-2011">
<CHAR_METHODS MODIFIED="2015-05-26 17:27:45 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-05-26 17:27:32 +0100" MODIFIED_BY="[Empty name]">
<P>110 women with SUI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:07:44 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 60)</P>
<P>Group B: TVT-O (n = 50)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 17:38:54 +0100" MODIFIED_BY="[Empty name]">
<P>Subjective cure:</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:07:44 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 17:42:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hassan-2013">
<CHAR_METHODS MODIFIED="2014-03-25 10:54:29 +0000" MODIFIED_BY="[Empty name]">
<P>RCT of inside-out TOT vs outside-in TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:08:03 +0100" MODIFIED_BY="[Empty name]">
<P>250 women</P>
<P>Inclusion criteria: women with SUI in a university teaching hospital in Cairo, Egypt</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:08:03 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: inside-out TOT (n = 125)</P>
<P>Group B: outside-in TOT (n = 125)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 17:42:02 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcomes:</P>
<UL>
<LI>improvement of stress incontinence symptom and signs</LI>
<LI>intraoperative time</LI>
<LI>intra- and postoperative complications</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>recurrence of stress incontinence at 12 months</LI>
<LI>subjective cure at 12 months</LI>
<LI>vascular injury/haematoma</LI>
<LI>groin/thigh pain</LI>
<LI>tape erosion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:08:13 +0100" MODIFIED_BY="[Empty name]">
<P>Lost to follow-up: Group A: 23/125; Group B: 28/125</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 17:59:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Houwert-2009">
<CHAR_METHODS MODIFIED="2015-06-08 11:09:06 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT-O and TOT (Monarc)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:09:06 +0100" MODIFIED_BY="[Empty name]">
<P>191 women</P>
<P>Inclusion criteria: women with SUI, USI and MUI. Those with MUI failed anti-cholinergic medical treatment before surgical treatment<BR/>Exclusion criteria: women with recurrent UTIs; those with predominantly symptoms of UUI; post voiding residuals of &gt; 150 ml and bladder capacity &lt; 100ml<BR/>There was no concomitant POP surgery<BR/>Preoperative multichannel urodynamic investigation was carried in all women</P>
<P>Mean age (years; SD): Group A: 49.2 (8.9); Group B: 49.5 (10.3)</P>
<P>SUI: Group A: 74/93 (80%); Group B: 74 /98 (76%)<BR/>MUI: Group A: 19/93 (20%); Group B: 23/98 (24%)</P>
<P>Postmenopausal: Group A: 33/93; Group B: 34/98</P>
<P>Previous incontinence surgery: Group A: 8/93; Group B: 9/98</P>
<P>Previous POP surgery: Group A: 19/93; Group B: 15/98</P>
<P>Urethral hypermobility: Group A: 80/93; Group B: 90/98</P>
<P>POP &#8805; grade 1: Group A: 25/93; Group B: 24/98</P>
<P>ISD: Group A: 5/93; Group B: 1/98</P>
<P>DO: Group A: 5/93; Group B: 7/98<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:09:11 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 93)</P>
<P>Group B: Monarc TOT (n = 98)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 17:49:41 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cure of SUI: defined as woman stating she did not experience any loss of urine upon physical exercise</LI>
<LI>QoL measured with validated Dutch short forms of the IIIQ-7 and the UDI-6</LI>
<LI>Subjective cure at 12 months (short term): A: 66/86, B: 73/95</LI>
<LI>Subjective cure and improvement at 12 months (short term)</LI>
<LI>Subjective cure at 2-4years (medium term)</LI>
<LI>Subjective cure and improvement at 2-4years (medium term)</LI>
<LI>Operating time</LI>
<LI>Voiding dysfunction at 2 months</LI>
<LI>Vaginal tape erosion at 12 months</LI>
<LI>Thigh pain</LI>
<LI>De novo urgency/UI</LI>
<LI>Repeat incontinence surgery</LI>
<LI>QOL: Assessed using IIQ-7 and UDI-6 </LI>
<LI>Sexual dysfunction</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-20 17:59:30 +0100" MODIFIED_BY="[Empty name]">
<P>No concomitant urogynaecological surgery performed</P>
<P>Follow-up occurred at 12 months and at 2 -4 years</P>
<P>Loss to follow-up at 12 months: Group A: 15/39; Group B: 14/36.</P>
<P>Loss to follow-up at 4 years: Group A: 18/93; Group B: 12/98</P>
<P>Cystoscopy was performed only when bloody urine was encountered</P>
<P>Analysis of cure used the numbers that completed follow-up as denominator</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 18:01:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jakimiuk-2012">
<CHAR_METHODS MODIFIED="2014-01-02 16:12:21 +0000" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT and TVT-O: POLTOS study</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:11:53 +0100" MODIFIED_BY="[Empty name]">
<P>Multicentre RCT in Poland</P>
<P>35 women</P>
<P>Inclusion criteria: women with urodynamically proven (bladder filled to a minimum of 300 ml) SUI; no prior incontinence surgery</P>
<P>Exclusion criteria: women with UTI; BMI &gt; 33 kg/m; previous hysterectomy; neurological incontinence; POP; PVR &gt; 150 ml; OAB and MUI</P>
<P>Age: 40-80 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:11:53 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 19)</P>
<P>Group B: TVT-O (n = 16)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 18:01:52 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure: self-reported</LI>
<LI>Objective cure: negative cough test and pad test</LI>
<LI>Bladder perforation</LI>
<LI>Voiding dysfunction</LI>
<LI>Vascular injury</LI>
<LI>Mean procedure time</LI>
<LI>Mean hospital stay</LI>
<LI>QoL: used non-validated KHQ and validated SF-36 questionnaires.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:17:03 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up at 6 months</P>
<P>Cystoscopy was performed in both groups</P>
<P>Lost to follow-up: Group A: 4/19; Group B: 0/16 (3 participants with bladder perforation had the tape removed and were excluded)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 18:07:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Juang-2007">
<CHAR_METHODS MODIFIED="2015-06-20 18:02:56 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of trans-obturator tension-free vaginal tape (TVT-O) versus TVT-O with modified Ingelman-Sundberg (IS) procedure</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:21:01 +0100" MODIFIED_BY="[Empty name]">
<P>96 women</P>
<P>Inclusion criteria: women with MUI after poor response to medical treatment</P>
<P>DO at baseline: Group A: 19/43; Group B: 15/49</P>
<P>Post menopausal: Group A: 32/43; Group B: 27/49</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:17:38 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 47)</P>
<P>Group B: TVT-O plus IS: (n = 49)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 18:07:04 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: defined as 1-h pad test &lt; 2g and complete discontinuation of antimuscarinic medication</LI>
<LI>Objective improvement: defined as improvement of urine leakage on pad test or decreased dosage of antimuscarinic medication</LI>
<LI>Blood loss</LI>
<LI>Operating time</LI>
<LI>Mean hospital stay</LI>
<LI>Bladder perforation</LI>
<LI>Major vascular injury</LI>
<LI>Tape erosion</LI>
<LI>Post operative complications</LI>
<LI>QOL: assessed with IIQ-7 and UDI-6</LI>
</UL>
<P>Follow-up QOL scores: Both IIQ-7 and UDI-6 demonstrated a significant decrease at the</P>
<P>3-months follow-up in the TVT-O plus IS group. Scores remained relatively stable after 3 months of follow-up and until the end of the study.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:20:25 +0100" MODIFIED_BY="[Empty name]">
<P>The IS bladder denervation procedure is designed to disrupt most of the innervations from the inferior hypogastric plexus to the bladder to treat refractory urgency or urge incontinence (the vaginal epithelium and perivesical fascia were dissected off the trigone. The plane of dissection was just within the serosal layer of the bladder. Lateral and posterior sharp dissection was performed to obtain more extensive division in the area of the terminal branches of the pelvic nerve).</P>
<P>Follow-up was at 12-months, but urodynamic profile was repeated at the 3-month follow-up</P>
<P>Loss to follow-up: Group A: 2/47; Group B: 1/49</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 18:08:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kamel-2009">
<CHAR_METHODS MODIFIED="2015-05-26 18:04:47 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:21:46 +0100" MODIFIED_BY="[Empty name]">
<P>120 women</P>
<P>Inclusion criteria: women with urodynamically proven SUI and urethral hypermobility</P>
<P>Exclusion criteria: not defined</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:21:49 +0100" MODIFIED_BY="[Empty name]">
<P>A: TVT (n = 60)</P>
<P>B: TVT-O (n = 60)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 18:08:44 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure</LI>
<LI>Bladder perforation</LI>
<LI>Vascular injury</LI>
<LI>Mean operative time</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-04-01 00:05:19 +0100" MODIFIED_BY="[Empty name]">
<P>TVT group underwent cystoscopy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 18:12:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karateke-2009">
<CHAR_METHODS MODIFIED="2015-06-08 11:23:23 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT and TVT-O </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-20 18:09:12 +0100" MODIFIED_BY="[Empty name]">
<P>167 women</P>
<P>Inclusion criteria: women with urodynamically proven SUI</P>
<P>Exclusion criteria: urogenital prolapse &gt; stage 1 (POP-Q); DO; symptoms of OAB; urinary retention; previous anti-incontinence surgery including anterior colporrhaphy and neurological bladder</P>
<P>Mean age (years; SD): Group A: 49.31 (5.00); Group B: 49.08 (4.93)</P>
<P>Postmenopausal: Group A: 16/83; Group B: 14/84</P>
<P>Mean BMI kg/m (SD): Group A: 25.99 (1.27); Group B: 26.18 (1.88)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:23:41 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 83)</P>
<P>Group B: TVT-O (n = 84)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 18:12:10 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure (very satisfied and satisfied)</LI>
<LI>Obective cure (negative cough test at cystometry)</LI>
<LI>Mean operative time</LI>
<LI>Vascular injury/haematoma</LI>
<LI>Bladder perforation</LI>
<LI>Tape erosion</LI>
<LI>Voiding dysfunction</LI>
<LI>De novo UI</LI>
<LI>De novo DO</LI>
<LI>Mean hospital stay </LI>
<LI>Time to return to normal activity </LI>
<LI>QOL: IIQ-7 and UDI 6 questionnaires </LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:24:43 +0100" MODIFIED_BY="[Empty name]">
<P>Cystoscopy only performed in TVT group</P>
<P>Lost to follow-up: Group A: 2/83; Group B: 1/84</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 18:14:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kilic-2007">
<CHAR_METHODS MODIFIED="2015-06-01 15:46:41 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-01 15:46:41 +0100" MODIFIED_BY="[Empty name]">
<P>20 women</P>
<P>Inclusion criteria: women with SUI confirmed on urodynamics</P>
<P>Mean age (years; SD): Group A: 55.8 (13.7); Group B: 60.2 (12.2)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-01 15:46:41 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 10)</P>
<P>Group B: TOT (n = 10)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 18:14:33 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Primary outcome: Subjective cure: improvement of urinary incontinence (after coughing, laughing and during stairs climbing)</LI>
<LI>Mean operative time</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-01 15:46:40 +0100" MODIFIED_BY="[Empty name]">
<P>None lost to follow-up</P>
<P>Follow-up assessment at 12 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 18:21:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2004">
<CHAR_METHODS MODIFIED="2015-06-08 11:25:15 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing the IRIS (Innovative Replacement of Incontinence Surgery) tape with TVT and SPARC procedure</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:25:16 +0100" MODIFIED_BY="[Empty name]">
<P>96 women with SUI were randomised<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:25:16 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 32)</P>
<P>Group B: SPARC (n = 30)<BR/>Group C: IRIS (n = 34).</P>
<P>All 3 groups had comparable background characteristics</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 18:21:38 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure</LI>
<LI>Objective cure</LI>
<LI>Operating time</LI>
<LI>Length of hospital stay </LI>
<LI>Perioperative complications</LI>
<LI>Bladder perforation</LI>
<LI>Voiding dysfunction</LI>
<LI>De no urgency/urgency urinary incontinence</LI>
<LI>Vaginal tape erosions</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:25:16 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up was for 1 year</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:47:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2005">
<CHAR_METHODS MODIFIED="2015-06-08 11:25:40 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing Monarc TOT with SPARC retropubic tape</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:25:31 +0100" MODIFIED_BY="[Empty name]">
<P>130 women</P>
<P>Inclusion criteria: women with SUI with similar background characteristics</P>
<P>Preoperative assessment included the use of voiding diaries, stress and pad tests, and urodynamics</P>
<P>Mean age (years; SD): Group A: 45.7 (9.8); Group B: 45.4 (12.4)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:25:32 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: Monarc (TOR; n = 65)</P>
<P>Group B: SPARC (RPR; n = 65)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 15:47:40 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective and objective cure assessed via questionnaires and UDS respectively</LI>
<LI>Stress and pad test and uroflowmetry with PVR</LI>
<LI>Operative time in mins</LI>
<LI>Perioperative complications</LI>
<LI>Bladder perforation</LI>
<LI>Voiding dysfunction</LI>
<LI>De no urgency/urgency urinary incontinence</LI>
<LI>Vaginal tape erosion</LI>
<LI>Bladder erosion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:25:32 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up at 3 months. Cystoscopy only in the TVT group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 09:00:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krofta-2010">
<CHAR_METHODS MODIFIED="2015-06-08 11:25:50 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:25:52 +0100" MODIFIED_BY="[Empty name]">
<P>300 women</P>
<P>Inclusion criteria: women with SUI after failed conservative treatment. All confirmed on a positive stress test (cough provocation). Women with symptoms of MUI were included if SUI was the predominant symptom</P>
<P>Exclusion criteria: DO; previous incontinence, POP surgery, or pelvic radiotherapy; POP-Q &#8805; stage 2; PVR &gt; 100 ml; preoperative use of anticholinergics; need for concomitant surgery</P>
<P>Cough provocation test, multichannel UDS, urethral pressure profilometry and uroflometry were done preoperatively and at 12-month follow-up</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:26:09 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT<SUP>TM</SUP> (n = 149)</P>
<P>Group B: TVT &#8211;O<SUP>TM</SUP> (n = 151)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 09:00:19 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure (negative stress cough provocation test with 300 ml of saline in the bladder during UDS and 1-hour pad test weight &lt; 5g)</LI>
<LI>Subjective cure (self-reported absence of SUI)</LI>
<LI>Subjective improvement (women&#8217;s perception of urine loss less than the presurgical loss)</LI>
<LI>De novo urge/urgency urinary incontinence</LI>
<LI>Duration of operation</LI>
<LI>Mean blood loss</LI>
<LI>Haematoma</LI>
<LI>Groin/suprapubic pain</LI>
<LI>Tape erosion/extrusion</LI>
<LI>Quality of life: ICIQ UI- SF and CONTILIFE questionnaires used </LI>
<LI>Sexual dysfunction: assessed using PISQ-12</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:28:29 +0100" MODIFIED_BY="[Empty name]">
<P>All women with TVT had intraoperative cystoscopy but this was not performed in those with TVT-O</P>
<P>Loss to follow-up: Group A: 8/141; Group B: 4/147</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 19:48:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Laurikainen-2007">
<CHAR_METHODS MODIFIED="2015-06-01 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT and TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-01 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<P>Multicenter study from 7 Finnish hospitals (4 university hospitals and 3 central hospitals)<BR/>267 of the 273 patients originally randomized underwent the allocated operation. After randomisation 6 patients dropped out</P>
<P>Inclusion criteria: history of SUI; indication for surgical treatment of stress incontinence; positive cough-stress test; detrusor instability score (DIS) &#8804; 7<BR/>Exclusion criteria: previous incontinence surgery; PVR volume &gt; 100 ml; lower urinary tract anomaly; current (UTI or &gt; 3 UTI episodes within the past year; urogenital prolapse of more than second degree (Baden-Walker); BMI &gt; 35 kg/m; previous radiation therapy of the pelvis; active malignancy; anticoagulant therapy; haemophilia; neurogenic disease that can be associated with bladder disorders; anticholinergic medication; duloxetine medication; patient unable to understand the purpose of the trial; patient immobile</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-20 19:47:59 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 131)<BR/>Group B: TVT (n = 136)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 19:48:24 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: defined as a negative stress test.</LI>
<LI>24 hour pad test</LI>
<LI>Subjective cure: evaluated by questionnaires through short, medium and long term</LI>
<LI>Perioperative complications</LI>
<LI>Mean operating time (minutes)</LI>
<LI>Length of hospital stay (days)</LI>
<LI>Time to return to normal activity (weeks)</LI>
<LI>Operative blood loss (ml)</LI>
<LI>Major vascular injury</LI>
<LI>Bladder perforation</LI>
<LI>De novo urgency/urgency urinary incontinence</LI>
<LI>Voiding dysfunction</LI>
<LI>Repeat incontinence surgery</LI>
<LI>Tape erosion</LI>
<LI>Groin pain</LI>
<LI>Tape erosion</LI>
<LI>QoL questionnaires include: urinary incontinence severity score (UISS), detrusor instability score (DIS), incontinence impact questionnaire - short form (IIQ-7), urogenital distress inventory - short form (UDI-6), EuroQOL-5D questionnaire, Visual analogue scale (VAS-0 to 100)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-01 15:56:44 +0100" MODIFIED_BY="[Empty name]">
<P>Cystoscopy with 70 optic was performed twice during the TVT and once during the TVT-O to detect possible bladder injury</P>
<P>Follow-up was for 5 years:</P>
<UL>
<LI>loss to follow-up: at 12 months: Group A: 2/136; Group B: 0/131</LI>
<LI>loss to follow-up: at 36 months: Group A: 5/136; Group B: 5/131</LI>
<LI>loss to follow-up: at 60 months: Group A: 5/136; Group B: 9/131</LI>
</UL>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 18:34:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leanza-2009">
<CHAR_METHODS MODIFIED="2015-06-08 11:30:52 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of retropubic versus transobturator tension-free incontinence cystocoele treatment (TICT) procedures</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:30:54 +0100" MODIFIED_BY="[Empty name]">
<P>449 women with USI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:31:00 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: r-TICT (n = 229; retropubic)</P>
<P>Group B: t-TICT (n = 220; transobturator)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 18:34:17 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure</LI>
<LI>QoL: using KHQ</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-20 18:34:47 +0100" MODIFIED_BY="[Empty name]">
<P>TICT, a retropubic technique developed using a polypropylene T-shaped mesh made up by a central body (positioned under both urethra and bladder) and 2 wings that cross the Retzius (retropubic TICT or r-TICT) and the transobturator foramen (transobturator TICT or t-TICT). The advantage of T-shaped mesh is to give a good support both on the mid-urethral complex (with tapes) and on the whole anterior compartment (with body of mesh). The target consists of treating the functional (incontinence) and the anatomical defect (cystocoele)</P>
<P>Average follow-up was 45 months.</P>
<P>Loss to follow-up: Group A: 14/229; Group B: 12/220</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-08 11:33:05 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2007">
<CHAR_METHODS MODIFIED="2015-06-08 11:33:05 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT versus TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:33:02 +0100" MODIFIED_BY="[Empty name]">
<P>120 women</P>
<P>Inclusion criteria: women with USI</P>
<P>Exclusion criteria: predominant urge incontinence or POP</P>
<P>Women had similar characteristics with regard to age, parity, incontinence symptoms and menopausal status</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:33:02 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 60)</P>
<P>Group B: TVT-O (n = 60)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 11:33:02 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Duration of operation</LI>
<LI>Intraoperative blood loss</LI>
<LI>Postoperative pain</LI>
<LI>Patient satisfaction</LI>
<LI>Operative complications</LI>
<LI>Cure: defined as no SUI symptoms and a negative cough-stress test. Participants were considered to have improved if they had no leakage on the cough-stress test but may have had occasional urine leakage during stress. However, this occasional leakage did not influence daily activities or require any further treatment. Participants who did not meet these criteria treatment were considered to have failed</LI>
</UL>
<P>Follow-up was for 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:33:02 +0100" MODIFIED_BY="[Empty name]">
<P>Cystoscopy was performed only in the TVT group</P>
<P>Mean follow-up 13 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-01 16:17:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee-2008">
<CHAR_METHODS MODIFIED="2015-06-01 16:17:11 +0100" MODIFIED_BY="[Empty name]">
<P>QRCT comparing the efficacy and safety of TVT-O and TOT (TOT, Dow Medics, Korea)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-01 16:17:11 +0100" MODIFIED_BY="[Empty name]">
<P>100 women</P>
<P>Inclusion criteria: women with USI</P>
<P>Exclusion criteria: predominant urge incontinence or POP</P>
<P>Preoperative work-up included a medical history, physical examination, urinalysis, urodynamic evaluation, and I-QOL questionnaire</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-01 16:17:11 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 50)</P>
<P>Group B: TOT (n = 50)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-01 16:17:11 +0100" MODIFIED_BY="[Empty name]">
<P>Surgical outcomes were evaluated by the cough-stress test and symptom questionnaire and scored as cured, improved, or failed. Participants were considered &#8216;cured&#8217; of SUI if they had a negative cough-stress test result and there were no reports of urine leakage during stress. Participants were considered &#8216;improved&#8217; if they did not leak on the cough-stress test but may have had occasional urine leakage during stress; this occasional leakage did not influence their daily activities or require further treatment. Participants who did not meet these criteria were considered to have &#8216;failed&#8217; treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-01 16:17:11 +0100" MODIFIED_BY="[Empty name]">
<P>Surgical outcomes in the 2 groups were compared about 1 year after surgery.</P>
<P>TOT, Dow Medics, Korea = woven monofilament polypropylene mesh</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 18:38:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liapis-2006">
<CHAR_METHODS MODIFIED="2015-06-08 11:33:27 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT and TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:33:27 +0100" MODIFIED_BY="[Empty name]">
<P>89 women</P>
<P>Inclusion criteria: women with confirmed SUI without DO</P>
<P>Exclusion criteria: DO; other gynaecological disease requiring hysterectomy; other gynaecologic operation; failed surgical treatment for incontinence</P>
<P>Mean age (years): Group A: 53; Group B 52</P>
<P>Post menopausal: Group A: 22/46; Group B: 26/43</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:33:27 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 46)</P>
<P>Group B: TVT-O (n = 43)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 18:38:18 +0100" MODIFIED_BY="[Empty name]">
<P>Participants assessed by means of voiding diaries, pad test, negative cough-stress test at UDS, unvalidated symptom questionnaire</P>
<UL>
<LI>Objective cure: negative cough-stress test during multichannel UDS study, and 1-h pad test with a weight of &lt;1g</LI>
<LI>Objective improvement: negative cough-stress test during multichannel UDS study, and 1-h pad test with a weight of &lt;5g</LI>
<LI>Failure: defined as positive cough-stress test during multichannel UDS study, and 1-hr pad test with a weight of &gt;5g</LI>
</UL>
<P>Subjective cure and failure determined by direct questions using an unvalidated questionnaire</P>
<P>Follow-up 12 months</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:33:41 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 18:21:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liapis-2008">
<CHAR_METHODS MODIFIED="2015-06-08 11:34:08 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing Monarc TOT and TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 15:48:44 +0100" MODIFIED_BY="[Empty name]">
<P>120 women were randomised<BR/>Inclusion criteria: women with USI without DO</P>
<P>Exclusion criteria: preoperative maximum urethral closure pressure &lt; 20 cm water; urodynamic findings of DO; previous operation of the anterior vaginal wall or prolapse &gt; stage 1 according to the ICS classification</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:34:08 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 61)</P>
<P>Group B: Monarc TOT (n = 53)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 16:18:55 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: defined as a negative cough-stress test during multichannel urodynamic examination and a 1-hr pad test giving a weight of &lt;1g</LI>
<LI>Objective improvement: defined as a negative cough-stress test and a 1-hr pad test weight of &lt;5g</LI>
<LI>Failure: defined as a positive cough-stress test and urine leakage &gt;5g in the 1-hr pad test</LI>
<LI>Subjective cure, improvement, and failure were assessed with the use of a simple questionnaire administered by a blinded outcome assessor</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-21 18:21:14 +0100" MODIFIED_BY="[Empty name]">
<P>Both groups had perioperative cystoscopy.<BR/>Groin or thigh pain was resolved with simple analgesics within 1 week to 4 months</P>
<P>Follow-up was 12 months. 6 lost to follow-up leaving a total of 114 women</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:49:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lim-2005">
<CHAR_METHODS MODIFIED="2015-06-08 11:36:33 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT with IVS and SPARC</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-20 22:08:20 +0100" MODIFIED_BY="[Empty name]">
<P>195 women</P>
<P>Inclusion criteria: women with USI were randomly allocated to suburethral slingoplasty with either TVT, IVS or SPARC.</P>
<P>Exclusion criteria: women with a past history of urogenital malignancy, fistula or pelvic radiotherapy</P>
<P>At 6-12 weeks follow-up, 4, 5 and 4 women from the TVT, IVS and SPARC groups, respectively, were excluded from statistical analysis because of incomplete or missing hospital charts</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-21 15:49:20 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 61)</P>
<P>Group B: IVS (n = 60)</P>
<P>Group C: SPARC (n = 61)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 11:36:33 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure based on UDS</LI>
<LI>Subjective cure</LI>
<LI>Postoperative morbidity</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-20 22:09:41 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: 4 patients; Group B: 5 patients; and Group C: 4 patients were excluded from the analysis due to incomplete or missing data. </P>
<P>Those with missing records, those lost to follow-up and those who failed to have postoperative UDS were assumed to be failures in the assessment of objective cure.</P>
<P>Occult cases were excluded from subjective cure rates</P>
<P>Follow-up initially for 12 weeks and results reported, a follow-on study reviewed the incidence of erosion and tape infections</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-08 11:37:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lord-2006">
<CHAR_METHODS MODIFIED="2015-06-08 11:37:06 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT with SPARC sling</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:37:06 +0100" MODIFIED_BY="[Empty name]">
<P>301 women</P>
<P>Inclusion criteria: women presenting with SUI whether or not they had had previous incontinence or other pelvic surgery, or both</P>
<P>Exclusion criteria: &lt; 18 years old; pregnant; had a major voiding dysfunction specified as an abnormal flow (i.e. maximum urinary flow rate &lt; 10 ml/s) or residual urinary volume of &gt; 150 ml</P>
<P>254 women had UDS and USI diagnosed</P>
<P>MUI: 47 women</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:37:06 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 147)<BR/>Group B: SPARC (n = 154)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 11:37:06 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome:</P>
<P>bladder perforation</P>
<P>Secondary outcomes:</P>
<UL>
<LI>blood loss</LI>
<LI>voiding difficulty</LI>
<LI>urgency</LI>
<LI>cure of SUI symptoms at 6 weeks after surgery</LI>
</UL>
<P>The subjective assessments of cure were the participants' reported use of protection, their perceptions of the severity of their SUI symptoms and a scale of improvement (1 to 100). The objective definition of cure was the observed absence of urinary leakage when the participant coughed while supine and with a comfortably full bladder</P>
<P>Follow-up was 6 weeks</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:37:06 +0100" MODIFIED_BY="[Empty name]">
<P>The women and the outcome assessors were blinded, but no clear description was provided for how this was achieved</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-08 11:37:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mansoor-2003">
<CHAR_METHODS MODIFIED="2015-06-08 11:37:20 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT-O and TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:37:20 +0100" MODIFIED_BY="[Empty name]">
<P>102 women with SUI with or without POP</P>
<P>Preoperative urodynamics carried out</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:37:20 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 48)<BR/>Group B: TVT (n = 54)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 11:37:20 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure rate</LI>
<LI>Objective cure rate</LI>
<LI>Complications</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:37:20 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up 6 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 23:58:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mehdiyev-2010">
<CHAR_METHODS MODIFIED="2015-05-27 07:31:15 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-06-29 17:07:09 +0100" MODIFIED_BY="[Empty name]">
<P>32 women with SUI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:37:35 +0100" MODIFIED_BY="[Empty name]">
<P>A: TOT (n = 17)</P>
<P>B: TVT (n = 15)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 23:58:03 +0100" MODIFIED_BY="[Empty name]">
<P>Subjective cure</P>
<P>Bladder Injury</P>
<P>Major vascular injury:</P>
<P>De novo UUI</P>
<P>Mean operative time</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:38:05 +0100" MODIFIED_BY="[Empty name]">
<P>I-QoL questionnaire was used</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 18:30:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meschia-2006">
<CHAR_METHODS MODIFIED="2015-06-08 11:38:32 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT compared with IVS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 00:10:07 +0100" MODIFIED_BY="[Empty name]">
<P>190 women randomised with 11 lost to follow-up, thus 179 available for analysis at 2-year follow-up. The 2 groups were no different in terms of age, parity, BMI, previous hysterectomy, or presence of OAB symptoms<BR/>Inclusion criteria: women with urodynamically proven SUI and urethral hypermobility</P>
<P>Exclusion criteria: previous anti-incontinence surgery; vaginal prolapse requiring treatment; coexisting pelvic pathology; known bleeding diathesis or current anticoagulant therapy; DO; and urethral hypomobility (Q-tip &lt;20 from the horizontal with straining)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:38:32 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 92)<BR/>Group B: IVS (n = 87)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 18:30:04 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: success rate</P>
<P>Secondary outcome measure: complication rate</P>
<P>The outcome of surgical treatment was estimated both subjectively and objectively. Objective cure was defined as no leakage of urine while performing the cough provocation test, with at least 300 ml of saline in the bladder and as a pad weight gain &lt; 1g during the 1-h test. Test-retest reliability of the cough test and 1-hr pad test have been previously demonstrated. Subjective cure was defined as no urine loss during 'stress' and failure as any reported leakage of urine during exertion</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:38:32 +0100" MODIFIED_BY="[Empty name]">
<P>IVS = multifilament threads with smaller pores with insertion similar to TVT</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 18:30:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meschia-2007">
<CHAR_METHODS MODIFIED="2015-05-27 07:38:25 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT versus TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 00:10:26 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: women with urodynamic SUI and urethral hypermobility</P>
<P>Exclusion criteria: previous anti-incontinence surgery; vaginal prolapse requiring treatment; coexisting pelvic pathology; known bleeding diathesis or current anticoagulant therapy; DO and urethral hypomobility (Q-tip &lt;20 from the horizontal with straining)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:38:51 +0100" MODIFIED_BY="[Empty name]">
<P>206 women randomised, but 25 lost to follow-up<BR/>Group A: TVT (n = 114)</P>
<P>Group B: TVT-O (n = 117)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 11:38:51 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: success rate</P>
<P>Secondary outcome: complication rate</P>
<P>Outcome of surgical treatment was estimated both subjectively and objectively. Objective cure was defined as no leakage of urine whilst performing the cough provocation test. Subjective cure was defined as no urine loss during &#8216;stress&#8217;, and failure as any reported leakage of urine during exertion</P>
<P>ICIQ-SF, Women Irritative Prostate Symptoms Score (W-IPSS), PGI-S and PGI-I questionnaires were used to evaluate the impact of incontinence and voiding dysfunction on QoL, and to measure the participant&#8217;s perception of incontinence severity and improvement</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-21 18:30:14 +0100" MODIFIED_BY="[Empty name]">
<P>Median follow-up time was 6 months</P>
<P>6 women from Group A and 7 from Group B were lost to follow-up without outcome data; reasons for loss to follow-up not explored</P>
<P>Cystoscopy was performed in all cases of TVT and 50% of cases of TVT-O</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 00:26:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Naumann-2006">
<CHAR_METHODS MODIFIED="2015-06-08 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of classic TVT tape by Gynecare compared with LIFT by Cousin Biotech, with the distinctive feature of a suburethral pad (assumed to be inserted as classic TVT)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-03-16 17:37:38 +0000" MODIFIED_BY="[Empty name]">
<P>254 women with SUI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:39:15 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 123)</P>
<P>Group B: LIFT (n = 125)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 00:26:40 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure or improvement: assessed with VAS</LI>
<LI>Subjective evaluation of QoL</LI>
<LI>Objective cure: evaluation of preoperative and postoperative urodynamic measurements, or results of a pad or clinical stress test</LI>
<LI>Subjective cure, 6 months and 12 months</LI>
<LI>Subjective cure or improvement, 6 months and 12 months</LI>
<LI>Bladder perforation</LI>
<LI>Excess bleeding</LI>
<LI>Need for division of tape</LI>
<LI>Tape erosion into bladder or urethra</LI>
<LI>Vaginal mesh erosion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:40:58 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up 12 months</P>
<P>LIFT is a woven monofilament polypropylene tape that can be passed through the transobturator and also the retropubic routes</P>
<P>The study seemed to compare the 2 tapes (TVT and LIFT), which have similar characteristics and were both passed through the retropubic routes</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 21:24:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nerli-2009">
<CHAR_METHODS MODIFIED="2015-06-08 11:41:11 +0100" MODIFIED_BY="[Empty name]">
<P>QRCT of TVT vs TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:41:12 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: women &gt; 18 years; with SUI or MUI if SUI is the predominant symptom; women with ISD</P>
<P>Exclusion criteria: predominant urge incontinence; UTI; malignancy; pregnancy; POP stage 3 or 4</P>
<P>Mean age (years; SD): Group A: 39.5 (1.95); Group B: 50.2 (1.89)</P>
<P>Post menopausal status: Group A 8/18; Group B: 6/18</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:41:12 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 18)</P>
<P>Group B: TOT (n = 18)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 21:24:00 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: negative cough stress test</LI>
<LI>Subjective cure: self-reported absence of SUI</LI>
<LI>Improved: persistence of SUI not affecting daily activity or requiring further treatment plus negative cough test</LI>
<LI>Mean operative time</LI>
<LI>Mean operative blood loss</LI>
<LI>Voiding dysfunction</LI>
<LI>Bladder perforation</LI>
<LI>De novo urge incontinence</LI>
<LI>Tape erosion</LI>
<LI>Days to return to normal activity </LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:43:06 +0100" MODIFIED_BY="[Empty name]">
<P>Cystoscopy performed only in the TVT group</P>
<P>I-QOL questionnaire assessed at 12 month F/U: significant improvement in I-QOL total scores in both groups from the pre-operative baseline scores.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:51:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nyyssonen-2014">
<CHAR_METHODS MODIFIED="2015-06-01 16:33:57 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT (Gynecare) vs TOT ('outside-in' Monarc)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 11:44:36 +0100" MODIFIED_BY="[Empty name]">
<P>100 women</P>
<P>Inclusion criteria: women with SUI or MUI with a predominant stress component, after failed conservative treatment</P>
<P>Exclusion criteria: urge incontinence; previous mini invasive operation for SUI and the need for another concomitant surgical procedure</P>
<P>SUI diagnosed with a positive cough test</P>
<P>Urodynamic testing was only done in 5 patients (10%)</P>
<P>Pure SUI: Group A: 38/50; Group B: 30/50</P>
<P>Preoperative characteristics similar between groups</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:44:37 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT (n = 50)</P>
<P>Group B: TVT (n = 50)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 15:51:06 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure at 14 and 46 months: success defined as a postoperative UISS &lt; 8 and failure as &#8805; 8</LI>
<UL>
<LI>At 14 months</LI>
<LI>At 46 months</LI>
</UL>
<LI>Vaginal tape erosion</LI>
<LI>Voiding dysfunction</LI>
<LI>De novo UUI</LI>
</UL>
<P>Follow-up at 3, 14 and 46 months</P>
<P>Cough stress test was performed.</P>
<P>Subjective cure and patient satisfaction recorded with aid of UISS and Detrusor Instability Score questionnaires with a specific question about satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:47:25 +0100" MODIFIED_BY="[Empty name]">
<P>Cystoscopy only performed in the TVT group</P>
<P>Number available for follow-up assessments:</P>
<P>14 months: Group A: 43/50; Group B: 43/50</P>
<P>At 46 months: Group A: 46/50; Group B: 47/50</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:51:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Okulu-2013">
<CHAR_METHODS MODIFIED="2014-04-01 00:58:47 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of Vypro mesh (Ethicon, USA) vs Ultrapro mesh (Ethicon) vs Prolene light mesh (condensed monofilament non-absorbable polypropylene)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 15:51:19 +0100" MODIFIED_BY="[Empty name]">
<P>144 women with SUI in Turkey</P>
<P>Inclusion criteria: previous incontinence surgery or hysterectomy; SUI or USI; positive stress test</P>
<P>Exclusion criteria: urodynamically MUI and DO; &#8805; 100 ml PVR; contraindication to anaesthesia; POP; pregnancy; neurogenic bladder; bladder outlet obstructions; urinary fistula; or active urinary or vaginal infection</P>
<P>Mean age (years; SD): Group A: 50.06 (9.2); Group B: 50.9 (8.8); Group C: 48.1 (7.9)</P>
<P>Mean BMI kg/m (SD): Group A: 27.8 (3.4); Group B: 27.9 (4.1); Group C: 27.7 (2.9)</P>
<P>Post menopausal: Group A: 10/48; Group B: 11/48; Group C: 8/48</P>
<P>Previous incontinence surgery: Group A: 4/48; Group B: 5/48; Group C:4/48</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 11:48:17 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: Vypro mesh: (n = 48; multifilament)</P>
<P>Group B: Ultrapro mesh: (n = 48; monofilament + biological combined mesh)</P>
<P>Group C: Prolene light mesh: (n = 48; monofilament)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 21:47:19 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: urinary continence rates at 4-year follow-up</P>
<P>Secondary outcomes assessed at 4-year follow-up:</P>
<UL>
<LI>urinary retention</LI>
<LI>suture granuloma rates at 4 years.</LI>
<LI>cure defined as no need for pad use or pad weight of &lt; 2g on 24-hr pad test</LI>
<UL>
<LI>Subjective cure at 12 months</LI>
<LI>Subjective cure at 48 months</LI>
</UL>
<LI>bladder perforation</LI>
<LI>major vascular visceral injury</LI>
<LI>de novo urgency</LI>
<LI>tape erosion</LI>
<LI>mean 24hr pad weight at 12 months and 48 months</LI>
<LI>QOL: ICIQ-SF questionnaire at pre-op, 12 months follow up and 48 months follow up.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 11:58:42 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up at 6, 12, 24 and 48 months</P>
<P>Loss to follow-up Group A: 2/48; Group B: 0/48; Group C: 1/48</P>
<P>QoL and incontinence was evaluated with the ICIQ-SF</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-08 12:00:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Oliveira-2006">
<CHAR_METHODS MODIFIED="2015-06-01 16:39:42 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT-O and TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 12:00:20 +0100" MODIFIED_BY="[Empty name]">
<P>45 women</P>
<P>Inclusion criteria: women with SUI with and without ISD</P>
<P>Exclusion criteria: women with stage 2 or more POP, women with ISD</P>
<P>Mean age of 53.9 years</P>
<P>Participants had preoperative UDS diagnosis</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 12:00:20 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 17)<BR/>Group B: TVT-O (n = 28)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 12:00:21 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure by UDS: negative stress test at UDS and pad testing</LI>
<LI>Complications</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 12:00:21 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up 12 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-08 12:00:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Palomba-2008">
<CHAR_METHODS MODIFIED="2015-06-08 12:00:31 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TOT + mesh repair of POP vs TVT + mesh repair of POP</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 12:00:31 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: 15 women with cystocoele and SUI with urethral hypermobility</P>
<P>Exclusion criteria: BMI &gt; 30 kg/m; previous incontinence surgery and detrusor instability and/or intrinsic sphincter dysfunction</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 12:00:31 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT + mesh repair of POP</P>
<P>Group B: TVT + mesh repair of POP</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 12:00:31 +0100" MODIFIED_BY="[Empty name]">
<P>Trial terminated due to poor recruitment, no results published</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 12:00:31 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 21:58:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Paparella-2010">
<CHAR_METHODS MODIFIED="2015-06-08 12:01:00 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of synthetic UretexTO vs biological PelviLaceTO outside-inside TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 12:01:15 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: women with SUI and USI; SUI with urethro-vesical junction hypermobility without ISD</P>
<P>Exclusion criteria: POP &gt; stage 1; previous urogynaecological or anti-incontinence surgery; concurrent diseases such as psychiatric disease, diabetes, peripheral vascular disease; history of pelvic radiation; urge and mixed incontinence; DO; urgency or neurologic bladder; maximum urethral closure pressure &lt; 20 cm H<SUB>2</SUB>O and VLPP &lt; 60 cm H<SUB>2</SUB>O (indicators of intrinsic sphincter deficiency); maximum flow &#8804; 12 ml/s; and PVR volume &#8805; 100 ml</P>
<P>Mean age (years; SD): Group A: 60.7 (7.1); Group B: 59.4 (8.4)</P>
<P>Mean BMI kg/m (SD): Group A: 25.4 (1.8); Group B: 24.9 (1.8)</P>
<P>Menopausal: Group A: 26/34; Group B: 30/36 (participants in menopause were subjected to at least 1 month of local hormone replacement therapy both before and after the surgery)</P>
<P>QoL and sexual impact measured via: KHQ and PISQ-12</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 12:01:30 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: synthetic UretexTO (n = 34)</P>
<P>Group B: biological PelviLaceTO (n-36)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 21:58:36 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure of incontinence was defined as the absence of SUI, with a negative cough stress test; objective improvement as the improvement of SUI, with a positive cough stress test at a higher bladder filling than in the preoperative test; in all other cases it was considered a failure. </LI>
<LI>Subjective cure rates were self-evaluated by the participants as 'very satisfied', 'satisfied', or 'not satisfied'.</LI>
<LI>Mean operating time </LI>
<LI>Mean length of hospital stay days</LI>
<LI>Perioperative complications</LI>
<LI>Major vascular injury</LI>
<LI>Voiding dysfunction</LI>
<LI>Tape erosion</LI>
<LI>QoL: assessed with KHQ</LI>
<LI>PISQ-12 scores pre-operatively and at 2 years follow up.</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 12:05:57 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: synthetic (UretexTO; Bard, Covington, GA) is self-anchoring transobturator suburethral sling (1.2 cm wide and 45 cm long) made of the same monofilament polypropylene fibres used in many modern tension-free sling devices (for example TVT, TVT-O, TOT Monarc, TOT ARIS etc). Polypropylene is a very biocompatible material that has been used for many years in the construction of medical-grade synthetic meshes. The important difference is how the polypropylene fibres are knitted to form a cohesive macroporous mesh</P>
<P>Group B: biological material (PelviLaceTO; Bard, Covington, GA) is a tension-free and self-anchoring transobturator suburethral sling (1.5 cm wide and 40 cm long). It consists of a porcine dermal collagen implant that is intended to provide a matrix for the incorporation of new tissue, cells and blood vessels, thanks to a natural porosity and artificial V-shaped holes along the arms. Its collagen matrix consists of 3 amino acid chains arranged in a triple helix that has been cross-linked with hexamethylenediisocyanate to improve durability making the collagen non-resorbable by the collagenase (enzymes produced by inflammatory cells and fibroblasts that increase during surgery). It is also described as an acellular and deproteinised material so it should not cause an immune response</P>
<P>Follow-up evaluation was carried out after 6 weeks, 6 months, 1, and 2 years</P>
<P>2-year follow-up: Group A: 16.6 (3.0); Group B: 17.2 (3.0)</P>
<P>Loss to follow-up: Group A: 1/34; Group B: 0/36</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-20 22:03:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Park-2012">
<CHAR_METHODS MODIFIED="2015-05-27 08:44:23 +0100" MODIFIED_BY="[Empty name]">
<P>Pseudo RCT of TVT-O vs TOT (Monarc)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 12:06:20 +0100" MODIFIED_BY="[Empty name]">
<P>74 women</P>
<P>Inclusion criteria: women with SUI including those with MUI</P>
<P>Exclusion criteria: neurogenic bladder; POP; suspected ISD; or a past history of radical pelvic surgery</P>
<P>Mean age (years): Group A: 54.4 (10.13); Group B: 55.1 (10.63)</P>
<P>Mean BMI kg/m: Group A: 28.9 (0.53); Group B: 25.9 (0.48)</P>
<P>Urgency/UUI: Group A: 25/39; Group B: 22/35</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 12:06:20 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 39)</P>
<P>Group B: TOT Monarc (n = 35)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-20 22:03:06 +0100" MODIFIED_BY="[Empty name]">
<P>Cure was defined as the absence of any episodes of involuntary urine leakage during stressful activities and a stress test. Improvement was defined as a significant reduction in urine leakage, such that it did not require further treatment</P>
<UL>
<LI>Objective cure at 12 months and 3 years</LI>
<LI>Subjective cure at 12 months and 3 years</LI>
</UL>
<UL>
<LI>Subjective cure &amp; improvement at 1yr and 3 years </LI>
</UL>
<UL>
<LI>Voiding dysfunction</LI>
<LI>Bladder and urethral perforation</LI>
<LI>Groin pain</LI>
<LI>Post operative dyspareunia</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-04 14:14:10 +0000" MODIFIED_BY="[Empty name]">
<P>Cystoscopy was performed in all women</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-08 12:08:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peattie-2006">
<CHAR_METHODS MODIFIED="2014-07-02 15:35:51 +0100" MODIFIED_BY="[Empty name]">
<P>RCT TVT-O vs Monarc TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 12:08:57 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: women having a primary continence procedure without other surgery; diagnosis of USI; completed course of physiotherapy; completed family</P>
<P>Exclusion criteria: previous continence or prolapse surgery; neurological disease; pregnancy; UTI or vaginal infection; DO; voiding problem; anticoagulant use</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 12:08:57 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O</P>
<P>Group B: TOT</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 12:08:57 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcomes: objective and subjective cure of USI</P>
<P>Secondary outcomes:</P>
<UL>
<LI>operating time</LI>
<LI>blood loss</LI>
<LI>complications</LI>
<LI>pain</LI>
<LI>catheter use postoperatively</LI>
<LI>voiding</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 12:08:57 +0100" MODIFIED_BY="[Empty name]">
<P>Note: trial started recruitment 2006 but no evidence of current status i.e. completed or recruitment stopped or abandoned. No data published</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:52:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Porena-2007">
<CHAR_METHODS MODIFIED="2015-06-08 12:49:37 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT versus TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 12:50:09 +0100" MODIFIED_BY="[Empty name]">
<P>145 women</P>
<P>Inclusion criteria: women with stress or MUI (stress component clinically predominant) associated with urethral hypermobility (ICS definitions)</P>
<P>Exclusion criteria: previous anti-incontinence surgery and POP &gt; stage 1, according to the Half-Way system and POP-Q system classification, in any vaginal compartment</P>
<P>With the exception of DO, which was significantly more common in the TOT group, no significant intergroup differences emerged with regard to surgical histories, SUI grade, frequency of mixed incontinence, preoperative voiding or storage symptoms and preoperative urodynamic parameters</P>
<P>VLPP determined at a bladder volume of 200 mL and participants performed several Valsalva manoeuvers with a gradual increase in abdominal pressure. Participants stratified by VLPP &gt; 60 cm H<SUB>2</SUB>O or VLPP &#8804; 60 cm H<SUB>2</SUB>O</P>
<P>VLPP &#8804; 60 cm H<SUB>2</SUB>O (ISD): Group A: 25/70; Group B: 25/75</P>
<P>Mean age (years; SD): Group A: 61.8 (10.7); Group B: 60.6 (10)</P>
<P>Postmenopausal: Group A: 61/70; Group B: 64/75</P>
<P>SUI: Group A: 42/70; Group B: 41/75</P>
<P>MUI: Group A: 28/70; Group B: 34/75</P>
<P>DO: Group A: 4/70; Group B: 14/75</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 12:50:11 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 70)</P>
<P>Group B: TOT (n = 75)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 15:52:59 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcomes:</P>
<UL>
<LI>objective cure: participants were classified in 2 categories: 'dry' (no leakage during clinical examination and/or stress test and/or reported by participants) vs 'wet'. Wet participants were then sub-divided into 'improved' (&gt; 50% reduction in incontinence episodes) or 'failure'</LI>
<LI>operating time</LI>
<LI>intra- and postoperative complications including bladder injury, vaginal penetration and major vascular injury</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>postoperative lower urinary tract dysfunctions including voiding dysfunction</LI>
<LI>subjective and objective changes in SUI</LI>
<LI>tape erosion</LI>
</UL>
<P>All participants completed 2 validated questionnaires on QoL, the UDI-6 and the IIQ-7 before surgery, at 3, 6, 12 months postoperatively and then annually</P>
<P>Patient satisfaction outcome was measured via a VAS scale</P>
<P>Objective cure (dry)</P>
<P>Objective cure and improved (dry + wet but improved)</P>
<P>Subjective cure (dry)</P>
<P>Subjective cure and improved(dry + wet but improved)</P>
<P>Bladder injury</P>
<P>Vaginal perforation</P>
<P>Major vascular injury</P>
<P>Voiding Dysfunction</P>
<P>Tape erosion</P>
<P>Long-term follow-up (&gt; 6 years, mean 99  19 months): 83 participants (45 TOT; 38 TVT) underwent a telephone interview in October 2012.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 12:51:10 +0100" MODIFIED_BY="[Empty name]">
<P>TVT<SUP>TM</SUP> (Gynecare; Ethicon, Somerville, NJ, USA)</P>
<P>TOT<SUP>TM</SUP> was a fusion-welded, non woven, non knitted polypropylene tape (Obtapej; Mentor-Porges, Le Plessis-Robinson, France)</P>
<P>All participants underwent a preoperative urodynamic assessment and intraoperative cystoscopy</P>
<P>Follow-up was at 3, 6, and 12 months postoperatively, and then annually</P>
<P>Lower urinary tract dysfunctions and continence status were measured at each follow-up visit by a blinded assessor</P>
<P>The overall median follow-up was 35 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-08 12:58:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rechberger-2003">
<CHAR_METHODS MODIFIED="2015-06-08 12:58:23 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT and IVS</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 12:58:23 +0100" MODIFIED_BY="[Empty name]">
<P>100 women</P>
<P>Inclusion criteria: women with USI without concomitant pelvic pathology requiring surgery, some had had anti-incontinence surgery previously</P>
<P>Exclusion criteria: ISD</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 12:58:23 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 50)</P>
<P>Group B: IVS (n = 50)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 12:58:23 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cure rates</LI>
<LI>Operative and postoperative complications</LI>
</UL>
<P>Participants were considered totally cured when free of all SUI symptoms, and cough tests in supine and standing positions were negative. The operation was noted as a failure if the participant still reported urine leakage during increases in intra-abdominal pressure, the cough test with a comfortably full bladder was positive, and the woman had to change her pads because of being wet during the day</P>
<P>In the improvement group the cough test was negative but participants still experienced stress urinary leakage (much less frequent than previously) and the pads were occasionally wet</P>
<P>Postoperative UDS was not performed</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 12:58:22 +0100" MODIFIED_BY="[Empty name]">
<P>Median follow-up of 13.5 months (range 4 to 18 months)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 00:44:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rechberger-2009">
<CHAR_METHODS MODIFIED="2015-06-08 12:59:23 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of retropubic IVS-02 vs transobturator IVS-04, multifilament type 3 tape</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 12:59:23 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: women with SUI with a positive cough provocation test</P>
<P>Exclusion criteria: presence of uterine myoma; ovarian cyst; or advanced uterine or vaginal prolapse (POP-Q scale &gt; grade 1)</P>
<P>Mean age (years; SD): Group A: 55.56 (10.19); Group B: 55.75 (11.29)</P>
<P>Postmenopausal: Group A: 119/269; Group B: 125/268</P>
<P>VLPP: leak pressure during Valsalva manoeuvre was measured. VLPP was determined at 180 ml of bladder filling. ISD was defined as VLPP of &#8804; 60 cm H<SUB>2</SUB>O</P>
<P>ISD: Group A: 45/269; Group B: 40/268</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 12:59:23 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: retropubic (IVS-02; n = 269)</P>
<P>Group B: transobturator (IVS-04; n = 268)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 00:44:44 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure</LI>
<LI>Subjective improvement</LI>
<LI>Mean operating time</LI>
<LI>Bladder perforation</LI>
<LI>Major vascular injury</LI>
<LI>De novo urgency/UI</LI>
<LI>Voiding dysfunction</LI>
<LI>Vaginal tape erosion</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 13:00:16 +0100" MODIFIED_BY="[Empty name]">
<P>The follow-up visits were at 1, 4, 6, 12, and 18 months</P>
<P>Cystoscopy only performed in the retropubic group</P>
<P>Loss to follow-up: Group A: 68/269; Group B: 71/268</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:53:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rechberger-2011">
<CHAR_METHODS MODIFIED="2015-06-08 13:00:37 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of standard TOT vs TOT with 2-point tape fixation sutures to prevent tape displacement</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 15:53:27 +0100" MODIFIED_BY="[Empty name]">
<P>463 women</P>
<P>Inclusion criteria: women with urodynamically proven SUI, Including women with ISD</P>
<P>Exclusion criteria: OAB, MUI</P>
<P>Mean age (years; SD): Group A: 55.8 (11.3); Group B: 54.8 (9.8)</P>
<P>Mean BMI kg/m (SD): Group A: 28.9 (6.7); Group B: 28.2 (3.8)</P>
<P>ISD: Group A: 41/232; Group B: 42/231</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 13:00:37 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT (n = 232)</P>
<P>Group B: TOT with fixation (n = 231)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 00:46:55 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cured: self-reported subjective cure plus negative pad test plus negative cough stress test</LI>
<LI>Improved: negative cough stress test, negative pad test, but occasional symptoms persisting</LI>
<LI>Subjective cure and improvement</LI>
<LI>Objective cure</LI>
<LI>Bladder perforation</LI>
<LI>ISD cohort: Objective cure</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 14:18:06 +0100" MODIFIED_BY="[Empty name]">
<P>Both tapes were monofilament</P>
<P>Lost to follow-up: Group A: 19/232; Group B: 26/231</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 18:32:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Richter-2010">
<CHAR_METHODS MODIFIED="2015-06-08 13:02:42 +0100" MODIFIED_BY="[Empty name]">
<P>RCT: multi-centre randomised equivalence trial conducted in the USA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 18:32:12 +0100" MODIFIED_BY="[Empty name]">
<P>597 women</P>
<P>Inclusion criteria: age &gt;21 years; predominant SUI for &gt;3 months (urgency UI allowed); positive urinary stress test; bladder volume &gt;300 ml</P>
<P>Exclusion criteria: not defined</P>
<P>Baseline characteristics similar between groups</P>
<P>Mean age (years; SD): Group A: 52.7 (10.5); Group B: 53.1 (11.5)</P>
<P>Previous incontinence surgery: Group A: 38/297; Group B: 41/298</P>
<P>Previous prolapse surgery: Group A: 13/297; Group B: 10/298</P>
<P>Postmenopausal: Group A: 209/297; Group B: 206/298</P>
<P>BMI kg/m: Group A: 30.6; Group B: 30</P>
<P>HRT: Group A: 81/297; Group B: 90/298</P>
<P>Concomitant pelvic surgery: Group A: 73/298; Group B: 78/299</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 13:02:42 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: retropubic sling (TVT; n = 298)</P>
<P>Group B: transobturator tapes (TVT-O, and TOT Monarc; n = 299)</P>
<P>(Group C (?): TVT-O (inside-out) - separate data not provided)</P>
<P>(Group D (?): TOT (Monarch, outside-in) - separate data not provided)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 00:54:05 +0100" MODIFIED_BY="[Empty name]">
<P>Composite primary outcomes:</P>
<UL>
<LI>objective cure: negative stress test, dry pad test, no repeat treatment;</LI>
<LI>subjective cure: no SUI symptoms on questionnaire, no leakage in urinary diary</LI>
</UL>
<P>Secondary outcomes:</P>
<UL>
<LI>median blood loss</LI>
<LI>median operative time</LI>
<LI>bladder or urethral perforation</LI>
<LI>vaginal perforation</LI>
<LI>voiding dysfunction</LI>
<LI>mesh erosion/exposure</LI>
<LI>vascular injury</LI>
<LI>suprapubic/groin pain</LI>
<LI>de novo urgency incontinence</LI>
<LI>QOL: UDI questionnaire, IIQ questionnaire,</LI>
<LI>Sexual function: assessed via PISQ-12</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 13:22:07 +0100" MODIFIED_BY="[Empty name]">
<P>TOMUS trial NCT00325039</P>
<P>Per protocol</P>
<P>Lost to follow-up: Group A: 18/298; Group B: 14/299</P>
<P>PISQ measures dyspareunia, coital incontinence and fear of coital incontinence</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-08 13:28:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Riva-2006">
<CHAR_METHODS MODIFIED="2015-06-08 13:28:25 +0100" MODIFIED_BY="[Empty name]">
<P>RCT TVT versus TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 13:28:25 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: SUI with urethral hypermobility; age 40-85 years; urethro-cystocoele of grade 0-2</P>
<P>Exclusion criteria: previous prolapse or IU surgery; anterior or posterior vaginal wall repair with mesh</P>
<P>No difference recorded between the 2 groups for age, parity, or incontinence severity</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 13:28:25 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT (n = 65)</P>
<P>Group B: TVT (n = 66)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-08 13:28:25 +0100" MODIFIED_BY="[Empty name]">
<P>Gynaecological examination, full urodynamic evaluation, voiding diary and KHQ were performed pre- and postoperatively</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 13:28:26 +0100" MODIFIED_BY="[Empty name]">
<P>12-month follow-up</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 01:02:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salem-2014">
<CHAR_METHODS MODIFIED="2015-06-02 06:08:14 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TOT vs TVT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-02 06:08:14 +0100" MODIFIED_BY="[Empty name]">
<P>76 women with SUI, all had urodynamics</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-02 06:08:14 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TOT (n = 37)</P>
<P>Group B: TVT (n = 39)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:02:01 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cure of SUI: defined as no leak during Bonny test, and high leak point pressure and urethral pressure profile</LI>
<LI>Mean operative time</LI>
<LI>Perioperative complications</LI>
<LI>Intraoperative blood loss</LI>
<LI>Hospital stay</LI>
<LI>Postoperative urodynamic</LI>
<LI>Time to return to normal activities</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-06-29 14:54:34 +0100" MODIFIED_BY="[Empty name]">
<P>No usable data provided</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 01:11:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Scheiner-2012">
<CHAR_METHODS MODIFIED="2014-04-15 09:30:21 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TOT (Monarc) vs TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 13:32:55 +0100" MODIFIED_BY="[Empty name]">
<P>2 public teaching hospitals in Switzerland</P>
<P>Inclusion criteria: women with urodynamically confirmed SUI, or MUI with predominant SUI</P>
<P>Exclusion criteria: missing urodynamic assessment; previous sling procedure; predominant OAB; a PVR &gt; 100 ml</P>
<P>Mean age (years; SD): Group A: 57.8 (13.0); Group B: 56.6 (10.3); Group C: 59.3 (12.1)</P>
<P>Mean BMI kg/m (SD): Group A: 26.4 (3.7) Group B: 27.8 (4.6); Group C: 27.6 (4.8)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 13:32:55 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 80)</P>
<P>Group B: TOT outside-in approach (Monarc; n = 40)</P>
<P>Group C: TVT-O inside-out approach (Gynecare; n = 40)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:11:51 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: negative cough test (performed with a bladder filling of 300 ml) and a negative short-pad test (pad weight gain &lt;3g was defined as negative)</LI>
<LI>Subjective cure: participant&#8217;s global impression (cured, improved, failed)</LI>
<LI>Subjective cured and improved</LI>
<LI>Mean operation time</LI>
<LI>Mean blood loss </LI>
<LI>Mean hospital stay </LI>
<LI>Bladder perforation</LI>
<LI>Vaginal perforation</LI>
<LI>Thigh/groin pain</LI>
<LI>Vascular damage</LI>
<LI>Voiding dysfunction</LI>
<LI>Tape erosion</LI>
<LI>QoL: assessed by means of the validated German version of the KHQ</LI>
<LI>Sexual function: assessed by direct questioning. </LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 13:35:53 +0100" MODIFIED_BY="[Empty name]">
<P>Preoperatively, conservative measures for SUI were recommended, such as use of local estrogens, pelvic floor re-education, or incontinence pessaries. A symptomatic cystocele stage 2 or higher according to the POP-Q system was corrected first. Participants with concomitant sling insertion to repair prolapse were included</P>
<P>Cystoscopy was mandatory for every procedure</P>
<P>Lost to follow-up: Group A: 15; Group B: 6; Group C: 3</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 18:47:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schierlitz-2008">
<CHAR_METHODS MODIFIED="2015-06-08 13:37:24 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of retropubic (TVT&#8482; ) versus transobturator (Monarc&#8482;)) sling in the treatment of women with USI and ISD</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 18:33:28 +0100" MODIFIED_BY="[Empty name]">
<P>163 women</P>
<P>Inclusion criteria: women with SUI who had unsuccessful conservative therapy and, on UDS, had a diagnosis of USI and ISD</P>
<P>ISD was defined as either a maximum urethral closure pressure (measured both with the bladder empty and at capacity) of &lt;20 cm H<SUB>2</SUB>O and/or a pressure rise from baseline required to cause incontinence (Valsalva or cough leak point pressure) of &#8804;60 cm H<SUB>2</SUB>O</P>
<P>Exclusion criteria: presence of pelvic infection; a persistent PVR volume &gt; 100 ml; malignancy; fistula; or congenital or neurogenic bladder disorder</P>
<P>Mean age (years; SD): Group A: 60 (11.5); Group B: 60 (10.9)</P>
<P>Post menopausal: Group A: 66/82; Group B: 68/82</P>
<P>Previous incontinence surgery: Group A: 6/82; Group B: 11/82</P>
<P>Concomitant surgery: Group A: 29/82; Group B: 26/82</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 13:37:57 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 81)</P>
<P>Group B: Monarc sling (n = 82)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:18:10 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: absence of USI</LI>
<LI>Subjective cure: absence of self-reported SUI</LI>
<LI>Bladder perforation</LI>
<LI>Major vascular injury</LI>
<LI>Groin pain</LI>
<LI>Voiding dysfunction</LI>
<LI>De novo urgency</LI>
<LI>De novo urgency incontinence</LI>
<LI>De novo urgency and UUI</LI>
<LI>Re-operation</LI>
<LI>Vaginal perforation</LI>
<LI>QoL: via UDI-6 AND IIQ-7</LI>
<UL>
<LI>The short forms of the UDI-6 and the IIQ-7 were used for subjective assessment of QoL. </LI>
</UL>
<LI>Sexual function: via PISQ-12</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-21 18:45:39 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up was at 6 weeks and 6 months, then yearly for 3 years</P>
<P>Loss to follow-up: Group A: 5/82; Group B: 4/82</P>
<P>At 3-year follow-up:</P>
<P>Group A: 72 followed-up with 70 completing questionnaires, and 48 completing examination</P>
<P>Group B: 75 followed-up with 60 completing questionnaires, and 40 completing examination</P>
<P>The number available for follow up or number lost to follow up at 5yrs was not made clear (authors have been contacted and response is awaited)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 18:33:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tanuri-2010">
<CHAR_METHODS MODIFIED="2015-06-08 14:16:53 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of retropubic Safyre VS adjustable sling system and Safyre T adjustable transobturator sling system</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 14:16:53 +0100" MODIFIED_BY="[Empty name]">
<P>30 women</P>
<P>Inclusion criteria: women with SUI</P>
<P>Exclusion criteria: use of drugs (adrenergic, anticholinergic or serotonergic); hormone therapy within the previous 6 months; prior pelvic radiotherapy or current chemotherapy or hormone therapy; POP &gt; stage 2; MUI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:16:53 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: Safyre VS retropubic tape (n = 10)</P>
<P>Group B: Safyre T transobturator tape (n = 20)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 18:33:48 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure: no reported SUI</LI>
<LI>Objective cure: negative stress test or &lt;1g urine weight at modified pad test</LI>
</UL>
<UL>
<LI>Pad test</LI>
<LI>De novo urgency incontinence</LI>
<LI>Voiding dysfunction</LI>
<LI>Groin pain</LI>
<LI>Bladder perforation</LI>
<LI>Tape erosion</LI>
<LI>Mean QoL Scores: via KHQ</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-21 15:55:48 +0100" MODIFIED_BY="[Empty name]">
<P>Follow-up was at 1, 6 and 12 months</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 01:25:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tarcan-2011">
<CHAR_METHODS MODIFIED="2015-06-08 14:20:02 +0100" MODIFIED_BY="[Empty name]">
<P>RCT: TVT (Advantage<SUP>R</SUP>) vs TOT (Obtryx<SUP>R</SUP>)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 01:25:04 +0100" MODIFIED_BY="[Empty name]">
<P>54 women with urodynamic SUI</P>
<P>SUI: n = 10; MUI: n = 35</P>
<P>Median age in years (range): 54 (31-76)</P>
<P>BMI kg/m: Group A: 27.8 (4.6); Group B: 27.4 (4.04)</P>
<P>Concomittant POP surgery: Group A: 5/27; Group B: 2/27</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:22:01 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 27)</P>
<P>Group B: TOT (n = 27)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:25:52 +0100" MODIFIED_BY="[Empty name]">
<P>12-month follow-up assessed:</P>
<UL>
<LI>cure: negative stress provocation test</LI>
</UL>
<UL>
<LI>mean operative time in minutes</LI>
</UL>
<P>2 year follow-up assessed:</P>
<UL>
<LI>subjective cure</LI>
<LI>mean operating time</LI>
<LI>QoL: via SEAPI</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 14:25:22 +0100" MODIFIED_BY="[Empty name]">
<P>Concomitant POP surgery was performed in 7 women (6 cystocele, 1 rectocoele)</P>
<P>No mention of intraoperative cystoscopy</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:56:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Teo-2011">
<CHAR_METHODS MODIFIED="2015-06-02 06:22:46 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 14:26:09 +0100" MODIFIED_BY="[Empty name]">
<P>127 women recruited from 2 hospitals in the UK</P>
<P>Inclusion criteria: women with USI</P>
<P>Exclusion criteria: previous continence surgery; OAB symptoms; DO; POP-Q &gt; stage 1; presence of voiding dysfunction (defined as maximum flow rate &lt; 15 ml/s or PVR volume &#8805; 100 ml)</P>
<P>Women in both groups had similar background characteristics, degree of severity of symptoms and QoL scores</P>
<P>Mean age (years; SD): Group A: 52.4 (11.8); Group B: 50.9 (11.4)</P>
<P>Median BMI kg/m (range): Group A: 27 (21-37); Group B: 29 (21-50)</P>
<P>Postmenopausal: Group A: 24/66; Group B: 19/61</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:26:13 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 66)</P>
<P>Group B: TVT-O (n = 61)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 15:56:49 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: via 24-hour pad test (cure defined as a test result of &lt; 5 g)</LI>
<LI>Subjective cure: self-reported on PGII scale - considered cured if they were "very much better"</LI>
</UL>
<UL>
<LI>Major vascular injury</LI>
<LI>Voiding dysfunction</LI>
<LI>Bladder perforation</LI>
<LI>De novo urgency/UI</LI>
<LI>Tape erosion</LI>
<LI>Groin pain</LI>
</UL>
<UL>
<LI>QoL: via KHQ14 and ICIQ-SF15 questionnaires</LI>
</UL>
<UL>
<UL>
<LI>Baseline scores:</LI>
<UL>
<LI>Median KHQ score (range) A: 384 (122&#8211;814), B: 399 (106&#8211;814)</LI>
<LI>Median ICIQ-SF score (range): A: 15 (7&#8211;21), B: 14 (3&#8211;21)</LI>
</UL>
<LI>12 months follow up scores:</LI>
<UL>
<LI>Median KHQ score (range): A: 50 (0&#8211;510), B: 61 (0&#8211;748)</LI>
<LI>Median ICIQ-SF score (range): A: 4 (0&#8211;16), B<B>: </B>0 (0&#8211;11)</LI>
</UL>
</UL>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 14:34:47 +0100" MODIFIED_BY="[Empty name]">
<P>Intraoperative cystoscopy with a 70 cystoscope performed in all cases</P>
<P>Loss to follow-up at 12 months: Group A: 25/66; Group B: 32/61</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 01:34:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tommaselli-2012">
<CHAR_METHODS MODIFIED="2015-06-08 14:35:51 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT-O and a modified version of TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 14:36:33 +0100" MODIFIED_BY="[Empty name]">
<P>72 women</P>
<P>Inclusion criteria: urodynamically proved SUI; age &gt; 30 years; and previously failed pelvic floor muscle training</P>
<P>Exclusion criteria: previous surgery for SUI; isolated OAB; POP &#8805; stage 2; neurological disease</P>
<P>Mean age (years; SD): Group A: 51 (9.5); Group B: 55 (6.8)</P>
<P>Mean BMI kg/m (SD): Group A: 27.5 (4.9); Group B: 28.9 (3.7)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:36:36 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 48)</P>
<P>Group B: modified TVT-O (n = 24)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:34:00 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure (negative stress test)</LI>
<LI>No intraoperative complications reported in either group.</LI>
<LI>Voiding dysfunction</LI>
<LI>Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (QoL: via PISQ-12 and PGI-S)</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 14:38:16 +0100" MODIFIED_BY="[Empty name]">
<P>For the modified TVT-O: &#8220;Briefly, in contrast with the traditional technique, the paraurethral dissection was minimal and carried only up to the pubic ramus, without perforating the obturator membrane with the scissors The aim of this reduced dissection was to create a passage of very limited size to introduce the guide only up to the bone, without perforating the membrane. Thus, as opposed to the original procedure, the obturator membrane was perforated only by the helical passer&#8221;</P>
<P>Lost to follow-up: Group A: 2/48; Group B: 1/24</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:41:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tseng-2005">
<CHAR_METHODS MODIFIED="2015-06-08 14:40:07 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT with SPARC</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 01:35:05 +0100" MODIFIED_BY="[Empty name]">
<P>62 women</P>
<P>Inclusion criteria: women with USI with or without POP</P>
<P>Exclusion criteria: those with POP &gt; ICS stage 2 and those with previous anti-incontinence surgery</P>
<P>Mean age was 51 years and median parity of 3. The 2 groups were similar in terms of age, parity and menopausal status</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:40:07 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: SPARC (n = 31)<BR/>Group B: TVT (n = 31)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 15:41:27 +0100" MODIFIED_BY="[Empty name]">
<P>Objective cure: defined as pad weight &#8804;1g</P>
<P>Improved: participants whose loss decreased to &lt; half of the preoperative value were considered to have improved</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-21 01:34:49 +0100" MODIFIED_BY="[Empty name]">
<P>All women had routine suprapubic ultrasonography for detecting unrecognised subcutaneous or retropubic haematoma on the day immediately after the operation, and 7/8 of those with retropubic haematoma of &gt;5 cm diameter were discharged uneventfully from the hospital within 7 days of the operation. Ultrasonography performed at the 1 month follow-up visit revealed complete resolution of the haematoma for every participant</P>
<P>Follow-up at 2 years</P>
<P>Women and their outcome assessors were blinded, but the exact method used to achieve this was unclear</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 18:35:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ugurlucan-2013">
<CHAR_METHODS MODIFIED="2015-06-08 14:40:51 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of PELVILACE TO (biological TOT material) vs synthetic TOT material (ALIGN TO urethral support system)</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 18:35:08 +0100" MODIFIED_BY="[Empty name]">
<P>100 women</P>
<P>Inclusion criteria: women &gt;18 years with SUI, MUI or USI in whom conservative treatment had failed. Women with or without POP were included</P>
<P>Exclusion criteria: women with ISD</P>
<P>Pre- and postoperative assessments included evaluation of urinalysis and urine culture POP evaluation using POP-Q system, 1-hr pad test, 4-day bladder diary, stress test, Q-tip test, and QoL assessment using the KHQ, UDI-6, and the IIQ-7. This was repeated at the 12-month follow-up. Postoperative urodynamics was performed in all patients accepting the procedure</P>
<P>Mean age (years; SD): Group A: 55.0 (12.3); Group B: 52.9 (10.6)</P>
<P>Mean BMI kg/m (SD): Group A: 31.8 (6.6); Group B: 31.3 (4.8)</P>
<P>Postmenopausal: Group A: 29 (56.9%); Group B: 30 (58.8%)</P>
<P>Previous incontinence surgery: Group A: 2 (4%); Group B: 2 (4%)</P>
<P>Concomitant POP surgery: Group A: 28/50; Group B: 28/50</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:41:52 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: biological PELVILACE TO (n = 50)</P>
<P>Group B: synthetic TOT ALIGN <SUP></SUP>TO (n = 50)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:41:19 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: patient-reported improvement in urinary incontinence (either completely dry or improvement in symptoms of SUI; reported as 'cure,' 'better than before,' 'no change at all,' and 'worse than before.')<BR/>Secondary outcomes:</P>
<UL>
<LI>objective cure: defined as the absence of SUI and a negative stress test at 200 ml in the standing position</LI>
<LI>objective improvement: defined as improvement in the bladder diary and questionnaires</LI>
<LI>Subjective evaluation by the patients was reported as &#8220;cure,&#8221; &#8220;better than before,&#8221; &#8220;no change at all,&#8221; and &#8220;worse than before.&#8221;</LI>
<LI>intra- and postoperative complications</LI>
<LI>reoperation rate</LI>
<LI>Groin pain</LI>
<LI>Vaginal tape erosion</LI>
<LI>QoL: assessed via KHQ, P-QoL, UDI-6, and IIQ-7</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 14:44:40 +0100" MODIFIED_BY="[Empty name]">
<P>Biological tape was PELVILACE TO system; Bard, Covington, GA, USA and the synthetic tape was ALIGN TO urethral support system; Bard TOT operation. The PELVILACE TO system consists of a PELVICOL self-anchoring, natural tissue sling implant and an introducer system. This system contains a self-anchoring, 1.5 cm wide, and 40 cm long suburethral sling of porcine dermal collagen. The ALIGN TO urethral support system is a suburethral sling device made of type 1 monofilament polypropylene mesh designed for the treatment of SUI through the TOR</P>
<P>Postmenopausal patients received local estrogen treatment for 1 month before and after the operation</P>
<P>Concomitant POP was performed in a cohort of women</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:57:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-Leijsen-2013">
<CHAR_METHODS MODIFIED="2015-06-08 14:45:04 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing RPR and TOT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 15:57:59 +0100" MODIFIED_BY="[Empty name]">
<P>Dutch multicentre diagnostic cohort study with an embedded RCT</P>
<P>587 women with SUI; 123 randomised to surgery</P>
<P>Inclusion criteria: women with urodynamically-proven SUI, or MUI with SUI as predominant symptom following failed conservative treatment</P>
<P>Exclusion criteria: prior incontinence surgery; POP &gt; stage 2 POP-Q; post PVR of &gt;150 ml (by USS or characterisation)</P>
<P>MUI: Group A: 18/33; Group B: 61/90</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:45:04 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: RPR (n = 33)</P>
<P>Group B: TOT (n = 90)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:44:05 +0100" MODIFIED_BY="[Empty name]">
<P>Outcome results for TOT and RPR not reported as separate figures; we contacted the authors who supplied separate figures</P>
<UL>
<LI>Subjective cure: defined as self-reported absence of SUI</LI>
<LI>Objective cure: defined as negative stress test (any leakage of urine was a defined as a failure)</LI>
<LI>Subjective cure3</LI>
<LI>Objective cure</LI>
<LI>De novo urgency incontinence</LI>
<LI>Voiding dysfunction</LI>
<LI>Tape release for POVD</LI>
<LI>Repeat incontinence surgery</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 14:46:12 +0100" MODIFIED_BY="[Empty name]">
<P>QoL questionnaires: UDI</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 15:58:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2006">
<CHAR_METHODS MODIFIED="2015-06-08 14:47:04 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TOT (Monarc) and SPARC suburethral sling procedures</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 15:58:33 +0100" MODIFIED_BY="[Empty name]">
<P>60 women with an average age of 50 years (SD 10.71 )<BR/>Inclusion criteria: women with USI</P>
<P>Exclusion criteria: women suffering from preoperative voiding dysfunction, which was defined as either: free Q max of &#8804; 12ml/s in repeated free uroflow studies combined with Pdet Q max of &#8805;20cm H<SUB>2</SUB>O, PVR urine &#8805; 100 ml, and participants with a pad increase of at least 10cm H<SUB>2</SUB>O, compared to the baseline abdominal pressure in a pressure-flow study. Women who had previous anti-incontinence surgery and/or with pelvic prolapse &gt; stage 2 of the ICS grading system were also excluded.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:47:27 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: Monarc (n = 31)</P>
<P>Group B: SPARC (n = 29)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:45:43 +0100" MODIFIED_BY="[Empty name]">
<P>Assessed via 1-hr pad test, multichannel urodynamic assessment, complications and postoperative voiding function. Transabdominal USS to detect subcutaneous, retropubic or obturator haematoma</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 14:47:42 +0100" MODIFIED_BY="[Empty name]">
<P>The women were blinded to the procedure performed</P>
<P>Intraoperative cystoscopy was performed in both groups</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 16:00:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2008">
<CHAR_METHODS MODIFIED="2015-06-08 14:48:34 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs TVT-O</P>
<P>Single-blinded</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 16:00:07 +0100" MODIFIED_BY="[Empty name]">
<P>69 women</P>
<P>Inclusion criteria: severe female SUI with or without prolapse (&lt; POP-Q stage 3)</P>
<P>Exclusion criteria: pregnancy; previous surgery for urinary incontinence</P>
<P>Mean BMI kg/m (SD): Group A: 25 (3); Group B: 25 (3)</P>
<P>Mean age (years; SD): Group A: 52 (11); Group B: 52 (11)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:49:02 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 35)</P>
<P>Group B: TVT-O (n = 34)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 16:00:03 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure: no self-reported leaking and negative stress test: </LI>
<LI>Subjective cure and improvement</LI>
<LI>Failure: 1-h pad test not reduced by 50%</LI>
<LI>Operative time </LI>
<LI>Blood loss </LI>
<LI>Length of hospital stay </LI>
<LI>Bladder/visceral perforation</LI>
<LI>Voiding dysfunction</LI>
<LI>Haematoma</LI>
</UL>
<UL>
<LI>QoL: UDI-6 and IIQ-7 before and after surgery</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 14:51:10 +0100" MODIFIED_BY="[Empty name]">
<P>Concomittant surgery: some women also had transvaginal hysterectomy and prolapse repair</P>
<P>Follow-up: mean 14.5 months</P>
<P>Cystoscopy performed in TVT group only</P>
<P>Article written in Chinese and translated to English for interpretation and data extraction</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 16:03:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2009">
<CHAR_METHODS MODIFIED="2015-06-08 14:51:29 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT vs inside-out TVT-O</P>
<P>55 were participants in a previous study (ref 8, Zhu 2007: 23870; 27325) &#8211; already included</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-21 16:03:05 +0100" MODIFIED_BY="[Empty name]">
<P>300 women</P>
<P>Inclusion criteria: demonstrable severe SUI, or mild to moderate SUI that failed to respond to conservative treatment. All women had urodynamically confirmed USI (no detrusor contraction on leakage)</P>
<P>Exclusion criteria: ;ISD MUI; pregnancy; UTI; UUI; PVR volume &gt; 100 ml; neurological disease; urogenital malignancy, fistula, or pelvic radiotherapy</P>
<P>Menopausal: Group A: 87/154; Group B: 88/146</P>
<P>Previous prolapse surgery:</P>
<P>Previous incontinence surgery: Group A: 5; Group B: 5</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 14:51:29 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 154)</P>
<P>Group B: TVT-O (n = 146)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 01:55:35 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Cure: negative cough test at follow-up (possibly objective):</LI>
<LI>Improvement: frequency of UI episodes and urine weight on pad test reduced by &gt; 50%</LI>
<LI>Failure: frequency of UI episodes ad urine weight on pad test reduced by &lt; 50% or worse than before surgery)</LI>
<LI>Mean operative time in minutes </LI>
<LI>Mean blood loss </LI>
<LI>Operative time</LI>
<LI>Mean length of hospital stay</LI>
<LI>Adverse effects</LI>
<LI>Urinary retention</LI>
<LI>De novo UUI</LI>
<LI>Vaginal tape erosion: </LI>
<LI>Groin/thigh pain</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-21 16:03:23 +0100" MODIFIED_BY="[Empty name]">
<P>Signed informed consent, approved by Ethics committee</P>
<P>Mean follow-up: (months; SD): Group A: 19.6 (11.9); Group B: 20.5 (10.7; twice in first year, then yearly)</P>
<P>Loss to follow-up: Group A: 6; Group B: 8, + 1 withdrawn (operation postponed)</P>
<P>Cystoscopy only performed in the TVT group</P>
<P>Concomitant prolapse and other surgery </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 02:00:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2010">
<CHAR_METHODS MODIFIED="2015-06-08 15:02:19 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT and TOT-outside/in</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 15:02:19 +0100" MODIFIED_BY="[Empty name]">
<P>140 women</P>
<P>Inclusion criteria: women with urodynamically proven SUI</P>
<P>Exclusion criteria: OAB syndrome dry or wet</P>
<P>Age (years; SD): Group A: 60 (10.8); Group B: 58 (11.6)</P>
<P>Previous incontinence surgery: Group A: 5; Group B: 3</P>
<P>BMI kg/m (SD): Group A: 24 (2.4); Group B: 24.6 (2.6)</P>
<P>Concomitant POP: Group A: 30/70; Group B: 22/70</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 15:02:19 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 70)</P>
<P>Group B: TOT (n = 70)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 02:00:45 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure</LI>
<LI>Objective cure: negative cough test, 1-h pad test of &lt;2g. </LI>
<LI>Improved: persistence of SUI (though occasional) not affecting daily activities or requiring further treatment</LI>
<LI>Vascular injury/haematoma</LI>
<LI>Tape erosion</LI>
<LI>Bladder perforation</LI>
<LI>Voiding dysfunction</LI>
<LI>De novo urgency/UII</LI>
<LI>QoL assessed by UDI-6) and IIQ-7-SF</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 15:03:15 +0100" MODIFIED_BY="[Empty name]">
<P>Cystoscopy only performed when bladder perforation suspected in TOT group. All TVT participants cystoscoped post procedure</P>
<P>Concomitant surgery: All participants with POP had this repaired at the time of tape insertion</P>
<P>Lost to follow-up: Group A: 0 women; Group B: 0 women</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 02:03:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2011">
<CHAR_METHODS MODIFIED="2015-06-08 15:03:43 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT, TVT-O and TVT-Secur</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 15:03:43 +0100" MODIFIED_BY="[Empty name]">
<P>Total of 102 women included in this Chinese trial</P>
<P>Inclusion criteria: women with urodynamically proven SUI. If MUI, then SUI was the predominant symptom</P>
<P>Exclusion criteria: women with previous surgical procedures for SUI</P>
<P>Mean age (years; SD): Group A: 56.6 (9.6); Group B: 56.0 (9.1)</P>
<P>Mean BMI kg/m (SD): Group A: 25.3 (2.0); Group B: 27.3 (1.9)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 15:03:43 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 32)</P>
<P>Group B: TVT-O (n = 36)</P>
<P>Group C: TVT- Secur (data not included in this review)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 02:03:33 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure: negative cough stress test</LI>
<LI>Subjective cure: absence of SUI symptoms</LI>
<LI>Improvement: negative or a positive cough stress test and reduced SUI symptoms:</LI>
<LI>Mean length of surgery</LI>
<LI>Bladder perforation</LI>
<LI>Voiding dysfunction</LI>
<LI>Groin pain</LI>
<LI>De novo urgency or urgency incontinence</LI>
<LI>Vascular injury</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 15:04:19 +0100" MODIFIED_BY="[Empty name]">
<P>Power test calculation performed</P>
<P>Women with SUI were put on anticholinergic treatment prior to surgery</P>
<P>QoL assessment was performed using the ICI-Q-SF pre-operatively; no data for post-operative scores</P>
<P>Cystoscopy routinely performed in TVT. Cystoscopy only performed if bladder injury was suspected in the TVT-O group</P>
<P>Follow-up 1, 3, 6 and 12 months</P>
<P>All women completed the trial (no loss to follow-up)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 02:05:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2011">
<CHAR_METHODS MODIFIED="2015-06-08 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT-O with a modified version of TVT-O using a self-tailored mesh</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>156 women in a Chinese hospital</P>
<P>Inclusion criteria: women with SUI aged &gt; 18 years</P>
<P>Exclusion criteria: women with urgency; persistent urinary retention (PVR &gt; 50 ml); dysuria; other urologic diseases and psychiatric disorders</P>
<P>Mean age (years; SD): Group A: 61.4 (5.4); Group B: 62.6 (3.2)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 15:04:53 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT-O (n = 76)</P>
<P>Group B: modified TVT-O (n = 80)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 02:05:24 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Subjective cure: disappearance of SUI symptoms</LI>
<LI>Subjective improvement</LI>
<LI>Mean operative time</LI>
<LI>Mean blood loss </LI>
<LI>Mean hospital stay in days</LI>
<LI>Voiding dysfunction</LI>
<LI>QOL: self-administered I-QOL</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 15:06:05 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2015-06-21 02:07:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zullo-2007">
<CHAR_METHODS MODIFIED="2015-06-08 15:07:04 +0100" MODIFIED_BY="[Empty name]">
<P>RCT comparing TVT and TVT-O</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-08 15:07:04 +0100" MODIFIED_BY="[Empty name]">
<P>72 women</P>
<P>Inclusion criteria: women affected by SUI with no contraindications to vaginal surgery</P>
<P>Excluded criteria: women with urogenital prolapse &gt; stage 1; DO; symptoms of OAB; intrinsic urethral sphincter deficiency; urinary retention; previous anti-incontinence surgery; neurologic bladder; and psychiatric disease</P>
<P>Age (years; SD): Group A: 52.8 (11.8); Group B: 53.4 (10.7)</P>
<P>BMI kg/m: Group A: 25.7 (2.9); Group B: 26.5 (2.7)</P>
<P>Menopausal: Group A: 6/35; Group B: 8/37</P>
<P>POP stage 1 and 2: Group A: 34/35; Group B: 35/37<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-08 15:07:11 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: TVT (n = 35)</P>
<P>Group B: TVT-O (n = 37)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-21 02:07:32 +0100" MODIFIED_BY="[Empty name]">
<UL>
<LI>Objective cure (no leakage of urine with urodynamic stress testing)</LI>
<LI>Subjective cure: VAS used to quantify participant perception of SUI symptom severity</LI>
<LI>Incidence of overall perioperative complications</LI>
<LI>De novo urgency and urge incontinence</LI>
<LI>Tape erosion</LI>
<LI>Voiding dysfunction</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2015-06-08 15:09:24 +0100" MODIFIED_BY="[Empty name]">
<P>Intraoperative cystoscopy only performed in the TVT group</P>
<P>12 participants did not return for 5-year follow-up: 3 participants were lost (2 in the TVT group and 1 in the TVT-O group), and 9 withdrew (4 in the TVT group and 5 in the TVT-O group)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Abbreviations</B>
</P>
<P>BFLUTS: Bristol lower urinary tract symptoms questionnaires</P>
<P>BMI: body-mass index</P>
<P>DO: detrusor overactivity</P>
<P>DUP: distal urethral polypropylene sling</P>
<P>EQOL-5D: Euro Quality of life -5 Dimension</P>
<P>g: gram</P>
<P>hr: hour</P>
<P>HRT: hormone replacement therapy</P>
<P>ICIQ: International Consultation on Incontinence questionnaire</P>
<P>ICIQ-FLUTS: International Consultation on Incontinence questionnaire - female lower urinary tract symptoms</P>
<P>ICIQ- LUTSquol: International Consultation on Incontinence questionnaire - lower urinary tract quality of life questionnaire</P>
<P>ICIQ-SF: International Consultation on Incontinence questionnaire short form</P>
<P>ICIQ-SF15: International Consultation on Incontinence questionnaire short form 15</P>
<P>IIQ: Incontinence Impact questionnaire</P>
<P>ICS: International Continence Society</P>
<P>I-QoL: Incontinence Quality of Life questionnaire</P>
<P>ISD: intrinsic sphincter deficiency</P>
<P>IVS: intravaginal slingoplasty</P>
<P>KHQ: King's Health questionnaireMUI: mixed urinary incontinence</P>
<P>MUCP: Maximum urethral closure pressure</P>
<P>MUI: mixed urinary incontinence</P>
<P>OAB: overactive bladder</P>
<P>PGI-I: Patient Global Impression of Improvment</P>
<P>PGI-S: Patient Global Impression of Severity</P>
<P>PISQ-12: pelvic organ prolapse/urinary incontinence sexual questionnaire</P>
<P>POP: pelvic organ prolapse</P>
<P>POP-Q: pelvic organ prolapse quantification</P>
<P>POP-Q ICS: pelvic organ prolapse quantification International Continence Society</P>
<P>PVR: post void residual</P>
<P>RCT: randomized controlled trial</P>
<P>RPR: retropubic route</P>
<P>QoL: quality of life</P>
<P>QRCT: quasi-randomised trial</P>
<P>SEAPI-QMM: Stress related leak, Empyting ability, Anatomy, Protection, Inhibition-Quality of life, Mobility and Mental status incontinence classification system</P>
<P>SD: standard deviation</P>
<P>SIS: Single incision sling</P>
<P>SPARC: suprapubic arc (procedure)</P>
<P>SUI: stress urinary incontinence</P>
<P>TOR: transobturator</P>
<P>TOT: transobturator tape</P>
<P>TOT-ARIS: transobturator tape-ARIS</P>
<P>TVT: tension-free vaginal tape</P>
<P>TVT-O: transobturator tension-free vaginal tape</P>
<P>UDI: Urinary Distress Impact questionnaire</P>
<P>UDI-6: Urinary Distress Impact questionnaire short form</P>
<P>UDS: urodynamics study</P>
<P>UI: urinary incontinence</P>
<P>UISS: urinary incontinence severity score</P>
<P>USI: urodynamic stress incontinence</P>
<P>USS: ultrasound</P>
<P>UTI: urinary tract infection</P>
<P>UUI: urgency urinary incontinence</P>
<P>VAS: visual analogue scale</P>
<P>VLPP: Valsalval leak point pressure</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2015-06-21 16:21:53 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2008-07-06 03:57:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Al_x002d_Tayyem-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-07-06 03:57:55 +0100" MODIFIED_BY="[Empty name]">
<P> Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:11:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Amat-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:11:31 +0100" MODIFIED_BY="[Empty name]">
<P>Sling apparently equivalent to TVT, but too little information provided to determine equivalence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:11:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ballert-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:11:35 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:11:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bekker-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:11:42 +0100" MODIFIED_BY="[Empty name]">
<P>Sexual function analysis of 2 retrospective studies (not RCTs)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:11:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Borrell-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:11:48 +0100" MODIFIED_BY="[Empty name]">
<P>Retrospective study, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bracken-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:01 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of bupivacaine and saline versus saline only for hydrodissection during TVT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bruschini-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:07 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-02 07:05:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-02 07:05:18 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chen-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:15 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective comparative study with participants assigned not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chene-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:20 +0100" MODIFIED_BY="[Empty name]">
<P>Was prospective, but not stated that randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chong-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:26 +0100" MODIFIED_BY="[Empty name]">
<P>All women had TVT. Intervention groups were division vs no division of tape</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Corcos-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:35 +0100" MODIFIED_BY="[Empty name]">
<P>Traditional slings. No minimally invasive sling</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Corcos-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:46 +0100" MODIFIED_BY="[Empty name]">
<P>No minimally invasive sling</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cotte-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:51 +0100" MODIFIED_BY="[Empty name]">
<P>An ultrasound study comparing tape position between RPR and TOR</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:13:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Courtney_x002d_Watson-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:13:58 +0100" MODIFIED_BY="[Empty name]">
<P>Trial stopped due to difficulty recruiting. Planned to recruit 30 participants to each arm but actually randomized less than 15 participants in total</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:14:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Debodinance-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:14:19 +0100" MODIFIED_BY="[Empty name]">
<P>Non randomized prospective study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 16:27:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dietz-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 16:27:30 +0100" MODIFIED_BY="[Empty name]">
<P>Imaging study: aim of the study was to determine the mobility of the slings from ultrasound imaging of slings inserted in the parent trial (SUSPEND trial, <LINK REF="STD-Lim-2005" TYPE="STUDY">Lim 2005</LINK>)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:14:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Du-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:14:52 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:14:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Falconer-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:14:57 +0100" MODIFIED_BY="[Empty name]">
<P>All had TVT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:15:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fischer-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:15:01 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:15:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Foote-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:15:09 +0100" MODIFIED_BY="[Empty name]">
<P>Monarc vs mini single incision sling</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:15:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Goldberg-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:15:16 +0100" MODIFIED_BY="[Empty name]">
<P>No minimally invasive sling</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:15:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gopinath-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:15:21 +0100" MODIFIED_BY="[Empty name]">
<P>Qualitative analysis on nonresponders of single incision sling RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:15:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Harmanli-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:15:27 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of antibiotic use preoperatively for TVT and TOT (surgeons discretion for what tape was used)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-03-23 19:08:18 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jackson-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-03-23 19:08:18 +0000" MODIFIED_BY="[Empty name]">
<P>RCT of antibiotic vs. placebo for MUS surgery</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:15:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jeon-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:15:34 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-03-23 19:14:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jones-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-03-23 19:14:46 +0000" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:15:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karagkounis-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:15:40 +0100" MODIFIED_BY="[Empty name]">
<P>A prospective cohort study not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2014-03-23 21:45:24 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2005a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2014-03-23 21:45:24 +0000" MODIFIED_BY="[Empty name]">
<P>Retrospective review of medical records</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:15:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kim-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:15:49 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-21 16:18:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kulseng_x002d_Hanssen-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-21 16:18:19 +0100" MODIFIED_BY="[Empty name]">
<P>RCT - does not meet the inclusion criteria. Not MUS vs MUS. Tradition Sling vs TVT. This trial compares three techniques for performing sling surgery: TVT, porcine xenograft (Pelvicol) sling and the short autologous fascial sling technique 'Sling on a string'.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:16:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kulseng_x002d_Hanssen-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:16:28 +0100" MODIFIED_BY="[Empty name]">
<P>A prospective cohort study not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:16:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kwon-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:16:33 +0100" MODIFIED_BY="[Empty name]">
<P>Prolapse trial not urinary incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:16:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liapis-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:16:37 +0100" MODIFIED_BY="[Empty name]">
<P>RCT with randomisation based on the type of anaesthesia used for one minimally invasive sling procedure (TVT)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:16:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liapis-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:16:44 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of TVT-O vs TVT-O plus 6 months postoperative estrodiol therapy. Both groups had TVT-O performed</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-21 16:18:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Markland-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-21 16:18:30 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of Burch colposuspension versus traditional sling - SISTEr Trial. Not MUS vs MUS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:16:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McClure-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:16:55 +0100" MODIFIED_BY="[Empty name]">
<P>Statistical modelling and not a trial in itself. No minimally invasive sling</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:17:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meschia-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:17:12 +0100" MODIFIED_BY="[Empty name]">
<P>1 tape used (TVT) and only occult urinary incontinence investigated</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:17:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Osman-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:17:19 +0100" MODIFIED_BY="[Empty name]">
<P>No minimally invasive sling arm in the trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:17:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pace-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:17:25 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective study of SPARC vs Monarc TOT but no evidence of randomisation</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-05-28 12:45:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Padilla_x002d_Fern_x00e1_ndez-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-05-28 12:45:16 +0100" MODIFIED_BY="[Empty name]">
<P>Randomisation based on immediate or deferred cutting and readjustment of tape</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:17:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Park-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:17:34 +0100" MODIFIED_BY="[Empty name]">
<P>Same tape TOT randomized to either high-tension or tension-free</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:17:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sabadell-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:17:53 +0100" MODIFIED_BY="[Empty name]">
<P>Cohort study, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:17:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schierlitz-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:17:59 +0100" MODIFIED_BY="[Empty name]">
<P>Investigated occult incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:18:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schostak-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:18:13 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT and no minimally invasive sling</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:18:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Seo-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:18:18 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT, retrospective study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:18:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shin-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:18:24 +0100" MODIFIED_BY="[Empty name]">
<P>Non randomized longitudinal study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:18:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sivaslioglu-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:18:30 +0100" MODIFIED_BY="[Empty name]">
<P>No minimally invasive sling</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:18:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Surkont-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:18:35 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT and only 1 arm, IVS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:18:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Takeyama-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:18:43 +0100" MODIFIED_BY="[Empty name]">
<P>Improvised instrument used</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:18:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tantanasis-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:18:48 +0100" MODIFIED_BY="[Empty name]">
<P>A review article, not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:18:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tincello-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:18:56 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of colposuspension or TVT with concomitant anterior repair (1 tape)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:19:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tinelli-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:19:51 +0100" MODIFIED_BY="[Empty name]">
<P>Same tape TVT: randomized to either immediate TVT or TVT after 21 days of preoperative estrogen treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:19:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trezza-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:19:56 +0100" MODIFIED_BY="[Empty name]">
<P>Investigated occult urinary incontinence</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:20:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wang-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:20:02 +0100" MODIFIED_BY="[Empty name]">
<P>All women received TVT. Compared types of anaesthesia </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:20:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wei-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:20:08 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of women with occult stress urinary incontinence undergoing POP surgery with and without concomitant MUS insertion </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:20:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Williams-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:20:15 +0100" MODIFIED_BY="[Empty name]">
<P>Statistical modelling and not a trial in itself</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:20:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:20:20 +0100" MODIFIED_BY="[Empty name]">
<P>Non randomised inferiority study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:20:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yoo-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:20:25 +0100" MODIFIED_BY="[Empty name]">
<P>A comparative study but not an RCT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:20:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yoon-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:20:30 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of single incision sling and TOT</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:20:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zaccardi-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:20:35 +0100" MODIFIED_BY="[Empty name]">
<P>RCT of pelvic floor muscle training on comfort.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2015-06-08 15:20:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zullo-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2015-06-08 15:20:40 +0100" MODIFIED_BY="[Empty name]">
<P>All had TVT. Women were randomly allocated to receive TVT plus postoperative vaginal oestrogen therapy (ET group) or TVT without adjunctive medical treatment (no ET group)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>
<B>Abbreviations</B>
</P>
<P>IVS: intravaginal slingoplasty</P>
<P>MUS: mid-urethral sling</P>
<P>POP: pelvic organ prolapse</P>
<P>RCT: randomized controlled trial</P>
<P>RPR: retropubic route</P>
<P>SIS: Single incision sling</P>
<P>TOR: transobturator route</P>
<P>TOT: transobturator tape</P>
<P>TVT: tension-free vaginal tape</P>
<P>TVT-O: tension-free vaginal tape - Obturator</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2014-07-10 14:16:17 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2015-06-22 09:55:37 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2015-06-22 09:55:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cavkaytar-2013">
<CHAR_STUDY_NAME MODIFIED="2015-06-05 13:14:06 +0100" MODIFIED_BY="[Empty name]">
<P>Prospective randomised study comparing TVT and TOT in female SUI with no ISD</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-05 13:14:09 +0100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2015-06-22 09:55:22 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: women aged 18-70 years; with USI; with or without POP</P>
<P>Exclusion criteria: previous incontinence surgery; UI or OAB; mixed incontinence; ISD; BMI &gt; 35</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:15:12 +0100" MODIFIED_BY="[Empty name]">
<P>Participants underwent either TVT or TOT procedures</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-22 09:55:24 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome: postoperative UDI-6 and IIQ-7 score &lt;10 and negative cough test will be defined as 'cured'</P>
<P>Secondary outcomes:</P>
<UL>
<LI>objective effectiveness by cough test at 6 and 12 months postoperatively</LI>
<LI>short-term and long-term surgical complications</LI>
<LI>bleeding</LI>
<LI>bladder and bowel perforation</LI>
<LI>mesh erosion</LI>
<LI>prevalence of voiding dysfunction at 1 and 12 months postoperatively</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2014-03-27 13:09:13 +0000" MODIFIED_BY="[Empty name]">
<P>June 2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-05 13:15:12 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2015-06-05 13:15:20 +0100" MODIFIED_BY="[Empty name]">
<P>NCT01903590, expected completion date June 2014</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2015-06-22 09:55:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sung-2013">
<CHAR_STUDY_NAME MODIFIED="2015-06-05 13:15:25 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>E</B>ffects of <B>s</B>urgical <B>t</B>reatment <B>e</B>nhanced with <B>e</B>xercise for <B>m</B>ixed urinary incontinence (ESTEEM)</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2015-06-05 13:15:36 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_PARTICIPANTS MODIFIED="2015-06-22 09:55:33 +0100" MODIFIED_BY="[Empty name]">
<P>Women &gt; 21 years</P>
<P>Inclusion criteria:</P>
<UL>
<LI>presence of both SUI and UUI</LI>
<LI>reporting at least 'moderate bother' from UUI item on the UDI question "Do you usually experience urine leakage associated with a feeling of urgency, that is a strong sensation of needing to go to the bathroom?"</LI>
<LI>reporting at least 'moderate bother' from SUI item on the UDI question "Do you usually experience urine leakage related to coughing, sneezing, or laughing?"</LI>
<LI>diagnosis of SUI defined by a positive cough stress test or urodynamic evaluation within the past 18 months</LI>
<LI>desire surgical treatment for SUI symptoms</LI>
<LI>urinary symptoms for &gt;3 months</LI>
<LI>subjects understand that BPTx is a treatment option for MUI outside the ESTEEM study protocol</LI>
<LI>urodynamics within past 18 months</LI>
</UL>
<P>Exclusion criteria:</P>
<UL>
<LI>anterior or apical compartment prolapse at or beyond the hymen (&gt;0 on POP-Q), regardless of whether patient is symptomatic (women with anterior or apical prolapse above the hymen (&lt;0) who do not report vaginal bulge symptoms will be eligible)</LI>
<LI>planned concomitant surgery for anterior vaginal wall or apical prolapse &gt; 0a (women undergoing only rectocoele repair are eligible)</LI>
<LI>women undergoing hysterectomy for any indication</LI>
<LI>active pelvic organ malignancy</LI>
<LI>aged &lt;21 years</LI>
<LI>pregnant or plans for future pregnancy in next 12 months, or within 12 months post-partum</LI>
<LI>PVR &gt;150 ml on 2 occasions, or current catheter use</LI>
<LI>participation in other trial that may influence results of this study</LI>
<LI>unevaluated haematuria</LI>
<LI>prior sling, synthetic mesh for prolapse, implanted nerve stimulator for incontinence</LI>
<LI>spinal cord injury or advanced/severe neurologic conditions including multiple sclerosis and Parkinson's disease (women on anti-muscarinic therapy will be eligible after 3 week wash-out period)</LI>
<LI>non-ambulatory</LI>
<LI>history of serious adverse reaction to synthetic mesh</LI>
<LI>not able to complete study assessments according to clinician's judgment, or not available for 12 month follow-up</LI>
<LI>women who only report "other IE" on bladder diary, and do not report at minimum 1 stress and 1 urge IE/3 days</LI>
<LI>diagnosis of and/or history of bladder pain or chronic pelvic pain</LI>
<LI>women who had intravesical Botox injection within the past 12 months</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2015-06-05 13:15:36 +0100" MODIFIED_BY="[Empty name]">
<P>Group A: mid-urethral sling combined with peri- and postoperative behavioral/pelvic floor therapy</P>
<P>Group B: mid-urethral sling</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2015-06-05 13:15:48 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_STARTING_DATE MODIFIED="2015-06-05 13:15:36 +0100" MODIFIED_BY="[Empty name]">
<P>October 2013, expected completion date October 2016</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2015-06-05 13:15:48 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2015-06-02 07:13:34 +0100" MODIFIED_BY="[Empty name]">
<P>NCT01959347</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>
<B>Abbreviations</B>
</P>
<P>BMI: body-mass index<BR/>BPTx: behavioural/pelvic floor therapy<BR/>ESTEEM: <B>E</B>ffects of <B>s</B>urgical <B>t</B>reatment <B>e</B>nhanced with <B>e</B>xercise for <B>m</B>ixed urinary incontinence trial<BR/>IE; incontinence event<BR/>IIQ-7: Incontinence Impact questionnaire<BR/>ISD: intrinsic sphincter deficiency<BR/>MUI: mixed urinary incontinence<BR/>OAB: overactive bladder<BR/>POP: pelvic organ prolapse<BR/>POP-Q: pelvic organ prolapse quantification<BR/>PVF: post void residual<BR/>SUI: stress urinary incontinence<BR/>TOT: transobturator tape<BR/>TVT: tension-free vaginal tape<BR/>UDI: Urinary Distress Impact questionnaire<BR/>UDI-6: Urinary Distress Impact questionnaire short form<BR/>UI: urinary incontinence<BR/>USI: urodynamic stress incontinence<BR/>UUI: urgency urinary incontinence<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:21:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Fattah-2010">
<DESCRIPTION>
<P>Quote: "A single-blinded, prospective, randomized study &#8230; Women were assigned to either procedure by random allocation (computer generated)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:22:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aigmuller-2014">
<DESCRIPTION>
<P>Quote: "randomized according to a computer generated<BR/>random list allocating trial identification number<BR/>and treatment group. Randomization was by fax through the central office"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:35:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alkady-2009">
<DESCRIPTION>
<P>Women were randomised using numbered, opaque, sealed envelopes containing computer-generated random allocations in a ratio of 1:1 in balanced blocks of 10.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:36:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andonian-2005">
<DESCRIPTION>
<P>Quote: "Patients were blinded to the procedure and had envelope randomization immediately prior to the start of the surgery"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:38:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andonian-2007">
<DESCRIPTION>
<P>Quote: "Randomization was performed by an envelope method immediately before the start of surgery."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-06 12:12:20 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aniuliene-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 22:49:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Araco-2008">
<DESCRIPTION>
<P>Quote: "A stratified randomisation was carried out. Presented two identical closed envelopes to patients, one containing the paper &#8220;TVT&#8221; and the other &#8220;TVT-O&#8221;. After choosing and opening of the envelope, further stratification was performed with a sampling chart. Four groups were formed on the basis of which operation they were going to receive."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:40:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barber-2008">
<DESCRIPTION>
<P>Quote: "were randomised using computer generated random allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:41:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barry-2008">
<DESCRIPTION>
<P>Participants were blinded and randomly allocated in a balanced way (blocks of 20) Randomisation was stratified according to a history of previous incontinence surgery</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 22:56:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-But-2008">
<DESCRIPTION>
<P>Quote: "Before the beginning of the study, the computer-generated list of 120 random numbers (from one to 120) was made for two groups (60 random numbers for each group, optimum allocation ratio 1)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 16:22:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Cervigni-2006">
<DESCRIPTION>
<P>Women randomised into 2 groups (computer generated randomisation list)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:06:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:09:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2012">
<DESCRIPTION>
<P>Stated: &#8216;randomly allocated &#8217;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:10:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cho-2010">
<DESCRIPTION>
<P>Quote: "93 female patients were prospectively, randomly assigned to the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:10:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choe-2013">
<DESCRIPTION>
<P>Quote: "were randomized to receive"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:12:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Darabi-Mahboub-2012">
<DESCRIPTION>
<P>Quote: &#8220;In this randomised clinical trial, eighty female patients with SUI were randomly allocated to &#8220;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:28:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-David_x002d_Montefiore-2006">
<DESCRIPTION>
<P>" ... Prospective randomised Multicentre study .... using a predetermined computer generated randomisation code ..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:33:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deffieux-2010">
<DESCRIPTION>
<P>Quote: "The patients were randomized using sealed opaque envelopes, following computer-generated random allocations"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:37:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diab-2012">
<DESCRIPTION>
<P>Quote: "were randomly distributed to two groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:46:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-El_x002d_Hefnawy-2010">
<DESCRIPTION>
<P>"Patient&#8217;s randomisation is accomplished through closed envelopes. A randomly selected envelope is dispatched to a running nurse with the patient&#8217;s name and ID hand typed on the envelope"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:48:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Elbadry-2014">
<DESCRIPTION>
<P>Quote: "Patients were randomized into 2 equal groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-12 12:24:29 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Enzelsberger-2005">
<DESCRIPTION>
<P>Quasi-RCT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:07:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Freeman-2011">
<DESCRIPTION>
<P>Quote: "randomisation list was stratified by study sites, using<BR/>randomly permuted blocks of varying sizes of 4, 6 and 8"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 18:15:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hammoud-2011">
<DESCRIPTION>
<P>Quote: "in a prospective randomized trial ... women were randomized between TVT and TVT-O for treatment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:08:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hassan-2013">
<DESCRIPTION>
<P>Quote: "A prospective single-blinded randomised trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 22:55:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Houwert-2009">
<DESCRIPTION>
<P>Quote: "Women with an indication for surgical treatment of SUI were at random assigned to either TVT-O or Monarc..."(from abstract Vervest HAM 2005)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:17:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jakimiuk-2012">
<DESCRIPTION>
<P>Quote: &#8220;The randomisation was done through a web page secured with a 128-bit code&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:20:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juang-2007">
<DESCRIPTION>
<P>Quote: &#8220;After an objective evaluation, 96 eligible patients were randomised&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:22:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kamel-2009">
<DESCRIPTION>
<P>Stated: "randomised"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 22:58:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karateke-2009">
<DESCRIPTION>
<P>Quote: "predetermined computer-generated randomisation code"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:00:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kilic-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:00:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2004">
<DESCRIPTION>
<P>Quote: "In this controlled, prospective, randomised study ...."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:01:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2005">
<DESCRIPTION>
<P>Quote: "43 women withUI were randomly assigned..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:28:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krofta-2010">
<DESCRIPTION>
<P>Quote: "women were prospectively, randomly assigned to the study. We used the method of block randomisation with a random-number generator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 19:03:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Laurikainen-2007">
<DESCRIPTION>
<P>The investigator called an independent randomisation centre to enter the patient participant in the allocated group. Participant were randomized using computer-generated random allocations in a ratio of 1:1 in balanced blocks of 4.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:32:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leanza-2009">
<DESCRIPTION>
<P>Quote: &#8220;women with urodynamic stress incontinence were randomly allocated to 2 treatment groups&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 18:20:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Quote: "Patients were alternately assigned to the TVT or TVT-O group" (Randomisation was by alternation method)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:04:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee-2008">
<DESCRIPTION>
<P>100 women with SUI were alternately assigned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:33:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liapis-2006">
<DESCRIPTION>
<P>Quote: "... All patients were randomly assigned to an operation from the outpatient department ..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:34:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liapis-2008">
<DESCRIPTION>
<P>Quote: "The patients were randomly allocated on an alternative fashion to one or another operation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:07:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lim-2005">
<DESCRIPTION>
<P>Quote: "...195 consenting patients with urodynamic stress incontinence (USI) were randomly allocated in a balanced way (three groups of 65 patients each)..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:37:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lord-2006">
<DESCRIPTION>
<P>Participants were stratified based on previous UI surgery (yes, no) and the experience of the surgeon (consultant, registrar) and allocated to either TVT or SPARC using computer-generated random numbers. The biostatistician generated the random allocations, which were sealed in opaque, sequentially numbered envelopes. The surgeons recruited participants and accessed the allocations by a telephone call to a third party. Varying block sizes of 4, 6 and 8 were used within each stratum to preclude prediction of allocation by the surgeons</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:08:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mansoor-2003">
<DESCRIPTION>
<P>Quote: "A prospectively randomised and comparative study....."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:09:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mehdiyev-2010">
<DESCRIPTION>
<P>Quote: "The patients were randomised for TOT and TVT operations"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:10:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meschia-2006">
<DESCRIPTION>
<P>Quote: "...a prospective randomised multicenter trial ... were randomly assigned to treatments according to a centralized computer-generated random list.... Researchers randomly assigned participants by a telephone system to 1 of the treatment groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:11:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meschia-2007">
<DESCRIPTION>
<P>Women with SUI and urethral hypermobility were randomised to treatments according to a centralised computer-generated random list. Researchers randomised participants by a telephone system to one of the treatment groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:12:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Naumann-2006">
<DESCRIPTION>
<P>Quote: "..an open, prospective, randomised, multicentric study". How sequence generation was achieved not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:13:40 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nerli-2009">
<DESCRIPTION>
<P>Allocation of participants by alternation (quasi randomised)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:47:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nyyssonen-2014">
<DESCRIPTION>
<P>Quote: "This prospective randomized study included ... 100 patients were randomized either to the TVT or to the TOT"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:58:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Okulu-2013">
<DESCRIPTION>
<P>Quote: &#8220;The patients and the mesh materials were randomised </P>
<P>1:1:1 to each group in blocks of three via a centralized computerized system to ensure a good balance of participant characteristics in each group."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:14:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2006">
<DESCRIPTION>
<P>Quote: "...women with SUI were randomly assigned ..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:15:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Palomba-2008">
<DESCRIPTION>
<P>Stated: "randomised"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 12:06:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paparella-2010">
<DESCRIPTION>
<P>Quote: &#8220;Randomization was done using sealed opaque envelopes containing computer-generated random allocations in a ratio of 2:2 in balanced blocks of 4&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 12:08:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-2012">
<DESCRIPTION>
<P>Quote: &#8220;were included in this randomised, prospective, observational study&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 12:09:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peattie-2006">
<DESCRIPTION>
<P>Quote: "patient allocation by random numbers with blocking"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 12:58:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Porena-2007">
<DESCRIPTION>
<P>Quote: "prospectively randomized by a predetermined computer-generated randomization code, to the retropubic approach (TVT) or the transobturator route (TOT)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:16:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2003">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:18:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2009">
<DESCRIPTION>
<P>Quote: &#8220;Simple randomisation was used from pseudorandom numbers generated by a computer to allocate patients into the IVS-02 group or the IVS-04 group&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 13:02:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2011">
<DESCRIPTION>
<P>Quote: "Patients were randomly allocated to 2 groups"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-05 16:24:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Richter-2010">
<DESCRIPTION>
<P>Permuted block randomisation schedule with stratification by centre</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:20:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Riva-2006">
<DESCRIPTION>
<P>Quote: "A randomised study". No description of how randomisation was achieved or if allocation was concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 15:54:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salem-2014">
<DESCRIPTION>
<P>Quote: "were included in this randomized controlled study .... Patients were randomly grouped"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 13:36:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Scheiner-2012">
<DESCRIPTION>
<P>Predetermined computer generated block randomisation in blocks of 8 to promote group balance</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:16:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Schierlitz-2008">
<DESCRIPTION>
<P>Quote: "... A prospective, randomised controlled trial was conducted using computer generated random allocation."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:19:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanuri-2010">
<DESCRIPTION>
<P>Participants were randomised into 2 groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:25:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tarcan-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:35:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Teo-2011">
<DESCRIPTION>
<P>Randomisation was done by a computer generated list randomised in blocks to ensure balanced allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:39:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tommaselli-2012">
<DESCRIPTION>
<P>Quote: &#8220;Patients were randomised using a randomisation list generated by computer&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:40:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tseng-2005">
<DESCRIPTION>
<P>By using a predetermined computer-generated randomisation code, those subjects who acquiesced and satisfied the inclusion criteria were assigned randomly by the authors (except LHT) to the SPARC or TVT procedure at the outpatient clinic</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:44:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ugurlucan-2013">
<DESCRIPTION>
<P>Quote: " In this prospective randomized study ... Randomization was carried out using computer-generated random allocations prepared by an investigator with no clinical involvement in the trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:47:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>Quote: "By using a predetermined computer-generated randomisation code ... were assigned randomly by the senior author ..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-04-23 10:16:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Computer-generated randomisation schedule</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:01:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>The 315 women were allocated to the TVT or the TVT-O group by an SAS randomisation schedule (SAS Institute Inc, Cary, NC, USA)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:03:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2010">
<DESCRIPTION>
<P>Quote: &#8220;Our study was a single blind randomised trial and the patients were randomly allocated to ...&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:04:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2011">
<DESCRIPTION>
<P>Quote: "computer generated randomisation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:06:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2011">
<DESCRIPTION>
<P>Quote: &#8220;stratified randomisation&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:09:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zullo-2007">
<DESCRIPTION>
<P>Quote: " .. were randomly allocated to undergo a TVT or TVTO procedure by using a predetermined computer-generated randomisation code"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:30:51 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-de-Leval-2011">
<DESCRIPTION>
<P>Quote: "The randomisation process was performed with five sequential patients undergoing one approach before alternating surgical modality"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:33:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Tayrac-2004">
<DESCRIPTION>
<P>Women were randomised using numbered, opaque sealed envelopes containing computer-generated random allocations in a ratio of 1:1 in balanced blocks of 10. Envelopes were opened in the operating room by a nurse just before starting the procedure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:46:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2013">
<DESCRIPTION>
<P>Quote: "A web-based application was used for block randomisation and computer-generated random number list prepared by a database designer"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:21:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Fattah-2010">
<DESCRIPTION>
<P>Quote: "Allocation was concealed using opaque sealed envelopes, which were opened by the nursing staff on the morning of the operation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:22:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aigmuller-2014">
<DESCRIPTION>
<P>Quote: "computer generated random list allocating trial identification number and treatment group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:35:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alkady-2009">
<DESCRIPTION>
<P>Women were randomised using numbered, opaque, sealed envelopes containing computer-generated random allocations in a ratio of 1:1 in balanced blocks of 10.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-06 20:50:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Andonian-2005">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-06 20:49:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andonian-2007">
<DESCRIPTION>
<P>Not mentioned</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-06 12:12:21 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aniuliene-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 22:49:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Araco-2008">
<DESCRIPTION>
<P>Quote: "Presented two identical closed envelopes to patients, one containing the paper &#8220;TVT&#8221; and the other &#8220;TVT-O&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 13:40:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barber-2008">
<DESCRIPTION>
<P>Quote: "group assignment were concealed in consecutively numbered sealed opaque envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-15 22:04:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barry-2008">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 22:57:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-But-2008">
<DESCRIPTION>
<P>Quote: "the consecutive study numbers were given after admission, and based on this admission number, either inside-out or outside-in procedure was selected later in the OR according to a computer- generated list of random number"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:05:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cervigni-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:06:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:09:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2012">
<DESCRIPTION>
<P>Stated: &#8216;randomized&#8217;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-23 17:42:20 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cho-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:10:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choe-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-12-10 22:27:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Darabi-Mahboub-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:28:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-David_x002d_Montefiore-2006">
<DESCRIPTION>
<P>Surgeon informed of allocated procedures by an uninvolved third-party immediately before the operation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:33:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deffieux-2010">
<DESCRIPTION>
<P>Quote: "The patients were randomized using sealed opaque envelopes, following computer-generated random allocations, with a ratio of 1:1 in balanced blocks of four. The envelopes were opened just before each participant's surgical procedure"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-26 15:41:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diab-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:46:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hefnawy-2010">
<DESCRIPTION>
<P>Quote: &#8220;randomisation is accomplished through closed envelopes. A randomly selected envelope is dispatched to a running nurse with the patient&#8217;s name and ID hand typed on the envelope&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-26 15:41:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Elbadry-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-15 22:08:32 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Enzelsberger-2005">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:07:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Freeman-2011">
<DESCRIPTION>
<P>Quote: "The study co-ordinator placed a treatment into consecutively<BR/>numbered opaque envelopes which were opened immediately before surgery by someone other than the surgeon. Allocation concealment was therefore ensured"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-05-26 15:42:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hammoud-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:08:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hassan-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 22:55:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Houwert-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:17:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jakimiuk-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:20:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juang-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:22:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kamel-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 22:58:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karateke-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:00:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kilic-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:00:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2004">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:01:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:28:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Krofta-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-20 19:03:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Laurikainen-2007">
<DESCRIPTION>
<P>The investigator called an independent randomisation centre to enter the patient participant in the allocated group. Participant were randomized using computer-generated random allocations in a ratio of 1:1 in balanced blocks of 4.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:32:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leanza-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:04:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>Not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:05:21 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee-2008">
<DESCRIPTION>
<P>Quasi-randomised study with no mention of allocation concealment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:33:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liapis-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-16 06:07:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liapis-2008">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:07:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lim-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-16 06:08:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lord-2006">
<DESCRIPTION>
<P>Concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:09:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mansoor-2003">
<DESCRIPTION>
<P>Quote:"...technique was randomly drawn using blinded envelopes containing the same no of ..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:09:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mehdiyev-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:10:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meschia-2006">
<DESCRIPTION>
<P>Concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:11:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meschia-2007">
<DESCRIPTION>
<P>Concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:13:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Naumann-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:13:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nerli-2009">
<DESCRIPTION>
<P>Allocation not concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:47:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nyyssonen-2014">
<DESCRIPTION>
<P>Quote: "randomization was performed with sealed and numbered envelopes"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 11:58:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Okulu-2013">
<DESCRIPTION>
<P>Quote: &#8220;via a centralized computerized system to ensure a good balance of participant characteristics in each group&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:15:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:15:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Palomba-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 12:06:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paparella-2010">
<DESCRIPTION>
<P>Quote: &#8220;Randomization was done using sealed opaque envelopes containing computer-generated random allocations in a ratio of 2:2 in balanced blocks of 4&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 12:08:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Park-2012">
<DESCRIPTION>
<P>Quote: "The procedure was performed by a single surgeon, and patients underwent one of the two techniques in accordance with the scheduling order (MONARC and TVT-O), in alternation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 12:09:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peattie-2006">
<DESCRIPTION>
<P>Quote: "patient allocation by random numbers with blocking"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 12:58:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Porena-2007">
<DESCRIPTION>
<P>Quote: " Randomization was done using sealed, opaque, numbered envelopes, which contained the randomized allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-21 00:36:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2003">
<DESCRIPTION>
<P>Simple randomisation was used from pseudo-random numbers (pseudo-random number means that the participants were operated on by the TVT or the IVS method in a ratio of 1:1).</P>
<P>Generated by computer in order to allocate participant to the monofilament or the multifilament group. Investigator KR was not involved in surgical procedure but was responsible for proper</P>
<P>randomisation. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:18:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2009">
<DESCRIPTION>
<P>Investigators Jankiewicz and Futyma were not involved in the surgical procedures, but they were responsible for the randomisation process</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 13:02:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 13:28:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richter-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 23:20:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Riva-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 13:32:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salem-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 13:36:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Scheiner-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-08-12 12:24:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schierlitz-2008">
<DESCRIPTION>
<P>No description of how allocation was concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:19:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanuri-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:25:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tarcan-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:35:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Teo-2011">
<DESCRIPTION>
<P>Randomization was done by a computer generated list randomised in blocks to ensure balanced allocation. Block size was randomised between 4 and 10. Numbered opaque envelopes were opened immediately before surgery</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:39:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tommaselli-2012">
<DESCRIPTION>
<P>Quote: "The allocation sequence was concealed from the researchers (CF and AF) who enrolled, assessed, and assigned the participants to the interventions in sequentially numbered, opaque, sealed, and stapled envelopes. The envelopes were opened on the morning of the procedure for the surgeon to perform the allocated procedure"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-16 06:37:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tseng-2005">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:44:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ugurlucan-2013">
<DESCRIPTION>
<P>Quote: "computer-generated random allocations prepared by an investigator with no clinical involvement in the trial"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:47:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:51:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:01:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>Stated: &#8216;randomly allocated&#8217;, no further information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:03:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2010">
<DESCRIPTION>
<P>Quote: &#8220;Our study was a single blind randomised trial and the patients were randomly allocated to ...&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:04:20 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2011">
<DESCRIPTION>
<P>Quote: &#8220;allocation was concealed using opaque sealed envelopes&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:06:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 15:09:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zullo-2007">
<DESCRIPTION>
<P>Allocation concealed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-05 14:30:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Leval-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-07-15 22:07:09 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Tayrac-2004">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-06-08 14:46:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2013">
<DESCRIPTION>
<P>Quote: "Patient data were entered into a password-protected web- based database"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-03-11 16:53:27 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.02" NO="2">
<NAME>All Outcomes:Outcome assessors blinded</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 13:21:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Fattah-2010">
<DESCRIPTION>
<P>Quote: &#8220;a single-blinded, prospective, randomized study&#8230; Women were informed about the type of operation if they wished, for ethical considerations, but they were instructed not to disclose this information to the clinician at follow-up&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 13:22:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aigmuller-2014">
<DESCRIPTION>
<P>Patients, surgeons, and physicians performing<BR/>follow-up exams were not blinded to the type of surgery</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 13:35:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alkady-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 13:36:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Andonian-2005">
<DESCRIPTION>
<P>Both groups and outcome assessors were said to have been blinded but how this was achieved was not clear. Quote: "Patients were blinded to the procedure and had envelope randomization immediately prior to the start of the surgery"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-03-09 12:25:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Andonian-2007">
<DESCRIPTION>
<P>The patients were blinded to the procedure</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-12-06 12:12:23 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aniuliene-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 22:49:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Araco-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 13:40:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barber-2008">
<DESCRIPTION>
<P>Quote: "blinding of surgeon and participants was not possible ..."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 13:42:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barry-2008">
<DESCRIPTION>
<P>Participants were blinded. How this was achieved was not explained</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 13:43:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-But-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 14:05:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cervigni-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 14:06:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-03-26 15:23:38 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-03-23 17:42:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cho-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 14:10:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choe-2013">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-12-10 22:27:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Darabi-Mahboub-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-12-06 13:01:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-David_x002d_Montefiore-2006">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 14:33:58 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Deffieux-2010">
<DESCRIPTION>
<P>Quote: "blinding of surgeons and participants not possible"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-26 15:41:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diab-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 14:46:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-El_x002d_Hefnawy-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-26 15:41:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Elbadry-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-03-27 11:36:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Enzelsberger-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:07:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Freeman-2011">
<DESCRIPTION>
<P>Quote: "Patients and ward staff were blinded to the intervention group by ensuring that dressings were applied both suprapubically and to the obturator areas"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-26 15:42:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hammoud-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:08:49 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hassan-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 22:55:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Houwert-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:17:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jakimiuk-2012">
<DESCRIPTION>
<P>Quote: &#8220;every patient had extra skin incisions for masking the type of procedure (&#8220;sham operation&#8221;). Each patient had 4 skin incisions in localization typical for needle introduced in TVT and TVT-O procedure&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:20:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juang-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:22:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kamel-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 22:58:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karateke-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:00:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kilic-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:00:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2004">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:01:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-21 15:48:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Krofta-2010">
<DESCRIPTION>
<P>Quote: "The current randomised, non-blinded study" </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:03:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laurikainen-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:32:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leanza-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:04:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:05:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:33:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liapis-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:34:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liapis-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:07:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lim-2005">
<DESCRIPTION>
<P>Quote: " ... and the patients were blinded to the type of slings being implanted ..." No description of how this was achieved.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:37:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lord-2006">
<DESCRIPTION>
<P>Quote: "The analyst was unaware of the treatment allocation, but it was obviously not possible to ensure that the surgeons were unaware of treatment, although the patients were unable to detect, from their incisions, which sling they had received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:09:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mansoor-2003">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:09:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mehdiyev-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:10:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meschia-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:11:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meschia-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:13:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Naumann-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:14:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nerli-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:47:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nyyssonen-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 11:59:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Okulu-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:15:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:15:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Palomba-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 12:06:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Paparella-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 12:08:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 12:09:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peattie-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 12:58:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Porena-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:17:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2003">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:18:38 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2009">
<DESCRIPTION>
<P>Quote: "the surgeon was aware of the procedure being used&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 13:02:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 13:28:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richter-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 23:20:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Riva-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 13:32:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salem-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 13:36:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Scheiner-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:16:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schierlitz-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:19:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanuri-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:25:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tarcan-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:35:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Teo-2011">
<DESCRIPTION>
<P>Participants and assessors were not blinded to the treatment received</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:39:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tommaselli-2012">
<DESCRIPTION>
<P>Quote: &#8220;Patients were blinded to the procedure until the end of the study&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:40:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tseng-2005">
<DESCRIPTION>
<P>Quote: "The patients were blinded to the procedure, but the principle based on the integral theory was briefly explained to them"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:44:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ugurlucan-2013">
<DESCRIPTION>
<P>Quote: "The patients were blinded to the sling material used."<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:47:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>Quote: " ... The patients were blinded to the procedure ..." How this was achieved was not explained</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-05-26 14:59:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Single-blinded (no information about who was blinded)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 15:01:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 15:03:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wang-2010">
<DESCRIPTION>
<P>Quote: &#8220;The patients were not blinded to the operative procedure&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 15:04:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 15:06:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 15:09:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zullo-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 14:30:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Leval-2011">
<DESCRIPTION>
<P>Patients were blinded to the type of surgery they underwent</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-05 14:33:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Tayrac-2004">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2015-06-08 14:46:15 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-van-Leijsen-2013">
<DESCRIPTION>
<P>Quote: "Participants and health professionals were not blinded to the allocated arm and the urodynamic results"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 13:21:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Fattah-2010">
<DESCRIPTION>
<P>Quote: &#8220;Post-operative assessment at 6 months was performed by an independent clinician who was blinded to the type of surgery &#8230; &#8220;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 13:22:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aigmuller-2014">
<DESCRIPTION>
<P>Patients, surgeons, and physicians performing<BR/>follow-up exams were not blinded to the type of surgery</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 13:35:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alkady-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 13:36:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Andonian-2005">
<DESCRIPTION>
<P>Outcome assessors blinded, quote: "dedicated UDS nurse (BS), who was blinded to the procedure"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 13:38:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Andonian-2007">
<DESCRIPTION>
<P>Outcome assessors blinded, but how this was achieved was not explained</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-12-06 12:12:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aniuliene-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 22:49:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Araco-2008">
<DESCRIPTION>
<P>Quote: "Data was analysed by a surgeon who was not involved in the surgical intervention"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 13:40:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barber-2008">
<DESCRIPTION>
<P>Quote: "all post op assessments were performed by research nurses who were blinded to treatment given"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 13:42:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Barry-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 22:57:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-But-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 14:05:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cervigni-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 14:06:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-26 15:23:39 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-23 17:42:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cho-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 14:10:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choe-2013">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-12-10 22:28:00 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Darabi-Mahboub-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-12-06 13:01:47 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-David_x002d_Montefiore-2006">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 14:33:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Deffieux-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-26 15:41:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diab-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 14:46:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hefnawy-2010">
<DESCRIPTION>
<P>Quote: &#8220;Follow up was carried out by a nurse blinded to the procedure&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-26 15:41:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Elbadry-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-27 11:36:34 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Enzelsberger-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:07:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Freeman-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-05-26 15:42:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hammoud-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:08:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hassan-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 22:55:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Houwert-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:17:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jakimiuk-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:20:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juang-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:22:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kamel-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 22:58:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karateke-2009">
<DESCRIPTION>
<P>Quote: "two independent physicians blinded to the different procedures"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:00:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kilic-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:00:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2004">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:01:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:29:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krofta-2010">
<DESCRIPTION>
<P>All participants were evaluated at follow-up by 3 urogynaecologists, blinded to the different procedures</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:30:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Laurikainen-2007">
<DESCRIPTION>
<P>The 3-year postoperative evaluation was performed by an independent physician or by the operating surgeon together with a study nurse</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:32:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leanza-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:04:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:05:23 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:33:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Liapis-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-11 10:06:31 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liapis-2008">
<DESCRIPTION>
<P>Blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:07:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lim-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:37:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lord-2006">
<DESCRIPTION>
<P>Quote: "The analyst was unaware of the treatment allocation, but it was obviously not possible to ensure that the surgeons were unaware of treatment, although the patients were unable to detect, from their incisions, which sling they had received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:09:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mansoor-2003">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:09:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mehdiyev-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:10:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meschia-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:11:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meschia-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:13:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Naumann-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:14:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nerli-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:47:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nyyssonen-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 11:59:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Okulu-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:15:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:15:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Palomba-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 12:06:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paparella-2010">
<DESCRIPTION>
<P>Quote: &#8220;Follow-up evaluation was carried out after 6 weeks, 6 months, 1, and 2 years (and/or earlier if problems were experienced) for all patients by two independent physicians&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 12:08:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Park-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 12:09:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peattie-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-12-29 11:44:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Porena-2007">
<DESCRIPTION>
<P>Outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:17:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rechberger-2003">
<DESCRIPTION>
<P>Blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:18:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2009">
<DESCRIPTION>
<P>Quote:"Only investigators Jankiewicz and Futyma were involved in the follow-up process, and they were blinded with regard to the treatment procedure used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 13:02:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 13:28:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richter-2010">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 23:20:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Riva-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 13:32:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salem-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 13:36:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Scheiner-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 14:16:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schierlitz-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 14:19:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tanuri-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 14:25:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tarcan-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 14:35:03 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Teo-2011">
<DESCRIPTION>
<P>Participants and assessors were not blinded to the treatment received</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 14:39:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tommaselli-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-11 10:54:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tseng-2005">
<DESCRIPTION>
<P>Blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 14:44:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ugurlucan-2013">
<DESCRIPTION>
<P>Quote: "Follow-up was performed ... by the same physician who was blinded to the type of sling used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 14:47:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>Quote: "an independent continence advisor and one of the authors both of whom were blinded to the procedures performed carried out the follow-up examinations and post operative outcome assessments"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-26 15:16:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Single-blinded (no information about who was blinded)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-26 14:55:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>Outcome assessors blind: &#8216;independent gynaecologist&#8217;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 15:03:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2010">
<DESCRIPTION>
<P>Quote: &#8220;post op assessment was performed by FMW who did not take part in the operation , YFS who performed the surgery was not involved in follow up&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 15:04:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wang-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 15:06:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 15:09:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zullo-2007">
<DESCRIPTION>
<P>" ... outcome assessors at 5 years follow up blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-05 14:30:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Leval-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-09 15:05:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Tayrac-2004">
<DESCRIPTION>
<P>Outcome assessors were blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2015-06-08 14:46:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-van-Leijsen-2013">
<DESCRIPTION>
<P>Quote: "Data input of subjective outcome measurements was per-formed by researchers who were blinded to the treat-ment allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 13:21:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abdel_x002d_Fattah-2010">
<DESCRIPTION>
<P>Quote: &#8220;No woman assigned to an arm asked to change her operation or to withdraw from the study prior to the operation. Withdrawals, unattendants and untraceables were accounted for without significant inter group differences&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 13:22:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aigmuller-2014">
<DESCRIPTION>
<P>Accounted for and no differentials in the groups in terms of loss to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 13:35:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alkady-2009">
<DESCRIPTION>
<P>Quote: &#8220;All accounted for&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-08-06 20:50:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Andonian-2005">
<DESCRIPTION>
<P>Addressed</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-08-06 20:50:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Andonian-2007">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 13:39:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aniuliene-2009">
<DESCRIPTION>
<P>No participants lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 22:50:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Araco-2008">
<DESCRIPTION>
<P>Disproportionately higher numbers lost to follow-up in TVT-O group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-04-15 10:21:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barber-2008">
<DESCRIPTION>
<P>All accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 13:42:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Barry-2008">
<DESCRIPTION>
<P>No differential loss to follow-up or differential attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 22:57:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-But-2008">
<DESCRIPTION>
<P>All data/information accounted for at follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 14:05:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cervigni-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 14:06:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2010">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-26 15:23:39 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chen-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-23 17:42:29 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Cho-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 14:10:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Choe-2013">
<DESCRIPTION>
<P>No information </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-12-10 22:28:10 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Darabi-Mahboub-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-07-15 22:06:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-David_x002d_Montefiore-2006">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 14:33:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Deffieux-2010">
<DESCRIPTION>
<P>Data complete</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 15:41:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Diab-2012">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 14:46:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-El_x002d_Hefnawy-2010">
<DESCRIPTION>
<P>All outcomes included </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 15:41:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Elbadry-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-27 11:36:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Enzelsberger-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-12-17 22:18:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Freeman-2011">
<DESCRIPTION>
<P>Patients and their data accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 15:42:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hammoud-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 11:08:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hassan-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 22:55:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Houwert-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-26 22:51:00 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jakimiuk-2012">
<DESCRIPTION>
<P>Information not clear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 11:20:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juang-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 11:22:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kamel-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 22:59:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karateke-2009">
<DESCRIPTION>
<P>All data included</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:00:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kilic-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:00:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2004">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:01:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kim-2005">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 11:29:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Krofta-2010">
<DESCRIPTION>
<P>Quote: "In the TVT group, 141/149 patients returned for a 1-year follow-up (dropout rate of 5.3%), and in the TVT-O group, 147/151 patients were present for the 1-year follow-up (dropout rate of 2.6%)"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:03:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Laurikainen-2007">
<DESCRIPTION>
<P>All data accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 11:32:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Leanza-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:04:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2007">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:05:25 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-27 07:07:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liapis-2006">
<DESCRIPTION>
<P>No differential loss to follow-up or differential attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-27 07:13:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Liapis-2008">
<DESCRIPTION>
<P>No differential loss to follow-up or differential attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:08:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lim-2005">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-27 07:29:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lord-2006">
<DESCRIPTION>
<P>No differential loss to follow-up or differential attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:09:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mansoor-2003">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:09:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mehdiyev-2010">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:11:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meschia-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:12:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meschia-2007">
<DESCRIPTION>
<P>No differential loss to follow-up or differential attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:13:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Naumann-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:14:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nerli-2009">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-27 08:19:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nyyssonen-2014">
<DESCRIPTION>
<P>No evidence suggestive of attrition bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 11:59:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Okulu-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:15:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Oliveira-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:15:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Palomba-2008">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 12:06:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Paparella-2010">
<DESCRIPTION>
<P>Quote: &#8220;All patients in both arms completed the follow-up (2 years)&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-04 14:15:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Park-2012">
<DESCRIPTION>
<P>All accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 12:09:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peattie-2006">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 12:58:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Porena-2007">
<DESCRIPTION>
<P>Quote: "No patient was lost during follow-up"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:17:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2003">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:19:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rechberger-2009">
<DESCRIPTION>
<P>All outcome data accounted for and the equivalent no of women were lost to follow-up in the 2 groups</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 13:02:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rechberger-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 13:28:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Richter-2010">
<DESCRIPTION>
<P>Quote: "patients who were lost to follow-up were considered to have had treatment failure and when patients who were lost to follow-up were excluded&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 23:20:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Riva-2006">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 13:32:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salem-2014">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 13:36:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Scheiner-2012">
<DESCRIPTION>
<P>All participants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 14:17:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Schierlitz-2008">
<DESCRIPTION>
<P>The number of participants who withdrew or were lost to follow-up (dropouts) was higher in the TVT group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-12-21 21:48:46 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tanuri-2010">
<DESCRIPTION>
<P>Data for all participants accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 14:25:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tarcan-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 14:35:06 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Teo-2011">
<DESCRIPTION>
<P>High numbers lost to follow-up; disproportionately higher in TVT-O group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-01-03 11:28:23 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tommaselli-2012">
<DESCRIPTION>
<P>All data accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-27 17:55:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tseng-2005">
<DESCRIPTION>
<P>No differential loss to follow-up or differential attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 15:46:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ugurlucan-2013">
<DESCRIPTION>
<P>All accounted for</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-26 15:46:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2006">
<DESCRIPTION>
<P>No differential loss to follow-up or differential attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 14:51:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2008">
<DESCRIPTION>
<P>Quote: "All patients were evaluable"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 15:01:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2009">
<DESCRIPTION>
<P>No differential dropout (Group A: 6; Group B: 9)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 15:03:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2010">
<DESCRIPTION>
<P>No participants withdrew. None were lost to follow-up</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 15:04:23 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wang-2011">
<DESCRIPTION>
<P>All participants completed follow-up. All outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 15:06:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zhang-2011">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-05-28 11:10:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zullo-2007">
<DESCRIPTION>
<P>No differential loss to follow-up or differential attrition</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 14:30:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-de-Leval-2011">
<DESCRIPTION>
<P>Quote: "no patients withdrew from the study prior to their operation". 2 participants were completely lost to follow-up after the 1-month visit and 2 more after the 6-month visit. One patient died before the 6-month visit; the cause of death was unrelated to the surgery</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-05 14:33:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-de-Tayrac-2004">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2015-06-08 14:46:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-van-Leijsen-2013">
<DESCRIPTION>
<P>No information</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-07-06 16:00:27 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-07-06 15:59:48 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2015-05-21 03:26:36 +0100" MODIFIED_BY="GDT">Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women</TITLE>
<TABLE COLS="7" ROWS="52">
<TR>
<TD COLSPAN="7">
<P>
<B>Transobturator (TOR) compared to retropubic (RPR) route for stress urinary incontinence in women</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> women with stress urinary incontinence<BR/>
<B>Settings: </B>Secondary care<BR/>
<B>Intervention: </B>transobturator (TOR)<BR/>
<B>Comparison: </B>retropubic (RPR) route</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Retropubic (RPR) route</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Transobturator (TOR)</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Subjective cure (Short term &lt; 1 year)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.98<BR/>(0.96 to 1.00)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>5514<BR/>(36 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>844 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>827 per 1000<BR/>(810 to 844)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>833 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>816 per 1000<BR/>(800 to 833)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Subjective cure (medium term, 1 to 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.97<BR/>(0.92 to 1.03)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>683<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>881 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>854 per 1000<BR/>(810 to 907)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>869 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>843 per 1000<BR/>(799 to 895)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Subjective cure (long term, &gt; 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.95<BR/>(0.87 to 1.04)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>714<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>707 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>671 per 1000<BR/>(615 to 735)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>843 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>801 per 1000<BR/>(733 to 877)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Bladder or urethral perforation</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.13<BR/>(0.08 to 0.20)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>6372<BR/>(40 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>49 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>6 per 1000<BR/>(4 to 10)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>25 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>3 per 1000<BR/>(2 to 5)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Voiding dysfunction (short and medium term, up to 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.53<BR/>(0.43 to 0.65)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>6217<BR/>(37 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>6</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>72 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>38 per 1000<BR/>(31 to 47)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>55 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>29 per 1000<BR/>(24 to 36)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>De novo urgency or urgency incontinence (short term, up to 12 months)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.98<BR/>(0.82 to 1.17)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>4923<BR/>(31 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>82 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>80 per 1000<BR/>(67 to 96)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>83 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>81 per 1000<BR/>(68 to 97)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Groin pain</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 4.62<BR/>(3.09 to 6.92)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>3226<BR/>(18 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>8</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>14 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>66 per 1000<BR/>(44 to 99)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>45 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>208 per 1000<BR/>(139 to 311)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Suprapubic pain</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.29<BR/>(0.11 to 0.78)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1105<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>9</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>29 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>8 per 1000<BR/>(3 to 23)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>18 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>5 per 1000<BR/>(2 to 14)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Vaginal tape erosion (short and medium term, up to 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.13<BR/>(0.78 to 1.65)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>4743<BR/>(31 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>10</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>22 per 1000<BR/>(15 to 32)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>21 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>24 per 1000<BR/>(16 to 34)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Repeat incontinence surgery (short term, within 12 months)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.64<BR/>(0.85 to 3.16)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1402<BR/>(9 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>11</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>19 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>31 per 1000<BR/>(16 to 60)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>mean control group across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>24 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>39 per 1000<BR/>(20 to 76)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Repeat incontinence surgery (long term, &gt; 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 8.79<BR/>(3.36 to 23.00)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>695<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>12,13</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>11 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>100 per 1000<BR/>(38 to 262)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>67 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>589 per 1000<BR/>(225 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Quality of life</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>16 different validated questionnaires were used by different studies to assess QoL. This outcome was reported in 11 RCTs, but reported in different ways which precluded meta-analysis. In all but one of the RCTs where QoL was assessed there was improvement in the QoL in women after the intervention, irrespective of which route was used, with no significant difference in scores between groups. Where assessment of sexual function was performed, there was an equal amount of improvement in sexual function following surgical treatment, irrespective of the route employed</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(11 RCTs)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>CAD: Canadian dollars</P>
<P>CI: confidence interval</P>
<P>RCT: randomised controlled trial</P>
<P>RPR: retropubic route</P>
<P>RR: risk ratio<BR/>QoL: quality of life</P>
<P>TOR: transobturator route</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality: </B>Further research is very unlikely to change our confidence in the estimate of effect<BR/>
<B>Moderate quality: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<BR/>
<B>Low quality: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<BR/>
<B>Very low quality: </B>We are very uncertain about the estimate<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Random sequence generation was unclear in 13 studies and at high risk of bias in 2 studies, and allocation concealment was unclear in 20 studies and at high risk in 2/37 studies</P>
<P>
<SUP>2</SUP>Allocation concealment was unclear in 2/5 trials and sequence generation was unclear in 1/5 trials, so we decided to downgrade by 1 level</P>
<P>
<SUP>3</SUP>There was potential substantial heterogeneity with an I value of 67%, so we downgraded the quality rating by 1 level</P>
<P>
<SUP>4</SUP>There was potential substantial heterogeneity among studies with an I value of 65%, which lead us to downgrade by 1 level</P>
<P>
<SUP>5</SUP>As allocation concealment was unclear in 18/40 trials and at high risk in 3/40, and sequence generation was unclear in 14/40 trials and at high risk in 3/40, we decided to downgrade by 1 level</P>
<P>
<SUP>6</SUP>As allocation concealment was unclear in 16/37 trials and at high risk in 2/37, and sequence generation was unclear in 11/37 trials and at high risk in 2/37, we decided to downgrade by 1 level</P>
<P>
<SUP>7</SUP>Random sequence generation was unclear in 10/31 studies and at high risk of bias in 2/31, and allocation concealment was unclear in 15/31 studies and at high risk in 2/31, so we downgraded by 1 level</P>
<P>
<SUP>8</SUP>Random sequence generation was unclear in 4/18 studies and at high risk in 2/18, and allocation concealment was unclear in 9/18 studies and at high risk in 2/18, so we downgraded the quality of the evidence by 1 level</P>
<P>
<SUP>9</SUP>Random sequence generation was at high risk in 1/4 studies, while allocation concealment was unclear in 2/4 and at high risk in 1/4, so we downgraded by 1 level</P>
<P>
<SUP>10</SUP>Allocation concealment was unclear in 12/31 trials and at high risk in 1/31, while sequence generation was unclear in 6/31 trials and at high risk in 1/31, so we decided to downgrade by 1 level</P>
<P>
<SUP>11</SUP>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded the level by 1</P>
<P>
<SUP>12</SUP>There was potential substantial heterogeneity with an I value of 46%, so we downgraded the quality rating by 1 level</P>
<P>
<SUP>13</SUP>Due to the low number of studies reporting data for this outcome, and the low number of events and wide CI around the estimate of the effect, we downgraded the quality of evidence by 1 level due to imprecision</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2017-07-06 16:00:02 +0100" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2015-05-21 03:30:44 +0100" MODIFIED_BY="GDT">Retropubic bottom-to-top approach compared to retropubic top-to-bottom approach for stress urinary incontinence in women</TITLE>
<TABLE COLS="7" ROWS="32">
<TR>
<TD COLSPAN="7">
<P>
<B>Retropubic bottom-to-top approach compared to retropubic top-to-bottom approach for stress urinary incontinence in women</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>women with stress urinary incontinence<BR/>
<B>Settings: </B>Secondary care<BR/>
<B>Intervention: </B>retropubic bottom-to-top approach<BR/>
<B>Comparison: </B>retropubic top-to-bottom approach</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>retropubic top-to-bottom approach</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Retropubic bottom-to-top approach</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Subjective cure (short term, &#8804; 1 year)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.10<BR/>(1.01 to 1.20)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>492<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>770 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>847 per 1000<BR/>(778 to 924)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>890 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>979 per 1000<BR/>(899 to 1000)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Subjective cure (medium term, 1 to 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Subjective cure long term: &gt; 5 years</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Bladder or urethral perforation</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.55<BR/>(0.31 to 0.98)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>631<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>85 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>47 per 1000<BR/>(26 to 83)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>115 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>63 per 1000<BR/>(36 to 113)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Voiding dysfunction</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.40<BR/>(0.18 to 0.90)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>631<BR/>(5 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>60 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>24 per 1000<BR/>(11 to 54)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>49 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>20 per 1000<BR/>(9 to 44)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>De novo urgency or urgency incontinence</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.84<BR/>(0.52 to 1.34)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>547<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>3,4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>123 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>103 per 1000<BR/>(64 to 165)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>187 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>157 per 1000<BR/>(97 to 250)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Vaginal tape erosion</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.27<BR/>(0.08 to 0.95)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>569<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>35 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>9 per 1000<BR/>(3 to 33)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>69 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>19 per 1000<BR/>(6 to 65)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Repeat incontinence surgery short term</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Repeat incontinence surgery long term</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Quality of life (IIQ scores)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean quality of life (IIQ scores) in the control group was 49.9</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean quality of life (IIQ scores) in the intervention group was 4.6 lower (14.17 lower to 4.97 higher)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>84<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>CI: confidence interval</P>
<P>IIQ: Incontinence Impact questionnaire</P>
<P>RCT: randomised controlled trial</P>
<P>RR risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality: </B>Further research is very unlikely to change our confidence in the estimate of effect<BR/>
<B>Moderate quality: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<BR/>
<B>Low quality: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<BR/>
<B>Very low quality: </B>We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Sequence generation and allocation concealment was unclear in 2/3 trials, so we downgraded by 1 level</P>
<P>
<SUP>2</SUP>Sequence generation and allocation concealment was unclear in 3/5 trials, so we downgraded by 1 level</P>
<P>
<SUP>3</SUP>Sequence generation was unclear in 2/4 studies and allocation concealment unclear in 3/4 studies, so we downgraded by 1 level</P>
<P>
<SUP>4</SUP>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded the level by 1</P>
<P>
<SUP>5</SUP>Sequence generation unclear in 3/4 studies and allocation concealment unclear in 2/4 studies, so we downgraded by 1 level</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2017-07-06 16:00:16 +0100" MODIFIED_BY="[Empty name]" NO="3" READONLY="YES">
<TITLE MODIFIED="2015-05-21 03:33:31 +0100" MODIFIED_BY="GDT">Obturator medial-to-lateral approach compared to obturator lateral-to-medial approach for stress urinary incontinence in women</TITLE>
<TABLE COLS="7" ROWS="42">
<TR>
<TD COLSPAN="7">
<P>
<B>Obturator medial-to-lateral approach compared to obturator lateral-to-medial approach for stress urinary incontinence in women</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>women with stress urinary incontinence<BR/>
<B>Settings: </B>Secondary care<BR/>
<B>Intervention: </B>obturator medial-to-lateral approach<BR/>
<B>Comparison: </B>obturator lateral-to-medial approach</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Obturator lateral-to-medial approach</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Obturator medial-to-lateral approach</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Subjective cure (short term &#8804; 1 year)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.00<BR/>(0.96 to 1.06)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>759<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>877 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>877 per 1000<BR/>(842 to 930)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>880 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>880 per 1000<BR/>(845 to 933)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Subjective cure (medium term, 1 to 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.06<BR/>(0.91 to 1.23)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>235<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>711 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>753 per 1000<BR/>(647 to 874)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>736 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>780 per 1000<BR/>(670 to 905)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Subjective cure</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Bladder or urethral perforation</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.38<BR/>(0.07 to 1.92)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>794<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>11 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>4 per 1000<BR/>(1 to 20)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>6 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>2 per 1000<BR/>(0 to 12)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Voiding dysfunction (short and medium term, up to 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.74<BR/>(1.06 to 2.88)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1121<BR/>(8 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>4</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>40 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>70 per 1000<BR/>(43 to 116)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>55 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>96 per 1000<BR/>(58 to 158)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>De novo urgency or urgency incontinence (short term, up to 12 months)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.01<BR/>(0.46 to 2.20)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>357<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>63 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>63 per 1000<BR/>(29 to 138)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>64 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>65 per 1000<BR/>(29 to 141)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Groin pain</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.15<BR/>(0.75 to 1.76)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>837<BR/>(6 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>6,7</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>80 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>92 per 1000<BR/>(60 to 140)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>74 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>85 per 1000<BR/>(56 to 130)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Vaginal tape erosion (short and medium term, up to 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.42<BR/>(0.16 to 1.09)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>1087<BR/>(7 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>7,8</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>24 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>10 per 1000<BR/>(4 to 26)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>17 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>7 per 1000<BR/>(3 to 19)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Repeat incontinence surgery (short term, up to 12 months)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.64<BR/>(0.32 to 1.30)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>532<BR/>(2 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>7,9</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>71 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>45 per 1000<BR/>(23 to 92)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>58 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>37 per 1000<BR/>(19 to 75)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Repeat incontinence surgery</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Quality of life</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean quality of life in the control group was 0</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean quality of life in the intervention group was 16.54 higher (4.84 higher to 28.24 higher)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>46<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>10,11</SUP>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>CI: confidence interval</P>
<P>RCT: randomised controlled trial</P>
<P>RR: risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality: </B>Further research is very unlikely to change our confidence in the estimate of effect<BR/>
<B>Moderate quality: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<BR/>
<B>Low quality: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<BR/>
<B>Very low quality: </B>We are very uncertain about the estimate<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Random sequence generation was unclear in 4/6 studies, allocation concealment was unclear in5/6 and at high risk in 1/6 studies, so we downgraded the quality of evidence due to risk of bias by 2 levels</P>
<P>
<SUP>2</SUP>Random sequence generation was unclear in all both studies, allocation concealment was unclear in 1 and high risk of bias in the other study, so we downgraded by 2 levels</P>
<P>
<SUP>3</SUP>Sequence generation was unclear in 2 studies and allocation concealment was unclear in 3 studies, so we downgraded the quality rating by 1 level</P>
<P>
<SUP>4</SUP>Sequence generation was unclear in 3 studies and at high risk in 1 study, while allocation concealment was unclear in 4 studies and at high risk in 1 study, so we downgraded by 1 level</P>
<P>
<SUP>5</SUP>Sequence generation was unclear in 2/3 studies and at high risk in 1/3, allocation concealment was unclear in 2/3 studies and high in 1/3, so we downgraded by 2 levels</P>
<P>
<SUP>6</SUP>Random sequence generation was unclear in 2/5 and high in 1/5 studies, while allocation concealment was unclear in 2/5 and high in 2/5 studies, so we downgraded the quality of evidence due to high risk of bias by 2 levels</P>
<P>
<SUP>7</SUP>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was &gt; 65% increase in RR for harm, so we downgraded by 1 level </P>
<P>
<SUP>8</SUP>Sequence generation was unclear in 3/7 studies and at high risk in 1/7. Allocation concealment was unclear in 5/7 studies and at high risk in 1/7. We downgraded the quality rating by 2 levels</P>
<P>
<SUP>9</SUP>Sequence generation and allocation concealment were unclear in 1/2 studies, so we downgraded by 1 level</P>
<P>
<SUP>10</SUP>Sequence generation and allocation concealment were unclear, so we downgraded by 1 level</P>
<P>
<SUP>11</SUP>As there was only 1 study with very few events and CIs around estimates of effect included appreciable benefit and appreciable harm, we downgraded by 2 levels</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-04" MODIFIED="2017-07-06 16:00:27 +0100" MODIFIED_BY="[Empty name]" NO="4" READONLY="YES">
<TITLE MODIFIED="2015-05-21 03:35:25 +0100" MODIFIED_BY="GDT">Monofilament compared to multifilament tapes for stress urinary incontinence in women</TITLE>
<TABLE COLS="7" ROWS="32">
<TR>
<TD COLSPAN="7">
<P>
<B>Monofilament compared to multifilament tapes for stress urinary incontinence in women</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>women with stress urinary incontinence<BR/>
<B>Settings: </B>Secondary care<BR/>
<B>Intervention:</B> monofilament<BR/>
<B>Comparison: </B>multifilament tapes</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>multifilament tapes</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Monofilament</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Subjective cure (short term &#8804; 1 year)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.07<BR/>(0.98 to 1.16)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>505<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>784 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>839 per 1000<BR/>(768 to 909)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>810 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>867 per 1000<BR/>(794 to 939)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Subjective cure (medium term: 1 to 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Subjective cure (long term: &gt; 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Bladder or urethral perforation</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.76<BR/>(0.29 to 1.99)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>496<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8861;<BR/>MODERATE <SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>37 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>28 per 1000<BR/>(11 to 73)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>32 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>25 per 1000<BR/>(9 to 64)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Voiding dysfunction</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 2.20<BR/>(0.98 to 4.92)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>400<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>2,3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>41 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>89 per 1000<BR/>(40 to 200)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>65 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>143 per 1000<BR/>(64 to 320)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>De novo urgency or urgency incontinence</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 1.09<BR/>(0.66 to 1.82)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>496<BR/>(4 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>LOW <SUP>4,5</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>102 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>111 per 1000<BR/>(67 to 186)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>107 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>117 per 1000<BR/>(71 to 195)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>Vaginal tape erosion</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>RR 0.43<BR/>(0.16 to 1.14)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>396<BR/>(3 RCTs)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="4" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>62 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>26 per 1000<BR/>(10 to 70)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Mean control group risk across studies</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>43 per 1000</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>18 per 1000<BR/>(7 to 49)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Repeat incontinence surgery (short term &#8804; 1 year)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Repeat incontinence surgery (long term &gt; 5 years)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>No studies reported this outcome</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(0 studies)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Quality of life scores ICIQ</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean quality of life scores ICIQ in the control group was 2.1</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The mean quality of life scores ICIQ in the intervention group was 0.6 lower (0.76 lower to 0.44 lower)</P>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>96<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;&#8853;<BR/>HIGH</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>CI: confidence interval</P>
<P>ICIQ: International Consultation on Incontinence questionnaire</P>
<P>RCT: randomised controlled trial</P>
<P>RR: risk ratio</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality: </B>Further research is very unlikely to change our confidence in the estimate of effect<BR/>
<B>Moderate quality: </B>Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<BR/>
<B>Low quality: </B>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<BR/>
<B>Very low quality: </B>We are very uncertain about the estimate<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP>Random sequence generation and allocation concealment unclear in 2/4 studies, so we downgraded by 1 level</P>
<P>
<SUP>2</SUP>Random sequence generation and allocation concealment unclear in 2/3 studies, so downgraded by 1 level</P>
<P>
<SUP>3</SUP>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was much more than a 25% increase in RR for harm, so we downgraded by 1 level</P>
<P>
<SUP>4</SUP>Sequence generation and allocation concealment were unclear in 2/4 studies, so we downgraded the quality rating by 1 level</P>
<P>
<SUP>5</SUP>The wide confidence interval was judged to include a threshold for appreciable harm considered to be &gt; 25% increase in RR, in this case there was &gt; 65% increase in RR for harm, so we downgraded by 1 level</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2017-07-24 17:45:34 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2017-07-24 17:45:34 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2015-06-22 09:56:07 +0100" MODIFIED_BY="[Empty name]">Tabulated Results of Included Studies</TITLE>
<TABLE COLS="2" ROWS="81">
<TR>
<TD>
<P>Study</P>
</TD>
<TD>
<P>Outcome data</P>
</TD>
</TR>
<TR>
<TD>
<P>Abdel-Fattah 2010</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 170)</P>
<P>Group B: TOT (n = 171)</P>
<P/>
<P>Loss to follow up at 1yr: A: 18/170, B: 24/171</P>
<P>Loss to follow up at 3yrs: A: 44/170, B: 59/171</P>
<P>Objective cure: A: 114/121, B: 96/109</P>
<P>Subjective success: A: 121/149, B: 111/143</P>
<P>Bladder/urethral perforation: A: 1/170, B: 2/171</P>
<P>Voiding dysfunction: A: 12/170, B: 9/171</P>
<P>Tape erosion: A: 3/153, B: 5/149</P>
<P>Groin pain: A: 27/150, B: 19/147</P>
<P>Repeat continence surgery: A: 7/170, B: 15/171</P>
<P>QoL assessed via: King&#8217;s Health Questionnaire (KHQ) [10], Birmingham Bowel Urinary Symptom (BBUSQ-22) [11] and Pelvic Organ Prolapse/Incontinence Sexual Function Questionnaire (PISQ-12). In addition Patient Global Impression of Improvement (PGI-I) [13] and International Consultation on Incontinence Questionnaire- Short form (ICIQ-SF) [14] questionnaires. QOL scores were much improve following surgery with no significant inter group (A vs B) differences.</P>
<P>Sexual dysfunction: PISQ-12 employed. 199 patients completed this assessment and in most domains a significant improvement in postoperative PISQ-12 scores was found with no significant difference demonstrated between the two groups.</P>
<P>Intermediate (3 yr) Subjective success (very much &amp; much improved) on PGI-I: A: 93/126, B: 81/112</P>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Aigmuller 2014</P>
</TD>
<TD>
<P>Group A: TVT: (n = 285; 38 of whom were lost to follow-up)</P>
<P>Group B: TVT-O: (n = 269; 36 of whom were lost to follow-up)</P>
<P/>
<P>Participants were evaluated at 3 months, with a further evaluation scheduled at 5 years</P>
<UL>
<LI>Objective cure of SUI: defined as a negative cough stress test and stable cystometry to 300 ml</LI>
<LI>Subjective cure defined on PGI as 'very much better' and 'better'</LI>
<LI>Objective cure: A: 215/247, B: 196/233</LI>
<LI>Subjective cure A: 123/139, B: 107/122</LI>
<LI>Subjective cure and improvement: A: 136/139, B: 116/122</LI>
<LI>Operating time (minutes; SD): A: 2112.22, B: 16.88.8</LI>
<LI>Bladder perforation: A: 11/285, B:0/269</LI>
<LI>Vascular injury: A: 2/285, B: 3/269</LI>
<LI>Voiding dysfunction: A: 4/285, B: 1/269</LI>
<LI>Major visceral injury: A: 1/285, B: 0/269</LI>
<LI>Infection: A: 1/285, B: 0/269</LI>
<LI>De novo OAB: A: 26/247, B: 24/233</LI>
</UL>
<P>At 5-year review:</P>
<UL>
<LI>A negative cough stress test was seen in 83% of patients after TVT and 76% of patients after TVT-O.</LI>
<LI>No pad use was reported by 56% of patients after TVT and 58% of patients after TVT-O. None of these differences reached statistical significance.</LI>
<LI>One tape exposure was noted after TVT and 3 after TVT-O.</LI>
<LI>There were 9 (6%) re-operation after TVT and 5 (3%) after TVT-</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Alkady 2009</P>
</TD>
<TD>
<P>Group A: TVT (n = 15)</P>
<P>Group B: TVT-O (n = 15)</P>
<P/>
<UL>
<LI>Objective cure: absence of SUI and a negative stress test</LI>
<LI>Objective improvement: lower volume and frequency of SUI, but positive stress test</LI>
<LI>Objective cure: A 13/15, B: 13/15</LI>
<LI>Objective cure &amp; improvement: A 14/15, B: 15/15</LI>
<LI>Mean blood loss (ml)s (SD): A: 26(10.23), B: 22(7.15)</LI>
<LI>Mean hospital stay (days)s (SD): A: 1.1(1.0), B: 1.2(0.9)</LI>
<LI>Bladder perforation: A: 1/15, B: 0/15</LI>
<LI>Major vascular injury: A: 1/15, B: 0/15</LI>
<LI>Voiding dysfunction: A: 2/15, B: 1/15</LI>
<LI>Tape erosion: A: 1/15, B: 0/15</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Andonian 2005</P>
</TD>
<TD>
<P>Group A: SPARC</P>
<P>Group B: TVT</P>
<P/>
<UL>
<LI>Objective Cure: A: 34/41, B: 40/42</LI>
<LI>Perioperative complications: A: 3/41, B: 0/40</LI>
<LI>Bladder perforation: A: 10/41, B: 10/43</LI>
<LI>Voiding dysfunction: A: 2/41, B: 4/43</LI>
<LI>Tape erosion: A: 1/41, B: 0/41</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Andonian 2007</P>
</TD>
<TD>
<P>Group A: Obtape (n = 78)</P>
<P>Group B: DUPS (n = 32) - suspended</P>
<P>Group C: TVT (n = 80)</P>
<P/>
<UL>
<LI>Objective cure short term: A: 64/77, B: 69/80</LI>
<LI>Perioperative complications: A: 11/77, B: 6/80</LI>
<LI>Bladder perforation: A: 0/77, B: 11/80</LI>
<LI>De novo urgency or urgency incontinence: A: 6/77, B: 5/80</LI>
<LI>Tape erosion: A: 2/77, B: 0/80</LI>
<LI>Repeat incontinence surgery: A: 2.77, B:0/80</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Aniuliene 2009</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 150)</P>
<P>Group B: TVT (n = 114)</P>
<P/>
<UL>
<LI>Objective cure: negative stress provocation test with 300 ml of urine in the bladder: A: 142/150, B: 108/114</LI>
<LI>Subjective cure: self-reported absence of SUI with or without mild urgency incontinence. A: 145/150, B: 111/114</LI>
<LI>Mean duration of procedure (SD): A: 19 (5.6), B: 27 (7.1)</LI>
<LI>Mean hospital stay days (SD) A: 1.5 (0.5), B: 4.0 (1.6)</LI>
<LI>Bladder perforation: A: 0/150, B: 1/114</LI>
<LI>Post operative urinary retention: A: 5/150, B: 18/114</LI>
<LI>Haematoma: A: 0/150, B: 1/114</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Araco 2008</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 120)<BR/>Group B: TVT (n = 120)</P>
<P/>
<UL>
<LI>Objective cure short term: A: 83/100, B: 108/108</LI>
<LI>Operative time in minutes (standard deviation): A: 34 (11), B: 48 (7)</LI>
<LI>Perioperative complications: A: 6/120, B: 21/120</LI>
<LI>Major vascular injury: A: 0/120, B: 6/120</LI>
<LI>Bladder perforation: A: 0/120, B: 3/120</LI>
<LI>Voiding dysfunction: A: 0/100, B: 12/108</LI>
<LI>de novo urgency/UUI: A: 6/100, B: 8/108</LI>
<LI>Detrusor overactivity: A: 3/100, B: 2/108</LI>
<LI>Vaginal tape erosion: A: 3/100, B: 1/108</LI>
<LI>Repeat incontinence surgery medium term (1-5 years): A: 17/100 B: 1/108</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Barber 2008</P>
</TD>
<TD>
<P>Group A: TVT (n = 88)</P>
<P>Group B: TOT (n = 82)</P>
<P/>
<UL>
<LI>subjective cure (self-reported): A: 74/85, B: 68/75</LI>
<LI>objective cure (negative cough stress test): A: 73/85, B: 62/75</LI>
<LI>mean operating time (minutes; no concomitant surgery): A: 29(10), B: 28(7)</LI>
<LI>bladder perforation: A: 7/88, B: 0/82</LI>
<LI>major vascular injury: A: 1/88, B: 0/82</LI>
<LI>vaginal tape erosion: A: 5/85, B: 1/75</LI>
<LI>de novo urgency/UUI: A: 27/85, B: 21/75</LI>
<LI>voiding dysfunction: A: 5/88, B: 2/82</LI>
<LI>re-operation: A: 4/85, B: 1/75</LI>
<LI>QoL: overall improvement in QoL and sexual function scores at follow-up assessments compared with preoperative baseline scores. No difference between the groups.Used PFDI-20, PFIQ-7, PISQ-12</LI>
<LI>sexual dysfunction assessed using PISQ-12. Scores improved post operatively and at 12 months follow up in both groups, though the relative change in scores post-operatively was small (1.9%) showing moderate responsiveness to incontinence specific outcome measures. There was no significant difference reported between the two groups.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Barry 2008</P>
</TD>
<TD>
<P>Group A: TOT (n = 58)<BR/>Group B: TVT (n = 82)</P>
<P/>
<UL>
<LI>Subjective cure: A: 49/58, B: 70/82</LI>
<LI>Objective cure: A: 48/58, B: 64/82</LI>
<LI>Operating time: A: 14.6 (6), B: 58 (18.5)</LI>
<LI>Operative blood loss in mls A: 49 (31.2), B: 64 (41.4)</LI>
<LI>Peri-operative complications: A: 0/58, B: 2/82</LI>
<LI>Bladder perforation: A: 1/58, B: 7/82</LI>
<LI>Voiding dysfunction: A: 6/58, B: 7/82</LI>
<LI>de novo urgency/UUI: A: 0/58, B: 1/82</LI>
<LI>Vaginal tape erosionL A: 3/58, B: 1/82</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>But 2008</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 60)</P>
<P>Group B: TOT (n = 60)</P>
<P/>
<UL>
<LI>Objective cure rates: negative pad test. A: 54/60, B 58/60</LI>
<LI>Subjective cure rates: absence of reported SUI: A: 59/60, B 59/60</LI>
<LI>Post operative voiding difficulties: A: 8/60, B: 3/60</LI>
<LI>Tape erosion: A: 0/60, B: 0/60</LI>
<LI>Duration of operation:</LI>
<LI>Duration and intensity of postoperative pain according to a modified VAS</LI>
<LI>QoL (UDI) significantly improved post operatively in each group with no significant intergroup difference.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Cervigni 2006</P>
</TD>
<TD>
<P>Numbers in each group unreported. It was, thus, impossible to abstract results</P>
</TD>
</TR>
<TR>
<TD>
<P>Chen 2010</P>
</TD>
<TD>
<P>Group A: TVT (n = 77)</P>
<P>Group B: TOT (n = 45)</P>
<P>Group C: TVT-O (n = 65)</P>
<P/>
<UL>
<LI>Objective cure: negative stress test: A: 70/77, B: 41/45, C: 60/65</LI>
<LI>Mean operative time in minutes (SD): A: 48.2 (21.9), B: 20 (13.5), C: 26.9 (16.8)</LI>
<LI>Mean postoperative hospital stay days (SD): A: 5.0 (2.4), B: 4.0 (2.2), C: 2.3 (0.8)</LI>
<LI>Bladder perforation: A: 4/77, B: 0/45, C: 0/65</LI>
<LI>Vascular injury: A: 1/77, B: 0/45, C: 0/65</LI>
<LI>Voiding dysfunction: A: 7/77, B: 2/45, C: 3/65</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Chen 2012</P>
</TD>
<TD>
<P>A: TVT (n = 102)</P>
<P>B: TVT-O (n = 103)</P>
<P/>
<UL>
<LI>Objective cure: negative pad test and stress test</LI>
<LI>Objective cure: A: 89/102, B: 85/103</LI>
<LI>Cure and improvement: A: 99/102, B: 96/103</LI>
<LI>Operative time (mean minutes (SD)): A: 27.3 (13.3) 102, B: 18.5 (7.4)</LI>
<LI>Blood loss (ml): A: 18 (15.4), B: 18.5 (7.4)</LI>
<LI>Length of stay (days): A: 3.4 (2.1), B: 3.1 (1.8)</LI>
<LI>Bladder injury: A: 5/102, B: 0/103</LI>
<LI>Voiding dysfunction: A: 2/102, B: 2/103</LI>
<LI>Groin pain: A: 0/102, B: 3/103</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Cho 2010</P>
</TD>
<TD>
<P>Group A: Monarc TOT (n = 48)</P>
<P>Group B: TOT (n = 45)</P>
<P/>
<UL>
<LI>Subjective cure: A: 41/48, B: 37/45</LI>
<LI>Voiding dysfunction: A: 1/48, B: 2/45</LI>
<LI>Tape erosion: A: 0/48, B: 3/45</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Choe 2013</P>
</TD>
<TD>
<P>We were not able to use the data provided, as the number in each group was not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>Darabi Mahboub 2012</P>
</TD>
<TD>
<P>Group A: TOT (n = 40)</P>
<P>Group B: TVT (n = 40)</P>
<P/>
<P>Operative time (minutes (SD): A: 64.50 (9.04), B: 64.00 (9.48)</P>
<P>Mean hospital stay (days): A: 2.56 (0.51), B: 2.52 (0.47)</P>
</TD>
</TR>
<TR>
<TD>
<P>David-Montefiore 2006</P>
</TD>
<TD>
<P>Group A: RPR (n = 42)</P>
<P>Group B: TOR (n = 46)</P>
<P/>
<UL>
<LI>4 year objective cure A: 27/34, B: 32/37. There is a significant reduction in cure at 4 years in comparison to 1 year.</LI>
<LI>De novo urgency and urge incontinence: A: 7/34, B: 10/37</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>de Leval 2011</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 87)</P>
<P>Group B: modified TVT-O (n = 88)</P>
<P/>
<UL>
<LI>subjective cure: disappearance of SUI using symptom scoring system: A: 77/84, B: 78/86.</LI>
<LI>subjective cure and improvement: A: 80/84, B: 84/86</LI>
<LI>Intraoperative complications: A: 0/87, B: 0/88</LI>
<LI>de novo urgency: A: 8/84 B: 10/86</LI>
<LI>mesh erosion: A: 1/84, B: 0/86</LI>
<LI>groin pain: A: 3/84, B: 4/86</LI>
</UL>
<P>At 3-year follow-up:</P>
<UL>
<LI>objective cure: negative cough test A: 48/56, B: 50/57</LI>
<LI>subjective cure: A: 63/74, B: 66/79</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>de Tayrac 2004</P>
</TD>
<TD>
<P>Group: A: TOT (n = 30)</P>
<P>Group: B: TVT (n = 31)</P>
<P/>
<UL>
<LI>Subjective cure: A: 26/30, B: 30/31</LI>
<LI>Objective cure (negative cough stress test): A: 27/30, B: 26/31</LI>
<LI>Objective cure and improvement: A: 28/30, B: 29/31</LI>
<LI>Mean operating time (minutes): A: 14.8(4.3), B: 26.5(7.7)</LI>
<LI>Mean length of hospital stay (days): A: 1.2(1.3), B: 1.1(0.4)</LI>
<LI>Bladder perforation: A: 0/30, B: 3/31</LI>
<LI>Vaginal tape erosion: A: 0/30, B: 0/31</LI>
<LI>Urethral tape erosion: A: 0/30, B: 1/31</LI>
<LI>De novo urgency/UUI: A: 2/30, B: 2/31</LI>
<LI>Voiding dysfunction: A: 8/30, B: 10/31</LI>
<LI>Sexual dysfunction measured using mean VAS score. No significant difference between the 2 groups in terms of improvement of sexual function: A: Pre-operatively 8.73 (2.18), post operatively: 9.86 (0.54), B: Pre-operatively 8.12 (2.93), post operatively: 8.25 (4.12)</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Deffieux 2010</P>
</TD>
<TD>
<P>Group A: TVT (n = 75)</P>
<P>Group B: TVT-O (n = 74)</P>
<P/>
<UL>
<LI>Subjective cure (self-reported via questionnaires) short term: A: 63/69 , B: 61/69</LI>
<LI>Subjective cure at 24 months: A: 55/67, B: 56/65</LI>
<LI>Objective cure (negative cough stress test) short term: A: 65/69 , B: 67/69</LI>
<LI>Objective cure at 24 months: A: 61/67, B: 65/65</LI>
<LI>Bladder injury: A: 5/75, B: 2/74</LI>
<LI>Major vascular injury: A: 0/75, B: 0/74</LI>
<LI>Tape erosion: A: 0/67, B: 1/65</LI>
<LI>Voiding dysfunction: A: 6/67, B: 2/65</LI>
<LI>Groin/suprapubic pain: A: 2/67, B: 1/65</LI>
<LI>Re-operation rates: A: 2/67, B: 1/65</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Diab 2012</P>
</TD>
<TD>
<P>Group A: TOT (n = 31)</P>
<P>Group B: TVT (n = 32)</P>
<P/>
<UL>
<LI>Retropubic haematoma: A: 0/31, B: 2/32.</LI>
<LI>Vaginal tape extrusion: A: 2/31, B: 2/32</LI>
</UL>
<P>All the preoperative parameters were comparable in both groups. The mean operative time was significantly longer and bladder injury was significantly higher in the TVT group.</P>
<P>There were no significant difference in cure rates, voiding dysfunction, de novo urgency and reoperation rate. The postoperative groin/thigh pain was higher in the TOT group.</P>
</TD>
</TR>
<TR>
<TD>
<P>El-Hefnway 2010</P>
</TD>
<TD>
<P>Preliminary results:</P>
<P>Group A: TVT: (n = 19)</P>
<P>Group B: TOT: (n = 21)</P>
<P/>
<P>At 24 months:</P>
<P>Group A: TVT: (n = 45)</P>
<P>Group B: TOT: (n = 42)</P>
<P/>
<UL>
<LI>Objective cure: negative stress test, 1-h pad test &lt; 2g, and no re-treatment for stress incontinence</LI>
<LI>12 months negative stress test: A: 18/19, B: 18/21</LI>
<LI>24 months negative stress test: A: 31/36, B: 28/35</LI>
<LI>24 months negative 1hr pad test: A:29/36, B: 26/35</LI>
<LI>Subjective cure: no reported SUI</LI>
<LI>Mean operative time in minutes (SD): A: 23.8(5), B: 19.6(5)</LI>
<LI>Mean blood loss (ml): A: 52(14), B: 40(13)</LI>
<LI>Vascular injury: A 3/36, B: 0/35</LI>
<LI>Bladder injury: A: 3/45, B: 0/42</LI>
<LI>Groin pain: A: 0/36, B: 2/35 (no report of suprapubic pain)</LI>
<LI>Tape erosion: A: 0/19, B: 1/21</LI>
<LI>De novo urgency: A: 0/36 , B 3/35</LI>
<LI>QOL: Pre-operative UDI-6 mean scores (SD): A: 13 (3), B: 15(3)</LI>
<LI>Pre-operative IIQ-7 mean scores (SD): A: 17 (3), B: 17 (4)</LI>
<LI>UDI-6 at 12- and 24-month follow-up (SD): A: 2.8 (3), B: 4.7 (6)</LI>
<LI>IQ-7 at 12- and 24-month follow-up (SD): A: 3.2 (5), B: 4.3 (7)</LI>
<LI>24 month follow up UDI-6 (SD): A: 3.5 (4), B: 4.6 (4)</LI>
<LI>24 month follow up IIQ-7: A: 3.6 (6), B: 3.0 (4)</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Elbadry 2014</P>
</TD>
<TD>
<P>Group A: adjustable TOT (n = 48)</P>
<P>Group B: TOT: (n = 48)</P>
<P/>
<UL>
<LI>cure rates: A: 40/48, B: 38/48.</LI>
<LI>Mean operative time in group 2 was significantly shorter than that in group A (11 minutes versus 20 minutes, respectively).</LI>
<LI>Major vascular injury: A: 0/48, B: 0/48</LI>
<LI>bladder injury: A: 0/48, B: 0/48</LI>
<LI>Postoperative adjustment of the tape was only required in 3 cases in group</LI>
<LI>Length of hospital stay: No statistically significant difference was found between the 2 group</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Enzelsberger 2005</P>
</TD>
<TD>
<P>Group A: TOT (n = 56)</P>
<P>Group B: TVT (n = 54)</P>
<P/>
<UL>
<LI>Objective cure rate: A: 45/53, B: 45/52</LI>
<LI>Operative complications: A: 6/53, B: 10/52</LI>
<LI>Operative time in minutes (standard deviation): A: 15 (7), B: 26 (10)</LI>
<LI>Bladder perforation: A: 0/53, B: 4/52</LI>
<LI>Voiding dysfunction: A: 3/53, B: 4/52</LI>
<LI>Detrusor overactivity: A: 6/53, B: 5/52</LI>
<LI>Tape erosion: A: 1/53, B: 1/52</LI>
<LI>Groin pain: A: 5/53, B: 0/52</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Freeman 2011</P>
</TD>
<TD>
<P>Group A: Monarc TOT (n = 100)</P>
<P>Group B: Gynaecare TVT (n = 92)</P>
<P/>
<UL>
<LI>Subjective cure: A: 59/95, B: 55/85</LI>
<LI>Mean operation time (minutes), SD): A: 28 (15), B: 30 (14.2)</LI>
<LI>Operative blood loss (ml) SD: A: 49 (46), B: 62 (65)</LI>
<LI>Bladder perforation: A: 0/100, B:2/92</LI>
<LI>Vaginal perforation: A: 4/100, B: 0/92</LI>
<LI>Tape erosion: A: 3/95, B: 2/85</LI>
<LI>Voiding dysfunction: A: 5/100, B: 5/95</LI>
<LI>De novo OAB: A: 4/95, B: 4/85</LI>
<LI>Groin pain: A: 8/95 , B: 1/85</LI>
<LI>Sexual function: assessed via ICIQ-LUTSqol scores. QoL were improved by both operations from baseline scores without a significant difference between the groups at 12 months follow up. Percentage of women reporting moderate or severe impact of incontinence on sexual function reduced post-operatively by 27.9% in the TVT group and by 30.7% in the TOT group.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Hammoud 2011</P>
</TD>
<TD>
<P>Group A: TVT (n = 60)</P>
<P>Group B: TVT-O (n = 50)</P>
<P/>
<P>Subjective cure: A: 56/60, B: 48/50</P>
</TD>
</TR>
<TR>
<TD>
<P>Hassan 2013</P>
</TD>
<TD>
<P>Group A: inside-out TOT (n = 125)</P>
<P>Group B: outside-in TOT (n = 125)</P>
<P/>
<UL>
<LI>subjective cure at 12 months: A: 102/102, B: 95/97</LI>
<LI>vascular injury/haematoma: A: 5/125, B: 7/125</LI>
<LI>groin/thigh pain: A: 91/125, B: 84/125</LI>
<LI>tape erosion: A: 1/102, B: 0/97</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Houwert 2009</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 93)</P>
<P>Group B: Monarc TOT (n = 98)</P>
<P/>
<UL>
<LI>Subjective cure at 12 months (short term): A: 66/86, B: 73/95</LI>
<LI>Subjective cure and improvement at 12 months (short term): A: 79/86, B: 89/95</LI>
<LI>Subjective cure at 2-4years (medium term): A: 54/75, B: 56/86</LI>
<LI>Subjective cure and improvement at 2-4years (medium term): A: 63/75, B: 74/86</LI>
<LI>Operating time (minutes) (SD): A: 16 (5), B: 16 (6)</LI>
<LI>Voiding dysfunction at 2 months: A: 10/93, B: 3/98</LI>
<LI>Vaginal tape erosion at 12 months: A: 1/86, B: 4/95</LI>
<LI>Thigh pain: A: 0/86, B: 1/95</LI>
<LI>De novo urgency/UI: A: 2/71, B: 4/72</LI>
<LI>Repeat incontinence surgery: A: 5/93, B: 4/98</LI>
<LI>QOL: both the IIQ-7 and UDI-6 demonstrated a statistically significant increase in QoL decrease in impairment caused by symptoms of SUI after 2 months, 1 year, and 2&#8211;4 years in both TOT groups.</LI>
<LI>Sexual dysfunction: Rates of post operative dyspareunia were low with only 1 patient in each group reporting the complication at 12 months, and by 24 months this had resolved in the TOT group.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Jakimiuk 2012</P>
</TD>
<TD>
<P>Group A: TVT (n = 19)</P>
<P>Group B: TVT-O (n = 16)</P>
<P/>
<UL>
<LI>Subjective cure: self-reported: A: 14/15, B: 13/16</LI>
<LI>Objective cure: negative cough test and pad test: A: 14/15, B: 14/16</LI>
<LI>Bladder perforation: A: 3/19, B: 0/16</LI>
<LI>Voiding dysfunction: A: 2/19, B: 0/16</LI>
<LI>Vascular injury: A: 2/19, B: 0/16</LI>
<LI>Mean procedure time (minutes) (SD): A: 47.75 (42.89), B: 12.4 (3.52)</LI>
<LI>Mean hospital stay (days) (SD): A: 2.41 (1.37), B: 2.0 (0)</LI>
<LI>QoL: used non-validated KHQ and validated SF-36 questionnaires the result showed post operative improvement from baseline scores in all domains with no significant differences demonstrated between groups.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Juang 2007</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 47)</P>
<P>Group B: TVT-O plus IS: (n = 49)</P>
<P/>
<UL>
<LI>Objective cure: A:22/45, B:34/48</LI>
<LI>Objective improvement: A:5/45, B:5/48</LI>
<LI>Blood loss (mls) (SD): A: 30.3 (15.2), B: 82.4 (25.1)</LI>
<LI>Operating time (minutes) (SD): A: 16.3 (4.1), B: 28.3 (10.2)</LI>
<LI>Mean hospital stay (days) (SD): A: 1.7 (0.8), B: 3.2 (2.8)</LI>
<LI>Bladder perforation: A: 0/47, B: 0/49</LI>
<LI>Major vascular injury: A: 1/47, B: 3/49</LI>
<LI>Tape erosion: A: 1/45, B: 1/48</LI>
<LI>Complications: One subject in the TVT-O plus IS group, who presented with temporary adductor muscle weakness and a numbness sensation in the medial aspect of right thigh, was noted to have obturator nerve injury, which resolved at 3-months follow-up after conservative treatment, with resolution of symptoms. At the 1-yr follow-up, about 25% of subjects in the TVT-O plus IS group still needed antimuscarinics,whereas about 45% of subjects in the TVT-O alone group still needed some antimuscarinic medication</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Kamel 2009</P>
</TD>
<TD>
<P>A: TVT (n = 60)</P>
<P>B: TVT-O (n = 60)</P>
<P/>
<UL>
<LI>Objective cure: A: 54/60, B: 55/60</LI>
<LI>Bladder perforation: A: 5/60, B: 0/60</LI>
<LI>Vascular injury: A: 2/60, B: 0/60</LI>
<LI>Mean operative time (minutes): A: 30 mins, B: 15 mins</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Karateke 2009</P>
</TD>
<TD>
<P>Group A: TVT (n = 83)</P>
<P>Group B: TVT-O (n = 84)</P>
<P/>
<UL>
<LI>Subjective cure (very satisfied and satisfied): A: 76/81, B: 76/83</LI>
<LI>Obective cure: A: 72/81, B: 73/83</LI>
<LI>Mean operative time (minutes) (SD): A: 31.27 (4.73), B: 18.64 (2.47)</LI>
<LI>Vascular injury/haematoma: A: 4/83, B: 2/84</LI>
<LI>Bladder perforation: A: 3/83, B: 0/84</LI>
<LI>Tape erosion: A: 4/81, B: 2/83</LI>
<LI>Voiding dysfunction: A: 8/83, B: 6/84</LI>
<LI>De novo UI: A: 6/81, B: 5/83</LI>
<LI>De novo DO: A: 12/81, B: 10/83</LI>
<LI>Mean hospital stay (days) (SD): A: 1.36 (0.76) B: 1.25 (0.66)</LI>
<LI>Time to return to normal activity (weeks): A: 2.7 (2.4), B: 2.43 (2.02)</LI>
<LI>QOL: Mean IIQ-7 scores; mean (SD): TVT A: Preop 13.83 (3.88), Postop 6.94 (3.40), TVT-O B: Preop 13.83 (3.88), Postop 6.88 (3.38)</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Kilic 2007</P>
</TD>
<TD>
<P>Group A: TVT (n = 10)</P>
<P>Group B: TOT (n = 10)</P>
<P/>
<UL>
<LI>Subjective cure: A: 7/10, B: 8/10</LI>
<LI>Mean operative time in mins (standard deviation): A: 32 (5.3), B: 26 (9.5)</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Kim 2004</P>
</TD>
<TD>
<P>Group A: TVT (n = 32)</P>
<P>Group B: SPARC (n = 30)<BR/>Group C: IRIS (n = 34).</P>
<P/>
<UL>
<LI>Subjective cure: A: 31/32, B: 29/30</LI>
<LI>Objective cure: A: 31/32, B: 29/30</LI>
<LI>Operating time in mins (standard deviation): A: 27.5 (2.7), B: 28.1 (7.5)</LI>
<LI>Length of hospital stay (days): A: 2.5 (0.9), B: 2.3 (0.6)</LI>
<LI>Perioperative complications: A: 6/32, B: 7/30</LI>
<LI>Bladder perforation: A: 3/32, B: 3/30</LI>
<LI>Voiding dysfunction: A: 0/32, B: 3/30</LI>
<LI>De no urgency/urgency urinary incontinence: A: 3/32, B: 1/30</LI>
<LI>Vaginal tape erosions: A: 0/32, B: 0/30</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Kim 2005</P>
</TD>
<TD>
<P>Group A: Monarc (n = 65)</P>
<P>Group B: SPARC (n = 65)</P>
<P/>
<UL>
<LI>Subjective cure: A: 56/65, B: 56/65</LI>
<LI>Subjective cure and improvement: A: 62/65, B: 63/65</LI>
<LI>Objective cure: A: 17/21, B: 18/22</LI>
<LI>Objective cure and improvement: A: 21/21, B: 22/22</LI>
<LI>Operative time in mins (standard deviation): A: 26.8 (11.8), B: 31.6 (9.6)</LI>
<LI>Perioperative complications: A: 1/21, B: 2/22</LI>
<LI>Bladder perforation: A: 0/65, B: 4/65</LI>
<LI>Voiding dysfunction: A: 4/65, B: 5/65</LI>
<LI>De no urgency/urgency urinary incontinence: A: 1/21, B: 1/22</LI>
<LI>Vaginal tape erosion: A: 0/65, B: 0/65</LI>
<LI>Bladder erosion: A: 0/65, B: 0/65</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Krofta 2010</P>
</TD>
<TD>
<P>Group A: TVT<SUP>TM</SUP> (n = 149)</P>
<P>Group B: TVT &#8211;O<SUP>TM</SUP> (n = 151)</P>
<P/>
<UL>
<LI>Objective cure: A: 127/141, B: 130/147</LI>
<LI>Subjective cure: A: 111/141, B: 12/147</LI>
<LI>Subjective improvement: A: 27/141, B: 31/147</LI>
<LI>De novo urge: A: 9/141, B: 20/147</LI>
<LI>Duration of operation (minutes) (SD): A: 32.62 (9.3) B: 23.76 (12.01)</LI>
<LI>Mean blood loss (SD): A: 31.57 (31.92), TVT-O: 32.26 (34.80)</LI>
<LI>Haematoma: A: 1/149, B: 0/151</LI>
<LI>Groin/suprapubic pain: A: 6/141, B: 8/147</LI>
<LI>Tape erosion/extrusion: A: 2/141, B: 2/147</LI>
<LI>QOL: ICIQ UI- SF and CONTILIFE questionnaires were used pre- postoperatively both showing significant improvement in mean QoL scores following surgery with no significant difference between the two comparators.</LI>
<LI>Sexual dysfunction: assessed using PISQ-12 which showed a significant improvement post operatively from baseline scores but not significant difference between the groups.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Laurikainen 2007</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 131)<BR/>Group B: TVT (n = 136)</P>
<P/>
<UL>
<LI>Objective cure short term: A: 122/131, B: 128/134</LI>
<LI>Objective cure medium term: A: 113/126, B: 124/131</LI>
<LI>Objective cure long term: A: 106/122, B: 111/131</LI>
<LI>Subjective cure short term: A: 122/131, B: 121/134</LI>
<LI>Subjective cure medium term: A: 115/126, B: 118/131</LI>
<LI>Subjective cure long term: A: 113/122, B: 115/131</LI>
<LI>Subjective cure and improvement long term: A: 121/122, B: 128/131</LI>
<LI>Perioperative complications: A: 32/131, B: 22/136</LI>
<LI>Mean operating time (minutes) (standard deviation): A: 29 (8), B: 29 (16)</LI>
<LI>Length of hospital stay (days) (standard deviation): A: 0.71 (0.58), B: 0.58 (0.42)</LI>
<LI>Time to return to normal activity (weeks) (standard deviation): A: 1.71 (0.57), B: 1.71 (0.57)</LI>
<LI>Operative blood loss (mls) (standard deviation): A: 46 (57), B: 55 (86)</LI>
<LI>Major vascular injury: A: 0/131, B: 4/136</LI>
<LI>Bladder perforation: A: 0/131, B: 1/136</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 4/131, B: 6/134</LI>
<LI>De novo urgency/urgency urinary incontinence long term: A: 3/122, B: 4/131</LI>
<LI>Voiding dysfunction: A: 2/131, B: 1/136</LI>
<LI>Repeat incontinence surgery: A: 1/131, B: 2/134</LI>
<LI>Repeat incontinence surgery long term: A: 3/122, B: 2/131</LI>
<LI>Vaginal tape erosion: A: 1/131, B: 2/134</LI>
<LI>Groin pain at 2 months: A: 21/131, B: 2/136</LI>
<LI>Groin pain at 12 months: A: 0/131, B: 0/131</LI>
<LI>Tape erosion: A: 1/131, B: 0/136</LI>
<LI>Tape erosion long term: A: 0/122, B: 0/131</LI>
</UL>
<P/>
<P>QoL: The scores of the condition specific quality of life questionnaires were significantly lower at the 3 and 5 year follow up compared with pre-operative scores. This improvements were statistically significant, but with no difference between the groups.</P>
<P/>
<P>84% of women with pre-operative moderate and severe frequency and urgency symptoms were cured of these symptoms at the 5 year follow up.</P>
</TD>
</TR>
<TR>
<TD>
<P>Leanza 2009</P>
</TD>
<TD>
<P>Group A: r-TICT (n = 229; retropubic)</P>
<P>Group B: t-TICT (n = 220; transobturator)</P>
<P/>
<P>Subjective cure: A: 190/215, B: 178/208</P>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Lee 2007</P>
</TD>
<TD>
<P>Group A: TVT (n = 60)</P>
<P>Group B: TVT-O (n = 60)</P>
<P/>
<UL>
<LI>Subjective cure: A: 52/60, B: 52/60</LI>
<LI>Subjective cure and improvement: A: 56/60, B: 57/60</LI>
<LI>Duration of operation mins (standard deviation): A: 15.2 (1.8), B: 11.5 (1.4)</LI>
<LI>Intraoperative blood loss mls (standard deviation): A: 40 (23.8), B: 31.1 (28.6)</LI>
<LI>Postoperative pain: A:</LI>
<LI>Major vascular injury: A: 0/60, B: 0/60</LI>
<LI>Time to return to normal activities in weeks (SD): A: 5.2 (3.3), B: 4.9 (3.3)</LI>
<LI>Bladder perforation: A: 2/60, B: 0/60</LI>
<LI>Voiding dysfunction: A: 0/60, B: 0/60</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 0/60, B: 4/60</LI>
<LI>Vaginal tape erosion: A: 0/60, B: 0/60</LI>
<LI>Groin pain: A: 5/60, B: 8/60</LI>
<LI>Suprapubic pain: A: 5/60, B: 0/60</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Lee 2008</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 50)</P>
<P>Group B: TOT (n = 50)</P>
<P/>
<UL>
<LI>Subjective cure short term: A: 43/50, B: 46/50</LI>
<LI>Objective cure and improvement: A: 48/50, B: 48/50</LI>
<LI>Operative time minutes (SD): A: 11.2 (2.6), B: 11.5 (1.9)</LI>
<LI>Operative blood loss mls (SD): A: 33.1 (19.2), B: 32.9 (23.1)</LI>
<LI>Time to return to normal activity in weeks (SD): A: 5.1 (3), B: 5.7 (3.1)</LI>
<LI>Perioperative complications: A: 0/50, B: 0/50</LI>
<LI>Voiding dysfunction: A: 0/50, B: 0/50</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 2/50, B: 1/50</LI>
<LI>Vaginal tape erosion: A: 0/50, B: 0/50</LI>
<LI>Groin pain: A: 7/50, B: 9/50</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Liapis 2006</P>
</TD>
<TD>
<P>Group A: TVT (n = 46)</P>
<P>Group B: TVT-O (n = 43)</P>
<P/>
<UL>
<LI>Subjective cure short term: A: 34/46, B: 33/42</LI>
<LI>Objective cure: A: 41/46, B: 39/43</LI>
<LI>Objective cure and improvement: A: 44/46, B: 42/43</LI>
<LI>Operative time in mins (SD): A: 26.7 (8.6), B: 17.4 (6.9)</LI>
<LI>Length of hospital stay days (SD): A: 1.26 (1.34), B: 1.04 (0.21)</LI>
<LI>Perioperative complications: A: 11/46, B: 2/43</LI>
<LI>Major vascular injury: A: 3/46, B: 1/43</LI>
<LI>Bladder perforation: A: 3/46, B: 0/43</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 5/46, B: 6/43</LI>
<LI>Detrusor activity: A: 4/46, B: 4/43</LI>
<LI>Vaginal tape erosion: A: 1/46, B: 0/43</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Liapis 2008</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 61)</P>
<P>Group B: Monarc TOT (n = 53)</P>
<P/>
<UL>
<LI>Short term subjective cure: A: 49/61, B: 41/53</LI>
<LI>Subjective cure and improvement: A: 57/61, B: 47/53</LI>
<LI>Objective cure short term: A: 53/61, B: 48/53</LI>
<LI>Objective cure and improvement: A: 58/61, B: 50/53</LI>
<LI>Peri-operative complications: A: 3/61, B: 2/53</LI>
<LI>Bladder perforation: A: 0/61, B: 1/53</LI>
<LI>Voiding dysfunction: A: 3/61, B: 2/53</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 8/61, B: 6/53</LI>
<LI>Detrusor activity: A: 5/61, B: 5/53</LI>
<LI>Vaginal tape erosion: A: 0/61, B: 0/51</LI>
<LI>Groin pain: A: 3/61, B: 1/53</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Lim 2005</P>
</TD>
<TD>
<P>Group A: TVT (n = 61)</P>
<P>Group B: IVS (n = 60)</P>
<P>Group C: SPARC (n = 61)</P>
<P/>
<UL>
<LI>Subjective cure: A: 48/58, B: 50/56, C: 45/57</LI>
<LI>Objective cure: A: 51/58, B: 44/54, C: 42/58</LI>
<LI>Bladder perforation: A: 1/61, B: 2/60, C: 7/61</LI>
<LI>Voiding dysfunction: A: 2/61, B: 2/60, C: 2/61</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 8/58, B: 6/54, C: 9/58</LI>
<LI>Detrusor activity: A: 2/58, B: 2/54, C: 1/58</LI>
<LI>Vaginal tape erosion: A: 2/58, B: 1/54, C: 8/58</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Lord 2006</P>
</TD>
<TD>
<P>Group A: TVT (n = 147)<BR/>Group B: SPARC (n = 154)</P>
<P/>
<UL>
<LI>Subjective cure: A: 128/147, B: 117/153</LI>
<LI>Objective cure: A: 143/147, B: 148/152</LI>
<LI>Perioperative complications: A: 6/147, B: 4/154</LI>
<LI>Bladder perforation: A: 1/147, B: 3/154</LI>
<LI>Voiding dysfunction: A: 0/147, B: 10/154</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 12/147, B: 17/154</LI>
<LI>Vaginal tape erosion: A: 0/147, B: 1/154</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Mansoor 2003</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 48)<BR/>Group B: TVT (n = 54)</P>
<P/>
<UL>
<LI>Objective cure: A: 46/48, B: 50/54</LI>
<LI>Bladder perforation: A: 0/48, B: 6/54</LI>
<LI>Voiding dysfunction: A: 1/48, B: 5/54</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 2/48, B: 4/54</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Mehdiyev 2010</P>
</TD>
<TD>
<P>A: TOT (n = 17)</P>
<P>B: TVT (n = 15)</P>
<P/>
<UL>
<LI>Subjective cure: A: 14/17, B: 13/15</LI>
<LI>Bladder Injury: A: 0/17, B: 1/15</LI>
<LI>Major vascular injury: A: 0/17, B: 1/15</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 1/17, B: 3/15</LI>
<LI>The mean operation time of TOT group (13.5 min) was significantly shorter than TVT groups (18.3 min).</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Meschia 2006</P>
</TD>
<TD>
<P>Group A: TVT (n = 92)<BR/>Group B: IVS (n = 87)</P>
<P/>
<UL>
<LI>Subjective cure: A: 80/92, B: 68/87</LI>
<LI>Objective cure: A: 79/92, B: 65/87</LI>
<LI>Mean operating time mins (SD): A: 27 (6), B: 27 (4)</LI>
<LI>Length of hospital stay days (SD): A: 2.5 (1), B: 2.3 (1)</LI>
<LI>Perioperative complications: A: 3/92, B: 4/87</LI>
<LI>Bladder perforation: A: 3/92, B: 3/87</LI>
<LI>Voiding dysfunction: A: 5/92, B: 4/87</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 8/92, B: 10/87</LI>
<LI>Vaginal tape erosion: A: 0/92, B: 8/87</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Meschia 2007</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 117)</P>
<P>Group B: TVT (n = 114)</P>
<P/>
<UL>
<LI>Subjective cure: A: 96/110, B: 99/108</LI>
<LI>Objective cure: A: 98/110, B: 99/108</LI>
<LI>Operative time mins (SD): A: 17 (7), B: 26 (9)</LI>
<LI>Operative blood loss mls (SD): A: 27 (33), B: 31 (25)</LI>
<LI>Length of hospital stay days (SD): A: 1.6 (0.8), B: 1.8 (1)</LI>
<LI>Perioperative complications: A: 6/99, B: 7/107</LI>
<LI>Bladder perforation: A: 0/117, B: 5/114</LI>
<LI>Voiding dysfunction: A: 6/99, B: 11/107</LI>
<LI>De novo urgency/urgency urinary incontinence: A: 4/99, B: 6/107</LI>
<LI>Groin pain: A: 6/117, B: 0/114</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Naumann 2006</P>
</TD>
<TD>
<P>Group A: TVT (n = 123)</P>
<P>Group B: LIFT (n = 125)</P>
<P/>
<UL>
<LI>Subjective cure, 6 months: A: 90/123, B: 92/125</LI>
<LI>Subjective cure, 12 months: A: 107/123, B: 109/125</LI>
<LI>Subjective cure or improvement, 6 months: A: 118/123, B: 119/125</LI>
<LI>Subjective cure or improvement, 12 months: A: 117/123, B: 122/125</LI>
<LI>Bladder perforation: A: 2/123, B: 1/125</LI>
<LI>Excess bleeding: A: 2/123, B: 0/125</LI>
<LI>Need for division of tape: A: 4/123, B: 9/125</LI>
<LI>Tape erosion into bladder or urethra: A: 1/123, B: 1/125</LI>
<LI>Vaginal mesh erosion: A: 3/123, B: 7/125</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Nerli 2009</P>
</TD>
<TD>
<P>Group A: TVT (n = 18)</P>
<P>Group B: TOT (n = 18)</P>
<P/>
<UL>
<LI>Objective cure: A: 16/18, B: 16/18</LI>
<LI>Subjective cure: A: 16/18, B: 16/18</LI>
<LI>Improved: A: 2/18, B: 2/18</LI>
<LI>Mean operative time in minutes (SD): A 21.4 (2.75), B: 18.4 (1.85)</LI>
<LI>Mean operative blood loss in ml (SD): A: 38.7 (5.09), B: 37.2 (4.53)</LI>
<LI>Voiding dysfunction: A: 3/18, B: 2/18</LI>
<LI>Bladder perforation: A:1/18, B: 0/18</LI>
<LI>De novo urge incontinence: A: 2/18, B: 3/18</LI>
<LI>Tape erosion: A: 0/18, B: 0/18</LI>
<LI>Days to return to normal activity (SD): A: 4.8 (3.2), B: 5.1 (3.1)</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Nyyssonen 2014</P>
</TD>
<TD>
<P>Group A: TOT (n = 50)</P>
<P>Group B: TVT (n = 50)</P>
<P/>
<UL>
<LI>Subjective cure at 14 and 46 months:</LI>
<UL>
<LI>At 14 months: A: 36/43, B: 40/43</LI>
<LI>At 46 months: A: 38/46, B: 38/47</LI>
</UL>
<LI>Vaginal tape erosion: A: 2/43, B: 0/43</LI>
<LI>Voiding dysfunction: A: 4/46, B: 7/47</LI>
<LI>De novo UUI: A: 2/46, B: 5/47</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Okulu 2013</P>
</TD>
<TD>
<P>Group A: Vypro mesh: (n = 48; multifilament)</P>
<P>Group B: Ultrapro mesh: (n = 48; monofilament + biological combined mesh)</P>
<P>Group C: Prolene light mesh: (n = 48; monofilament)</P>
<P/>
<UL>
<LI>cure:</LI>
<UL>
<LI>Subjective cure at 12 months: A: 41/46, B: 45/48, C: 41/47</LI>
<LI>Subjective cure at 48 months: A: 39/46, B: 44/48, C: 40/47</LI>
</UL>
<LI>bladder perforation: A: 0/48, B: 0/48, C: 0/48</LI>
<LI>major vascular visceral injury: A: 0/48, B: 0/48, C: 0/48</LI>
<LI>de novo urgency/urgency incontinence: A: 5/46, B: 2/48, C: 4/47</LI>
<LI>vaginal tape erosion: A: 3/46, B: 1/48, C: 3/47</LI>
<LI>mean 24hr pad weight (g) (SD):</LI>
<UL>
<LI>Preop: A: 27.2 (9.1), B: 28.7 (9.3), C: 32.4 (0.2)</LI>
<LI>Post op 12 months: A: 2.1 (1.4), B: 2.0 (1.1), C: 2.4 (3.8)</LI>
<LI>Post op 48 months: A: 2.3 (1.1), B: 1.3 (0.8), C: 2.4 (1.1)</LI>
</UL>
<LI>Mean Total ICIQ-SF score (SD):</LI>
<UL>
<LI>Preop: A: 19.3 (1.2), B: 20.1 (0.4), C: 18.8 (1.4)</LI>
<LI>Post op 12 months: A: 2.0 (0.7), B: 1.2 (0.6), C: 1.7 (0.4)</LI>
<LI>Post op 48 months: A: 2.1 (0.5), B: 0.8 (0.5), C: 1.5 (0.3)</LI>
</UL>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Oliveira 2006</P>
</TD>
<TD>
<P>Group A: TVT (n = 17)<BR/>Group B: TVT-O (n = 28)</P>
<P/>
<UL>
<LI>Objective cure: A: 38/42, B: 37/42</LI>
<LI>Bladder perforation: A: 3/42, B: 0/42</LI>
<LI>Voiding dysfunction: A: 5/42, B: 3/42</LI>
<LI>de novo urgency/urgency incontinence: A: 8/42, B: 9/42</LI>
<LI>vaginal tape erosion: A: 2/42, B: 1/42</LI>
<LI>Groin pain: A: 1/42, B: 7/42</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Palomba 2008</P>
</TD>
<TD>
<P>Trial terminated.</P>
</TD>
</TR>
<TR>
<TD>
<P>Paparella 2010</P>
</TD>
<TD>
<P>Group A: synthetic UretexTO (n = 34)</P>
<P>Group B: biological PelviLaceTO (n-36)</P>
<P/>
<UL>
<LI>Objective cure: A: 30/33, B: 33/36</LI>
<LI>Subjective cure: A: 28/33, B: 30/36</LI>
<LI>Mean operating time (minutes) (SD): A: 10.4 (1.0), B: 10.8 (1.2)</LI>
<LI>Mean length of hospital stay days (SD): A: 2.1 (0.3), B: 2.1 (0.4)</LI>
<LI>Perioperative complications: A: 0/34, B: 0/36</LI>
<LI>Major vascular injury: A: 0/34, B: 0/36</LI>
<LI>Voiding dysfunction: A: 0/34, B: 0/36</LI>
<LI>Tape erosion: A: 0/33, B: 0/36</LI>
<LI>QoL: assessed with KHQ improved in most domains from preoperative values but no significant difference between the groups</LI>
<LI>Mean PISQ-12 scores</LI>
<UL>
<LI>Preoperative: A: 24 (2), B: 24.4 (2.4)</LI>
<LI>2yrs Follow up: A: 16.6 (3.0), B: 17.2 (3.0)</LI>
</UL>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Park 2012</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 39)</P>
<P>Group B: TOT Monarc (n = 35)</P>
<P/>
<UL>
<LI>Objective cure at 1yr: A: 35/39, B: 32/35</LI>
<LI>Subjective cure at 1yr: A: 35/39, B: 32/35</LI>
<LI>Objective cure at 3yrs: A: 33/39, B: 30/35</LI>
<LI>Subjective cure at 3yrs: A: 33/39, B: 30/35</LI>
<LI>Subjective cure &amp; improvement at 1yr: A: 37/39, B: 33/35</LI>
<LI>Subjective cure &amp; improved at 3yr: A: 36/39, B: 33/35</LI>
<LI>Voiding dysfunction: A: 3/39, B: 2/35</LI>
<LI>Bladder and urethral perforation: A: 0/39, B: 0/35</LI>
<LI>Groin pain: A: 1/39, B: 0/35</LI>
<LI>Post operative dyspareunia: A: 1/39, B: 1/35</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Peattie 2006</P>
</TD>
<TD>
<P>No published data.</P>
</TD>
</TR>
<TR>
<TD>
<P>Porena 2007</P>
</TD>
<TD>
<P>Group A: TVT (n = 70)</P>
<P>Group B: TOT (n = 75)</P>
<P/>
<UL>
<LI>Objective cure (dry): A: 50/70, B: 58/75</LI>
<LI>Objective cure and improved (dry + wet but improved): A: 63/70, B: 68/75</LI>
<LI>Subjective cure (dry): A: 50/70, B: 58/75</LI>
<LI>Subjective cure and improved (dry + wet but improved): A: 63/70, B: 68/75</LI>
<LI>Bladder injury: A: 2/70, B:1/75</LI>
<LI>Vaginal perforation: A: 0/70, B: 4/75</LI>
<LI>Major vascular injury: A: 1/70, B: 0/75</LI>
<LI>Voiding Dysfunction: A: 7/70, B: 6/75</LI>
<LI>Tape erosion: A: 0/70, B: 3/75</LI>
<LI>Subjective cure long term: A: 30/38, B: 27/45</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Rechberger 2003</P>
</TD>
<TD>
<P>Group A: TVT (n = 50)</P>
<P>Group B: IVS (n = 50)</P>
<P/>
<UL>
<LI>Subjective cure: A: 80/92, B: 68/87</LI>
<LI>Perioperative complications: A: 3/92, B: 4/87</LI>
<LI>Bladder perforation: A: 3/50, B: 4/50</LI>
<LI>Voiding dysfunction: A: 11/50, B: 2/50</LI>
<LI>de novo urgency/urgency incontinence: A: 8/50, B: 4/50</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Rechberger 2009</P>
</TD>
<TD>
<P>Group A: retropubic (IVS-02; n = 269)</P>
<P>Group B: transobturator (IVS-04; n = 268)</P>
<P/>
<UL>
<LI>Subjective cure: A: 151/201, B: 146/197</LI>
<LI>Subjective improvement: A: 34/201, B: 28/197</LI>
<LI>Mean operating time in minutes (SD): A: 23(5), B: 12(4)</LI>
<LI>Bladder perforation: A: 13/269, B: 0/268</LI>
<LI>Major vascular injury: A: 4/269, B: 0/268</LI>
<LI>De novo urgency/UI: A: 17/201 ,B: 10/197</LI>
<LI>Voiding dysfunction: A: 10/269, B: 7/268</LI>
<LI>Vaginal tape erosion: A: 4/201, B: 5/197</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Rechberger 2011</P>
</TD>
<TD>
<P>Group A: TOT (n = 232)</P>
<P>Group B: TOT with fixation (n = 231)</P>
<P/>
<UL>
<LI>Subjective cure and improvement: A: 186/213, B: 191/205</LI>
<LI>Objective cure: A: 189/213, B: 195/205</LI>
<LI>Bladder perforation: A: 4/232, B: 3/231</LI>
<LI>ISD cohort: Objective cure: A: 31/41, B: 39/42</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Richter 2010</P>
</TD>
<TD>
<P>Group A: retropubic sling (TVT; n = 298)</P>
<P>Group B: transobturator tapes (TVT-O, and TOT Monarc; n = 299)</P>
<P>(Group C (?): TVT-O (inside-out) - separate data not provided)</P>
<P>(Group D (?): TOT (Monarch, outside-in) - separate data not provided)</P>
<P/>
<P>Objective cure at 1 year: A: 232/280 (80.8%), B: 233/285 (77.7%)</P>
<P>Subjective cure at 1 year: A: 181/280 (62.2%), B: 163/285 (55.8%)</P>
<P>Secondary outcomes:</P>
<UL>
<LI>median blood loss (ml): A: 50mls; B: 25mls p=0.001</LI>
<LI>median operative time (minutes): A: 30mins; B: 25mins p=0.001</LI>
<LI>bladder or urethral perforation: A: 16/298, B: 0/299</LI>
<LI>vaginal perforation: A: 6/298, B: 13/299</LI>
<LI>voiding dysfunction: A: 16/298, B: 5/229</LI>
<LI>mesh erosion/exposure A: 10/280, B: 2/285</LI>
<LI>vascular injury: A: 20/298, B: 7/299</LI>
<LI>suprapubic/groin pain: A: 3/280, B: 2/285</LI>
<LI>de novo urgency incontinence: A: 0/280, B: 1/285</LI>
<LI>mean (SD) of change in UDI score Total: A: 106.7 (48), B: 110.3 (51.2) P=0.47</LI>
<LI>mean of change in IIQ score Total: A: 126.8 (94.5), B: 132.9 (97.8) P=0.41</LI>
</UL>
<P/>
<P>PISQ-12 (Prolapse / urinary incontinence sexual questionnaire): Analysis of results for group A and group B combined showed significant improvement in sexual function in both groups with a mean PISQ-12 score increase from 32.8+/-7.1 at baseline to 37.3+/- 6 at 24 months. These changes are &gt;0.6 SD units, which reflects &#8220;medium&#8221; improvement in the PISQ-12 score after surgery. Compared with women with successful surgery, women who experienced surgical failure, regardless of assigned type of surgery, reported worse adjusted sexual function scores at all postoperative time points. Improvement in PISQ-12 scores was consistent with change in the 3 specific items from the sexual function measure of interest: (1) the experience of pain during sexual activity, (2) UI during sexual activity, and (3) fear of incontinence during sexual activities. Pain with intercourse was reported by 153 of 406 of sexually active women (38%) at baseline and decreased to 27% at 12 months after surgery (P.003).</P>
<P>Self-reported UI and the fear of incontinence occurring during sexual activity also significantly improved by 12 months after surgery, regardless of sling route. To specifically investigate the association of synthetic mesh slings on dyspareunia, we repeated the analysis on the 247 women who underwent MUS only (no concurrent procedures) and who completed baseline and 12-month assessments. In this subset of women, dyspareunia decreased from 57% at baseline to 43% at 12 months after surgery (P .03).</P>
<P/>
<P/>
<P>5-year data provided, but without numbers in each group, so could not be used for meta-analysis</P>
</TD>
</TR>
<TR>
<TD>
<P>Riva 2006</P>
</TD>
<TD>
<P>Group A: TOT (n = 65)</P>
<P>Group B: TVT (n = 66)</P>
<P/>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Salem 2014</P>
</TD>
<TD>
<P>Group A: TOT (n = 37)</P>
<P>Group B: TVT (n = 39)</P>
<P/>
<P>No significant difference was noticed between the two groups as regard the mean operative time, perioperative complications, intraoperative blood loss, hospital stay, and time to return to normal activities. The mean of abdominal leak point pressure and urethral closure pressure showed marked and maintained improvement for 5 years later in group I whereas in group II, they showed marked and maintained improvement for only one year then shows significant decline in comparison with group I. As regard the mean of objective SEAPI score shows marked decrease (improvement) in both groups and this was maintained for the five years in group I but in group II, it increased after one year later.</P>
<P/>
<P>No usable data provided.</P>
</TD>
</TR>
<TR>
<TD>
<P>Scheiner 2012</P>
</TD>
<TD>
<P>Group A: TVT (n = 80)</P>
<P>Group B: TOT outside-in approach (Monarc; n = 40)</P>
<P>Group C: TVT-O inside-out approach (Gynecare; n = 40)</P>
<P/>
<UL>
<LI>Objective cure: A: 60/65, B: 31/34, C: 33/37</LI>
<LI>Subjective cure: A: 57/65, B: 28/34, C: 29/37</LI>
<LI>Subjective cure and improvement: A: 63/65, B: 31/34, C: 34/37</LI>
<LI>Mean operation time (minutes) (SD) A: 26.7 (11.5), B: 25.8 (9.7) C: 27.4 (10.0)</LI>
<LI>Mean blood loss (ml) A: 34.4 (36.5), B: 31.5 (22.2), C: 49.4 (89.6)</LI>
<LI>Mean hospital stay in days (SD): A: 3.5 (1.1), B: 3.2 (0.5), C: 3.3 (0.8)</LI>
<LI>Bladder perforation A: 3/80, B: 0/40, C: 0/40</LI>
<LI>Vaginal perforation A: 1/80, B: 6/40, C: 4/40</LI>
<LI>Thigh/groin pain: B: 3/34, C: 1/37</LI>
<LI>Vascular damage: A: 1/65, B: 0/34, C: 0/37</LI>
<LI>Voiding dysfunction: A: 3/80, B: 1/40, C: 1/40</LI>
<LI>Tape erosion: A: 1/65, B: 4/34, C: 0/37</LI>
</UL>
<P/>
<UL>
<LI>Sexual function: Two percent (1/52) of sexually active patients after TVT, 17% (5/29) after TOT, but 0% (0/25) after TVTO reported de novo female sexual dysfunction (P=0.011). Complaints included de novo dyspareunia in one TVT and two TOT, a feeling of vaginal narrowing in two TOT, and neuralgiform pain at the ischiocrural tape exit point in one TOT. In two patients with TOT, de novo FSD subsided after 12 months. The other four patients preferred an expectant procedure. No association between tape exposure or FSD and surgeon was found.</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Schierlitz 2008</P>
</TD>
<TD>
<P>Group A: TVT (n = 81)</P>
<P>Group B: Monarc sling (n = 82)</P>
<P/>
<UL>
<LI>Objective cure: absence of USI: A: 53/67, B: 48/71</LI>
<LI>Subjective cure: absence of self-reported SUI: A: 63/66, B: 55/70</LI>
<LI>Bladder perforation: A: 7/82, B: 0/82</LI>
<LI>Major vascular injury: A: 0/82, B: 0/82</LI>
<LI>Groin pain: A: 1/82, B: 3/82</LI>
<LI>Voiding dysfunction: A: 9/82, B: 4/82</LI>
<LI>De novo urgency: A: 14/66, B: 7/70</LI>
<LI>De novo urgency incontinence: A: 9/66, B: 9/70</LI>
<LI>De novo urgency and UUI: A: 23/66, B: 16/70</LI>
<LI>Re-operation: A: 0/82, B: 9/82</LI>
<LI>Vaginal perforation: A: 0/82, B: 4/82</LI>
</UL>
<P/>
<UL>
<LI>QOL: The baseline QoL assessment (UDI-6, IIQ-7) did not differ between the two groups. In both the TVT and transobturator tape groups, there was an overall marked improvement postoperatively in UDI-6 and IIQ-7 scores with no difference in improvement between groups.</LI>
</UL>
<UL>
<LI>Sexual function: Comparison of pre-operative and post-operative mean total PISQ-12 scores revealed a significant improvement in both groups at 6 months, which was maintained at 12 months. There was a significant difference between the TVT and the Monarc mean score at 6 months, with the TVT score being greater. At 12 months, there was no difference between slings, coital incontinence and fear of incontinence were significantly reduced in both treatment groups at 6 and 12 months with no difference between slings. No change to dyspareunia or orgasm intensity was detected in either sling group, and no difference existed between the two slings at 6 or 12 month. At least 8 of 57 (14%) women who were not sexually active prior to their surgery had resumed intercourse at 6 months post-operatively, and this was unchanged at 12 months 7 of 57 (12%). No change to dyspareunia or orgasm intensity was detected in either sling group, and no difference existed between the two slings at 6 or 12 months.</LI>
</UL>
<P/>
<UL>
<LI>The 3-year primary end point was symptomatic stress incontinence considered as failure requiring a repeat procedure on request of the patient.</LI>
<LI>Repeat incontinence surgery: A: 1/72, B: 15/75</LI>
<LI>Subjective cure @ 3 yrs (intermediate term): A: 71/72, B: 60/75</LI>
<LI>The baseline quality-of- life assessment (Urogenital Distress Inventory short form, Incontinence Impact Questionnaire short form) did not differ between groups. At 36 months on average, the overall mean UDI short form and IIQ short form scores improved by 5.8 (SD 4.34) and 6.0 (SD 5.48), respectively (P&lt;.001); no between-group difference was found.</LI>
</UL>
<P/>
<UL>
<LI>5yrs Follow up:</LI>
<LI>Mean follow up in months was A: 63, B: 64</LI>
<LI>Primary outcome was subjective SUI requiring repeat surgery</LI>
<LI>Subj cure at 5yrs A: 69/72, B: 56/75</LI>
<LI>Repeat surgery: A: 3/82, B: 19/82</LI>
</UL>
<UL>
<LI>Median time to repeat surgery months (25th to 75th percentile): A: 82 (43 to 82), B: 24 (12 to 52)Both groups showed improvement in QoL scores post surgery at 5 yrs follow up but no difference between the groups.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Tanuri 2010</P>
</TD>
<TD>
<P>Group A: Safyre VS retropubic tape (n = 10)</P>
<P>Group B: Safyre T transobturator tape (n = 20)</P>
<P/>
<UL>
<LI>Objective cure: A: 8/9, B: 16/19</LI>
<LI>Subjective cure: A: 8/9, B: 17/19</LI>
<LI>Pad test: mean weight of urine grams (SD) A: 0.0(0.0), B: 1.2(5.4)</LI>
<LI>De novo urgency incontinence: A: 1/9, B: 1/19</LI>
<LI>Voiding dysfunction: A: 1/10, B: 0/20</LI>
<LI>Groin pain: A: 0/9, B: 1/19</LI>
<LI>Bladder perforation: A: 0/10, B: 0/20</LI>
<LI>Tape erosion: A: 0/9 B: 0/19</LI>
<LI>Mean QoL Scores: via KHQ</LI>
<UL>
<LI>Improvement in the domains between baseline pre-op scores and 12 months scores without a significant difference between the two groups.</LI>
</UL>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Tarcan 2011</P>
</TD>
<TD>
<P>Group A: TVT (n = 27)</P>
<P>Group B: TOT (n = 27)</P>
<P/>
<P>12-month follow-up assessed:</P>
<UL>
<LI>cure: negative stress provocation test</LI>
<UL>
<LI>objective cure rates: A: 20/23, B: 19/22</LI>
<LI>subjective cure rate: A: 20/23, B: 20/22</LI>
</UL>
<LI>mean operative time in minutes (SD) A: 32.6 (16.6), B: 31.6 (7.7)</LI>
</UL>
<P>2 year follow-up assessed:</P>
<UL>
<LI>subjective cure: A: 21/27, B: 22/27</LI>
<LI>mean operating time in mins (SD): A: 39.1 (17.7), B: 33.4 (13.9)</LI>
<LI>QoL: via SEAPI</LI>
<UL>
<LI>scores were significantly improved in both groups post-operatively with no significant difference between groups</LI>
</UL>
<LI>No significant post operative complications in either group.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Teo 2011</P>
</TD>
<TD>
<P>Group A: TVT (n = 66)</P>
<P>Group B: TVT-O (n = 61)</P>
<P/>
<UL>
<LI>Objective cure: A: 33/41, B: 25/29</LI>
<LI>Subjective cure: A: 35/41, B: 26/29</LI>
<LI>Major vascular injury: A: 1/66, B: 1/61</LI>
<LI>Voiding dysfunction: A: 3/66, B: 1/61</LI>
<LI>Bladder perforation: A: 0/66, B: 0/61</LI>
<LI>De novo urgency incontinence: A: 3/41, B: 6/29</LI>
<LI>Tape erosion A: 3/41, B: 1/29</LI>
<LI>Groin pain: A: 1/66, B: 14/61</LI>
<LI>There was a significant improvement in quality of life, symptom severity and pad use from baseline in both groups</LI>
</UL>
<P/>
<UL>
<LI>QoL:</LI>
</UL>
<UL>
<UL>
<LI>Baseline scores:</LI>
<UL>
<LI>Median KHQ score (range): A: 384 (122&#8211;814), B: 399 (106&#8211;814)</LI>
<LI>Median ICIQ-SF score (range): A: 15 (7&#8211;21), B: 14 (3&#8211;21)</LI>
</UL>
<LI>12 months follow up scores:</LI>
<UL>
<LI>Median KHQ score (range): A: 50 (0&#8211;510) B: 61 (0&#8211;748)</LI>
<LI>Median ICIQ-SF score (range): A: 4 (0&#8211;16) B<B>: </B>0 (0&#8211;11)</LI>
</UL>
</UL>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Tommaselli 2012</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 48)</P>
<P>Group B: modified TVT-O (n = 24)</P>
<P/>
<UL>
<LI>Objective cure: A: 43/46, B:22/23</LI>
<LI>No leakage with urodynamic studies: A: 43/46, B: 21/23 (91.3)</LI>
<LI>No intraoperative complications reported in either group.</LI>
<LI>Voiding dysfunction: A: 1/48, B: 1/24</LI>
</UL>
<P/>
<UL>
<LI>QOL/sexual function:</LI>
<LI>The PISQ-12 score showed a slight decrease after the procedure in both groups, but did not reach statistical significance (A: 18.86.7 vs 125.3, P00.3; B: 16.95.3 vs 12.64.9, P00.6). No differences were observed between groups before or after the procedure. The PGI-S score was significantly lower 6 months after surgery in both groups (P&lt;0.001).</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Tseng 2005</P>
</TD>
<TD>
<P>Group A: SPARC (n = 31)<BR/>Group B: TVT (n = 31)</P>
<P/>
<P/>
<UL>
<LI>Objective cure: A: 25/31, B: 27/31</LI>
<LI>Operative time in mins(SD): A: 40.77 (13.29) B: 32.74 (8.43)</LI>
<LI>Length of hospital stay (days) (SD): A: 3.97 (1.43), B: 3.14 (1.38)</LI>
<LI>Perioperative complications: A: 3/31, B: 5/32</LI>
<LI>Bladder perforation: A: 4/31, B: 0/31</LI>
<LI>Denovo U/UUI: A: 7/31, B: 5/31</LI>
<LI>voiding dysfunction: A: 2/31, B: 1/31</LI>
</UL>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Ugurlucan 2013</P>
</TD>
<TD>
<P>Group A: biological PELVILACE TO (n = 50)</P>
<P>Group B: synthetic TOT ALIGN <SUP></SUP>TO (n = 50)</P>
<P/>
<UL>
<LI>Subjective cure: A: 34/50, B: 35/50</LI>
<LI>Objective cure: A: 28/31, B: 35/36</LI>
<LI>groin pain: A: 2/50, B: 1/50</LI>
<LI>voiding dysfunction: A: 0/50, B: 2/50</LI>
<LI>vaginal tape erosion: A: 0/50, B; 1/50</LI>
</UL>
<P/>
<UL>
<LI>QOL: There was an improvement in quality of life in both groups in all domains when the preoperative and postoperative KHQ, P-QoL, UDI-6, and IIQ-7 were compared. There was no difference between the two groups regarding the improvement in quality of life.</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>van Leijsen 2013</P>
</TD>
<TD>
<P>Group A: RPR (n = 33)</P>
<P>Group B: TOT (n = 90)</P>
<P/>
<UL>
<LI>Subjective cure: A: 25/31, B: 62/83</LI>
<LI>Objective cure: A: 13/13, B: 57/59</LI>
<LI>De novo urgency incontinence: A: 9/30, B: 25/83</LI>
<LI>Voiding dysfunction: A: 5/31, B: 7/80</LI>
<LI>Tape release for POVD: A: 1/31, B: 1/80</LI>
<LI>Repeat incontinence surgery: A: 0/33, B: 0/90</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2006</P>
</TD>
<TD>
<P>Group A: Monarc (n = 31)</P>
<P>Group B: SPARC (n = 29)</P>
<P/>
<UL>
<LI>Operative time in mins (SD): A: 33.83 (8.4) B: 39.21 (12.18)</LI>
<LI>Blood loss ml (SD): A: 117.2 (79.43), B: 125.13 (81.2)</LI>
<LI>Length of hospital stay (days) (SD): A: 3.44 (1.48), B: 3.92 (1.40)</LI>
<LI>Perioperative complications: A: 4/31, B: 2/29</LI>
<LI>Major vascular injury: A: 0/31, B: 0/29</LI>
<LI>Bladder perforation: A: 0/31, B: 1/29</LI>
<LI>Denovo U/UUI: A: 3/31, B: 3/29</LI>
<LI>voiding dysfunction: A: 7/31, B: 16/29</LI>
<LI>Vaginal tape erosion: A: 4/31, B: 0/29</LI>
</UL>
<P/>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2008</P>
</TD>
<TD>
<P>Group A: TVT (n = 35)</P>
<P>Group B: TVT-O (n = 34)</P>
<P/>
<UL>
<LI>Subjective cure: A: 31/35, B: 29/34</LI>
<LI>Subjective cure and improvement: A: 34/35, B: 33/34</LI>
<LI>Failure: A: 1/35, B: 1/34</LI>
<LI>Operative time in minutes; mean (SD): A: 27 (5) 35, B: 18 (5)</LI>
<LI>Blood loss ml (SD): A: 21 (6) B: 20 (7)</LI>
<LI>Length of hospital stay (days) (SD): A: 3.9 (4.4), B: 3.2 (2.2)</LI>
<LI>Bladder/visceral perforation: A: 0/35, B: 0/34</LI>
<LI>Voiding dysfunction: A: 4/35, B: 4/34</LI>
<LI>Haematoma: A: 1/35, B; 0/34</LI>
<LI>No significant differences in postoperative complications: including tape erosion, pain in thigh or behind pubis</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2009</P>
</TD>
<TD>
<P>Group A: TVT (n = 154)</P>
<P>Group B: TVT-O (n = 146)</P>
<P/>
<UL>
<UL>
<LI>6 months</LI>
<UL>
<LI>cured: A: 144/154, B: 133/146</LI>
<LI>Improved: A 8, B 10</LI>
<LI>Failed: A 2, B 3</LI>
</UL>
<LI>12 months</LI>
<UL>
<LI>cured: A: 103/115, B: 106/118</LI>
<LI>Improved: A 10, B 9</LI>
<LI>Failed: A 2, B 3</LI>
</UL>
<LI>24 months</LI>
<UL>
<LI>cured: A: 68/78, B: 75/87</LI>
<LI>Improved: A 8, B 10</LI>
<LI>Failed: A 2, B 2</LI>
</UL>
<LI>36 months</LI>
<UL>
<LI>cured: A: 29/35, B: 25/30</LI>
<LI>Improved: A 5, B 4</LI>
<LI>Failed: A 1, B 1</LI>
</UL>
</UL>
</UL>
<UL>
<LI>Mean operative time in minutes (SD) N: A: 25.1 (4.8) 68, B: 18.4 (4) 68, P&lt;0.001</LI>
<LI>Mean blood loss in ml (SD) N): A: 22.5 (12.5) 68, B: 20.7 (11.8) 68 P=0.18</LI>
<LI>With concomitant prolapse surgery:</LI>
<UL>
<LI>Operative time (mean mins (SD) N): A: 46.6 (16.3) 86, B: 54.9 (24.4) 78 P=0.06</LI>
<LI>Blood loss (mean ml (SD) N): A: 47.9 (35.3) 86, B: 60.8 (41.8) 78 P=0.12</LI>
</UL>
<LI>Mean length of hospital stay (days) (SD) N: A: 3.6 (2.9) 154, B: 3.9 (2.8) 146</LI>
<LI>Adverse effects:</LI>
<UL>
<LI>Any: A: 24/154, B: 27/146</LI>
<LI>haematoma: A: 2, B: 2</LI>
<LI>wound infection: A: 0, B: 0</LI>
</UL>
<LI>Urinary retention: A: 6, B: 4</LI>
<LI>De novo UUI: A: 9/154, B: 6/146</LI>
<LI>Vaginal tape erosion: A: 3/154, B: 3/146 (no urethral or bladder erosion)</LI>
<LI>Groin/thigh pain: A: 4/154, B: 12/146 (no incapacitating pain)</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2010</P>
</TD>
<TD>
<P>Group A: TVT (n = 70)</P>
<P>Group B: TOT (n = 70)</P>
<P/>
<UL>
<LI>Subjective cure: A: 63/70, B: 64/70</LI>
<LI>Objective cure: A: 65/70, B: 64/70</LI>
</UL>
<P/>
<UL>
<LI>Vascular injury/haematoma: A: 0/70, B: 0/70</LI>
<LI>Tape erosion: A: 1/70, B: 2/70</LI>
<LI>Bladder perforation: A: 3/70, B: 1/70</LI>
<LI>Voiding dysfunction: A: 8/70, B: 6/70</LI>
<LI>De novo urgency/UII: A: 1/70 B: 4/70</LI>
<LI>QoL assessed by UDI-6 and IIQ-7-SF</LI>
<LI>QoL Scores:</LI>
<LI>Pre-op UDI-6: A: 49 (21), 1 yr f/u: 15 (15), Pre-op UDI-6: B: 46 (20), 1 yr f/u: 14 (17)</LI>
<LI>Pre-op IIQ-7: A: 40 (21), 1 yr f/u: 13 (12), Pre-op IIQ-7: B: 42 (20), 1 yr f/u: 10 (12)</LI>
<LI>Lost to follow up: A: 0 women, B: 0 women</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Wang 2011</P>
</TD>
<TD>
<P>Group A: TVT (n = 32)</P>
<P>Group B: TVT-O (n = 36)</P>
<P/>
<UL>
<LI>Objective cure: A: 30/32, B: 33/36</LI>
<LI>Subjective cure: A: 30/32, B: 33/36</LI>
<LI>Improvement: A: 2/32, B: 3/36</LI>
<LI>Mean length of surgery (minutes) (SD): A: 34.5 (6.3), B: 16.2 (1.5)</LI>
<LI>Bladder perforation: A: 1/32, B: 0/36</LI>
<LI>Voiding dysfunction: A: 3/32 , B: 1/36</LI>
<LI>Groin pain: A: 0/32, B: 0/36</LI>
<LI>De novo urgency or UI: A: 5/32, B: 6/36</LI>
<LI>Vascular injury: A: 2/32, B: 1/36</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Zhang 2011</P>
</TD>
<TD>
<P>Group A: TVT-O (n = 76)</P>
<P>Group B: modified TVT-O (n = 80)</P>
<P/>
<UL>
<LI>Subjective cure: A: 70/76, B: 75/80</LI>
<LI>Subjective improvement: A: 6/76, B: 5/80</LI>
<LI>Mean operative time (minutes) (SD): A: 49 (5), B: 24 (6)</LI>
<LI>Mean blood loss in (mls); SD: A 70 (5), B: 55 (5)</LI>
<LI>Mean hospital stay in days (SD): A: 8 (0.5),B: 5 (0.5)</LI>
<LI>Voiding dysfunction: A: 1/76, B: 1/80</LI>
<LI>QOL: self-administered I-QOL: A: 23.9 (2.7), B: 24.6 (3.5)</LI>
</UL>
</TD>
</TR>
<TR>
<TD>
<P>Zullo 2007</P>
</TD>
<TD>
<P>Group A: TVT (n = 35)</P>
<P>Group B: TVT-O (n = 37)</P>
<P/>
<UL>
<LI>Objective cure: A: 25/29, B: 27/31</LI>
<LI>Subjective cure: A: 21/29, B: 23/31</LI>
<LI>Incidence of overall perioperative complications</LI>
<LI>De novo urgency and urge incontinence: A: 1/29, B: 2/31</LI>
<LI>Tape erosion: A: 2/29, B: 1/31</LI>
<LI>Voiding dysfunction: A: 0/35, B: 0/37</LI>
</UL>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<B>Abbreviations</B>
</P>
<P>BFLUTS: Bristol lower urinary tract symptoms questionnaires</P>
<P>BMI: body-mass index</P>
<P>DO: detrusor overactivity</P>
<P>DUP: distal urethral polypropylene sling</P>
<P>EQOL-5D: Euro Quality of life -5 Dimension</P>
<P>hr: hour/s</P>
<P>HRT: hormone replacement therapy</P>
<P>ICIQ: International Consultation on Incontinence questionnaire</P>
<P>ICIQ-FLUTS: International Consultation on Incontinence questionnaire - female lower urinary tract symptoms</P>
<P>ICIQ- LUTSquol: International Consultation on Incontinence questionnaire - lower urinary tract quality of life questionnaire</P>
<P>ICIQ-SF: International Consultation on Incontinence questionnaire short form</P>
<P>ICIQ-SF15: International Consultation on Incontinence questionnaire short form 15</P>
<P>IIQ: Incontinence Impact questionnaire</P>
<P>ICS: International Continence Society</P>
<P>I-QoL: Incontinence Quality of Life questionnaire</P>
<P>ISD: intrinsic sphincter deficiency</P>
<P>IVS: intravaginal slingoplasty</P>
<P>KHQ: King's Health questionnaireMUI: mixed urinary incontinence</P>
<P>MUCP: Maximum urethral closure pressure</P>
<P>MUI: mixed urinary incontinence</P>
<P>OAB: overactive bladder</P>
<P>PGI-I: Patient Global Impression of Improvment</P>
<P>PGI-S: Patient Global Impression of Severity</P>
<P>PISQ-12: pelvic organ prolapse/urinary incontinence sexual questionnaire</P>
<P>POP: pelvic organ prolapse</P>
<P>POP-Q: pelvic organ prolapse quantification</P>
<P>POP-Q ICS: pelvic organ prolapse quantification International Continence Society</P>
<P>PVR: post void residual</P>
<P>RCT: randomized controlled trial</P>
<P>RPR: retropubic route</P>
<P>QoL: quality of life</P>
<P>QRCT: quasi-randomised trial</P>
<P>SEAPI-QMM: Stress related leak, Empyting ability, Anatomy, Protection, Inhibition-Quality of life, Mobility and Mental status incontinence classification system</P>
<P>SD: standard deviation</P>
<P>SIS: Single incision sling</P>
<P>SPARC: suprapubic arc (procedure)</P>
<P>SUI: stress urinary incontinence</P>
<P>TOR: transobturator</P>
<P>TOT: transobturator tape</P>
<P>TOT-ARIS: transobturator tape-ARIS</P>
<P>TVT: tension-free vaginal tape</P>
<P>TVT-O: transobturator tension-free vaginal tape</P>
<P>UDI: Urinary Distress Impact questionnaire</P>
<P>UDI-6: Urinary Distress Impact questionnaire short form</P>
<P>UDS: urodynamics study</P>
<P>UI: urinary incontinence</P>
<P>UISS: urinary incontinence severity score</P>
<P>USI: urodynamic stress incontinence</P>
<P>USS: ultrasound</P>
<P>UTI: urinary tract infection</P>
<P>UUI: urgency urinary incontinence</P>
<P>VAS: visual analogue scale</P>
<P>VLPP: Valsalval leak point pressure</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Transobturator (TOR) versus retropubic route (RPR)</NAME>
<DICH_OUTCOME CHI2="26.726425941401626" CI_END="0.997653500413362" CI_START="0.9519545300500338" CI_STUDY="95" CI_TOTAL="95" DF="34" EFFECT_MEASURE="RR" EFFECT_SIZE="0.974536181544212" ESTIMABLE="YES" EVENTS_1="2202" EVENTS_2="2219" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.0010202693217247585" LOG_CI_START="-0.02138379512389711" LOG_EFFECT_SIZE="-0.011202032222810932" METHOD="MH" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8083147193879922" P_Q="1.0" P_Z="0.03105530910566713" Q="0.0" RANDOM="NO" SCALE="1.25" SORT_BY="STUDY" STUDIES="35" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2693" TOTAL_2="2640" WEIGHT="100.0" Z="2.1563632863641384">
<NAME>Subjective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RPR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TOR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0839273874746314" CI_START="0.9062897786666216" EFFECT_SIZE="0.9911368785819006" ESTIMABLE="YES" EVENTS_1="107" EVENTS_2="123" LOG_CI_END="0.035000189697445075" LOG_CI_START="-0.04273291804712797" LOG_EFFECT_SIZE="-0.0038663641748414358" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="570" O_E="0.0" SE="0.04566081227425127" STUDY_ID="STD-Aigmuller-2014" TOTAL_1="122" TOTAL_2="139" VAR="0.0020849097775444154" WEIGHT="5.173958164887066"/>
<DICH_DATA CI_END="1.0357442534624193" CI_START="0.9516224938023039" EFFECT_SIZE="0.9927927927927928" ESTIMABLE="YES" EVENTS_1="145" EVENTS_2="111" LOG_CI_END="0.015252532415434238" LOG_CI_START="-0.021535300957216723" LOG_EFFECT_SIZE="-0.0031413842708912063" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="257" O_E="0.0" SE="0.021609355425807296" STUDY_ID="STD-Aniuliene-2009" TOTAL_1="150" TOTAL_2="114" VAR="4.6696424191886715E-4" WEIGHT="5.675560911807366"/>
<DICH_DATA CI_END="1.1619587798118411" CI_START="0.933424054962827" EFFECT_SIZE="1.0414414414414415" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="74" LOG_CI_END="0.06519072184279236" LOG_CI_START="-0.02992101124708669" LOG_EFFECT_SIZE="0.017634855297852824" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="352" O_E="0.0" SE="0.055869102827666876" STUDY_ID="STD-Barber-2008" TOTAL_1="75" TOTAL_2="85" VAR="0.0031213566507684153" WEIGHT="3.1215585014940515"/>
<DICH_DATA CI_END="1.140781900452176" CI_START="0.8585491756988424" EFFECT_SIZE="0.9896551724137931" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="70" LOG_CI_END="0.05720262208343737" LOG_CI_START="-0.06623482441336491" LOG_EFFECT_SIZE="-0.004516101164963772" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="265" O_E="0.0" SE="0.07250776709743631" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" VAR="0.005257376289456068" WEIGHT="2.6097353958436758"/>
<DICH_DATA CI_END="1.0450449800195767" CI_START="0.7674499838958087" EFFECT_SIZE="0.8955555555555555" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="30" LOG_CI_END="0.019134983417308203" LOG_CI_START="-0.11494991868577664" LOG_EFFECT_SIZE="-0.04790746763423424" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="534" O_E="0.0" SE="0.07876213522632196" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" VAR="0.006203473945409425" WEIGHT="1.3277342319159458"/>
<DICH_DATA CI_END="1.0832925579336368" CI_START="0.8654317249514323" EFFECT_SIZE="0.9682539682539683" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="63" LOG_CI_END="0.034745759615189005" LOG_CI_START="-0.0627671885008183" LOG_EFFECT_SIZE="-0.01401071444281467" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="342" O_E="0.0" SE="0.05727958842022071" STUDY_ID="STD-Deffieux-2010" TOTAL_1="69" TOTAL_2="69" VAR="0.0032809512495898824" WEIGHT="2.834712585140544"/>
<DICH_DATA CI_END="1.198497873437127" CI_START="0.7686559925821121" EFFECT_SIZE="0.9598086124401913" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="55" LOG_CI_END="0.07863726777698134" LOG_CI_START="-0.11426798263029073" LOG_EFFECT_SIZE="-0.017815357426654712" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="0.11331349898562149" STUDY_ID="STD-Freeman-2011" TOTAL_1="95" TOTAL_2="85" VAR="0.012839949052364442" WEIGHT="2.6122351423914187"/>
<DICH_DATA CI_END="1.123381493141568" CI_START="0.9417630521176351" EFFECT_SIZE="1.0285714285714285" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="56" LOG_CI_END="0.05052726492671837" LOG_CI_START="-0.026058352092695167" LOG_EFFECT_SIZE="0.012234456417011586" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1209" O_E="0.0" SE="0.04498677054212188" STUDY_ID="STD-Hammoud-2011" TOTAL_1="50" TOTAL_2="60" VAR="0.002023809523809525" WEIGHT="2.2906768364772074"/>
<DICH_DATA CI_END="1.1420533728233795" CI_START="0.663570064132317" EFFECT_SIZE="0.8705357142857143" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="14" LOG_CI_END="0.05768640074085546" LOG_CI_START="-0.178113214684145" LOG_EFFECT_SIZE="-0.06021340697164479" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="383" O_E="0.0" SE="0.13850986132756643" STUDY_ID="STD-Jakimiuk-2012" TOTAL_1="16" TOTAL_2="15" VAR="0.019184981684981686" WEIGHT="0.6502566503548202"/>
<DICH_DATA CI_END="1.0634653181440796" CI_START="0.8955514095879795" EFFECT_SIZE="0.9759036144578314" ESTIMABLE="YES" EVENTS_1="76" EVENTS_2="76" LOG_CI_END="0.026723331207013108" LOG_CI_START="-0.047909478201861366" LOG_EFFECT_SIZE="-0.01059307349742414" MODIFIED="2015-01-16 01:09:30 +0000" MODIFIED_BY="[Empty name]" ORDER="607" O_E="0.0" SE="0.04383968168513764" STUDY_ID="STD-Karateke-2009" TOTAL_1="83" TOTAL_2="81" VAR="0.0019219176902541928" WEIGHT="3.4613563660601145"/>
<DICH_DATA CI_END="1.9042539824534621" CI_START="0.6858971865175091" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.27972487252628847" LOG_CI_START="-0.163740978570915" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="466" O_E="0.0" SE="0.2604940361258638" STUDY_ID="STD-Kilic-2007" TOTAL_1="10" TOTAL_2="10" VAR="0.06785714285714284" WEIGHT="0.31496806501561603"/>
<DICH_DATA CI_END="1.1477767303786748" CI_START="0.8712495849868639" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="56" LOG_CI_END="0.05985741576676957" LOG_CI_START="-0.05985741576676958" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="261" O_E="0.0" SE="0.07032108464077429" STUDY_ID="STD-Kim-2005" TOTAL_1="65" TOTAL_2="65" VAR="0.004945054945054941" WEIGHT="2.5197445201249282"/>
<DICH_DATA CI_END="1.0962708130363747" CI_START="0.8544286295017146" EFFECT_SIZE="0.9678249678249679" ESTIMABLE="YES" EVENTS_1="112" EVENTS_2="111" LOG_CI_END="0.039917851665813874" LOG_CI_START="-0.06832420808435788" LOG_EFFECT_SIZE="-0.014203178209272008" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="270" O_E="0.0" SE="0.06358192170408802" STUDY_ID="STD-Krofta-2010" TOTAL_1="147" TOTAL_2="141" VAR="0.0040426607675847805" WEIGHT="5.098545552440284"/>
<DICH_DATA CI_END="1.1088054097777036" CI_START="0.9593135747100646" EFFECT_SIZE="1.0313544886757933" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="121" LOG_CI_END="0.044855336162819566" LOG_CI_START="-0.01803941002813663" LOG_EFFECT_SIZE="0.013407963067341492" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="565" O_E="0.0" SE="0.03694468524658246" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="134" VAR="0.0013649097679690478" WEIGHT="5.382812720822134"/>
<DICH_DATA CI_END="1.042660695317248" CI_START="0.8993734238065466" EFFECT_SIZE="0.9683704453441295" ESTIMABLE="YES" EVENTS_1="178" EVENTS_2="190" LOG_CI_END="0.018143002457603117" LOG_CI_START="-0.04605994983978553" LOG_EFFECT_SIZE="-0.013958473691091213" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="450" O_E="0.0" SE="0.03771313198922553" STUDY_ID="STD-Leanza-2009" TOTAL_1="208" TOTAL_2="215" VAR="0.0014222803244367463" WEIGHT="8.407658175898106"/>
<DICH_DATA CI_END="1.1506832958049518" CI_START="0.8690488544030333" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="52" LOG_CI_END="0.06095580859014775" LOG_CI_START="-0.060955808590147764" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="391" O_E="0.0" SE="0.07161148740394331" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="0.005128205128205131" WEIGHT="2.339762768687433"/>
<DICH_DATA CI_END="1.317033310800326" CI_START="0.8185628649186746" EFFECT_SIZE="1.0383036935704515" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="34" LOG_CI_END="0.11959675940659764" LOG_CI_START="-0.0869479615313578" LOG_EFFECT_SIZE="0.016324398937619927" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="260" O_E="0.0" SE="0.12132539149181294" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="0.014719850620641677" WEIGHT="1.478277082031559"/>
<DICH_DATA CI_END="1.27799374708589" CI_START="0.7065213875253911" EFFECT_SIZE="0.9502262443438914" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.10652872892978575" LOG_CI_START="-0.15087468683216868" LOG_EFFECT_SIZE="-0.02217297895119145" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="1203" O_E="0.0" SE="0.15120004058602954" STUDY_ID="STD-Mehdiyev-2010" TOTAL_1="17" TOTAL_2="15" VAR="0.02286145227321698" WEIGHT="0.6214994854325995"/>
<DICH_DATA CI_END="1.0430282710638124" CI_START="0.8690367402451276" EFFECT_SIZE="0.9520661157024793" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="99" LOG_CI_END="0.01829608004744541" LOG_CI_START="-0.060961862505959086" LOG_EFFECT_SIZE="-0.02133289122925684" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="267" O_E="0.0" SE="0.0465565077890129" STUDY_ID="STD-Meschia-2007" TOTAL_1="110" TOTAL_2="108" VAR="0.0021675084175084187" WEIGHT="4.49541576411541"/>
<DICH_DATA CI_END="1.2598390449808052" CI_START="0.793752189205436" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="16" LOG_CI_END="0.10031506389394648" LOG_CI_START="-0.10031506389394652" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="319" O_E="0.0" SE="0.11785113019775795" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" VAR="0.013888888888888895" WEIGHT="0.7199270057499795"/>
<DICH_DATA CI_END="1.0510485715750286" CI_START="0.7706589608757948" EFFECT_SIZE="0.9" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="40" LOG_CI_END="0.02162278632281227" LOG_CI_START="-0.11313776744416254" LOG_EFFECT_SIZE="-0.045757490560675115" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="609" O_E="0.0" SE="0.07915901635822059" STUDY_ID="STD-Nyyssonen-2014" TOTAL_1="43" TOTAL_2="43" VAR="0.006266149870801034" WEIGHT="1.7998175143749486"/>
<DICH_DATA CI_END="1.3121760031523286" CI_START="0.8933002190979984" EFFECT_SIZE="1.0826666666666667" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="50" LOG_CI_END="0.11799209119157389" LOG_CI_START="-0.0490025594926234" LOG_EFFECT_SIZE="0.034494765849475265" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="960" O_E="0.0" SE="0.09809348444875023" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="0.009622331691297203" WEIGHT="2.327350234105537"/>
<DICH_DATA CI_END="1.1063403971339236" CI_START="0.8796759301781761" EFFECT_SIZE="0.9865196490402394" ESTIMABLE="YES" EVENTS_1="146" EVENTS_2="151" LOG_CI_END="0.043888770596284696" LOG_CI_START="-0.055677291095957475" LOG_EFFECT_SIZE="-0.00589426024983639" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="0.05848559749797716" STUDY_ID="STD-Rechberger-2009" TOTAL_1="197" TOTAL_2="201" VAR="0.0034205651146953925" WEIGHT="6.726026582928593"/>
<DICH_DATA CI_END="1.010242270590861" CI_START="0.7748521910241383" EFFECT_SIZE="0.8847533197634971" ESTIMABLE="YES" EVENTS_1="163" EVENTS_2="181" LOG_CI_END="0.004425536320744446" LOG_CI_START="-0.11078113458377986" LOG_EFFECT_SIZE="-0.05317779913151769" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="999" O_E="0.0" SE="0.06767296877153595" STUDY_ID="STD-Richter-2010" TOTAL_1="285" TOTAL_2="280" VAR="0.004579630702353279" WEIGHT="8.216246591064754"/>
<DICH_DATA CI_END="1.1223400914954855" CI_START="0.9788434746446195" EFFECT_SIZE="1.0481389578163771" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="62" LOG_CI_END="0.05012447677715249" LOG_CI_START="-0.009286750007859716" LOG_EFFECT_SIZE="0.020418863384646373" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="512" O_E="0.0" SE="0.03489844870383178" STUDY_ID="STD-Riva-2006" TOTAL_1="65" TOTAL_2="66" VAR="0.0012179017219339783" WEIGHT="2.768421596538566"/>
<DICH_DATA CI_END="1.0603732850734449" CI_START="0.7904078379580686" EFFECT_SIZE="0.9154929577464789" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="57" LOG_CI_END="0.025458777632031204" LOG_CI_START="-0.10214876178447058" LOG_EFFECT_SIZE="-0.03834499207621971" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="362" O_E="0.0" SE="0.07495730032076064" STUDY_ID="STD-Scheiner-2012" TOTAL_1="71" TOTAL_2="65" VAR="0.0056185968713767034" WEIGHT="2.677890250248315"/>
<DICH_DATA CI_END="0.9403936740816867" CI_START="0.7204873700016698" EFFECT_SIZE="0.8231292517006803" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="63" LOG_CI_END="-0.02669030098548279" LOG_CI_START="-0.14237362787796917" LOG_EFFECT_SIZE="-0.084531964431726" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="516" O_E="0.0" SE="0.06795295885835008" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="70" TOTAL_2="66" VAR="0.004617604617604618" WEIGHT="2.9180864847035015"/>
<DICH_DATA CI_END="1.3288285682174257" CI_START="0.7624769676983167" EFFECT_SIZE="1.006578947368421" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="8" LOG_CI_END="0.12346895635319419" LOG_CI_START="-0.11777327060754168" LOG_EFFECT_SIZE="0.0028478428728262407" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="0.14170687828501902" STUDY_ID="STD-Tanuri-2010" TOTAL_1="19" TOTAL_2="9" VAR="0.020080839353285196" WEIGHT="0.48852189675891466"/>
<DICH_DATA CI_END="1.2848492615694616" CI_START="0.8506641512767695" EFFECT_SIZE="1.0454545454545454" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.10885217925594333" LOG_CI_START="-0.07024186886517012" LOG_EFFECT_SIZE="0.019305155195386624" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="266" O_E="0.0" SE="0.10520073039617801" STUDY_ID="STD-Tarcan-2011" TOTAL_1="22" TOTAL_2="23" VAR="0.011067193675889334" WEIGHT="0.8799107848055305"/>
<DICH_DATA CI_END="1.2536674338534919" CI_START="0.8798324597578819" EFFECT_SIZE="1.0502463054187192" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="35" LOG_CI_END="0.09818234447107183" LOG_CI_START="-0.055600019588428404" LOG_EFFECT_SIZE="0.02129116244132174" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="525" O_E="0.0" SE="0.09033252188352958" STUDY_ID="STD-Teo-2011" TOTAL_1="29" TOTAL_2="41" VAR="0.00815996450983835" WEIGHT="1.3048676979218379"/>
<DICH_DATA CI_END="1.1462744866747756" CI_START="0.7484829958242116" EFFECT_SIZE="0.9262650602409639" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="25" LOG_CI_END="0.0592886261604315" LOG_CI_START="-0.12581806159160142" LOG_EFFECT_SIZE="-0.033264717715584945" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="607" O_E="0.0" SE="0.1087325846784263" STUDY_ID="STD-van-Leijsen-2013" TOTAL_1="83" TOTAL_2="31" VAR="0.011822774970851144" WEIGHT="1.6379918168105343"/>
<DICH_DATA CI_END="1.1568651867951973" CI_START="0.8016191998340582" EFFECT_SIZE="0.9629981024667932" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="31" LOG_CI_END="0.06328275217367635" LOG_CI_START="-0.09603188942826849" LOG_EFFECT_SIZE="-0.016374568627296075" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="544" O_E="0.0" SE="0.09358220909717703" STUDY_ID="STD-Wang-2008" TOTAL_1="34" TOTAL_2="35" VAR="0.008757629859507763" WEIGHT="1.3746432319936202"/>
<DICH_DATA CI_END="1.1295037471337386" CI_START="0.9136738032058457" EFFECT_SIZE="1.0158730158730158" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="63" LOG_CI_END="0.05288767603266002" LOG_CI_START="-0.039208826972049096" LOG_EFFECT_SIZE="0.006839424530305442" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.05409794175000841" STUDY_ID="STD-Wang-2010" TOTAL_1="70" TOTAL_2="70" VAR="0.0029265873015873033" WEIGHT="2.834712585140544"/>
<DICH_DATA CI_END="1.1169283452695322" CI_START="0.8559630407493506" EFFECT_SIZE="0.9777777777777777" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="30" LOG_CI_END="0.04802531254960568" LOG_CI_START="-0.0675449871279182" LOG_EFFECT_SIZE="-0.009759837289156262" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="472" O_E="0.0" SE="0.06788656611278739" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" VAR="0.004608585858585854" WEIGHT="1.4292668496506946"/>
<DICH_DATA CI_END="1.134786099219623" CI_START="0.8385839702587985" EFFECT_SIZE="0.9755067567567568" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="32" LOG_CI_END="0.05491400718269059" LOG_CI_START="-0.07645344350016625" LOG_EFFECT_SIZE="-0.01076971815873784" MODIFIED="2014-07-12 19:58:55 +0100" MODIFIED_BY="[Empty name]" ORDER="507" O_E="0.0" SE="0.07716589081047859" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" VAR="0.005954574704574705" WEIGHT="1.4798499562638465"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.568245347509675" CI_END="1.0041404472488504" CI_START="0.9582349773160522" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9809192110931627" ESTIMABLE="YES" EVENTS_1="772" EVENTS_2="788" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.0017944610154890265" LOG_CI_START="-0.018527980651625996" LOG_EFFECT_SIZE="-0.00836675981806849" METHOD="MH" MODIFIED="2015-05-28 16:47:14 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9374686367215035" P_Q="1.0" P_Z="0.10656291982174615" Q="0.0" RANDOM="NO" SCALE="1.2" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="825" TOTAL_2="826" WEIGHT="100.0" Z="1.6138363863281893">
<NAME>Subjective cure and improvement (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RPR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TOR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0188746076965782" CI_START="0.9268882184707884" EFFECT_SIZE="0.9717936354869817" ESTIMABLE="YES" EVENTS_1="116" EVENTS_2="136" LOG_CI_END="0.008120738926623872" LOG_CI_START="-0.03297263805452815" LOG_EFFECT_SIZE="-0.012425949563952165" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="571" O_E="0.0" SE="0.024138453054225382" STUDY_ID="STD-Aigmuller-2014" TOTAL_1="122" TOTAL_2="139" VAR="5.826649158510427E-4" WEIGHT="16.145525311927344"/>
<DICH_DATA CI_END="1.0542366305999977" CI_START="0.9186798227032459" EFFECT_SIZE="0.9841269841269841" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="63" LOG_CI_END="0.022938102175908914" LOG_CI_START="-0.036835822086564586" LOG_EFFECT_SIZE="-0.006948859955327855" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="524" O_E="0.0" SE="0.03511149899747399" STUDY_ID="STD-Kim-2005" TOTAL_1="65" TOTAL_2="65" VAR="0.0012328173618496169" WEIGHT="8.000267378978462"/>
<DICH_DATA CI_END="1.0307582335267211" CI_START="0.9584305433082807" EFFECT_SIZE="0.9939367051168293" ESTIMABLE="YES" EVENTS_1="143" EVENTS_2="138" LOG_CI_END="0.013156812559925504" LOG_CI_START="-0.01843935461786728" LOG_EFFECT_SIZE="-0.002641271028970916" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="271" O_E="0.0" SE="0.01855974500378544" STUDY_ID="STD-Krofta-2010" TOTAL_1="147" TOTAL_2="141" VAR="3.444641346055386E-4" WEIGHT="17.889486777993504"/>
<DICH_DATA CI_END="1.1127365426214002" CI_START="0.9310677986943834" EFFECT_SIZE="1.0178571428571428" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="56" LOG_CI_END="0.04639235065116048" LOG_CI_START="-0.031018693318578566" LOG_EFFECT_SIZE="0.007686828666290955" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="392" O_E="0.0" SE="0.04547163041867236" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="0.0020676691729323293" WEIGHT="7.111348781314188"/>
<DICH_DATA CI_END="1.1102005841375073" CI_START="0.9007381317285831" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="0.04540145150208338" LOG_CI_START="-0.04540145150208339" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="0.05333807470626661" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" VAR="0.002844950213371278" WEIGHT="2.34928486525558"/>
<DICH_DATA CI_END="1.1207644371615424" CI_START="0.9055156024307673" EFFECT_SIZE="1.0074074074074073" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="63" LOG_CI_END="0.049514341951577924" LOG_CI_START="-0.0431040622011552" LOG_EFFECT_SIZE="0.0032051398752113544" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="359" O_E="0.0" SE="0.054404509067810095" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="0.0029598506069094307" WEIGHT="8.276138667908754"/>
<DICH_DATA CI_END="1.0241291908432204" CI_START="0.8992075759402987" EFFECT_SIZE="0.9596378103992317" ESTIMABLE="YES" EVENTS_1="174" EVENTS_2="185" LOG_CI_END="0.010354745049301261" LOG_CI_START="-0.046140042772337575" LOG_EFFECT_SIZE="-0.017892648861518153" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="337" O_E="0.0" SE="0.03318531802014058" STUDY_ID="STD-Rechberger-2009" TOTAL_1="197" TOTAL_2="201" VAR="0.0011012653320978671" WEIGHT="23.256739620871823"/>
<DICH_DATA CI_END="1.026185277958082" CI_START="0.8694204484360402" EFFECT_SIZE="0.944556226246367" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="63" LOG_CI_END="0.01122577981124831" LOG_CI_START="-0.060770149585140015" LOG_EFFECT_SIZE="-0.02477218488694587" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="363" O_E="0.0" SE="0.04229076531303671" STUDY_ID="STD-Scheiner-2012" TOTAL_1="71" TOTAL_2="65" VAR="0.001788508830762349" WEIGHT="8.353220351580452"/>
<DICH_DATA CI_END="1.084038709369196" CI_START="0.9208809942676882" EFFECT_SIZE="0.9991349480968859" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="34" LOG_CI_END="0.03504479047292525" LOG_CI_START="-0.03579649018561947" LOG_EFFECT_SIZE="-3.758498563471156E-4" MODIFIED="2014-07-12 19:58:59 +0100" MODIFIED_BY="[Empty name]" ORDER="582" O_E="0.0" SE="0.04161251892882397" STUDY_ID="STD-Wang-2008" TOTAL_1="34" TOTAL_2="35" VAR="0.0017316017316017333" WEIGHT="4.2550306372666675"/>
<DICH_DATA CI_END="1.0583217929920863" CI_START="0.9448921931134018" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="32" LOG_CI_END="0.024617739222805766" LOG_CI_START="-0.02461773922280576" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-10-22 21:21:02 +0100" MODIFIED_BY="[Empty name]" ORDER="474" O_E="0.0" SE="0.02892116375850114" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" VAR="8.364337131460398E-4" WEIGHT="4.36295760690322"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="11.943608010413403" CI_END="1.0857303693731173" CI_START="0.87112421855939" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9725255881396411" ESTIMABLE="YES" EVENTS_1="291" EVENTS_2="303" I2="66.50928265133554" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.03572198581229691" LOG_CI_START="-0.059919912055052794" LOG_EFFECT_SIZE="-0.012098963121377928" METHOD="MH" MODIFIED="2015-05-28 16:47:21 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.017775597150343825" P_Q="1.0" P_Z="0.6199779018724495" Q="0.0" RANDOM="YES" SCALE="1.44" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.009639393873215458" TOTALS="YES" TOTAL_1="339" TOTAL_2="344" WEIGHT="99.99999999999999" Z="0.49588166895367314">
<NAME>Subjective cure (medium term, 1 to 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RPR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TOR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2173464910395124" CI_START="0.9048140982868252" EFFECT_SIZE="1.0495104895104894" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="55" LOG_CI_END="0.08541420824580781" LOG_CI_START="-0.04344064110595299" LOG_EFFECT_SIZE="0.020986783569927392" MODIFIED="2014-07-12 19:59:04 +0100" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="0.07568997635101556" STUDY_ID="STD-Deffieux-2010" TOTAL_1="65" TOTAL_2="67" VAR="0.005728972520017294" WEIGHT="20.537324679679152"/>
<DICH_DATA CI_END="1.0958877124124455" CI_START="0.9368436333139325" EFFECT_SIZE="1.0132499327414581" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="118" LOG_CI_END="0.03976605745317054" LOG_CI_START="-0.028332890281795253" LOG_EFFECT_SIZE="0.005716583585687647" MODIFIED="2014-07-12 19:59:04 +0100" MODIFIED_BY="[Empty name]" ORDER="566" O_E="0.0" SE="0.04000165899474679" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="126" TOTAL_2="131" VAR="0.0016001327223320065" WEIGHT="28.081710357723207"/>
<DICH_DATA CI_END="1.2382525658718273" CI_START="0.8430839389592562" EFFECT_SIZE="1.0217391304347827" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="38" LOG_CI_END="0.09280923658812688" LOG_CI_START="-0.07412918407984" LOG_EFFECT_SIZE="0.009340026254143432" MODIFIED="2014-07-12 19:59:04 +0100" MODIFIED_BY="[Empty name]" ORDER="610" O_E="0.0" SE="0.09806045465887336" STUDY_ID="STD-Nyyssonen-2014" TOTAL_1="46" TOTAL_2="47" VAR="0.00961585276790496" WEIGHT="16.39164308288108"/>
<DICH_DATA CI_END="0.9114434834218617" CI_START="0.722101962350831" EFFECT_SIZE="0.8112676056338028" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="71" LOG_CI_END="-0.04027025580658158" LOG_CI_START="-0.1414014747851449" LOG_EFFECT_SIZE="-0.09083586529586322" MODIFIED="2014-07-12 19:59:04 +0100" MODIFIED_BY="[Empty name]" ORDER="471" O_E="0.0" SE="0.05940497863561574" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="75" TOTAL_2="72" VAR="0.003528951486697962" WEIGHT="23.968473015213043"/>
<DICH_DATA CI_END="1.3725618910899" CI_START="0.7996037745611255" EFFECT_SIZE="1.0476190476190477" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="21" LOG_CI_END="0.13753193662144103" LOG_CI_START="-0.09712516444486703" LOG_EFFECT_SIZE="0.02020338608828699" MODIFIED="2014-07-12 19:59:04 +0100" MODIFIED_BY="[Empty name]" ORDER="1057" O_E="0.0" SE="0.13783874273773322" STUDY_ID="STD-Tarcan-2011" TOTAL_1="27" TOTAL_2="27" VAR="0.018999518999519002" WEIGHT="11.020848864503515"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.514636005065109" CI_END="1.120856188485464" CI_START="0.7974670237438078" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9454342117124446" ESTIMABLE="YES" EVENTS_1="243" EVENTS_2="241" I2="64.76655022932997" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.0495498939921443" LOG_CI_START="-0.09828726651805149" LOG_EFFECT_SIZE="-0.024368686262953593" METHOD="MH" MODIFIED="2015-05-28 16:47:34 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.03649113471775978" P_Q="1.0" P_Z="0.5181887316823754" Q="0.0" RANDOM="YES" SCALE="1.59" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.01855140918629502" TOTALS="YES" TOTAL_1="373" TOTAL_2="341" WEIGHT="100.0" Z="0.6461399456147024">
<NAME>Subjective cure (long term, &gt; 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RPR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TOR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.144304169084845" CI_START="0.972842770792439" EFFECT_SIZE="1.055096222380613" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="115" LOG_CI_END="0.05854148022348646" LOG_CI_START="-0.0119573440018382" LOG_EFFECT_SIZE="0.02329206811082411" MODIFIED="2014-07-12 19:59:08 +0100" MODIFIED_BY="[Empty name]" ORDER="567" O_E="0.0" SE="0.041411358324763795" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="122" TOTAL_2="131" VAR="0.0017149005983019836" WEIGHT="37.21069248140643"/>
<DICH_DATA CI_END="1.0514893378264645" CI_START="0.647726209143135" EFFECT_SIZE="0.8252740167633784" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="33" LOG_CI_END="0.021804873269027105" LOG_CI_START="-0.1886085296005003" LOG_EFFECT_SIZE="-0.0834018281657366" MODIFIED="2014-07-12 19:59:08 +0100" MODIFIED_BY="[Empty name]" ORDER="1005" O_E="0.0" SE="0.12359787440870271" STUDY_ID="STD-Porena-2007" TOTAL_1="47" TOTAL_2="40" VAR="0.015276434558349448" WEIGHT="22.292979322601607"/>
<DICH_DATA CI_END="1.0736613650246074" CI_START="0.6713302662793743" EFFECT_SIZE="0.8489884393063584" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="72" LOG_CI_END="0.030867325598716265" LOG_CI_START="-0.17306377262468411" LOG_EFFECT_SIZE="-0.07109822351298394" MODIFIED="2015-04-11 21:13:20 +0100" MODIFIED_BY="[Empty name]" ORDER="627" O_E="0.0" SE="0.11979013657164221" STUDY_ID="STD-Richter-2010" TOTAL_1="173" TOTAL_2="141" VAR="0.014349676819852691" WEIGHT="22.92092792884241"/>
<DICH_DATA CI_END="1.3911954950695695" CI_START="0.7545734634295075" EFFECT_SIZE="1.0245775729646698" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="21" LOG_CI_END="0.1433881626766608" LOG_CI_START="-0.12229847197994666" LOG_EFFECT_SIZE="0.010544845348357037" MODIFIED="2014-07-12 19:59:08 +0100" MODIFIED_BY="[Empty name]" ORDER="494" O_E="0.0" SE="0.15606564436734355" STUDY_ID="STD-Zullo-2007" TOTAL_1="31" TOTAL_2="29" VAR="0.024356485351794147" WEIGHT="17.575400267149554"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.83139043432386" CI_END="1.2815808909549118" CI_START="0.6672236088228223" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.924716728009883" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="164" I2="90.76757498436142" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.1077460232293113" LOG_CI_START="-0.1757285951639685" LOG_EFFECT_SIZE="-0.03399128596732863" METHOD="MH" MODIFIED="2015-05-28 16:47:40 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="9.979445628891526E-4" P_Q="1.0" P_Z="0.6383290046530385" Q="0.0" RANDOM="YES" SCALE="6.8" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.05072635824627059" TOTALS="YES" TOTAL_1="169" TOTAL_2="171" WEIGHT="100.00000000000001" Z="0.47003641216116154">
<NAME>Subjective cure and improvement (long term, &gt; 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RPR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TOR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0467793993058536" CI_START="0.9842797815455376" EFFECT_SIZE="1.0150486680327868" ESTIMABLE="YES" EVENTS_1="121" EVENTS_2="128" LOG_CI_END="0.01985516710518852" LOG_CI_START="-0.006881435805993063" LOG_EFFECT_SIZE="0.006486865649597717" MODIFIED="2014-07-12 19:59:12 +0100" MODIFIED_BY="[Empty name]" ORDER="567" O_E="0.0" SE="0.01570521289834696" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="122" TOTAL_2="131" VAR="2.4665371218240365E-4" WEIGHT="54.39553670839571"/>
<DICH_DATA CI_END="1.0072941312376105" CI_START="0.6796714856777821" EFFECT_SIZE="0.8274231678486997" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="36" LOG_CI_END="0.003156303643559069" LOG_CI_START="-0.1677009496930925" LOG_EFFECT_SIZE="-0.08227232302476671" MODIFIED="2014-07-12 19:59:12 +0100" MODIFIED_BY="[Empty name]" ORDER="1005" O_E="0.0" SE="0.10036239636699339" STUDY_ID="STD-Porena-2007" TOTAL_1="47" TOTAL_2="40" VAR="0.010072610604525488" WEIGHT="45.604463291604304"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="24.861621335091332" CI_END="1.0005564344363722" CI_START="0.9617497905343111" CI_STUDY="95" CI_TOTAL="95" DF="38" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9809612332997355" ESTIMABLE="YES" EVENTS_1="2600" EVENTS_2="2568" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="2.4158919721466016E-4" LOG_CI_START="-0.016937899608932445" LOG_EFFECT_SIZE="-0.0083481552058589" METHOD="MH" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9503499945135965" P_Q="1.0" P_Z="0.05680095108187273" Q="0.0" RANDOM="NO" SCALE="1.21" SORT_BY="STUDY" STUDIES="39" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3028" TOTAL_2="2946" WEIGHT="99.99999999999999" Z="1.904839396033649">
<NAME>Objective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RPR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TOR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0402858032050748" CI_START="0.8977690217575848" EFFECT_SIZE="0.9664038327178361" ESTIMABLE="YES" EVENTS_1="196" EVENTS_2="215" LOG_CI_END="0.017152671705379444" LOG_CI_START="-0.04683538435634449" LOG_EFFECT_SIZE="-0.014841356325482507" MODIFIED="2014-05-22 15:17:32 +0100" MODIFIED_BY="[Empty name]" ORDER="572" O_E="0.0" SE="0.037586900876642584" STUDY_ID="STD-Aigmuller-2014" TOTAL_1="233" TOTAL_2="247" VAR="0.001412775117510555" WEIGHT="8.072584973413854"/>
<DICH_DATA CI_END="1.6587437267659693" CI_START="0.6028658820911936" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="15" LOG_CI_END="0.219779293409146" LOG_CI_START="-0.21977929340914606" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-24 18:10:44 +0000" MODIFIED_BY="[Empty name]" ORDER="423" O_E="0.0" SE="0.25819888974716115" STUDY_ID="STD-Alkady-2009" TOTAL_1="30" TOTAL_2="30" VAR="0.06666666666666668" WEIGHT="0.580123882708651"/>
<DICH_DATA CI_END="1.1011691178801166" CI_START="0.8433469273536354" EFFECT_SIZE="0.963674007152268" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="69" LOG_CI_END="0.041854023169602766" LOG_CI_START="-0.07399373303741566" LOG_EFFECT_SIZE="-0.016069854933906426" MODIFIED="2008-03-23 01:09:21 +0000" MODIFIED_BY="[Empty name]" ORDER="465" O_E="0.0" SE="0.06804954545164442" STUDY_ID="STD-Andonian-2007" TOTAL_1="77" TOTAL_2="80" VAR="0.004630740636175419" WEIGHT="2.617578079686677"/>
<DICH_DATA CI_END="1.0584798584251556" CI_START="0.9433519771467321" EFFECT_SIZE="0.9992592592592593" ESTIMABLE="YES" EVENTS_1="142" EVENTS_2="108" LOG_CI_END="0.02468259834216942" LOG_CI_START="-0.02532623598837311" LOG_EFFECT_SIZE="-3.2181882310185504E-4" MODIFIED="2013-12-06 12:16:40 +0000" MODIFIED_BY="[Empty name]" ORDER="258" O_E="0.0" SE="0.029375436833482992" STUDY_ID="STD-Aniuliene-2009" TOTAL_1="150" TOTAL_2="114" VAR="8.629162891579494E-4" WEIGHT="4.746468131252599"/>
<DICH_DATA CI_END="0.9089280140700101" CI_START="0.7589169171953121" EFFECT_SIZE="0.8305425012547337" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="108" LOG_CI_END="-0.041470510980601255" LOG_CI_START="-0.11980576610532917" LOG_EFFECT_SIZE="-0.0806381385429652" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="147" O_E="0.0" SE="0.04601451662603185" STUDY_ID="STD-Araco-2008" TOTAL_1="100" TOTAL_2="108" VAR="0.0021173357403273616" WEIGHT="4.0363730594684135"/>
<DICH_DATA CI_END="1.1014519142503751" CI_START="0.841177100606926" EFFECT_SIZE="0.9625570776255707" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="73" LOG_CI_END="0.041965542039157554" LOG_CI_START="-0.07511255863837626" LOG_EFFECT_SIZE="-0.016573508299609355" MODIFIED="2014-04-16 12:41:32 +0100" MODIFIED_BY="[Empty name]" ORDER="353" O_E="0.0" SE="0.0687722558839285" STUDY_ID="STD-Barber-2008" TOTAL_1="75" TOTAL_2="85" VAR="0.004729623179364539" WEIGHT="2.6468152148582202"/>
<DICH_DATA CI_END="1.2496106674068423" CI_START="0.8997451628049908" EFFECT_SIZE="1.0603448275862069" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="64" LOG_CI_END="0.09677472394051838" LOG_CI_START="-0.04588047951555954" LOG_EFFECT_SIZE="0.025447122212479436" MODIFIED="2008-03-22 21:45:19 +0000" MODIFIED_BY="[Empty name]" ORDER="145" O_E="0.0" SE="0.08379637266474599" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" VAR="0.007021832071768989" WEIGHT="2.0508760501090597"/>
<DICH_DATA CI_END="1.105120940473807" CI_START="0.923066392681551" EFFECT_SIZE="1.01" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="70" LOG_CI_END="0.04340980825307625" LOG_CI_START="-0.0347670606877911" LOG_EFFECT_SIZE="0.004321373782642578" MODIFIED="2014-01-24 18:45:04 +0000" MODIFIED_BY="[Empty name]" ORDER="431" O_E="0.0" SE="0.04592147979760788" STUDY_ID="STD-Chen-2010" TOTAL_1="110" TOTAL_2="77" VAR="0.002108782306802108" WEIGHT="3.1849938658514176"/>
<DICH_DATA CI_END="1.0618501620784346" CI_START="0.842404143981379" EFFECT_SIZE="0.9457837896803752" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="89" LOG_CI_END="0.026063237674275132" LOG_CI_START="-0.07447950542202456" LOG_EFFECT_SIZE="-0.024208133873874705" MODIFIED="2014-05-23 21:36:01 +0100" MODIFIED_BY="[Empty name]" ORDER="578" O_E="0.0" SE="0.05905930498937145" STUDY_ID="STD-Chen-2012" TOTAL_1="103" TOTAL_2="102" VAR="0.003488001505827596" WEIGHT="3.45885894815623"/>
<DICH_DATA CI_END="1.1557436732314978" CI_START="0.8430200955083129" EFFECT_SIZE="0.9870740305522914" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="37" LOG_CI_END="0.06286152470309411" LOG_CI_START="-0.07416207274850665" LOG_EFFECT_SIZE="-0.00565027402270624" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="135" O_E="0.0" SE="0.08048833942081682" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="42" VAR="0.006478372782720614" WEIGHT="1.4960164369244302"/>
<DICH_DATA CI_END="1.3042325535341537" CI_START="0.8828901561458247" EFFECT_SIZE="1.073076923076923" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="26" LOG_CI_END="0.11535503596023737" LOG_CI_START="-0.05409332535467823" LOG_EFFECT_SIZE="0.030630855302779574" MODIFIED="2014-03-27 11:02:03 +0000" MODIFIED_BY="[Empty name]" ORDER="535" O_E="0.0" SE="0.09953480621929765" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" VAR="0.009907177649113134" WEIGHT="0.989063668880323"/>
<DICH_DATA CI_END="1.106979515224274" CI_START="0.9598056626055379" EFFECT_SIZE="1.0307692307692307" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="65" LOG_CI_END="0.04413958428669485" LOG_CI_START="-0.01781669217075322" LOG_EFFECT_SIZE="0.013161446057970814" MODIFIED="2013-12-28 08:08:54 +0000" MODIFIED_BY="[Empty name]" ORDER="146" O_E="0.0" SE="0.03639342347961966" STUDY_ID="STD-Deffieux-2010" TOTAL_1="69" TOTAL_2="69" VAR="0.0013244812725669314" WEIGHT="2.5138701584041545"/>
<DICH_DATA CI_END="1.1097908113317854" CI_START="0.7376111749619284" EFFECT_SIZE="0.9047619047619048" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="18" LOG_CI_END="0.04524112469113864" LOG_CI_START="-0.13217251225331925" LOG_EFFECT_SIZE="-0.0434656937810903" MODIFIED="2013-12-21 15:20:13 +0000" MODIFIED_BY="[Empty name]" ORDER="311" O_E="0.0" SE="0.10421364855284106" STUDY_ID="STD-El_x002d_Hefnawy-2010" TOTAL_1="21" TOTAL_2="19" VAR="0.01086048454469507" WEIGHT="0.7309560922129001"/>
<DICH_DATA CI_END="1.1469233021149994" CI_START="0.8393064712734228" EFFECT_SIZE="0.9811320754716981" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="45" LOG_CI_END="0.059534376417438535" LOG_CI_START="-0.07607942834941828" LOG_EFFECT_SIZE="-0.008272525965989885" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="0.07966022021921185" STUDY_ID="STD-Enzelsberger-2005" TOTAL_1="53" TOTAL_2="52" VAR="0.006345750685373328" WEIGHT="1.7569466162033431"/>
<DICH_DATA CI_END="1.1791450348924664" CI_START="0.745375864708749" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="14" LOG_CI_END="0.07156722662144056" LOG_CI_START="-0.1276246738219276" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2014-01-03 10:50:05 +0000" MODIFIED_BY="[Empty name]" ORDER="384" O_E="0.0" SE="0.11700630833624392" STUDY_ID="STD-Jakimiuk-2012" TOTAL_1="16" TOTAL_2="15" VAR="0.013690476190476183" WEIGHT="0.5589150525881197"/>
<DICH_DATA CI_END="1.1411970827615059" CI_START="0.9090278868001239" EFFECT_SIZE="1.0185185185185186" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="54" LOG_CI_END="0.05736065280084692" LOG_CI_START="-0.04142279345829621" LOG_EFFECT_SIZE="0.007968929671275373" MODIFIED="2014-03-23 19:43:20 +0000" MODIFIED_BY="[Empty name]" ORDER="518" O_E="0.0" SE="0.05802588531856594" STUDY_ID="STD-Kamel-2009" TOTAL_1="60" TOTAL_2="60" VAR="0.0033670033670033656" WEIGHT="2.0884459777511437"/>
<DICH_DATA CI_END="1.1053522543578207" CI_START="0.8857147539267977" EFFECT_SIZE="0.9894578313253012" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="72" LOG_CI_END="0.04350070131978826" LOG_CI_START="-0.05270612093626169" LOG_EFFECT_SIZE="-0.004602709808236722" MODIFIED="2013-12-21 16:55:51 +0000" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="0.05651236362465449" STUDY_ID="STD-Karateke-2009" TOTAL_1="83" TOTAL_2="81" VAR="0.0031936472424451724" WEIGHT="2.81855310818447"/>
<DICH_DATA CI_END="1.31711771808063" CI_START="0.7432501623397101" EFFECT_SIZE="0.9894179894179894" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="18" LOG_CI_END="0.11962459199150191" LOG_CI_START="-0.1288649872649922" LOG_EFFECT_SIZE="-0.0046201976367451734" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="137" O_E="0.0" SE="0.14596400889851985" STUDY_ID="STD-Kim-2005" TOTAL_1="21" TOTAL_2="22" VAR="0.021305491893727185" WEIGHT="0.6799591555468839"/>
<DICH_DATA CI_END="1.0637532898576973" CI_START="0.9062372350214685" EFFECT_SIZE="0.9818415555198458" ESTIMABLE="YES" EVENTS_1="130" EVENTS_2="127" LOG_CI_END="0.026840916232324513" LOG_CI_START="-0.04275809771615709" LOG_EFFECT_SIZE="-0.007958590741916283" MODIFIED="2013-12-10 21:03:47 +0000" MODIFIED_BY="[Empty name]" ORDER="269" O_E="0.0" SE="0.0408828053140135" STUDY_ID="STD-Krofta-2010" TOTAL_1="147" TOTAL_2="141" VAR="0.0016714037703435304" WEIGHT="5.014042947355466"/>
<DICH_DATA CI_END="1.0344331475235593" CI_START="0.9188916366424185" EFFECT_SIZE="0.9749522900763359" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="128" LOG_CI_END="0.014702428689736868" LOG_CI_START="-0.03673570121789044" LOG_EFFECT_SIZE="-0.011016636264076767" MODIFIED="2008-09-04 13:09:08 +0100" MODIFIED_BY="[Empty name]" ORDER="134" O_E="0.0" SE="0.030215012130589858" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="134" VAR="9.129469580516922E-4" WEIGHT="4.894348309564106"/>
<DICH_DATA CI_END="1.169438551726165" CI_START="0.8854475612558241" EFFECT_SIZE="1.017583664208735" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="41" LOG_CI_END="0.06797740669466898" LOG_CI_START="-0.0528371538771665" LOG_EFFECT_SIZE="0.007570126408751225" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="136" O_E="0.0" SE="0.07096707092161607" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="0.0050363251551936855" WEIGHT="1.5322223299106392"/>
<DICH_DATA CI_END="1.139016129490848" CI_START="0.9404827308976286" EFFECT_SIZE="1.035" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="50" LOG_CI_END="0.056529874122360074" LOG_CI_START="-0.026649174536487068" LOG_EFFECT_SIZE="0.014940349792936524" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="144" O_E="0.0" SE="0.048859784925138205" STUDY_ID="STD-Mansoor-2003" TOTAL_1="48" TOTAL_2="54" VAR="0.0023872785829307623" WEIGHT="1.8199964947722385"/>
<DICH_DATA CI_END="1.0598817527576956" CI_START="0.8912232086166609" EFFECT_SIZE="0.971900826446281" ESTIMABLE="YES" EVENTS_1="98" EVENTS_2="99" LOG_CI_END="0.025257415274746467" LOG_CI_START="-0.05001351242740727" LOG_EFFECT_SIZE="-0.012378048576330415" MODIFIED="2008-03-24 14:08:54 +0000" MODIFIED_BY="[Empty name]" ORDER="148" O_E="0.0" SE="0.04421451552934639" STUDY_ID="STD-Meschia-2007" TOTAL_1="110" TOTAL_2="108" VAR="0.001954923383494813" WEIGHT="3.863944393086978"/>
<DICH_DATA CI_END="1.2598390449808052" CI_START="0.793752189205436" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="16" LOG_CI_END="0.10031506389394648" LOG_CI_START="-0.10031506389394652" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-12-21 18:57:16 +0000" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="0.11785113019775795" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" VAR="0.013888888888888895" WEIGHT="0.6187988082225611"/>
<DICH_DATA CI_END="1.1293180919336023" CI_START="0.8394985864478612" EFFECT_SIZE="0.9736842105263158" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="38" LOG_CI_END="0.05281628569302113" LOG_CI_START="-0.0759800307926514" LOG_EFFECT_SIZE="-0.011581872549815147" MODIFIED="2014-01-17 23:44:25 +0000" MODIFIED_BY="[Empty name]" ORDER="143" O_E="0.0" SE="0.07565559385573298" STUDY_ID="STD-Oliveira-2006" TOTAL_1="42" TOTAL_2="42" VAR="0.005723768881663621" WEIGHT="1.4696471695285824"/>
<DICH_DATA CI_END="1.3121760031523286" CI_START="0.8933002190979984" EFFECT_SIZE="1.0826666666666667" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="50" LOG_CI_END="0.11799209119157389" LOG_CI_START="-0.0490025594926234" LOG_EFFECT_SIZE="0.034494765849475265" MODIFIED="2009-07-19 20:26:51 +0100" MODIFIED_BY="[Empty name]" ORDER="956" O_E="0.0" SE="0.09809348444875023" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="0.009622331691297203" WEIGHT="2.000427181753969"/>
<DICH_DATA CI_END="1.1063403971339236" CI_START="0.8796759301781761" EFFECT_SIZE="0.9865196490402394" ESTIMABLE="YES" EVENTS_1="146" EVENTS_2="151" LOG_CI_END="0.043888770596284696" LOG_CI_START="-0.055677291095957475" LOG_EFFECT_SIZE="-0.00589426024983639" MODIFIED="2013-12-22 17:24:48 +0000" MODIFIED_BY="[Empty name]" ORDER="138" O_E="0.0" SE="0.05848559749797716" STUDY_ID="STD-Rechberger-2009" TOTAL_1="197" TOTAL_2="201" VAR="0.0034205651146953925" WEIGHT="5.7812211520717725"/>
<DICH_DATA CI_END="1.0650960342409315" CI_START="0.9140573544181133" EFFECT_SIZE="0.9866908650937689" ESTIMABLE="YES" EVENTS_1="233" EVENTS_2="232" LOG_CI_END="0.02738876764385926" LOG_CI_START="-0.03902655270620264" LOG_EFFECT_SIZE="-0.005818892531171681" MODIFIED="2013-12-21 17:53:03 +0000" MODIFIED_BY="[Empty name]" ORDER="1000" O_E="0.0" SE="0.03901268793476432" STUDY_ID="STD-Richter-2010" TOTAL_1="285" TOTAL_2="280" VAR="0.0015219898198953054" WEIGHT="9.051986106122952"/>
<DICH_DATA CI_END="1.1237328942886176" CI_START="0.8866455276501681" EFFECT_SIZE="0.9981747066492829" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="59" LOG_CI_END="0.050663093864662764" LOG_CI_START="-0.05224997222505042" LOG_EFFECT_SIZE="-7.934391801938293E-4" MODIFIED="2008-03-28 12:51:10 +0000" MODIFIED_BY="[Empty name]" ORDER="513" O_E="0.0" SE="0.06045164444899059" STUDY_ID="STD-Riva-2006" TOTAL_1="65" TOTAL_2="66" VAR="0.0036544013165871747" WEIGHT="2.2644021274174824"/>
<DICH_DATA CI_END="1.083692444606543" CI_START="0.8799569333441692" EFFECT_SIZE="0.9765258215962441" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="60" LOG_CI_END="0.03490604552136519" LOG_CI_START="-0.05553858247331755" LOG_EFFECT_SIZE="-0.010316268475976175" MODIFIED="2013-12-30 22:15:59 +0000" MODIFIED_BY="[Empty name]" ORDER="364" O_E="0.0" SE="0.053127622192205765" STUDY_ID="STD-Scheiner-2012" TOTAL_1="71" TOTAL_2="65" VAR="0.0028225442397977543" WEIGHT="2.4228703336655424"/>
<DICH_DATA CI_END="1.0466351379227616" CI_START="0.6978600425829715" EFFECT_SIZE="0.854637257507308" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="53" LOG_CI_END="0.01979531090221145" LOG_CI_START="-0.1562316673891128" LOG_EFFECT_SIZE="-0.06821817824345067" MODIFIED="2014-02-02 00:00:49 +0000" MODIFIED_BY="[Empty name]" ORDER="515" O_E="0.0" SE="0.1033991183959193" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="71" TOTAL_2="67" VAR="0.010691377685053337" WEIGHT="2.1091847059252693"/>
<DICH_DATA CI_END="1.2814983696363544" CI_START="0.7003574459969373" EFFECT_SIZE="0.9473684210526315" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="8" LOG_CI_END="0.10771805799713745" LOG_CI_START="-0.15468024969618321" LOG_EFFECT_SIZE="-0.023481095849522914" MODIFIED="2013-12-21 21:55:50 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.15413406483162792" STUDY_ID="STD-Tanuri-2010" TOTAL_1="19" TOTAL_2="9" VAR="0.023757309941520477" WEIGHT="0.41989919129388076"/>
<DICH_DATA CI_END="1.2492658945398758" CI_START="0.7895918141031556" EFFECT_SIZE="0.9931818181818182" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="20" LOG_CI_END="0.09665488372362747" LOG_CI_START="-0.10259736275515872" LOG_EFFECT_SIZE="-0.002971239515765598" MODIFIED="2013-12-06 16:08:28 +0000" MODIFIED_BY="[Empty name]" ORDER="267" O_E="0.0" SE="0.11704175589616617" STUDY_ID="STD-Tarcan-2011" TOTAL_1="22" TOTAL_2="23" VAR="0.013698772623257749" WEIGHT="0.7563096544942414"/>
<DICH_DATA CI_END="1.3207329047086716" CI_START="0.8685780644492905" EFFECT_SIZE="1.071055381400209" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="33" LOG_CI_END="0.1208149979781402" LOG_CI_START="-0.061191142748281094" LOG_EFFECT_SIZE="0.029811927614929568" MODIFIED="2013-12-22 21:22:09 +0000" MODIFIED_BY="[Empty name]" ORDER="142" O_E="0.0" SE="0.10691130800762673" STUDY_ID="STD-Teo-2011" TOTAL_1="29" TOTAL_2="41" VAR="0.011430027779901632" WEIGHT="1.0574829633374838"/>
<DICH_DATA CI_END="1.1135906807638212" CI_START="0.8869438672544895" EFFECT_SIZE="0.9938271604938271" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="13" LOG_CI_END="0.04672558782882244" LOG_CI_START="-0.05210386485038496" LOG_EFFECT_SIZE="-0.002689138510781247" MODIFIED="2014-07-04 00:09:36 +0100" MODIFIED_BY="[Empty name]" ORDER="608" O_E="0.0" SE="0.058052909717447115" STUDY_ID="STD-van-Leijsen-2013" TOTAL_1="59" TOTAL_2="13" VAR="0.003370140326662066" WEIGHT="0.8466672882774906"/>
<DICH_DATA CI_END="1.0941792555729768" CI_START="0.9193491321410361" EFFECT_SIZE="1.002961987822939" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="103" LOG_CI_END="0.03908847677704906" LOG_CI_START="-0.03651952956288039" LOG_EFFECT_SIZE="0.0012844736070843528" MODIFIED="2014-03-26 15:05:17 +0000" MODIFIED_BY="[Empty name]" ORDER="534" O_E="0.0" SE="0.04441251718974201" STUDY_ID="STD-Wang-2009" TOTAL_1="118" TOTAL_2="115" VAR="0.0019724716831291296" WEIGHT="4.034807250609982"/>
<DICH_DATA CI_END="1.0846690459490855" CI_START="0.8937910224708383" EFFECT_SIZE="0.9846153846153847" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="65" LOG_CI_END="0.03529724653153903" LOG_CI_START="-0.048764011849475805" LOG_EFFECT_SIZE="-0.0067333826589683786" MODIFIED="2013-12-19 20:11:02 +0000" MODIFIED_BY="[Empty name]" ORDER="306" O_E="0.0" SE="0.04937799928294803" STUDY_ID="STD-Wang-2010" TOTAL_1="70" TOTAL_2="70" VAR="0.0024381868131868167" WEIGHT="2.5138701584041545"/>
<DICH_DATA CI_END="1.1169283452695322" CI_START="0.8559630407493506" EFFECT_SIZE="0.9777777777777777" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="30" LOG_CI_END="0.04802531254960568" LOG_CI_START="-0.0675449871279182" LOG_EFFECT_SIZE="-0.009759837289156262" MODIFIED="2014-02-02 01:01:48 +0000" MODIFIED_BY="[Empty name]" ORDER="473" O_E="0.0" SE="0.06788656611278739" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" VAR="0.004608585858585854" WEIGHT="1.228497633971261"/>
<DICH_DATA CI_END="1.134786099219623" CI_START="0.8385839702587985" EFFECT_SIZE="0.9755067567567568" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="32" LOG_CI_END="0.05491400718269059" LOG_CI_START="-0.07645344350016625" LOG_EFFECT_SIZE="-0.01076971815873784" MODIFIED="2014-02-02 02:46:09 +0000" MODIFIED_BY="[Empty name]" ORDER="508" O_E="0.0" SE="0.07716589081047859" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" VAR="0.005954574704574705" WEIGHT="1.2719753280130421"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.841282585722012" CI_END="1.0070507580634809" CI_START="0.9624916641280113" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9845191516623204" ESTIMABLE="YES" EVENTS_1="713" EVENTS_2="696" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.0030513607138319457" LOG_CI_START="-0.016603023106613247" LOG_EFFECT_SIZE="-0.006775831196390653" METHOD="MH" MODIFIED="2015-05-28 16:47:50 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.8479187160217969" P_Q="1.0" P_Z="0.17657000652937985" Q="0.0" RANDOM="NO" SCALE="1.2" SORT_BY="STUDY" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="754" TOTAL_2="724" WEIGHT="99.99999999999999" Z="1.3513916520174873">
<NAME>Objective cure and improvement (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>FavoursTOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2804299640342376" CI_START="0.8924246613620915" EFFECT_SIZE="1.0689655172413792" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.10735582875111621" LOG_CI_START="-0.04942843688048306" LOG_EFFECT_SIZE="0.028963695935316558" MODIFIED="2014-01-24 18:11:17 +0000" MODIFIED_BY="[Empty name]" ORDER="424" O_E="0.0" SE="0.09209585372663295" STUDY_ID="STD-Alkady-2009" TOTAL_1="15" TOTAL_2="15" VAR="0.008481646273637372" WEIGHT="2.039330890985127"/>
<DICH_DATA CI_END="1.0218420817834106" CI_START="0.9024313769707252" EFFECT_SIZE="0.9602824360105914" ESTIMABLE="YES" EVENTS_1="96" EVENTS_2="99" LOG_CI_END="0.009383783950078498" LOG_CI_START="-0.04458581295255072" LOG_EFFECT_SIZE="-0.017601014501236134" MODIFIED="2014-05-23 21:37:48 +0100" MODIFIED_BY="[Empty name]" ORDER="579" O_E="0.0" SE="0.03170200837441767" STUDY_ID="STD-Chen-2012" TOTAL_1="103" TOTAL_2="102" VAR="0.001005017334971648" WEIGHT="13.991627986795855"/>
<DICH_DATA CI_END="1.044909459347285" CI_START="0.9570207170147181" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="42" LOG_CI_END="0.01907866077301129" LOG_CI_START="-0.019078660773011236" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-07-19 20:03:40 +0100" MODIFIED_BY="[Empty name]" ORDER="253" O_E="0.0" SE="0.02241379955792152" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="42" VAR="5.023784106226829E-4" WEIGHT="6.243009126042591"/>
<DICH_DATA CI_END="1.1396387079242367" CI_START="0.8734413605322313" EFFECT_SIZE="0.9977011494252873" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="29" LOG_CI_END="0.05676719166643131" LOG_CI_START="-0.05876624655068458" LOG_EFFECT_SIZE="-9.99527442126642E-4" MODIFIED="2014-03-27 11:02:38 +0000" MODIFIED_BY="[Empty name]" ORDER="536" O_E="0.0" SE="0.06786491350847655" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" VAR="0.004605646485513003" WEIGHT="4.011798474069103"/>
<DICH_DATA CI_END="1.0921635201498592" CI_START="0.9156138083267851" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.03828766637439782" LOG_CI_START="-0.03828766637439781" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-07-19 20:03:47 +0100" MODIFIED_BY="[Empty name]" ORDER="255" O_E="0.0" SE="0.04498072951065294" STUDY_ID="STD-Kim-2005" TOTAL_1="21" TOTAL_2="22" VAR="0.0020232660273105246" WEIGHT="3.0941572139084688"/>
<DICH_DATA CI_END="1.0245646742308128" CI_START="0.9637392830489706" EFFECT_SIZE="0.9936866833064161" ESTIMABLE="YES" EVENTS_1="144" EVENTS_2="139" LOG_CI_END="0.010539377842189146" LOG_CI_START="-0.016040438345472408" LOG_EFFECT_SIZE="-0.0027505302516416296" MODIFIED="2013-12-10 21:24:32 +0000" MODIFIED_BY="[Empty name]" ORDER="272" O_E="0.0" SE="0.015613115600844496" STUDY_ID="STD-Krofta-2010" TOTAL_1="147" TOTAL_2="141" VAR="2.4376937876533378E-4" WEIGHT="19.956728015085776"/>
<DICH_DATA CI_END="1.1028326921085516" CI_START="0.9455017745512309" EFFECT_SIZE="1.0211416490486258" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="44" LOG_CI_END="0.04250963174630644" LOG_CI_START="-0.024337651718905312" LOG_EFFECT_SIZE="0.009085990013700588" MODIFIED="2009-07-19 20:04:00 +0100" MODIFIED_BY="[Empty name]" ORDER="254" O_E="0.0" SE="0.039266425206855235" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="0.0015418521485255562" WEIGHT="5.9797195594635575"/>
<DICH_DATA CI_END="1.1207644371615424" CI_START="0.9055156024307673" EFFECT_SIZE="1.0074074074074073" ESTIMABLE="YES" EVENTS_1="68" EVENTS_2="63" LOG_CI_END="0.049514341951577924" LOG_CI_START="-0.0431040622011552" LOG_EFFECT_SIZE="0.0032051398752113544" MODIFIED="2013-12-29 13:13:01 +0000" MODIFIED_BY="[Empty name]" ORDER="360" O_E="0.0" SE="0.054404509067810095" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="0.0029598506069094307" WEIGHT="9.166077012989037"/>
<DICH_DATA CI_END="1.0153530251047755" CI_START="0.8802486933323785" EFFECT_SIZE="0.9453904873752202" ESTIMABLE="YES" EVENTS_1="138" EVENTS_2="131" LOG_CI_END="0.006617067075581271" LOG_CI_START="-0.055394610937083893" LOG_EFFECT_SIZE="-0.0243887719307513" MODIFIED="2009-07-19 20:04:13 +0100" MODIFIED_BY="[Empty name]" ORDER="256" O_E="0.0" SE="0.03642596662739634" STUDY_ID="STD-Rechberger-2009" TOTAL_1="156" TOTAL_2="140" VAR="0.001326851044740192" WEIGHT="19.420207869604873"/>
<DICH_DATA CI_END="1.0301922178241036" CI_START="0.9548874708831541" EFFECT_SIZE="0.9918254087295635" ESTIMABLE="YES" EVENTS_1="115" EVENTS_2="113" LOG_CI_END="0.012918264852641609" LOG_CI_START="-0.02004780501728512" LOG_EFFECT_SIZE="-0.003564770082321757" MODIFIED="2014-03-26 15:06:24 +0000" MODIFIED_BY="[Empty name]" ORDER="535" O_E="0.0" SE="0.019364432626272614" STUDY_ID="STD-Wang-2009" TOTAL_1="118" TOTAL_2="115" VAR="3.749812509374513E-4" WEIGHT="16.097343851055605"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.415972517761073" CI_END="1.0557631071434588" CI_START="0.9471700871268905" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9999936170688424" ESTIMABLE="YES" EVENTS_1="263" EVENTS_2="272" I2="52.471327686035124" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.023566481832434403" LOG_CI_START="-0.023572025993688683" LOG_EFFECT_SIZE="-2.7720806271330806E-6" METHOD="MH" MODIFIED="2015-05-28 16:47:56 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.07747565217579688" P_Q="1.0" P_Z="0.9998160718632382" Q="0.0" RANDOM="NO" SCALE="1.39" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="293" TOTAL_2="303" WEIGHT="100.0" Z="2.3051973607069088E-4">
<NAME>Objective cure (medium term, 1 to 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RPR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TOR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3480822588109562" CI_START="0.8798536114695897" EFFECT_SIZE="1.0890890890890892" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="27" LOG_CI_END="0.12971639328069834" LOG_CI_START="-0.05558957900834068" LOG_EFFECT_SIZE="0.03706340713617883" MODIFIED="2013-12-21 16:14:08 +0000" MODIFIED_BY="[Empty name]" ORDER="264" O_E="0.0" SE="0.10884964540193805" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="37" TOTAL_2="34" VAR="0.011848245304127654" WEIGHT="10.514317637371162"/>
<DICH_DATA CI_END="1.1888181686185164" CI_START="1.012854096638459" EFFECT_SIZE="1.0973146095097315" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="61" LOG_CI_END="0.07511543375707039" LOG_CI_START="0.005546889004397623" LOG_EFFECT_SIZE="0.04033116138073398" MODIFIED="2014-04-16 12:37:47 +0100" MODIFIED_BY="[Empty name]" ORDER="343" O_E="0.0" SE="0.040864907557570405" STUDY_ID="STD-Deffieux-2010" TOTAL_1="65" TOTAL_2="67" VAR="0.0016699406696887749" WEIGHT="22.635401712132715"/>
<DICH_DATA CI_END="1.1476234549078879" CI_START="0.7520767659752381" EFFECT_SIZE="0.9290322580645162" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="31" LOG_CI_END="0.05979941569192466" LOG_CI_START="-0.12373782784200828" LOG_EFFECT_SIZE="-0.03196920607504181" MODIFIED="2013-12-21 15:21:08 +0000" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="0.10781068537584018" STUDY_ID="STD-El_x002d_Hefnawy-2010" TOTAL_1="35" TOTAL_2="36" VAR="0.0116231438812084" WEIGHT="11.419454090638348"/>
<DICH_DATA CI_END="1.0180352516841662" CI_START="0.8817636695920222" EFFECT_SIZE="0.947452636968766" ESTIMABLE="YES" EVENTS_1="113" EVENTS_2="124" LOG_CI_END="0.007762816651863533" LOG_CI_START="-0.0546477989330915" LOG_EFFECT_SIZE="-0.023442491140613975" MODIFIED="2014-01-26 19:46:05 +0000" MODIFIED_BY="[Empty name]" ORDER="459" O_E="0.0" SE="0.03666030453213221" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="126" TOTAL_2="131" VAR="0.0013439779283886738" WEIGHT="45.42898779092859"/>
<DICH_DATA CI_END="1.2530040466786723" CI_START="0.807281736253838" EFFECT_SIZE="1.0057471264367817" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="29" LOG_CI_END="0.09795247358583355" LOG_CI_START="-0.09297487277844406" LOG_EFFECT_SIZE="0.0024888004036947415" MODIFIED="2014-03-26 15:07:01 +0000" MODIFIED_BY="[Empty name]" ORDER="536" O_E="0.0" SE="0.1121516683599836" STUDY_ID="STD-Wang-2009" TOTAL_1="30" TOTAL_2="35" VAR="0.012577996715927745" WEIGHT="10.001838768929186"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.127297418284423" CI_END="1.0590377112514604" CI_START="0.8952840946404884" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.973724611226346" ESTIMABLE="YES" EVENTS_1="166" EVENTS_2="171" I2="51.5421401147453" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.024911425165854498" LOG_CI_START="-0.048039130989304714" LOG_EFFECT_SIZE="-0.011563852911725113" METHOD="MH" MODIFIED="2015-05-28 16:48:01 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.12699006868984786" P_Q="1.0" P_Z="0.5343545560467413" Q="0.0" RANDOM="NO" SCALE="1.59" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="200" TOTAL_2="200" WEIGHT="100.0" Z="0.6213725137692995">
<NAME>Objective cure (long term, &gt; 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours RPR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours TOR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.133451244077928" CI_START="0.9276536536586513" EFFECT_SIZE="1.0254024516319598" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="111" LOG_CI_END="0.054402843489158824" LOG_CI_START="-0.03261414057090116" LOG_EFFECT_SIZE="0.010894351459128808" MODIFIED="2014-05-09 21:26:43 +0100" MODIFIED_BY="[Empty name]" ORDER="459" O_E="0.0" SE="0.051114207177897227" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="122" TOTAL_2="131" VAR="0.002612662175425" WEIGHT="62.71287419368532"/>
<DICH_DATA CI_END="0.9998781149603408" CI_START="0.6439749811554909" EFFECT_SIZE="0.8024316109422492" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="35" LOG_CI_END="-5.2937226344035506E-5" LOG_CI_START="-0.19113100493394242" LOG_EFFECT_SIZE="-0.09559197108014324" MODIFIED="2014-05-10 08:58:21 +0100" MODIFIED_BY="[Empty name]" ORDER="1128" O_E="0.0" SE="0.11224020282313292" STUDY_ID="STD-Porena-2007" TOTAL_1="47" TOTAL_2="40" VAR="0.012597863129778016" WEIGHT="22.153434564835266"/>
<DICH_DATA CI_END="1.2326270737033034" CI_START="0.8281107390370332" EFFECT_SIZE="1.0103225806451612" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="25" LOG_CI_END="0.09083170244286454" LOG_CI_START="-0.08191158333959841" LOG_EFFECT_SIZE="0.0044600595516330836" MODIFIED="2014-02-02 02:10:57 +0000" MODIFIED_BY="[Empty name]" ORDER="494" O_E="0.0" SE="0.10147026116167415" STUDY_ID="STD-Zullo-2007" TOTAL_1="31" TOTAL_2="29" VAR="0.010296213900218357" WEIGHT="15.13369124147941"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="656.6644255946953" CI_END="-5.773964862818535" CI_START="-9.3086480329187" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="MD" EFFECT_SIZE="-7.541306447868618" ESTIMABLE="YES" I2="95.43145648969319" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2015-06-09 11:15:07 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="7.771561172376096E-16" P_Q="1.0" P_Z="6.10226582387548E-17" Q="0.0" RANDOM="YES" SCALE="22.13" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="21.64650775428634" TOTALS="YES" TOTAL_1="2365" TOTAL_2="2348" UNITS="" WEIGHT="100.00000000000004" Z="8.363232755473993">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.4340296628266254" CI_START="-5.965970337173373" EFFECT_SIZE="-4.199999999999999" ESTIMABLE="YES" MEAN_1="16.8" MEAN_2="21.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="573" SD_1="8.8" SD_2="12.22" SE="0.9010218305556239" STUDY_ID="STD-Aigmuller-2014" TOTAL_1="269" TOTAL_2="285" WEIGHT="3.6204870788189063"/>
<CONT_DATA CI_END="-6.418296132746408" CI_START="-9.581703867253593" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="19.0" MEAN_2="27.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="259" SD_1="5.6" SD_2="7.1" SE="0.807006597942549" STUDY_ID="STD-Aniuliene-2009" TOTAL_1="150" TOTAL_2="114" WEIGHT="3.6465605552701064"/>
<CONT_DATA CI_END="-11.667176246980922" CI_START="-16.332823753019078" EFFECT_SIZE="-14.0" ESTIMABLE="YES" MEAN_1="34.0" MEAN_2="48.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="198" SD_1="11.0" SD_2="7.0" SE="1.1902380714238083" STUDY_ID="STD-Araco-2008" TOTAL_1="120" TOTAL_2="120" WEIGHT="3.525540656276209"/>
<CONT_DATA CI_END="1.612221276033789" CI_START="-3.612221276033789" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="28.0" MEAN_2="29.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="354" SD_1="7.0" SD_2="10.0" SE="1.33279044749733" STUDY_ID="STD-Barber-2008" TOTAL_1="88" TOTAL_2="82" WEIGHT="3.471405071764535"/>
<CONT_DATA CI_END="-1.8110667831141858" CI_START="-5.988933216885815" EFFECT_SIZE="-3.9000000000000004" ESTIMABLE="YES" MEAN_1="14.6" MEAN_2="18.5" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="457" SD_1="6.0" SD_2="6.5" SE="1.0658018378720493" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" WEIGHT="3.568983585679045"/>
<CONT_DATA CI_END="-21.916274371905132" CI_START="-34.483725628094874" EFFECT_SIZE="-28.200000000000003" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="48.2" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="432" SD_1="13.5" SD_2="21.9" SE="3.206041375076326" STUDY_ID="STD-Chen-2010" TOTAL_1="45" TOTAL_2="77" WEIGHT="2.5468951181777815"/>
<CONT_DATA CI_END="-5.849706524456728" CI_START="-11.750293475543273" EFFECT_SIZE="-8.8" ESTIMABLE="YES" MEAN_1="18.5" MEAN_2="27.3" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="548" SD_1="7.4" SD_2="13.3" SE="1.5052794330991848" STUDY_ID="STD-Chen-2012" TOTAL_1="103" TOTAL_2="102" WEIGHT="3.4003382238623416"/>
<CONT_DATA CI_END="3.559444549321208" CI_START="-4.559444549321208" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="64.0" MEAN_2="64.5" MODIFIED="2014-10-22 21:29:17 +0100" MODIFIED_BY="[Empty name]" ORDER="279" SD_1="9.48" SD_2="9.04" SE="2.071183236703117" STUDY_ID="STD-Darabi-Mahboub-2012" TOTAL_1="40" TOTAL_2="40" WEIGHT="3.134993610276763"/>
<CONT_DATA CI_END="-0.5514846988191788" CI_START="-7.448515301180821" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="21.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="6.6" SD_2="9.5" SE="1.7594789130730308" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="42" WEIGHT="3.286284831445103"/>
<CONT_DATA CI_END="-8.583155616739127" CI_START="-14.816844383260872" EFFECT_SIZE="-11.7" ESTIMABLE="YES" MEAN_1="14.8" MEAN_2="26.5" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="537" SD_1="4.3" SD_2="7.7" SE="1.5902559474797207" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" WEIGHT="3.363339840876728"/>
<CONT_DATA CI_END="1.133334646579745" CI_START="-4.333334646579748" EFFECT_SIZE="-1.6000000000000014" ESTIMABLE="YES" MEAN_1="18.7" MEAN_2="20.3" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="8.0" SD_2="9.0" SE="1.3945841189633794" STUDY_ID="STD-Deffieux-2010" TOTAL_1="74" TOTAL_2="75" WEIGHT="3.4466056891430163"/>
<CONT_DATA CI_END="-1.0971438411373629" CI_START="-7.302856158862635" EFFECT_SIZE="-4.199999999999999" ESTIMABLE="YES" MEAN_1="19.6" MEAN_2="23.8" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="313" SD_1="5.0" SD_2="5.0" SE="1.5831189671532588" STUDY_ID="STD-El_x002d_Hefnawy-2010" TOTAL_1="21" TOTAL_2="19" WEIGHT="3.366493680670166"/>
<CONT_DATA CI_END="-7.692590407994264" CI_START="-14.307409592005737" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="26.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="193" SD_1="7.0" SD_2="10.0" SE="1.6874848814030057" STUDY_ID="STD-Enzelsberger-2005" TOTAL_1="53" TOTAL_2="52" WEIGHT="3.3195796538025455"/>
<CONT_DATA CI_END="2.186944469426898" CI_START="-6.186944469426898" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="28.0" MEAN_2="30.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="291" SD_1="15.0416" SD_2="14.159" SE="2.1362354116978586" STUDY_ID="STD-Freeman-2011" TOTAL_1="99" TOTAL_2="88" WEIGHT="3.102255995733337"/>
<CONT_DATA CI_END="-15.9876853694775" CI_START="-54.7123146305225" EFFECT_SIZE="-35.35" ESTIMABLE="YES" MEAN_1="12.4" MEAN_2="47.75" MODIFIED="2015-05-15 12:47:23 +0100" MODIFIED_BY="[Empty name]" ORDER="385" SD_1="3.52" SD_2="42.89" SE="9.878913481701689" STUDY_ID="STD-Jakimiuk-2012" TOTAL_1="16" TOTAL_2="19" WEIGHT="0.6819065867680328"/>
<CONT_DATA CI_END="-11.523491807577823" CI_START="-13.816508192422173" EFFECT_SIZE="-12.669999999999998" ESTIMABLE="YES" MEAN_1="18.6" MEAN_2="31.27" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="283" SD_1="2.47" SD_2="4.73" SE="0.584963908248154" STUDY_ID="STD-Karateke-2009" TOTAL_1="84" TOTAL_2="83" WEIGHT="3.697817247436157"/>
<CONT_DATA CI_END="0.7423900572493052" CI_START="-12.742390057249306" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="26.0" MEAN_2="32.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="544" SD_1="9.5" SD_2="5.3" SE="3.440058139043583" STUDY_ID="STD-Kilic-2007" TOTAL_1="10" TOTAL_2="10" WEIGHT="2.4285820179489246"/>
<CONT_DATA CI_END="-1.1019473500677304" CI_START="-8.498052649932271" EFFECT_SIZE="-4.800000000000001" ESTIMABLE="YES" MEAN_1="26.8" MEAN_2="31.6" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="521" SD_1="11.8" SD_2="9.6" SE="1.8867962264113207" STUDY_ID="STD-Kim-2005" TOTAL_1="65" TOTAL_2="65" WEIGHT="3.225760580421246"/>
<CONT_DATA CI_END="-6.431144930149594" CI_START="-11.288855069850397" EFFECT_SIZE="-8.859999999999996" ESTIMABLE="YES" MEAN_1="23.76" MEAN_2="32.62" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="274" SD_1="12.01" SD_2="9.3" SE="1.2392345415573454" STUDY_ID="STD-Krofta-2010" TOTAL_1="151" TOTAL_2="149" WEIGHT="3.5074377754481487"/>
<CONT_DATA CI_END="3.0179006859382143" CI_START="-3.0179006859382143" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="29.0" MEAN_2="29.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="188" SD_1="8.0" SD_2="16.0" SE="1.5397735416278204" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="136" WEIGHT="3.385467376438833"/>
<CONT_DATA CI_END="-3.1230022260642376" CI_START="-4.276997773935761" EFFECT_SIZE="-3.6999999999999993" ESTIMABLE="YES" MEAN_1="11.5" MEAN_2="15.2" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="382" SD_1="1.4" SD_2="1.8" SE="0.2943920288775949" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" WEIGHT="3.7412923445489863"/>
<CONT_DATA CI_END="-6.070495913510181" CI_START="-12.52950408648982" EFFECT_SIZE="-9.3" ESTIMABLE="YES" MEAN_1="17.4" MEAN_2="26.7" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="190" SD_1="6.9" SD_2="8.6" SE="1.6477364441202673" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" WEIGHT="3.337644032017142"/>
<CONT_DATA CI_END="-6.917147707967744" CI_START="-11.082852292032257" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="17.0" MEAN_2="26.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="961" SD_1="7.0" SD_2="9.0" SE="1.0626992681812162" STUDY_ID="STD-Meschia-2007" TOTAL_1="117" TOTAL_2="114" WEIGHT="3.5700184076023844"/>
<CONT_DATA CI_END="-1.4688706937302602" CI_START="-4.53112930626974" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="18.4" MEAN_2="21.4" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="321" SD_1="1.85" SD_2="2.75" SE="0.781202776350531" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" WEIGHT="3.6532750413001143"/>
<CONT_DATA CI_END="-10.15908727517385" CI_START="-11.84091272482615" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="12.0" MEAN_2="23.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="192" SD_1="4.0" SD_2="5.0" SE="0.4290449883054803" STUDY_ID="STD-Rechberger-2009" TOTAL_1="268" TOTAL_2="201" WEIGHT="3.7245978661440966"/>
<CONT_DATA CI_END="3.022560786519152" CI_START="-4.8225607865191495" EFFECT_SIZE="-0.8999999999999986" ESTIMABLE="YES" MEAN_1="25.8" MEAN_2="26.7" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="365" SD_1="9.7" SD_2="11.5" SE="2.0013432988870252" STUDY_ID="STD-Scheiner-2012" TOTAL_1="40" TOTAL_2="80" WEIGHT="3.169754043502818"/>
<CONT_DATA CI_END="2.7889882760650213" CI_START="-14.188988276065027" EFFECT_SIZE="-5.700000000000003" ESTIMABLE="YES" MEAN_1="33.4" MEAN_2="39.1" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="268" SD_1="13.9" SD_2="17.7" SE="4.331196054123994" STUDY_ID="STD-Tarcan-2011" TOTAL_1="27" TOTAL_2="27" WEIGHT="2.0123404428036467"/>
<CONT_DATA CI_END="-0.5513019703544302" CI_START="-11.208698029645575" EFFECT_SIZE="-5.880000000000003" ESTIMABLE="YES" MEAN_1="33.83" MEAN_2="39.71" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="191" SD_1="8.4" SD_2="12.18" SE="2.718773442613059" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" WEIGHT="2.8001066208515955"/>
<CONT_DATA CI_END="-6.657394972412694" CI_START="-11.342605027587306" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="18.0" MEAN_2="27.0" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="545" SD_1="5.0" SD_2="5.0" SE="1.1952286093343936" STUDY_ID="STD-Wang-2008" TOTAL_1="35" TOTAL_2="35" WEIGHT="3.523721779653254"/>
<CONT_DATA CI_END="-16.062881190049225" CI_START="-20.537118809950776" EFFECT_SIZE="-18.3" ESTIMABLE="YES" MEAN_1="16.2" MEAN_2="34.5" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="475" SD_1="1.5" SD_2="6.3" SE="1.141408121576152" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" WEIGHT="3.5430312611839856"/>
<CONT_DATA CI_END="-7.587923499055698" CI_START="-15.212076500944306" EFFECT_SIZE="-11.400000000000002" ESTIMABLE="YES" MEAN_1="16.9" MEAN_2="28.3" MODIFIED="2014-07-12 19:59:29 +0100" MODIFIED_BY="[Empty name]" ORDER="498" SD_1="6.2" SD_2="9.8" SE="1.9449727296080321" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" WEIGHT="3.197482984134088"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="158.2305975873142" CI_END="-0.6454414058089952" CI_START="-12.326835436383005" CI_STUDY="95" CI_TOTAL="95" DF="13" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.486138421096" ESTIMABLE="YES" I2="91.7841427649122" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2015-05-28 16:48:15 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="-4.440892098500626E-16" P_Q="1.0" P_Z="0.0295137933224094" Q="0.0" RANDOM="YES" SCALE="27.28" SORT_BY="STUDY" STUDIES="14" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="97.22577402527459" TOTALS="YES" TOTAL_1="912" TOTAL_2="957" UNITS="" WEIGHT="100.00000000000001" Z="2.176554899323942">
<NAME>Operative blood loss (ml)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.316142200094167" CI_START="-10.316142200094166" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="22.0" MEAN_2="26.0" MODIFIED="2014-01-24 18:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="425" SD_1="7.15" SD_2="10.23" SE="3.222580746337734" STUDY_ID="STD-Alkady-2009" TOTAL_1="15" TOTAL_2="15" WEIGHT="8.25234376514004"/>
<CONT_DATA CI_END="-2.9680878368030204" CI_START="-27.031912163196978" EFFECT_SIZE="-15.0" ESTIMABLE="YES" MEAN_1="49.0" MEAN_2="64.0" MODIFIED="2008-03-22 19:01:05 +0000" MODIFIED_BY="[Empty name]" ORDER="213" SD_1="31.2" SD_2="41.4" SE="6.138843498198521" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" WEIGHT="6.58241491032579"/>
<CONT_DATA CI_END="1.525979405443918" CI_START="-7.525979405443918" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="15.0" MEAN_2="18.0" MODIFIED="2014-05-23 21:39:39 +0100" MODIFIED_BY="[Empty name]" ORDER="580" SD_1="17.6" SD_2="15.4" SE="2.309215598421331" STUDY_ID="STD-Chen-2012" TOTAL_1="103" TOTAL_2="102" WEIGHT="8.65889691024403"/>
<CONT_DATA CI_END="-3.6010549684993123" CI_START="-20.398945031500688" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="40.0" MEAN_2="52.0" MODIFIED="2013-12-21 15:24:10 +0000" MODIFIED_BY="[Empty name]" ORDER="314" SD_1="13.0" SD_2="14.0" SE="4.285254779042112" STUDY_ID="STD-El_x002d_Hefnawy-2010" TOTAL_1="21" TOTAL_2="19" WEIGHT="7.682737264743814"/>
<CONT_DATA CI_END="3.734069973808978" CI_START="-29.734069973808978" EFFECT_SIZE="-13.0" ESTIMABLE="YES" MEAN_1="48.7" MEAN_2="61.7" MODIFIED="2015-03-16 15:07:46 +0000" MODIFIED_BY="[Empty name]" ORDER="292" SD_1="45.9" SD_2="65.03" SE="8.537947689756132" STUDY_ID="STD-Freeman-2011" TOTAL_1="96" TOTAL_2="83" WEIGHT="5.2200163694518995"/>
<CONT_DATA CI_END="8.244967440795161" CI_START="-6.864967440795166" EFFECT_SIZE="0.6899999999999977" ESTIMABLE="YES" MEAN_1="32.26" MEAN_2="31.57" MODIFIED="2013-12-10 21:26:14 +0000" MODIFIED_BY="[Empty name]" ORDER="275" SD_1="34.8" SD_2="31.92" SE="3.854646054921306" STUDY_ID="STD-Krofta-2010" TOTAL_1="151" TOTAL_2="149" WEIGHT="7.92299314521616"/>
<CONT_DATA CI_END="8.440803105700862" CI_START="-26.440803105700862" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="46.0" MEAN_2="55.0" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="210" SD_1="57.0" SD_2="86.0" SE="8.898532444101876" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="136" WEIGHT="5.033972356992221"/>
<CONT_DATA CI_END="0.5146300966181965" CI_START="-18.314630096618195" EFFECT_SIZE="-8.899999999999999" ESTIMABLE="YES" MEAN_1="31.1" MEAN_2="40.0" MODIFIED="2008-03-18 01:27:24 +0000" MODIFIED_BY="[Empty name]" ORDER="385" SD_1="28.6" SD_2="23.8" SE="4.803470967262458" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" WEIGHT="7.381944385544317"/>
<CONT_DATA CI_END="3.5376220530821945" CI_START="-11.537622053082195" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="31.0" MODIFIED="2008-03-24 13:47:03 +0000" MODIFIED_BY="[Empty name]" ORDER="962" SD_1="33.0" SD_2="25.0" SE="3.8457962046945737" STUDY_ID="STD-Meschia-2007" TOTAL_1="117" TOTAL_2="114" WEIGHT="7.927813301393831"/>
<CONT_DATA CI_END="-17.79808637587756" CI_START="-22.80191362412245" EFFECT_SIZE="-20.300000000000004" ESTIMABLE="YES" MEAN_1="18.4" MEAN_2="38.7" MODIFIED="2013-12-21 19:01:38 +0000" MODIFIED_BY="[Empty name]" ORDER="322" SD_1="1.85" SD_2="5.09" SE="1.2765099990904019" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" WEIGHT="8.983248779954538"/>
<CONT_DATA CI_END="7.65001933899385" CI_START="-13.450019338993847" EFFECT_SIZE="-2.8999999999999986" ESTIMABLE="YES" MEAN_1="31.5" MEAN_2="34.4" MODIFIED="2013-12-30 22:26:02 +0000" MODIFIED_BY="[Empty name]" ORDER="367" SD_1="22.2" SD_2="36.5" SE="5.382761837570004" STUDY_ID="STD-Scheiner-2012" TOTAL_1="40" TOTAL_2="80" WEIGHT="7.036783127489009"/>
<CONT_DATA CI_END="32.754252283396035" CI_START="-48.61425228339602" EFFECT_SIZE="-7.929999999999993" ESTIMABLE="YES" MEAN_1="117.2" MEAN_2="125.13" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="211" SD_1="79.43" SD_2="81.2" SE="20.75765299990623" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" WEIGHT="1.6815590702375982"/>
<CONT_DATA CI_END="2.080167990892328" CI_START="-4.080167990892328" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="20.0" MEAN_2="21.0" MODIFIED="2014-03-26 15:19:55 +0000" MODIFIED_BY="[Empty name]" ORDER="546" SD_1="7.0" SD_2="6.0" SE="1.5715431585418405" STUDY_ID="STD-Wang-2008" TOTAL_1="34" TOTAL_2="35" WEIGHT="8.907534691728415"/>
<CONT_DATA CI_END="7.7685491355736165" CI_START="-0.5685491355736136" EFFECT_SIZE="3.6000000000000014" ESTIMABLE="YES" MEAN_1="42.5" MEAN_2="38.9" MODIFIED="2014-03-27 17:06:08 +0000" MODIFIED_BY="[Empty name]" ORDER="499" SD_1="8.6" SD_2="9.4" SE="2.126849864821292" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" WEIGHT="8.727741921538348"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="264.8692788894212" CI_END="0.09174942605562594" CI_START="-0.5895956689231545" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.2489231214337643" ESTIMABLE="YES" I2="93.95928434317226" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2015-05-28 16:48:21 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="5.551115123125783E-16" P_Q="1.0" P_Z="0.15211251861695152" Q="0.0" RANDOM="YES" SCALE="2.3" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.4287162528733408" TOTALS="YES" TOTAL_1="1050" TOTAL_2="1120" UNITS="" WEIGHT="100.00000000000003" Z="1.4321093863445593">
<NAME>Length of hospital stay (days)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.7808348045087181" CI_START="-0.5808348045087184" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.1" MODIFIED="2014-01-24 18:15:12 +0000" MODIFIED_BY="[Empty name]" ORDER="426" SD_1="0.9" SD_2="1.0" SE="0.3473710792030141" STUDY_ID="STD-Alkady-2009" TOTAL_1="15" TOTAL_2="15" WEIGHT="5.499243386688477"/>
<CONT_DATA CI_END="-2.195587829091138" CI_START="-2.804412170908862" EFFECT_SIZE="-2.5" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="4.0" MODIFIED="2013-12-06 12:20:06 +0000" MODIFIED_BY="[Empty name]" ORDER="260" SD_1="0.5" SD_2="1.6" SE="0.1553151860493489" STUDY_ID="STD-Aniuliene-2009" TOTAL_1="150" TOTAL_2="114" WEIGHT="6.671664736182375"/>
<CONT_DATA CI_END="1.8369774865680104" CI_START="0.16302251343198948" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="4.0" MODIFIED="2014-01-24 18:55:15 +0000" MODIFIED_BY="[Empty name]" ORDER="433" SD_1="2.4" SD_2="2.2" SE="0.4270371767899727" STUDY_ID="STD-Chen-2010" TOTAL_1="77" TOTAL_2="45" WEIGHT="4.944042029155919"/>
<CONT_DATA CI_END="0.7599511020813465" CI_START="-1.3599511020813462" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="3.1" MEAN_2="3.4" MODIFIED="2014-05-23 21:40:52 +0100" MODIFIED_BY="[Empty name]" ORDER="581" SD_1="1.8" SD_2="2.1" SE="0.5408013159640205" STUDY_ID="STD-Chen-2012" TOTAL_1="13" TOTAL_2="102" WEIGHT="4.189218619319286"/>
<CONT_DATA CI_END="0.1749268301512095" CI_START="-0.25492683015120954" EFFECT_SIZE="-0.040000000000000036" ESTIMABLE="YES" MEAN_1="2.52" MEAN_2="2.56" MODIFIED="2013-12-10 22:35:28 +0000" MODIFIED_BY="[Empty name]" ORDER="280" SD_1="0.47" SD_2="0.51" SE="0.10965856099730655" STUDY_ID="STD-Darabi-Mahboub-2012" TOTAL_1="40" TOTAL_2="40" WEIGHT="6.854793753350374"/>
<CONT_DATA CI_END="0.13404723178440547" CI_START="-0.9340472317844057" EFFECT_SIZE="-0.40000000000000013" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.8" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="0.5" SD_2="1.7" SE="0.2724780842897635" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="42" WEIGHT="6.006813717750473"/>
<CONT_DATA CI_END="0.5860340157522685" CI_START="-0.38603401575226876" EFFECT_SIZE="0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.1" MODIFIED="2014-03-27 11:04:02 +0000" MODIFIED_BY="[Empty name]" ORDER="538" SD_1="1.3" SD_2="0.4" SE="0.24798109535993665" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" WEIGHT="6.16304233890187"/>
<CONT_DATA CI_END="0.2060158108949257" CI_START="-1.026015810894926" EFFECT_SIZE="-0.41000000000000014" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.41" MODIFIED="2014-01-03 11:02:21 +0000" MODIFIED_BY="[Empty name]" ORDER="386" SD_1="1.0E-4" SD_2="1.37" SE="0.314299556396944" STUDY_ID="STD-Jakimiuk-2012" TOTAL_1="16" TOTAL_2="19" WEIGHT="5.72737010312616"/>
<CONT_DATA CI_END="0.105994348688979" CI_START="-0.3259943486889792" EFFECT_SIZE="-0.1100000000000001" ESTIMABLE="YES" MEAN_1="1.25" MEAN_2="1.36" MODIFIED="2013-12-13 12:35:56 +0000" MODIFIED_BY="[Empty name]" ORDER="284" SD_1="0.66" SD_2="0.76" SE="0.11020322332079312" STUDY_ID="STD-Karateke-2009" TOTAL_1="84" TOTAL_2="83" WEIGHT="6.852931795737023"/>
<CONT_DATA CI_END="0.2518492089315464" CI_START="0.008150791068453636" EFFECT_SIZE="0.13" ESTIMABLE="YES" MEAN_1="0.71" MEAN_2="0.58" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="200" SD_1="0.58" SD_2="0.42" SE="0.062169106112498686" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="136" WEIGHT="6.984099247604484"/>
<CONT_DATA CI_END="0.17228846358713407" CI_START="-0.612288463587134" EFFECT_SIZE="-0.21999999999999997" ESTIMABLE="YES" MEAN_1="1.04" MEAN_2="1.26" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="0.21" SD_2="1.34" SE="0.20015085311845288" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" WEIGHT="6.4448402037728485"/>
<CONT_DATA CI_END="0.03390193517387133" CI_START="-0.4339019351738712" EFFECT_SIZE="-0.19999999999999996" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.8" MODIFIED="2008-03-24 13:52:58 +0000" MODIFIED_BY="[Empty name]" ORDER="964" SD_1="0.8" SD_2="1.0" SE="0.11933991492642716" STUDY_ID="STD-Meschia-2007" TOTAL_1="117" TOTAL_2="114" WEIGHT="6.820485368825391"/>
<CONT_DATA CI_END="-0.013449511791836122" CI_START="-0.5865504882081636" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="3.5" MODIFIED="2013-12-30 22:22:52 +0000" MODIFIED_BY="[Empty name]" ORDER="366" SD_1="0.5" SD_2="1.1" SE="0.1462019151721345" STUDY_ID="STD-Scheiner-2012" TOTAL_1="40" TOTAL_2="80" WEIGHT="6.712395248192439"/>
<CONT_DATA CI_END="0.24873841385553108" CI_START="-1.208738413855531" EFFECT_SIZE="-0.48" ESTIMABLE="YES" MEAN_1="3.44" MEAN_2="3.92" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="203" SD_1="1.48" SD_2="1.4" SE="0.3718121453270196" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" WEIGHT="5.328749106200305"/>
<CONT_DATA CI_END="0.9345392222915563" CI_START="-2.3345392222915557" EFFECT_SIZE="-0.6999999999999997" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="3.9" MODIFIED="2014-03-26 15:20:28 +0000" MODIFIED_BY="[Empty name]" ORDER="547" SD_1="2.2" SD_2="4.4" SE="0.8339639070843101" STUDY_ID="STD-Wang-2008" TOTAL_1="34" TOTAL_2="35" WEIGHT="2.6873848077280744"/>
<CONT_DATA CI_END="0.9450307273838133" CI_START="-0.3450307273838137" EFFECT_SIZE="0.2999999999999998" ESTIMABLE="YES" MEAN_1="3.9" MEAN_2="3.6" MODIFIED="2014-03-26 15:08:05 +0000" MODIFIED_BY="[Empty name]" ORDER="537" SD_1="2.8" SD_2="2.9" SE="0.3291033572411195" STUDY_ID="STD-Wang-2009" TOTAL_1="146" TOTAL_2="154" WEIGHT="5.625788098009609"/>
<CONT_DATA CI_END="0.2770262699773338" CI_START="-0.47702626997733355" EFFECT_SIZE="-0.09999999999999987" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="1.2" MODIFIED="2014-02-02 02:36:34 +0000" MODIFIED_BY="[Empty name]" ORDER="505" SD_1="0.3" SD_2="1.1" SE="0.19236387655654327" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" WEIGHT="6.487137439454898"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.3919584730437657" CI_END="0.061411640958361276" CI_START="-0.15174023611578855" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.04516429757871363" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2015-05-28 16:48:26 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.7074209949391326" P_Q="1.0" P_Z="0.4062080095068584" Q="0.0" RANDOM="NO" SCALE="0.97" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="312" TOTAL_2="314" UNITS="" WEIGHT="100.0" Z="0.8305851945233813">
<NAME>Time to return to normal activity level (weeks)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4031949353711549" CI_START="-0.943194935371155" EFFECT_SIZE="-0.27" ESTIMABLE="YES" MEAN_1="2.43" MEAN_2="2.7" MODIFIED="2013-12-13 12:37:19 +0000" MODIFIED_BY="[Empty name]" ORDER="285" SD_1="2.02" SD_2="2.4" SE="0.34347311515988593" STUDY_ID="STD-Karateke-2009" TOTAL_1="84" TOTAL_2="83" WEIGHT="2.5063207617126184"/>
<CONT_DATA CI_END="0.13676452937856162" CI_START="-0.13676452937856162" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="1.71" MEAN_2="1.71" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="207" SD_1="0.57" SD_2="0.57" SE="0.06977910331890931" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="136" WEIGHT="60.72553937598354"/>
<CONT_DATA CI_END="0.8808681348533238" CI_START="-1.4808681348533235" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="4.9" MEAN_2="5.2" MODIFIED="2008-03-18 01:30:11 +0000" MODIFIED_BY="[Empty name]" ORDER="387" SD_1="3.3" SD_2="3.3" SE="0.6024948132556827" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.8145458298928431"/>
<CONT_DATA CI_END="0.07774116020548263" CI_START="-0.2777411602054828" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.1" MODIFIED="2014-02-02 02:37:31 +0000" MODIFIED_BY="[Empty name]" ORDER="506" SD_1="0.2" SD_2="0.5" SE="0.09068593178623807" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" WEIGHT="35.953594032411"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="25.530811821986436" CI_END="1.1427390456814224" CI_START="0.7323301689162074" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9148017699758902" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="141" I2="45.16429756478177" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.05794706682602514" LOG_CI_START="-0.135293074392505" LOG_EFFECT_SIZE="-0.038673003783239936" METHOD="MH" MODIFIED="2015-05-28 16:48:37 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.02967474905757883" P_Q="1.0" P_Z="0.43275134660207326" Q="0.0" RANDOM="NO" SCALE="4.11" SORT_BY="STUDY" STUDIES="15" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1084" TOTAL_2="1121" WEIGHT="100.00000000000001" Z="0.7844922293180687">
<NAME>Perioperative complications</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.896796542344227" CI_START="0.7409166140472977" EFFECT_SIZE="1.9047619047619047" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="6" LOG_CI_END="0.6899120598334458" LOG_CI_START="-0.13023066664535962" LOG_EFFECT_SIZE="0.2798406965940431" MODIFIED="2008-03-23 01:06:41 +0000" MODIFIED_BY="[Empty name]" ORDER="463" O_E="0.0" SE="0.4817558973056215" STUDY_ID="STD-Andonian-2007" TOTAL_1="77" TOTAL_2="80" VAR="0.23208874458874457" WEIGHT="4.192252524596743"/>
<DICH_DATA CI_END="0.6828545189644513" CI_START="0.11954618559897706" EFFECT_SIZE="0.2857142857142857" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="21" LOG_CI_END="-0.1656718121908712" LOG_CI_START="-0.92246427650968" LOG_EFFECT_SIZE="-0.5440680443502757" MODIFIED="2014-03-28 01:00:45 +0000" MODIFIED_BY="[Empty name]" ORDER="940" O_E="0.0" SE="0.44454363972398436" STUDY_ID="STD-Araco-2008" TOTAL_1="120" TOTAL_2="120" VAR="0.1976190476190476" WEIGHT="14.958719235492923"/>
<DICH_DATA CI_END="5.7536224160906535" CI_START="0.013758490714415908" EFFECT_SIZE="0.28135593220338984" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.7599413577300318" LOG_CI_START="-1.86142920493421" LOG_EFFECT_SIZE="-0.5507439236020891" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="185" O_E="0.0" SE="1.539806044502535" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" VAR="2.3710026546865426" WEIGHT="1.4798196426795482"/>
<DICH_DATA CI_END="1.3927287384652225" CI_START="0.1847444370768363" EFFECT_SIZE="0.5072463768115942" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.14386653719953854" LOG_CI_START="-0.7334286299734978" LOG_EFFECT_SIZE="-0.29478104638697966" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="178" O_E="0.0" SE="0.515327523878557" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="42" VAR="0.2655624568668047" WEIGHT="6.702283293824751"/>
<DICH_DATA CI_END="1.5025461597563396" CI_START="0.2306373428708386" EFFECT_SIZE="0.5886792452830188" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.1768278228508371" LOG_CI_START="-0.6370703740155296" LOG_EFFECT_SIZE="-0.23012127558234627" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="182" O_E="0.0" SE="0.4780878297003549" STUDY_ID="STD-Enzelsberger-2005" TOTAL_1="53" TOTAL_2="52" VAR="0.22856797290759556" WEIGHT="7.191039632481859"/>
<DICH_DATA CI_END="5.355709120276285" CI_START="0.051230642118854634" EFFECT_SIZE="0.5238095238095238" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7288169815421001" LOG_CI_START="-1.2904702006934885" LOG_EFFECT_SIZE="-0.2808266095756942" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="180" O_E="0.0" SE="1.1861392864779443" STUDY_ID="STD-Kim-2005" TOTAL_1="21" TOTAL_2="22" VAR="1.406926406926407" WEIGHT="1.3915087660923648"/>
<DICH_DATA CI_END="2.45730947120886" CI_START="0.9279615162975905" EFFECT_SIZE="1.5100624566273422" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="22" LOG_CI_END="0.39045985455690363" LOG_CI_START="-0.03247003413259759" LOG_EFFECT_SIZE="0.178994910212153" MODIFIED="2014-04-16 13:28:14 +0100" MODIFIED_BY="[Empty name]" ORDER="446" O_E="0.0" SE="0.24843111015292615" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="136" VAR="0.061718016491815325" WEIGHT="15.377574045546853"/>
<DICH_DATA CI_END="0.8276476492153435" CI_START="0.04570964910145661" EFFECT_SIZE="0.1945031712473573" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="11" LOG_CI_END="-0.08215451414503037" LOG_CI_START="-1.339992112639482" LOG_EFFECT_SIZE="-0.7110733133922563" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="179" O_E="0.0" SE="0.7388600317521715" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="0.5459141465208199" WEIGHT="7.571400961357039"/>
<DICH_DATA CI_END="2.662249214227477" CI_START="0.32237019310897486" EFFECT_SIZE="0.9264069264069265" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.4252487075240092" LOG_CI_START="-0.4916451206099161" LOG_EFFECT_SIZE="-0.03319820654295345" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="186" O_E="0.0" SE="0.5385879733435162" STUDY_ID="STD-Meschia-2007" TOTAL_1="99" TOTAL_2="107" VAR="0.29007700503027606" WEIGHT="4.792599366711325"/>
<DICH_DATA CI_END="1.986026460239105" CI_START="0.508695492718972" EFFECT_SIZE="1.005128205128205" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.29798503039263563" LOG_CI_START="-0.29354211040471956" LOG_EFFECT_SIZE="0.0022214599939580325" MODIFIED="2013-12-29 13:13:27 +0000" MODIFIED_BY="[Empty name]" ORDER="953" O_E="0.0" SE="0.34746597061093726" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="0.12073260073260073" WEIGHT="9.579475372483154"/>
<DICH_DATA CI_END="3.8891261490009854" CI_START="0.2650996336091082" EFFECT_SIZE="1.0153846153846153" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5898520302974959" LOG_CI_START="-0.5765908724994697" LOG_EFFECT_SIZE="0.006630578899013076" MODIFIED="2008-03-28 12:26:29 +0000" MODIFIED_BY="[Empty name]" ORDER="507" O_E="0.0" SE="0.6851743350884281" STUDY_ID="STD-Riva-2006" TOTAL_1="65" TOTAL_2="66" VAR="0.4694638694638695" WEIGHT="2.8275296264835768"/>
<DICH_DATA CI_END="8.495798663083438" CI_START="0.6099603824195433" EFFECT_SIZE="2.2764227642276422" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.9292042117708276" LOG_CI_START="-0.21469837196518513" LOG_EFFECT_SIZE="0.35725291990282126" MODIFIED="2008-03-29 15:25:29 +0000" MODIFIED_BY="[Empty name]" ORDER="517" O_E="0.0" SE="0.6719340400956456" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="82" TOTAL_2="80" VAR="0.45149535423925663" WEIGHT="2.1633421116585887"/>
<DICH_DATA CI_END="9.455079373628532" CI_START="0.3702264310045431" EFFECT_SIZE="1.8709677419354838" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9756651790175671" LOG_CI_START="-0.431532579560238" LOG_EFFECT_SIZE="0.2720662997286646" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="181" O_E="0.0" SE="0.8265949291298498" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" VAR="0.6832591768631814" WEIGHT="1.4721279247627959"/>
<DICH_DATA CI_END="1.9585589774577843" CI_START="0.7189589942470059" EFFECT_SIZE="1.1866438356164384" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="24" LOG_CI_END="0.29193665385111556" LOG_CI_START="-0.143295878852301" LOG_EFFECT_SIZE="0.07432038749940727" MODIFIED="2014-03-26 15:11:24 +0000" MODIFIED_BY="[Empty name]" ORDER="542" O_E="0.0" SE="0.2556577441457701" STUDY_ID="STD-Wang-2009" TOTAL_1="146" TOTAL_2="154" VAR="0.06536088214170405" WEIGHT="16.63979434957689"/>
<DICH_DATA CI_END="1.8248415452835502" CI_START="0.0784562350601268" EFFECT_SIZE="0.3783783783783784" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2612251597532516" LOG_CI_START="-1.1053725365307656" LOG_EFFECT_SIZE="-0.422073688388757" MODIFIED="2014-02-02 02:32:40 +0000" MODIFIED_BY="[Empty name]" ORDER="502" O_E="0.0" SE="0.8027462515649291" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" VAR="0.6444015444015444" WEIGHT="3.6605331462515753"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.122527509490264" CI_END="0.5487442231587126" CI_START="0.19434059289427139" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3265628234750101" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="-0.2606300387106417" LOG_CI_START="-0.711436476658574" LOG_EFFECT_SIZE="-0.4860332576846078" METHOD="MH" MODIFIED="2015-06-20 19:13:28 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.9988317367274583" P_Q="1.0" P_Z="2.3763051211235088E-5" Q="0.0" RANDOM="NO" SCALE="58.09" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2359" TOTAL_2="2317" WEIGHT="100.0" Z="4.22623813753313">
<NAME>Major vascular or visceral injury</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.203778112392241" CI_START="0.21570806842553994" EFFECT_SIZE="1.0594795539033457" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.7163187700920656" LOG_CI_START="-0.666133610079861" LOG_EFFECT_SIZE="0.025092580006102212" MODIFIED="2014-05-22 15:28:47 +0100" MODIFIED_BY="[Empty name]" ORDER="575" O_E="0.0" SE="0.8120593713626381" STUDY_ID="STD-Aigmuller-2014" TOTAL_1="269" TOTAL_2="285" VAR="0.6594404226178829" WEIGHT="5.144871601658185"/>
<DICH_DATA CI_END="7.584304769707433" CI_START="0.014650137947370117" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87991577648491" LOG_CI_START="-1.8341582859242351" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-01-24 18:25:27 +0000" MODIFIED_BY="[Empty name]" ORDER="428" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-Alkady-2009" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="2.6489394677682476"/>
<DICH_DATA CI_END="6.174586401851048" CI_START="0.010437377816752684" EFFECT_SIZE="0.25386313465783666" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7906078721487685" LOG_CI_START="-1.981408595467209" LOG_EFFECT_SIZE="-0.5954003616592202" MODIFIED="2013-12-06 12:21:53 +0000" MODIFIED_BY="[Empty name]" ORDER="261" O_E="0.0" SE="1.6282961947804406" STUDY_ID="STD-Aniuliene-2009" TOTAL_1="150" TOTAL_2="114" VAR="2.6513484979364623" WEIGHT="3.0074425536316194"/>
<DICH_DATA CI_END="1.3504434382084367" CI_START="0.0043816420561557145" EFFECT_SIZE="0.07692307692307693" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.13047639897264934" LOG_CI_START="-2.3583631035863233" LOG_EFFECT_SIZE="-1.1139433523068367" MODIFIED="2014-03-28 01:02:45 +0000" MODIFIED_BY="[Empty name]" ORDER="545" O_E="0.0" SE="1.4619566437573717" STUDY_ID="STD-Araco-2008" TOTAL_1="120" TOTAL_2="120" VAR="2.1373172282263186" WEIGHT="11.478737693662406"/>
<DICH_DATA CI_END="8.651973797930193" CI_START="0.014766110822709998" EFFECT_SIZE="0.357429718875502" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9371151955299338" LOG_CI_START="-1.830733876431581" LOG_EFFECT_SIZE="-0.44680934045082354" MODIFIED="2013-12-28 09:33:31 +0000" MODIFIED_BY="[Empty name]" ORDER="355" O_E="0.0" SE="1.625848245944068" STUDY_ID="STD-Barber-2008" TOTAL_1="82" TOTAL_2="88" VAR="2.6433825188394025" WEIGHT="2.556534602613541"/>
<DICH_DATA CI_END="5.674866279893289" CI_START="0.009668188426164964" EFFECT_SIZE="0.23423423423423423" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7539556324574647" LOG_CI_START="-2.0146548940891433" LOG_EFFECT_SIZE="-0.6303496308158395" MODIFIED="2014-01-24 18:59:19 +0000" MODIFIED_BY="[Empty name]" ORDER="435" O_E="0.0" SE="1.626295528136613" STUDY_ID="STD-Chen-2010" TOTAL_1="110" TOTAL_2="77" VAR="2.644837144837145" WEIGHT="3.1114527081722274"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-12-28 08:17:36 +0000" MODIFIED_BY="[Empty name]" ORDER="347" O_E="0.0" SE="0.0" STUDY_ID="STD-Deffieux-2010" TOTAL_1="74" TOTAL_2="75" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.130948483373665" CI_START="0.010297650205809193" EFFECT_SIZE="0.20625" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6160497789693116" LOG_CI_START="-1.9872618645253863" LOG_EFFECT_SIZE="-0.6856060427780373" MODIFIED="2014-06-29 02:24:05 +0100" MODIFIED_BY="[Empty name]" ORDER="1199" O_E="0.0" SE="1.5291981459892532" STUDY_ID="STD-Diab-2012" TOTAL_1="31" TOTAL_2="32" VAR="2.3384469696969696" WEIGHT="4.346977588132509"/>
<DICH_DATA CI_END="2.7426812219450363" CI_START="0.007860081215580388" EFFECT_SIZE="0.14682539682539683" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43817533308923146" LOG_CI_START="-2.10457296651833" LOG_EFFECT_SIZE="-0.8331988167145491" MODIFIED="2013-12-21 15:24:48 +0000" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="1.4936229379965618" STUDY_ID="STD-El_x002d_Hefnawy-2010" TOTAL_1="35" TOTAL_2="36" VAR="2.2309094809094807" WEIGHT="6.096189460069392"/>
<DICH_DATA CI_END="4.57134053328148" CI_START="0.01211095988063836" EFFECT_SIZE="0.23529411764705882" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6600435744322882" LOG_CI_START="-1.916821434532911" LOG_EFFECT_SIZE="-0.6283889300503115" MODIFIED="2014-04-16 13:08:11 +0100" MODIFIED_BY="[Empty name]" ORDER="387" O_E="0.0" SE="1.5136632619536736" STUDY_ID="STD-Jakimiuk-2012" TOTAL_1="16" TOTAL_2="19" VAR="2.2911764705882356" WEIGHT="4.056934320005424"/>
<DICH_DATA CI_END="4.0800683007869605" CI_START="0.009803757449914465" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106674332875778" LOG_CI_START="-2.008607441959615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2014-03-23 19:45:57 +0000" MODIFIED_BY="[Empty name]" ORDER="520" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Kamel-2009" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="4.414899112947079"/>
<DICH_DATA CI_END="2.6246051555454155" CI_START="0.09299800747968082" EFFECT_SIZE="0.49404761904761907" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.41906397758358144" LOG_CI_START="-1.0315263562831591" LOG_EFFECT_SIZE="-0.30623118934978893" MODIFIED="2013-12-13 12:38:34 +0000" MODIFIED_BY="[Empty name]" ORDER="286" O_E="0.0" SE="0.8520839426512823" STUDY_ID="STD-Karateke-2009" TOTAL_1="84" TOTAL_2="83" VAR="0.7260470453241538" WEIGHT="7.106137015330388"/>
<DICH_DATA CI_END="8.010806924260384" CI_START="0.013507549515821865" EFFECT_SIZE="0.32894736842105265" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9036762645365537" LOG_CI_START="-1.869423431754061" LOG_EFFECT_SIZE="-0.4828735836087537" MODIFIED="2013-12-10 21:22:14 +0000" MODIFIED_BY="[Empty name]" ORDER="276" O_E="0.0" SE="1.6289324886659908" STUDY_ID="STD-Krofta-2010" TOTAL_1="151" TOTAL_2="149" VAR="2.6534210526315785" WEIGHT="2.6664821132501566"/>
<DICH_DATA CI_END="2.121028443574474" CI_START="0.006269916548115787" EFFECT_SIZE="0.11531986531986532" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3265464925639977" LOG_CI_START="-2.202738239541534" LOG_EFFECT_SIZE="-0.938095873488768" MODIFIED="2015-06-20 19:13:28 +0100" MODIFIED_BY="[Empty name]" ORDER="216" O_E="0.0" SE="1.4857143718001358" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="136" VAR="2.207347194573472" WEIGHT="7.79910802406116"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-03-18 01:25:05 +0000" MODIFIED_BY="[Empty name]" ORDER="384" O_E="0.0" SE="0.0" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.298560016943189" CI_START="0.038548887790308975" EFFECT_SIZE="0.35658914728682173" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5183243904295445" LOG_CI_START="-1.4139881476648941" LOG_EFFECT_SIZE="-0.4478318786176749" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="217" O_E="0.0" SE="1.135049949978001" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="1.2883383889450621" WEIGHT="5.1192987466981865"/>
<DICH_DATA CI_END="6.770423965889751" CI_START="0.012966912506691929" EFFECT_SIZE="0.2962962962962963" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8306158651816438" LOG_CI_START="-1.8871634195157312" LOG_EFFECT_SIZE="-0.5282737771670437" MODIFIED="2014-06-29 17:56:54 +0100" MODIFIED_BY="[Empty name]" ORDER="1206" O_E="0.0" SE="1.596437005055668" STUDY_ID="STD-Mehdiyev-2010" TOTAL_1="17" TOTAL_2="15" VAR="2.548611111111111" WEIGHT="2.8047594364604973"/>
<DICH_DATA CI_END="7.519890060927144" CI_START="0.012895420609847778" EFFECT_SIZE="0.31140350877192985" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8762114913520541" LOG_CI_START="-1.8895644879148112" LOG_EFFECT_SIZE="-0.5066764982813785" MODIFIED="2013-12-29 13:14:29 +0000" MODIFIED_BY="[Empty name]" ORDER="361" O_E="0.0" SE="1.6246305010332567" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="2.639424264887571" WEIGHT="2.739039449665127"/>
<DICH_DATA CI_END="2.061317008794751" CI_START="0.006033831286817332" EFFECT_SIZE="0.11152416356877323" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.31414478682202635" LOG_CI_START="-2.2194068373875173" LOG_EFFECT_SIZE="-0.9526310252827456" MODIFIED="2014-10-22 16:15:07 +0100" MODIFIED_BY="[Empty name]" ORDER="338" O_E="0.0" SE="1.488220765343489" STUDY_ID="STD-Rechberger-2009" TOTAL_1="268" TOTAL_2="269" VAR="2.2148010463995598" WEIGHT="7.932074769903435"/>
<DICH_DATA CI_END="7.370671829902099" CI_START="0.012666986088309441" EFFECT_SIZE="0.3055555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.867507075202536" LOG_CI_START="-1.8973267064206605" LOG_EFFECT_SIZE="-0.5149098156090622" MODIFIED="2013-12-30 22:31:13 +0000" MODIFIED_BY="[Empty name]" ORDER="368" O_E="0.0" SE="1.6240770494734118" STUDY_ID="STD-Scheiner-2012" TOTAL_1="71" TOTAL_2="65" VAR="2.6376262626262625" WEIGHT="2.764110748975563"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-02-02 00:03:11 +0000" MODIFIED_BY="[Empty name]" ORDER="467" O_E="0.0" SE="0.0" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="82" TOTAL_2="82" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="16.92247310382935" CI_START="0.06917742123581233" EFFECT_SIZE="1.0819672131147542" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2284638325126684" LOG_CI_START="-1.1600356314504654" LOG_EFFECT_SIZE="0.034214100531101674" MODIFIED="2013-12-22 21:23:57 +0000" MODIFIED_BY="[Empty name]" ORDER="340" O_E="0.0" SE="1.4030164083949745" STUDY_ID="STD-Teo-2011" TOTAL_1="61" TOTAL_2="66" VAR="1.968455042225534" WEIGHT="1.6964336748962006"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-02 20:05:52 +0100" MODIFIED_BY="[Empty name]" ORDER="592" O_E="0.0" SE="0.0" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.134952272224053" CI_START="0.01445011801845833" EFFECT_SIZE="0.34285714285714286" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9103550092740414" LOG_CI_START="-1.840128605879343" LOG_EFFECT_SIZE="-0.4648867983026508" MODIFIED="2014-05-23 23:13:59 +0100" MODIFIED_BY="[Empty name]" ORDER="584" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Wang-2008" TOTAL_1="34" TOTAL_2="35" VAR="2.6103174603174604" WEIGHT="2.6116304611799626"/>
<DICH_DATA CI_END="7.390462593210287" CI_START="0.15054422731266126" EFFECT_SIZE="1.0547945205479452" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.86867162315679" LOG_CI_START="-0.8223358930527381" LOG_EFFECT_SIZE="0.02316786505202597" MODIFIED="2014-03-26 15:09:01 +0000" MODIFIED_BY="[Empty name]" ORDER="538" O_E="0.0" SE="0.9933061856436818" STUDY_ID="STD-Wang-2009" TOTAL_1="146" TOTAL_2="154" VAR="0.9866571784380004" WEIGHT="3.437734775948126"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-12-19 20:11:32 +0000" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="0.0" STUDY_ID="STD-Wang-2010" TOTAL_1="70" TOTAL_2="70" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.673089416084276" CI_START="0.04226986616555006" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6696040910051549" LOG_CI_START="-1.37396912722788" LOG_EFFECT_SIZE="-0.35218251811136253" MODIFIED="2014-02-02 01:08:14 +0000" MODIFIED_BY="[Empty name]" ORDER="480" O_E="0.0" SE="1.2004050242406612" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" VAR="1.4409722222222223" WEIGHT="3.7396792486139967"/>
<DICH_DATA CI_END="7.502975334214647" CI_START="0.013291126152980877" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8752335187236451" LOG_CI_START="-1.8764382198620155" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2014-02-02 02:31:19 +0000" MODIFIED_BY="[Empty name]" ORDER="501" O_E="0.0" SE="1.6163456002399996" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" VAR="2.6125730994152048" WEIGHT="2.720532426356579"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.547978347497672" CI_END="0.19528517063398487" CI_START="0.07928209792758797" CI_STUDY="95" CI_TOTAL="95" DF="35" EFFECT_MEASURE="RR" EFFECT_SIZE="0.12442916869451999" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="154" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="-0.7093307344712507" LOG_CI_START="-1.1008248662634474" LOG_EFFECT_SIZE="-0.9050778003673491" METHOD="MH" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.9999794040308068" P_Q="1.0" P_Z="1.2772081712645242E-19" Q="0.0" RANDOM="NO" SCALE="22.91" SORT_BY="STUDY" STUDIES="39" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3104" TOTAL_2="3069" WEIGHT="99.99999999999999" Z="9.062306419797507">
<NAME>Bladder or urethral perforation</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7777192397100013" CI_START="0.002727256735264154" EFFECT_SIZE="0.04605475040257649" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.10917715706065045" LOG_CI_START="-2.564273977034424" LOG_EFFECT_SIZE="-1.336725567047537" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="574" O_E="0.0" SE="1.4421360249778532" STUDY_ID="STD-Aigmuller-2014" TOTAL_1="269" TOTAL_2="285" VAR="2.0797563145389235" WEIGHT="6.61462349740124"/>
<DICH_DATA CI_END="7.584304769707433" CI_START="0.014650137947370117" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87991577648491" LOG_CI_START="-1.8341582859242351" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="427" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-Alkady-2009" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="0.888340740230698"/>
<DICH_DATA CI_END="0.753177605599981" CI_START="0.002706622961301533" EFFECT_SIZE="0.0451505016722408" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="11" LOG_CI_END="-0.12310260143941623" LOG_CI_START="-2.567572238219431" LOG_EFFECT_SIZE="-1.3453374198294235" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="461" O_E="0.0" SE="1.4358935649644342" STUDY_ID="STD-Andonian-2007" TOTAL_1="77" TOTAL_2="80" VAR="2.061790329906272" WEIGHT="6.682110222112671"/>
<DICH_DATA CI_END="6.174586401851048" CI_START="0.010437377816752684" EFFECT_SIZE="0.25386313465783666" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7906078721487685" LOG_CI_START="-1.981408595467209" LOG_EFFECT_SIZE="-0.5954003616592202" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="262" O_E="0.0" SE="1.6282961947804406" STUDY_ID="STD-Aniuliene-2009" TOTAL_1="150" TOTAL_2="114" VAR="2.6513484979364623" WEIGHT="1.0085673065777097"/>
<DICH_DATA CI_END="2.7361270272107046" CI_START="0.007458777703793545" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43713625603639966" LOG_CI_START="-2.1273323360649132" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="231" O_E="0.0" SE="1.5063815453245737" STUDY_ID="STD-Araco-2008" TOTAL_1="120" TOTAL_2="120" VAR="2.2691853600944505" WEIGHT="2.072795060538295"/>
<DICH_DATA CI_END="1.2321872979572832" CI_START="0.004147291703045921" EFFECT_SIZE="0.0714859437751004" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.09067672754171653" LOG_CI_START="-2.3822354171154014" LOG_EFFECT_SIZE="-1.1457793447868423" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="356" O_E="0.0" SE="1.4526008348841293" STUDY_ID="STD-Barber-2008" TOTAL_1="82" TOTAL_2="88" VAR="2.1100491855060692" WEIGHT="4.2867605487876705"/>
<DICH_DATA CI_END="1.5975889194716029" CI_START="0.025533514591718574" EFFECT_SIZE="0.2019704433497537" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.2034650397012618" LOG_CI_START="-1.5928894020882165" LOG_EFFECT_SIZE="-0.6947121811934774" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="229" O_E="0.0" SE="1.0551874912050363" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" VAR="1.1134206415955785" WEIGHT="3.434917528892032"/>
<DICH_DATA CI_END="1.4294787716210533" CI_START="0.004264621761016625" EFFECT_SIZE="0.07807807807807808" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.15517771028072205" LOG_CI_START="-2.370119481351726" LOG_EFFECT_SIZE="-1.107470885535502" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="434" O_E="0.0" SE="1.4833720707876028" STUDY_ID="STD-Chen-2010" TOTAL_1="110" TOTAL_2="77" VAR="2.2003927003927006" WEIGHT="3.1303435608129355"/>
<DICH_DATA CI_END="1.6074552915830762" CI_START="0.005042936479349309" EFFECT_SIZE="0.09003496503496504" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.20613890266078166" LOG_CI_START="-2.297316502164448" LOG_EFFECT_SIZE="-1.0455887997518332" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="549" O_E="0.0" SE="1.4705420970984542" STUDY_ID="STD-Chen-2012" TOTAL_1="103" TOTAL_2="102" VAR="2.1624940593387194" WEIGHT="3.2729848851011862"/>
<DICH_DATA CI_END="1.833352647903987" CI_START="0.00563650850006868" EFFECT_SIZE="0.1016548463356974" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2632460101385467" LOG_CI_START="-2.2489898337294587" LOG_EFFECT_SIZE="-0.9928719117954559" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="220" O_E="0.0" SE="1.4756997704560548" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="42" VAR="2.177689812524053" WEIGHT="2.7834676527228535"/>
<DICH_DATA CI_END="2.7389368446952904" CI_START="0.007939597214199805" EFFECT_SIZE="0.14746543778801843" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43758201826471066" LOG_CI_START="-2.1002015293219576" LOG_EFFECT_SIZE="-0.8313097555286235" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="539" O_E="0.0" SE="1.4907066180835706" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" VAR="2.2222062211981566" WEIGHT="2.039893551640862"/>
<DICH_DATA CI_END="2.024256752132156" CI_START="0.08119204372607726" EFFECT_SIZE="0.40540540540540543" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.30626559658788355" LOG_CI_START="-1.090486526610511" LOG_EFFECT_SIZE="-0.39211046501131375" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="230" O_E="0.0" SE="0.8204591112012549" STUDY_ID="STD-Deffieux-2010" TOTAL_1="74" TOTAL_2="75" VAR="0.6731531531531532" WEIGHT="2.9412624061329598"/>
<DICH_DATA CI_END="2.8731459838364963" CI_START="0.00812877268916761" EFFECT_SIZE="0.15282392026578073" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4583576929477225" LOG_CI_START="-2.0899750207722607" LOG_EFFECT_SIZE="-0.8158086639122692" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="1.4969032504894946" STUDY_ID="STD-El_x002d_Hefnawy-2010" TOTAL_1="42" TOTAL_2="45" VAR="2.2407193413260145" WEIGHT="2.002925564115656"/>
<DICH_DATA CI_END="1.9761357476875958" CI_START="0.006018141935535829" EFFECT_SIZE="0.10905349794238683" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2958167744857758" LOG_CI_START="-2.2205375738087842" LOG_EFFECT_SIZE="-0.9623603996615043" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="225" O_E="0.0" SE="1.4781190003431393" STUDY_ID="STD-Enzelsberger-2005" TOTAL_1="53" TOTAL_2="52" VAR="2.1848357791754016" WEIGHT="2.689928970418188"/>
<DICH_DATA CI_END="3.7860034662005257" CI_START="0.00895781592068029" EFFECT_SIZE="0.18415841584158416" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5781810072376755" LOG_CI_START="-2.0477978663671283" LOG_EFFECT_SIZE="-0.7348084295647263" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="293" O_E="0.0" SE="1.542512989160528" STUDY_ID="STD-Freeman-2011" TOTAL_1="100" TOTAL_2="92" VAR="2.379346321728947" WEIGHT="1.5416222467921046"/>
<DICH_DATA CI_END="3.0294966904900793" CI_START="0.009323856614010542" EFFECT_SIZE="0.16806722689075632" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4813704823969383" LOG_CI_START="-2.030404413854037" LOG_EFFECT_SIZE="-0.7745169657285496" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="388" O_E="0.0" SE="1.4754290075440841" STUDY_ID="STD-Jakimiuk-2012" TOTAL_1="16" TOTAL_2="19" VAR="2.1768907563025213" WEIGHT="1.9047305961703254"/>
<DICH_DATA CI_END="1.6085426237362968" CI_START="0.005137857516464679" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.20643257348058153" LOG_CI_START="-2.289217943797032" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="519" O_E="0.0" SE="1.465957467518168" STUDY_ID="STD-Kamel-2009" TOTAL_1="60" TOTAL_2="60" VAR="2.1490312965722804" WEIGHT="3.2572493808458924"/>
<DICH_DATA CI_END="2.0228914085952243" CI_START="0.006102986527051893" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.30597256991184496" LOG_CI_START="-2.2144575887904945" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="222" O_E="0.0" SE="1.4805131515522556" STUDY_ID="STD-Kim-2005" TOTAL_1="65" TOTAL_2="65" VAR="2.191919191919192" WEIGHT="2.665022220692094"/>
<DICH_DATA CI_END="8.416847093094159" CI_START="0.014220056597526695" EFFECT_SIZE="0.34595959595959597" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9251494375206003" LOG_CI_START="-1.847098675058811" LOG_EFFECT_SIZE="-0.4609746187691055" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="219" O_E="0.0" SE="1.6284322641786229" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="136" VAR="2.651791639017916" WEIGHT="0.8718288305609824"/>
<DICH_DATA CI_END="4.0800683007869605" CI_START="0.009803757449914465" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6106674332875778" LOG_CI_START="-2.008607441959615" LOG_EFFECT_SIZE="-0.6989700043360187" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="388" O_E="0.0" SE="1.5385750273399406" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="2.3672131147540987" WEIGHT="1.4805679003844965"/>
<DICH_DATA CI_END="2.8707491880891514" CI_START="0.008111460024473108" EFFECT_SIZE="0.1525974025974026" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4579952506688928" LOG_CI_START="-2.0909009677983463" LOG_EFFECT_SIZE="-0.8164528585647268" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="221" O_E="0.0" SE="1.4972342559674259" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="2.2417104172423317" WEIGHT="2.004461157443626"/>
<DICH_DATA CI_END="1.4934957676316682" CI_START="0.004991631516263842" EFFECT_SIZE="0.08634222919937205" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.17420399620910168" LOG_CI_START="-2.301757481891315" LOG_EFFECT_SIZE="-1.0637767428411067" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="228" O_E="0.0" SE="1.4543920284431668" STUDY_ID="STD-Mansoor-2003" TOTAL_1="48" TOTAL_2="54" VAR="2.1152561723990297" WEIGHT="3.6273913559420166"/>
<DICH_DATA CI_END="6.770423965889751" CI_START="0.012966912506691929" EFFECT_SIZE="0.2962962962962963" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8306158651816438" LOG_CI_START="-1.8871634195157312" LOG_EFFECT_SIZE="-0.5282737771670437" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="1204" O_E="0.0" SE="1.596437005055668" STUDY_ID="STD-Mehdiyev-2010" TOTAL_1="17" TOTAL_2="15" VAR="2.548611111111111" WEIGHT="0.9405960778913272"/>
<DICH_DATA CI_END="1.584068908943089" CI_START="0.004955325939877141" EFFECT_SIZE="0.08859784283513097" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19977407000776903" LOG_CI_START="-2.304927774229246" LOG_EFFECT_SIZE="-1.0525768521107388" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="963" O_E="0.0" SE="1.4712742617789119" STUDY_ID="STD-Meschia-2007" TOTAL_1="117" TOTAL_2="114" VAR="2.1646479533730822" WEIGHT="3.299188214075668"/>
<DICH_DATA CI_END="7.676698731922972" CI_START="0.014473814199463616" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8851744972786274" LOG_CI_START="-1.8394170067179525" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="1.6004385363930504" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" VAR="2.5614035087719293" WEIGHT="0.888340740230698"/>
<DICH_DATA CI_END="2.6831009876717293" CI_START="0.007606185290481881" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4286370191360396" LOG_CI_START="-2.1188330991645534" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="422" O_E="0.0" SE="1.4963965576702283" STUDY_ID="STD-Oliveira-2006" TOTAL_1="42" TOTAL_2="42" VAR="2.2392026578073088" WEIGHT="2.072795060538295"/>
<DICH_DATA CI_END="5.033490482809504" CI_START="0.043265757335101296" EFFECT_SIZE="0.4666666666666667" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7018692517956782" LOG_CI_START="-1.3638556898785268" LOG_EFFECT_SIZE="-0.3309932190414244" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="954" O_E="0.0" SE="1.2134170562428042" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="1.4723809523809523" WEIGHT="1.2252975727319972"/>
<DICH_DATA CI_END="0.62218990634565" CI_START="0.0022211223316697475" EFFECT_SIZE="0.03717472118959108" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.2060770386370607" LOG_CI_START="-2.6534275213677554" LOG_EFFECT_SIZE="-1.429752280002408" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="224" O_E="0.0" SE="1.4375857881362808" STUDY_ID="STD-Rechberger-2009" TOTAL_1="268" TOTAL_2="269" VAR="2.0666528982514114" WEIGHT="7.980233514280221"/>
<DICH_DATA CI_END="0.501115982270003" CI_START="0.0018202612899138402" EFFECT_SIZE="0.030202020202020202" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="16" LOG_CI_END="-0.30006174592848056" LOG_CI_START="-2.73986626661776" LOG_EFFECT_SIZE="-1.5199640062731203" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="1001" O_E="0.0" SE="1.433153252680039" STUDY_ID="STD-Richter-2010" TOTAL_1="299" TOTAL_2="298" VAR="2.0539282456673758" WEIGHT="9.788061578501846"/>
<DICH_DATA CI_END="8.157458228634331" CI_START="0.014036678934799663" EFFECT_SIZE="0.3383838383838384" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9115548586021058" LOG_CI_START="-1.852735633723515" LOG_EFFECT_SIZE="-0.47059038756070465" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="506" O_E="0.0" SE="1.6237579186506907" STUDY_ID="STD-Riva-2006" TOTAL_1="65" TOTAL_2="66" VAR="2.636589778380823" WEIGHT="0.8816614865447528"/>
<DICH_DATA CI_END="2.7216234063974545" CI_START="0.007498525775952188" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.43482803128669784" LOG_CI_START="-2.125024111315212" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="369" O_E="0.0" SE="1.5036698200368304" STUDY_ID="STD-Scheiner-2012" TOTAL_1="80" TOTAL_2="80" VAR="2.261022927689594" WEIGHT="2.072795060538295"/>
<DICH_DATA CI_END="1.1205895199342322" CI_START="0.003777328699739544" EFFECT_SIZE="0.06506024096385542" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="0.04944655650740533" LOG_CI_START="-2.422815221613616" LOG_EFFECT_SIZE="-1.1866843325531053" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="519" O_E="0.0" SE="1.4522188063614598" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="82" TOTAL_2="80" VAR="2.108939461549903" WEIGHT="4.495870819460239"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanuri-2010" TOTAL_1="20" TOTAL_2="10" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="526" O_E="0.0" SE="0.0" STUDY_ID="STD-Teo-2011" TOTAL_1="61" TOTAL_2="66" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.377700948278992" CI_START="0.013236677751594202" EFFECT_SIZE="0.3125" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8679210473201091" LOG_CI_START="-1.8782210039599212" LOG_EFFECT_SIZE="-0.5051499783199059" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="223" O_E="0.0" SE="1.6130974345442786" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" VAR="2.6020833333333333" WEIGHT="0.9169968931413656"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="583" O_E="0.0" SE="0.0" STUDY_ID="STD-Wang-2008" TOTAL_1="34" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.1273299882361476" CI_START="0.03552906521827559" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4951737093557621" LOG_CI_START="-1.449416218795087" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="308" O_E="0.0" SE="1.1422617496711973" STUDY_ID="STD-Wang-2010" TOTAL_1="70" TOTAL_2="70" VAR="1.3047619047619048" WEIGHT="1.776681480461396"/>
<DICH_DATA CI_END="7.049760522956213" CI_START="0.012537402184438221" EFFECT_SIZE="0.2972972972972973" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8481743644630135" LOG_CI_START="-1.9017924422805537" LOG_EFFECT_SIZE="-0.52680903890877" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="476" O_E="0.0" SE="1.6153441148364052" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" VAR="2.609336609336609" WEIGHT="0.9391030682438806"/>
<DICH_DATA CI_END="3.8131084618028526" CI_START="0.00941496350495534" EFFECT_SIZE="0.18947368421052632" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5812791587204423" LOG_CI_START="-2.0261813590915256" LOG_EFFECT_SIZE="-0.7224511001855417" MODIFIED="2014-07-12 19:59:56 +0100" MODIFIED_BY="[Empty name]" ORDER="500" O_E="0.0" SE="1.5316352153004769" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" VAR="2.345906432748538" WEIGHT="1.520583249043537"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.135446004917462" CI_END="0.6513907236313325" CI_START="0.42905806897156695" CI_STUDY="95" CI_TOTAL="95" DF="35" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5286628850479776" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="222" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="-0.18615843045706856" LOG_CI_START="-0.36748392616663966" LOG_EFFECT_SIZE="-0.2768211783118541" METHOD="MH" MODIFIED="2015-06-20 16:54:24 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.9688269563455452" P_Q="1.0" P_Z="2.1722736785480832E-9" Q="0.0" RANDOM="NO" SCALE="4.17" SORT_BY="STUDY" STUDIES="37" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3128" TOTAL_2="3072" WEIGHT="99.99999999999999" Z="5.984371227289422">
<NAME>Voiding dysfunction</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3547784449926383" CI_START="0.02979306098643235" EFFECT_SIZE="0.2648698884758364" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.37195005174366486" LOG_CI_START="-1.5258848743873854" LOG_EFFECT_SIZE="-0.5769674113218601" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="576" O_E="0.0" SE="1.1147976300437745" STUDY_ID="STD-Aigmuller-2014" TOTAL_1="269" TOTAL_2="285" VAR="1.2427737559512164" WEIGHT="1.6991540345656546"/>
<DICH_DATA CI_END="4.943824870337866" CI_START="0.05056813430021737" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6940630779397805" LOG_CI_START="-1.296123069267743" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="429" O_E="0.0" SE="1.1690451944500122" STUDY_ID="STD-Alkady-2009" TOTAL_1="15" TOTAL_2="15" VAR="1.3666666666666667" WEIGHT="0.8748432482800861"/>
<DICH_DATA CI_END="0.5515877056516405" CI_START="0.08079930132220009" EFFECT_SIZE="0.2111111111111111" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="18" LOG_CI_END="-0.258385422385882" LOG_CI_START="-1.0925923945871097" LOG_EFFECT_SIZE="-0.6754889084864959" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="263" O_E="0.0" SE="0.4900173048621115" STUDY_ID="STD-Aniuliene-2009" TOTAL_1="150" TOTAL_2="114" VAR="0.24011695906432748" WEIGHT="8.947260493773607"/>
<DICH_DATA CI_END="0.7196864606980646" CI_START="0.0025893269914693986" EFFECT_SIZE="0.043168316831683165" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="12" LOG_CI_END="-0.14285666752152318" LOG_CI_START="-2.58681310150659" LOG_EFFECT_SIZE="-1.3648348845140565" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="172" O_E="0.0" SE="1.435592107102287" STUDY_ID="STD-Araco-2008" TOTAL_1="100" TOTAL_2="108" VAR="2.0609246979743845" WEIGHT="5.259474290255279"/>
<DICH_DATA CI_END="2.1518323940719277" CI_START="0.08563458176880455" EFFECT_SIZE="0.4292682926829268" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.33280844117444597" LOG_CI_START="-1.0673508189856173" LOG_EFFECT_SIZE="-0.3672711889055857" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="359" O_E="0.0" SE="0.8224604803181391" STUDY_ID="STD-Barber-2008" TOTAL_1="82" TOTAL_2="88" VAR="0.6764412416851441" WEIGHT="2.109916069381384"/>
<DICH_DATA CI_END="3.4191866283748737" CI_START="0.4294922503912101" EFFECT_SIZE="1.2118226600985222" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.53392280640096" LOG_CI_START="-0.3670446680206275" LOG_EFFECT_SIZE="0.08343906919016623" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="458" O_E="0.0" SE="0.5292327543361666" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" VAR="0.2800873082622452" WEIGHT="2.5370454200122494"/>
<DICH_DATA CI_END="1.5172886580956015" CI_START="0.16476759294687085" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.18106821143435867" LOG_CI_START="-0.7831282027623211" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="436" O_E="0.0" SE="0.5663737465483555" STUDY_ID="STD-Chen-2010" TOTAL_1="110" TOTAL_2="77" VAR="0.3207792207792208" WEIGHT="3.602295728212119"/>
<DICH_DATA CI_END="6.89634494312387" CI_START="0.14220239734970916" EFFECT_SIZE="0.9902912621359223" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8386189760110684" LOG_CI_START="-0.8470930818975777" LOG_EFFECT_SIZE="-0.004237052943254643" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="550" O_E="0.0" SE="0.9901956072248023" STUDY_ID="STD-Chen-2012" TOTAL_1="103" TOTAL_2="102" VAR="0.9804873405672949" WEIGHT="0.8791107763204767"/>
<DICH_DATA CI_END="1.8079283393519483" CI_START="0.3779894163408791" EFFECT_SIZE="0.8266666666666667" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.25718121239996594" LOG_CI_START="-0.4225203601868583" LOG_EFFECT_SIZE="-0.08266957389344617" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="541" O_E="0.0" SE="0.39926006831454813" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" VAR="0.15940860215053765" WEIGHT="4.302507778426653"/>
<DICH_DATA CI_END="1.6408179893039863" CI_START="0.07194820672958535" EFFECT_SIZE="0.3435897435897436" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="0.21506040882583088" LOG_CI_START="-1.142980026149214" LOG_EFFECT_SIZE="-0.46395980866169156" MODIFIED="2015-06-20 16:54:24 +0100" MODIFIED_BY="[Empty name]" ORDER="349" O_E="0.0" SE="0.7977196739129121" STUDY_ID="STD-Deffieux-2010" TOTAL_1="65" TOTAL_2="67" VAR="0.6363566781477228" WEIGHT="2.584764142645709"/>
<DICH_DATA CI_END="3.1283548031588975" CI_START="0.17308581288730523" EFFECT_SIZE="0.7358490566037735" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.49531600280076304" LOG_CI_START="-0.7617385279493428" LOG_EFFECT_SIZE="-0.13321126257428986" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="169" O_E="0.0" SE="0.7384000538828949" STUDY_ID="STD-Enzelsberger-2005" TOTAL_1="53" TOTAL_2="52" VAR="0.5452346395742621" WEIGHT="1.7663501774797927"/>
<DICH_DATA CI_END="3.1774298705978263" CI_START="0.2840345929744144" EFFECT_SIZE="0.95" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.5020759739708173" LOG_CI_START="-0.5466287633931218" LOG_EFFECT_SIZE="-0.022276394711152253" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="296" O_E="0.0" SE="0.6160143538997499" STUDY_ID="STD-Freeman-2011" TOTAL_1="100" TOTAL_2="95" VAR="0.37947368421052635" WEIGHT="2.243187816102785"/>
<DICH_DATA CI_END="4.57134053328148" CI_START="0.01211095988063836" EFFECT_SIZE="0.23529411764705882" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6600435744322882" LOG_CI_START="-1.916821434532911" LOG_EFFECT_SIZE="-0.6283889300503115" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="389" O_E="0.0" SE="1.5136632619536736" STUDY_ID="STD-Jakimiuk-2012" TOTAL_1="16" TOTAL_2="19" VAR="2.2911764705882356" WEIGHT="1.0048875149163152"/>
<DICH_DATA CI_END="2.043058286976178" CI_START="0.2688062625260292" EFFECT_SIZE="0.7410714285714286" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.3102807569168463" LOG_CI_START="-0.5705606175050617" LOG_EFFECT_SIZE="-0.1301399302941077" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="290" O_E="0.0" SE="0.5174105835705531" STUDY_ID="STD-Karateke-2009" TOTAL_1="84" TOTAL_2="83" VAR="0.2677137119908204" WEIGHT="3.520327322420466"/>
<DICH_DATA CI_END="2.845943261690503" CI_START="0.2248815036529706" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4542262374979651" LOG_CI_START="-0.6480462635140779" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="164" O_E="0.0" SE="0.6474803234313528" STUDY_ID="STD-Kim-2005" TOTAL_1="65" TOTAL_2="65" VAR="0.41923076923076924" WEIGHT="2.1871081207002154"/>
<DICH_DATA CI_END="22.624626441233197" CI_START="0.19055212641400174" EFFECT_SIZE="2.0763358778625953" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3545814172319184" LOG_CI_START="-0.7199862004750496" LOG_EFFECT_SIZE="0.3172976083784344" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="163" O_E="0.0" SE="1.2186112879164013" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="136" VAR="1.48501347103727" WEIGHT="0.4292302079576452"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="390" O_E="0.0" SE="0.0" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.8587060976514098" CI_START="0.02723668904081599" EFFECT_SIZE="0.225" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.26921072368312" LOG_CI_START="-1.5648456874603949" LOG_EFFECT_SIZE="-0.6478174818886375" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="171" O_E="0.0" SE="1.0773338146313556" STUDY_ID="STD-Mansoor-2003" TOTAL_1="48" TOTAL_2="54" VAR="1.160648148148148" WEIGHT="2.0584547018354966"/>
<DICH_DATA CI_END="1.5341943473678408" CI_START="0.22653427373109147" EFFECT_SIZE="0.5895316804407713" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="11" LOG_CI_END="0.18588037828517304" LOG_CI_START="-0.6448660816590165" LOG_EFFECT_SIZE="-0.2294928516869217" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.4879845828325154" STUDY_ID="STD-Meschia-2007" TOTAL_1="99" TOTAL_2="107" VAR="0.2381289530822241" WEIGHT="4.624778142606863"/>
<DICH_DATA CI_END="3.526070197838072" CI_START="0.12604526271681865" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5472909540864591" LOG_CI_START="-0.8994734721978215" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="0.8498365855987974" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" VAR="0.7222222222222221" WEIGHT="1.3122648724201291"/>
<DICH_DATA CI_END="1.8610819816465722" CI_START="0.1831632962877493" EFFECT_SIZE="0.5838509316770186" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2697655044539915" LOG_CI_START="-0.7371615493182936" LOG_EFFECT_SIZE="-0.23369802243215104" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="611" O_E="0.0" SE="0.5914739357551433" STUDY_ID="STD-Nyyssonen-2014" TOTAL_1="46" TOTAL_2="47" VAR="0.34984141667767943" WEIGHT="3.029027160711696"/>
<DICH_DATA CI_END="2.351694421308094" CI_START="0.15308111323398704" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3713808889340593" LOG_CI_START="-0.8150783881667721" LOG_EFFECT_SIZE="-0.2218487496163564" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="170" O_E="0.0" SE="0.6969320524371696" STUDY_ID="STD-Oliveira-2006" TOTAL_1="42" TOTAL_2="42" VAR="0.48571428571428565" WEIGHT="2.1871081207002154"/>
<DICH_DATA CI_END="2.2648160230731964" CI_START="0.282583659546688" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.35503292890546434" LOG_CI_START="-0.5488529549215772" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="959" O_E="0.0" SE="0.5309470424672897" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="0.28190476190476194" WEIGHT="3.167535898945139"/>
<DICH_DATA CI_END="1.818482466311365" CI_START="0.2714700569268548" EFFECT_SIZE="0.7026119402985075" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.25970911797201635" LOG_CI_START="-0.5662780659962643" LOG_EFFECT_SIZE="-0.153284474012124" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="166" O_E="0.0" SE="0.48518896056547045" STUDY_ID="STD-Rechberger-2009" TOTAL_1="268" TOTAL_2="269" VAR="0.23540832745460163" WEIGHT="4.3660705873196095"/>
<DICH_DATA CI_END="0.8392751691076674" CI_START="0.11558083313624365" EFFECT_SIZE="0.31145484949832775" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="16" LOG_CI_END="-0.07609562578364934" LOG_CI_START="-0.9371141793525115" LOG_EFFECT_SIZE="-0.5066049025680804" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="1003" O_E="0.0" SE="0.5057665604769283" STUDY_ID="STD-Richter-2010" TOTAL_1="299" TOTAL_2="298" VAR="0.25579981369666227" WEIGHT="7.010469178847457"/>
<DICH_DATA CI_END="8.157458228634331" CI_START="0.014036678934799663" EFFECT_SIZE="0.3383838383838384" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9115548586021058" LOG_CI_START="-1.852735633723515" LOG_EFFECT_SIZE="-0.47059038756070465" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="510" O_E="0.0" SE="1.6237579186506907" STUDY_ID="STD-Riva-2006" TOTAL_1="65" TOTAL_2="66" VAR="2.636589778380823" WEIGHT="0.651199109622019"/>
<DICH_DATA CI_END="3.8833056478900945" CI_START="0.11445002911010188" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5892015744162583" LOG_CI_START="-0.9413840925276209" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="370" O_E="0.0" SE="0.8990735972840785" STUDY_ID="STD-Scheiner-2012" TOTAL_1="80" TOTAL_2="80" VAR="0.8083333333333333" WEIGHT="1.3122648724201291"/>
<DICH_DATA CI_END="1.351457037635083" CI_START="0.13911853281300546" EFFECT_SIZE="0.43360433604336046" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="9" LOG_CI_END="0.1308022441785987" LOG_CI_START="-0.8566150111848698" LOG_EFFECT_SIZE="-0.3629063835031356" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="518" O_E="0.0" SE="0.5800137835947449" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="82" TOTAL_2="80" VAR="0.33641598915989157" WEIGHT="3.985397019942614"/>
<DICH_DATA CI_END="3.9397884469536053" CI_START="0.007738047103793055" EFFECT_SIZE="0.1746031746031746" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.5954729023363976" LOG_CI_START="-2.1113686309271107" LOG_EFFECT_SIZE="-0.7579478642953567" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="1.5900121157206721" STUDY_ID="STD-Tanuri-2010" TOTAL_1="20" TOTAL_2="10" VAR="2.5281385281385282" WEIGHT="0.8611738225257097"/>
<DICH_DATA CI_END="3.3750425810668063" CI_START="0.03853953187706581" EFFECT_SIZE="0.36065573770491804" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5282792564576188" LOG_CI_START="-1.4140935648347404" LOG_EFFECT_SIZE="-0.4429071541885608" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="341" O_E="0.0" SE="1.140959410127664" STUDY_ID="STD-Teo-2011" TOTAL_1="61" TOTAL_2="66" VAR="1.3017883755588673" WEIGHT="1.260600901065006"/>
<DICH_DATA CI_END="1.5817673058081199" CI_START="0.18606165958755855" EFFECT_SIZE="0.5425" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.199142594688548" LOG_CI_START="-0.7303431096474138" LOG_EFFECT_SIZE="-0.2656002574794329" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="609" O_E="0.0" SE="0.5459845037553848" STUDY_ID="STD-van-Leijsen-2013" TOTAL_1="80" TOTAL_2="31" VAR="0.2980990783410138" WEIGHT="3.1525882820904005"/>
<DICH_DATA CI_END="0.8490377850870668" CI_START="0.19728846989713816" EFFECT_SIZE="0.4092741935483871" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" LOG_CI_END="-0.07107298173524804" LOG_CI_START="-0.704898295418721" LOG_EFFECT_SIZE="-0.38798563857698454" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="165" O_E="0.0" SE="0.37231212674357544" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" VAR="0.13861631972032418" WEIGHT="7.232037519115379"/>
<DICH_DATA CI_END="3.788828032293272" CI_START="0.27968769558366013" EFFECT_SIZE="1.0294117647058822" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5785048939208184" LOG_CI_START="-0.5533266393047774" LOG_EFFECT_SIZE="0.012589127308020467" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="585" O_E="0.0" SE="0.6648434452731629" STUDY_ID="STD-Wang-2008" TOTAL_1="34" TOTAL_2="35" VAR="0.44201680672268906" WEIGHT="1.724328721247706"/>
<DICH_DATA CI_END="2.441494956990309" CI_START="0.2025337390369471" EFFECT_SIZE="0.7031963470319634" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3876558315676979" LOG_CI_START="-0.6935026195750085" LOG_EFFECT_SIZE="-0.1529233940036553" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="539" O_E="0.0" SE="0.6350778260218719" STUDY_ID="STD-Wang-2009" TOTAL_1="146" TOTAL_2="154" VAR="0.40332384510466696" WEIGHT="2.554542284977851"/>
<DICH_DATA CI_END="2.049587461589255" CI_START="0.2744454728288766" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.3116664555996478" LOG_CI_START="-0.5615439288162476" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="310" O_E="0.0" SE="0.5129281022670117" STUDY_ID="STD-Wang-2010" TOTAL_1="70" TOTAL_2="70" VAR="0.26309523809523805" WEIGHT="3.4993729931203443"/>
<DICH_DATA CI_END="2.7077359050655376" CI_START="0.03242247334190359" EFFECT_SIZE="0.2962962962962963" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4326063038218754" LOG_CI_START="-1.489153858155963" LOG_EFFECT_SIZE="-0.5282737771670437" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="477" O_E="0.0" SE="1.1288514320120056" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" VAR="1.2743055555555556" WEIGHT="1.3894569237389602"/>
<DICH_DATA CI_END="7.502975334214647" CI_START="0.013291126152980877" EFFECT_SIZE="0.3157894736842105" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8752335187236451" LOG_CI_START="-1.8764382198620155" LOG_EFFECT_SIZE="-0.5006023505691853" MODIFIED="2014-07-12 20:00:00 +0100" MODIFIED_BY="[Empty name]" ORDER="503" O_E="0.0" SE="1.6163456002399996" STUDY_ID="STD-Zullo-2007" TOTAL_1="37" TOTAL_2="35" VAR="2.6125730994152048" WEIGHT="0.6738657452968231"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="21.40852113672194" CI_END="1.1698662901589436" CI_START="0.8170974009857976" CI_STUDY="95" CI_TOTAL="95" DF="30" EFFECT_MEASURE="RR" EFFECT_SIZE="0.977698678115998" ESTIMABLE="YES" EVENTS_1="209" EVENTS_2="202" I2="0.0" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="0.06813622690467144" LOG_CI_START="-0.08772617089798318" LOG_EFFECT_SIZE="-0.009794971996655875" METHOD="MH" MODIFIED="2015-05-28 16:49:01 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.8746805251325345" P_Q="1.0" P_Z="0.8054168553429393" Q="0.0" RANDOM="NO" SCALE="2.34" SORT_BY="STUDY" STUDIES="31" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2460" TOTAL_2="2463" WEIGHT="100.00000000000003" Z="0.246342833341127">
<NAME>De novo urgency or urgency incontinence (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6544109936612967" CI_START="0.5787812382634154" EFFECT_SIZE="0.9785407725321889" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.21864340733658402" LOG_CI_START="-0.23748555538771443" LOG_EFFECT_SIZE="-0.009421074025565178" MODIFIED="2014-05-22 15:31:17 +0100" MODIFIED_BY="[Empty name]" ORDER="577" O_E="0.0" SE="0.26793241057903294" STUDY_ID="STD-Aigmuller-2014" TOTAL_1="233" TOTAL_2="247" VAR="0.07178777663869147" WEIGHT="12.258186105502771"/>
<DICH_DATA CI_END="3.9171690626317677" CI_START="0.39681556589376205" EFFECT_SIZE="1.2467532467532467" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5929723158377828" LOG_CI_START="-0.4014113001036097" LOG_EFFECT_SIZE="0.09578050786708653" MODIFIED="2008-03-23 01:13:47 +0000" MODIFIED_BY="[Empty name]" ORDER="466" O_E="0.0" SE="0.5841058582822584" STUDY_ID="STD-Andonian-2007" TOTAL_1="77" TOTAL_2="80" VAR="0.3411796536796537" WEIGHT="2.381766903265159"/>
<DICH_DATA CI_END="2.252940758544618" CI_START="0.29121937517071494" EFFECT_SIZE="0.81" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="8" LOG_CI_END="0.35274977202767743" LOG_CI_START="-0.5357797342703778" LOG_EFFECT_SIZE="-0.09151498112135022" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="160" O_E="0.0" SE="0.5219266302914686" STUDY_ID="STD-Araco-2008" TOTAL_1="100" TOTAL_2="108" VAR="0.2724074074074074" WEIGHT="3.7356383997265725"/>
<DICH_DATA CI_END="1.422148078948629" CI_START="0.5463633595519941" EFFECT_SIZE="0.8814814814814815" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="27" LOG_CI_END="0.15294481898311243" LOG_CI_START="-0.2625184331880631" LOG_EFFECT_SIZE="-0.054786807102475334" MODIFIED="2014-04-16 12:42:30 +0100" MODIFIED_BY="[Empty name]" ORDER="357" O_E="0.0" SE="0.2440451709016148" STUDY_ID="STD-Barber-2008" TOTAL_1="75" TOTAL_2="85" VAR="0.059558045440398374" WEIGHT="12.292585109100253"/>
<DICH_DATA CI_END="11.311833410000647" CI_START="0.019439122268596364" EFFECT_SIZE="0.4689265536723164" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="1.0535330006209465" LOG_CI_START="-1.7113233485924118" LOG_EFFECT_SIZE="-0.3288951739857327" MODIFIED="2008-03-22 19:17:31 +0000" MODIFIED_BY="[Empty name]" ORDER="460" O_E="0.0" SE="1.6240903057875844" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" VAR="2.637669321353209" WEIGHT="0.6053312646317495"/>
<DICH_DATA CI_END="2.0088501860531354" CI_START="0.18443903858424665" EFFECT_SIZE="0.6086956521739131" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3029475495922066" LOG_CI_START="-0.7341471502709164" LOG_EFFECT_SIZE="-0.21559980033935483" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="151" O_E="0.0" SE="0.609194560401158" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="42" VAR="0.3711180124223602" WEIGHT="3.0462433132315776"/>
<DICH_DATA CI_END="6.871520031696502" CI_START="0.1553917870940348" EFFECT_SIZE="1.0333333333333334" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.837052816878854" LOG_CI_START="-0.8085719386496334" LOG_EFFECT_SIZE="0.014240439114610285" MODIFIED="2014-03-27 11:05:43 +0000" MODIFIED_BY="[Empty name]" ORDER="540" O_E="0.0" SE="0.96664812737135" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" VAR="0.9344086021505377" WEIGHT="0.9553435907497464"/>
<DICH_DATA CI_END="134.3913798753068" CI_START="0.38514397956343904" EFFECT_SIZE="7.194444444444445" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1283714131177454" LOG_CI_START="-0.414376886489816" LOG_EFFECT_SIZE="0.8569972633139645" MODIFIED="2013-12-21 15:27:52 +0000" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="1.4936229379965618" STUDY_ID="STD-El_x002d_Hefnawy-2010" TOTAL_1="35" TOTAL_2="36" VAR="2.2309094809094807" WEIGHT="0.23949024261260765"/>
<DICH_DATA CI_END="3.4674961413408187" CI_START="0.23087380172568522" EFFECT_SIZE="0.8947368421052632" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5400159864590002" LOG_CI_START="-0.6366253456081102" LOG_EFFECT_SIZE="-0.04830467957455503" MODIFIED="2013-12-21 16:43:44 +0000" MODIFIED_BY="[Empty name]" ORDER="295" O_E="0.0" SE="0.6911649429247503" STUDY_ID="STD-Freeman-2011" TOTAL_1="95" TOTAL_2="85" VAR="0.4777089783281734" WEIGHT="2.0504504105165853"/>
<DICH_DATA CI_END="2.5598431406057496" CI_START="0.2583675738228835" EFFECT_SIZE="0.8132530120481928" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4082133538835272" LOG_CI_START="-0.5877619929736252" LOG_EFFECT_SIZE="-0.08977431954504898" MODIFIED="2013-12-21 16:56:16 +0000" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="0.5850408489013709" STUDY_ID="STD-Karateke-2009" TOTAL_1="83" TOTAL_2="81" VAR="0.3422727948832367" WEIGHT="2.9493320731499795"/>
<DICH_DATA CI_END="15.690631300346018" CI_START="0.06994655905973891" EFFECT_SIZE="1.0476190476190477" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1956404174391426" LOG_CI_START="-1.1552336452625687" LOG_EFFECT_SIZE="0.02020338608828699" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="153" O_E="0.0" SE="1.3809150614452748" STUDY_ID="STD-Kim-2005" TOTAL_1="21" TOTAL_2="22" VAR="1.906926406926407" WEIGHT="0.47433920145365316"/>
<DICH_DATA CI_END="4.521523165848436" CI_START="1.004832719061306" EFFECT_SIZE="2.131519274376417" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="9" LOG_CI_END="0.6552847602738342" LOG_CI_START="0.002093767989886056" LOG_EFFECT_SIZE="0.3286892641318601" MODIFIED="2013-12-10 21:09:59 +0000" MODIFIED_BY="[Empty name]" ORDER="273" O_E="0.0" SE="0.3836876222151497" STUDY_ID="STD-Krofta-2010" TOTAL_1="147" TOTAL_2="141" VAR="0.14721619144111542" WEIGHT="4.461753113673425"/>
<DICH_DATA CI_END="9.034237814179713" CI_START="0.2605901554401019" EFFECT_SIZE="1.534351145038168" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.955891518594933" LOG_CI_START="-0.5840419950654837" LOG_EFFECT_SIZE="0.1859247617647246" MODIFIED="2014-01-28 11:21:49 +0000" MODIFIED_BY="[Empty name]" ORDER="150" O_E="0.0" SE="0.9045645687179603" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="134" VAR="0.8182370589799095" WEIGHT="0.9602705199599023"/>
<DICH_DATA CI_END="163.58495412635662" CI_START="0.4951555626407661" EFFECT_SIZE="9.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.2137433565456317" LOG_CI_START="-0.3052583376669818" LOG_EFFECT_SIZE="0.9542425094393249" MODIFIED="2008-03-18 01:34:00 +0000" MODIFIED_BY="[Empty name]" ORDER="389" O_E="0.0" SE="1.479674064439977" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="2.189435336976321" WEIGHT="0.2428164959822272"/>
<DICH_DATA CI_END="3.9015666688886053" CI_START="0.42237889713840876" EFFECT_SIZE="1.283720930232558" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5912390324185555" LOG_CI_START="-0.3742977881193307" LOG_EFFECT_SIZE="0.10847062214961235" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="152" O_E="0.0" SE="0.5671611078682985" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="0.32167172227839574" WEIGHT="2.3463167027496112"/>
<DICH_DATA CI_END="2.9355196892544484" CI_START="0.10778542932558552" EFFECT_SIZE="0.5625" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.46768499764363747" LOG_CI_START="-0.9674399440768371" LOG_EFFECT_SIZE="-0.2498774732165999" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="159" O_E="0.0" SE="0.8429994947496399" STUDY_ID="STD-Mansoor-2003" TOTAL_1="48" TOTAL_2="54" VAR="0.7106481481481481" WEIGHT="1.8282653815132401"/>
<DICH_DATA CI_END="2.535174728230377" CI_START="0.03412198352568848" EFFECT_SIZE="0.29411764705882354" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4040078969597769" LOG_CI_START="-1.4669657310442872" LOG_EFFECT_SIZE="-0.5314789170422551" MODIFIED="2014-06-29 17:46:46 +0100" MODIFIED_BY="[Empty name]" ORDER="1205" O_E="0.0" SE="1.099019170558413" STUDY_ID="STD-Mehdiyev-2010" TOTAL_1="17" TOTAL_2="15" VAR="1.2078431372549019" WEIGHT="1.5479551618866985"/>
<DICH_DATA CI_END="2.4781656779413805" CI_START="0.2095001364988872" EFFECT_SIZE="0.7205387205387206" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3941303377989022" LOG_CI_START="-0.6788156897349451" LOG_EFFECT_SIZE="-0.1423426759680215" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="161" O_E="0.0" SE="0.6302538077418757" STUDY_ID="STD-Meschia-2007" TOTAL_1="99" TOTAL_2="107" VAR="0.39721986217313315" WEIGHT="2.8006407497755914"/>
<DICH_DATA CI_END="3.526070197838072" CI_START="0.12604526271681865" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5472909540864591" LOG_CI_START="-0.8994734721978215" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2013-12-21 19:04:08 +0000" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="0.8498365855987974" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" VAR="0.7222222222222221" WEIGHT="1.4568989758933633"/>
<DICH_DATA CI_END="2.634555781683098" CI_START="0.48039407963928166" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" LOG_CI_END="0.42070739836171755" LOG_CI_START="-0.31840235346695495" LOG_EFFECT_SIZE="0.05115252244738129" MODIFIED="2014-01-17 23:46:14 +0000" MODIFIED_BY="[Empty name]" ORDER="158" O_E="0.0" SE="0.43415672687643975" STUDY_ID="STD-Oliveira-2006" TOTAL_1="42" TOTAL_2="42" VAR="0.1884920634920635" WEIGHT="3.8850639357156354"/>
<DICH_DATA CI_END="2.660191911169226" CI_START="0.22740399633011876" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.4249129685691768" LOG_CI_START="-0.6432019074193129" LOG_EFFECT_SIZE="-0.10914446942506803" MODIFIED="2008-03-24 12:13:53 +0000" MODIFIED_BY="[Empty name]" ORDER="958" O_E="0.0" SE="0.6274159654095468" STUDY_ID="STD-Porena-2007" TOTAL_1="36" TOTAL_2="35" VAR="0.39365079365079364" WEIGHT="2.4623644662986424"/>
<DICH_DATA CI_END="1.2781973770091482" CI_START="0.2818148653141187" EFFECT_SIZE="0.6001791579575992" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="17" LOG_CI_END="0.10659792199706063" LOG_CI_START="-0.5500361022358167" LOG_EFFECT_SIZE="-0.22171909011937802" MODIFIED="2013-12-22 17:33:38 +0000" MODIFIED_BY="[Empty name]" ORDER="339" O_E="0.0" SE="0.3857100762252337" STUDY_ID="STD-Rechberger-2009" TOTAL_1="197" TOTAL_2="201" VAR="0.14877226290167556" WEIGHT="8.172788392406822"/>
<DICH_DATA CI_END="72.04898175315951" CI_START="0.12058554083162232" EFFECT_SIZE="2.9475524475524475" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.857627847438573" LOG_CI_START="-0.9187047644471742" LOG_EFFECT_SIZE="0.4694615414956993" MODIFIED="2013-12-21 17:53:28 +0000" MODIFIED_BY="[Empty name]" ORDER="1002" O_E="0.0" SE="1.630831519289762" STUDY_ID="STD-Richter-2010" TOTAL_1="285" TOTAL_2="280" VAR="2.659611444308953" WEIGHT="0.2449577349238694"/>
<DICH_DATA CI_END="1.1280591834532825" CI_START="0.38136795577163174" EFFECT_SIZE="0.6559006211180124" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="23" LOG_CI_END="0.05233188543891528" LOG_CI_START="-0.4186558011070278" LOG_EFFECT_SIZE="-0.18316195783405628" MODIFIED="2014-02-02 00:07:00 +0000" MODIFIED_BY="[Empty name]" ORDER="469" O_E="0.0" SE="0.27666049850373614" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="70" TOTAL_2="66" VAR="0.07654103143233577" WEIGHT="11.498075250923112"/>
<DICH_DATA CI_END="6.744347902546933" CI_START="0.03326885483134782" EFFECT_SIZE="0.47368421052631576" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="0.8289399649766078" LOG_CI_START="-1.477962148003616" LOG_EFFECT_SIZE="-0.3245110915135041" MODIFIED="2013-12-21 22:00:00 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="1.3550857205142117" STUDY_ID="STD-Tanuri-2010" TOTAL_1="19" TOTAL_2="9" VAR="1.8362573099415205" WEIGHT="0.6590733462374739"/>
<DICH_DATA CI_END="10.393497623653477" CI_START="0.7692543979839942" EFFECT_SIZE="2.8275862068965516" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="1.016761721092963" LOG_CI_START="-0.11393001212344164" LOG_EFFECT_SIZE="0.45141585448476057" MODIFIED="2013-12-22 21:25:20 +0000" MODIFIED_BY="[Empty name]" ORDER="157" O_E="0.0" SE="0.6641739211056629" STUDY_ID="STD-Teo-2011" TOTAL_1="29" TOTAL_2="41" VAR="0.4411269974768713" WEIGHT="1.2071448657402153"/>
<DICH_DATA CI_END="1.8989699290860576" CI_START="0.5308395050633212" EFFECT_SIZE="1.0040160642570282" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="9" LOG_CI_END="0.27851808757251384" LOG_CI_START="-0.2750367644199112" LOG_EFFECT_SIZE="0.00174066157630129" MODIFIED="2014-07-04 00:11:47 +0100" MODIFIED_BY="[Empty name]" ORDER="610" O_E="0.0" SE="0.3251608602010602" STUDY_ID="STD-van-Leijsen-2013" TOTAL_1="83" TOTAL_2="30" VAR="0.10572958500669344" WEIGHT="6.420669822963672"/>
<DICH_DATA CI_END="4.269071591426954" CI_START="0.20499306561131594" EFFECT_SIZE="0.9354838709677419" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6303334378915493" LOG_CI_START="-0.6882608297621826" LOG_EFFECT_SIZE="-0.028963695935316617" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="154" O_E="0.0" SE="0.7745487999666955" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" VAR="0.599925843529848" WEIGHT="1.5054622750898088"/>
<DICH_DATA CI_END="1.9266020333775131" CI_START="0.25666177752974706" EFFECT_SIZE="0.7031963470319634" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="9" LOG_CI_END="0.2847920143141903" LOG_CI_START="-0.5906388023215009" LOG_EFFECT_SIZE="-0.1529233940036553" MODIFIED="2014-03-26 15:10:09 +0000" MODIFIED_BY="[Empty name]" ORDER="540" O_E="0.0" SE="0.5142323951442365" STUDY_ID="STD-Wang-2009" TOTAL_1="146" TOTAL_2="154" VAR="0.2644349562157781" WEIGHT="4.254145009608621"/>
<DICH_DATA CI_END="34.89740413801905" CI_START="0.45848682431277926" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5427931229344514" LOG_CI_START="-0.33867314027852674" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2013-12-19 20:12:31 +0000" MODIFIED_BY="[Empty name]" ORDER="309" O_E="0.0" SE="1.105182596419511" STUDY_ID="STD-Wang-2010" TOTAL_1="70" TOTAL_2="70" VAR="1.2214285714285715" WEIGHT="0.4856329919644544"/>
<DICH_DATA CI_END="3.1633656803701573" CI_START="0.3596731749472106" EFFECT_SIZE="1.0666666666666667" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5001493986141973" LOG_CI_START="-0.4440919514137102" LOG_EFFECT_SIZE="0.028028723600243534" MODIFIED="2014-02-02 01:07:27 +0000" MODIFIED_BY="[Empty name]" ORDER="479" O_E="0.0" SE="0.5546520430764579" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" VAR="0.3076388888888889" WEIGHT="2.570998192752994"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9374589301154135" CI_END="1.7259707492919103" CI_START="0.5548920273083673" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.978635482776672" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="0.2370334312814159" LOG_CI_START="-0.25579151508645853" LOG_EFFECT_SIZE="-0.009379041902521302" METHOD="MH" MODIFIED="2015-05-28 16:49:09 +0100" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.5854885321458674" P_Q="1.0" P_Z="0.940532283638447" Q="0.0" RANDOM="NO" SCALE="29.16" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="240" TOTAL_2="241" WEIGHT="99.99999999999999" Z="0.0746008678087976">
<NAME>De novo urgency or urgency incontinence (medium term, 1 to 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.0598177609136137" CI_START="0.5632001278609605" EFFECT_SIZE="1.3127413127413128" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.4856955611918867" LOG_CI_START="-0.2493372552698801" LOG_EFFECT_SIZE="0.11817915296100331" MODIFIED="2013-12-21 16:10:42 +0000" MODIFIED_BY="[Empty name]" ORDER="151" O_E="0.0" SE="0.4317619148607638" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="37" TOTAL_2="34" VAR="0.18641835112423347" WEIGHT="34.54487411463211"/>
<DICH_DATA CI_END="2.4347360219431606" CI_START="0.33991139661392766" EFFECT_SIZE="0.9097222222222222" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.3864518811859054" LOG_CI_START="-0.46863427406487623" LOG_EFFECT_SIZE="-0.0410911964394854" MODIFIED="2014-03-27 23:19:06 +0000" MODIFIED_BY="[Empty name]" ORDER="457" O_E="0.0" SE="0.5022818403390424" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="126" TOTAL_2="131" VAR="0.25228704713437533" WEIGHT="37.1423696443368"/>
<DICH_DATA CI_END="2.0014177072863752" CI_START="0.08345690931871033" EFFECT_SIZE="0.40869565217391307" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.3013377378304981" LOG_CI_START="-1.0785377026662863" LOG_EFFECT_SIZE="-0.3885999824178942" MODIFIED="2014-06-30 20:05:49 +0100" MODIFIED_BY="[Empty name]" ORDER="612" O_E="0.0" SE="0.8105456642414025" STUDY_ID="STD-Nyyssonen-2014" TOTAL_1="46" TOTAL_2="47" VAR="0.6569842738205365" WEIGHT="23.42001055722765"/>
<DICH_DATA CI_END="19.54855216614242" CI_START="0.17906800777941861" EFFECT_SIZE="1.8709677419354838" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2911145975610654" LOG_CI_START="-0.7469819981037364" LOG_EFFECT_SIZE="0.2720662997286646" MODIFIED="2014-02-02 02:14:17 +0000" MODIFIED_BY="[Empty name]" ORDER="497" O_E="0.0" SE="1.1971880290343624" STUDY_ID="STD-Zullo-2007" TOTAL_1="31" TOTAL_2="29" VAR="1.4332591768631813" WEIGHT="4.892745683803429"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-05-28 16:49:14 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="7.47" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="122" TOTAL_2="131" WEIGHT="0.0" Z="0.0">
<NAME>De novo urgency or urgency incontinence (long term, &gt; 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.5253858376518825" CI_START="0.1839665234436916" EFFECT_SIZE="0.805327868852459" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5472066555098435" LOG_CI_START="-0.7352611987644114" LOG_EFFECT_SIZE="-0.09402727162728393" MODIFIED="2014-05-09 21:32:16 +0100" MODIFIED_BY="[Empty name]" ORDER="457" O_E="0.0" SE="0.7533279659189603" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="122" TOTAL_2="131" VAR="0.5675030242355983" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.6465415506167219" CI_END="1.7321733264557193" CI_START="0.5817851873041588" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0038689073655527" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.23859134666346057" LOG_CI_START="-0.2352373404178711" LOG_EFFECT_SIZE="0.0016770031227947423" METHOD="MH" MODIFIED="2015-05-28 16:49:20 +0100" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.8856998849584119" P_Q="1.0" P_Z="0.9889307871916139" Q="0.0" RANDOM="NO" SCALE="18.61" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="279" TOTAL_2="287" WEIGHT="100.0" Z="0.01387364594948939">
<NAME>Detrusor overactivity</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.495559835991457" CI_START="0.2763818084798556" EFFECT_SIZE="1.62" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9775205748144185" LOG_CI_START="-0.5584905457291566" LOG_EFFECT_SIZE="0.20951501454263097" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="0.9022605355849683" STUDY_ID="STD-Araco-2008" TOTAL_1="100" TOTAL_2="108" VAR="0.814074074074074" WEIGHT="8.367677695081472"/>
<DICH_DATA CI_END="3.620967870649439" CI_START="0.3828183692387531" EFFECT_SIZE="1.1773584905660377" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5588246712788836" LOG_CI_START="-0.4170072311156138" LOG_EFFECT_SIZE="0.07090872008163493" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.5732084899123491" STUDY_ID="STD-Enzelsberger-2005" TOTAL_1="53" TOTAL_2="52" VAR="0.3285679729075956" WEIGHT="21.963161645375745"/>
<DICH_DATA CI_END="1.776544157337607" CI_START="0.3722848423855822" EFFECT_SIZE="0.8132530120481928" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="12" LOG_CI_END="0.24957600667461405" LOG_CI_START="-0.42912464576471204" LOG_EFFECT_SIZE="-0.08977431954504898" MODIFIED="2013-12-21 16:56:32 +0000" MODIFIED_BY="[Empty name]" ORDER="289" O_E="0.0" SE="0.398672122865273" STUDY_ID="STD-Karateke-2009" TOTAL_1="83" TOTAL_2="81" VAR="0.15893946154990332" WEIGHT="52.85106868093409"/>
<DICH_DATA CI_END="4.012909796137409" CI_START="0.2851801903860929" EFFECT_SIZE="1.069767441860465" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6034593975907879" LOG_CI_START="-0.5448806453868129" LOG_EFFECT_SIZE="0.029289376101987508" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.6745406256199319" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="0.45500505561172905" WEIGHT="16.81809197860869"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="18.77006620824101" CI_END="1.51146779639215" CI_START="0.6982990025644095" CI_STUDY="95" CI_TOTAL="95" DF="23" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0273541038166267" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="47" I2="0.0" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="0.17939889845516693" LOG_CI_START="-0.15595857829563306" LOG_EFFECT_SIZE="0.011720160079766955" METHOD="MH" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.7144867845963783" P_Q="1.0" P_Z="0.8910350165391373" Q="0.0" RANDOM="NO" SCALE="15.39" SORT_BY="STUDY" STUDIES="30" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2270" TOTAL_2="2298" WEIGHT="99.99999999999996" Z="0.13699465938227376">
<NAME>Vaginal tape erosion</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.584304769707433" CI_START="0.014650137947370117" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.87991577648491" LOG_CI_START="-1.8341582859242351" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="430" O_E="0.0" SE="1.5942605391424158" STUDY_ID="STD-Alkady-2009" TOTAL_1="15" TOTAL_2="15" VAR="2.5416666666666665" WEIGHT="3.020026302358378"/>
<DICH_DATA CI_END="106.43983710357865" CI_START="0.25328918105504317" EFFECT_SIZE="5.1923076923076925" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0271042012319342" LOG_CI_START="-0.5963833601835581" LOG_EFFECT_SIZE="0.7153604205241881" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="462" O_E="0.0" SE="1.5410495800483324" STUDY_ID="STD-Andonian-2007" TOTAL_1="77" TOTAL_2="80" VAR="2.3748338081671414" WEIGHT="0.9876815580039978"/>
<DICH_DATA CI_END="30.64103784250607" CI_START="0.34259936148237935" EFFECT_SIZE="3.24" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4863034711968608" LOG_CI_START="-0.46521345078363635" LOG_EFFECT_SIZE="0.5105450102066121" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="248" O_E="0.0" SE="1.1463307001359049" STUDY_ID="STD-Araco-2008" TOTAL_1="100" TOTAL_2="108" VAR="1.314074074074074" WEIGHT="1.9359142963835756"/>
<DICH_DATA CI_END="1.8968354163208718" CI_START="0.027086049393484447" EFFECT_SIZE="0.22666666666666666" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.2780296498741441" LOG_CI_START="-1.5672543339009963" LOG_EFFECT_SIZE="-0.6446123420134261" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="360" O_E="0.0" SE="1.0839289463725534" STUDY_ID="STD-Barber-2008" TOTAL_1="75" TOTAL_2="85" VAR="1.1749019607843136" WEIGHT="9.43758219486993"/>
<DICH_DATA CI_END="39.76305121846139" CI_START="0.4524124256809799" EFFECT_SIZE="4.241379310344827" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.599479702598961" LOG_CI_START="-0.34446547551807744" LOG_EFFECT_SIZE="0.6275071135404419" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="459" O_E="0.0" SE="1.1418830203097727" STUDY_ID="STD-Barry-2008" TOTAL_1="58" TOTAL_2="82" VAR="1.303896832071769" WEIGHT="1.6682050051122468"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="240" O_E="0.0" SE="0.0" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="542" O_E="0.0" SE="0.0" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="74.5227731003321" CI_START="0.12819865137603004" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8722890072516347" LOG_CI_START="-0.8921165434835745" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="350" O_E="0.0" SE="1.6238255045300312" STUDY_ID="STD-Deffieux-2010" TOTAL_1="65" TOTAL_2="67" VAR="2.6368092691622103" WEIGHT="0.9916504276400643"/>
<DICH_DATA CI_END="6.878874912437529" CI_START="0.15490276030924435" EFFECT_SIZE="1.032258064516129" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8375174121778957" LOG_CI_START="-0.8099408432066292" LOG_EFFECT_SIZE="0.013788284485633285" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="1200" O_E="0.0" SE="0.967725134262757" STUDY_ID="STD-Diab-2012" TOTAL_1="31" TOTAL_2="32" VAR="0.936491935483871" WEIGHT="3.9627858358988237"/>
<DICH_DATA CI_END="15.275220658716089" CI_START="0.06301841204304488" EFFECT_SIZE="0.9811320754716981" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1839874925755158" LOG_CI_START="-1.2005325445074957" LOG_EFFECT_SIZE="-0.008272525965989885" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="243" O_E="0.0" SE="1.4006788733471098" STUDY_ID="STD-Enzelsberger-2005" TOTAL_1="53" TOTAL_2="52" VAR="1.961901306240929" WEIGHT="2.0325256384126225"/>
<DICH_DATA CI_END="7.84080599794734" CI_START="0.22972721654733888" EFFECT_SIZE="1.3421052631578947" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8943607084075358" LOG_CI_START="-0.6387875494452833" LOG_EFFECT_SIZE="0.1277865794811262" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="294" O_E="0.0" SE="0.9005788758690194" STUDY_ID="STD-Freeman-2011" TOTAL_1="95" TOTAL_2="85" VAR="0.8110423116615066" WEIGHT="4.250407388504383"/>
<DICH_DATA CI_END="2.5909070579133058" CI_START="0.09189714677365776" EFFECT_SIZE="0.4879518072289157" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4134518340744545" LOG_CI_START="-1.0366979723972651" LOG_EFFECT_SIZE="-0.3116230691614053" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="291" O_E="0.0" SE="0.8518251746788011" STUDY_ID="STD-Karateke-2009" TOTAL_1="83" TOTAL_2="81" VAR="0.72560612821657" WEIGHT="8.151615710430743"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="522" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2005" TOTAL_1="65" TOTAL_2="65" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.716900980767968" CI_START="0.13697288706272373" EFFECT_SIZE="0.9591836734693877" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8271689460621218" LOG_CI_START="-0.8633653902477142" LOG_EFFECT_SIZE="-0.01809822209279622" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="277" O_E="0.0" SE="0.9930282374283242" STUDY_ID="STD-Krofta-2010" TOTAL_1="147" TOTAL_2="141" VAR="0.9861050803300043" WEIGHT="4.110591355987792"/>
<DICH_DATA CI_END="71.92874965831938" CI_START="0.12149723685251115" EFFECT_SIZE="2.9562043795620436" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8569025109999102" LOG_CI_START="-0.9154335988833867" LOG_EFFECT_SIZE="0.47073445605826175" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="239" O_E="0.0" SE="1.6284839542305187" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="136" TOTAL_2="134" VAR="2.6519599891862664" WEIGHT="1.0140774593703377"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="386" O_E="0.0" SE="0.0" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.511653968434665" CI_START="0.014894773173158193" EFFECT_SIZE="0.3560606060606061" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9300139595639816" LOG_CI_START="-1.8269661061042464" LOG_EFFECT_SIZE="-0.4484760732701324" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="241" O_E="0.0" SE="1.6194637378449426" STUDY_ID="STD-Liapis-2006" TOTAL_1="43" TOTAL_2="46" VAR="2.6226627981947126" WEIGHT="2.9204649956872224"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="0.0" STUDY_ID="STD-Nerli-2009" TOTAL_1="18" TOTAL_2="18" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="101.18091723147054" CI_START="0.24708216414768958" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0050986120834273" LOG_CI_START="-0.6071586034113897" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="613" O_E="0.0" SE="1.5344528192634188" STUDY_ID="STD-Nyyssonen-2014" TOTAL_1="43" TOTAL_2="43" VAR="2.354545454545454" WEIGHT="1.0066754341194593"/>
<DICH_DATA CI_END="5.306321714020261" CI_START="0.047113615320280106" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.724793577042504" LOG_CI_START="-1.3268535683704665" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="247" O_E="0.0" SE="1.2051476890327395" STUDY_ID="STD-Oliveira-2006" TOTAL_1="42" TOTAL_2="42" VAR="1.4523809523809526" WEIGHT="4.026701736477837"/>
<DICH_DATA CI_END="124.37887176855166" CI_START="0.34382620985708895" EFFECT_SIZE="6.5394736842105265" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.0947466130425902" LOG_CI_START="-0.4636610201375087" LOG_EFFECT_SIZE="0.8155427964525408" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="955" O_E="0.0" SE="1.5028213080520219" STUDY_ID="STD-Porena-2007" TOTAL_1="75" TOTAL_2="70" VAR="2.25847188393519" WEIGHT="1.0409160951439307"/>
<DICH_DATA CI_END="4.679831084665898" CI_START="0.34757578376132203" EFFECT_SIZE="1.2753807106598984" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6702301777917704" LOG_CI_START="-0.45895048925786575" LOG_EFFECT_SIZE="0.10563984426695235" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="242" O_E="0.0" SE="0.663286313359405" STUDY_ID="STD-Rechberger-2009" TOTAL_1="197" TOTAL_2="201" VAR="0.43994873348991087" WEIGHT="7.97246474458426"/>
<DICH_DATA CI_END="0.8887493557592698" CI_START="0.043441722301493776" EFFECT_SIZE="0.19649122807017544" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" LOG_CI_END="-0.051220701075449335" LOG_CI_START="-1.3620929649291702" LOG_EFFECT_SIZE="-0.7066568330023097" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="1004" O_E="0.0" SE="0.7700128567100337" STUDY_ID="STD-Richter-2010" TOTAL_1="285" TOTAL_2="280" VAR="0.5929197994987468" WEIGHT="20.31168132559617"/>
<DICH_DATA CI_END="21.852412198345903" CI_START="0.18872166748489294" EFFECT_SIZE="2.0307692307692307" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3394993839429794" LOG_CI_START="-0.7241782348169907" LOG_EFFECT_SIZE="0.3076605745629943" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="508" O_E="0.0" SE="1.2122144486285706" STUDY_ID="STD-Riva-2006" TOTAL_1="65" TOTAL_2="66" VAR="1.4694638694638695" WEIGHT="1.9979817776416748"/>
<DICH_DATA CI_END="31.922902355600147" CI_START="0.420075766969912" EFFECT_SIZE="3.6619718309859155" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5041023695120288" LOG_CI_START="-0.37667237100854334" LOG_EFFECT_SIZE="0.5637149992517427" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="371" O_E="0.0" SE="1.1047763925668992" STUDY_ID="STD-Scheiner-2012" TOTAL_1="71" TOTAL_2="65" VAR="1.2205308775731312" WEIGHT="2.102175171249459"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="0.0" STUDY_ID="STD-Tanuri-2010" TOTAL_1="19" TOTAL_2="9" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.307279328819186" CI_START="0.051561574585408984" EFFECT_SIZE="0.47126436781609193" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.6342030368499443" LOG_CI_START="-1.2876738286477103" LOG_EFFECT_SIZE="-0.32673539589888306" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="246" O_E="0.0" SE="1.1289199842372375" STUDY_ID="STD-Teo-2011" TOTAL_1="29" TOTAL_2="41" VAR="1.2744603308102045" WEIGHT="5.00461501533674"/>
<DICH_DATA CI_END="5.142577972053889" CI_START="0.21634897645190448" EFFECT_SIZE="1.0547945205479452" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.7111808852138264" LOG_CI_START="-0.6648451551097744" LOG_EFFECT_SIZE="0.02316786505202597" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="541" O_E="0.0" SE="0.8082845075248362" STUDY_ID="STD-Wang-2009" TOTAL_1="146" TOTAL_2="154" VAR="0.653323845104667" WEIGHT="5.878984535257642"/>
<DICH_DATA CI_END="21.555513291946433" CI_START="0.1855673741480552" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3335583689763033" LOG_CI_START="-0.7314983776483408" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="1.2130245551630732" STUDY_ID="STD-Wang-2010" TOTAL_1="70" TOTAL_2="70" VAR="1.4714285714285715" WEIGHT="2.0133508682389185"/>
<DICH_DATA CI_END="4.887138041535607" CI_START="0.04476700194485466" EFFECT_SIZE="0.46774193548387094" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6890546062331032" LOG_CI_START="-1.3490419894316987" LOG_EFFECT_SIZE="-0.3299936915992978" MODIFIED="2014-07-12 20:00:18 +0100" MODIFIED_BY="[Empty name]" ORDER="504" O_E="0.0" SE="1.1971880290343624" STUDY_ID="STD-Zullo-2007" TOTAL_1="31" TOTAL_2="29" VAR="1.4332591768631813" WEIGHT="4.1609251276937655"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="8.128711794201093" CI_START="0.01456506186870345" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.34408602150537637" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="0.9100217257910883" LOG_CI_START="-1.8366876662591465" LOG_EFFECT_SIZE="-0.4633329702340291" METHOD="MH" MODIFIED="2015-05-28 16:49:32 +0100" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="1.0" P_Q="1.0" P_Z="0.5084589421343428" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="180" TOTAL_2="194" WEIGHT="100.0" Z="0.6612391810629943">
<NAME>Bladder/urethral erosion</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="249" O_E="0.0" SE="0.0" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="8.128711794201093" CI_START="0.01456506186870345" EFFECT_SIZE="0.34408602150537637" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9100217257910883" LOG_CI_START="-1.8366876662591465" LOG_EFFECT_SIZE="-0.4633329702340291" MODIFIED="2014-03-28 00:02:56 +0000" MODIFIED_BY="[Empty name]" ORDER="543" O_E="0.0" SE="1.613430693321079" STUDY_ID="STD-de-Tayrac-2004" TOTAL_1="30" TOTAL_2="31" VAR="2.6031586021505375" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-03-31 04:46:06 +0100" MODIFIED_BY="[Empty name]" ORDER="523" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2005" TOTAL_1="65" TOTAL_2="65" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="251" O_E="0.0" SE="0.0" STUDY_ID="STD-Teo-2011" TOTAL_1="39" TOTAL_2="52" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.185420993200404" CI_END="7.0810695337498295" CI_START="2.7965729532823174" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="4.450025566038492" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.24" LOG_CI_END="0.8500988590351386" LOG_CI_START="0.4466261531098915" LOG_EFFECT_SIZE="0.648362506072515" METHOD="MH" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="0.6591552278391131" P_Q="1.0" P_Z="2.992859689381075E-10" Q="0.0" RANDOM="NO" SCALE="23.88" SORT_BY="STUDY" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1538" TOTAL_2="1512" WEIGHT="100.00000000000001" Z="6.299148081970635">
<NAME>Groin pain</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="132.53978018014303" CI_START="0.36262488565932255" EFFECT_SIZE="6.9326923076923075" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1223462459696547" LOG_CI_START="-0.4405423951283573" LOG_EFFECT_SIZE="0.8409019254206487" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="551" O_E="0.0" SE="1.505453474284351" STUDY_ID="STD-Chen-2012" TOTAL_1="103" TOTAL_2="102" VAR="2.2663901632348233" WEIGHT="2.3743548057394883"/>
<DICH_DATA CI_END="74.5227731003321" CI_START="0.12819865137603004" EFFECT_SIZE="3.090909090909091" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8722890072516347" LOG_CI_START="-0.8921165434835745" LOG_EFFECT_SIZE="0.49008623188403005" MODIFIED="2015-04-11 15:55:11 +0100" MODIFIED_BY="[Empty name]" ORDER="351" O_E="0.0" SE="1.6238255045300312" STUDY_ID="STD-Deffieux-2010" TOTAL_1="65" TOTAL_2="67" VAR="2.6368092691622103" WEIGHT="2.3276718826071248"/>
<DICH_DATA CI_END="190.44254743028458" CI_START="0.6120481756320255" EFFECT_SIZE="10.796296296296296" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.2797639821257047" LOG_CI_START="-0.21321439225361327" LOG_EFFECT_SIZE="1.0332747949360455" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="234" O_E="0.0" SE="1.4643878375523887" STUDY_ID="STD-Enzelsberger-2005" TOTAL_1="53" TOTAL_2="52" VAR="2.144431738771361" WEIGHT="2.3850231864266713"/>
<DICH_DATA CI_END="56.05722948313581" CI_START="0.9139848247249805" EFFECT_SIZE="7.157894736842105" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="1" LOG_CI_END="1.7486316298152944" LOG_CI_START="-0.039061014980517325" LOG_EFFECT_SIZE="0.8547853074173886" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="297" O_E="0.0" SE="1.05009950877437" STUDY_ID="STD-Freeman-2011" TOTAL_1="95" TOTAL_2="85" VAR="1.1027089783281734" WEIGHT="4.988428125519983"/>
<DICH_DATA CI_END="279.97122712551214" CI_START="0.9502496097100543" EFFECT_SIZE="16.31081081081081" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="0" LOG_CI_END="2.4471134008325635" LOG_CI_START="-0.02216230009981736" LOG_EFFECT_SIZE="1.2124755503663731" MODIFIED="2015-04-11 15:55:19 +0100" MODIFIED_BY="[Empty name]" ORDER="278" O_E="0.0" SE="1.4504647698395319" STUDY_ID="STD-Krofta-2010" TOTAL_1="147" TOTAL_2="141" VAR="2.103848048545646" WEIGHT="2.4118280447160134"/>
<DICH_DATA CI_END="72.97482251883257" CI_START="0.12333020745171913" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8631730474190737" LOG_CI_START="-0.9089305379797485" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2015-06-20 19:33:16 +0100" MODIFIED_BY="[Empty name]" ORDER="232" O_E="0.0" SE="1.6283473681973237" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="131" VAR="2.651515151515151" WEIGHT="2.3629396384042023"/>
<DICH_DATA CI_END="4.611278541353421" CI_START="0.5551605649153942" EFFECT_SIZE="1.6" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.663821356294266" LOG_CI_START="-0.25558139098241633" LOG_EFFECT_SIZE="0.2041199826559248" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="383" O_E="0.0" SE="0.5400617248673217" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="0.2916666666666667" WEIGHT="23.629396384042025"/>
<DICH_DATA CI_END="222.32701049976947" CI_START="0.7219816213601723" EFFECT_SIZE="12.669491525423728" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="0" LOG_CI_END="2.3469922283238436" LOG_CI_START="-0.14147385761519762" LOG_EFFECT_SIZE="1.102759185354323" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="965" O_E="0.0" SE="1.461737296986382" STUDY_ID="STD-Meschia-2007" TOTAL_1="117" TOTAL_2="114" VAR="2.1366759254010543" WEIGHT="2.3933637539201364"/>
<DICH_DATA CI_END="54.43914552732532" CI_START="0.900087602870343" EFFECT_SIZE="7.0" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="1" LOG_CI_END="1.7359112999317405" LOG_CI_START="-0.0457152199032269" LOG_EFFECT_SIZE="0.8450980400142568" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="237" O_E="0.0" SE="1.0465362369445672" STUDY_ID="STD-Oliveira-2006" TOTAL_1="42" TOTAL_2="42" VAR="1.0952380952380953" WEIGHT="4.725879276808405"/>
<DICH_DATA CI_END="3.8900131310919193" CI_START="0.11027898423596863" EFFECT_SIZE="0.6549707602339181" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5899510673285706" LOG_CI_START="-0.9575072427725151" LOG_EFFECT_SIZE="-0.18377808772197224" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="1005" O_E="0.0" SE="0.9089846713955523" STUDY_ID="STD-Richter-2010" TOTAL_1="285" TOTAL_2="280" VAR="0.8262531328320801" WEIGHT="14.3031036519334"/>
<DICH_DATA CI_END="103.72602480376645" CI_START="0.2483785049759752" EFFECT_SIZE="5.075757575757576" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0158877343125043" LOG_CI_START="-0.604885991322551" LOG_EFFECT_SIZE="0.7055008714949766" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="509" O_E="0.0" SE="1.5394554594771999" STUDY_ID="STD-Riva-2006" TOTAL_1="65" TOTAL_2="66" VAR="2.3699231117141566" WEIGHT="2.345173174957554"/>
<DICH_DATA CI_END="28.247034496021477" CI_START="0.31861751722176823" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.450972860310625" LOG_CI_START="-0.4967303508712998" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="468" O_E="0.0" SE="1.1440905075346506" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="82" TOTAL_2="82" VAR="1.3089430894308942" WEIGHT="4.725879276808405"/>
<DICH_DATA CI_END="33.60762673786949" CI_START="0.06694908919184915" EFFECT_SIZE="1.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.5264378450776686" LOG_CI_START="-1.1742553269663063" LOG_EFFECT_SIZE="0.17609125905568124" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="1.5864005379054391" STUDY_ID="STD-Tanuri-2010" TOTAL_1="19" TOTAL_2="9" VAR="2.5166666666666666" WEIGHT="3.1505861845389362"/>
<DICH_DATA CI_END="111.77694056702701" CI_START="2.052731061398589" EFFECT_SIZE="15.147540983606557" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="1" LOG_CI_END="2.0483522184214005" LOG_CI_START="0.3123320539972788" LOG_EFFECT_SIZE="1.1803421362093396" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="1.0197468380211363" STUDY_ID="STD-Teo-2011" TOTAL_1="61" TOTAL_2="66" VAR="1.0398836136541054" WEIGHT="4.539821037563979"/>
<DICH_DATA CI_END="150.1535231707872" CI_START="0.47412411475037863" EFFECT_SIZE="8.4375" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1765355268492232" LOG_CI_START="-0.32410795517106095" LOG_EFFECT_SIZE="0.9262137858390813" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="233" O_E="0.0" SE="1.4688903597235872" STUDY_ID="STD-Wang-2006" TOTAL_1="31" TOTAL_2="29" VAR="2.157638888888889" WEIGHT="2.439163497707564"/>
<DICH_DATA CI_END="9.58946300016563" CI_START="1.0442006319883372" EFFECT_SIZE="3.164383561643836" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="4" LOG_CI_END="0.9817942878177277" LOG_CI_START="0.01878395172564913" LOG_EFFECT_SIZE="0.5002891197716884" MODIFIED="2014-07-12 20:00:24 +0100" MODIFIED_BY="[Empty name]" ORDER="543" O_E="0.0" SE="0.5656770383985316" STUDY_ID="STD-Wang-2009" TOTAL_1="146" TOTAL_2="154" VAR="0.3199905117713337" WEIGHT="18.399423317707388"/>
<DICH_DATA CI_END="170.75925751482026" CI_START="0.5636708086363544" EFFECT_SIZE="9.81081081081081" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="2.232384257762751" LOG_CI_START="-0.2489744558245159" LOG_EFFECT_SIZE="0.9917049009691176" MODIFIED="2015-04-11 16:00:44 +0100" MODIFIED_BY="[Empty name]" ORDER="478" O_E="0.0" SE="1.4575623912848892" STUDY_ID="STD-Wang-2011" TOTAL_1="36" TOTAL_2="32" VAR="2.124488124488124" WEIGHT="2.497964760598728"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.9790261720929005" CI_END="0.7816939372972358" CI_START="0.10803547864255408" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2906039894218411" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="16" I2="24.6046678194617" I2_Q="0.0" ID="CMP-001.25" LOG_CI_END="-0.1069632563537001" LOG_CI_START="-0.966433599620443" LOG_EFFECT_SIZE="-0.5366984279870715" METHOD="MH" MODIFIED="2015-06-09 11:10:49 +0100" MODIFIED_BY="[Empty name]" NO="25" P_CHI2="0.26373792306616606" P_Q="1.0" P_Z="0.014372785323625552" Q="0.0" RANDOM="NO" SCALE="477.73" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="557" TOTAL_2="548" WEIGHT="100.0" Z="2.4478089271021104">
<NAME>Suprapubic pain</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.546891280304013" CI_START="0.04788651667255857" EFFECT_SIZE="0.5153846153846153" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7440496537413267" LOG_CI_START="-1.3197867529533474" LOG_EFFECT_SIZE="-0.2878685496060104" MODIFIED="2015-04-11 17:40:59 +0100" MODIFIED_BY="[Empty name]" ORDER="351" O_E="0.0" SE="1.2123077214474287" STUDY_ID="STD-Deffieux-2010" TOTAL_1="65" TOTAL_2="67" VAR="1.4696900114810563" WEIGHT="11.49803396331544"/>
<DICH_DATA CI_END="1.298068167197262" CI_START="0.004196324393530105" EFFECT_SIZE="0.07380457380457381" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="0.11329749975269407" LOG_CI_START="-2.377130946390169" LOG_EFFECT_SIZE="-1.1319167233187377" MODIFIED="2015-04-11 17:41:57 +0100" MODIFIED_BY="[Empty name]" ORDER="278" O_E="0.0" SE="1.4628899970839468" STUDY_ID="STD-Krofta-2010" TOTAL_1="147" TOTAL_2="141" VAR="2.14004714356827" WEIGHT="38.72855025988456"/>
<DICH_DATA CI_END="1.6085426237362968" CI_START="0.005137857516464679" EFFECT_SIZE="0.09090909090909091" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.20643257348058153" LOG_CI_START="-2.289217943797032" LOG_EFFECT_SIZE="-1.041392685158225" MODIFIED="2015-04-11 17:42:25 +0100" MODIFIED_BY="[Empty name]" ORDER="383" O_E="0.0" SE="1.465957467518168" STUDY_ID="STD-Lee-2007" TOTAL_1="60" TOTAL_2="60" VAR="2.1490312965722804" WEIGHT="32.106048682180806"/>
<DICH_DATA CI_END="4.82631761167554" CI_START="0.19999099631945882" EFFECT_SIZE="0.9824561403508771" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.683615898687412" LOG_CI_START="-0.6989895560199941" LOG_EFFECT_SIZE="-0.0076868286662910065" MODIFIED="2015-04-11 17:43:11 +0100" MODIFIED_BY="[Empty name]" ORDER="1005" O_E="0.0" SE="0.8121492881025099" STUDY_ID="STD-Richter-2010" TOTAL_1="285" TOTAL_2="280" VAR="0.6595864661654135" WEIGHT="17.667367094619202"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.820128287392867" CI_END="3.7997185897714356" CI_START="0.7483920222588234" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.6863211673383838" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="8" I2="36.06242997239963" I2_Q="0.0" ID="CMP-001.26" LOG_CI_END="0.579751433607607" LOG_CI_START="-0.1258708506581815" LOG_EFFECT_SIZE="0.2269402914747127" METHOD="MH" MODIFIED="2017-07-07 09:01:38 +0100" MODIFIED_BY="[Empty name]" NO="26" P_CHI2="0.16643137117322804" P_Q="1.0" P_Z="0.207411062833461" Q="0.0" RANDOM="NO" SCALE="52.6" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="635" TOTAL_2="586" WEIGHT="99.99999999999999" Z="1.2607164140068945">
<NAME>Repeat incontinence surgery (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="106.43983710357865" CI_START="0.25328918105504317" EFFECT_SIZE="5.1923076923076925" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0271042012319342" LOG_CI_START="-0.5963833601835581" LOG_EFFECT_SIZE="0.7153604205241881" MODIFIED="2014-07-12 20:00:30 +0100" MODIFIED_BY="[Empty name]" ORDER="464" O_E="0.0" SE="1.5410495800483324" STUDY_ID="STD-Andonian-2007" TOTAL_1="77" TOTAL_2="80" VAR="2.3748338081671414" WEIGHT="5.320521271333563"/>
<DICH_DATA CI_END="2.479518993511896" CI_START="0.03237635121482792" EFFECT_SIZE="0.2833333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3943674394050335" LOG_CI_START="-1.4897720974157729" LOG_EFFECT_SIZE="-0.5477023290053697" MODIFIED="2014-07-12 20:00:30 +0100" MODIFIED_BY="[Empty name]" ORDER="358" O_E="0.0" SE="1.106752890569667" STUDY_ID="STD-Barber-2008" TOTAL_1="75" TOTAL_2="85" VAR="1.2249019607843137" WEIGHT="40.67129241067483"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:30 +0100" MODIFIED_BY="[Empty name]" ORDER="252" O_E="0.0" SE="0.0" STUDY_ID="STD-David_x002d_Montefiore-2006" TOTAL_1="46" TOTAL_2="42" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.387075771584433" CI_START="0.04640736655658188" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7313530841313599" LOG_CI_START="-1.3334130754593223" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2014-07-12 20:00:30 +0100" MODIFIED_BY="[Empty name]" ORDER="348" O_E="0.0" SE="1.212853862900895" STUDY_ID="STD-Deffieux-2010" TOTAL_1="69" TOTAL_2="69" VAR="1.471014492753623" WEIGHT="21.69135595235991"/>
<DICH_DATA CI_END="5.572486006233996" CI_START="0.04694161503992279" EFFECT_SIZE="0.5114503816793893" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7460489865424974" LOG_CI_START="-1.328441972452373" LOG_EFFECT_SIZE="-0.2911964929549379" MODIFIED="2014-07-12 20:00:30 +0100" MODIFIED_BY="[Empty name]" ORDER="421" O_E="0.0" SE="1.2185662582094485" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="131" TOTAL_2="134" VAR="1.4849037256465765" WEIGHT="21.445793432144516"/>
<DICH_DATA CI_END="103.72602480376645" CI_START="0.2483785049759752" EFFECT_SIZE="5.075757575757576" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.0158877343125043" LOG_CI_START="-0.604885991322551" LOG_EFFECT_SIZE="0.7055008714949766" MODIFIED="2014-07-12 20:00:30 +0100" MODIFIED_BY="[Empty name]" ORDER="511" O_E="0.0" SE="1.5394554594771999" STUDY_ID="STD-Riva-2006" TOTAL_1="65" TOTAL_2="66" VAR="2.3699231117141566" WEIGHT="5.382065762615617"/>
<DICH_DATA CI_END="252.13264198520213" CI_START="0.8498989574413971" EFFECT_SIZE="14.63855421686747" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.401629074618768" LOG_CI_START="-0.07063270350225359" LOG_EFFECT_SIZE="1.1654981855582571" MODIFIED="2014-07-12 20:00:30 +0100" MODIFIED_BY="[Empty name]" ORDER="514" O_E="0.0" SE="1.4522188063614598" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="82" TOTAL_2="80" VAR="2.108939461549903" WEIGHT="5.4889711708715625"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:00:30 +0100" MODIFIED_BY="[Empty name]" ORDER="611" O_E="0.0" SE="0.0" STUDY_ID="STD-van-Leijsen-2013" TOTAL_1="90" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3147346379175374" CI_END="109.76832425383132" CI_START="4.364178167480767" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="21.88717716357046" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.27" LOG_CI_END="2.0404770342265923" LOG_CI_START="0.6399024723412057" LOG_EFFECT_SIZE="1.3401897532838989" METHOD="MH" MODIFIED="2015-05-28 16:49:54 +0100" MODIFIED_BY="[Empty name]" NO="27" P_CHI2="0.5747893675532457" P_Q="1.0" P_Z="1.7618482389958882E-4" Q="0.0" RANDOM="NO" SCALE="272.35" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="175" TOTAL_2="180" WEIGHT="100.0" Z="3.750922971712542">
<NAME>Repeat incontinence surgery (medium term , 1 to 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="619.949311044333" CI_START="2.301389648396461" EFFECT_SIZE="37.772277227722775" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="0" LOG_CI_END="2.792356181701998" LOG_CI_START="0.36199015531451545" LOG_EFFECT_SIZE="1.5771731685082566" MODIFIED="2014-03-28 01:33:14 +0000" MODIFIED_BY="[Empty name]" ORDER="548" O_E="0.0" SE="1.4276090344058634" STUDY_ID="STD-Araco-2008" TOTAL_1="100" TOTAL_2="108" VAR="2.0380675551172414" WEIGHT="32.03443588581785"/>
<DICH_DATA CI_END="106.21583402745583" CI_START="1.952251299428664" EFFECT_SIZE="14.4" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="1" LOG_CI_END="2.026189263620791" LOG_CI_START="0.290535720569708" LOG_EFFECT_SIZE="1.1583624920952498" MODIFIED="2015-01-15 18:11:36 +0000" MODIFIED_BY="[Empty name]" ORDER="606" O_E="0.0" SE="1.0195314828118083" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="75" TOTAL_2="72" VAR="1.0394444444444444" WEIGHT="67.96556411418214"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.547203137742156" CI_END="22.999167858163265" CI_START="3.358854007749622" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="8.789246107334687" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="4" I2="45.91869225793178" I2_Q="0.0" ID="CMP-001.28" LOG_CI_END="1.3617121229243034" LOG_CI_START="0.5261911276860716" LOG_EFFECT_SIZE="0.9439516253051875" METHOD="MH" MODIFIED="2015-05-28 16:49:59 +0100" MODIFIED_BY="[Empty name]" NO="28" P_CHI2="0.1358425549831701" P_Q="1.0" P_Z="9.482879867892485E-6" Q="0.0" RANDOM="NO" SCALE="112.27" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="344" TOTAL_2="351" WEIGHT="99.99999999999999" Z="4.42864081044114">
<NAME>Repeat incontinence surgery (long term &gt; 5 years)</NAME>
<GROUP_LABEL_1>TOR</GROUP_LABEL_1>
<GROUP_LABEL_2>RPR</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours TOR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours RPR</GRAPH_LABEL_2>
<DICH_DATA CI_END="619.949311044333" CI_START="2.301389648396461" EFFECT_SIZE="37.772277227722775" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="0" LOG_CI_END="2.792356181701998" LOG_CI_START="0.36199015531451545" LOG_EFFECT_SIZE="1.5771731685082566" MODIFIED="2015-03-16 15:16:15 +0000" MODIFIED_BY="[Empty name]" ORDER="548" O_E="0.0" SE="1.4276090344058634" STUDY_ID="STD-Araco-2008" TOTAL_1="100" TOTAL_2="108" VAR="2.0380675551172414" WEIGHT="10.662538981227284"/>
<DICH_DATA CI_END="9.475977862783058" CI_START="0.2737671977464776" EFFECT_SIZE="1.610655737704918" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9766240374789258" LOG_CI_START="-0.5626185894055312" LOG_EFFECT_SIZE="0.20700272403669726" MODIFIED="2014-07-12 20:00:36 +0100" MODIFIED_BY="[Empty name]" ORDER="421" O_E="0.0" SE="0.9041587384058168" STUDY_ID="STD-Laurikainen-2007" TOTAL_1="122" TOTAL_2="131" VAR="0.8175030242355983" WEIGHT="42.76198469049317"/>
<DICH_DATA CI_END="29.235611925820475" CI_START="0.3963985534955959" EFFECT_SIZE="3.404255319148936" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.4659121884153379" LOG_CI_START="-0.4018679389749231" LOG_EFFECT_SIZE="0.5320221247202073" MODIFIED="2014-07-12 20:00:36 +0100" MODIFIED_BY="[Empty name]" ORDER="1129" O_E="0.0" SE="1.097143292489782" STUDY_ID="STD-Porena-2007" TOTAL_1="47" TOTAL_2="40" VAR="1.2037234042553193" WEIGHT="23.953399281828446"/>
<DICH_DATA CI_END="106.21583402745583" CI_START="1.952251299428664" EFFECT_SIZE="14.4" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="1" LOG_CI_END="2.026189263620791" LOG_CI_START="0.290535720569708" LOG_EFFECT_SIZE="1.1583624920952498" MODIFIED="2014-07-12 20:00:36 +0100" MODIFIED_BY="[Empty name]" ORDER="470" O_E="0.0" SE="1.0195314828118083" STUDY_ID="STD-Schierlitz-2008" TOTAL_1="75" TOTAL_2="72" VAR="1.0394444444444444" WEIGHT="22.622077046451096"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2015-06-20 22:40:08 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Retropubic bottom-to-top approach versus retropubic top-to-bottom approach</NAME>
<DICH_OUTCOME CHI2="4.409412332734455" CI_END="1.1861882317586798" CI_START="1.0118626694006567" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0955635949587694" ESTIMABLE="YES" EVENTS_1="207" EVENTS_2="191" I2="54.642481830232484" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.07415361105828402" LOG_CI_START="0.005121573799603853" LOG_EFFECT_SIZE="0.039637592428943935" METHOD="MH" MODIFIED="2015-06-20 22:33:25 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.11028302027949255" P_Q="1.0" P_Z="0.02439894397301146" Q="0.0" RANDOM="NO" SCALE="2.02" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="237" TOTAL_2="240" WEIGHT="99.99999999999997" Z="2.2507883782566194">
<NAME>Subjective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours top-to-bottom</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bottom-to-top</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0976711540069182" CI_START="0.9149506989680715" EFFECT_SIZE="1.0021551724137931" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="29" LOG_CI_END="0.0404722514156825" LOG_CI_START="-0.03860230674553639" LOG_EFFECT_SIZE="9.349723350730735E-4" MODIFIED="2014-07-01 12:29:25 +0100" MODIFIED_BY="[Empty name]" ORDER="294" O_E="0.0" SE="0.046448786889275735" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" VAR="0.002157489803485353" WEIGHT="15.756613473823895"/>
<DICH_DATA CI_END="1.2528092302956944" CI_START="0.877134567995695" EFFECT_SIZE="1.0482758620689656" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="45" LOG_CI_END="0.09788494446779464" LOG_CI_START="-0.05693377304819924" LOG_EFFECT_SIZE="0.020475585709797694" MODIFIED="2015-06-20 22:33:25 +0100" MODIFIED_BY="[Empty name]" ORDER="296" O_E="0.0" SE="0.09094128103390628" STUDY_ID="STD-Lim-2005" TOTAL_1="58" TOTAL_2="57" VAR="0.008270316596087922" WEIGHT="23.891821517374275"/>
<DICH_DATA CI_END="1.2681834606241111" CI_START="1.0223846561874848" EFFECT_SIZE="1.1386708529565672" ESTIMABLE="YES" EVENTS_1="128" EVENTS_2="117" LOG_CI_END="0.10318208491266662" LOG_CI_START="0.009614323029592265" LOG_EFFECT_SIZE="0.05639820397112942" MODIFIED="2014-07-01 12:29:25 +0100" MODIFIED_BY="[Empty name]" ORDER="295" O_E="0.0" SE="0.054962166498009085" STUDY_ID="STD-Lord-2006" TOTAL_1="147" TOTAL_2="153" VAR="0.0030208397461548723" WEIGHT="60.35156500880181"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="13.50474398055029" CI_END="1.167729319928782" CI_START="0.9681419224746245" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0632627656068074" ESTIMABLE="YES" EVENTS_1="292" EVENTS_2="278" I2="70.38077874144928" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.06734218482700749" LOG_CI_START="-0.014060973652697152" LOG_EFFECT_SIZE="0.026640605587155163" METHOD="MH" MODIFIED="2015-06-20 22:37:08 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.009055603272415724" P_Q="1.0" P_Z="0.19953941100711622" Q="0.0" RANDOM="YES" SCALE="2.09" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.006935477957435412" TOTALS="YES" TOTAL_1="310" TOTAL_2="312" WEIGHT="99.99999999999997" Z="1.2828649023533596">
<NAME>Objective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours top-to-bottom</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bottom-to-top</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.340306522879324" CI_START="0.9840726234011068" EFFECT_SIZE="1.1484593837535013" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="34" LOG_CI_END="0.12720413117955218" LOG_CI_START="-0.00697284996446764" LOG_EFFECT_SIZE="0.060115640607542264" MODIFIED="2014-07-01 12:32:37 +0100" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="0.07881622291076577" STUDY_ID="STD-Andonian-2005" TOTAL_1="42" TOTAL_2="41" VAR="0.0062119969939195205" WEIGHT="17.390631955315914"/>
<DICH_DATA CI_END="1.0976711540069182" CI_START="0.9149506989680715" EFFECT_SIZE="1.0021551724137931" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="29" LOG_CI_END="0.0404722514156825" LOG_CI_START="-0.03860230674553639" LOG_EFFECT_SIZE="9.349723350730735E-4" MODIFIED="2014-07-01 12:32:37 +0100" MODIFIED_BY="[Empty name]" ORDER="308" O_E="0.0" SE="0.046448786889275735" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" VAR="0.002157489803485353" WEIGHT="25.145024598393164"/>
<DICH_DATA CI_END="1.4614334981813344" CI_START="1.0089338979524423" EFFECT_SIZE="1.2142857142857142" ESTIMABLE="YES" EVENTS_1="51" EVENTS_2="42" LOG_CI_END="0.16477905778446486" LOG_CI_START="0.0038627136156068904" LOG_EFFECT_SIZE="0.08432088570003587" MODIFIED="2015-06-20 22:37:08 +0100" MODIFIED_BY="[Empty name]" ORDER="305" O_E="0.0" SE="0.09452305711353741" STUDY_ID="STD-Lim-2005" TOTAL_1="58" TOTAL_2="58" VAR="0.008934608326089055" WEIGHT="14.407161620672113"/>
<DICH_DATA CI_END="1.0373649402138683" CI_START="0.9622093760128273" EFFECT_SIZE="0.9990807133664277" ESTIMABLE="YES" EVENTS_1="143" EVENTS_2="148" LOG_CI_END="0.015931566070375425" LOG_CI_START="-0.016730415536973634" LOG_EFFECT_SIZE="-3.994247332991188E-4" MODIFIED="2014-07-01 12:32:37 +0100" MODIFIED_BY="[Empty name]" ORDER="306" O_E="0.0" SE="0.019185809675573328" STUDY_ID="STD-Lord-2006" TOTAL_1="147" TOTAL_2="152" VAR="3.680952929073231E-4" WEIGHT="31.305621260116627"/>
<DICH_DATA CI_END="1.3448397528395977" CI_START="0.8673152303366805" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="25" LOG_CI_END="0.12867053816469115" LOG_CI_START="-0.06182302719079172" LOG_EFFECT_SIZE="0.03342375548694973" MODIFIED="2014-07-01 12:32:37 +0100" MODIFIED_BY="[Empty name]" ORDER="304" O_E="0.0" SE="0.11189686324816697" STUDY_ID="STD-Tseng-2005" TOTAL_1="31" TOTAL_2="31" VAR="0.01252090800477898" WEIGHT="11.751560565502169"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="5.469741605055834" CI_END="0.38077869546671916" CI_START="-4.676832805529029" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.148027055031155" ESTIMABLE="YES" I2="81.71760071671991" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2015-06-09 11:11:07 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.01934857462462769" P_Q="1.0" P_Z="0.09594478384828863" Q="0.0" RANDOM="NO" SCALE="20.09" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="63" TOTAL_2="61" UNITS="" WEIGHT="100.00000000000001" Z="1.6648394859311835">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bottom-to-top</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours top-to-bottom</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.242158972751324" CI_START="-3.4421589727513267" EFFECT_SIZE="-0.6000000000000014" ESTIMABLE="YES" MEAN_1="27.5" MEAN_2="28.1" MODIFIED="2014-07-01 12:32:46 +0100" MODIFIED_BY="[Empty name]" ORDER="340" SD_1="2.7" SD_2="7.5" SE="1.4501077546168768" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" WEIGHT="79.16518095516618"/>
<CONT_DATA CI_END="-2.4898617292237573" CI_START="-13.570138270776244" EFFECT_SIZE="-8.030000000000001" ESTIMABLE="YES" MEAN_1="32.74" MEAN_2="40.77" MODIFIED="2014-07-01 12:32:46 +0100" MODIFIED_BY="[Empty name]" ORDER="341" SD_1="8.43" SD_2="13.29" SE="2.826653098973322" STUDY_ID="STD-Tseng-2005" TOTAL_1="31" TOTAL_2="31" WEIGHT="20.834819044833836"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.441045928921687" CI_END="0.2996310212084569" CI_START="-0.36629417892280675" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.033331578857174936" ESTIMABLE="YES" I2="84.47457119487716" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2015-05-28 16:50:49 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.011151321905777167" P_Q="1.0" P_Z="0.8444502621135844" Q="0.0" RANDOM="NO" SCALE="2.9" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="63" TOTAL_2="61" UNITS="" WEIGHT="100.0" Z="0.19620430070837497">
<NAME>Length of hospital stay (days)</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bottom-to-top</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours top-to-bottom</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5785953410267348" CI_START="-0.17859534102673452" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="2.3" MODIFIED="2014-07-01 12:32:49 +0100" MODIFIED_BY="[Empty name]" ORDER="345" SD_1="0.9" SD_2="0.6" SE="0.19316443772081857" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" WEIGHT="77.3464486546432"/>
<CONT_DATA CI_END="-0.13043623453341724" CI_START="-1.529563765466583" EFFECT_SIZE="-0.8300000000000001" ESTIMABLE="YES" MEAN_1="3.14" MEAN_2="3.97" MODIFIED="2014-07-01 12:32:49 +0100" MODIFIED_BY="[Empty name]" ORDER="344" SD_1="1.38" SD_2="1.43" SE="0.35692684711793304" STUDY_ID="STD-Tseng-2005" TOTAL_1="31" TOTAL_2="31" WEIGHT="22.653551345356803"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.854767065864542" CI_END="1.8355721982462638" CI_START="0.5285064187594705" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9849424799802178" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.26377147120628236" LOG_CI_START="-0.2769497337777648" LOG_EFFECT_SIZE="-0.006589131285741186" METHOD="MH" MODIFIED="2015-05-28 16:50:55 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.4145635728241699" P_Q="1.0" P_Z="0.9619015089449515" Q="0.0" RANDOM="NO" SCALE="319.96" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="251" TOTAL_2="256" WEIGHT="100.0" Z="0.047767536728432314">
<NAME>Perioperative complications</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bottom-to-top</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours top-to-bottom</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.745504920919437" CI_START="0.007800322538545951" EFFECT_SIZE="0.14634146341463414" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4386222264559737" LOG_CI_START="-2.1078874391281572" LOG_EFFECT_SIZE="-0.8346326063360919" MODIFIED="2014-07-01 12:32:52 +0100" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="1.495832382990261" STUDY_ID="STD-Andonian-2005" TOTAL_1="40" TOTAL_2="41" VAR="2.237514518002323" WEIGHT="19.604181517550312"/>
<DICH_DATA CI_END="2.1198082149731468" CI_START="0.3046157837559407" EFFECT_SIZE="0.8035714285714286" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32629657085962205" LOG_CI_START="-0.5162475973213354" LOG_EFFECT_SIZE="-0.09497551323085672" MODIFIED="2014-07-01 12:32:52 +0100" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="0.49491461505039047" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" VAR="0.2449404761904762" WEIGHT="40.966723926525276"/>
<DICH_DATA CI_END="5.456386114019925" CI_START="0.4525683673222952" EFFECT_SIZE="1.5714285714285714" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7369050950162775" LOG_CI_START="-0.3443158047283411" LOG_EFFECT_SIZE="0.1962946451439682" MODIFIED="2014-07-01 12:32:52 +0100" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.6351145086397607" STUDY_ID="STD-Lord-2006" TOTAL_1="147" TOTAL_2="154" VAR="0.40337043908472475" WEIGHT="22.150612355621227"/>
<DICH_DATA CI_END="6.18737387193585" CI_START="0.4213224211489519" EFFECT_SIZE="1.6145833333333333" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7915063590477949" LOG_CI_START="-0.37538542878634884" LOG_EFFECT_SIZE="0.20806046513072304" MODIFIED="2014-07-01 12:32:52 +0100" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="0.6854380123812833" STUDY_ID="STD-Tseng-2005" TOTAL_1="32" TOTAL_2="31" VAR="0.4698252688172043" WEIGHT="17.278482200303177"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.461337921483617" CI_END="0.9793071269296185" CI_START="0.305566550982017" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5470315357710119" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="27" I2="26.75787403183857" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-0.009081084894565428" LOG_CI_START="-0.5148941877893914" LOG_EFFECT_SIZE="-0.2619876363419784" METHOD="MH" MODIFIED="2015-05-28 16:51:02 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.2431490779690726" P_Q="1.0" P_Z="0.042321973302609395" Q="0.0" RANDOM="NO" SCALE="352.35" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="314" TOTAL_2="317" WEIGHT="100.0" Z="2.0303401738164313">
<NAME>Bladder or urethral perforation</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bottom-to-top</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours top-to-bottom</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0490898893713774" CI_START="0.44367993831422936" EFFECT_SIZE="0.9534883720930233" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="10" LOG_CI_END="0.311561010427398" LOG_CI_START="-0.3529302081470999" LOG_EFFECT_SIZE="-0.02068459885985102" MODIFIED="2014-07-01 12:32:54 +0100" MODIFIED_BY="[Empty name]" ORDER="349" O_E="0.0" SE="0.3903254310752409" STUDY_ID="STD-Andonian-2005" TOTAL_1="43" TOTAL_2="41" VAR="0.15235394214407263" WEIGHT="36.87396949545726"/>
<DICH_DATA CI_END="4.289956105296717" CI_START="0.20487534800527057" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6324528485192353" LOG_CI_START="-0.6885102957197223" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2014-07-01 12:32:54 +0100" MODIFIED_BY="[Empty name]" ORDER="352" O_E="0.0" SE="0.7759402897989853" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" VAR="0.6020833333333333" WEIGHT="11.153476744612428"/>
<DICH_DATA CI_END="1.1264886343473037" CI_START="0.018116617108286014" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="7" LOG_CI_END="0.051726814288744344" LOG_CI_START="-1.7419228943172582" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2014-07-01 12:32:54 +0100" MODIFIED_BY="[Empty name]" ORDER="348" O_E="0.0" SE="1.0535987175444175" STUDY_ID="STD-Lim-2005" TOTAL_1="61" TOTAL_2="61" VAR="1.1100702576112411" WEIGHT="25.21150472480101"/>
<DICH_DATA CI_END="3.3193419500800037" CI_START="0.03673772577817345" EFFECT_SIZE="0.3492063492063492" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5210519946150405" LOG_CI_START="-1.4348877318777915" LOG_EFFECT_SIZE="-0.4569178686313755" MODIFIED="2014-07-01 12:32:54 +0100" MODIFIED_BY="[Empty name]" ORDER="350" O_E="0.0" SE="1.1489286773996858" STUDY_ID="STD-Lord-2006" TOTAL_1="147" TOTAL_2="154" VAR="1.3200371057513913" WEIGHT="10.553653140614376"/>
<DICH_DATA CI_END="1.9800799093780772" CI_START="0.006234939788982219" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.2966827172825762" LOG_CI_START="-2.205167736161226" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2014-07-01 12:32:54 +0100" MODIFIED_BY="[Empty name]" ORDER="351" O_E="0.0" SE="1.4695993407123664" STUDY_ID="STD-Tseng-2005" TOTAL_1="31" TOTAL_2="31" VAR="2.1597222222222223" WEIGHT="16.207395894514935"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="7.024615607294383" CI_END="0.8957748210294946" CI_START="0.17570967029078216" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.39673202348421144" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" I2="43.05738244457977" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="-0.047801149126912613" LOG_CI_START="-0.7552043361805448" LOG_EFFECT_SIZE="-0.40150274265372876" METHOD="MH" MODIFIED="2015-05-28 16:51:07 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.13459330287736215" P_Q="1.0" P_Z="0.026091703506914254" Q="0.0" RANDOM="NO" SCALE="694.67" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="314" TOTAL_2="317" WEIGHT="99.99999999999999" Z="2.224844133295375">
<NAME>Voiding dysfunction</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bottom-to-top</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours top-to-bottom</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.856168621716987" CI_START="0.3689628741591993" EFFECT_SIZE="1.9069767441860466" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.9937081248989604" LOG_CI_START="-0.4330173312907002" LOG_EFFECT_SIZE="0.2803453968041302" MODIFIED="2014-07-01 12:32:57 +0100" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="0.8380655953707159" STUDY_ID="STD-Andonian-2005" TOTAL_1="43" TOTAL_2="41" VAR="0.7023539421440725" WEIGHT="10.282092419420527"/>
<DICH_DATA CI_END="2.4940882787181518" CI_START="0.007220838080780863" EFFECT_SIZE="0.1341991341991342" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3969118213484771" LOG_CI_START="-2.1414123934642206" LOG_EFFECT_SIZE="-0.8722502860578716" MODIFIED="2014-07-01 12:32:57 +0100" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="1.4910242086884862" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" VAR="2.2231531908951263" WEIGHT="18.124429624494542"/>
<DICH_DATA CI_END="6.872759188303407" CI_START="0.1455019698204874" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.837131127115344" LOG_CI_START="-0.8371311271153441" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-01 12:32:57 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="0.9834699358669274" STUDY_ID="STD-Lim-2005" TOTAL_1="61" TOTAL_2="61" VAR="0.9672131147540983" WEIGHT="10.042973991061912"/>
<DICH_DATA CI_END="0.8434703875587191" CI_START="0.0029487064247172147" EFFECT_SIZE="0.04987129987129987" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="10" LOG_CI_END="-0.07393015995759934" LOG_CI_START="-2.530368463959571" LOG_EFFECT_SIZE="-1.3021493119585852" MODIFIED="2014-07-01 12:32:57 +0100" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="1.4429240193364699" STUDY_ID="STD-Lord-2006" TOTAL_1="147" TOTAL_2="154" VAR="2.082029725578113" WEIGHT="51.50752997396109"/>
<DICH_DATA CI_END="5.2337006044292" CI_START="0.0477673483631121" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.718808875055234" LOG_CI_START="-1.3208688663831967" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2014-07-01 12:32:57 +0100" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="1.1981168018885897" STUDY_ID="STD-Tseng-2005" TOTAL_1="31" TOTAL_2="31" VAR="1.435483870967742" WEIGHT="10.042973991061912"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.385661491774221" CI_END="1.3395123590230615" CI_START="0.5240513443811015" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8378384406084124" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="34" I2="0.0" I2_Q="0.0" ID="CMP-002.08" LOG_CI_END="0.1269467249847322" LOG_CI_START="-0.2806261605563648" LOG_EFFECT_SIZE="-0.07683971778581625" METHOD="MH" MODIFIED="2015-06-20 22:38:37 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.7088993723532085" P_Q="1.0" P_Z="0.4598924078587736" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="268" TOTAL_2="273" WEIGHT="100.0" Z="0.7390240361180055">
<NAME>De novo urgency or urgency incontinence</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bottom-to-top</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours top-to-bottom</GRAPH_LABEL_2>
<DICH_DATA CI_END="25.57854064907196" CI_START="0.3092497089073374" EFFECT_SIZE="2.8125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4078757627331415" LOG_CI_START="-0.5096907004943037" LOG_EFFECT_SIZE="0.4490925311194189" MODIFIED="2014-07-01 12:33:02 +0100" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="1.126388032606881" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" VAR="1.2687499999999998" WEIGHT="3.068825549756902"/>
<DICH_DATA CI_END="2.143200967323241" CI_START="0.3686651269931775" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.3310628966168802" LOG_CI_START="-0.43336794151164276" LOG_EFFECT_SIZE="-0.05115252244738131" MODIFIED="2015-06-20 22:38:37 +0100" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="0.4490304583103706" STUDY_ID="STD-Lim-2005" TOTAL_1="58" TOTAL_2="58" VAR="0.20162835249042144" WEIGHT="26.756322761942993"/>
<DICH_DATA CI_END="1.4944896818078022" CI_START="0.365913557242122" EFFECT_SIZE="0.7394957983193278" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="17" LOG_CI_END="0.1744929209481306" LOG_CI_START="-0.43662149943285483" LOG_EFFECT_SIZE="-0.1310642892423621" MODIFIED="2014-07-01 12:33:02 +0100" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="0.3589716355969593" STUDY_ID="STD-Lord-2006" TOTAL_1="147" TOTAL_2="154" VAR="0.12886063516315616" WEIGHT="49.364378429011104"/>
<DICH_DATA CI_END="2.0088576481625897" CI_START="0.2539772203865781" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.30294916282696294" LOG_CI_START="-0.595205234183439" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2014-07-01 12:33:02 +0100" MODIFIED_BY="[Empty name]" ORDER="314" O_E="0.0" SE="0.5275803387398784" STUDY_ID="STD-Tseng-2005" TOTAL_1="31" TOTAL_2="31" VAR="0.27834101382488485" WEIGHT="20.810473259288994"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-05-28 16:51:17 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="58" TOTAL_2="58" WEIGHT="0.0" Z="0.0">
<NAME>Detrusor overactivity</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bottom-to-top</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours top-to-bottom</GRAPH_LABEL_2>
<DICH_DATA CI_END="21.45271372832667" CI_START="0.18645659708395335" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3314822374387787" LOG_CI_START="-0.7294222461108163" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2014-07-01 12:33:05 +0100" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.2105854952787558" STUDY_ID="STD-Lim-2005" TOTAL_1="58" TOTAL_2="58" VAR="1.4655172413793105" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.04486111881078098" CI_END="0.9509265443664277" CI_START="0.07821134687902337" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.27271458673476506" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-002.10" LOG_CI_END="-0.02185302944368636" LOG_CI_START="-1.106730235054459" LOG_EFFECT_SIZE="-0.5642916322490726" METHOD="MH" MODIFIED="2015-06-20 22:40:08 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.9778191455380183" P_Q="1.0" P_Z="0.041457578208507595" Q="0.0" RANDOM="NO" SCALE="448.13" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="280" TOTAL_2="283" WEIGHT="100.0" Z="2.0389243506371653">
<NAME>Vaginal tape erosion</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours bottom-to-top</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours top-to-bottom</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.594506686530682" CI_START="0.013330644583017127" EFFECT_SIZE="0.3181818181818182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8804995688142517" LOG_CI_START="-1.8751488504301506" LOG_EFFECT_SIZE="-0.4973246408079494" MODIFIED="2014-07-01 12:32:59 +0100" MODIFIED_BY="[Empty name]" ORDER="360" O_E="0.0" SE="1.618681522143831" STUDY_ID="STD-Andonian-2005" TOTAL_1="43" TOTAL_2="41" VAR="2.62012987012987" WEIGHT="13.953196299242265"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-01 12:32:59 +0100" MODIFIED_BY="[Empty name]" ORDER="357" O_E="0.0" SE="0.0" STUDY_ID="STD-Kim-2004" TOTAL_1="32" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.127319068214381" CI_START="0.055441269257511104" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.05204685300541767" LOG_CI_START="-1.2561668356613422" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2015-06-20 22:40:08 +0100" MODIFIED_BY="[Empty name]" ORDER="358" O_E="0.0" SE="0.7684511964850534" STUDY_ID="STD-Lim-2005" TOTAL_1="58" TOTAL_2="58" VAR="0.5905172413793103" WEIGHT="72.7257504081718"/>
<DICH_DATA CI_END="8.501749552546249" CI_START="0.01433471784114164" EFFECT_SIZE="0.3490990990990991" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9295083072237627" LOG_CI_START="-1.8436108511124192" LOG_EFFECT_SIZE="-0.4570512719443284" MODIFIED="2014-07-01 12:32:59 +0100" MODIFIED_BY="[Empty name]" ORDER="359" O_E="0.0" SE="1.6289439207678957" STUDY_ID="STD-Lord-2006" TOTAL_1="147" TOTAL_2="154" VAR="2.6534582970066842" WEIGHT="13.321053292585924"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.11" MODIFIED="2015-05-28 16:51:30 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="40.55" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="43" TOTAL_2="41" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>QoL specific</NAME>
<GROUP_LABEL_1>Bottom-to-top</GROUP_LABEL_1>
<GROUP_LABEL_2>Top-to-bottom</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours top-to-bottom</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bottom-to-top</GRAPH_LABEL_2>
<CONT_DATA CI_END="4.973351463957933" CI_START="-14.173351463957935" EFFECT_SIZE="-4.600000000000001" ESTIMABLE="YES" MEAN_1="45.3" MEAN_2="49.9" MODIFIED="2014-07-01 12:33:15 +0100" MODIFIED_BY="[Empty name]" ORDER="528" SD_1="18.4" SD_2="25.6" SE="4.884452744780674" STUDY_ID="STD-Andonian-2005" TOTAL_1="43" TOTAL_2="41" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2015-06-09 11:11:36 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Obturator medial-to-lateral approach versus obturator lateral-to-medial approach</NAME>
<DICH_OUTCOME CHI2="1.2947701393440207" CI_END="1.0568729227725557" CI_START="0.9555313937600893" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.004925498195841" ESTIMABLE="YES" EVENTS_1="340" EVENTS_2="328" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.02402277135998066" LOG_CI_START="-0.019755039731106105" LOG_EFFECT_SIZE="0.0021338658144372745" METHOD="MH" MODIFIED="2015-05-28 17:04:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9354689147739703" P_Q="1.0" P_Z="0.8484712179113467" Q="0.0" RANDOM="NO" SCALE="1.39" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="385" TOTAL_2="374" WEIGHT="99.99999999999999" Z="0.19106940433528488">
<NAME>Subjective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lateral-to-medial</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours medial-to-lateral</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0476888546727583" CI_START="0.954481853596072" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="59" EVENTS_2="59" LOG_CI_END="0.020232323905208793" LOG_CI_START="-0.020232323905208797" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:02:06 +0100" MODIFIED_BY="[Empty name]" ORDER="398" O_E="0.0" SE="0.023769134427076424" STUDY_ID="STD-But-2008" TOTAL_1="60" TOTAL_2="60" VAR="5.649717514124297E-4" WEIGHT="17.715812659234157"/>
<DICH_DATA CI_END="1.0573146575991343" CI_START="0.9863122718099592" EFFECT_SIZE="1.0211965638184313" ESTIMABLE="YES" EVENTS_1="102" EVENTS_2="95" LOG_CI_END="0.024204252891913133" LOG_CI_START="-0.005985563301214402" LOG_EFFECT_SIZE="0.009109344795349377" MODIFIED="2014-07-12 20:02:06 +0100" MODIFIED_BY="[Empty name]" ORDER="513" O_E="0.0" SE="0.017733647473843463" STUDY_ID="STD-Hassan-2013" TOTAL_1="102" TOTAL_2="97" VAR="3.1448225272655457E-4" WEIGHT="29.388918327440223"/>
<DICH_DATA CI_END="1.1724622656389636" CI_START="0.8507335977446959" EFFECT_SIZE="0.9987257088244664" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="73" LOG_CI_END="0.06909887433937235" LOG_CI_START="-0.07020641540598668" LOG_EFFECT_SIZE="-5.537705333071662E-4" MODIFIED="2014-07-12 20:02:06 +0100" MODIFIED_BY="[Empty name]" ORDER="369" O_E="0.0" SE="0.0818286167687294" STUDY_ID="STD-Houwert-2009" TOTAL_1="86" TOTAL_2="95" VAR="0.006695922522283583" WEIGHT="20.829641703281588"/>
<DICH_DATA CI_END="1.257432561522796" CI_START="0.8574954286508277" EFFECT_SIZE="1.0383846461415434" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="41" LOG_CI_END="0.09948470232129049" LOG_CI_START="-0.06676818652369015" LOG_EFFECT_SIZE="0.016358257898800167" MODIFIED="2014-07-12 20:02:06 +0100" MODIFIED_BY="[Empty name]" ORDER="370" O_E="0.0" SE="0.09765776987261404" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.009537040016492443" WEIGHT="13.174917472716213"/>
<DICH_DATA CI_END="1.1367647914289953" CI_START="0.8475637870764451" EFFECT_SIZE="0.9815705128205128" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="32" LOG_CI_END="0.05567061389469489" LOG_CI_START="-0.07182760718640271" LOG_EFFECT_SIZE="-0.008078496645853932" MODIFIED="2014-07-12 20:02:06 +0100" MODIFIED_BY="[Empty name]" ORDER="402" O_E="0.0" SE="0.07489308618940975" STUDY_ID="STD-Park-2012" TOTAL_1="39" TOTAL_2="35" VAR="0.005608974358974356" WEIGHT="10.127958863364281"/>
<DICH_DATA CI_END="1.1977311275514824" CI_START="0.7562667081145587" EFFECT_SIZE="0.9517374517374517" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="28" LOG_CI_END="0.07835933647877497" LOG_CI_START="-0.12132501741478105" LOG_EFFECT_SIZE="-0.021482840468003014" MODIFIED="2014-07-12 20:02:06 +0100" MODIFIED_BY="[Empty name]" ORDER="372" O_E="0.0" SE="0.11729557793056815" STUDY_ID="STD-Scheiner-2012" TOTAL_1="37" TOTAL_2="34" VAR="0.013758252602065986" WEIGHT="8.762750973963518"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4992149939721953" CI_END="1.0788060853985195" CI_START="0.9671187255721558" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0214370105151382" ESTIMABLE="YES" EVENTS_1="328" EVENTS_2="311" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.03294338758391552" LOG_CI_START="-0.014520207720725141" LOG_EFFECT_SIZE="0.009211589931595213" METHOD="MH" MODIFIED="2015-05-28 17:04:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8267806173088058" P_Q="1.0" P_Z="0.4467958516974023" Q="0.0" RANDOM="NO" SCALE="1.48" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="372" TOTAL_2="360" WEIGHT="100.0" Z="0.7607676742732195">
<NAME>Subjective cure and improvement (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lateral-to-medial</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours medial-to-lateral</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1761542409885848" CI_START="0.9305935589581567" EFFECT_SIZE="1.046193844851563" ESTIMABLE="YES" EVENTS_1="121" EVENTS_2="111" LOG_CI_END="0.07046427889807676" LOG_CI_START="-0.031239957732915775" LOG_EFFECT_SIZE="0.019612160582580463" MODIFIED="2014-07-12 20:02:14 +0100" MODIFIED_BY="[Empty name]" ORDER="561" O_E="0.0" SE="0.05974157204113577" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="149" TOTAL_2="143" VAR="0.0035690554299462147" WEIGHT="35.933955125739914"/>
<DICH_DATA CI_END="1.0640652576692882" CI_START="0.903558371309491" EFFECT_SIZE="0.9805330546119676" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="89" LOG_CI_END="0.026968263463349993" LOG_CI_START="-0.04404378608173258" LOG_EFFECT_SIZE="-0.008537761309191311" MODIFIED="2014-07-12 20:02:14 +0100" MODIFIED_BY="[Empty name]" ORDER="374" O_E="0.0" SE="0.041712829418095926" STUDY_ID="STD-Houwert-2009" TOTAL_1="86" TOTAL_2="95" VAR="0.001739960138063169" WEIGHT="26.828013017102613"/>
<DICH_DATA CI_END="1.1844155334089943" CI_START="0.9374367396178822" EFFECT_SIZE="1.0537146843390304" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="47" LOG_CI_END="0.07350409445313996" LOG_CI_START="-0.028058029799548027" LOG_EFFECT_SIZE="0.022723032326795956" MODIFIED="2014-07-12 20:02:14 +0100" MODIFIED_BY="[Empty name]" ORDER="375" O_E="0.0" SE="0.05965809452665207" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.0035590882425509535" WEIGHT="15.955171141939324"/>
<DICH_DATA CI_END="1.1225830635479481" CI_START="0.9019115680984481" EFFECT_SIZE="1.0062160062160062" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="33" LOG_CI_END="0.05021848571622568" LOG_CI_START="-0.044836042690457864" LOG_EFFECT_SIZE="0.002691221512883921" MODIFIED="2014-07-12 20:02:14 +0100" MODIFIED_BY="[Empty name]" ORDER="403" O_E="0.0" SE="0.05583550051359011" STUDY_ID="STD-Park-2012" TOTAL_1="39" TOTAL_2="35" VAR="0.0031176031176031217" WEIGHT="11.03380876329459"/>
<DICH_DATA CI_END="1.161337216455621" CI_START="0.8746423231075791" EFFECT_SIZE="1.007846556233653" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="31" LOG_CI_END="0.06495834375353149" LOG_CI_START="-0.0581695113870464" LOG_EFFECT_SIZE="0.0033944161832425396" MODIFIED="2014-07-12 20:02:14 +0100" MODIFIED_BY="[Empty name]" ORDER="373" O_E="0.0" SE="0.07232591160228817" STUDY_ID="STD-Scheiner-2012" TOTAL_1="37" TOTAL_2="34" VAR="0.005231037489102003" WEIGHT="10.24905195192355"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.7010112214680968" CI_END="1.2327360721121603" CI_START="0.9131601195115405" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0609832321653945" ESTIMABLE="YES" EVENTS_1="87" EVENTS_2="86" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.09087010441834144" LOG_CI_START="-0.03945306373269368" LOG_EFFECT_SIZE="0.025708520342823886" METHOD="MH" MODIFIED="2015-05-28 17:04:45 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.40244455101054755" P_Q="1.0" P_Z="0.43936010813795334" Q="0.0" RANDOM="NO" SCALE="1.8" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="114" TOTAL_2="121" WEIGHT="100.0" Z="0.7732742333175073">
<NAME>Subjective cure (medium term, 1 to 5 years)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lateral-to-medial</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours medial-to-lateral</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3632761639344269" CI_START="0.8968132165563629" EFFECT_SIZE="1.1057142857142856" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="56" LOG_CI_END="0.1345838413988795" LOG_CI_START="-0.04729800006160804" LOG_EFFECT_SIZE="0.04364292066863574" MODIFIED="2014-07-12 20:02:18 +0100" MODIFIED_BY="[Empty name]" ORDER="586" O_E="0.0" SE="0.10683829400352596" STUDY_ID="STD-Houwert-2009" TOTAL_1="75" TOTAL_2="86" VAR="0.011414421065583852" WEIGHT="62.26335717290703"/>
<DICH_DATA CI_END="1.1940652605642443" CI_START="0.8161390939783757" EFFECT_SIZE="0.9871794871794872" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="30" LOG_CI_END="0.07702806341681054" LOG_CI_START="-0.08823581845280752" LOG_EFFECT_SIZE="-0.005603877517998511" MODIFIED="2014-07-12 20:02:18 +0100" MODIFIED_BY="[Empty name]" ORDER="405" O_E="0.0" SE="0.09707682227962254" STUDY_ID="STD-Park-2012" TOTAL_1="39" TOTAL_2="35" VAR="0.009423909423909419" WEIGHT="37.73664282709297"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.2012434351157014" CI_END="1.1103956261541827" CI_START="0.902035254275053" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0008076743230414" ESTIMABLE="YES" EVENTS_1="156" EVENTS_2="155" I2="0.0" I2_Q="100.0" ID="CMP-003.04" LOG_CI_END="0.04547774242918364" LOG_CI_START="-0.04477648858009806" LOG_EFFECT_SIZE="3.506269245427742E-4" METHOD="MH" MODIFIED="2015-05-28 17:05:11 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.653719057979554" P_Q="0.0" P_Z="0.9878499223156226" Q="4.182252041200471E-36" RANDOM="NO" SCALE="2.04" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="201" TOTAL_2="198" WEIGHT="100.0" Z="0.015228452703634652">
<NAME>Subjective cure and improvement (medium term, 1 to 5 years)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lateral-to-medial</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours medial-to-lateral</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1913757832370269" CI_START="0.8742628943990148" EFFECT_SIZE="1.0205761316872428" ESTIMABLE="YES" EVENTS_1="93" EVENTS_2="81" LOG_CI_END="0.07604876806984434" LOG_CI_START="-0.058357953614036166" LOG_EFFECT_SIZE="0.008845407227904086" MODIFIED="2014-07-12 20:02:26 +0100" MODIFIED_BY="[Empty name]" ORDER="560" O_E="0.0" SE="0.07895117364111395" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="126" TOTAL_2="112" VAR="0.006233287819309326" WEIGHT="55.436214983067174"/>
<DICH_DATA CI_END="1.1121679279290313" CI_START="0.8568832789290055" EFFECT_SIZE="0.9762162162162162" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="74" LOG_CI_END="0.04617036698231534" LOG_CI_START="-0.06707833183336896" LOG_EFFECT_SIZE="-0.010453982425526802" MODIFIED="2014-07-12 20:02:26 +0100" MODIFIED_BY="[Empty name]" ORDER="587" O_E="0.0" SE="0.06652284627443315" STUDY_ID="STD-Houwert-2009" TOTAL_1="75" TOTAL_2="86" VAR="0.004425289076451865" WEIGHT="44.56378501693282"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.030795904436679" CI_END="1.040537117319566" CI_START="0.9490384895731957" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9937352636219609" ESTIMABLE="YES" EVENTS_1="357" EVENTS_2="320" I2="17.09220343003736" I2_Q="100.0" ID="CMP-003.05" LOG_CI_END="0.017257576676006307" LOG_CI_START="-0.022716173800021663" LOG_EFFECT_SIZE="-0.002729298562007704" METHOD="MH" MODIFIED="2015-05-28 17:05:24 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.3032339243503446" P_Q="0.0" P_Z="0.7889749134723768" Q="1.3645062269339798E-33" RANDOM="NO" SCALE="1.39" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="394" TOTAL_2="351" WEIGHT="100.0" Z="0.26764198109456977">
<NAME>Objective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lateral-to-medial</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours medial-to-lateral</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1611310739879068" CI_START="0.9855263582126685" EFFECT_SIZE="1.0697314049586777" ESTIMABLE="YES" EVENTS_1="114" EVENTS_2="96" LOG_CI_END="0.06488124772873952" LOG_CI_START="-0.0063317558865840715" LOG_EFFECT_SIZE="0.029274745921077736" MODIFIED="2014-07-12 20:02:29 +0100" MODIFIED_BY="[Empty name]" ORDER="392" O_E="0.0" SE="0.04183087083369418" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="121" TOTAL_2="109" VAR="0.0017498217547052067" WEIGHT="29.960325046411132"/>
<DICH_DATA CI_END="1.0254065806785466" CI_START="0.8453478107308462" EFFECT_SIZE="0.9310344827586207" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="58" LOG_CI_END="0.01089610025398971" LOG_CI_START="-0.07296456773392734" LOG_EFFECT_SIZE="-0.03103423373996879" MODIFIED="2014-07-12 20:02:29 +0100" MODIFIED_BY="[Empty name]" ORDER="399" O_E="0.0" SE="0.04926017149310396" STUDY_ID="STD-But-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.002426564495530012" WEIGHT="17.20345799410832"/>
<DICH_DATA CI_END="1.136747086262846" CI_START="0.9029615382995162" EFFECT_SIZE="1.0131332082551594" ESTIMABLE="YES" EVENTS_1="60" EVENTS_2="41" LOG_CI_END="0.055663849684632505" LOG_CI_START="-0.04433074809184007" LOG_EFFECT_SIZE="0.005666550796396211" MODIFIED="2014-07-12 20:02:29 +0100" MODIFIED_BY="[Empty name]" ORDER="437" O_E="0.0" SE="0.058737321715141955" STUDY_ID="STD-Chen-2010" TOTAL_1="65" TOTAL_2="45" VAR="0.0034500729622680866" WEIGHT="14.372167885360087"/>
<DICH_DATA CI_END="1.0736660614644755" CI_START="0.8138643446808447" EFFECT_SIZE="0.9347826086956522" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="46" LOG_CI_END="0.03086922529775066" LOG_CI_START="-0.0894479775017257" LOG_EFFECT_SIZE="-0.02928937610198753" MODIFIED="2014-07-12 20:02:29 +0100" MODIFIED_BY="[Empty name]" ORDER="950" O_E="0.0" SE="0.07067492050417162" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.004994944388270979" WEIGHT="13.644121857396254"/>
<DICH_DATA CI_END="1.0931968152633873" CI_START="0.8419047810299763" EFFECT_SIZE="0.9593579234972678" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="48" LOG_CI_END="0.038698357821618436" LOG_CI_START="-0.07473702419117069" LOG_EFFECT_SIZE="-0.01801933318477615" MODIFIED="2014-07-12 20:02:29 +0100" MODIFIED_BY="[Empty name]" ORDER="381" O_E="0.0" SE="0.06663250490850926" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.004439890710382512" WEIGHT="15.236456444872706"/>
<DICH_DATA CI_END="1.140333358907973" CI_START="0.8391257509123782" EFFECT_SIZE="0.978204010462075" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="31" LOG_CI_END="0.057031829205468565" LOG_CI_START="-0.07617295116771874" LOG_EFFECT_SIZE="-0.009570560981125088" MODIFIED="2014-07-12 20:02:29 +0100" MODIFIED_BY="[Empty name]" ORDER="374" O_E="0.0" SE="0.0782451473655073" STUDY_ID="STD-Scheiner-2012" TOTAL_1="37" TOTAL_2="34" VAR="0.006122303086249954" WEIGHT="9.583470771851502"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.017189806725487883" CI_END="1.0657687401636056" CI_START="0.9460899480893125" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0041479433114413" ESTIMABLE="YES" EVENTS_1="106" EVENTS_2="98" I2="0.0" I2_Q="0.0" ID="CMP-003.06" LOG_CI_END="0.027662977892558258" LOG_CI_START="-0.024067571735825095" LOG_EFFECT_SIZE="0.0017977030783665837" METHOD="MH" MODIFIED="2015-05-28 17:05:41 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.8956883721718261" P_Q="1.0" P_Z="0.8916453613620252" Q="0.0" RANDOM="NO" SCALE="1.25" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="111" TOTAL_2="103" WEIGHT="100.0" Z="0.13622253441367135">
<NAME>Objective cure and improvement (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lateral-to-medial</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours medial-to-lateral</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.083303527920105" CI_START="0.9231023201040947" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="48" LOG_CI_END="0.03475015748576663" LOG_CI_START="-0.03475015748576668" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:02:33 +0100" MODIFIED_BY="[Empty name]" ORDER="951" O_E="0.0" SE="0.04082482904638626" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0016666666666666635" WEIGHT="47.28655375043208"/>
<DICH_DATA CI_END="1.0997151743906002" CI_START="0.9236933775329172" EFFECT_SIZE="1.0078688524590165" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="50" LOG_CI_END="0.04128021769643864" LOG_CI_START="-0.03447217006255764" LOG_EFFECT_SIZE="0.003404023816940524" MODIFIED="2014-07-12 20:02:33 +0100" MODIFIED_BY="[Empty name]" ORDER="384" O_E="0.0" SE="0.04449732755000144" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.0019800121590921177" WEIGHT="52.71344624956792"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.621778475296931" CI_END="2.1338509240861523" CI_START="-1.0896117767764184" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5221195736548669" ESTIMABLE="YES" I2="54.694950741832606" I2_Q="0.0" ID="CMP-003.07" MODIFIED="2015-06-09 11:11:26 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0849818171225386" P_Q="1.0" P_Z="0.5254744890822194" Q="0.0" RANDOM="YES" SCALE="11.45" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="1.256498291386891" TOTALS="YES" TOTAL_1="248" TOTAL_2="233" UNITS="" WEIGHT="100.0" Z="0.6349293632050476">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.577861694064925" CI_START="1.222138305935073" EFFECT_SIZE="6.899999999999999" ESTIMABLE="YES" MEAN_1="26.9" MEAN_2="20.0" MODIFIED="2014-07-12 20:02:37 +0100" MODIFIED_BY="[Empty name]" ORDER="438" SD_1="16.8" SD_2="13.5" SE="2.8969214428689374" STUDY_ID="STD-Chen-2010" TOTAL_1="65" TOTAL_2="45" WEIGHT="7.008458017329623"/>
<CONT_DATA CI_END="1.563265287413134" CI_START="-1.563265287413134" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="16.0" MEAN_2="16.0" MODIFIED="2014-07-12 20:02:37 +0100" MODIFIED_BY="[Empty name]" ORDER="414" SD_1="5.0" SD_2="6.0" SE="0.7975989863813678" STUDY_ID="STD-Houwert-2009" TOTAL_1="93" TOTAL_2="98" WEIGHT="35.72859702736226"/>
<CONT_DATA CI_END="0.5925909250109821" CI_START="-1.1925909250109834" EFFECT_SIZE="-0.3000000000000007" ESTIMABLE="YES" MEAN_1="11.2" MEAN_2="11.5" MODIFIED="2014-07-12 20:02:37 +0100" MODIFIED_BY="[Empty name]" ORDER="943" SD_1="2.6" SD_2="1.9" SE="0.45541190146942806" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="46.19321835925296"/>
<CONT_DATA CI_END="5.917374035535149" CI_START="-2.717374035535153" EFFECT_SIZE="1.5999999999999979" ESTIMABLE="YES" MEAN_1="27.4" MEAN_2="25.8" MODIFIED="2014-07-12 20:02:37 +0100" MODIFIED_BY="[Empty name]" ORDER="375" SD_1="10.0" SD_2="9.7" SE="2.202782331507133" STUDY_ID="STD-Scheiner-2012" TOTAL_1="40" TOTAL_2="40" WEIGHT="11.069726596055158"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.4211852553547346" CI_END="8.216707799051584" CI_START="-6.005088066785262" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="1.1058098661331601" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.08" MODIFIED="2015-05-28 17:06:02 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.49135298911789627" P_Q="1.0" P_Z="0.7605242851922259" Q="0.0" RANDOM="NO" SCALE="46.48" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="129" TOTAL_2="126" UNITS="" WEIGHT="100.0" Z="0.30479238090829125">
<NAME>Operative blood loss (ml)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<CONT_DATA CI_END="14.863307401068063" CI_START="-16.26330740106807" EFFECT_SIZE="-0.7000000000000028" ESTIMABLE="YES" MEAN_1="54.9" MEAN_2="55.6" MODIFIED="2014-07-12 20:02:41 +0100" MODIFIED_BY="[Empty name]" ORDER="419" SD_1="34.2" SD_2="34.5" SE="7.940608870279989" STUDY_ID="STD-Houwert-2009" TOTAL_1="39" TOTAL_2="36" WEIGHT="20.87589476109013"/>
<CONT_DATA CI_END="8.525810736464381" CI_START="-8.125810736464375" EFFECT_SIZE="0.20000000000000284" ESTIMABLE="YES" MEAN_1="33.1" MEAN_2="32.9" MODIFIED="2014-07-12 20:02:41 +0100" MODIFIED_BY="[Empty name]" ORDER="949" SD_1="19.2" SD_2="23.1" SE="4.247940677551889" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="72.94504919945807"/>
<CONT_DATA CI_END="46.50641126178476" CI_START="-10.706411261784766" EFFECT_SIZE="17.9" ESTIMABLE="YES" MEAN_1="49.4" MEAN_2="31.5" MODIFIED="2014-07-12 20:02:41 +0100" MODIFIED_BY="[Empty name]" ORDER="376" SD_1="89.6" SD_2="22.2" SE="14.595375980083555" STUDY_ID="STD-Scheiner-2012" TOTAL_1="40" TOTAL_2="40" WEIGHT="6.179056039451807"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="23.20057530180393" CI_END="0.9896377692773605" CI_START="-2.5367757084986335" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.7735689696106366" ESTIMABLE="YES" I2="95.68976205550278" I2_Q="0.0" ID="CMP-003.09" MODIFIED="2015-05-28 17:06:13 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="1.4595680125628618E-6" P_Q="1.0" P_Z="0.38984860300426105" Q="0.0" RANDOM="YES" SCALE="11.98" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="1.5501741452991453" TOTALS="YES" TOTAL_1="105" TOTAL_2="85" UNITS="" WEIGHT="100.0" Z="0.8598919721409469">
<NAME>Length of hospital stay (days)</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.0284392565480283" CI_START="-2.371560743451972" EFFECT_SIZE="-1.7000000000000002" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="4.0" MODIFIED="2015-05-19 10:45:09 +0100" MODIFIED_BY="[Empty name]" ORDER="439" SD_1="0.8" SD_2="2.2" SE="0.3426393284515212" STUDY_ID="STD-Chen-2010" TOTAL_1="65" TOTAL_2="45" WEIGHT="48.531609422813126"/>
<CONT_DATA CI_END="0.39235673202518206" CI_START="-0.19235673202518278" EFFECT_SIZE="0.09999999999999964" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="3.2" MODIFIED="2014-07-12 20:02:44 +0100" MODIFIED_BY="[Empty name]" ORDER="397" SD_1="0.8" SD_2="0.5" SE="0.149164338901763" STUDY_ID="STD-Scheiner-2012" TOTAL_1="40" TOTAL_2="40" WEIGHT="51.468390577186874"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.10" MODIFIED="2015-05-28 17:06:25 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="5.46" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="50" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Time to return to normal activity level</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.595738672562844" CI_START="-1.795738672562845" EFFECT_SIZE="-0.6000000000000005" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.7" MODIFIED="2014-07-12 20:02:48 +0100" MODIFIED_BY="[Empty name]" ORDER="947" SD_1="3.0" SD_2="3.1" SE="0.6100819617067857" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.506839272049502" CI_START="0.22626504690017754" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.3032786885245902" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-003.11" LOG_CI_END="0.8754571173437723" LOG_CI_START="-0.6453825300523659" LOG_EFFECT_SIZE="0.11503729364570325" METHOD="MH" MODIFIED="2015-05-28 17:06:34 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.7668437741188703" Q="0.0" RANDOM="NO" SCALE="752.05" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="111" TOTAL_2="103" WEIGHT="100.0" Z="0.29650588451000337">
<NAME>Perioperative complications</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:02:53 +0100" MODIFIED_BY="[Empty name]" ORDER="948" O_E="0.0" SE="0.0" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.506839272049502" CI_START="0.22626504690017754" EFFECT_SIZE="1.3032786885245902" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8754571173437723" LOG_CI_START="-0.6453825300523659" LOG_EFFECT_SIZE="0.11503729364570325" MODIFIED="2014-07-12 20:02:53 +0100" MODIFIED_BY="[Empty name]" ORDER="408" O_E="0.0" SE="0.8933487371581608" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.7980719661820805" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.190362451053202" CI_START="0.23293134950671263" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-003.12" LOG_CI_END="0.34051598583001186" LOG_CI_START="-0.6327720571864879" LOG_EFFECT_SIZE="-0.146128035678238" METHOD="MH" MODIFIED="2015-05-28 17:06:43 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.556175115801735" Q="0.0" RANDOM="NO" SCALE="358.06" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="320" TOTAL_2="302" WEIGHT="100.0" Z="0.5885322215061369">
<NAME>Major vascular or visceral injury</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:02:57 +0100" MODIFIED_BY="[Empty name]" ORDER="441" O_E="0.0" SE="0.0" STUDY_ID="STD-Chen-2010" TOTAL_1="65" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.190362451053202" CI_START="0.23293134950671263" EFFECT_SIZE="0.7142857142857143" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.34051598583001186" LOG_CI_START="-0.6327720571864879" LOG_EFFECT_SIZE="-0.146128035678238" MODIFIED="2014-07-12 20:02:57 +0100" MODIFIED_BY="[Empty name]" ORDER="514" O_E="0.0" SE="0.5717142143214062" STUDY_ID="STD-Hassan-2013" TOTAL_1="125" TOTAL_2="125" VAR="0.32685714285714285" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:02:57 +0100" MODIFIED_BY="[Empty name]" ORDER="588" O_E="0.0" SE="0.0" STUDY_ID="STD-Houwert-2009" TOTAL_1="93" TOTAL_2="98" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:02:57 +0100" MODIFIED_BY="[Empty name]" ORDER="398" O_E="0.0" SE="0.0" STUDY_ID="STD-Scheiner-2012" TOTAL_1="37" TOTAL_2="34" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.536716946142871" CI_END="0.5329571514766851" CI_START="0.11789533937570781" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2506654428636989" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="32" I2="43.450379816762215" I2_Q="0.0" ID="CMP-003.13" LOG_CI_END="-0.2733077058425997" LOG_CI_START="-0.9285033630424826" LOG_EFFECT_SIZE="-0.6009055344425411" METHOD="MH" MODIFIED="2015-05-28 17:06:53 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.17061287641478784" P_Q="1.0" P_Z="3.2424322750378577E-4" Q="0.0" RANDOM="NO" SCALE="85.62" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="270" TOTAL_2="271" WEIGHT="100.0" Z="3.5951190844321257">
<NAME>Vaginal perforation/injury</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5946067189145471" CI_START="0.05299186841784719" EFFECT_SIZE="0.17750865051903114" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.22577018767896898" LOG_CI_START="-1.2757907676104943" LOG_EFFECT_SIZE="-0.7507804776447315" MODIFIED="2014-07-12 20:03:00 +0100" MODIFIED_BY="[Empty name]" ORDER="396" O_E="0.0" SE="0.6167872863374758" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="170" TOTAL_2="171" VAR="0.3804265565875473" WEIGHT="53.05185865075723"/>
<DICH_DATA CI_END="0.8500442566604848" CI_START="0.014523572055939016" EFFECT_SIZE="0.1111111111111111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.07055846261149344" LOG_CI_START="-1.8379265562671567" LOG_EFFECT_SIZE="-0.9542425094393249" MODIFIED="2014-07-12 20:03:00 +0100" MODIFIED_BY="[Empty name]" ORDER="505" O_E="0.0" SE="1.0381607668264958" STUDY_ID="STD-But-2008" TOTAL_1="60" TOTAL_2="60" VAR="1.077777777777778" WEIGHT="28.168884809545666"/>
<DICH_DATA CI_END="2.1844236592731723" CI_START="0.20346073553896835" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.33933687168887666" LOG_CI_START="-0.6915193898002392" LOG_EFFECT_SIZE="-0.17609125905568127" MODIFIED="2014-07-12 20:03:00 +0100" MODIFIED_BY="[Empty name]" ORDER="380" O_E="0.0" SE="0.6055300708194983" STUDY_ID="STD-Scheiner-2012" TOTAL_1="40" TOTAL_2="40" VAR="0.3666666666666666" WEIGHT="18.77925653969711"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.09713094789457838" CI_END="1.9177130747637614" CI_START="0.07450687896837296" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.37799843380295894" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-003.14" LOG_CI_END="0.2827836292328029" LOG_CI_START="-1.1278036284585726" LOG_EFFECT_SIZE="-0.4225099996128849" METHOD="MH" MODIFIED="2015-05-28 17:07:02 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.9525949692734899" P_Q="1.0" P_Z="0.24034412983717257" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="414" TOTAL_2="380" WEIGHT="100.0" Z="1.1741271273137626">
<NAME>Bladder or urethral perforation</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.494619427549341" CI_START="0.046035913919963284" EFFECT_SIZE="0.5029411764705882" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7399376173711482" LOG_CI_START="-1.3369032306713506" LOG_EFFECT_SIZE="-0.2984828066501013" MODIFIED="2014-07-12 20:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="393" O_E="0.0" SE="1.2199465946681638" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="170" TOTAL_2="171" VAR="1.4882696938424493" WEIGHT="38.67582102766621"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="440" O_E="0.0" SE="0.0" STUDY_ID="STD-Chen-2010" TOTAL_1="65" TOTAL_2="45" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.335004447263945" CI_START="0.01296106159552591" EFFECT_SIZE="0.30833333333333335" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8654003814951304" LOG_CI_START="-1.88735942545639" LOG_EFFECT_SIZE="-0.5109795219806298" MODIFIED="2014-07-12 20:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="658" O_E="0.0" SE="1.616984736984131" STUDY_ID="STD-Houwert-2009" TOTAL_1="39" TOTAL_2="36" VAR="2.6146396396396394" WEIGHT="30.225641643470237"/>
<DICH_DATA CI_END="6.9795517642529346" CI_START="0.012076305711229002" EFFECT_SIZE="0.2903225806451613" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8438275325712602" LOG_CI_START="-1.9180659013611558" LOG_EFFECT_SIZE="-0.5371191843949478" MODIFIED="2014-07-12 20:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="425" O_E="0.0" SE="1.6223498746848917" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="2.6320191158900834" WEIGHT="31.098537328863554"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="411" O_E="0.0" SE="0.0" STUDY_ID="STD-Park-2012" TOTAL_1="39" TOTAL_2="35" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:03:04 +0100" MODIFIED_BY="[Empty name]" ORDER="377" O_E="0.0" SE="0.0" STUDY_ID="STD-Scheiner-2012" TOTAL_1="40" TOTAL_2="40" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.7321964574586373" CI_END="2.882993241964085" CI_START="1.0555495401087656" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.744460429672129" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="22" I2="0.0" I2_Q="0.0" ID="CMP-003.15" LOG_CI_END="0.45984362435798015" LOG_CI_START="0.02347862086582601" LOG_EFFECT_SIZE="0.2416611226119031" METHOD="MH" MODIFIED="2015-05-28 17:07:12 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.8416298011374999" P_Q="1.0" P_Z="0.029940567732669142" Q="0.0" RANDOM="NO" SCALE="29.65" SORT_BY="STUDY" STUDIES="8" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="575" TOTAL_2="546" WEIGHT="99.99999999999999" Z="2.170875725561545">
<NAME>Voiding dysfunction</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.0997927509210688" CI_START="0.5802821252243512" EFFECT_SIZE="1.3411764705882352" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.49133265830518036" LOG_CI_START="-0.2363608070608206" LOG_EFFECT_SIZE="0.12748592562217984" MODIFIED="2014-07-12 20:03:07 +0100" MODIFIED_BY="[Empty name]" ORDER="394" O_E="0.0" SE="0.42745074369673713" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="170" TOTAL_2="171" VAR="0.18271413828689367" WEIGHT="39.795286491872815"/>
<DICH_DATA CI_END="9.569389833948613" CI_START="0.743110191402544" EFFECT_SIZE="2.6666666666666665" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="3" LOG_CI_END="0.9808842470561309" LOG_CI_START="-0.1289467825115685" LOG_EFFECT_SIZE="0.4259687322722811" MODIFIED="2014-07-12 20:03:07 +0100" MODIFIED_BY="[Empty name]" ORDER="400" O_E="0.0" SE="0.6519202405202649" STUDY_ID="STD-But-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.425" WEIGHT="13.30411048404768"/>
<DICH_DATA CI_END="5.966120363559969" CI_START="0.1807543765711803" EFFECT_SIZE="1.0384615384615385" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.7756920107931609" LOG_CI_START="-0.742911178416822" LOG_EFFECT_SIZE="0.016390416188169384" MODIFIED="2014-07-12 20:03:07 +0100" MODIFIED_BY="[Empty name]" ORDER="442" O_E="0.0" SE="0.8920350305489665" STUDY_ID="STD-Chen-2010" TOTAL_1="65" TOTAL_2="45" VAR="0.7957264957264957" WEIGHT="10.48202644197696"/>
<DICH_DATA CI_END="12.366140019999168" CI_START="0.9977220840292162" EFFECT_SIZE="3.5125448028673834" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="3" LOG_CI_END="1.0922341596437495" LOG_CI_START="-9.904148059549558E-4" LOG_EFFECT_SIZE="0.5456218724188973" MODIFIED="2014-07-12 20:03:07 +0100" MODIFIED_BY="[Empty name]" ORDER="590" O_E="0.0" SE="0.6421655265806763" STUDY_ID="STD-Houwert-2009" TOTAL_1="93" TOTAL_2="98" VAR="0.4123765635286373" WEIGHT="12.955835340486221"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:03:07 +0100" MODIFIED_BY="[Empty name]" ORDER="942" O_E="0.0" SE="0.0" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.506839272049502" CI_START="0.22626504690017754" EFFECT_SIZE="1.3032786885245902" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8754571173437723" LOG_CI_START="-0.6453825300523659" LOG_EFFECT_SIZE="0.11503729364570325" MODIFIED="2014-07-12 20:03:07 +0100" MODIFIED_BY="[Empty name]" ORDER="398" O_E="0.0" SE="0.8933487371581608" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.7980719661820805" WEIGHT="9.491821514934601"/>
<DICH_DATA CI_END="7.593321325390753" CI_START="0.23864789857573165" EFFECT_SIZE="1.3461538461538463" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8804317782384333" LOG_CI_START="-0.622242385479518" LOG_EFFECT_SIZE="0.1290946963794577" MODIFIED="2014-07-12 20:03:07 +0100" MODIFIED_BY="[Empty name]" ORDER="410" O_E="0.0" SE="0.8826782421249993" STUDY_ID="STD-Park-2012" TOTAL_1="39" TOTAL_2="35" VAR="0.779120879120879" WEIGHT="9.348834394195665"/>
<DICH_DATA CI_END="14.123795771264454" CI_START="0.05978647618688399" EFFECT_SIZE="0.918918918918919" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1499514290798054" LOG_CI_START="-1.2233970431292849" LOG_EFFECT_SIZE="-0.03672280702473985" MODIFIED="2014-07-12 20:03:07 +0100" MODIFIED_BY="[Empty name]" ORDER="378" O_E="0.0" SE="1.3941166408400305" STUDY_ID="STD-Scheiner-2012" TOTAL_1="37" TOTAL_2="34" VAR="1.9435612082670908" WEIGHT="4.622085332486048"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.0513477465334606" CI_END="2.2043481925120423" CI_START="0.45839969808967407" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.005222635007807" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" I2="0.0" I2_Q="0.0" ID="CMP-003.16" LOG_CI_END="0.34328019550778904" LOG_CI_START="-0.3387556770747671" LOG_EFFECT_SIZE="0.0022622592165109515" METHOD="MH" MODIFIED="2015-05-28 17:07:23 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.5911569560634993" P_Q="1.0" P_Z="0.989626123810596" Q="0.0" RANDOM="NO" SCALE="237.41" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="182" TOTAL_2="175" WEIGHT="100.0" Z="0.013002092019781744">
<NAME>De novo urgency or urgency incontinence</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.6811949478399804" CI_START="0.09588703986739214" EFFECT_SIZE="0.5070422535211268" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4283283923838975" LOG_CI_START="-1.0182400882874736" LOG_EFFECT_SIZE="-0.29495584795178803" MODIFIED="2014-07-12 20:03:10 +0100" MODIFIED_BY="[Empty name]" ORDER="389" O_E="0.0" SE="0.8497214861758279" STUDY_ID="STD-Houwert-2009" TOTAL_1="71" TOTAL_2="72" VAR="0.7220266040688577" WEIGHT="34.86351154902277"/>
<DICH_DATA CI_END="21.357023897403046" CI_START="0.1872920131201609" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3295407336099563" LOG_CI_START="-0.7274807422819939" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2014-07-12 20:03:10 +0100" MODIFIED_BY="[Empty name]" ORDER="952" O_E="0.0" SE="1.2083045973594573" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" VAR="1.46" WEIGHT="8.77725730899693"/>
<DICH_DATA CI_END="3.1253831112187527" CI_START="0.4294041935127506" EFFECT_SIZE="1.1584699453551912" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.4949032610049505" LOG_CI_START="-0.36713371860830657" LOG_EFFECT_SIZE="0.06388477119832195" MODIFIED="2014-07-12 20:03:10 +0100" MODIFIED_BY="[Empty name]" ORDER="438" O_E="0.0" SE="0.506364788976696" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.2564052995154139" WEIGHT="56.35923114198029"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-003.17" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-05-28 17:07:32 +0100" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="47.62" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="61" TOTAL_2="53" WEIGHT="0.0" Z="0.0">
<NAME>Detrusor overactivity</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.8380317388655314" CI_START="0.2659958256282918" EFFECT_SIZE="0.8688524590163934" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4530172480407948" LOG_CI_START="-0.5751251788607508" LOG_EFFECT_SIZE="-0.061053965409978005" MODIFIED="2014-07-12 20:03:13 +0100" MODIFIED_BY="[Empty name]" ORDER="439" O_E="0.0" SE="0.6039359509490616" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.3647386328487473" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.6548094723596773" CI_END="1.091185014310166" CI_START="0.164128920644808" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.42319619400759845" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-003.18" LOG_CI_END="0.03789839300971665" LOG_CI_START="-0.7848148865288552" LOG_EFFECT_SIZE="-0.3734582467595693" METHOD="MH" MODIFIED="2015-05-28 17:07:42 +0100" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.44796171250280037" P_Q="1.0" P_Z="0.07517551735819754" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="549" TOTAL_2="538" WEIGHT="100.0" Z="1.7793919986043232">
<NAME>Vaginal tape erosion</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.4016349286412346" CI_START="0.14216254340929238" EFFECT_SIZE="0.5843137254901961" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3805069911907671" LOG_CI_START="-0.8472148152341292" LOG_EFFECT_SIZE="-0.2333539120216811" MODIFIED="2014-07-12 20:03:23 +0100" MODIFIED_BY="[Empty name]" ORDER="395" O_E="0.0" SE="0.7211698664149396" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="153" TOTAL_2="149" VAR="0.5200859762249419" WEIGHT="36.02085619751916"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:03:23 +0100" MODIFIED_BY="[Empty name]" ORDER="401" O_E="0.0" SE="0.0" STUDY_ID="STD-But-2008" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="69.23359420415046" CI_START="0.1176801824871905" EFFECT_SIZE="2.854368932038835" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8403168782315598" LOG_CI_START="-0.9292966668175895" LOG_EFFECT_SIZE="0.4555101057069851" MODIFIED="2014-07-12 20:03:23 +0100" MODIFIED_BY="[Empty name]" ORDER="516" O_E="0.0" SE="1.6268847061700273" STUDY_ID="STD-Hassan-2013" TOTAL_1="102" TOTAL_2="97" VAR="2.646753847169936" WEIGHT="3.6434323574286442"/>
<DICH_DATA CI_END="2.4230718576882557" CI_START="0.031474876291406974" EFFECT_SIZE="0.2761627906976744" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.38436629359881447" LOG_CI_START="-1.502035968164179" LOG_EFFECT_SIZE="-0.5588348372826824" MODIFIED="2014-07-12 20:03:23 +0100" MODIFIED_BY="[Empty name]" ORDER="434" O_E="0.0" SE="1.108082026401377" STUDY_ID="STD-Houwert-2009" TOTAL_1="86" TOTAL_2="95" VAR="1.227845777233782" WEIGHT="27.025852805025604"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:03:23 +0100" MODIFIED_BY="[Empty name]" ORDER="941" O_E="0.0" SE="0.0" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-12 20:03:23 +0100" MODIFIED_BY="[Empty name]" ORDER="433" O_E="0.0" SE="0.0" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.833031432138652" CI_START="0.005713654355714873" EFFECT_SIZE="0.1023391812865497" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.26316991214570323" LOG_CI_START="-2.2430860355574223" LOG_EFFECT_SIZE="-0.9899580617058594" MODIFIED="2014-07-12 20:03:23 +0100" MODIFIED_BY="[Empty name]" ORDER="379" O_E="0.0" SE="1.4721871498478412" STUDY_ID="STD-Scheiner-2012" TOTAL_1="37" TOTAL_2="34" VAR="2.16733500417711" WEIGHT="33.30985864002658"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.852878537175797" CI_END="1.7589974805162238" CI_START="0.7490917387405562" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1478895770587674" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="33" I2="0.0" I2_Q="0.0" ID="CMP-003.19" LOG_CI_END="0.24526521740022142" LOG_CI_START="-0.1254649924619945" LOG_EFFECT_SIZE="0.05990011246911347" METHOD="MH" MODIFIED="2015-06-09 11:11:36 +0100" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.5707865204241166" P_Q="1.0" P_Z="0.5265013299088689" Q="0.0" RANDOM="NO" SCALE="111.36" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="423" TOTAL_2="414" WEIGHT="100.0" Z="0.6333557934380055">
<NAME>Groin/thigh pain</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.392234122259808" CI_START="0.8107160986606855" EFFECT_SIZE="1.3926315789473684" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="19" LOG_CI_END="0.3788036807636436" LOG_CI_START="-0.09113120296633713" LOG_EFFECT_SIZE="0.1438362388986532" MODIFIED="2014-07-12 20:03:27 +0100" MODIFIED_BY="[Empty name]" ORDER="396" O_E="0.0" SE="0.27604207691818183" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="150" TOTAL_2="147" VAR="0.07619922822930342" WEIGHT="55.88566254492847"/>
<DICH_DATA CI_END="8.910758777405627" CI_START="0.015182621466913926" EFFECT_SIZE="0.367816091954023" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9499146870682453" LOG_CI_START="-1.8186532356656702" LOG_EFFECT_SIZE="-0.4343692742987126" MODIFIED="2014-07-12 20:03:27 +0100" MODIFIED_BY="[Empty name]" ORDER="591" O_E="0.0" SE="1.626270502446145" STUDY_ID="STD-Houwert-2009" TOTAL_1="86" TOTAL_2="95" VAR="2.6447557471264367" WEIGHT="4.153090694559698"/>
<DICH_DATA CI_END="1.9257206937088356" CI_START="0.3141360393442413" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.2845932973381821" LOG_CI_START="-0.5028822361883182" LOG_EFFECT_SIZE="-0.10914446942506803" MODIFIED="2014-07-12 20:03:27 +0100" MODIFIED_BY="[Empty name]" ORDER="945" O_E="0.0" SE="0.46256702646022446" STUDY_ID="STD-Lee-2008" TOTAL_1="50" TOTAL_2="50" VAR="0.21396825396825397" WEIGHT="26.2074343829112"/>
<DICH_DATA CI_END="24.314559937425077" CI_START="0.279426869222993" EFFECT_SIZE="2.6065573770491803" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3858664137981935" LOG_CI_START="-0.5537318351788246" LOG_EFFECT_SIZE="0.41606728930968445" MODIFIED="2014-07-12 20:03:27 +0100" MODIFIED_BY="[Empty name]" ORDER="437" O_E="0.0" SE="1.1393296126152785" STUDY_ID="STD-Liapis-2008" TOTAL_1="61" TOTAL_2="53" VAR="1.2980719661820805" WEIGHT="3.116283620580084"/>
<DICH_DATA CI_END="64.20162950009765" CI_START="0.11354851982361147" EFFECT_SIZE="2.7" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8075460510271049" LOG_CI_START="-0.9448185227091305" LOG_EFFECT_SIZE="0.43136376415898736" MODIFIED="2014-07-12 20:03:27 +0100" MODIFIED_BY="[Empty name]" ORDER="412" O_E="0.0" SE="1.6167525750370366" STUDY_ID="STD-Park-2012" TOTAL_1="39" TOTAL_2="35" VAR="2.613888888888889" WEIGHT="1.5325985019246313"/>
<DICH_DATA CI_END="2.8055087415977464" CI_START="0.03344261662488349" EFFECT_SIZE="0.3063063063063063" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.44801162624630175" LOG_CI_START="-1.4756997497351063" LOG_EFFECT_SIZE="-0.5138440617444023" MODIFIED="2014-07-12 20:03:27 +0100" MODIFIED_BY="[Empty name]" ORDER="380" O_E="0.0" SE="1.1299975847763677" STUDY_ID="STD-Scheiner-2012" TOTAL_1="37" TOTAL_2="34" VAR="1.276894541600424" WEIGHT="9.104930255095908"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.698867605885551" CI_END="1.299977525690883" CI_START="0.31962112457804365" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6445931109525626" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="19" I2="41.13726128300972" I2_Q="0.0" ID="CMP-003.20" LOG_CI_END="0.11393584418929506" LOG_CI_START="-0.4953645247757742" LOG_EFFECT_SIZE="-0.19071434029323958" METHOD="MH" MODIFIED="2015-05-28 17:08:00 +0100" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.1924362232314918" P_Q="1.0" P_Z="0.2198380828991029" Q="0.0" RANDOM="NO" SCALE="200.28" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="263" TOTAL_2="269" WEIGHT="100.00000000000001" Z="1.2269588444365278">
<NAME>Repeat incontinence surgery</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours medial-to-lateral</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours lateral-to-medial</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1223212531532463" CI_START="0.1963318472542581" EFFECT_SIZE="0.46941176470588236" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="0.050117187135797533" LOG_CI_START="-0.7070092471908865" LOG_EFFECT_SIZE="-0.3284460300275445" MODIFIED="2014-07-12 20:03:30 +0100" MODIFIED_BY="[Empty name]" ORDER="398" O_E="0.0" SE="0.44473981535978846" STUDY_ID="STD-Abdel_x002d_Fattah-2010" TOTAL_1="170" TOTAL_2="171" VAR="0.19779350336625875" WEIGHT="79.3367671061505"/>
<DICH_DATA CI_END="4.755563622767243" CI_START="0.36484154316951023" EFFECT_SIZE="1.3172043010752688" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6772019963000839" LOG_CI_START="-0.4378957160068517" LOG_EFFECT_SIZE="0.11965314014661614" MODIFIED="2014-07-12 20:03:30 +0100" MODIFIED_BY="[Empty name]" ORDER="589" O_E="0.0" SE="0.6550139160317924" STUDY_ID="STD-Houwert-2009" TOTAL_1="93" TOTAL_2="98" VAR="0.42904323019530394" WEIGHT="20.66323289384951"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="28.240116633537234" CI_START="4.8398833664627645" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="16.54" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.21" MODIFIED="2015-05-28 17:08:09 +0100" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="1.0" P_Q="1.0" P_Z="0.0055931662355448945" Q="0.0" RANDOM="NO" SCALE="57.94" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="24" TOTAL_2="22" UNITS="" WEIGHT="100.0" Z="2.77072488417509">
<NAME>QoL specific</NAME>
<GROUP_LABEL_1>Medial-to-lateral</GROUP_LABEL_1>
<GROUP_LABEL_2>Lateral-to-medial</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lateral-to-medial</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours medial-to-lateral</GRAPH_LABEL_2>
<CONT_DATA CI_END="28.240116633537234" CI_START="4.8398833664627645" EFFECT_SIZE="16.54" ESTIMABLE="YES" MEAN_1="22.93" MEAN_2="6.39" MODIFIED="2014-07-12 20:03:33 +0100" MODIFIED_BY="[Empty name]" ORDER="411" SD_1="26.01" SD_2="12.8" SE="5.969556954018676" STUDY_ID="STD-Houwert-2009" TOTAL_1="24" TOTAL_2="22" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2015-06-22 10:36:02 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>One method of mid-urethral tape insertion versus another method, same route</NAME>
<DICH_OUTCOME CHI2="0.3520513774553673" CI_END="1.0714825737778149" CI_START="0.9649437375354192" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0168187643062234" ESTIMABLE="YES" EVENTS_1="406" EVENTS_2="393" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.02998511221995884" LOG_CI_START="-0.01549800809686648" LOG_EFFECT_SIZE="0.007243552061546168" METHOD="MH" MODIFIED="2015-06-22 10:08:25 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9992029300470266" P_Q="0.9967569456108762" P_Z="0.5324437201704256" Q="0.342926634244793" RANDOM="NO" SCALE="2.05" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="472" TOTAL_2="465" WEIGHT="600.0" Z="0.6242799993438227">
<NAME>Subjective cure (short term, up to 1 year)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method B</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method A</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.113960233853289" CI_START="0.9003497085061614" DF="0" EFFECT_SIZE="1.0014757969303423" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="77" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.046869687672238335" LOG_CI_START="-0.04558877169934159" LOG_EFFECT_SIZE="6.404579864483816E-4" MODIFIED="2015-06-22 10:08:25 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.978337489991607" STUDIES="1" TAU2="0.0" TOTAL_1="88" TOTAL_2="87" WEIGHT="100.0" Z="0.027153266355111248">
<NAME>Modified TVT-O (short tape) vs TVT-O</NAME>
<DICH_DATA CI_END="1.113960233853289" CI_START="0.9003497085061614" EFFECT_SIZE="1.0014757969303423" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="77" LOG_CI_END="0.046869687672238335" LOG_CI_START="-0.04558877169934159" LOG_EFFECT_SIZE="6.404579864483816E-4" MODIFIED="2014-03-26 09:24:23 +0000" MODIFIED_BY="[Empty name]" ORDER="297" O_E="0.0" SE="0.05431055671162123" STUDY_ID="STD-de-Leval-2011" TOTAL_1="88" TOTAL_2="87" VAR="0.0029496365703262258" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1031923952039235" CI_START="0.9108028438786395" DF="0" EFFECT_SIZE="1.002392523364486" ESTIMABLE="YES" EVENTS_1="109" EVENTS_2="107" I2="0.0" ID="CMP-004.01.02" LOG_CI_END="0.042651259392996806" LOG_CI_START="-0.04057562201948579" LOG_EFFECT_SIZE="0.0010378186867554858" MODIFIED="2014-03-28 18:04:50 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.9610145010651753" STUDIES="1" TAU2="0.0" TOTAL_1="125" TOTAL_2="123" WEIGHT="100.0" Z="0.04888053508678821">
<NAME>Modified TVT (suburethral pad) versus TVT</NAME>
<DICH_DATA CI_END="1.1031923952039235" CI_START="0.9108028438786395" EFFECT_SIZE="1.002392523364486" ESTIMABLE="YES" EVENTS_1="109" EVENTS_2="107" LOG_CI_END="0.042651259392996806" LOG_CI_START="-0.04057562201948579" LOG_EFFECT_SIZE="0.0010378186867554858" MODIFIED="2014-03-28 18:04:50 +0000" MODIFIED_BY="[Empty name]" ORDER="554" O_E="0.0" SE="0.048887882121399585" STUDY_ID="STD-Naumann-2006" TOTAL_1="125" TOTAL_2="123" VAR="0.0023900250183158615" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1101513945796977" CI_START="0.9332359246889449" DF="0" EFFECT_SIZE="1.0178571428571428" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="70" I2="0.0" ID="CMP-004.01.03" LOG_CI_END="0.04538220882909076" LOG_CI_START="-0.030008551496508887" LOG_EFFECT_SIZE="0.007686828666290955" MODIFIED="2014-03-26 17:09:51 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.6893957862761504" STUDIES="1" TAU2="0.0" TOTAL_1="80" TOTAL_2="76" WEIGHT="100.0" Z="0.3996751664578865">
<NAME>Self-tailored TVT-O vs TVT-O</NAME>
<DICH_DATA CI_END="1.1101513945796977" CI_START="0.9332359246889449" EFFECT_SIZE="1.0178571428571428" ESTIMABLE="YES" EVENTS_1="75" EVENTS_2="70" LOG_CI_END="0.04538220882909076" LOG_CI_START="-0.030008551496508887" LOG_EFFECT_SIZE="0.007686828666290955" MODIFIED="2014-03-26 09:26:32 +0000" MODIFIED_BY="[Empty name]" ORDER="489" O_E="0.0" SE="0.04428490580553959" STUDY_ID="STD-Zhang-2011" TOTAL_1="80" TOTAL_2="76" VAR="0.0019611528822055142" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.242765917491171" CI_START="0.86839533898965" DF="0" EFFECT_SIZE="1.0388513513513513" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="37" I2="0.0" ID="CMP-004.01.04" LOG_CI_END="0.09438933434116" LOG_CI_START="-0.06128251623616608" LOG_EFFECT_SIZE="0.016553409052496942" MODIFIED="2015-06-09 11:15:36 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.6768052318292515" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="45" WEIGHT="100.0" Z="0.4168266188643724">
<NAME>Monarc<SUP></SUP>TOT open edge + tension suture vs TOT<SUP></SUP>
</NAME>
<DICH_DATA CI_END="1.242765917491171" CI_START="0.8683953389896499" EFFECT_SIZE="1.0388513513513513" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="37" LOG_CI_END="0.09438933434116" LOG_CI_START="-0.06128251623616614" LOG_EFFECT_SIZE="0.016553409052496942" MODIFIED="2014-03-26 15:47:30 +0000" MODIFIED_BY="[Empty name]" ORDER="513" O_E="0.0" SE="0.0914424156172096" STUDY_ID="STD-Cho-2010" TOTAL_1="48" TOTAL_2="45" VAR="0.008361715373910499" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2761151909627662" CI_START="0.8682862243503843" DF="0" EFFECT_SIZE="1.0526315789473684" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="38" I2="0.0" ID="CMP-004.01.05" LOG_CI_END="0.10588987857130688" LOG_CI_START="-0.061337089149002454" LOG_EFFECT_SIZE="0.022276394711152208" MODIFIED="2015-06-09 11:15:45 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.6015479899655205" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0" Z="0.52217572242631">
<NAME>AdjustableTOT vs TOT<SUP></SUP>
</NAME>
<DICH_DATA CI_END="1.2761151909627662" CI_START="0.8682862243503843" EFFECT_SIZE="1.0526315789473684" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="38" LOG_CI_END="0.10588987857130688" LOG_CI_START="-0.061337089149002454" LOG_EFFECT_SIZE="0.022276394711152208" MODIFIED="2014-07-01 00:54:54 +0100" MODIFIED_BY="[Empty name]" ORDER="615" O_E="0.0" SE="0.09822994862575031" STUDY_ID="STD-Elbadry-2014" TOTAL_1="48" TOTAL_2="48" VAR="0.009649122807017546" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.004636057180149709" CI_END="1.215112149648454" CI_START="0.8634040998331906" DF="1" EFFECT_SIZE="1.024271844660194" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="64" I2="0.0" ID="CMP-004.01.06" LOG_CI_END="0.08461636330529843" LOG_CI_START="-0.06378589344822004" LOG_EFFECT_SIZE="0.010415234928539166" MODIFIED="2014-07-01 00:55:15 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9457151068075207" P_Z="0.7832315955428553" STUDIES="2" TAU2="0.0" TOTAL_1="83" TOTAL_2="86" WEIGHT="100.0" Z="0.2751101741581351">
<NAME>Synthetic vs biological</NAME>
<DICH_DATA CI_END="1.250159218153584" CI_START="0.8292497466100139" EFFECT_SIZE="1.018181818181818" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="30" LOG_CI_END="0.09696532753771661" LOG_CI_START="-0.08131465251380358" LOG_EFFECT_SIZE="0.007825337511956526" MODIFIED="2014-06-21 23:18:20 +0100" MODIFIED_BY="[Empty name]" ORDER="420" O_E="0.0" SE="0.10472254278239701" STUDY_ID="STD-Paparella-2010" TOTAL_1="33" TOTAL_2="36" VAR="0.010966810966810972" WEIGHT="45.769764216366156"/>
<DICH_DATA CI_END="1.3388640199493698" CI_START="0.7914833512031727" EFFECT_SIZE="1.0294117647058822" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="34" LOG_CI_END="0.1267364706755793" LOG_CI_START="-0.10155821605953838" LOG_EFFECT_SIZE="0.012589127308020467" MODIFIED="2014-06-21 23:32:03 +0100" MODIFIED_BY="[Empty name]" ORDER="604" O_E="0.0" SE="0.1341014290651331" STUDY_ID="STD-Ugurlucan-2013" TOTAL_1="50" TOTAL_2="50" VAR="0.017983193277310922" WEIGHT="54.23023578363384"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.397359306432951" CI_END="1.0839328115898492" CI_START="1.0084713579281044" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0455214939956248" ESTIMABLE="YES" EVENTS_1="397" EVENTS_2="383" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.035002362958718426" LOG_CI_START="0.0036635681210032177" LOG_EFFECT_SIZE="0.0193329655398608" METHOD="MH" MODIFIED="2015-06-22 10:08:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4972414600608648" P_Q="0.5761333112539266" P_Z="0.01559701059588769" Q="1.1028328552977817" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="416" TOTAL_2="420" WEIGHT="300.0" Z="2.4182114448689283">
<NAME>Subjective cure and improvement (short term, up to 1 year)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method B</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method A</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0866937140753616" CI_START="0.9679058458349793" DF="0" EFFECT_SIZE="1.0255813953488373" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="80" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="0.03610715491345563" LOG_CI_START="-0.01416688713695156" LOG_EFFECT_SIZE="0.010970133888252048" MODIFIED="2015-06-22 10:08:49 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.3923548610997548" STUDIES="1" TAU2="0.0" TOTAL_1="86" TOTAL_2="84" WEIGHT="100.0" Z="0.8553546303278475">
<NAME>Modified TVT-O (short tape) vs TVT-O</NAME>
<DICH_DATA CI_END="1.0866937140753616" CI_START="0.9679058458349793" EFFECT_SIZE="1.0255813953488373" ESTIMABLE="YES" EVENTS_1="84" EVENTS_2="80" LOG_CI_END="0.03610715491345563" LOG_CI_START="-0.01416688713695156" LOG_EFFECT_SIZE="0.010970133888252048" MODIFIED="2014-03-26 15:54:26 +0000" MODIFIED_BY="[Empty name]" ORDER="298" O_E="0.0" SE="0.02953122116093093" STUDY_ID="STD-de-Leval-2011" TOTAL_1="86" TOTAL_2="84" VAR="8.720930232558148E-4" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1365386382543825" CI_START="1.0016318505135036" DF="0" EFFECT_SIZE="1.066955153422502" ESTIMABLE="YES" EVENTS_1="191" EVENTS_2="186" I2="0.0" ID="CMP-004.02.02" LOG_CI_END="0.05558420477320165" LOG_CI_START="7.081260523875976E-4" LOG_EFFECT_SIZE="0.028146165412794626" MODIFIED="2015-06-22 10:08:59 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.04437331629239064" STUDIES="1" TAU2="0.0" TOTAL_1="205" TOTAL_2="213" WEIGHT="100.0" Z="2.010547101684968">
<NAME>TOT + 2-point tape fixation vs TOT</NAME>
<DICH_DATA CI_END="1.1365386382543825" CI_START="1.0016318505135036" EFFECT_SIZE="1.066955153422502" ESTIMABLE="YES" EVENTS_1="191" EVENTS_2="186" LOG_CI_END="0.05558420477320165" LOG_CI_START="7.081260523875976E-4" LOG_EFFECT_SIZE="0.028146165412794626" MODIFIED="2014-03-26 15:54:49 +0000" MODIFIED_BY="[Empty name]" ORDER="1061" O_E="0.0" SE="0.03223448028157683" STUDY_ID="STD-Rechberger-2011" TOTAL_1="205" TOTAL_2="213" VAR="0.0010390617190233651" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.077097389015888" CI_START="0.9774243667612775" DF="0" EFFECT_SIZE="1.0260512820512822" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="117" I2="0.0" ID="CMP-004.02.03" LOG_CI_END="0.03225497312156765" LOG_CI_START="-0.009916838401711404" LOG_EFFECT_SIZE="0.011169067359928146" MODIFIED="2014-03-28 18:06:10 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.29918618585896406" STUDIES="1" TAU2="0.0" TOTAL_1="125" TOTAL_2="123" WEIGHT="100.0" Z="1.038180195521224">
<NAME>TVT versus modified TVT (suburethral pad)</NAME>
<DICH_DATA CI_END="1.077097389015888" CI_START="0.9774243667612776" EFFECT_SIZE="1.0260512820512822" ESTIMABLE="YES" EVENTS_1="122" EVENTS_2="117" LOG_CI_END="0.03225497312156765" LOG_CI_START="-0.009916838401711354" LOG_EFFECT_SIZE="0.011169067359928146" MODIFIED="2014-03-28 18:06:10 +0000" MODIFIED_BY="[Empty name]" ORDER="555" O_E="0.0" SE="0.024771930842607873" STUDY_ID="STD-Naumann-2006" TOTAL_1="125" TOTAL_2="123" VAR="6.136485576709472E-4" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.1248753201911108" CI_START="0.8560746572124809" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9813140446051839" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="63" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.0511043884440658" LOG_CI_START="-0.06748835938642228" LOG_EFFECT_SIZE="-0.008191985471178245" METHOD="MH" MODIFIED="2015-06-22 10:10:03 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.7865638189090735" Q="0.0" RANDOM="NO" SCALE="2.11" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="79" TOTAL_2="74" WEIGHT="100.0" Z="0.2707753514293231">
<NAME>Subjective cure (medium term, 1 to 5 years)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method B</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method A</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1248753201911108" CI_START="0.8560746572124809" DF="0" EFFECT_SIZE="0.9813140446051839" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="63" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="0.0511043884440658" LOG_CI_START="-0.06748835938642228" LOG_EFFECT_SIZE="-0.008191985471178245" MODIFIED="2015-06-22 10:10:03 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7865638189090735" STUDIES="1" TAU2="0.0" TOTAL_1="79" TOTAL_2="74" WEIGHT="100.0" Z="0.2707753514293231">
<NAME>Modified TVT-O (short tape) vs TVT-O</NAME>
<DICH_DATA CI_END="1.1248753201911108" CI_START="0.8560746572124809" EFFECT_SIZE="0.9813140446051839" ESTIMABLE="YES" EVENTS_1="66" EVENTS_2="63" LOG_CI_END="0.0511043884440658" LOG_CI_START="-0.06748835938642228" LOG_EFFECT_SIZE="-0.008191985471178245" MODIFIED="2014-03-26 09:24:23 +0000" MODIFIED_BY="[Empty name]" ORDER="302" O_E="0.0" SE="0.06966196711919816" STUDY_ID="STD-de-Leval-2011" TOTAL_1="79" TOTAL_2="74" VAR="0.004852789662916246" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="50" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-05-28 17:09:20 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.19" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="57" TOTAL_2="56" WEIGHT="0.0" Z="0.0">
<NAME>Objective cure (medium term, 1 to 5 years)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method B</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method A</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="50" EVENTS_2="48" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-05-28 16:40:38 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="57" TOTAL_2="56" WEIGHT="0.0" Z="0.0">
<NAME>Modified TVT-O (short tape) vs TVT-O</NAME>
<DICH_DATA CI_END="1.1824402172245134" CI_START="0.8857367902273141" EFFECT_SIZE="1.023391812865497" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="48" LOG_CI_END="0.07277919255079361" LOG_CI_START="-0.052695315962512417" LOG_EFFECT_SIZE="0.010041938294140603" MODIFIED="2014-03-26 09:24:23 +0000" MODIFIED_BY="[Empty name]" ORDER="303" O_E="0.0" SE="0.0737043474095502" STUDY_ID="STD-de-Leval-2011" TOTAL_1="57" TOTAL_2="56" VAR="0.00543233082706767" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.4840336716047355" CI_END="1.1457289505852546" CI_START="1.0330952310425654" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.087955474694176" ESTIMABLE="YES" EVENTS_1="316" EVENTS_2="315" I2="27.06098759547693" I2_Q="21.945723053886415" ID="CMP-004.05" LOG_CI_END="0.059081887100637276" LOG_CI_START="0.014140356766495879" LOG_EFFECT_SIZE="0.036611121933566616" METHOD="MH" MODIFIED="2015-06-22 10:09:35 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.2411367226403761" P_Q="0.2788691498330266" P_Z="0.001406440309030489" Q="3.843479329225115" RANDOM="NO" SCALE="2.3" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="345" TOTAL_2="371" WEIGHT="400.0" Z="3.1933260790135005">
<NAME>Objective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method B</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method A</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1489241828089207" CI_START="0.911332946469761" DF="0" EFFECT_SIZE="1.0232558139534884" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="43" I2="0.0" ID="CMP-004.05.01" LOG_CI_END="0.060291370660333334" LOG_CI_START="-0.040322928847131484" LOG_EFFECT_SIZE="0.009984220906600923" MODIFIED="2015-06-22 10:09:20 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6972874383930483" STUDIES="1" TAU2="0.0" TOTAL_1="23" TOTAL_2="46" WEIGHT="100.0" Z="0.38898473649220805">
<NAME>Modified TVT-O (less dissection) vs TVT-O</NAME>
<DICH_DATA CI_END="1.1489241828089207" CI_START="0.9113329464697609" EFFECT_SIZE="1.0232558139534884" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="43" LOG_CI_END="0.060291370660333334" LOG_CI_START="-0.04032292884713154" LOG_EFFECT_SIZE="0.009984220906600923" MODIFIED="2014-03-26 09:24:23 +0000" MODIFIED_BY="[Empty name]" ORDER="391" O_E="0.0" SE="0.05910133757949987" STUDY_ID="STD-Tommaselli-2012" TOTAL_1="23" TOTAL_2="46" VAR="0.0034929681036860033" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6972506243418526" CI_END="1.1383499983664573" CI_START="0.9374889563565872" DF="1" EFFECT_SIZE="1.0330491527207661" ESTIMABLE="YES" EVENTS_1="65" EVENTS_2="61" I2="0.0" ID="CMP-004.05.02" LOG_CI_END="0.05627581125889813" LOG_CI_START="-0.02803383956999692" LOG_EFFECT_SIZE="0.014120985844450588" MODIFIED="2014-06-21 23:33:00 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4037094883995228" P_Z="0.5114722486866998" STUDIES="2" TAU2="0.0" TOTAL_1="69" TOTAL_2="67" WEIGHT="100.0" Z="0.6565469886120703">
<NAME>Synthetic vs biological</NAME>
<DICH_DATA CI_END="1.1477325349751684" CI_START="0.8569412696373385" EFFECT_SIZE="0.9917355371900827" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="33" LOG_CI_END="0.059840692837212814" LOG_CI_START="-0.06704894137486331" LOG_EFFECT_SIZE="-0.003604124268825242" MODIFIED="2014-06-21 23:19:18 +0100" MODIFIED_BY="[Empty name]" ORDER="421" O_E="0.0" SE="0.07453559924999295" STUDY_ID="STD-Paparella-2010" TOTAL_1="33" TOTAL_2="36" VAR="0.00555555555555555" WEIGHT="51.19671613514367"/>
<DICH_DATA CI_END="1.2230942426240916" CI_START="0.9472802665129928" EFFECT_SIZE="1.0763888888888888" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="28" LOG_CI_END="0.08745992185616862" LOG_CI_START="-0.02352150970608504" LOG_EFFECT_SIZE="0.031969206075041806" MODIFIED="2014-06-21 23:33:00 +0100" MODIFIED_BY="[Empty name]" ORDER="605" O_E="0.0" SE="0.06519104226661414" STUDY_ID="STD-Ugurlucan-2013" TOTAL_1="36" TOTAL_2="31" VAR="0.004249871991807472" WEIGHT="48.80328386485633"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0551529890777336" CI_START="1.0214353130561316" DF="0" EFFECT_SIZE="1.4488636363636365" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="22" I2="0.0" ID="CMP-004.05.03" LOG_CI_END="0.31284415703405904" LOG_CI_START="0.009210868205551588" LOG_EFFECT_SIZE="0.16102751261980539" MODIFIED="2014-04-16 13:13:55 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.037628660269843045" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="45" WEIGHT="100.0" Z="2.078876966834447">
<NAME>TVT-O + IS vs TVT-O</NAME>
<DICH_DATA CI_END="2.0551529890777336" CI_START="1.0214353130561316" EFFECT_SIZE="1.4488636363636365" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="22" LOG_CI_END="0.31284415703405904" LOG_CI_START="0.009210868205551588" LOG_EFFECT_SIZE="0.16102751261980539" MODIFIED="2014-04-16 13:13:55 +0100" MODIFIED_BY="[Empty name]" ORDER="453" O_E="0.0" SE="0.1783556968668852" STUDY_ID="STD-Juang-2007" TOTAL_1="48" TOTAL_2="45" VAR="0.031810754604872246" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1349100298342811" CI_START="1.0125947351757971" DF="0" EFFECT_SIZE="1.0720092915214867" ESTIMABLE="YES" EVENTS_1="195" EVENTS_2="189" I2="0.0" ID="CMP-004.05.04" LOG_CI_END="0.0549614341324478" LOG_CI_START="0.0054356650120668554" LOG_EFFECT_SIZE="0.030198549572257323" MODIFIED="2015-06-22 10:09:35 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.01683952803683966" STUDIES="1" TAU2="0.0" TOTAL_1="205" TOTAL_2="213" WEIGHT="100.00000000000001" Z="2.3901928470047595">
<NAME>TOT + 2-point tape fixation vs TOT</NAME>
<DICH_DATA CI_END="1.134910029834281" CI_START="1.0125947351757971" EFFECT_SIZE="1.0720092915214867" ESTIMABLE="YES" EVENTS_1="195" EVENTS_2="189" LOG_CI_END="0.054961434132447716" LOG_CI_START="0.0054356650120668554" LOG_EFFECT_SIZE="0.030198549572257323" MODIFIED="2014-03-26 17:34:43 +0000" MODIFIED_BY="[Empty name]" ORDER="1061" O_E="0.0" SE="0.029091681937822696" STUDY_ID="STD-Rechberger-2011" TOTAL_1="205" TOTAL_2="213" VAR="8.463259579714394E-4" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="419.9551072638166" CI_END="-14.649772350340992" CI_START="-17.667907343814097" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-16.158839847077545" ESTIMABLE="YES" I2="99.76187930978732" I2_Q="99.76187930978732" ID="CMP-004.06" MODIFIED="2015-06-09 11:12:58 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="-6.661338147750939E-16" P_Q="-6.661338147750939E-16" P_Z="0.0" Q="419.9551072638166" RANDOM="NO" SCALE="57.45" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="129" TOTAL_2="123" UNITS="" WEIGHT="200.0" Z="20.986963274149485">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="15.087129858950547" CI_START="8.912870141049453" DF="0" EFFECT_SIZE="12.0" ESTIMABLE="YES" I2="0.0" ID="CMP-004.06.01" MODIFIED="2014-10-10 16:15:04 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="2.5646734488561218E-14" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="47" WEIGHT="100.0" Z="7.6185871307907975">
<NAME>TVT-O + IS vs TVT-O</NAME>
<CONT_DATA CI_END="15.087129858950547" CI_START="8.912870141049453" EFFECT_SIZE="12.0" ESTIMABLE="YES" MEAN_1="28.3" MEAN_2="16.3" MODIFIED="2014-03-26 16:39:17 +0000" MODIFIED_BY="[Empty name]" ORDER="457" SD_1="10.2" SD_2="4.1" SE="1.575095197310478" STUDY_ID="STD-Juang-2007" TOTAL_1="49" TOTAL_2="47" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-23.27017508421299" CI_START="-26.72982491578701" DF="0" EFFECT_SIZE="-25.0" ESTIMABLE="YES" I2="0.0" ID="CMP-004.06.02" MODIFIED="2014-10-10 16:15:04 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="80" TOTAL_2="76" WEIGHT="100.0" Z="28.326045697641327">
<NAME>Self-tailored TVT-O vs TVT-O</NAME>
<CONT_DATA CI_END="-23.27017508421299" CI_START="-26.72982491578701" EFFECT_SIZE="-25.0" ESTIMABLE="YES" MEAN_1="24.0" MEAN_2="49.0" MODIFIED="2014-03-26 17:11:45 +0000" MODIFIED_BY="[Empty name]" ORDER="490" SD_1="6.0" SD_2="5.0" SE="0.8825799501580878" STUDY_ID="STD-Zhang-2011" TOTAL_1="80" TOTAL_2="76" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="458.82884820438" CI_END="-1.151301888689894" CI_START="-2.1306533955742184" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.640977642132056" ESTIMABLE="YES" I2="99.56410761707181" I2_Q="99.56410761707181" ID="CMP-004.07" MODIFIED="2015-05-28 17:10:00 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="-8.881784197001252E-16" P_Q="-8.881784197001252E-16" P_Z="5.09489053029961E-11" Q="458.82884820438" RANDOM="NO" SCALE="71.51" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="163" TOTAL_2="155" UNITS="" WEIGHT="300.0" Z="6.5681362726369406">
<NAME>Operative blood loss (ml)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.7693951025266984E-30" CI_END="60.468465593436186" CI_START="43.731534406563846" DF="0" EFFECT_SIZE="52.100000000000016" ESTIMABLE="YES" I2="100.0" ID="CMP-004.07.01" MODIFIED="2014-03-26 16:35:32 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="3.0234572763895823E-34" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="43" WEIGHT="100.0" Z="12.202251709636036">
<NAME>TVT-O + IS versus TVT-O</NAME>
<CONT_DATA CI_END="60.46846559343618" CI_START="43.73153440656384" EFFECT_SIZE="52.10000000000001" ESTIMABLE="YES" MEAN_1="82.4" MEAN_2="30.3" MODIFIED="2014-03-26 16:35:32 +0000" MODIFIED_BY="[Empty name]" ORDER="456" SD_1="25.1" SD_2="15.2" SE="4.269703759582094" STUDY_ID="STD-Juang-2007" TOTAL_1="49" TOTAL_2="43" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="4.919255696147438E-30" CI_END="-13.430256819912222" CI_START="-16.569743180087777" DF="0" EFFECT_SIZE="-14.999999999999998" ESTIMABLE="YES" I2="100.00000000000001" ID="CMP-004.07.02" MODIFIED="2014-03-26 17:13:27 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="80" TOTAL_2="76" WEIGHT="100.0" Z="18.728834207425475">
<NAME>Self-tailored TVT-O vs TVT-O</NAME>
<CONT_DATA CI_END="-13.430256819912223" CI_START="-16.569743180087777" EFFECT_SIZE="-15.0" ESTIMABLE="YES" MEAN_1="55.0" MEAN_2="70.0" MODIFIED="2014-03-26 17:13:27 +0000" MODIFIED_BY="[Empty name]" ORDER="491" SD_1="5.0" SD_2="5.0" SE="0.8009040943964844" STUDY_ID="STD-Zhang-2011" TOTAL_1="80" TOTAL_2="76" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.11637431751526595" CI_START="-0.9163743175152667" DF="0" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" I2="0.0" ID="CMP-004.07.03" MODIFIED="2014-06-21 23:19:52 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.12895124743185052" STUDIES="1" TAU2="0.0" TOTAL_1="34" TOTAL_2="36" WEIGHT="100.0" Z="1.5182505543429634">
<NAME>Synthetic vs biological</NAME>
<CONT_DATA CI_END="0.11637431751526595" CI_START="-0.9163743175152667" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="10.4" MEAN_2="10.8" MODIFIED="2014-06-21 23:19:52 +0100" MODIFIED_BY="[Empty name]" ORDER="429" SD_1="1.0" SD_2="1.2" SE="0.26346112560657287" STUDY_ID="STD-Paparella-2010" TOTAL_1="34" TOTAL_2="36" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="90.4581031990326" CI_END="-2.8045454777197043" CI_START="-3.118089039281123" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.9613172585004137" ESTIMABLE="YES" I2="98.89451584254456" I2_Q="98.89451584254456" ID="CMP-004.08" MODIFIED="2015-05-28 17:10:12 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="-1.3322676295501878E-15" P_Q="-1.3322676295501878E-15" P_Z="0.0" Q="90.4581031990326" RANDOM="NO" SCALE="19.74" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="129" TOTAL_2="123" UNITS="" WEIGHT="200.0" Z="37.02244845694759">
<NAME>Length of hospital stay (days)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="15.087129858950547" CI_START="8.912870141049453" DF="0" EFFECT_SIZE="12.0" ESTIMABLE="YES" I2="0.0" ID="CMP-004.08.01" MODIFIED="2014-10-10 16:15:00 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="2.5646734488561218E-14" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="47" WEIGHT="100.0" Z="7.6185871307907975">
<NAME>TVT-O + IS vs TVT-O</NAME>
<CONT_DATA CI_END="15.087129858950547" CI_START="8.912870141049453" EFFECT_SIZE="12.0" ESTIMABLE="YES" MEAN_1="28.3" MEAN_2="16.3" MODIFIED="2014-03-26 16:40:48 +0000" MODIFIED_BY="[Empty name]" ORDER="457" SD_1="10.2" SD_2="4.1" SE="1.575095197310478" STUDY_ID="STD-Juang-2007" TOTAL_1="49" TOTAL_2="47" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="-2.8430256819912225" CI_START="-3.1569743180087775" DF="0" EFFECT_SIZE="-3.0" ESTIMABLE="YES" I2="0.0" ID="CMP-004.08.02" MODIFIED="2014-10-10 16:15:00 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="80" TOTAL_2="76" WEIGHT="100.0" Z="37.45766841485096">
<NAME>Self-tailored TVT-O vs TVT-O</NAME>
<CONT_DATA CI_END="-2.8430256819912225" CI_START="-3.1569743180087775" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="5.0" MEAN_2="8.0" MODIFIED="2014-03-26 17:15:04 +0000" MODIFIED_BY="[Empty name]" ORDER="492" SD_1="0.5" SD_2="0.5" SE="0.08009040943964843" STUDY_ID="STD-Zhang-2011" TOTAL_1="80" TOTAL_2="76" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-05-28 17:10:25 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="95.23" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="84" TOTAL_2="86" WEIGHT="0.0" Z="0.0">
<NAME>Perioperative complications</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.09.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-10-10 16:14:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="84" TOTAL_2="86" WEIGHT="0.0" Z="0.0">
<NAME>Synthetic vs biological</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-21 23:21:33 +0100" MODIFIED_BY="[Empty name]" ORDER="424" O_E="0.0" SE="0.0" STUDY_ID="STD-Paparella-2010" TOTAL_1="34" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-21 23:34:02 +0100" MODIFIED_BY="[Empty name]" ORDER="606" O_E="0.0" SE="0.0" STUDY_ID="STD-Ugurlucan-2013" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.0438269085566985" CI_START="0.1700223954049172" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7193877551020408" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-004.10" LOG_CI_END="0.4834199520420146" LOG_CI_START="-0.769493869444207" LOG_EFFECT_SIZE="-0.14303695870109617" METHOD="MH" MODIFIED="2015-06-22 10:36:02 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.6545050783493339" Q="0.0" RANDOM="NO" SCALE="27.39" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="181" TOTAL_2="181" WEIGHT="100.0" Z="0.4475124828294101">
<NAME>Major vascular or visceral injury</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.0438269085566985" CI_START="0.1700223954049172" DF="0" EFFECT_SIZE="0.7193877551020408" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-004.10.01" LOG_CI_END="0.4834199520420146" LOG_CI_START="-0.769493869444207" LOG_EFFECT_SIZE="-0.14303695870109617" MODIFIED="2014-06-21 23:23:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6545050783493339" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="47" WEIGHT="100.0" Z="0.4475124828294101">
<NAME>TVT-O + IS vs TVT-O</NAME>
<DICH_DATA CI_END="3.0438269085566985" CI_START="0.1700223954049172" EFFECT_SIZE="0.7193877551020408" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4834199520420146" LOG_CI_START="-0.769493869444207" LOG_EFFECT_SIZE="-0.14303695870109617" MODIFIED="2014-03-26 16:38:00 +0000" MODIFIED_BY="[Empty name]" ORDER="460" O_E="0.0" SE="0.7359677807644478" STUDY_ID="STD-Juang-2007" TOTAL_1="49" TOTAL_2="47" VAR="0.5416485743233462" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.10.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-06-21 23:34:48 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="84" TOTAL_2="86" WEIGHT="0.0" Z="0.0">
<NAME>Synthetic vs biological</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-21 23:23:37 +0100" MODIFIED_BY="[Empty name]" ORDER="424" O_E="0.0" SE="0.0" STUDY_ID="STD-Paparella-2010" TOTAL_1="34" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-21 23:34:48 +0100" MODIFIED_BY="[Empty name]" ORDER="607" O_E="0.0" SE="0.0" STUDY_ID="STD-Ugurlucan-2013" TOTAL_1="50" TOTAL_2="50" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.10.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-22 10:36:02 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>AdjustableTOT vs TOT<SUP></SUP>
</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2015-06-20 17:25:32 +0100" MODIFIED_BY="[Empty name]" ORDER="615" O_E="0.0" SE="0.0" STUDY_ID="STD-Elbadry-2014" TOTAL_1="48" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.08817769659984745" CI_END="2.3369933400396814" CI_START="0.18955366274662136" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6655716696336931" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-004.11" LOG_CI_END="0.36865747474218946" LOG_CI_START="-0.7222678192814531" LOG_EFFECT_SIZE="-0.17680517226963188" METHOD="MH" MODIFIED="2015-06-09 11:16:11 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.7665067614173446" P_Q="0.7665795629537202" P_Z="0.5252335540449584" Q="0.0881210750485493" RANDOM="NO" SCALE="41.77" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="453" TOTAL_2="450" WEIGHT="200.0" Z="0.635298808868517">
<NAME>Bladder/urethral perforation</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-03-26 16:42:48 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="49" TOTAL_2="47" WEIGHT="0.0" Z="0.0">
<NAME>TVT-O + IS vs TVT-O</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-03-26 16:42:48 +0000" MODIFIED_BY="[Empty name]" ORDER="459" O_E="0.0" SE="0.0" STUDY_ID="STD-Juang-2007" TOTAL_1="49" TOTAL_2="47" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.3282889057186753" CI_START="0.17047218175738899" DF="0" EFFECT_SIZE="0.7532467532467533" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-004.11.02" LOG_CI_END="0.5222210173523568" LOG_CI_START="-0.7683464805714459" LOG_EFFECT_SIZE="-0.12306273160954458" MODIFIED="2015-05-28 16:41:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.7085629714775404" STUDIES="1" TAU2="0.0" TOTAL_1="231" TOTAL_2="232" WEIGHT="100.0" Z="0.3737867599824942">
<NAME>TOT + 2-point tape fixation vs TOT</NAME>
<DICH_DATA CI_END="3.328288905718674" CI_START="0.17047218175738899" EFFECT_SIZE="0.7532467532467533" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5222210173523567" LOG_CI_START="-0.7683464805714459" LOG_EFFECT_SIZE="-0.12306273160954458" MODIFIED="2014-03-26 17:35:42 +0000" MODIFIED_BY="[Empty name]" ORDER="1063" O_E="0.0" SE="0.7580857366925873" STUDY_ID="STD-Rechberger-2011" TOTAL_1="231" TOTAL_2="232" VAR="0.5746939841767428" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.356109514740332" CI_START="0.04519399749647117" DF="0" EFFECT_SIZE="0.492" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-004.11.03" LOG_CI_END="0.7288494483177852" LOG_CI_START="-1.3449192427830645" LOG_EFFECT_SIZE="-0.30803489723263966" MODIFIED="2014-03-28 18:07:23 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.5603909009848467" STUDIES="1" TAU2="0.0" TOTAL_1="125" TOTAL_2="123" WEIGHT="100.0" Z="0.5822609890372872">
<NAME>TVT versus modified TVT (suburethral pad)</NAME>
<DICH_DATA CI_END="5.356109514740332" CI_START="0.04519399749647117" EFFECT_SIZE="0.492" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7288494483177852" LOG_CI_START="-1.3449192427830645" LOG_EFFECT_SIZE="-0.30803489723263966" MODIFIED="2014-03-28 18:07:23 +0000" MODIFIED_BY="[Empty name]" ORDER="556" O_E="0.0" SE="1.218141994473217" STUDY_ID="STD-Naumann-2006" TOTAL_1="125" TOTAL_2="123" VAR="1.483869918699187" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.11.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-09 11:16:11 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>AdjustableTOT vs TOT<SUP></SUP>
</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-07-01 00:56:14 +0100" MODIFIED_BY="[Empty name]" ORDER="615" O_E="0.0" SE="0.0" STUDY_ID="STD-Elbadry-2014" TOTAL_1="48" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.017863737493335" CI_END="4.077047155239256" CI_START="0.7716931961579886" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.7737614129621313" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-004.12" LOG_CI_END="0.6103457345430985" LOG_CI_START="-0.1125553288080578" LOG_EFFECT_SIZE="0.24889520286752034" METHOD="MH" MODIFIED="2015-06-09 11:16:30 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.73247319576569" P_Q="0.7327441294229995" P_Z="0.17713367291882698" Q="2.016390731335736" RANDOM="NO" SCALE="82.91" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="361" TOTAL_2="378" WEIGHT="500.0" Z="1.349633188485612">
<NAME>Voiding dysfunction</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="30.60922967814943" CI_START="0.13067953823272538" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.12.01" LOG_CI_END="1.4858524001383797" LOG_CI_START="-0.8837924088104172" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2015-05-28 16:42:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6185040368805339" STUDIES="1" TAU2="0.0" TOTAL_1="24" TOTAL_2="48" WEIGHT="100.0" Z="0.4979716348539058">
<NAME>Modified TVT-O (less dissection) vs TVT-O</NAME>
<DICH_DATA CI_END="30.60922967814943" CI_START="0.13067953823272538" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.4858524001383797" LOG_CI_START="-0.8837924088104172" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2014-04-16 14:38:39 +0100" MODIFIED_BY="[Empty name]" ORDER="393" O_E="0.0" SE="1.3919410907075054" STUDY_ID="STD-Tommaselli-2012" TOTAL_1="24" TOTAL_2="48" VAR="1.9375" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.0005405064559" CI_START="0.7002025051465042" DF="0" EFFECT_SIZE="2.214" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" I2="0.0" ID="CMP-004.12.02" LOG_CI_END="0.8451315728583979" LOG_CI_START="-0.15477633977299007" LOG_EFFECT_SIZE="0.345177616542704" MODIFIED="2014-03-28 18:11:00 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.1759930210122454" STUDIES="1" TAU2="0.0" TOTAL_1="125" TOTAL_2="123" WEIGHT="100.0" Z="1.3531960056455303">
<NAME>TVT versus modified TVT (suburethral pad)</NAME>
<DICH_DATA CI_END="7.000540506455904" CI_START="0.7002025051465041" EFFECT_SIZE="2.214" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" LOG_CI_END="0.8451315728583981" LOG_CI_START="-0.15477633977299016" LOG_EFFECT_SIZE="0.345177616542704" MODIFIED="2014-03-28 18:11:00 +0000" MODIFIED_BY="[Empty name]" ORDER="557" O_E="0.0" SE="0.5873508575036714" STUDY_ID="STD-Naumann-2006" TOTAL_1="125" TOTAL_2="123" VAR="0.3449810298102981" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="14.919622229066352" CI_START="0.0604908077526087" DF="0" EFFECT_SIZE="0.95" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.12.03" LOG_CI_END="1.173757826762054" LOG_CI_START="-1.2183106161843587" LOG_EFFECT_SIZE="-0.022276394711152253" MODIFIED="2014-03-26 17:16:10 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.9708798905522137" STUDIES="1" TAU2="0.0" TOTAL_1="80" TOTAL_2="76" WEIGHT="100.0" Z="0.036504750913797374">
<NAME>Self-tailored TVT-O vs TVT-O</NAME>
<DICH_DATA CI_END="14.919622229066345" CI_START="0.06049080775260872" EFFECT_SIZE="0.95" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1737578267620539" LOG_CI_START="-1.2183106161843584" LOG_EFFECT_SIZE="-0.022276394711152253" MODIFIED="2014-03-26 17:16:10 +0000" MODIFIED_BY="[Empty name]" ORDER="493" O_E="0.0" SE="1.4051128443164833" STUDY_ID="STD-Zhang-2011" TOTAL_1="80" TOTAL_2="76" VAR="1.974342105263158" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.9931567211319345" CI_START="0.044005540937675315" DF="0" EFFECT_SIZE="0.46875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-004.12.04" LOG_CI_END="0.6983751975501289" LOG_CI_START="-1.3564926360785783" LOG_EFFECT_SIZE="-0.32905871926422475" MODIFIED="2015-06-09 11:16:30 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.5301858413445346" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="45" WEIGHT="100.0" Z="0.6277223556688283">
<NAME>Monarc<SUP></SUP>TOT open edge + tension suture vs TOT<SUP></SUP>
</NAME>
<DICH_DATA CI_END="4.9931567211319345" CI_START="0.044005540937675315" EFFECT_SIZE="0.46875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6983751975501289" LOG_CI_START="-1.3564926360785783" LOG_EFFECT_SIZE="-0.32905871926422475" MODIFIED="2014-03-26 17:30:41 +0000" MODIFIED_BY="[Empty name]" ORDER="514" O_E="0.0" SE="1.2070395372333271" STUDY_ID="STD-Cho-2010" TOTAL_1="48" TOTAL_2="45" VAR="1.4569444444444446" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="101.58460526662178" CI_START="0.24610028197072092" DF="0" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-004.12.05" LOG_CI_END="2.006827897373713" LOG_CI_START="-0.6088878887016753" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2014-06-21 23:36:17 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.29487789716409474" STUDIES="2" TAU2="0.0" TOTAL_1="84" TOTAL_2="86" WEIGHT="100.0" Z="1.047480802054477">
<NAME>Synthetic vs biological</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-21 23:24:24 +0100" MODIFIED_BY="[Empty name]" ORDER="422" O_E="0.0" SE="0.0" STUDY_ID="STD-Paparella-2010" TOTAL_1="34" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="101.58460526662178" CI_START="0.24610028197072092" EFFECT_SIZE="5.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.006827897373713" LOG_CI_START="-0.6088878887016753" LOG_EFFECT_SIZE="0.6989700043360189" MODIFIED="2014-06-21 23:36:17 +0100" MODIFIED_BY="[Empty name]" ORDER="608" O_E="0.0" SE="1.5364844007426468" STUDY_ID="STD-Ugurlucan-2013" TOTAL_1="50" TOTAL_2="50" VAR="2.3607843137254902" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.9427516838004397" CI_START="0.5065567172998213" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2209302325581395" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-004.13" LOG_CI_END="0.4687536168719174" LOG_CI_START="-0.29537192121917677" LOG_EFFECT_SIZE="0.08669084782637033" METHOD="MH" MODIFIED="2015-05-28 17:11:14 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.6565221440041655" Q="0.0" RANDOM="NO" SCALE="7.81" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="86" TOTAL_2="84" WEIGHT="100.0" Z="0.44471996042271417">
<NAME>De novo urgency or urgency incontinence</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.9427516838004397" CI_START="0.5065567172998213" DF="0" EFFECT_SIZE="1.2209302325581395" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" ID="CMP-004.13.01" LOG_CI_END="0.4687536168719174" LOG_CI_START="-0.29537192121917677" LOG_EFFECT_SIZE="0.08669084782637033" MODIFIED="2015-05-28 16:42:43 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.6565221440041655" STUDIES="1" TAU2="0.0" TOTAL_1="86" TOTAL_2="84" WEIGHT="100.0" Z="0.44471996042271417">
<NAME>Modified TVT-O (short tape) vs TVT-O</NAME>
<DICH_DATA CI_END="2.9427516838004397" CI_START="0.5065567172998212" EFFECT_SIZE="1.2209302325581395" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" LOG_CI_END="0.4687536168719174" LOG_CI_START="-0.2953719212191769" LOG_EFFECT_SIZE="0.08669084782637033" MODIFIED="2014-03-26 09:24:23 +0000" MODIFIED_BY="[Empty name]" ORDER="299" O_E="0.0" SE="0.4488511235571255" STUDY_ID="STD-de-Leval-2011" TOTAL_1="86" TOTAL_2="84" VAR="0.2014673311184939" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.1349979580616525" CI_END="2.541933104316401" CI_START="0.4527866249520086" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0728249210179661" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="8" I2="3.264764805952528" I2_Q="1.0609515232993072" ID="CMP-004.14" LOG_CI_END="0.40516411710369704" LOG_CI_START="-0.34410641043137935" LOG_EFFECT_SIZE="0.030528853336158856" METHOD="MH" MODIFIED="2015-06-09 11:16:47 +0100" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.38804435027244777" P_Q="0.4002322514042034" P_Z="0.8731043608023894" Q="4.042893136315098" RANDOM="NO" SCALE="397.9" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="390" TOTAL_2="383" WEIGHT="500.0" Z="0.1597165531787868">
<NAME>Vaginal tape erosion</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.883327121133262" CI_START="0.013453871911283003" DF="0" EFFECT_SIZE="0.32567049808429116" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-004.14.01" LOG_CI_END="0.896709548122632" LOG_CI_START="-1.8711527113706086" LOG_EFFECT_SIZE="-0.48722158162398826" MODIFIED="2015-05-28 16:42:50 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.4901831624332095" STUDIES="1" TAU2="0.0" TOTAL_1="86" TOTAL_2="84" WEIGHT="100.0" Z="0.6900175391303581">
<NAME>Modified TVT-O (short tape) vs TVT-O</NAME>
<DICH_DATA CI_END="7.883327121133262" CI_START="0.013453871911283003" EFFECT_SIZE="0.32567049808429116" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.896709548122632" LOG_CI_START="-1.8711527113706086" LOG_EFFECT_SIZE="-0.48722158162398826" MODIFIED="2014-03-26 09:24:23 +0000" MODIFIED_BY="[Empty name]" ORDER="300" O_E="0.0" SE="1.6258559923654832" STUDY_ID="STD-de-Leval-2011" TOTAL_1="86" TOTAL_2="84" VAR="2.6434077079107503" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.676064179236358" CI_START="0.6076045417709198" DF="0" EFFECT_SIZE="2.296" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" I2="0.0" ID="CMP-004.14.02" LOG_CI_END="0.9383227559499371" LOG_CI_START="-0.21637898849806536" LOG_EFFECT_SIZE="0.36097188372593586" MODIFIED="2014-03-28 18:11:57 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.2204205698033307" STUDIES="1" TAU2="0.0" TOTAL_1="125" TOTAL_2="123" WEIGHT="100.0" Z="1.2254106221561591">
<NAME>TVT versus modified TVT (suburethral pad)</NAME>
<DICH_DATA CI_END="8.676064179236358" CI_START="0.6076045417709198" EFFECT_SIZE="2.296" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.9383227559499371" LOG_CI_START="-0.21637898849806536" LOG_EFFECT_SIZE="0.36097188372593586" MODIFIED="2014-03-28 18:11:57 +0000" MODIFIED_BY="[Empty name]" ORDER="558" O_E="0.0" SE="0.6782775205545759" STUDY_ID="STD-Naumann-2006" TOTAL_1="125" TOTAL_2="123" VAR="0.46006039488966316" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="14.545350268777476" CI_START="0.06042523787733243" DF="0" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.14.03" LOG_CI_END="1.1627241840200402" LOG_CI_START="-1.2187816312205273" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2014-04-16 13:14:42 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.9632027143913605" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="45" WEIGHT="100.0" Z="0.04613491887153415">
<NAME>TVT-O + IS vs TVT-O</NAME>
<DICH_DATA CI_END="14.545350268777483" CI_START="0.0604252378773324" EFFECT_SIZE="0.9375" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1627241840200404" LOG_CI_START="-1.2187816312205275" LOG_EFFECT_SIZE="-0.028028723600243537" MODIFIED="2014-04-16 13:14:42 +0100" MODIFIED_BY="[Empty name]" ORDER="461" O_E="0.0" SE="1.3989083045162198" STUDY_ID="STD-Juang-2007" TOTAL_1="48" TOTAL_2="45" VAR="1.9569444444444446" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.5260355473705745" CI_START="0.007120130694367487" DF="0" EFFECT_SIZE="0.13411078717201166" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" ID="CMP-004.14.04" LOG_CI_END="0.4024394578259078" LOG_CI_START="-2.1475120345483005" LOG_EFFECT_SIZE="-0.8725362883611965" MODIFIED="2015-06-09 11:16:47 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.17981931982261398" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="45" WEIGHT="100.0" Z="1.3413115547542622">
<NAME>Monarc<SUP></SUP>TOT open edge + tension suture vs TOT<SUP></SUP>
</NAME>
<DICH_DATA CI_END="2.5260355473705745" CI_START="0.007120130694367487" EFFECT_SIZE="0.13411078717201166" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4024394578259078" LOG_CI_START="-2.1475120345483005" LOG_EFFECT_SIZE="-0.8725362883611965" MODIFIED="2014-03-26 17:31:41 +0000" MODIFIED_BY="[Empty name]" ORDER="514" O_E="0.0" SE="1.4978541290840697" STUDY_ID="STD-Cho-2010" TOTAL_1="48" TOTAL_2="45" VAR="2.243566992014197" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="71.92321045517915" CI_START="0.12513345751728625" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-004.14.05" LOG_CI_END="1.8568690648743624" LOG_CI_START="-0.9026265554350377" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2014-06-21 23:38:38 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Z="0.497922686342418" STUDIES="2" TAU2="0.0" TOTAL_1="83" TOTAL_2="86" WEIGHT="100.0" Z="0.6777618841839292">
<NAME>Synthetic vs biological</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-21 23:24:56 +0100" MODIFIED_BY="[Empty name]" ORDER="423" O_E="0.0" SE="0.0" STUDY_ID="STD-Paparella-2010" TOTAL_1="33" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="71.92321045517915" CI_START="0.12513345751728625" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8568690648743624" LOG_CI_START="-0.9026265554350377" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2014-06-21 23:38:38 +0100" MODIFIED_BY="[Empty name]" ORDER="609" O_E="0.0" SE="1.6209413870933633" STUDY_ID="STD-Ugurlucan-2013" TOTAL_1="50" TOTAL_2="50" VAR="2.627450980392157" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="15.556495497109765" CI_START="0.06224126765439504" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.984" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-004.15" LOG_CI_END="1.1919117676094828" LOG_CI_START="-1.2059215707467998" LOG_EFFECT_SIZE="-0.007004901568658489" METHOD="MH" MODIFIED="2015-05-28 17:11:35 +0100" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.9908632508967348" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="125" TOTAL_2="123" WEIGHT="100.0" Z="0.011451467097567555">
<NAME>Bladder/urethral erosion</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="15.556495497109765" CI_START="0.06224126765439504" DF="0" EFFECT_SIZE="0.984" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-004.15.01" LOG_CI_END="1.1919117676094828" LOG_CI_START="-1.2059215707467998" LOG_EFFECT_SIZE="-0.007004901568658489" MODIFIED="2014-03-28 18:17:22 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.9908632508967348" STUDIES="1" TAU2="0.0" TOTAL_1="125" TOTAL_2="123" WEIGHT="100.0" Z="0.011451467097567555">
<NAME>TVT versus modified TVT (suburethral pad)</NAME>
<DICH_DATA CI_END="15.556495497109765" CI_START="0.06224126765439504" EFFECT_SIZE="0.984" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1919117676094828" LOG_CI_START="-1.2059215707467998" LOG_EFFECT_SIZE="-0.007004901568658489" MODIFIED="2014-03-28 18:17:22 +0000" MODIFIED_BY="[Empty name]" ORDER="559" O_E="0.0" SE="1.4084991724169336" STUDY_ID="STD-Naumann-2006" TOTAL_1="125" TOTAL_2="123" VAR="1.983869918699187" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.644001246549217" CI_START="0.30050523482674846" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.302325581395349" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-004.16" LOG_CI_END="0.7515871010017621" LOG_CI_START="-0.5221479581485343" LOG_EFFECT_SIZE="0.11471957142661392" METHOD="MH" MODIFIED="2015-05-28 17:11:47 +0100" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="0.7240507840106274" Q="0.0" RANDOM="NO" SCALE="41.77" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="119" TOTAL_2="120" WEIGHT="99.99999999999999" Z="0.35305023081962994">
<NAME>Groin pain</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="5.644001246549217" CI_START="0.30050523482674846" DF="0" EFFECT_SIZE="1.302325581395349" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-004.16.01" LOG_CI_END="0.7515871010017621" LOG_CI_START="-0.5221479581485343" LOG_EFFECT_SIZE="0.11471957142661392" MODIFIED="2015-05-28 16:43:19 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7240507840106274" STUDIES="1" TAU2="0.0" TOTAL_1="86" TOTAL_2="84" WEIGHT="99.99999999999999" Z="0.35305023081962994">
<NAME>Modified TVT-O (short tape) vs TVT-O</NAME>
<DICH_DATA CI_END="5.644001246549217" CI_START="0.30050523482674846" EFFECT_SIZE="1.302325581395349" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7515871010017621" LOG_CI_START="-0.5221479581485343" LOG_EFFECT_SIZE="0.11471957142661392" MODIFIED="2014-03-26 09:24:23 +0000" MODIFIED_BY="[Empty name]" ORDER="301" O_E="0.0" SE="0.7481982788351141" STUDY_ID="STD-de-Leval-2011" TOTAL_1="86" TOTAL_2="84" VAR="0.5598006644518272" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-004.16.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2014-06-21 23:25:46 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="36" WEIGHT="0.0" Z="0.0">
<NAME>Synthetic vs biological</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-06-21 23:25:46 +0100" MODIFIED_BY="[Empty name]" ORDER="424" O_E="0.0" SE="0.0" STUDY_ID="STD-Paparella-2010" TOTAL_1="33" TOTAL_2="36" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2015-06-22 10:08:02 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>One type of tape material versus another</NAME>
<DICH_OUTCOME CHI2="9.336706303589231" CI_END="1.080786737868992" CI_START="0.95918301508921" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0181710474658034" ESTIMABLE="YES" EVENTS_1="344" EVENTS_2="285" I2="46.44792459544441" I2_Q="45.433971341293635" ID="CMP-005.01" LOG_CI_END="0.03374000690067583" LOG_CI_START="-0.01809852019104811" LOG_EFFECT_SIZE="0.007820743354813867" METHOD="MH" MODIFIED="2015-06-22 10:02:00 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.09636461691467924" P_Q="0.1599903800981276" P_Z="0.5542596063522438" Q="3.6652841505277607" RANDOM="NO" SCALE="2.17" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="401" TOTAL_2="337" WEIGHT="300.0" Z="0.5913893070551125">
<NAME>Subjective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method B</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method A</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.765599420521655" CI_END="1.1038078929960913" CI_START="0.9524400125270517" DF="3" EFFECT_SIZE="1.0253344836845466" ESTIMABLE="YES" EVENTS_1="258" EVENTS_2="199" I2="47.967248828941905" ID="CMP-005.01.01" LOG_CI_END="0.04289349524871585" LOG_CI_START="-0.02116236793464286" LOG_EFFECT_SIZE="0.010865563657036508" MODIFIED="2015-06-20 23:59:46 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.12358838853261267" P_Z="0.5060996467177576" STUDIES="4" TAU2="0.0" TOTAL_1="305" TOTAL_2="241" WEIGHT="100.0" Z="0.6649231586672757">
<NAME>Monofilament versus multifilament</NAME>
<DICH_DATA CI_END="1.0284107174586645" CI_START="0.7977001391311633" EFFECT_SIZE="0.9057391304347826" ESTIMABLE="YES" EVENTS_1="93" EVENTS_2="50" LOG_CI_END="0.012166593942142144" LOG_CI_START="-0.09816033220113203" LOG_EFFECT_SIZE="-0.042996869129494956" MODIFIED="2015-06-20 22:42:48 +0100" MODIFIED_BY="[Empty name]" ORDER="445" O_E="0.0" SE="0.06480658254365149" STUDY_ID="STD-Lim-2005" TOTAL_1="115" TOTAL_2="56" VAR="0.004199893140987114" WEIGHT="30.82795485235903"/>
<DICH_DATA CI_END="1.2750972533293465" CI_START="0.970692533062729" EFFECT_SIZE="1.1125319693094629" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="68" LOG_CI_END="0.10554331023940244" LOG_CI_START="-0.012918311121861453" LOG_EFFECT_SIZE="0.046312499558770495" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="443" O_E="0.0" SE="0.06958494278208939" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" VAR="0.004842064261986655" WEIGHT="32.04178404676924"/>
<DICH_DATA CI_END="1.1797589830127713" CI_START="0.8476307571282757" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="41" LOG_CI_END="0.07179329286645941" LOG_CI_START="-0.07179329286645945" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-03-28 13:09:30 +0000" MODIFIED_BY="[Empty name]" ORDER="451" O_E="0.0" SE="0.084343471224579" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.007113821138211386" WEIGHT="18.79432969303384"/>
<DICH_DATA CI_END="1.3068251318746709" CI_START="0.9259081192173181" EFFECT_SIZE="1.1" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="40" LOG_CI_END="0.11621747790742316" LOG_CI_START="-0.03343210759097302" LOG_EFFECT_SIZE="0.04139268515822508" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="444" O_E="0.0" SE="0.08790490729915326" STUDY_ID="STD-Rechberger-2003" TOTAL_1="50" TOTAL_2="50" VAR="0.0077272727272727285" WEIGHT="18.335931407837897"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0457629818657863" CI_START="0.7937969417401523" DF="0" EFFECT_SIZE="0.9111111111111111" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="45" I2="0.0" ID="CMP-005.01.02" LOG_CI_END="0.01943326451987467" LOG_CI_START="-0.10029057863109103" LOG_EFFECT_SIZE="-0.04042865705560819" MODIFIED="2015-06-21 17:06:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.18560555027269504" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0" Z="1.3236914166278004">
<NAME>Monofilament versus combined monofilament and biological</NAME>
<DICH_DATA CI_END="1.0457629818657863" CI_START="0.7937969417401521" EFFECT_SIZE="0.9111111111111111" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="45" LOG_CI_END="0.01943326451987467" LOG_CI_START="-0.10029057863109109" LOG_EFFECT_SIZE="-0.04042865705560819" MODIFIED="2014-03-28 13:14:50 +0000" MODIFIED_BY="[Empty name]" ORDER="557" O_E="0.0" SE="0.07032637810945891" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.0049457994579945805" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.2597680180120272" CI_START="0.9562396234525927" DF="0" EFFECT_SIZE="1.0975609756097562" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="41" I2="0.0" ID="CMP-005.01.03" LOG_CI_END="0.10029057863109113" LOG_CI_START="-0.019433264519874646" LOG_EFFECT_SIZE="0.04042865705560822" MODIFIED="2015-06-22 10:02:00 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.1856055502726947" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0" Z="1.3236914166278013">
<NAME>Combined monofilament and biological vs multifilament</NAME>
<DICH_DATA CI_END="1.2597680180120272" CI_START="0.9562396234525927" EFFECT_SIZE="1.0975609756097562" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="41" LOG_CI_END="0.10029057863109113" LOG_CI_START="-0.019433264519874646" LOG_EFFECT_SIZE="0.04042865705560822" MODIFIED="2014-03-28 13:19:44 +0000" MODIFIED_BY="[Empty name]" ORDER="563" O_E="0.0" SE="0.07032637810945891" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.0049457994579945805" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.6884250917401453" CI_END="1.1186166037126346" CI_START="0.9235117973202541" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0163934426229508" ESTIMABLE="YES" EVENTS_1="124" EVENTS_2="122" I2="45.77631508692429" I2_Q="45.660848837537564" ID="CMP-005.02" LOG_CI_END="0.0486812613066046" LOG_CI_START="-0.03455755233163091" LOG_EFFECT_SIZE="0.007061854487486849" METHOD="MH" MODIFIED="2015-06-22 10:02:49 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.15814989096348964" P_Q="0.1587708625062052" P_Z="0.7394658884001899" Q="3.680587490261723" RANDOM="NO" SCALE="2.02" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="144" TOTAL_2="144" WEIGHT="300.00000000000006" Z="0.33256073349846416">
<NAME>Subjective cure (medium term, 1 to 5 years)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method B</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method A</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.234901560839584" CI_START="0.8518407837810028" DF="0" EFFECT_SIZE="1.0256410256410255" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="39" I2="0.0" ID="CMP-005.02.01" LOG_CI_END="0.09163233954865597" LOG_CI_START="-0.06964157094572966" LOG_EFFECT_SIZE="0.010995384301463145" MODIFIED="2015-06-22 10:02:19 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.7892735218171507" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.00000000000001" Z="0.26725410403929034">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="1.234901560839584" CI_START="0.8518407837810027" EFFECT_SIZE="1.0256410256410255" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="39" LOG_CI_END="0.09163233954865597" LOG_CI_START="-0.06964157094572972" LOG_EFFECT_SIZE="0.010995384301463145" MODIFIED="2014-03-28 13:11:03 +0000" MODIFIED_BY="[Empty name]" ORDER="451" O_E="0.0" SE="0.0947330933431342" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.008974358974358977" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.058944661105356" CI_START="0.780443314317358" DF="0" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="44" I2="0.0" ID="CMP-005.02.02" LOG_CI_END="0.02487326510791737" LOG_CI_START="-0.1076586354243675" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2015-06-22 10:02:34 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.22084610400466542" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.00000000000001" Z="1.2242814267009454">
<NAME>Monofilament vs combined monofilament and biological</NAME>
<DICH_DATA CI_END="1.058944661105356" CI_START="0.780443314317358" EFFECT_SIZE="0.9090909090909091" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="44" LOG_CI_END="0.02487326510791737" LOG_CI_START="-0.1076586354243675" LOG_EFFECT_SIZE="-0.04139268515822506" MODIFIED="2014-03-28 13:15:23 +0000" MODIFIED_BY="[Empty name]" ORDER="558" O_E="0.0" SE="0.07784989441615232" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.006060606060606065" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3245562375654132" CI_START="0.9609609431517174" DF="0" EFFECT_SIZE="1.1282051282051282" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="39" I2="0.0" ID="CMP-005.02.03" LOG_CI_END="0.12207040215445888" LOG_CI_START="-0.017294263235082447" LOG_EFFECT_SIZE="0.05238806945968822" MODIFIED="2015-06-22 10:02:49 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.14060925689229964" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.00000000000001" Z="1.4735260056567714">
<NAME>Combined monofilament and biological vs multifilament</NAME>
<DICH_DATA CI_END="1.3245562375654132" CI_START="0.9609609431517174" EFFECT_SIZE="1.1282051282051282" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="39" LOG_CI_END="0.12207040215445888" LOG_CI_START="-0.017294263235082447" LOG_EFFECT_SIZE="0.05238806945968822" MODIFIED="2014-03-28 13:20:45 +0000" MODIFIED_BY="[Empty name]" ORDER="564" O_E="0.0" SE="0.08186349431603628" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.006701631701631704" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.0112501374709444" CI_END="1.1923247400300907" CI_START="0.9621012936395704" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0710448986020216" ESTIMABLE="YES" EVENTS_1="172" EVENTS_2="109" I2="50.279680216332785" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="0.07639455540054427" LOG_CI_START="-0.016779201399969766" LOG_EFFECT_SIZE="0.029807677000287226" METHOD="MH" MODIFIED="2015-06-21 17:50:29 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.15613698770988482" P_Q="1.0" P_Z="0.20982620879472513" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="208" TOTAL_2="141" WEIGHT="100.0" Z="1.2540435287684701">
<NAME>Objective cure (short term, &#8804; 1 year)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method B</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method A</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.0112501374709444" CI_END="1.1923247400300907" CI_START="0.9621012936395704" DF="1" EFFECT_SIZE="1.0710448986020216" ESTIMABLE="YES" EVENTS_1="172" EVENTS_2="109" I2="50.279680216332785" ID="CMP-005.03.01" LOG_CI_END="0.07639455540054427" LOG_CI_START="-0.016779201399969766" LOG_EFFECT_SIZE="0.029807677000287226" MODIFIED="2015-06-20 22:45:32 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.15613698770988482" P_Z="0.20982620879472513" STUDIES="2" TAU2="0.0" TOTAL_1="208" TOTAL_2="141" WEIGHT="100.0" Z="1.2540435287684701">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="1.1501281606253864" CI_START="0.8417552779060096" EFFECT_SIZE="0.9839341692789969" ESTIMABLE="YES" EVENTS_1="93" EVENTS_2="44" LOG_CI_END="0.06074623718072156" LOG_CI_START="-0.0748141518531261" LOG_EFFECT_SIZE="-0.007033957336202267" MODIFIED="2015-06-20 22:45:32 +0100" MODIFIED_BY="[Empty name]" ORDER="459" O_E="0.0" SE="0.07962884355323016" STUDY_ID="STD-Lim-2005" TOTAL_1="116" TOTAL_2="54" VAR="0.006340752725624805" WEIGHT="47.33231928447386"/>
<DICH_DATA CI_END="1.3322665326258818" CI_START="0.9915148009311817" EFFECT_SIZE="1.1493311036789298" ESTIMABLE="YES" EVENTS_1="79" EVENTS_2="65" LOG_CI_END="0.12459111827954107" LOG_CI_START="-0.0037007984382428187" LOG_EFFECT_SIZE="0.06044515992064911" MODIFIED="2014-07-12 20:04:10 +0100" MODIFIED_BY="[Empty name]" ORDER="458" O_E="0.0" SE="0.07535930693525603" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" VAR="0.005679025141762127" WEIGHT="52.66768071552614"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.04" MODIFIED="2015-06-22 10:03:13 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="3.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="92" TOTAL_2="87" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Operative time (minutes)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.04.01" MODIFIED="2015-03-16 11:22:32 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="92" TOTAL_2="87" WEIGHT="0.0" Z="0.0">
<NAME>Monofilament vs multifilament</NAME>
<CONT_DATA CI_END="1.4864907412922206" CI_START="-1.4864907412922206" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="27.0" MEAN_2="27.0" MODIFIED="2014-07-12 20:04:55 +0100" MODIFIED_BY="[Empty name]" ORDER="491" SD_1="6.0" SD_2="4.0" SE="0.7584275798011952" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.05" MODIFIED="2015-06-21 17:52:25 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="0.86" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="92" TOTAL_2="87" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of hospital stay (days)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.05.01" MODIFIED="2015-03-16 11:23:02 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="92" TOTAL_2="87" WEIGHT="0.0" Z="0.0">
<NAME>Monofilament vs multifilament</NAME>
<CONT_DATA CI_END="0.493103541892445" CI_START="-0.09310354189244463" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="2.3" MODIFIED="2014-07-12 20:05:07 +0100" MODIFIED_BY="[Empty name]" ORDER="494" SD_1="1.0" SD_2="1.0" SE="0.14954537134580437" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.1289399044693564" CI_END="3.6946024428024624" CI_START="0.36256177889421226" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.157377049180328" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="11.421325790584305" I2_Q="0.0" ID="CMP-005.06" LOG_CI_END="0.5675677130458217" LOG_CI_START="-0.4406179809637483" LOG_EFFECT_SIZE="0.06347486604103675" METHOD="MH" MODIFIED="2015-06-21 17:53:10 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.28800161138565394" P_Q="1.0" P_Z="0.805065564404019" Q="0.0" RANDOM="NO" SCALE="95.23" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="142" TOTAL_2="137" WEIGHT="100.0" Z="0.24679670045537389">
<NAME>Perioperative complications</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.1289399044693564" CI_END="3.6946024428024624" CI_START="0.36256177889421226" DF="1" EFFECT_SIZE="1.157377049180328" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" I2="11.421325790584305" ID="CMP-005.06.01" LOG_CI_END="0.5675677130458217" LOG_CI_START="-0.4406179809637483" LOG_EFFECT_SIZE="0.06347486604103675" MODIFIED="2015-03-16 11:23:22 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.28800161138565394" P_Z="0.805065564404019" STUDIES="2" TAU2="0.0" TOTAL_1="142" TOTAL_2="137" WEIGHT="100.0" Z="0.24679670045537389">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="3.078397898235468" CI_START="0.16340322491391276" EFFECT_SIZE="0.7092391304347826" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.4883247538449038" LOG_CI_START="-0.7867393765153773" LOG_EFFECT_SIZE="-0.1492073113352367" MODIFIED="2014-07-12 20:05:28 +0100" MODIFIED_BY="[Empty name]" ORDER="485" O_E="0.0" SE="0.7489789818428677" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" VAR="0.5609695152423787" WEIGHT="80.43715846994536"/>
<DICH_DATA CI_END="27.87074815972715" CI_START="0.32291921079481034" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4451486270297722" LOG_CI_START="-0.49090611759044706" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2014-07-12 20:05:28 +0100" MODIFIED_BY="[Empty name]" ORDER="486" O_E="0.0" SE="1.1372481406154653" STUDY_ID="STD-Rechberger-2003" TOTAL_1="50" TOTAL_2="50" VAR="1.2933333333333332" WEIGHT="19.562841530054644"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-22 10:04:03 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="144" TOTAL_2="144" WEIGHT="0.0" Z="0.0">
<NAME>Major vascular or visceral injury</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-22 10:03:37 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-03-28 13:12:28 +0000" MODIFIED_BY="[Empty name]" ORDER="556" O_E="0.0" SE="0.0" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-22 10:03:47 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Monofilament vs combined monofilament and biological</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-03-28 13:16:27 +0000" MODIFIED_BY="[Empty name]" ORDER="560" O_E="0.0" SE="0.0" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-22 10:04:03 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Combined monofilament and biological vs multifilament</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-03-28 13:21:42 +0000" MODIFIED_BY="[Empty name]" ORDER="566" O_E="0.0" SE="0.0" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.8746278749040917" CI_END="2.6950361347608656" CI_START="0.48731809008431043" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1460104109037872" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-005.08" LOG_CI_END="0.43056459253650237" LOG_CI_START="-0.31218746656254" LOG_EFFECT_SIZE="0.059188562986981184" METHOD="MH" MODIFIED="2015-06-22 10:04:44 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.6457686911269666" P_Q="1.0" P_Z="0.7547578713930564" Q="0.0" RANDOM="NO" SCALE="73.36" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="408" TOTAL_2="341" WEIGHT="100.0" Z="0.31237194250765343">
<NAME>Bladder or urethral perforation</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8746278749040917" CI_END="2.6950361347608656" CI_START="0.48731809008431043" DF="2" EFFECT_SIZE="1.1460104109037872" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="9" I2="0.0" ID="CMP-005.08.01" LOG_CI_END="0.43056459253650237" LOG_CI_START="-0.31218746656254" LOG_EFFECT_SIZE="0.059188562986981184" MODIFIED="2015-06-22 10:04:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6457686911269666" P_Z="0.7547578713930564" STUDIES="4" TAU2="0.0" TOTAL_1="312" TOTAL_2="245" WEIGHT="100.0" Z="0.31237194250765343">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="8.979752115858716" CI_START="0.43096149970844133" EFFECT_SIZE="1.9672131147540983" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="0.9532643482262587" LOG_CI_START="-0.3655615261525431" LOG_EFFECT_SIZE="0.2938514110368578" MODIFIED="2015-06-20 22:47:16 +0100" MODIFIED_BY="[Empty name]" ORDER="503" O_E="0.0" SE="0.7746848469034733" STUDY_ID="STD-Lim-2005" TOTAL_1="122" TOTAL_2="60" VAR="0.6001366120218579" WEIGHT="27.458130060856007"/>
<DICH_DATA CI_END="4.560137571348303" CI_START="0.19610330171728976" EFFECT_SIZE="0.9456521739130435" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6589779447644797" LOG_CI_START="-0.707515094218353" LOG_EFFECT_SIZE="-0.024268574726936755" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="504" O_E="0.0" SE="0.8026847753481513" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" VAR="0.6443028485757121" WEIGHT="31.579741487703064"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-26 09:39:10 +0000" MODIFIED_BY="[Empty name]" ORDER="452" O_E="0.0" SE="0.0" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.180472848141597" CI_START="0.17686049429055115" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5024916923343051" LOG_CI_START="-0.7523691655509052" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="502" O_E="0.0" SE="0.7371114795831993" STUDY_ID="STD-Rechberger-2003" TOTAL_1="50" TOTAL_2="50" VAR="0.5433333333333332" WEIGHT="40.96212845144093"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-22 10:04:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Monofilament vs combined monofilament and biological</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-03-28 13:15:52 +0000" MODIFIED_BY="[Empty name]" ORDER="559" O_E="0.0" SE="0.0" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-005.08.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-22 10:04:44 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Combined monofilament and biological vs multifilament</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-03-28 13:21:09 +0000" MODIFIED_BY="[Empty name]" ORDER="565" O_E="0.0" SE="0.0" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.250540717711244" CI_END="4.591442272700974" CI_START="0.9638447718118417" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="2.103672414996858" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" I2="38.47177520027404" I2_Q="0.0" ID="CMP-005.09" LOG_CI_END="0.6619491283883908" LOG_CI_START="-0.015992904036866852" LOG_EFFECT_SIZE="0.322978112175762" METHOD="MH" MODIFIED="2015-06-21 17:56:20 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.19685860492242546" P_Q="1.0" P_Z="0.06183299254908427" Q="0.0" RANDOM="NO" SCALE="226.16" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="264" TOTAL_2="197" WEIGHT="100.0" Z="1.867491429598065">
<NAME>Voiding dysfunction</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.250540717711244" CI_END="4.591442272700974" CI_START="0.9638447718118417" DF="2" EFFECT_SIZE="2.103672414996858" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="8" I2="38.47177520027404" ID="CMP-005.09.01" LOG_CI_END="0.6619491283883908" LOG_CI_START="-0.015992904036866852" LOG_EFFECT_SIZE="0.322978112175762" MODIFIED="2015-06-20 22:50:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.19685860492242546" P_Z="0.06183299254908427" STUDIES="3" TAU2="0.0" TOTAL_1="264" TOTAL_2="197" WEIGHT="100.0" Z="1.867491429598065">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="5.219894126370912" CI_START="0.1853451116618268" EFFECT_SIZE="0.9836065573770492" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="0.7176616944200415" LOG_CI_START="-0.7320188636742883" LOG_EFFECT_SIZE="-0.00717858462712341" MODIFIED="2015-06-20 22:50:01 +0100" MODIFIED_BY="[Empty name]" ORDER="476" O_E="0.0" SE="0.8515495358591054" STUDY_ID="STD-Lim-2005" TOTAL_1="122" TOTAL_2="60" VAR="0.7251366120218579" WEIGHT="30.49361167353208"/>
<DICH_DATA CI_END="4.258682884088868" CI_START="0.3281010153131641" EFFECT_SIZE="1.1820652173913044" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6292753022437859" LOG_CI_START="-0.4839924256815466" LOG_EFFECT_SIZE="0.0726414382811197" MODIFIED="2014-07-12 20:05:51 +0100" MODIFIED_BY="[Empty name]" ORDER="477" O_E="0.0" SE="0.65393897414747" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" VAR="0.4276361819090455" WEIGHT="46.76115338965301"/>
<DICH_DATA CI_END="23.55874453655621" CI_START="1.2840242803711779" EFFECT_SIZE="5.5" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="2" LOG_CI_END="1.3721521428479264" LOG_CI_START="0.10857323614056132" LOG_EFFECT_SIZE="0.7403626894942439" MODIFIED="2014-07-12 20:05:51 +0100" MODIFIED_BY="[Empty name]" ORDER="475" O_E="0.0" SE="0.7422325046163708" STUDY_ID="STD-Rechberger-2003" TOTAL_1="50" TOTAL_2="50" VAR="0.5509090909090909" WEIGHT="22.745234936814914"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.211053009873489" CI_END="1.655331861183818" CI_START="0.6802975001309242" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0611871310237517" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="32" I2="0.0" I2_Q="2.3397445904236247" ID="CMP-005.10" LOG_CI_END="0.21888507426447185" LOG_CI_START="-0.1673011249255709" LOG_EFFECT_SIZE="0.025791974669450463" METHOD="MH" MODIFIED="2015-06-22 10:07:04 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.51944705936145" P_Q="0.3591706636444729" P_Z="0.7934773644044497" Q="2.0479160039180933" RANDOM="NO" SCALE="164.13" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="402" TOTAL_2="335" WEIGHT="300.0" Z="0.2617977625731566">
<NAME>De novo urgency or urgency incontinence</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.1733733780592877" CI_END="1.818194910990672" CI_START="0.6815470117730631" DF="3" EFFECT_SIZE="1.1131870051373591" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="25" I2="0.0" ID="CMP-005.10.01" LOG_CI_END="0.25964043786854685" LOG_CI_START="-0.16650418201646988" LOG_EFFECT_SIZE="0.046568127926038455" MODIFIED="2015-06-22 10:06:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.5372120844128403" P_Z="0.6683883637588789" STUDIES="4" TAU2="0.0" TOTAL_1="306" TOTAL_2="239" WEIGHT="100.00000000000003" Z="0.42836093337100667">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="3.157401252988147" CI_START="0.5509816131305467" EFFECT_SIZE="1.3189655172413792" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="6" LOG_CI_END="0.49932977697781683" LOG_CI_START="-0.25886289379645633" LOG_EFFECT_SIZE="0.12023344159068029" MODIFIED="2015-06-20 22:51:39 +0100" MODIFIED_BY="[Empty name]" ORDER="467" O_E="0.0" SE="0.4453661279270578" STUDY_ID="STD-Lim-2005" TOTAL_1="116" TOTAL_2="54" VAR="0.19835098790474043" WEIGHT="29.810561376726113"/>
<DICH_DATA CI_END="1.8280618403555853" CI_START="0.31307756069434267" EFFECT_SIZE="0.7565217391304347" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.2619908831215115" LOG_CI_START="-0.5043480585914979" LOG_EFFECT_SIZE="-0.12117858773499318" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="466" O_E="0.0" SE="0.450151287801163" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" VAR="0.20263618190904548" WEIGHT="37.423519868682696"/>
<DICH_DATA CI_END="2.799084359645042" CI_START="0.22864619917391837" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.44701598756092625" LOG_CI_START="-0.6408360135770391" LOG_EFFECT_SIZE="-0.09691001300805639" MODIFIED="2014-03-28 13:12:49 +0000" MODIFIED_BY="[Empty name]" ORDER="453" O_E="0.0" SE="0.6390096504226939" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.4083333333333334" WEIGHT="18.203288196995114"/>
<DICH_DATA CI_END="6.218684266008886" CI_START="0.6432228794543986" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="4" LOG_CI_END="0.793698507446907" LOG_CI_START="-0.1916385161189447" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="468" O_E="0.0" SE="0.5787918451395112" STUDY_ID="STD-Rechberger-2003" TOTAL_1="50" TOTAL_2="50" VAR="0.33499999999999996" WEIGHT="14.56263055759609"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="10.409331626648866" CI_START="0.3842705894545261" DF="0" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-005.10.02" LOG_CI_END="1.0174228447673028" LOG_CI_START="-0.4153628534393405" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2015-06-22 10:06:53 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.4101773574083024" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0" Z="0.8235815733031668">
<NAME>Monofilament vs combined monofilament and biological</NAME>
<DICH_DATA CI_END="10.40933162664886" CI_START="0.38427058945452613" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0174228447673026" LOG_CI_START="-0.41536285343934043" LOG_EFFECT_SIZE="0.3010299956639812" MODIFIED="2014-03-28 13:17:14 +0000" MODIFIED_BY="[Empty name]" ORDER="561" O_E="0.0" SE="0.8416254115301731" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.7083333333333333" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.962030307151412" CI_START="0.08154817966716182" DF="0" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-005.10.03" LOG_CI_END="0.29270571156939484" LOG_CI_START="-1.08858572891347" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2015-06-22 10:07:04 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.25877017578365735" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0" Z="1.129302712151898">
<NAME>Combined monofilament and biological vs multifilament</NAME>
<DICH_DATA CI_END="1.9620303071514118" CI_START="0.08154817966716182" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.2927057115693948" LOG_CI_START="-1.08858572891347" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2014-03-28 13:22:16 +0000" MODIFIED_BY="[Empty name]" ORDER="567" O_E="0.0" SE="0.8113774296425389" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.6583333333333332" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-005.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2015-06-21 17:57:34 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="116" TOTAL_2="54" WEIGHT="0.0" Z="0.0">
<NAME>Detrusor overactivity</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-005.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2015-06-20 22:54:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="116" TOTAL_2="54" WEIGHT="0.0" Z="0.0">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="4.057948586382308" CI_START="0.12015656905669338" EFFECT_SIZE="0.6982758620689655" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.6083065402843385" LOG_CI_START="-0.9202524809808759" LOG_EFFECT_SIZE="-0.15597297034826874" MODIFIED="2015-06-20 22:54:44 +0100" MODIFIED_BY="[Empty name]" ORDER="479" O_E="0.0" SE="0.8978831355803729" STUDY_ID="STD-Lim-2005" TOTAL_1="116" TOTAL_2="54" VAR="0.8061941251596424" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.282332927327566" CI_END="3.2864350211857545" CI_START="0.25737515138888734" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9196992503571071" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="16" I2="51.70442875096223" I2_Q="0.0" ID="CMP-005.12" LOG_CI_END="0.5167250499072901" LOG_CI_START="-0.5894333849204336" LOG_EFFECT_SIZE="-0.03635416750657174" METHOD="MH" MODIFIED="2015-06-22 10:07:50 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.08176668407936538" P_Q="0.38671089945755865" P_Z="0.8974926483335898" Q="1.900156151110662" RANDOM="YES" SCALE="723.02" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="1.2261905355184337" TOTALS="SUB" TOTAL_1="352" TOTAL_2="285" WEIGHT="300.0" Z="0.1288293914459262">
<NAME>Vaginal tape erosion</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.464275307670381" CI_END="6.837447928807087" CI_START="0.09018583644182927" DF="2" EFFECT_SIZE="0.7852648983540014" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="12" I2="69.06072367266228" ID="CMP-005.12.01" LOG_CI_END="0.8348940319458223" LOG_CI_START="-1.0448616624375204" LOG_EFFECT_SIZE="-0.10498381524584913" MODIFIED="2015-06-22 10:07:22 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.03947309073382077" P_Z="0.826707030346951" STUDIES="3" TAU2="2.48814261963174" TOTAL_1="256" TOTAL_2="189" WEIGHT="100.0" Z="0.21892685039475054">
<NAME>Monofilament vs multifilament</NAME>
<DICH_DATA CI_END="35.44881832491882" CI_START="0.6113216526291624" EFFECT_SIZE="4.655172413793103" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="1" LOG_CI_END="1.5496017626919862" LOG_CI_START="-0.2137302214998863" LOG_EFFECT_SIZE="0.66793577059605" MODIFIED="2015-06-20 22:56:03 +0100" MODIFIED_BY="[Empty name]" ORDER="512" O_E="0.0" SE="1.0357899361484013" STUDY_ID="STD-Lim-2005" TOTAL_1="116" TOTAL_2="54" VAR="1.0728607918263091" WEIGHT="34.2377828028958"/>
<DICH_DATA CI_END="0.9500484167483515" CI_START="0.0032610380476146006" EFFECT_SIZE="0.055660974067046176" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.022254261457641474" LOG_CI_START="-2.4866441341064394" LOG_EFFECT_SIZE="-1.2544491977820404" MODIFIED="2008-03-25 12:55:19 +0000" MODIFIED_BY="[Empty name]" ORDER="511" O_E="0.0" SE="1.4475948101205152" STUDY_ID="STD-Meschia-2006" TOTAL_1="92" TOTAL_2="87" VAR="2.09553073428785" WEIGHT="26.59894192888216"/>
<DICH_DATA CI_END="4.709056553075023" CI_START="0.21235676164198924" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.672933906102297" LOG_CI_START="-0.672933906102297" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-03-28 13:13:07 +0000" MODIFIED_BY="[Empty name]" ORDER="454" O_E="0.0" SE="0.7905694150420948" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="0.6249999999999999" WEIGHT="39.16327526822204"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="27.830736341144103" CI_START="0.32338346674265595" DF="0" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-005.12.02" LOG_CI_END="1.444524696979576" LOG_CI_START="-0.49028218754025105" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2015-06-22 10:07:38 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.3337190744948523" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="99.99999999999999" Z="0.9666499359611069">
<NAME>Monofilament vs combined monofilament and biological</NAME>
<DICH_DATA CI_END="27.830736341144103" CI_START="0.32338346674265595" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.444524696979576" LOG_CI_START="-0.49028218754025105" LOG_EFFECT_SIZE="0.47712125471966244" MODIFIED="2014-03-28 13:17:53 +0000" MODIFIED_BY="[Empty name]" ORDER="562" O_E="0.0" SE="1.136515141415488" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="1.2916666666666667" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.0923040379049005" CI_START="0.035931496304739546" DF="0" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-005.12.03" LOG_CI_END="0.4902821875402511" LOG_CI_START="-1.444524696979576" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2015-06-22 10:07:50 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.3337190744948523" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="99.99999999999999" Z="0.9666499359611069">
<NAME>Combined monofilament and biological vs multifilament</NAME>
<DICH_DATA CI_END="3.0923040379049005" CI_START="0.035931496304739546" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4902821875402511" LOG_CI_START="-1.444524696979576" LOG_EFFECT_SIZE="-0.47712125471966244" MODIFIED="2014-03-28 13:23:08 +0000" MODIFIED_BY="[Empty name]" ORDER="568" O_E="0.0" SE="1.136515141415488" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" VAR="1.2916666666666667" WEIGHT="99.99999999999999"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.435044450492716" CI_START="-0.7649555495072842" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-005.13" MODIFIED="2015-06-22 10:08:02 +0100" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="1.0105498336116308E-12" Q="0.0" RANDOM="NO" SCALE="3.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="48" TOTAL_2="48" UNITS="" WEIGHT="100.0" Z="7.129062309432056">
<NAME>QoL specific (ICIQ)</NAME>
<GROUP_LABEL_1>Method A</GROUP_LABEL_1>
<GROUP_LABEL_2>Method B</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours method A</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours method B</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="-0.435044450492716" CI_START="-0.7649555495072842" DF="0" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" I2="0.0" ID="CMP-005.13.01" MODIFIED="2015-05-20 23:54:31 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.0105498336116308E-12" STUDIES="1" TAU2="0.0" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0" Z="7.129062309432056">
<NAME>Monofilament vs multifilament</NAME>
<CONT_DATA CI_END="-0.435044450492716" CI_START="-0.7649555495072842" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="2.1" MODIFIED="2015-05-20 23:54:31 +0100" MODIFIED_BY="[Empty name]" ORDER="615" SD_1="0.3" SD_2="0.5" SE="0.08416254115301731" STUDY_ID="STD-Okulu-2013" TOTAL_1="48" TOTAL_2="48" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-07-07 09:01:39 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2015-06-09 11:13:39 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA study flow diagram</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZIAAAONCAYAAACsneadAABeSklEQVR42u2dD4RVz///PyRJkmUl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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-07-07 09:01:39 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAADOCAMAAADYBvzeAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2017-07-07 09:01:39 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgments about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASoAAAq1CAIAAADDb3oUAAB/SUlEQVR42u3dvW4cy3r1cQIGDAcM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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2015-06-21 16:45:14 +0100" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.1 Subjective cure (short term, &#8804; 1 year)</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2015-06-21 16:45:14 +0100" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.16" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.16 Bladder or urethral perforation</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2015-06-21 16:45:14 +0100" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.17" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.17 Voiding dysfunction</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2015-06-21 16:45:14 +0100" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-001.22" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.22 Vaginal tape erosion</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Funnel plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2015-06-20 19:33:17 +0100" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-001.24" SETTINGS="SHOW_EFFECT_ESTIMATE:YES;SHOW_STUDY_NAMES:NO;SHOW_AUTOGENERATED_NUM_FOR_STUDY_NAMES:NO;DISTINGUISH_SUBGROUPS:YES;SHOW_CI_LINES:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FUNNEL_PLOT">
<CAPTION>
<P>Funnel plot of comparison: 1 Transobturator (TOR) versus retropubic (RPR) route, outcome: 1.24 Groin pain</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAlgAAAGQCAMAAABF6+6qAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2008-08-24 11:36:59 +0100" MODIFIED_BY="[Empty name]"/>
<APPENDICES MODIFIED="2017-07-24 17:29:11 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2015-05-28 17:27:48 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2014-10-09 11:01:19 +0100" MODIFIED_BY="[Empty name]">Searches performed for the 2014 version of this review</TITLE>
<APPENDIX_BODY MODIFIED="2015-05-28 17:27:48 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Cochrane Incontinence Group Specialised Register </HEADING>
<P>The terms used to search the Incontinence Group Specialised Register 26 June 2014 are given below:</P>
<P>(TOPIC.URINE.INCON*)<BR/>AND<BR/>({DESIGN.CCT*} OR {DESIGN.RCT*})<BR/>AND<BR/>{INTVENT.SURG.SLIN*} OR {INTVENT.SURG.SUBURETHRAL SLING.} OR {INTVENT.SURG.ABDO.SLING.}<BR/>(All searches were of the keyword field of <LINK REF="REF-Reference-Manager-2012" TYPE="REFERENCE">Reference Manager 2012</LINK>.)</P>
<P>
<B>Embase and Embase Classic </B>(on OVID SP) was searched from 1947 to Week 25 20014 on 26 June 2014 and was limited to those years not fully covered by the Embase search for CENTRAL carried out by the Cochrane Collaboration. Limited to: (2010* to 2014*).em. The following search strategy was used:</P>
<P>1. Randomized Controlled Trial/</P>
<P>2. crossover procedure/ or double blind procedure/ or parallel design/ or single blind procedure/</P>
<P>3. Placebo/</P>
<P>4. placebo$.tw,ot.</P>
<P>5. random$.tw,ot.</P>
<P>6. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw,ot.</P>
<P>7. crossover.tw,ot.</P>
<P>8. cross over$.tw,ot.</P>
<P>9. allocat$.tw,ot.</P>
<P>10. trial.ti.</P>
<P>11. parallel design/</P>
<P>12. triple blind procedure/</P>
<P>13. or/1-12</P>
<P>14. exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/</P>
<P>15. exp human/ or exp "human tissue, cells or cell components"/</P>
<P>16. 14 and 15</P>
<P>17. 14 not 16</P>
<P>18. 13 not 17</P>
<P>19. incontinence/ or mixed incontinence/ or stress incontinence/ or urge incontinence/ or urine incontinence/</P>
<P>20. continence/</P>
<P>21. overactive bladder/</P>
<P>22. micturition disorder/ or lower urinary tract symptom/ or pollakisuria/</P>
<P>23. urinary dysfunction/ or bladder instability/ or detrusor dyssynergia/ or neurogenic bladder/ or urinary urgency/ or urine extravasation/</P>
<P>24. (incontinen$ or continen$).tw.</P>
<P>25. ((bladder or detrusor or vesic$) adj5 (instab$ or stab$ or unstab* or irritab$ or hyperreflexi$ or dys?ynerg$ or dyskinesi$ or irritat$)).tw.</P>
<P>26. (urin$ adj2 leak$).tw.</P>
<P>27. ((bladder or detrusor or vesic$) adj2 (hyper$ or overactiv$)).tw.</P>
<P>28. (bladder$ adj2 (neuropath$ or neurogen* or neurolog$)).tw.</P>
<P>29. (nervous adj pollakisur$).tw.</P>
<P>30. or/19-29</P>
<P>31. (tape* or sling*).tw.</P>
<P>32. 18 and 30 and 31</P>
<P>33. (2010* or 2011* or 2012* or 2013* or 2014*).em.</P>
<P>34. 32 and 33</P>
<P>
<B>WHO ICTRP</B> (on http://www.who.int/ictrp/en/) was searched on 30 June 2014 using the following search string: Continent OR continence OR incontinent OR incontinence AND tape* OR sling* AND random*</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2014-06-30 16:45:54 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2014-06-30 16:41:25 +0100" MODIFIED_BY="[Empty name]">Search terms for the first version of this review published in 2009</TITLE>
<APPENDIX_BODY MODIFIED="2009-09-29 12:23:20 +0100" MODIFIED_BY="[Empty name]">
<P>The terms that we used to search the Incontinence Group Specialised Register are given below:<BR/>(TOPIC.URINE.INCON*)<BR/>AND<BR/>({DESIGN.CCT*} OR {DESIGN.RCT*})<BR/>AND<BR/>{INTVENT.SURG.SLIN*} OR {INTVENT.SURG.SUBURETHRAL SLING.} OR {INTVENT.SURG.ABDO.SLING.}<BR/>(All searches were of the keyword field of Reference Manager 9.5 N, ISI ResearchSoft). Date of last search: 20 March 2008.</P>
<P>The review authors also searched MEDLINE (January 1950 to April 2008), EMBASE (January 1988 to April 2008), CINAHL (January 1982 to April 2008), and AMED (January 1985 to April 2008) on 28 April 2008.</P>
<P>The following terms were used to search these electronic databases:</P>
<P>(Urinary incontinence OR urodynamic stress incontinence OR urgency urinary incontinence OR urge incontinence urinary)</P>
<P>AND</P>
<P>(suburethral slings OR tension free vaginal tape OR tvt OR transvaginal tape OR transobturator tape OR tot OR tvt-o OR ivs OR uretrex OR safyre OR I-stop OR sparc OR lynx OR monarc OR obtryx OR obtape OR aris)</P>
<P>The review authors also searched the UK National Research Register and ClinicalTrials.gov on 28 April 2008 using the term: urinary incontinence.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2017-07-24 17:29:11 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2017-07-24 17:28:46 +0100" MODIFIED_BY="[Empty name]">Search strategies for brief economic commentary</TITLE>
<APPENDIX_BODY MODIFIED="2017-07-24 17:29:11 +0100" MODIFIED_BY="[Empty name]">
<P>We performed additional searches for the Brief Economic Commentary (BECs). These were conducted in MEDLINE(1 January 1946 to March 2017), Embase (1 January 1980 to 2017 Week 12) and NHS EED (1st Quarter 2016). All searches were conducted on 6 April 2017. We used two different search strategies on MEDLINE and EMBASE (OvidSP) and one on NHS EED (OVID). Details of the searches run and the search terms used can be found below. There were no year, publication type or language restrictions applied.</P>
<SUBSECTION>
<HEADING LEVEL="3">NHS EED (Ovid) (1st Quarter 2016)</HEADING>
<P>NHS EED was searched using the following search strategy:</P>
<P>1. Urinary incontinence/ </P>
<P>2. Urinary incontinence, stress/ </P>
<P>3. ((stress$ or mix$ or urg$ or urin$) adj3 incontinen$).tw.</P>
<P>4. Colporrhaphy.tw. </P>
<P>5. Colpoperineoplast$.tw. </P>
<P>6. Sling procedure$.tw. </P>
<P>7. Sling$ procedure$.tw. </P>
<P>8. Bladder neck needle suspension$.tw. </P>
<P>9. Anterior vaginal repair$ .tw. </P>
<P>10. Or/1-9</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE (1 January 1946 to March 2017) and Embase (1 January 1980 to 2017 Week 12) </HEADING>
<P>We used two different search strategies on MEDLINE and Embase (OvidSP) - these are given below.</P>
<SUBSECTION>
<HEADING LEVEL="4">Search strategy 1:</HEADING>
<P>1. Economics, Pharmaceutical/ or Economics, Medical/ or Economics/ or Economics, Hospital/ or economics.mp. or Economics, Nursing/ </P>
<P>2. exp "costs and cost analysis"/ </P>
<P>3. "Value of Life"/ </P>
<P>4. exp "fees and charges"/ </P>
<P>5. exp budgets/ </P>
<P>6. budget*.ti,ab. </P>
<P>7. cost*.ti. </P>
<P>8. (economic* or pharmaco?economic*).ti. </P>
<P>9. (price* or pricing*).ti,ab. </P>
<P>10. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab. </P>
<P>11. (financ* or fee or fees).ti,ab. </P>
<P>12. (value adj2 (money or monetary)).ti,ab. </P>
<P>13. ((energy or oxygen) adj cost).ti,ab. </P>
<P>14. (metabolic adj cost).ti,ab. </P>
<P>15. ((energy or oxygen) adj expenditure).ti,ab. </P>
<P>16. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 </P>
<P>17. exp Urinary Incontinence/ </P>
<P>18. ((stress* or mix* or urg* or urin*) adj3 incontinen*).tw. </P>
<P>19. Urodynamics/ or Urinary Incontinence, Stress/ or Urinary Incontinence/ or Suburethral Slings/ or mixed incontinence.mp. or Urinary Bladder/ or Urinary Incontinence, Urge/ </P>
<P>20. 17 or 18 or 19 </P>
<P>21. anterior vaginal repair*.tw. </P>
<P>22. 16 and 20 and 21 </P>
<P>23. anterior colporrhaphy*.tw. </P>
<P>24. 21 or 23 </P>
<P>25. 16 and 20 and 23 </P>
<P>26. bladder neck needle suspension$.tw. </P>
<P>27. 16 and 20 </P>
<P>28. 26 and 27 </P>
<P>29. open abdominal retropubic colposuspension*.tw. </P>
<P>30. retropubic colposuspension*.tw. </P>
<P>31. burch colposuspension*.tw. </P>
<P>32. 29 or 30 or 31 </P>
<P>33. 27 and 32 </P>
<P>34. laparoscopic retropubic colposuspension*.tw. </P>
<P>35. laparoscopic colposuspension*.tw. </P>
<P>36. 34 or 35 </P>
<P>37. 27 and 36 </P>
<P>38. traditional suburethral retropubic sling procedure$*.tw. </P>
<P>39. traditional sling procedure$*.tw. </P>
<P>40. suburethral retropubic sling procedure$*.tw. </P>
<P>41. retropubic sling procedure$*.tw. </P>
<P>42. traditional suburethral sling*.tw. </P>
<P>43. Suburethral Slings/ or Urinary Incontinence, Stress/ or Urologic Surgical Procedures/ </P>
<P>44. 27 and 43 </P>
<P>45. remove duplicates from 44</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Search strategy 2: </HEADING>
<P>1. economics.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs] </P>
<P>2. value of life.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs] </P>
<P>3. exp "costs and cost analysis"/ </P>
<P>4. exp economics, hospital/ </P>
<P>5. exp economics, medical/ </P>
<P>6. economics, nursing.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs] </P>
<P>7. economics, pharmaceutical.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs] </P>
<P>8. exp "fees and charges"/ </P>
<P>9. exp budgets/ </P>
<P>10. budget*.ti,ab. </P>
<P>11. cost*.ti. </P>
<P>12. (economic* or pharmaco?economic*).ti. </P>
<P>13. (price* or pricing*).ti,ab. </P>
<P>14. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab. </P>
<P>15. (financ* or fee or fees).ti,ab. </P>
<P>16. (value adj2 (money or monetary)).ti,ab. </P>
<P>17. or/1-16 </P>
<P>18. economics.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs] </P>
<P>19. value of life.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs] </P>
<P>20. exp "costs and cost analysis"/ </P>
<P>21. exp economics, hospital/ </P>
<P>22. exp economics, medical/ </P>
<P>23. economics, nursing.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs] </P>
<P>24. economics, pharmaceutical.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, sy, tn, dm, mf, dv, kw, fs </P>
<P>25. exp "fees and charges"/ </P>
<P>26. exp budgets/ </P>
<P>27. budget*.ti,ab. </P>
<P>28. cost*.ti. </P>
<P>29. (economic* or pharmaco?economic*).ti. </P>
<P>30. (price* or pricing*).ti,ab. </P>
<P>31. (cost* adj2 (effective* or utilit* or benefit* or minimi* or unit* or estimat* or variable*)).ab. </P>
<P>32. (financ* or fee or fees).ti,ab. </P>
<P>33. (value adj2 (money or monetary)).ti,ab. </P>
<P>34. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 </P>
<P>35. ((energy or oxygen) adj cost).ti,ab. </P>
<P>36. (metabolic adj cost).ti,ab. </P>
<P>37. ((energy or oxygen) adj expenditure).ti,ab. </P>
<P>38. 34 or 35 or 36 or 37 </P>
<P>39. urinary incontinence.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>40. ((stress$ or mix$ or urg$ or urin$) adj3 incontinen$).tw. </P>
<P>41. URINARY INCONTINENCE, STRESS.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>42. stress urinary incontinence*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>43. 39 or 40 or 41 or 42 </P>
<P>44. intervention surgery*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>45. colporrhaphy.tw. </P>
<P>46. Bologna procedure*.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>47. Kelly-Kennedy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>48. Marion Kelly.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>49. Diaphragmplasty.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>50. Vaginal urethrocystopexy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>51. Cystocele repair.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>52. Kelly plication.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>53. anterior vaginal repair$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>54. anterior colporrhaphy.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>55. 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 </P>
<P>56. 38 and 43 and 55 </P>
<P>57. remove duplicates from 56 </P>
<P>58. Bladder neck needle suspension$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>59. 38 and 43 and 58 </P>
<P>60. burch colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>61. open abdominal retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>62. Paravaginal defect repair.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>63. Marshall-Marchetti-Krantz.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>64. abdominal burch.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>65. abdominal colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>66. endopelvic Fascia Plication.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>67. 60 or 61 or 62 or 63 or 64 or 65 or 66 </P>
<P>68. 38 and 43 </P>
<P>69. 67 and 68 </P>
<P>70. laparoscopic retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>71. laparoscopic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>72. retropubic colposuspension.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>73. 70 or 71 or 72 </P>
<P>74. 68 and 73 </P>
<P>75. remove duplicates from 74 </P>
<P>76. suburethral sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>77. abdominal sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>78. traditional sling procedure$*.tw. </P>
<P>79. suburethral sling procedure.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>80. 76 or 77 or 78 or 79 </P>
<P>81. 68 and 80 </P>
<P>82. remove duplicates from 81 </P>
<P>83. mid$urethral sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>84. retropubic sling procedure$*.tw. </P>
<P>85. transobturator sling procedure$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>86. 83 or 84 or 85 </P>
<P>87. remove duplicates from 86 </P>
<P>88. 68 and 87 </P>
<P>89. TVT-Secur.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>90. mini-arc.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>91. ajust.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>92. needleless.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>93. solyx.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>94. single$incision sling$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>95. miniarc.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>96. mini$sling.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>97. Ophira.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>98. Tissue Fixation System.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>99. 89 or 90 or 91 or 92 or 93 or 94 or 95 or 96 or 97 or 98 </P>
<P>100. 68 and 99 </P>
<P>101. remove duplicates from 100 </P>
<P>102. ((urethra$ or periurethra$ or transurethra$) adj3 (agent$ or bulk$ or injection$ or injectable$)).tw. </P>
<P>103. injection therapy.tw. </P>
<P>104. injectable$.tw. </P>
<P>105. (injectable$ adj2 agent$).tw. </P>
<P>106. (bulk$ adj3 agent$).tw. </P>
<P>107. Peri$urethral injection$.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>108. Autologous fat.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>109. Macroplastique.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>110. Calcium hydroxylapatite.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>111. Hyaluronic acid with dextranomer.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>112. Porcine dermal implant.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>113. Ethylene vinyl alcohol copolymer.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>114. Silicon particles.mp. [mp=ti, ab, ot, nm, hw, kf, px, rx, ui, an, eu, pm, sy, tn, dm, mf, dv, kw, fs] </P>
<P>115. 102 or 103 or 104 or 105 or 106 or 107 or 108 or 109 or 110 or 111 or 112 or 113 or 114 </P>
<P>116. 68 and 115 </P>
<P>117. remove duplicates from 116</P>
</SUBSECTION>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2008-08-18 08:13:59 +0100" MODIFIED_BY="[Empty name]">
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;196 reports of 68 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;217 reports of 81 studies included in qualitative synthesis, additionally 2 reports of 2 studies are currently 'Ongoing Studies'&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;290 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="110">
<FLOWCHARTBOX TEXT="&lt;p&gt;841 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;841 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;841 records retrieved from electronic database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;0 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;551 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;71 reports of 62 studies excluded, with reasons given in the Characteristics of Excluded Studies table&lt;/p&gt;" WIDTH="100"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>